logout  |  time: 2016-04-19 07:50:32 120721

login  |  time: 2016-04-19 07:50:47 224846

login  |  time: 2016-04-19 10:01:00 279209

doc/irrelevant  |  time: 2016-04-19 10:01:23 653922  |  # of fields: 2  |  topic_id: 383  |  docno: ebola-4e91e3c8d334874737e074ddecd416d903f75b54c9460c512a31b3e0db2205b4

list/go back  |  time: 2016-04-19 10:01:23 955747  |  # of fields: 3  |  topic_id: 383  |  docno: ebola-4e91e3c8d334874737e074ddecd416d903f75b54c9460c512a31b3e0db2205b4  |  listsource: pink_findmore

tagged/show  |  time: 2016-04-19 10:02:35 090845  |  # of fields: 2  |  topic_id: 383  |  topic_name: Economic impact of ebola

list/click  |  time: 2016-04-19 10:03:03 510619  |  # of fields: 4  |  topic_id: 383  |  docno: ebola-c2aa04c024e235c741b5327b7492902b5b0492a6517e71a3f48bf8615c5c3d77  |  listsource: pink_findmore

doc/irrelevant  |  time: 2016-04-19 10:03:19 198748  |  # of fields: 2  |  topic_id: 383  |  docno: ebola-c2aa04c024e235c741b5327b7492902b5b0492a6517e71a3f48bf8615c5c3d77

list/go back  |  time: 2016-04-19 10:03:32 927293  |  # of fields: 3  |  topic_id: 383  |  docno: ebola-83662dd0b499765130908b1459c619ee7351abd85cb673a2c724ec3353771072  |  listsource: pink_findmore

list/click  |  time: 2016-04-19 10:03:43 620115  |  # of fields: 4  |  topic_id: 383  |  docno: ebola-e98302c286b197faec4b90e1dede30778e00e5527497e0b719aa21c578ef06c8  |  listsource: pink_findmore

doc/irrelevant  |  time: 2016-04-19 10:03:53 396237  |  # of fields: 2  |  topic_id: 383  |  docno: ebola-e98302c286b197faec4b90e1dede30778e00e5527497e0b719aa21c578ef06c8

doc/duplicate  |  time: 2016-04-19 10:03:59 729150  |  # of fields: 2  |  topic_id: 383  |  docno: ebola-52efdc0c6128f1709cc006720281c408254584f90d022ea00c09f4eff67e9a12

doc/irrelevant  |  time: 2016-04-19 10:04:16 160462  |  # of fields: 2  |  topic_id: 383  |  docno: ebola-3dfb513c852dcccc7fc9c4905215ba48a750da7adb727aabcb0fc0e40ceaf45b

doc/irrelevant  |  time: 2016-04-19 10:04:26 718595  |  # of fields: 2  |  topic_id: 383  |  docno: ebola-77e873ff7f23c504658115ed80003edface257c1658e3bd784e2090fef6f0ea7

findmore/blue  |  time: 2016-04-19 10:05:03 385296  |  # of fields: 3  |  topic_id: 383  |  subtopic_id: 131  |  subtopic_name: Countries affected most by ebola

result_size: 6  |  num_tagged:  1
ebola-86f1401123ab0c15d008136b053ebe09288a4aa67627db32c2e1380139c7c1dd
ebola-5e61803a3099b7d070a76ea184c613c0f7fe51bad8829a7bfe54e3c5b03013ab
ebola-362a3dc2572208fef1a43e038ea30fd653e632f50fec47a909aa11c77ce61db8
ebola-c5f97036654894a2e87b0195964880dc6697b5baddfdf1ec9218e7d018b9c713
ebola-0ad5348a5fc98c39a27d544330f4106715268c44e5c5d37f7cf70ea17cfb3e92
ebola-8ab8c878543bc695d05ec1cc557a467395b248368af656bf88884ab1b398f9c0

list/click  |  time: 2016-04-19 10:05:32 566865  |  # of fields: 4  |  topic_id: 383  |  docno: ebola-5e61803a3099b7d070a76ea184c613c0f7fe51bad8829a7bfe54e3c5b03013ab  |  listsource: blue_findmore

passage/create  |  time: 2016-04-19 10:05:57 161989  |  # of fields: 6  |  topic_id: 383  |  topic_name: Economic impact of ebola  |  subtopic_id: 131  |  subtopic_name: Countries affected most by ebola  |  passage_id: 2538  |  passage_name:  The Ebola outbreak could be 'catastrophic' to the West African economy, the World Bank warns If health officials are slow to contain Ebola, West Africa faces $32.6-billion economic hit, World Bank says The Ebola outbreak could be "catastrophic" to the West African economy, with an impact of $32.6 billion by the end of next year if health officials are slow to contain the spread of the deadly virus, the World Bank said in a report Wednesday.  

doc/next  |  time: 2016-04-19 10:06:03 572621  |  # of fields: 2  |  topic_id: 383  |  docno: ebola-5e61803a3099b7d070a76ea184c613c0f7fe51bad8829a7bfe54e3c5b03013ab

doc/irrelevant  |  time: 2016-04-19 10:06:10 592096  |  # of fields: 2  |  topic_id: 383  |  docno: ebola-362a3dc2572208fef1a43e038ea30fd653e632f50fec47a909aa11c77ce61db8

doc/irrelevant  |  time: 2016-04-19 10:06:14 752020  |  # of fields: 2  |  topic_id: 383  |  docno: ebola-c5f97036654894a2e87b0195964880dc6697b5baddfdf1ec9218e7d018b9c713

doc/duplicate  |  time: 2016-04-19 10:06:26 247958  |  # of fields: 2  |  topic_id: 383  |  docno: ebola-0ad5348a5fc98c39a27d544330f4106715268c44e5c5d37f7cf70ea17cfb3e92

doc/irrelevant  |  time: 2016-04-19 10:06:56 720524  |  # of fields: 2  |  topic_id: 383  |  docno: ebola-8ab8c878543bc695d05ec1cc557a467395b248368af656bf88884ab1b398f9c0

list/go back  |  time: 2016-04-19 10:06:56 938942  |  # of fields: 3  |  topic_id: 383  |  docno: ebola-8ab8c878543bc695d05ec1cc557a467395b248368af656bf88884ab1b398f9c0  |  listsource: blue_findmore

list/click  |  time: 2016-04-19 10:13:52 615819  |  # of fields: 4  |  topic_id: 383  |  docno: ebola-86f1401123ab0c15d008136b053ebe09288a4aa67627db32c2e1380139c7c1dd  |  listsource: blue_findmore

tagged/view  |  time: 2016-04-19 10:19:43 873417  |  # of  fields: 1  |  topic_id: 383

irrelevant/view  |  time: 2016-04-19 10:19:58 311763  |  # of  fields: 1  |  topic_id: 383

duplicate/view  |  time: 2016-04-19 10:20:09 612173  |  # of  fields: 1  |  topic_id: 383

topic/select  |  time: 2016-04-19 10:40:49 599966  |  # of fields: 2  |  topic_id: 351  |  topic_name: is there a natural immunity to ebola

tagged/view  |  time: 2016-04-19 10:40:54 499232  |  # of  fields: 1  |  topic_id: 351

irrelevant/view  |  time: 2016-04-19 10:41:02 058171  |  # of  fields: 1  |  topic_id: 351

duplicate/view  |  time: 2016-04-19 10:41:08 464367  |  # of  fields: 1  |  topic_id: 351

topic/select  |  time: 2016-04-19 10:41:16 106536  |  # of fields: 2  |  topic_id: 367  |  topic_name: Emory University's role in Ebola treatment

tagged/view  |  time: 2016-04-19 10:41:21 103648  |  # of  fields: 1  |  topic_id: 367

irrelevant/view  |  time: 2016-04-19 10:41:29 034040  |  # of  fields: 1  |  topic_id: 367

duplicate/view  |  time: 2016-04-19 10:41:33 713664  |  # of  fields: 1  |  topic_id: 367

findmore/pink  |  time: 2016-04-19 10:42:33 773373  |  # of fields: 3  |  topic_id: 367  |  subtopic_id: 96  |  subtopic_name: Prevention progress at E. U.

result_size: 222  |  num_tagged:  14
ebola-40e9e45e1584ca132636d1dae6cbea1d6196c5ce7d79b83467deb81822abf575
ebola-9ef5e6489d32f26d5d2f52332d7a3da7ee280584f572b5cb68ba20088ae5b1af
ebola-9be2075352288ddbd081082fafc66e90456287224daa036a1b70f1747532e84e
ebola-8cfcdbb3503541488f82378b43ab05f2128a3684338a2276e13cf21749367128
ebola-72c41ba87082dd2c45e8b0907aabf636dca59363adcbb9003abefe31f6916ae3
ebola-b7058ddd12dcc759eed3909de9e9c1420edb9b1278f630c8872541e4903caef5
ebola-7a5bbb42a7447f51497a5034b050a641a91a0d2254d3ee0a49a8bdffc1d5cc1b
ebola-f43115b91d5713546a16f17c8e9802fe52ff6279c34415e7bc1f6556e5ca5dde
ebola-efbf6896b1f7bedbb6f2523e85386ad5de83baa6486d0198a323731b1e2da19d
ebola-868ae895450235411f4c2455b4e2a6ddbdd3da3b7355ebc9be6d88dbc227bdd0
ebola-30a74ef43a7ea0ef6a31d86486799d4064af6669c436b0529981fb9218db7b0d
ebola-a95bb3dd24ded2cee86a8a9bf40d6cce386d6aa64ae3675f68025a428257b21f
ebola-6af020be19bbc532cf4f0c666c3fd9dfd3e01bb9d23626ca3f0bcd5c2fb661b5
ebola-02caed42b30f5c844261b30196d8714fbdfdedbbd15819bcb8596a6b0dcb7277
ebola-ca1a050a8a659a9a402d8579a6112271ec0f7f54670f1f7d81797dd25cd6722c
ebola-2f2112e48adea8eb09c0ac8711dc8213cf2d827b98b4699f3104ca985fb3c682
ebola-9cd728c7b1ca7a344bf86e53be716d208d14ec2d3e9f576a78e0c7ec8aa21c3b
ebola-abe19193c3351063039402a73fc648758f22c27a56ebcbd8f4aeb0208cf2714b
ebola-2d0d424fcc19bc8dbdf72e183c68c5767891c6a15897be01b48b2107da02d684
ebola-61b7e97919ad31461162dcd8a830b990d96836b7419172cf4815f720035e0492
ebola-30bec5c5bbb6fd9d81e7d5896485c2ad791ff7a0de5ee258696a43f9a8487757
ebola-a9892e033ccb7545c4cc525e2b6f29a217ac0940ed26e357177d8b0406b90037
ebola-5f0a26fe833b2429b8051d10fbe1048758df4fab91f294629f7cf4f2dcf0fd46
ebola-6c9558951a236836bc342fdb78b0a4538707e9f1d2d99a02aa5bf4aae788349d
ebola-591b6df5785b9bb9804ab9a3a6113c55809eca9b0ac27eac850139e23b54f83c
ebola-c51d07035ebe7abf1fd05858c0a46d367524cc2238e915370cf3eefefaea5837
ebola-eda0589a271bc4a0eccef5e98a5ef287b3863def94b8e78b05569a6255d9cee4
ebola-199f1e2ea9a000469f45555be770b657ab99e496ba70294686444d37ebf782f8
ebola-2343408566070569320e74d86418adc131a85f6ff56cb6085613571e072b547a
ebola-c9a650f810a7ba3b2f8f9f59e9c5b2219b2d09cee1f22e05d5c7635525e6605e
ebola-aeb4a3eb9b2ee9b035067a31785ac2fd37fed0dbf654ae54c7faf5fbcd83f6be
ebola-ce585a480add131a1e269ba4ac5f58c4311f4503af12ecf58a219eff3d30ab61
ebola-a0b7dff4b5b885c665f077f125b74da6e571fe000b9a7a1bc77a0514a4be2790
ebola-86d7fc2f4915ccbcf73c9592c22462f964942aab47f1507fe4869e16f35e564b
ebola-6f7c47a59850feba877096557b85f5c9fa142b8a1f9f1628822a95fe2ff50943
ebola-d58e28b64d3e51487865305756a4254c7143c0225d0a5d22600acdeaffb7a955
ebola-846c79d748e855b69e3de214cbd9e3b39226d8e50762d3932ef00afaebb932e5
ebola-555bca17f4470ca14d666b73572bd11157e6c728ebbfa4ba03fae4d74011d856
ebola-c7a46ab61d8b142163d1f6a3b047ed7d8e2b382f60c8bc20959e5f030c76aef9
ebola-89633efe12c43c2575da89c48fa7fa4c6201c5ca72be44c41e62650d5a5cae4d
ebola-334a2ca02b16a429f3bd2abba7b6b6ac083541c0112403c06cc8d2816f7cf8b1
ebola-c241eeb749a79430a21a13fc489634cdb4559e28aa1a8fa32b43c26ff0646ab9
ebola-5258e1a197528a0ee2f5831e23501ed6404367643e7590158fe71a123832889d
ebola-f29faf625e5f73b1d609cdbd57cd91b30ca7c8ee198abb14ed455e6e2f2ef79a
ebola-a923c54c96c64dc3b4fe9bd8408a8ff9bc6b2c8050a957fb297b39fd712bb91c
ebola-9752c672a1c394e9d41a58d685bcc4f759e8049995b9382b9bc11315c6a200ff
ebola-48363a3b6f8948bb4b93fc0e73820779ce0a099ec282da2544ca7aa933e61a42
ebola-af876bb3eab4975908a3e81cfed8b35efc6acb2a0565189f7aaf0bcb68f369fc
ebola-2f5ba4841184f9e822089cd156aeeadd42b974c88298d0be7846814fd63663cc
ebola-9378c7162d9e4aa4ed12e1c7afaabf09bfa45d3fdc857c6a7a5ccd8bf64f5984
ebola-da9b4808c041cba9651f57cb6d919edfcc8bfc06f7fcff78dbb31fb4ab593ce7
ebola-2ac2d41346838bbd0c9d261634efd49acda9e283be01e7df89150f744e387d7a
ebola-a008277dea75819d4c57cb532a34a4268a0fb995d3cf9638dcb17c34a4a3ae5f
ebola-e1ca1f2e5fcf07bd3d35f12b7538bdbccfde7e760b02f51fa99e01e8df842bc8
ebola-b2c91586694811b5cf281254642389fae4d478dafe5732c1dc35fc0034f8a44d
ebola-3d436eed659f6dc12258e25a7277d48b4a3cfd5160345af251c6e54a0b7f317e
ebola-ade38eac15343591cf8cb2f5a1ad3b516636a3023e8316993df8da6328307b64
ebola-74b49f27a5ccbfee7a3324051b61b4b77189c797146166481aafc23af8dd925e
ebola-c70a3c1183db10a288c0e92ad68e8b3ecec328272eac7289ff4cea5105ffe118
ebola-d479fe93d427f6ca567113ccfdd8ae1736fb33b6feb147b952f967d868cea0aa
ebola-af11b22f284d7a9749d9510d7520488d1e108b85d050fb581a630b2965194f34
ebola-76a43bbacfd56db0ab18df2c288e9ec7be742985f333a5a24ccbfc6da677e8a3
ebola-5b37b767c3066e64f2a68e840ecf6f474035ebd9418c749b26541eed593ab82a
ebola-ee3b807907307698d5ce97571fe1f1f190d2380f9bf102282a4099fa6785cbd4
ebola-d1a5826615d5196a6c46897d6b812a967dafa5ac1b4cf1320c04b7493c640335
ebola-c4f96af16a6fc93335556e3ef00f703591e69acd766b150a57f36953e943f38f
ebola-b1276bda0578a948b6aff5c3a9c2cd5b6862573233eae4f016aea51ac541e191
ebola-617126bbae08648b7334a8fe5f16a496c70034c3ccd23ab096eb2e74c7084992
ebola-1a1fc818a76f0e1c250ee9faa069fa0962ecfac5ea7e90393f1c72b7d92b68d4
ebola-7b0c41ff78dd0eff9f589951b253ad630c5ff3cb59176b776ebe8e68746cf1a1
ebola-0ce5aaaa68db46fa8068cf48eb690f65b5ff786f36ccee70e4cfdbd495e50e5a
ebola-de792643719fb1b766ae4f878ddfcc87100253c794c97b4faf7784c45ed233a5
ebola-b8ac57472e8c20f0e38ea75539681a8e94bb261f59f219804effdf5552ced778
ebola-ecb7e4f4302b122cb9f52314940a67aaf04a498b1572b3e124b78bf5f17c9399
ebola-44ce9d4d60b93bbb6da982f9713630475a4ac1ea2252bbac9d4e5b10a133e973
ebola-516417af141999f393dadc4fb7caecbfb5f6a99d23ad9634ccb7c9887bd7530a
ebola-0a7d9fb049843fc5492a78424cb261e9b99d3397546fa7e35b162833ed18812c
ebola-e6db773814d1596ffa036991badfbde40902a9ad6cc9d3624320150007790e58
ebola-5ac7e14e5ef01e8889fbadbf1139c909e7ed804b7accdbeb2a6295ae384eea79
ebola-debfe41f5567bf6d95c27ec4e7d0134bb6f0cb46c9c459f45578614d723f7516
ebola-61fe7aa171df23cf050c43f458554d6dc4b6b0499daa3eeea8bf8dfce8644b3a
ebola-cfd79585f5ea713d3dcc0153e1e56b21a12aa2defee1ec8adb677335a5b460f7
ebola-e6f1116e939b49f1e484d2e863c4967652a7fb52dafa6319371b5c46b04fa9ee
ebola-d3df0c53747c0900a3a0e3e32a89f3c5e63a62254515a712b942a3243025ae19
ebola-ffddfc8b43f58aec650a797fcf502babb28bf841f3c3ec68c2c969e829293f2e
ebola-9e0db20598d5bc3e5b8a655d0487d6ddfe35694aa62892b725956e99efe08dc4
ebola-083305432fd70b421aa2a8238e7f2aecfb043308458bd7022d99bf42aaa1ecb3
ebola-12cebb56713e34447ac6b1ac4e75f3300387c9293ade8b506fee641f9c4018c9
ebola-63de723d3770394ad63463e85aa65903926bb4fc314ef80412c6e52baa7f5b74
ebola-74a40daa3ebf4899bd51a133210f4b27fe49cf5fda070b0df6069688841df201
ebola-81dbef3386fef4b55d5cc9e2b17c71990b78df03efdc4aecac87af8c94bd79f2
ebola-542c3c41c86afa279aa0f4c4d1d386754acec578890585a99001ab2a96bab930
ebola-4f1e8c45508c89487ec6c819ae4e073ce037a3ef38f2dfde037c1f85d4abcdcf
ebola-93dd205b84d4de3a339e41d0522db15c72f0ad79a0e36b41b3194cef98dd1220
ebola-1c4a9e98259635a82a6cfe419a45f34f7529dbaafc25b1c239e4298086a5770b
ebola-906286b772294f99970832eba937b3c872aea6013bc1653e8e20dc9bdf4bbbf5
ebola-20c93466e7785a4373d216487f46b5abd66d58ceb1ba260f3b8ac333caabb5b7
ebola-dcdc7cb18848ab0b2a56037afeb87cb902274823b9e8d6f913962d5dbb20a917
ebola-03bbd165223185f2e87741636cef86b8ec16efdaec4862763d090f1ce9c7333a
ebola-4459f09ac7a911e6c78917c203ffabe1920c3a94aa1673fe2586dd2de4d341a1
ebola-abebac70de8baf0580cf5808ebae988c0627977b24f5745ab12cda1954ad3773
ebola-5b14355911ef2b12bfb7ab352ad802ccee644fe8e0a872277d789aa01ed7ca3e
ebola-bff176f5e4824b9614b53391caff39828ef5ac30d570bda64f58e52373050461
ebola-d793c2233ced4112b488138934cf3045e9b5ea8afdd0257de6e74180e9596a45
ebola-f69edb2a61137fbce6e6dda0b830e4e11ca7bee1ad28bd7e1b6bc1906cebb914
ebola-d65cd5ce5fc1fa9af890f6564b24f6003a3263b610a77cd231a640b6409b59dd
ebola-32b97ad55200b5bdb11504f9ccc376e510640c002a1b8c618683e15923761aab
ebola-7eddf33637469a7cd735021da829068b104b952a90bf57df86507745720aa49f
ebola-8e438242f46d76210854ee64effd10d0a9c04540bc40f601001934e98ab503a6
ebola-5ddd1cbcdb6c1ab2037e6bc9626e73f247b694befc33520144c86af126142142
ebola-a1f986a26e1baae500b76573b1079d1c3d52df041c87b98796eb1d6bc852ed88
ebola-7269fe5e451a73bd91ce0af1f30214d8294e58556525d2abced8ea2f59cd9270
ebola-f3a4103127155417019727c8e5b09892bcbf446a791c39fded62d9c33d5f50ff
ebola-abda9d8b6bf7f8c095d340270cb826128c204486b39d03d8f8157b82960be99f
ebola-68c07ffcf761c13e833f5c07e7201f703a81bc22b12bc2fbea9d4b4ff337772e
ebola-f191b46fe257e00537357ee56c37488cd689ff5211ca6bc5c78f90ffce2a3ff3
ebola-4897c1f4e5050a994cf6d9fe39ed4f34527e0e5387404f2c3f0a0d5be8306033
ebola-c68f6b6489764650db7da5397bedebfd03c60ad71ec350c15f295b3b11d2e413
ebola-87b8ce73f7f8c97cd1580b8c4ca5072d5299b54e49d3cacfdedbb619dc19cd7f
ebola-9c2fc9f81a377f82c1443866b5864c19d7730550d9dd800cb1d6bd12551fd6ce
ebola-55e33cac5ce74496bb739575cd5621849e5c234761315f1bb791581f9801aeba
ebola-77f06317363d7d1b3cf9cec5a08f020fe31c5c4561f78865b15b22a7c2c66f19
ebola-437debcdff8e8ad0fa8991193d6084312b700ba18ec10cf023ca66a16b6836b3
ebola-ca535e3d64d2278d0fc96cd2715a0ef7d18ce249503e9076dd700cb05c69e0e7
ebola-5505849d4fc90d0bc8e8135e224736a593cd418f0828f7c953e96a60adc28329
ebola-d0baaf1906b793d2131468ea021f337c732937a0cbbe680ca98445493125461b
ebola-c922253239debc1f4cdef0e0459304ea66c0fd01a73287588c49dffc2fc6fbaa
ebola-37bf99785f4b6365a92e61dee860fbc902f641763bcd38beb6cce9fb8da941e3
ebola-397d52027568d060d93492d7797153391bad6f2117e812255358692a21ba582b
ebola-c5b67cfd96d86470857aa257330d2673bb28143452998dcba1bee941befbf526
ebola-a2328cc4c8ce6827d4ee52abeb3584b09c2a15957bac1dea3cd8a8a5382b6123
ebola-4011ce71c56dd9e1dd938f8ff48aa1a08942e229eaa0b60d579ada8eac1b7175
ebola-6f5d158b6389193a4ea87f3cf7b57d8ec2165b7dcb0f57e1cfd7e5237de66d87
ebola-e87e7fe4025fcf1b22592a4e17f1da0d247dfb524db8cd8ec37a60099901ea65
ebola-ad5334f350a1273d0d3fb944703861d07ae6da17e67d03381edd1f11b6c487be
ebola-37f82faad6fa1dcd9340f74d47f4d63452ea5d06984a3f53f66579c1d208ddd9
ebola-097b4a18ee96e7156a4ed8b7fa8f1150221ce444e89ddde9d3d9b7ded3096106
ebola-548e68c922bb0fee416c93603fcb273e381416cc0af2f6d70b2cd8808bbc7dbd
ebola-bcf877fa9849c8846716493792ec2cae0f6a95a8dfa43ccf189548b0beccd142
ebola-9e6ff11cbc79cec4ffec7c3624700b169737d11e211b6c6e046191a30bfc7b92
ebola-6586e6a90707b3111f84129134d1f57ad0f9f678350105c605c34946ec943644
ebola-a734f95ede8e79aede61d87421afd429390c5f96f2c97d26585d055e31f6bfb6
ebola-521279271616cd17a400f03c7e87183cbe23bf04309539b488f2837405ae6002
ebola-f7b050001e77d11ff481dfe0f11c0b460e904f338b4c2c9d8a69b43073df99d4
ebola-a218c3b808b1192fcc1fdc49c044b129fcbadee8c105cfa454614d923f6ee0b4
ebola-ea43d97e245053cfc851104648daf68bbccab96d61b86e5d689257de9a4e6668
ebola-1144aa3360093c05fb8f6c54dd7fbaf564c27bd2836b2b176ab8e94478f77882
ebola-e6b37ea79f1157841a91623d981523587ac8d91d882782aa774758d217888f93
ebola-34de0247a6beae54086701aa14e0df1e45afb73659fcc9923b53dcd1ce68a27a
ebola-d9e595cefa56ea33c370f9cbafde9860b3b4563b72f8df9999cdb226cf5db6e7
ebola-ccdf6f4c18fe21daad27f1fc0374038a3c1583fc0f59b4b410c06f46c3757b32
ebola-990fc02b61f40755defe82e8e702a712233236d601bc9598cac0a8daf07bed4f
ebola-49d6585681e6f6d05b8c13be3d26d19c3c0e5472ce1ac5cca3a01f9d382e2333
ebola-9053c3f81d154104aef6fdf8787b84dcb6f562be752dcf4f641b0010c9e85865
ebola-6adc1adc645029cc6e02aff27a038b6651958d093918f4a07ba247f0d13c468a
ebola-d6c9a21573fd5a972826f20d5d4e5be86165d1e3c5f78947c791fade6158e0da
ebola-3be1694a367248ae78272ba6a3a8fd1b9b1a868877e3da1bc28e65d5ab5fd71a
ebola-bf36fa2b897b61faa4160c8c797817c9a46ea55bd0f2a9d6ca803b34585c5e81
ebola-e4bd594783359fcf8764d81e73171999a07eca16d3b4a3acf5ac7519ccc71ea7
ebola-cd1bdc564c61bac55d670f61de4433e165b0dfc3bc43b100fdfe0aa65cd4e515
ebola-f513ad03bef85c5301ecea553687b5df38796633cc6a7fce10519d18dec55409
ebola-b98689515af995cf6654c2cb8e886dc31bc85d975a5064d19b2a5665fbbc7266
ebola-1dd1377a2de0b5f4e1deff23d332c947ca45bbe8dc863aeba4871b9c94f7ba29
ebola-16bd27f61558b24ef3d355c18f26d594e1f3639baa271d99345b887497d3998f
ebola-1c852c47b5bdd7665b016438be73b3fd6d3130e5c16c3f94933241b7e1f65e7b
ebola-46cb56154109a068e52ed6055c4b22bb0d7a3c53ee2c4b4af5f408916dfdda7d
ebola-761ede0cd99fcdf17cc53966a036c12d2e15bcc3f83a39daa36cb6c0b67cb86b
ebola-8710a2d3ef3d86f31b8aa34e964aa9fdade2cf5f7a7e1976ca7abe8786c1588b
ebola-6a5e1b30f4139ef30e006d6228f246f7b00b2c58851fcff9d8a598dd9ac4c0d9
ebola-60879cc911c7d30aa6e2796642f85757e4edcb3c9cc0cadd04829a6fd2ec9767
ebola-05f2e0da7f51ccc357e2ed059dbbbb350d6a507441325f8dccbc35394c4ea2cf
ebola-9c33e23fe7fbfefb8bc123ad821fe919009fc602eca5bb8484140532e9745600
ebola-3a2cac20621bf76fb8a16fca02cfd77cd350485033dec99f3ba4a545011cef7f
ebola-716052ef6d0b91a859e7434cfec307d8e297755d87333ba16976055e1b5c7803
ebola-61f9fb54742b5831c0b06c91093790fb48152cd08b406bebf5a2be42acdee06b
ebola-96cf342e95f3075f6c7743ab9dcb83170c088de7cc166101dc3454e28b568de2
ebola-4fc478f2c354bbb1971ef5fa56a9bcd3dca5fd74aa717b7c75e5d149d67c0d94
ebola-95bd26d14f93ac6151b0aa8d2cc5c82e224a219cea857fe071db085a030e2f95
ebola-843d49090673d2234018f43e8be70c0527a02c5652a6c0b7b461abd4e0746966
ebola-ddedf4e4b40c510b9414b503952865320f588a1e676d308c01bbbc1f398d8ce7
ebola-abcd18c1bd376f193817373954417c54405ff4b39c9d32bf938b876c7c069834
ebola-195e360c00a55e9a8abb9d1a0ec01eaa6c7581a5a9e92c418ed91c1ecfdc8f73
ebola-57794c99bd4e8fcd199be3e8bd1b9f460d908e5b30a650eb18e72f52ae55419e
ebola-f936b867051daaf9e76fe265061ac7045c6a3ca7b3a57d50780e0091891489de
ebola-80d0a36e294894f442841f6c974c19bb4688ed1cac99cbfb07e059f850a70caf
ebola-b6b14edd5d1a53df5cbe9a5bb46fbaaf84453e9ef8c393388e41fe40ca7a0389
ebola-bd5da751e8551a549e5a13788a8831abe9eee987b88eb37d89f83cc686a9c3be
ebola-c17bd6efb72303e69a73220b9e812f231705bc2f558102ce200482843330c3b9
ebola-d7b92b35daf0236d5f2a78121535a0f9f107c1ebca99ae6b4ef45df3bb170cbb
ebola-bf14355b41dd799a2eecf723238f7167f84672fd1d1e99689dfd1f719b053142
ebola-346b43ef0a6e9cdb34d092b9cf9025c341f3c37abdf0f65bee19e1df284c1cd2
ebola-044d18d62869c124eb0a63d71b91c56ad35277887a523022c4e2a69d982a68d3
ebola-2b76cf456c1f1df6fb372249f11cf30c128c2388ef056039b6808cba919a2242
ebola-54b44961e240a89545358e598147d03f107a9935a7cb7cff3d914c9a0dd53d7a
ebola-2330c28380979ea1f7ee20661f49ce004aaa55cb344c105e1b8ba5774bc9d6cd
ebola-024fe521cf7d15410dd92b8395bcde42173f8e7c285a71d1b4a55a0e0f9db310
ebola-1a26e1727d9116c38a0976e20063a6bee83d85828962423773b2c31128db9684
ebola-6c40dce15cb915ef86c41083f27460f5da18641e6c47479958b37918e2907629
ebola-7f9ccf79f560eb4aeacd4630ff4efc76da49b4631faa98362b37620e40935c0d
ebola-52a4fc5832de5dd3b734c6a9baaeb6e2c3e419825b44697d306ef8719983b886
ebola-9b462ff51853c6eef51c302ea37e72e86b56b34c5f6148aaff8ef8cb80d04686
ebola-4e0489e40e459eaee987444aaf595b7054f0459f456264fb71c65c1c15475cf0
ebola-7ec9ccbf3541aabf73933e95d1b7276d0f16a4553c6a8e24b53e1f9f20c0f849
ebola-1b983621633d8d2515a51f27c64a6c06d4ddf37ff59b90cc66239ef2bf73f4b7
ebola-a370133bf799d6aa80bce3ea018676b4f845962ced8e5841b0705a072ca8ac82
ebola-37ed1a4e6669ecbf1666743cb07e0bee15c1d2724f2660f62b8a2b282cfc0b4d
ebola-956c7616ec39a1d751f4f8b6343fe90ed4ce8cf1f88fd65e6ce7375a3ca7042b
ebola-ca8dd59965ce40cd591d208e4df1dec98e441d8d3bbe55255f1ce849df360e5e
ebola-324ed3d9891e52d6c7dfdcd62126d40ed2253c59ecbcf3ffa3534584dd623cfc
ebola-19df3cf50947fea1873864be5add334e71582943b9f2a776e917ef6db8b50b74
ebola-b3b5d177dbaa9391777ee1d161d1d06ecf87c9df267d6820f950c7fdc8ab670b
ebola-6b23e825587254b2195a587994392db5370a09f2c646317ecfd03fc827a26dae
ebola-ce7f55f811b2a5a591307d12eec6e6c7fc8f28365e4e7488cb7160c3dfc911c1
ebola-fbeacb9e3234711a7c23c8ac0339600b6a9a6f1c5daf149d416a7aefd8ccdc84
ebola-1973750193455e110ccc74c6856ab4f0ff513f701d052c863c912e6e301181ee
ebola-0ceffb5a7ee58c6af11f6c32ccde4f9927974edf308517fdc8d77829677accc9
ebola-f3d80631556c2816461e58377fec55335a8e99bdd678b7ce165a17f6c9eefe32
ebola-28832a3eac77bc7140112bc272c76f0b95cd2f68aa263a4a768c2bdefaf2641c
ebola-4dbaf427cc8aa48f7bd35b06888be8a8b74c7ffd6a3996487cf9bd5e656f6e96
ebola-a3d2ba86f627b50e63554b49a4b578451d7a84c392a2c70445152d21260255b2
ebola-147c9f0144ff1979e4093250c32f9d64bb25f5e39c53c2833ef96d2e9a2aaaa5
ebola-708f69a18313c964de370ec3ce74ae307acc1c58b48543f8b5d8f6a9e2ea8d1a

tagged/hide  |  time: 2016-04-19 10:42:45 270881  |  # of fields: 2  |  topic_id: 367  |  topic_name: Emory University's role in Ebola treatment

list/click  |  time: 2016-04-19 10:43:11 235603  |  # of fields: 4  |  topic_id: 367  |  docno: ebola-f43115b91d5713546a16f17c8e9802fe52ff6279c34415e7bc1f6556e5ca5dde  |  listsource: pink_findmore

findmore/pink  |  time: 2016-04-19 10:44:07 950741  |  # of fields: 3  |  topic_id: 367  |  subtopic_id: 96  |  subtopic_name: Prevention progress at E. U.

result_size: 208  |  num_tagged:  0
ebola-f43115b91d5713546a16f17c8e9802fe52ff6279c34415e7bc1f6556e5ca5dde
ebola-868ae895450235411f4c2455b4e2a6ddbdd3da3b7355ebc9be6d88dbc227bdd0
ebola-a95bb3dd24ded2cee86a8a9bf40d6cce386d6aa64ae3675f68025a428257b21f
ebola-02caed42b30f5c844261b30196d8714fbdfdedbbd15819bcb8596a6b0dcb7277
ebola-ca1a050a8a659a9a402d8579a6112271ec0f7f54670f1f7d81797dd25cd6722c
ebola-2f2112e48adea8eb09c0ac8711dc8213cf2d827b98b4699f3104ca985fb3c682
ebola-abe19193c3351063039402a73fc648758f22c27a56ebcbd8f4aeb0208cf2714b
ebola-2d0d424fcc19bc8dbdf72e183c68c5767891c6a15897be01b48b2107da02d684
ebola-30bec5c5bbb6fd9d81e7d5896485c2ad791ff7a0de5ee258696a43f9a8487757
ebola-5f0a26fe833b2429b8051d10fbe1048758df4fab91f294629f7cf4f2dcf0fd46
ebola-6c9558951a236836bc342fdb78b0a4538707e9f1d2d99a02aa5bf4aae788349d
ebola-591b6df5785b9bb9804ab9a3a6113c55809eca9b0ac27eac850139e23b54f83c
ebola-c51d07035ebe7abf1fd05858c0a46d367524cc2238e915370cf3eefefaea5837
ebola-eda0589a271bc4a0eccef5e98a5ef287b3863def94b8e78b05569a6255d9cee4
ebola-199f1e2ea9a000469f45555be770b657ab99e496ba70294686444d37ebf782f8
ebola-2343408566070569320e74d86418adc131a85f6ff56cb6085613571e072b547a
ebola-c9a650f810a7ba3b2f8f9f59e9c5b2219b2d09cee1f22e05d5c7635525e6605e
ebola-aeb4a3eb9b2ee9b035067a31785ac2fd37fed0dbf654ae54c7faf5fbcd83f6be
ebola-ce585a480add131a1e269ba4ac5f58c4311f4503af12ecf58a219eff3d30ab61
ebola-a0b7dff4b5b885c665f077f125b74da6e571fe000b9a7a1bc77a0514a4be2790
ebola-86d7fc2f4915ccbcf73c9592c22462f964942aab47f1507fe4869e16f35e564b
ebola-6f7c47a59850feba877096557b85f5c9fa142b8a1f9f1628822a95fe2ff50943
ebola-d58e28b64d3e51487865305756a4254c7143c0225d0a5d22600acdeaffb7a955
ebola-846c79d748e855b69e3de214cbd9e3b39226d8e50762d3932ef00afaebb932e5
ebola-555bca17f4470ca14d666b73572bd11157e6c728ebbfa4ba03fae4d74011d856
ebola-c7a46ab61d8b142163d1f6a3b047ed7d8e2b382f60c8bc20959e5f030c76aef9
ebola-89633efe12c43c2575da89c48fa7fa4c6201c5ca72be44c41e62650d5a5cae4d
ebola-334a2ca02b16a429f3bd2abba7b6b6ac083541c0112403c06cc8d2816f7cf8b1
ebola-c241eeb749a79430a21a13fc489634cdb4559e28aa1a8fa32b43c26ff0646ab9
ebola-5258e1a197528a0ee2f5831e23501ed6404367643e7590158fe71a123832889d
ebola-f29faf625e5f73b1d609cdbd57cd91b30ca7c8ee198abb14ed455e6e2f2ef79a
ebola-a923c54c96c64dc3b4fe9bd8408a8ff9bc6b2c8050a957fb297b39fd712bb91c
ebola-9752c672a1c394e9d41a58d685bcc4f759e8049995b9382b9bc11315c6a200ff
ebola-48363a3b6f8948bb4b93fc0e73820779ce0a099ec282da2544ca7aa933e61a42
ebola-af876bb3eab4975908a3e81cfed8b35efc6acb2a0565189f7aaf0bcb68f369fc
ebola-2f5ba4841184f9e822089cd156aeeadd42b974c88298d0be7846814fd63663cc
ebola-9378c7162d9e4aa4ed12e1c7afaabf09bfa45d3fdc857c6a7a5ccd8bf64f5984
ebola-da9b4808c041cba9651f57cb6d919edfcc8bfc06f7fcff78dbb31fb4ab593ce7
ebola-2ac2d41346838bbd0c9d261634efd49acda9e283be01e7df89150f744e387d7a
ebola-a008277dea75819d4c57cb532a34a4268a0fb995d3cf9638dcb17c34a4a3ae5f
ebola-e1ca1f2e5fcf07bd3d35f12b7538bdbccfde7e760b02f51fa99e01e8df842bc8
ebola-b2c91586694811b5cf281254642389fae4d478dafe5732c1dc35fc0034f8a44d
ebola-3d436eed659f6dc12258e25a7277d48b4a3cfd5160345af251c6e54a0b7f317e
ebola-ade38eac15343591cf8cb2f5a1ad3b516636a3023e8316993df8da6328307b64
ebola-74b49f27a5ccbfee7a3324051b61b4b77189c797146166481aafc23af8dd925e
ebola-c70a3c1183db10a288c0e92ad68e8b3ecec328272eac7289ff4cea5105ffe118
ebola-d479fe93d427f6ca567113ccfdd8ae1736fb33b6feb147b952f967d868cea0aa
ebola-af11b22f284d7a9749d9510d7520488d1e108b85d050fb581a630b2965194f34
ebola-76a43bbacfd56db0ab18df2c288e9ec7be742985f333a5a24ccbfc6da677e8a3
ebola-5b37b767c3066e64f2a68e840ecf6f474035ebd9418c749b26541eed593ab82a
ebola-ee3b807907307698d5ce97571fe1f1f190d2380f9bf102282a4099fa6785cbd4
ebola-d1a5826615d5196a6c46897d6b812a967dafa5ac1b4cf1320c04b7493c640335
ebola-c4f96af16a6fc93335556e3ef00f703591e69acd766b150a57f36953e943f38f
ebola-b1276bda0578a948b6aff5c3a9c2cd5b6862573233eae4f016aea51ac541e191
ebola-617126bbae08648b7334a8fe5f16a496c70034c3ccd23ab096eb2e74c7084992
ebola-1a1fc818a76f0e1c250ee9faa069fa0962ecfac5ea7e90393f1c72b7d92b68d4
ebola-7b0c41ff78dd0eff9f589951b253ad630c5ff3cb59176b776ebe8e68746cf1a1
ebola-0ce5aaaa68db46fa8068cf48eb690f65b5ff786f36ccee70e4cfdbd495e50e5a
ebola-de792643719fb1b766ae4f878ddfcc87100253c794c97b4faf7784c45ed233a5
ebola-b8ac57472e8c20f0e38ea75539681a8e94bb261f59f219804effdf5552ced778
ebola-ecb7e4f4302b122cb9f52314940a67aaf04a498b1572b3e124b78bf5f17c9399
ebola-44ce9d4d60b93bbb6da982f9713630475a4ac1ea2252bbac9d4e5b10a133e973
ebola-516417af141999f393dadc4fb7caecbfb5f6a99d23ad9634ccb7c9887bd7530a
ebola-0a7d9fb049843fc5492a78424cb261e9b99d3397546fa7e35b162833ed18812c
ebola-e6db773814d1596ffa036991badfbde40902a9ad6cc9d3624320150007790e58
ebola-5ac7e14e5ef01e8889fbadbf1139c909e7ed804b7accdbeb2a6295ae384eea79
ebola-debfe41f5567bf6d95c27ec4e7d0134bb6f0cb46c9c459f45578614d723f7516
ebola-61fe7aa171df23cf050c43f458554d6dc4b6b0499daa3eeea8bf8dfce8644b3a
ebola-cfd79585f5ea713d3dcc0153e1e56b21a12aa2defee1ec8adb677335a5b460f7
ebola-e6f1116e939b49f1e484d2e863c4967652a7fb52dafa6319371b5c46b04fa9ee
ebola-d3df0c53747c0900a3a0e3e32a89f3c5e63a62254515a712b942a3243025ae19
ebola-ffddfc8b43f58aec650a797fcf502babb28bf841f3c3ec68c2c969e829293f2e
ebola-9e0db20598d5bc3e5b8a655d0487d6ddfe35694aa62892b725956e99efe08dc4
ebola-083305432fd70b421aa2a8238e7f2aecfb043308458bd7022d99bf42aaa1ecb3
ebola-12cebb56713e34447ac6b1ac4e75f3300387c9293ade8b506fee641f9c4018c9
ebola-63de723d3770394ad63463e85aa65903926bb4fc314ef80412c6e52baa7f5b74
ebola-74a40daa3ebf4899bd51a133210f4b27fe49cf5fda070b0df6069688841df201
ebola-81dbef3386fef4b55d5cc9e2b17c71990b78df03efdc4aecac87af8c94bd79f2
ebola-542c3c41c86afa279aa0f4c4d1d386754acec578890585a99001ab2a96bab930
ebola-4f1e8c45508c89487ec6c819ae4e073ce037a3ef38f2dfde037c1f85d4abcdcf
ebola-93dd205b84d4de3a339e41d0522db15c72f0ad79a0e36b41b3194cef98dd1220
ebola-1c4a9e98259635a82a6cfe419a45f34f7529dbaafc25b1c239e4298086a5770b
ebola-906286b772294f99970832eba937b3c872aea6013bc1653e8e20dc9bdf4bbbf5
ebola-20c93466e7785a4373d216487f46b5abd66d58ceb1ba260f3b8ac333caabb5b7
ebola-dcdc7cb18848ab0b2a56037afeb87cb902274823b9e8d6f913962d5dbb20a917
ebola-03bbd165223185f2e87741636cef86b8ec16efdaec4862763d090f1ce9c7333a
ebola-4459f09ac7a911e6c78917c203ffabe1920c3a94aa1673fe2586dd2de4d341a1
ebola-abebac70de8baf0580cf5808ebae988c0627977b24f5745ab12cda1954ad3773
ebola-5b14355911ef2b12bfb7ab352ad802ccee644fe8e0a872277d789aa01ed7ca3e
ebola-bff176f5e4824b9614b53391caff39828ef5ac30d570bda64f58e52373050461
ebola-d793c2233ced4112b488138934cf3045e9b5ea8afdd0257de6e74180e9596a45
ebola-f69edb2a61137fbce6e6dda0b830e4e11ca7bee1ad28bd7e1b6bc1906cebb914
ebola-d65cd5ce5fc1fa9af890f6564b24f6003a3263b610a77cd231a640b6409b59dd
ebola-32b97ad55200b5bdb11504f9ccc376e510640c002a1b8c618683e15923761aab
ebola-7eddf33637469a7cd735021da829068b104b952a90bf57df86507745720aa49f
ebola-8e438242f46d76210854ee64effd10d0a9c04540bc40f601001934e98ab503a6
ebola-5ddd1cbcdb6c1ab2037e6bc9626e73f247b694befc33520144c86af126142142
ebola-a1f986a26e1baae500b76573b1079d1c3d52df041c87b98796eb1d6bc852ed88
ebola-7269fe5e451a73bd91ce0af1f30214d8294e58556525d2abced8ea2f59cd9270
ebola-f3a4103127155417019727c8e5b09892bcbf446a791c39fded62d9c33d5f50ff
ebola-abda9d8b6bf7f8c095d340270cb826128c204486b39d03d8f8157b82960be99f
ebola-68c07ffcf761c13e833f5c07e7201f703a81bc22b12bc2fbea9d4b4ff337772e
ebola-f191b46fe257e00537357ee56c37488cd689ff5211ca6bc5c78f90ffce2a3ff3
ebola-4897c1f4e5050a994cf6d9fe39ed4f34527e0e5387404f2c3f0a0d5be8306033
ebola-c68f6b6489764650db7da5397bedebfd03c60ad71ec350c15f295b3b11d2e413
ebola-87b8ce73f7f8c97cd1580b8c4ca5072d5299b54e49d3cacfdedbb619dc19cd7f
ebola-9c2fc9f81a377f82c1443866b5864c19d7730550d9dd800cb1d6bd12551fd6ce
ebola-55e33cac5ce74496bb739575cd5621849e5c234761315f1bb791581f9801aeba
ebola-77f06317363d7d1b3cf9cec5a08f020fe31c5c4561f78865b15b22a7c2c66f19
ebola-437debcdff8e8ad0fa8991193d6084312b700ba18ec10cf023ca66a16b6836b3
ebola-ca535e3d64d2278d0fc96cd2715a0ef7d18ce249503e9076dd700cb05c69e0e7
ebola-5505849d4fc90d0bc8e8135e224736a593cd418f0828f7c953e96a60adc28329
ebola-d0baaf1906b793d2131468ea021f337c732937a0cbbe680ca98445493125461b
ebola-c922253239debc1f4cdef0e0459304ea66c0fd01a73287588c49dffc2fc6fbaa
ebola-37bf99785f4b6365a92e61dee860fbc902f641763bcd38beb6cce9fb8da941e3
ebola-397d52027568d060d93492d7797153391bad6f2117e812255358692a21ba582b
ebola-c5b67cfd96d86470857aa257330d2673bb28143452998dcba1bee941befbf526
ebola-a2328cc4c8ce6827d4ee52abeb3584b09c2a15957bac1dea3cd8a8a5382b6123
ebola-4011ce71c56dd9e1dd938f8ff48aa1a08942e229eaa0b60d579ada8eac1b7175
ebola-6f5d158b6389193a4ea87f3cf7b57d8ec2165b7dcb0f57e1cfd7e5237de66d87
ebola-e87e7fe4025fcf1b22592a4e17f1da0d247dfb524db8cd8ec37a60099901ea65
ebola-ad5334f350a1273d0d3fb944703861d07ae6da17e67d03381edd1f11b6c487be
ebola-37f82faad6fa1dcd9340f74d47f4d63452ea5d06984a3f53f66579c1d208ddd9
ebola-097b4a18ee96e7156a4ed8b7fa8f1150221ce444e89ddde9d3d9b7ded3096106
ebola-548e68c922bb0fee416c93603fcb273e381416cc0af2f6d70b2cd8808bbc7dbd
ebola-bcf877fa9849c8846716493792ec2cae0f6a95a8dfa43ccf189548b0beccd142
ebola-9e6ff11cbc79cec4ffec7c3624700b169737d11e211b6c6e046191a30bfc7b92
ebola-6586e6a90707b3111f84129134d1f57ad0f9f678350105c605c34946ec943644
ebola-a734f95ede8e79aede61d87421afd429390c5f96f2c97d26585d055e31f6bfb6
ebola-521279271616cd17a400f03c7e87183cbe23bf04309539b488f2837405ae6002
ebola-f7b050001e77d11ff481dfe0f11c0b460e904f338b4c2c9d8a69b43073df99d4
ebola-a218c3b808b1192fcc1fdc49c044b129fcbadee8c105cfa454614d923f6ee0b4
ebola-ea43d97e245053cfc851104648daf68bbccab96d61b86e5d689257de9a4e6668
ebola-1144aa3360093c05fb8f6c54dd7fbaf564c27bd2836b2b176ab8e94478f77882
ebola-e6b37ea79f1157841a91623d981523587ac8d91d882782aa774758d217888f93
ebola-34de0247a6beae54086701aa14e0df1e45afb73659fcc9923b53dcd1ce68a27a
ebola-d9e595cefa56ea33c370f9cbafde9860b3b4563b72f8df9999cdb226cf5db6e7
ebola-ccdf6f4c18fe21daad27f1fc0374038a3c1583fc0f59b4b410c06f46c3757b32
ebola-990fc02b61f40755defe82e8e702a712233236d601bc9598cac0a8daf07bed4f
ebola-49d6585681e6f6d05b8c13be3d26d19c3c0e5472ce1ac5cca3a01f9d382e2333
ebola-9053c3f81d154104aef6fdf8787b84dcb6f562be752dcf4f641b0010c9e85865
ebola-6adc1adc645029cc6e02aff27a038b6651958d093918f4a07ba247f0d13c468a
ebola-d6c9a21573fd5a972826f20d5d4e5be86165d1e3c5f78947c791fade6158e0da
ebola-3be1694a367248ae78272ba6a3a8fd1b9b1a868877e3da1bc28e65d5ab5fd71a
ebola-bf36fa2b897b61faa4160c8c797817c9a46ea55bd0f2a9d6ca803b34585c5e81
ebola-e4bd594783359fcf8764d81e73171999a07eca16d3b4a3acf5ac7519ccc71ea7
ebola-cd1bdc564c61bac55d670f61de4433e165b0dfc3bc43b100fdfe0aa65cd4e515
ebola-f513ad03bef85c5301ecea553687b5df38796633cc6a7fce10519d18dec55409
ebola-b98689515af995cf6654c2cb8e886dc31bc85d975a5064d19b2a5665fbbc7266
ebola-1dd1377a2de0b5f4e1deff23d332c947ca45bbe8dc863aeba4871b9c94f7ba29
ebola-16bd27f61558b24ef3d355c18f26d594e1f3639baa271d99345b887497d3998f
ebola-1c852c47b5bdd7665b016438be73b3fd6d3130e5c16c3f94933241b7e1f65e7b
ebola-46cb56154109a068e52ed6055c4b22bb0d7a3c53ee2c4b4af5f408916dfdda7d
ebola-761ede0cd99fcdf17cc53966a036c12d2e15bcc3f83a39daa36cb6c0b67cb86b
ebola-8710a2d3ef3d86f31b8aa34e964aa9fdade2cf5f7a7e1976ca7abe8786c1588b
ebola-6a5e1b30f4139ef30e006d6228f246f7b00b2c58851fcff9d8a598dd9ac4c0d9
ebola-60879cc911c7d30aa6e2796642f85757e4edcb3c9cc0cadd04829a6fd2ec9767
ebola-05f2e0da7f51ccc357e2ed059dbbbb350d6a507441325f8dccbc35394c4ea2cf
ebola-9c33e23fe7fbfefb8bc123ad821fe919009fc602eca5bb8484140532e9745600
ebola-3a2cac20621bf76fb8a16fca02cfd77cd350485033dec99f3ba4a545011cef7f
ebola-716052ef6d0b91a859e7434cfec307d8e297755d87333ba16976055e1b5c7803
ebola-61f9fb54742b5831c0b06c91093790fb48152cd08b406bebf5a2be42acdee06b
ebola-96cf342e95f3075f6c7743ab9dcb83170c088de7cc166101dc3454e28b568de2
ebola-4fc478f2c354bbb1971ef5fa56a9bcd3dca5fd74aa717b7c75e5d149d67c0d94
ebola-95bd26d14f93ac6151b0aa8d2cc5c82e224a219cea857fe071db085a030e2f95
ebola-843d49090673d2234018f43e8be70c0527a02c5652a6c0b7b461abd4e0746966
ebola-ddedf4e4b40c510b9414b503952865320f588a1e676d308c01bbbc1f398d8ce7
ebola-abcd18c1bd376f193817373954417c54405ff4b39c9d32bf938b876c7c069834
ebola-195e360c00a55e9a8abb9d1a0ec01eaa6c7581a5a9e92c418ed91c1ecfdc8f73
ebola-57794c99bd4e8fcd199be3e8bd1b9f460d908e5b30a650eb18e72f52ae55419e
ebola-f936b867051daaf9e76fe265061ac7045c6a3ca7b3a57d50780e0091891489de
ebola-80d0a36e294894f442841f6c974c19bb4688ed1cac99cbfb07e059f850a70caf
ebola-b6b14edd5d1a53df5cbe9a5bb46fbaaf84453e9ef8c393388e41fe40ca7a0389
ebola-bd5da751e8551a549e5a13788a8831abe9eee987b88eb37d89f83cc686a9c3be
ebola-c17bd6efb72303e69a73220b9e812f231705bc2f558102ce200482843330c3b9
ebola-d7b92b35daf0236d5f2a78121535a0f9f107c1ebca99ae6b4ef45df3bb170cbb
ebola-bf14355b41dd799a2eecf723238f7167f84672fd1d1e99689dfd1f719b053142
ebola-346b43ef0a6e9cdb34d092b9cf9025c341f3c37abdf0f65bee19e1df284c1cd2
ebola-044d18d62869c124eb0a63d71b91c56ad35277887a523022c4e2a69d982a68d3
ebola-2b76cf456c1f1df6fb372249f11cf30c128c2388ef056039b6808cba919a2242
ebola-54b44961e240a89545358e598147d03f107a9935a7cb7cff3d914c9a0dd53d7a
ebola-2330c28380979ea1f7ee20661f49ce004aaa55cb344c105e1b8ba5774bc9d6cd
ebola-024fe521cf7d15410dd92b8395bcde42173f8e7c285a71d1b4a55a0e0f9db310
ebola-1a26e1727d9116c38a0976e20063a6bee83d85828962423773b2c31128db9684
ebola-7f9ccf79f560eb4aeacd4630ff4efc76da49b4631faa98362b37620e40935c0d
ebola-52a4fc5832de5dd3b734c6a9baaeb6e2c3e419825b44697d306ef8719983b886
ebola-9b462ff51853c6eef51c302ea37e72e86b56b34c5f6148aaff8ef8cb80d04686
ebola-4e0489e40e459eaee987444aaf595b7054f0459f456264fb71c65c1c15475cf0
ebola-7ec9ccbf3541aabf73933e95d1b7276d0f16a4553c6a8e24b53e1f9f20c0f849
ebola-1b983621633d8d2515a51f27c64a6c06d4ddf37ff59b90cc66239ef2bf73f4b7
ebola-a370133bf799d6aa80bce3ea018676b4f845962ced8e5841b0705a072ca8ac82
ebola-37ed1a4e6669ecbf1666743cb07e0bee15c1d2724f2660f62b8a2b282cfc0b4d
ebola-956c7616ec39a1d751f4f8b6343fe90ed4ce8cf1f88fd65e6ce7375a3ca7042b
ebola-ca8dd59965ce40cd591d208e4df1dec98e441d8d3bbe55255f1ce849df360e5e
ebola-324ed3d9891e52d6c7dfdcd62126d40ed2253c59ecbcf3ffa3534584dd623cfc
ebola-19df3cf50947fea1873864be5add334e71582943b9f2a776e917ef6db8b50b74
ebola-b3b5d177dbaa9391777ee1d161d1d06ecf87c9df267d6820f950c7fdc8ab670b
ebola-6b23e825587254b2195a587994392db5370a09f2c646317ecfd03fc827a26dae
ebola-ce7f55f811b2a5a591307d12eec6e6c7fc8f28365e4e7488cb7160c3dfc911c1
ebola-fbeacb9e3234711a7c23c8ac0339600b6a9a6f1c5daf149d416a7aefd8ccdc84
ebola-1973750193455e110ccc74c6856ab4f0ff513f701d052c863c912e6e301181ee
ebola-0ceffb5a7ee58c6af11f6c32ccde4f9927974edf308517fdc8d77829677accc9
ebola-f3d80631556c2816461e58377fec55335a8e99bdd678b7ce165a17f6c9eefe32
ebola-28832a3eac77bc7140112bc272c76f0b95cd2f68aa263a4a768c2bdefaf2641c
ebola-4dbaf427cc8aa48f7bd35b06888be8a8b74c7ffd6a3996487cf9bd5e656f6e96
ebola-a3d2ba86f627b50e63554b49a4b578451d7a84c392a2c70445152d21260255b2
ebola-147c9f0144ff1979e4093250c32f9d64bb25f5e39c53c2833ef96d2e9a2aaaa5
ebola-708f69a18313c964de370ec3ce74ae307acc1c58b48543f8b5d8f6a9e2ea8d1a

list/click  |  time: 2016-04-19 10:44:28 546277  |  # of fields: 4  |  topic_id: 367  |  docno: ebola-f43115b91d5713546a16f17c8e9802fe52ff6279c34415e7bc1f6556e5ca5dde  |  listsource: pink_findmore

doc/irrelevant  |  time: 2016-04-19 10:44:43 650817  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-f43115b91d5713546a16f17c8e9802fe52ff6279c34415e7bc1f6556e5ca5dde

doc/irrelevant  |  time: 2016-04-19 10:44:59 045335  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-868ae895450235411f4c2455b4e2a6ddbdd3da3b7355ebc9be6d88dbc227bdd0

doc/irrelevant  |  time: 2016-04-19 10:45:22 205877  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-a95bb3dd24ded2cee86a8a9bf40d6cce386d6aa64ae3675f68025a428257b21f

doc/irrelevant  |  time: 2016-04-19 10:45:50 152499  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-02caed42b30f5c844261b30196d8714fbdfdedbbd15819bcb8596a6b0dcb7277

doc/irrelevant  |  time: 2016-04-19 10:46:05 982531  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-ca1a050a8a659a9a402d8579a6112271ec0f7f54670f1f7d81797dd25cd6722c

doc/irrelevant  |  time: 2016-04-19 10:47:14 763511  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-2f2112e48adea8eb09c0ac8711dc8213cf2d827b98b4699f3104ca985fb3c682

passage/create  |  time: 2016-04-19 10:48:03 846304  |  # of fields: 6  |  topic_id: 367  |  topic_name: Emory University's role in Ebola treatment  |  subtopic_id: 97  |  subtopic_name: Key members of team at E. U.  |  passage_id: 2618  |  passage_name:  One of the teams tackling the problem is Crowe’s. He and his colleagues have been working with blood from about 40 Ebola survivors, most of whom got the disease in the 2007 outbreak in Uganda. The remainder includes samples from three patients treated at Emory University, and one from Nebraska.  

passage/grade  |  time: 2016-04-19 10:48:06 637224  |  # of fields: 2  |  passage_id: 2618  |  score: 1

doc/next  |  time: 2016-04-19 10:48:18 548917  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-abe19193c3351063039402a73fc648758f22c27a56ebcbd8f4aeb0208cf2714b

doc/irrelevant  |  time: 2016-04-19 10:48:39 397491  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-2d0d424fcc19bc8dbdf72e183c68c5767891c6a15897be01b48b2107da02d684

doc/irrelevant  |  time: 2016-04-19 10:48:52 187492  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-30bec5c5bbb6fd9d81e7d5896485c2ad791ff7a0de5ee258696a43f9a8487757

doc/duplicate  |  time: 2016-04-19 10:48:56 524759  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-5f0a26fe833b2429b8051d10fbe1048758df4fab91f294629f7cf4f2dcf0fd46

doc/duplicate  |  time: 2016-04-19 10:48:59 229659  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-6c9558951a236836bc342fdb78b0a4538707e9f1d2d99a02aa5bf4aae788349d

passage/create  |  time: 2016-04-19 10:49:20 915326  |  # of fields: 6  |  topic_id: 367  |  topic_name: Emory University's role in Ebola treatment  |  subtopic_id: 97  |  subtopic_name: Key members of team at E. U.  |  passage_id: 2623  |  passage_name:  Ebola victim Dr. Kent Brantly, left, embraces Dr. Bruce Ribner, medical director of Emory’s Infectious Disease Unit, after being released from Emory University Hospital, Thursday, Aug. 21, 2014, in Atlanta. (AP / John Bazemore)  

passage/grade  |  time: 2016-04-19 10:49:24 247160  |  # of fields: 2  |  passage_id: 2623  |  score: 1

doc/next  |  time: 2016-04-19 10:49:35 704722  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-591b6df5785b9bb9804ab9a3a6113c55809eca9b0ac27eac850139e23b54f83c

passage/create  |  time: 2016-04-19 10:50:12 094261  |  # of fields: 6  |  topic_id: 367  |  topic_name: Emory University's role in Ebola treatment  |  subtopic_id: 97  |  subtopic_name: Key members of team at E. U.  |  passage_id: 2625  |  passage_name:  Dr. James Crowe, director of the Vaccine Center at Vanderbilt University, is collaborating with Mapp on ZMapp, and has had problems as well. Crowe said he may soon get some samples from U.S. Ebola survivors through Emory University, after going to great lengths to get them.  Crowe said a mutation in a key area of the virus "could compromise the utility of the drug," adding that there is no evidence that such changes have occurred. Mapp did not respond to a request for comment.  Importing Ebola virus into the United States has always been tricky, said Dr. John Schieffelin of Tulane, who has treated Ebola patients in Sierra Leone.  

doc/next  |  time: 2016-04-19 10:50:16 751639  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-c51d07035ebe7abf1fd05858c0a46d367524cc2238e915370cf3eefefaea5837

passage/grade  |  time: 2016-04-19 10:50:20 491661  |  # of fields: 2  |  passage_id: 2625  |  score: 2

doc/duplicate  |  time: 2016-04-19 10:50:42 129555  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-eda0589a271bc4a0eccef5e98a5ef287b3863def94b8e78b05569a6255d9cee4

doc/irrelevant  |  time: 2016-04-19 10:50:57 454428  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-199f1e2ea9a000469f45555be770b657ab99e496ba70294686444d37ebf782f8

passage/create  |  time: 2016-04-19 10:51:23 976656  |  # of fields: 6  |  topic_id: 367  |  topic_name: Emory University's role in Ebola treatment  |  subtopic_id: 97  |  subtopic_name: Key members of team at E. U.  |  passage_id: 2631  |  passage_name:  The report by Michael Connor, Jr, MD, Harold Franch, MD (Emory University School of Medicine), and their colleagues details the measures the clinicians took to maximize safety and minimize risk of secondary transmission of Ebola virus, including careful considerations to the types of equipment used and the protocols that clinical staff followed. None of the staff developed Ebola virus disease after a 21-day observation period, and no detectable Ebola virus genetic material was found in the patient's dialysis waste fluids.  "In our opinion, this report confirms that with adequate training, preparation, and adherence to safety protocols, renal replacement therapies can be provided safely and should be considered a viable option to provide advanced supportive care in patients with Ebola" said Dr. Connor.  In light of their success, the team has proposed a set of clinical practice guidelines for acute renal replacement therapy in Ebola virus disease.  "More than anything else, in our report, we found that extra training of our volunteer ICU nurses made success possible. We thank them for their bravery and commitment." said Dr. Franch. "Our case also shows that dialysis is not a death sentence for patients suffering from Ebola virus disease and recovery of kidney function is possible."  

passage/grade  |  time: 2016-04-19 10:51:27 568700  |  # of fields: 2  |  passage_id: 2631  |  score: 2

doc/next  |  time: 2016-04-19 10:51:38 423340  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-2343408566070569320e74d86418adc131a85f6ff56cb6085613571e072b547a

doc/irrelevant  |  time: 2016-04-19 10:52:23 883854  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-c9a650f810a7ba3b2f8f9f59e9c5b2219b2d09cee1f22e05d5c7635525e6605e

doc/duplicate  |  time: 2016-04-19 10:52:30 546655  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-aeb4a3eb9b2ee9b035067a31785ac2fd37fed0dbf654ae54c7faf5fbcd83f6be

doc/irrelevant  |  time: 2016-04-19 10:52:50 187727  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-ce585a480add131a1e269ba4ac5f58c4311f4503af12ecf58a219eff3d30ab61

passage/create  |  time: 2016-04-19 11:06:34 878688  |  # of fields: 6  |  topic_id: 367  |  topic_name: Emory University's role in Ebola treatment  |  subtopic_id: 95  |  subtopic_name: Vaccine progress at E. U.  |  passage_id: 2677  |  passage_name:  Sacra is being treated with an experimental drug that is different than the one given to the two Americans treated for Ebola at Emory University Hospital in Atlanta. Dr. Kent Brantly and Nancy Writebol, who also work for SIM, have recovered.  Sacra came to Omaha instead of Atlanta because federal officials asked the medical center to treat him in order to prepare other isolation units to take more Ebola patients if needed.  

passage/grade  |  time: 2016-04-19 11:06:40 162028  |  # of fields: 2  |  passage_id: 2677  |  score: 2

doc/next  |  time: 2016-04-19 11:07:08 362116  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-a0b7dff4b5b885c665f077f125b74da6e571fe000b9a7a1bc77a0514a4be2790

doc/irrelevant  |  time: 2016-04-19 11:07:49 381448  |  # of fields: 2  |  topic_id: 367  |  docno: ebola-86d7fc2f4915ccbcf73c9592c22462f964942aab47f1507fe4869e16f35e564b

topic/create  |  time: 2016-04-19 11:10:04 766602  |  # of fields: 4  |  domain_id: 1  |  domain_name: Ebola  |  topic_id: 397  |  topic_name:  healthcare impacts of ebola

topic/select  |  time: 2016-04-19 11:10:04 934552  |  # of fields: 2  |  topic_id: 397  |  topic_name: healthcare impacts of ebola

highlight  |  time: 2016-04-19 11:11  |  # of fields: 3  |  topic_id: 397  |  docno: ebola-6f7c47a59850feba877096557b85f5c9fa142b8a1f9f1628822a95fe2ff50943  |  highlight_string: healthcare impacts costs

query/lemur  |  time: 2016-04-19 11:11:19 567894  |  # of fields: 3  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  query: healthcare impacts costs

result_size: 300  |  num_tagged:  0
ebola-3b494b1ad8b7e3671401b5c5d20cb082bf224a17f31eda835376b821e3e3abfa
ebola-334bba2cca2807a3d5096678010b6d9f0e6328ad284896fd5866304be5aaa0dc
ebola-9d0a8eed7597c1b520e3c01bba5717bcdd10adcbae666e90ab70861bace6ffe8
ebola-753d3a150a96ccebf1243c46c3a52a9a15503676cfdfe3697f3696a0b31dcffd
ebola-080008f6c58cec3cee9fedbb22e7874e3dfb33116ff5acc2e68ab0040fac4e1c
ebola-f61616659ba37e9f7b89407c4bc818ec2f46dfb3be7b646217a83438988bc9d9
ebola-1e9df05453557bedb84840932b01e4b57d08ef2ecabdf3c58227ad906ccefd15
ebola-d509bdb0afc26eed8ed04f6530217a8510eea3aaa2c3cd04cd2cc14fa8ecc7e8
ebola-849d25a28372bdaf22273a797812aed3a5711006ab39c729fb5ea63d54bdf4c9
ebola-207e580eae1656dd6fa141c07f7ffa24ad0b4be1413e7fd4e6f9ac23b2927987
ebola-21dbfd488c0c46d8eee9fa7224ebe6247ce03032f1d5eb12e9ef7f1d61cda69d
ebola-c60ec907f545bb871cd9b30094906a3f8117ad3648f01b3d3f4093b2486b2652
ebola-8656df476773eaef1202d7d27851ecb68e294d210bad1be10729568d0ac0136c
ebola-2d6b7302444b7997fa2b0c56df041febf0cc4eb98e72b22d405730285e0d9782
ebola-56e4e42cbaf1933193a5abaf1f1ca3d0254fbae25498e96dd69f36961a852762
ebola-42471be60460935d889f74a6bc6f1674fea651d0a67d8aa8bcbb3d1e8e08c152
ebola-f580ecba794cee1f42540b53a62f5b24e4819f3864df17d579e90c52f9d0fc71
ebola-a4afa9ba8873e8038b662957b17832531574408fd50821613b065f323fb189d7
ebola-aed19ff83ac981718fa08caa1158caf61c00edfac7ccc5786fd2f6f2ff007723
ebola-53d93c415f2234c1898a8e551416ccad4b032020a9f5bc50b8fecd00898184e9
ebola-c27d4d504920909e578d52b4f02e0074222e37c5f5fbd2c8d2d31232516935a3
ebola-1304d27a5aed50aa80d7ab061bb5c1f5eac52b22373523a29ff109df51b7d83b
ebola-f155f4046188598a9cb5a63d80c8d3c0289d99506d4ff7425ed5f2c8ed7ce23e
ebola-c203b08b595e032ecafb20aa10bcd8053ca4bd478eab7f3fa96f5e7c857c5a39
ebola-2ed22fbf565006334438f6931c760a3613f59d0f047d97e0dc7caf72d40a2aa3
ebola-6420ac8055e10e42a8b91f9070c33620fd6094049b0534020229b6075d8879cd
ebola-47a3856ee6048e459d1de88edc0a55343e2ad6e103a6154f46bf282f8108c258
ebola-c1452dc742faa1841b759c4f41157669dff179fa001012c5abc6e99d4a52bb2f
ebola-b51bb3f0107100e220f6e3d7a40aab058b82af388c4543b91aa12ad882d23994
ebola-967217a11c602e6a603247b5a91c5119d1cad68af6a0f4f4b6bdb10ca1ffac21
ebola-6523543ef516a6a973603c172c9b248072d22c2a3dbe9c62e44d89eafbb59456
ebola-8de06206d14ac4a96b72d79f49d4841521cd2a396c965459dd30bac970e812e0
ebola-80b5522e53614f55cb1492ceb07ec6f8cf6316b49e1901766f8489e33860226e
ebola-a9953ff579096eae4493f2c60e31f4314d3b0176e1e9c70ab3054ffe7a111475
ebola-abe7801efd195837f19077d5abf538054f92a2b3409c0450b5b31dda23eacd88
ebola-656efed7fd698911699487b736ca92c6995682b5534de107951de63e4fba69b4
ebola-0a0bfca873c823ebd484858c40811c53fa591452df3c685c39317a0bde26cadb
ebola-645a8af3ace496323fd3328f765a1820a9bc45bff1ebf6fb74372de778d575ba
ebola-70a40ef7ddc055c8e316d6a27f46b8ee98ac1c3701b02b4a70f591173517c086
ebola-534c708a6d7bfcbb9ef0c2829f7c4b3e9755cb00d4eab0ff222521360a5a5695
ebola-56ae37a08ef822a317e60ce94e76241e495dff639cd54f7da17e757875d3306b
ebola-8450ce3afc7008a4739c858960205f64e9d9b7b6f02d1ad471d6f5659f03a3f4
ebola-37bd96e0da796a4f1a79412873eebd4812552a10ccc30e1beb67e1221a3b88b2
ebola-e6912bf7d799d1db2c2acd15f4a7aac5924598d514c0c2e1823ec51efbf02575
ebola-77c399d1dedaa9f6d24c88d6fd2628037468bacdcad4b47c889ab4fb7572b4d9
ebola-47f0361cc8a2a20250b6772c7893d044c1fe1b9f3d5716bf9a56c1cc61196b3a
ebola-0d87e550a1551f3776117182ae850063d80c39bda0ed05300ede185748c7183b
ebola-c1cd79bd9fb8eac68bed419f101e6c0d8cdda9430c47ec729ec1370888b2f9a2
ebola-debb50eb07c9df9f62b7e25910f10da7ced01b186ad9ea309b2d434aa7fd4e1c
ebola-708b405aab5a5eb4b6109374dce653962f5a80a34c519d9f1bd3a7718566346b
ebola-22546759770bda96998534821dc1899fe609fe3d95bbf87e3a8831e61b5cbdcd
ebola-f82f85e8180b8d202a9899cdbb6a829f0d6fa525d2c6ed8f35196ee5c72a8823
ebola-7f065ef3bdbfc22b11a0693b604f6a75d237ac106775a0aa7363494fe229f7b0
ebola-84c8ef8ebcb64b4d6ba400ccaabe7aeb6f469ca31e5a804aac79fd73cdb4e523
ebola-3d611657a8d500e076f071ac379643ff849a338e87d11bdae71acdd4cfbf377b
ebola-e1e333e149c1892978591d622b73e22038bc918ddc0e13557476b276b9ea995b
ebola-67e3640ae2ac5c1d5ca9c40cfd4ddbeecad1ebb32fb884b75ab8465e3d62b9fe
ebola-1a2719ebc9d4868e44425e90e96ba44b151667efa6aa443bac187fc4240c014d
ebola-bdec02759ea1b376d362e879e33985e01027ebd505e775740c5c7df716edf289
ebola-fa81efe363d222ee556936ffe17a81da5d7a6131d79d1e05b5232d1c026dd535
ebola-b68e9ee9d6037be85daaf918da28b01ec999c8bca557518c276d3c8a9dfef4c8
ebola-0f3caa1ded8a6ee9dfd7052ea574bf082ffef67bfd2012761d17b7d21efa476f
ebola-2305e50bca61445851c0bcb0930ea207e0eebdebf1d7705a1756dc084112d367
ebola-a3d6cec81c1ae4558ba85cc5a4b945ea014720994907581854a026513eb97183
ebola-439325b73d844294a363aca72c1147399bd6f275a8baf199312ddf37f4234992
ebola-2221f29d6183a19f2cabfe096c791291e81cd91dd2f8bc9d05c709c785cf79b6
ebola-c4665c75539a519d14fddb40825b17194d4abd7a6454f6babfba76db757e1509
ebola-484b44670792de2aa891655c2b419c4dda0d68035846e934b049b2d3c3558860
ebola-aa67f0f5f13c56cb572c029e4d32b2be60360f08e4c4fd4c4b867fe2522e9303
ebola-2d33381c8fdb2147ceb925c4c746489f981118568f4b88825fe3bf9ad504ef98
ebola-5353142d7ac154552577129bcd106c53cdebf6154499d068751880c193220e50
ebola-adbc27f45404bfd9c00de865b5f3268c3e2818d65afdeb77b127fdebbdca2d56
ebola-1ff65aa6a4f36ca8e9bdddb49933a5b167be8bf20536f06a8b14f8e5c750fff6
ebola-88cf07bb51227255c6352f66884730ee6630b8bdc39e8db58126a9fe207113a6
ebola-c27f5a84427839f29d3858b077f72653c2c8c90de9cbd94aacc1357db57fac5e
ebola-9db789e50a5dd2494dd2f881e0c5678c8f389151306c235f6ddc71c8fe0c78e9
ebola-cacd9c2a906a7c8cac9faa760332f467847e0e35fe9275a9f506a244e02d9c63
ebola-5b916eb6d614bdd673b97f49ea842c99607c67732f9254ee623d42611461cb5c
ebola-49afd07054dadb7e404147adbb695599f693101b3ab9cf5acbfb68da228bcfbe
ebola-b6394c4200716d9fd01e90e5589041d407e63c4657a19900d8da62801c07f756
ebola-18f4caeed0b5667129db14f1c25f7b8bbcddc480b980288ba81b2b584ae432ba
ebola-919ebaa0683871218db09b4647ae0ee935a5ad801f6f14d07ae485a9dc083c2f
ebola-d1f91d0d95a763c68e4abafcca6f501c0663a99ede8c7eb5b86885373be42ff5
ebola-4d3f9e4aedcebd5d80697942ab121dba4fc793fe8956137dff97c34f21df8906
ebola-9e6503708e6e5ce821802508f0a5df7e0acd2c417902477fc40f79bd4c7c670d
ebola-bb558f36e17c55c6a5111cdb0250ccda898b6de733704980e7c56e96269c1e2b
ebola-7269fe5e451a73bd91ce0af1f30214d8294e58556525d2abced8ea2f59cd9270
ebola-ae1adeef917b0b73b7f145352c533a6d8b2e3d7afe034574821d9e4a2ca49983
ebola-73a13aaf9bc06de3059ef94a2f7f589e967ebe1d6ffe7ffb7e0f8f496e46d796
ebola-72b9d42f51307b169c3bcdc3c241fe1b493bc71c3027469d2b87a469fe784120
ebola-5db3bd6f20a345801b4a68f89ff1b5a308ef2fe86f290ea627dd85687388fb3d
ebola-65fdb3ce7f6664b16c0be963f9590286a3a5ab15c6fd39bbefdb5e921e8fda6d
ebola-a5c4ea27c6d03f69bc2480af8de268ff27d60f08e9368f58168271e13d2ac9d9
ebola-1bc7780700f01f6c06781766f5ef2a467c74e32f9c9320b1284746a67e936eda
ebola-144a260ad2f0233593c09e0f735fb5b6ee504e54708436b1d44d9c2ea6f52884
ebola-c8083a1e7bdb768e717d974c461d5ebe73b2ef406bf5730530ca952d8fadd813
ebola-a11475faf648efecc7df720156645794414179329d6be0b61dfdd53a6c8e2159
ebola-ead02635d8d4624c5e85c57ebe754df8447f7941e1aba54d00d37cd10a025157
ebola-3969ff94ac3602f07504584c14ededd601f3e7953e1b85fd8508ceb06ec0b3d6
ebola-e116db2b818654e162a93045be542632374e1f1fdfbefdd24dd38c13a826ae01
ebola-5f97f24f2f25826664d63db55879055d7d4d0c3df47067d461a494047de9a2c8
ebola-7a983224dcb45a59b39a20fef829c1b92e2abd13867dc23e1d976572305d7e01
ebola-2cc4026358fa8d4179cdda66a42ce1b228b6a25c03e7d7598b5c3674da977281
ebola-0117b4f6994387b95b0bf771146fabadcdb93989d494e201d660e549d7362a99
ebola-9bf3a6b53c6d8ef4ff7225305933c3ea95becfcb01e064f78f466d545e68c644
ebola-1d1f93f32b015b2fdabb585436b4865e79d8dbd456f33e0d5641d9f3d6024c42
ebola-fd0c1b605a3453215dc412f13642e7382fee3054ef6eb71015bcaf13dd6d06ed
ebola-fb9d62e6409ff67aae244fb4459550cbd4b8b06c270da99a44cf4b5679b3a26d
ebola-5ead8888f4444b00cecd2f146d92f064c51daba0283838a6eb97f21b07210d4c
ebola-4d00b3be5bf48513db9d2a074c31c6e11d6d218afbc93a2746c2b5f9becf1b29
ebola-f9920d4b0caec4f5a6a978ec96afd918e9bf03f5bb0580d04b92804b18e1e144
ebola-09facb19588b35bf8627a73dc613ad73d9514c29e1559c8484fc8805fcc82f3a
ebola-ba8004fd803c6158795bd550267387b663b24311d28c4c589115c87bd884623f
ebola-b20ad8859e0b6b8c3ed392a68dca6cdb4b00f89056e3eec2ba9f5bbb11cba2ce
ebola-007196c29e1f6afa0478759f3307793d6d2f335e48baa65d2fdb9fd1cd5e4e26
ebola-60294b2a63766a9b48af09c1691d3a424d26cf8baa1435c408217c6a5b39e1d1
ebola-761e008ae17942186b2b150535fd6fabaf32b7ff81e38dd051f702c5010fb8ed
ebola-afb585c037d098b44fce944074e9f92fecd88c312252dad39006d028f129bbcb
ebola-0327e347c891fc9088415e829d24c7a853fe7daeaa94172eda54ffaa0fb6c467
ebola-75aaa92451140763b7cc13f501330fcc2f4b656a5bd0af5b1d7e110e46c44d22
ebola-ac0bdbcfc44afebe73d6abb0d60ddfdcd76bafde982aad26d78090ecbd6f83c7
ebola-c467f20e535bc5a72bea8764b540bfbdbf4768ecb642348bdc7cf723ea4368a8
ebola-721c813a4ce5d3f9839e2c01474c685ee127c7f593d4f35373b3eb59dfffb07d
ebola-6e3342b0b4945075196a79a33cebdd0d2479ba599b0a7692615df289ff5ae323
ebola-f36d89d627e978fafad9108eecce434234c64e8a41c537b19ee732c90729aed5
ebola-0a49813915309df039fe740c89ab7f8071158236981cb78713def4236bd4d745
ebola-d9323c9afb59b83d5c50c17c331660de357cd8139e5ea6660c72ec00b0d51736
ebola-0e99dc4e69d57afa571419cac72aff8c2d2e58cecfdc958be6b662646aa24677
ebola-0f7147ee43dfafbc47b2304b39dd7894c1f50f76c287bf253eb5c3beb357bcab
ebola-5b772bfe38e68757305460e49514cbef9b23f0f2f896864cc729922fb4aa340c
ebola-30756ad762525195a488111a0137d3aece920d0049445db27626f5ce5d205093
ebola-3a7cfc7589ecc152457f7c2c3a6e8c4572f977997e0ecf70f8318184cfbcc10c
ebola-23dc72dbae43e84ea66ccfddde84372f5fb59a0e46f7ea185fbd1c6af9286e73
ebola-f5dc9abcdd8851968ba43991d40da0c2f4c031582c701b443c56d56d08bdae61
ebola-3043b15222884456adcf6e06a5cd978824cfcc4a0dd947fc3d0e52d22e435f6b
ebola-2cb3b9799af44881e6f13b0aa8084b8d670a1bf52b17fdc4d9db1b0007892428
ebola-c44244d74458dd3e105ccfa801f2b770bb56334dfe99b67bfa7333eb9a43aad1
ebola-08ea06f5c52f0fbd4fed6d260bf98f552bf0f979b42671764909ed6861a967bd
ebola-2929f7d2f68db418d07cd1cf9fd96905b4bbc61b6f0bf267a9bebe7c17bcc528
ebola-a373548060857318d7f1a93a9bd768db8d762d974f43713fcdffeb62e36a000a
ebola-17b3c34371053f984685fc3f01b3e498fc801c56ad18934feec19f136bb7078b
ebola-b4451c56c406c3fa3ac27e57313b510097cd364e302667a5ec8016d08cfeea92
ebola-0b2910ecc6dcfa3e98650ba5dcfa2ef71c2870ffa01aecb6e3e1b72593816604
ebola-e532d846ee27015fd6d8e83510fd4fd2655d27c699ecd88b91e5f7431998756f
ebola-8ab09183b2bcbed563abcfde70ee46d852f275b1482c429f065d9ca9af2365bc
ebola-613d444e54c838cfbe10f7c0e3688974f45b48bba65d78669c9038dd1eca5325
ebola-10160da9c8313304046d60c607aa7982ec79ee269efe8548eee6c7fcbfac9a2c
ebola-1a338cf7b9e4475737056b72c7e7954b81769d8ad3289cb38b1c4191a10e9f59
ebola-f03f8cb7f407cd7e63c851fb24e01b0a3f62f7c9a32c24ecb98ef338ba9f0446
ebola-eda4dd0eb84416dc55f1756dc6ea84931931ed092b95d39ff6d2bbc4e231bd7a
ebola-a60e954f8c78d153ab3285142047f6575e9fe12c77001ee766b47a7f23274b88
ebola-0e3f97052922a8444a30e4853a6ef58608991fbc4b692ad1d536ff86fe1cc8db
ebola-019772cf0c3144381bb27b83155296f64d0a2b3498e200331c259f78376c960e
ebola-3162b4ccb41053ada22915b17a359ee6155de90fc7253b1a2809708d10f509c2
ebola-12719bd04e01ac5cc8d49a479d00913ca2f9a557c6db69d8222fa8a69e5b3714
ebola-5d8f99864725b1daf940a9e5f9da401c0e37d7f88daf641ee7e54306f9bc2ad4
ebola-470cb2aec2a29fe9a59a63d55812fc6770eb92c09718833d4181eb2212020620
ebola-e9f96a5cec144f5da6cf694ec3087559894bdc470069f29c2b7638cf386053be
ebola-a798363583797e8e778960284a2dc7e78ca8e971966a2b056992ccce1db49ba4
ebola-f6cba29a1b164e29c42b74006481c4390b1a9dab007e993a88ad5a8a03773aa1
ebola-f3cc9eba2279f8214418adb0e5a3d8c6aa2b7e962e44b2c42e7f97abdfcba25c
ebola-e6956858a359e43c1eac4d88ad7217c40e91ef2844016baacb026c0c6a617e39
ebola-6d7395466b6cedf29877b75a90edbe3feeb35dbc3dc962447afee80a2f8ea1c3
ebola-43d55882795fbfa096cb6c510f108c763d638b23f6c0221964c37ee04a1d0f89
ebola-94244e9b0749f920ebfccf8f72db0dec1ff3d831195d801dae810bc0457196f2
ebola-1ad65731580b081760f76f4fc4bb52b85fc933c7aab81ae9fc8138ae987f0b9e
ebola-69011e54413760c68f0420f761250e215405fbbde8d065e86b810654644cd1e3
ebola-2cc40faaa86394751449c25c60b83ab99f185115d28741a021e5c73e0b906e50
ebola-a58d3695f2d9b442ee0e58c8300e8a6b9efa2452c56f173e9df5796673c2b67f
ebola-a9ce7a65f2f2f37ac7870eff872c6286a54f3994fd52338aa52888b744f12345
ebola-7549f89b9dffc203ef15e760a2b2f1bba2e2a169b2f0f087ac08ce9cf28f7337
ebola-0cd6b5793ee90cd6457ae95cdb376d946e76b79cd6060a77d8e9392f065c0a93
ebola-aea0e8075a0f724ba85a9cd713c1857b2c1eee1283e9e05805ff6855e7f352ca
ebola-386e364de13eb117318ec30543b494061969716715c3a512596d2c73916ebc0b
ebola-d04f1f26adf04ca744c28a9834608847458704ac478ab046176142ec9f5a299e
ebola-c3a5293a9bc75dfbacb15e833b3382655cadaf528d08189e41387e9e9fef4afb
ebola-5c82f99e2fdc97466b3b012b8e4d00d4b01f7048588202f9339c3a93c5cc77de
ebola-be8c0951750d65a759dc1a153a13ea8ed52018969b564ba323f97143b50a32c2
ebola-095810736223ea24f448c6af571bc27a4f890d666aa0e1984083ea771428a866
ebola-93946181ef41bb8a263fcd0d0e17e453b9f7421febe1ad65950f91b2e7d99b99
ebola-d7d8a70c4b7de2a3f5d77873ecc763b9cc77d28983a500eb46de529e86551051
ebola-2458ba39380584a1ff0ab626cad9bd86429ae91cbc200b33a5aab50d359f9875
ebola-1de946fb1e6d99e126a9507d8f10af1e3c9086508263dadb6bdf5c33b86732a7
ebola-e67f565bf94396f441997c013c29fe2360fac1e88a546b776ac102bcfd263f37
ebola-70e0851c61cd8a359caeefeae6a38cd1417a16458fa6c4100d9a3fbd4275635c
ebola-3873f067c8c9806a925fbd84c6d039ebbd0cc7ff6e856cba65bf569827f1b373
ebola-60d68d64885ca49037acaa5f7bdac24fb8d4cbe55f47487483d720e5ef6d9f30
ebola-d426d76d2073e896c2050ed449b0a46dfa93d624e353f650e2fbffdd837d73e3
ebola-6a152866da9b5024209ed33bc529564a1507c64af356f26bddc9ecb92b923aef
ebola-4e61d33132f89ccfcd16e82d757b555426be0718dd58f782fdb74a29344b2282
ebola-3ddf77385b3eb1f0ba22d25507498a7f97da4f5d7a20f8bd454415a825a9d8fa
ebola-2ad70b2e47c80f304f3de445b6073bc8cd6a22ad19f03f271a5cc0c18855ccaa
ebola-6f1452c2bc9788b7cedf3ac3463a968595d66136735a338771e1d6c137e91e31
ebola-140eee4a4193e69444d31eb9459aa2f39c57c1668bd1cf55f81eb9960bfbaa3e
ebola-f77b75dfc45b506cfa465405062ca8911710a123f90f45abb9e8d1e2c12a5211
ebola-fa0f1ff10c72b37d70ff86079a03d137a4d726ff599cd0ce4e445f4c4a70d17e
ebola-f6bb1c00a73395b1c017737211c7d6b0f0e111203e7762b997c1a3f89ad9ce33
ebola-c5f3a76ebffce2edd378367a4bb0349497b629f7ae7d002458b5926dff8fcee0
ebola-62429590b42cc2814d5884146e376208c5fd29b014fdec961adc3b14c739d195
ebola-913913728b8852f4e11f8c718ae4d01e3286db15cc6194c44f8707389b62f299
ebola-31879ed4171ec2e09a4d3383bda3c0887171f383395cd4f9256d5d7cc8fc418e
ebola-30c21953977455401d5628bf313911470ff668d3aa1591a20cca7dccdd0a7dce
ebola-876b206a5facef6d0d9e0ff72bfd7e9ddbbbbd3427787237a79223d209c92f23
ebola-16dc6f16bcae83b09c5e74c6265006988409c2816d1b6ec62e0e3dc6fd1c8978
ebola-b24f20dbe367ea2b52ab57252b0cd6b2c37267797fe29a9ca0bef6001d36c97d
ebola-f9d5b2b7f6ff5a13ad3ec5ea150756ec7755ddb475ff480de30b9097e07c6055
ebola-8210d7ec943df935f06ba6a9e1e531d145af9749980c6e6fc4cd0575b0fe722a
ebola-fec20cdd205325cb99e2198c10c8b44226e5868cf329fcfe9a770f2a57d821e5
ebola-5397dd42105b27dbee5120b27ce3500262e327e515a1fb1f1f8e90448a8d8f77
ebola-61369fd089adcc2c955edabf3e6d0e6ae638b0842f0b87afb5ef33c2ce7f327c
ebola-118f11288a6bdbf23305b4e94628dfa50829aa61e660d14c72924bb9c6ca0896
ebola-d69f5ec4561f614d7062adcb837a61fa444468803f0da523eaebdd5a23faeeba
ebola-30a0349c7ab4730915e5f763074ceadabc063babe3745804fbe9348326b6dc2d
ebola-780f5e529a5dca873b9c265eef0db0266c08c287624a2473bb2f665370b658f3
ebola-0e9008b26e49f6970bc5d7040a6a1025f2ad513100fbab2d199bd38832f4b111
ebola-6f3071b68bd6aa9f55e5d7d0ae963374b8d6c2c09e508fe7f773fd7821f45076
ebola-6483a13de65757c68d3f4f45c0442507c88fc201a6c31dd618899330e345639d
ebola-44fc0d18677b2ce2a4b2b6faacc58d4c4129c6f356d09c607d7e2980542fb4ec
ebola-d8b6ae8a45a09e894ddb3ecac7b2083467adf71cdb8cf8e352abed6649468aaf
ebola-a4b95d551ce55383e6a0068a3fa36ead781c023489778ad84c2e7e4d9a0f9c0f
ebola-23e2a5edbe5702010c1a213eb3ae84a04fe513d490a226aa7929044edc24eba4
ebola-4a9156243680940c888e74ec405adaecfdff9af864253df6c236db29dbf31a31
ebola-8d1a07840e6e7842c6c33a639eb38a1b5849b907c717b2931067216a61b606c6
ebola-139140bdf5024666bfef94078f3c40d6c8f917b5ca98165a7721c362e7b2af39
ebola-33e72f77ea4707222ff0cc21b54c862c02559a2f48cfbcf033534790a53113c1
ebola-b6f0ee2784b7cbd58ebd9f7d8010719f24da785d384fe0c92ee7206a43e03b43
ebola-23df89a3b16ffe0a68679ee2b82548922f57799f52475ec3e9dd005f76c3b83f
ebola-938ca859e81a1065f721d383d32590370dcd3bb2dc24ee18cb24c6dae1ef7530
ebola-9fe97fe6aa44de0b7092fa6584e73d669a1a816e103cc3b2d4041b4f9e816f87
ebola-a08b8dfd8effcc4ac02ee166b481d61db6edcc1310a0ca0080708db7b1a0e186
ebola-71dc2311b3b450ae80e71ec39d870c09371ce8b052cc446501556824c858fe38
ebola-7b2b09e7c81633a84a1dd626e84a1da8cdbeadbfb16707e4e0e6d3be5775071e
ebola-6073d2e066d6700ca794d86b26aeaff8cb1e88eb016c57b218c95e64a8406772
ebola-c320bd64d1c58203974f59beab4096e8c41063b668b15b48557b86f55efa241a
ebola-c0348525a2e08a68c0a33780f56ef6db380b7fe43b0a14f9a93805a53607e5a9
ebola-cf8acc132a9f64d77c34f7bc6bee1439f0ad85494ae9213be5625a500635c8a0
ebola-d3f614594c423bde74e0524e1f5d783f2fcb597053d0ccb8eca75184dffc4b48
ebola-b040f890530b669e335dff8dd120f066a33a97459c1e481242f4d17a105c8675
ebola-962cbec9a83a19ebbcde0345d73f14caf93c35351b4bf33041e9557c4a5a6c0a
ebola-e40fb24d9d13c95850a7f96d75c1ac2ba9d461eaa3168b3a4d10a34ce1fa413e
ebola-1e34b8dbe7344258854b6a359358009443409cee5c97db39629754ed5c1bb071
ebola-6adb5d6057e902c94b05b865a1b000ab93d1fa8d85b599dd2a83c57538389698
ebola-8d48eaba8cb78f4318cf05164fe3511d525ccaf13468acc7453f148862799a6d
ebola-edd587573d210c06e4961ae513be2ad7c7d0a20aad507762d91de8f9e92438ed
ebola-0861b94d7d17702759c3526c16fd9737d022f62618d0b3d1e85c0fae2ae03fc1
ebola-5ccf2af6d6a00b6dbebb1ba1227b510aed3be428735e62945e0771f7dff0c88a
ebola-7e549516d5968662a549ccb7f4a3d9567c6286efa20a68fad99ae28829b70a06
ebola-f77e65e48169b74fbad32f589ed8fca98ebceaf61a924008448830dc1ce88fa1
ebola-086aa60091ab72627f0a9bffe355f103ccb0f204a9065da70c4b1d1786cc45d8
ebola-e04cf29621e2d9158472f2ea05fefa052d283c376d5cfe1f55d37f94100636c7
ebola-9e9202f6248889aa015dbe19034d69dfe38e95115d56fdb8e226397b745c266c
ebola-cc9f61315e43dec8b5a11dcd0215c69fc8fb239501cae73db9979a55d19ab322
ebola-c40992330cb8fe917b0b07fcbf8608f4e68bb7dca0582af8630518bcb52bed57
ebola-5804661d7167b3fcff8ee12ceaf2487ee3d978b01bbabc30b0efbb09e49f5ae4
ebola-f8ba6700a3dc0741a7e0c1b50cfeb1507679e51af6925a4ff67224a80c24ead9
ebola-6858d4cd66d985cadea7f60e97665e08f8f761fd65314cba0da27e3744ce58dc
ebola-673b6cf839699032d35d19981ac6772356f6d6c95de2f119f2904721ba2b2609
ebola-48698609b6d78c8e52ebb35695a62b83be68c9e6050ece5078ec5129ea9cf1ca
ebola-5897bfd6a74d9535f1deafdcf005e63b84f58ef25daf509dc823f03a53146bd1
ebola-09a78a87b38b5daa4938b15390fe02a26acefca155cfb9098964c233e0aa0955
ebola-cb19d5f8339f122e09eca211b6dd1232def3d988b6c01b8aff99ee20f465875f
ebola-48fd37b30614e9d7ca2f750a043c9eb02c8671e891c4b46013dfd443a408e5f6
ebola-204f7efe912b356d18f7edb5a102a953ac2e80e05f49b0d505803e2636be8f9e
ebola-58a14c1635db0248c512fc5b51ebea1d3699bc34708229e496a12a17191c1fd4
ebola-9966acfb62b0d1131b552250578a986548883a230282f7a4578d6209429afb8c
ebola-48e00a3d42c7bb85fff722d9c97fd9fc6c65ebe558ec95e2f9c169b8010edc29
ebola-5412710fed3d862c8d519c80fc92187b004b2d27d771fbf0d6b157c1ccfa8822
ebola-d0d98dbf4a806ce3d513c4bab7899660f7fb3b432e6cce51b7c24ce527c3b8e0
ebola-57aed64eeb4008e1488938e89e630fc871ea2be3599c5336e0b4adf386613a0d
ebola-77b7ae5ba9dab21f36769b87568be2cb3d1234282abe0c02cd36573585b89e89
ebola-2f86381fd3eb94877171ee1ab18b007471fbc6b94dba7dc0dfc3f47ecc55f26c
ebola-4f7bb1973575628d92cfb02b1e9bf0e62baaa05e9344293a2f6c0dac548cea74
ebola-ed642478855f4bd4a4b2d0e18da50d96fd4eaf3670e14a3dc9fbf317c3839700
ebola-c2c44a34351ad3f53e812a7256179ff2d768609b947513b1584f3889ecb77385
ebola-25b652d85ef5578812da74be4f6910c13a345a1408b1e8ef03418e233e3118ba
ebola-1e00e429460833b80afd4e126607e0bc81c2346dcd99e8869a6a06ad0b75c469
ebola-a83c4efa4e6ed8f22b7e1c634b6b76bb553307680927cbd27728b577b622181e
ebola-d83f4d3ac74fd3ee6789b60f8036e3289cb4095f70fbbe5ac93784f607a6a4ea
ebola-b105d2fa33597743005287b4cc99a3ba3621c29ad11e5d584f117e8e5dcdb28c
ebola-d76e09b848e9fe5213c9500b24f50bf8e47ed01b3fed12862cf0d0ab6ecd70ee
ebola-16546929e0fcfbf4493add225f3673d859627a701e5d2cfc8e04d9c20367d189
ebola-1198ce90a1f79f88fbf19963712a76709f428018d310e50c31580373c8b0375d
ebola-28ce2d14db016b716e1cb8d79d5551f5ad9a7d33530917fc2b6186156d92f979
ebola-a13350917493aa3abf38c8f3dbd565f54aec38e8dd3929c606008c2938f50eae
ebola-9c1543ed0bc8bd0797b24b33b4e4e81a3491f4388504fbedf2680157312591cc
ebola-913d99646ff6a2c7d7b1e4b7aeb991f84f1e029b5edaf4371eff75e28a11bc75
ebola-ca8e75438df09d5416ef0c690a538caa1401383d8442a4cee7b4bb29aec86df6
ebola-448e365dd4758bbfe2d3006b7ce95d38f7661537d199afe300ee8c98cc9132bc
ebola-bdf9fdda79f820e4adb4c4511e6fb1feb0a84f92b4663df255cbd751a7b25219
ebola-a871fb844f450cac6a1b4a97500a1460f4c21be55090d3fa8cad10a96daab3bd
ebola-6406b9e30557337d8e3e1490b0a0425989c3d7c945adcd597a04adaa76e7bad4
ebola-3a7d2234019478c0aac08986568cb24292577f062d2c9e30e9e3edf4668cdc52
ebola-453d683531414a0948d5d2c7422bc064e95336951bac521d29cf5cdf7b20015a
ebola-d55d84ae4f2eb2c7d913bfd1b30e41407ae652b39a0799fa1e347943a06a13fe
ebola-0a1eea2be432d4c43484347d0055a15c8c160b69cc26125f35c5273cd9801c9e
ebola-7c5831b402960aa129a435376f036eddfd9fe68eda48a88eda66c0b8c339af5f
ebola-1a9f4ff2fc033a4cf65d291214f9e5f1e2486e12488478441dcc5cb78aef87a6
ebola-279fb510e0ea45e08092c625b82d53ec3057c6d018a5ca20018f29a6c021cbbd
ebola-35a6c69a3061d817b4c26b6852858508291cbab52ce1fea2b4bcb4509d9714e2
ebola-86da5d9c45f6e15c0afdb652498dfd1fe60d3ff2d29f1eab579d6a92d631831b

list/click  |  time: 2016-04-19 11:12:12 680337  |  # of fields: 4  |  topic_id: 397  |  docno: ebola-3b494b1ad8b7e3671401b5c5d20cb082bf224a17f31eda835376b821e3e3abfa  |  listsource: lemur

highlight  |  time: 2016-04-19 11:12  |  # of fields: 3  |  topic_id: 397  |  docno: ebola-3b494b1ad8b7e3671401b5c5d20cb082bf224a17f31eda835376b821e3e3abfa  |  highlight_string: healthcare impacts costs ebola

query/lemur  |  time: 2016-04-19 11:12:57 841353  |  # of fields: 3  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  query: healthcare impacts costs ebola

result_size: 300  |  num_tagged:  0
ebola-3b494b1ad8b7e3671401b5c5d20cb082bf224a17f31eda835376b821e3e3abfa
ebola-334bba2cca2807a3d5096678010b6d9f0e6328ad284896fd5866304be5aaa0dc
ebola-9d0a8eed7597c1b520e3c01bba5717bcdd10adcbae666e90ab70861bace6ffe8
ebola-753d3a150a96ccebf1243c46c3a52a9a15503676cfdfe3697f3696a0b31dcffd
ebola-080008f6c58cec3cee9fedbb22e7874e3dfb33116ff5acc2e68ab0040fac4e1c
ebola-f61616659ba37e9f7b89407c4bc818ec2f46dfb3be7b646217a83438988bc9d9
ebola-2d6b7302444b7997fa2b0c56df041febf0cc4eb98e72b22d405730285e0d9782
ebola-f580ecba794cee1f42540b53a62f5b24e4819f3864df17d579e90c52f9d0fc71
ebola-42471be60460935d889f74a6bc6f1674fea651d0a67d8aa8bcbb3d1e8e08c152
ebola-a4afa9ba8873e8038b662957b17832531574408fd50821613b065f323fb189d7
ebola-d509bdb0afc26eed8ed04f6530217a8510eea3aaa2c3cd04cd2cc14fa8ecc7e8
ebola-56e4e42cbaf1933193a5abaf1f1ca3d0254fbae25498e96dd69f36961a852762
ebola-b51bb3f0107100e220f6e3d7a40aab058b82af388c4543b91aa12ad882d23994
ebola-207e580eae1656dd6fa141c07f7ffa24ad0b4be1413e7fd4e6f9ac23b2927987
ebola-1e9df05453557bedb84840932b01e4b57d08ef2ecabdf3c58227ad906ccefd15
ebola-967217a11c602e6a603247b5a91c5119d1cad68af6a0f4f4b6bdb10ca1ffac21
ebola-8450ce3afc7008a4739c858960205f64e9d9b7b6f02d1ad471d6f5659f03a3f4
ebola-6523543ef516a6a973603c172c9b248072d22c2a3dbe9c62e44d89eafbb59456
ebola-534c708a6d7bfcbb9ef0c2829f7c4b3e9755cb00d4eab0ff222521360a5a5695
ebola-21dbfd488c0c46d8eee9fa7224ebe6247ce03032f1d5eb12e9ef7f1d61cda69d
ebola-e6912bf7d799d1db2c2acd15f4a7aac5924598d514c0c2e1823ec51efbf02575
ebola-849d25a28372bdaf22273a797812aed3a5711006ab39c729fb5ea63d54bdf4c9
ebola-77c399d1dedaa9f6d24c88d6fd2628037468bacdcad4b47c889ab4fb7572b4d9
ebola-8656df476773eaef1202d7d27851ecb68e294d210bad1be10729568d0ac0136c
ebola-6420ac8055e10e42a8b91f9070c33620fd6094049b0534020229b6075d8879cd
ebola-7f065ef3bdbfc22b11a0693b604f6a75d237ac106775a0aa7363494fe229f7b0
ebola-8de06206d14ac4a96b72d79f49d4841521cd2a396c965459dd30bac970e812e0
ebola-fa81efe363d222ee556936ffe17a81da5d7a6131d79d1e05b5232d1c026dd535
ebola-1a2719ebc9d4868e44425e90e96ba44b151667efa6aa443bac187fc4240c014d
ebola-c27d4d504920909e578d52b4f02e0074222e37c5f5fbd2c8d2d31232516935a3
ebola-c60ec907f545bb871cd9b30094906a3f8117ad3648f01b3d3f4093b2486b2652
ebola-0f3caa1ded8a6ee9dfd7052ea574bf082ffef67bfd2012761d17b7d21efa476f
ebola-0d87e550a1551f3776117182ae850063d80c39bda0ed05300ede185748c7183b
ebola-a3d6cec81c1ae4558ba85cc5a4b945ea014720994907581854a026513eb97183
ebola-3d611657a8d500e076f071ac379643ff849a338e87d11bdae71acdd4cfbf377b
ebola-1304d27a5aed50aa80d7ab061bb5c1f5eac52b22373523a29ff109df51b7d83b
ebola-aed19ff83ac981718fa08caa1158caf61c00edfac7ccc5786fd2f6f2ff007723
ebola-c203b08b595e032ecafb20aa10bcd8053ca4bd478eab7f3fa96f5e7c857c5a39
ebola-e1e333e149c1892978591d622b73e22038bc918ddc0e13557476b276b9ea995b
ebola-47a3856ee6048e459d1de88edc0a55343e2ad6e103a6154f46bf282f8108c258
ebola-c1452dc742faa1841b759c4f41157669dff179fa001012c5abc6e99d4a52bb2f
ebola-656efed7fd698911699487b736ca92c6995682b5534de107951de63e4fba69b4
ebola-2ed22fbf565006334438f6931c760a3613f59d0f047d97e0dc7caf72d40a2aa3
ebola-70a40ef7ddc055c8e316d6a27f46b8ee98ac1c3701b02b4a70f591173517c086
ebola-645a8af3ace496323fd3328f765a1820a9bc45bff1ebf6fb74372de778d575ba
ebola-f155f4046188598a9cb5a63d80c8d3c0289d99506d4ff7425ed5f2c8ed7ce23e
ebola-2221f29d6183a19f2cabfe096c791291e81cd91dd2f8bc9d05c709c785cf79b6
ebola-c4665c75539a519d14fddb40825b17194d4abd7a6454f6babfba76db757e1509
ebola-cacd9c2a906a7c8cac9faa760332f467847e0e35fe9275a9f506a244e02d9c63
ebola-47f0361cc8a2a20250b6772c7893d044c1fe1b9f3d5716bf9a56c1cc61196b3a
ebola-2d33381c8fdb2147ceb925c4c746489f981118568f4b88825fe3bf9ad504ef98
ebola-abe7801efd195837f19077d5abf538054f92a2b3409c0450b5b31dda23eacd88
ebola-c1cd79bd9fb8eac68bed419f101e6c0d8cdda9430c47ec729ec1370888b2f9a2
ebola-a9953ff579096eae4493f2c60e31f4314d3b0176e1e9c70ab3054ffe7a111475
ebola-439325b73d844294a363aca72c1147399bd6f275a8baf199312ddf37f4234992
ebola-80b5522e53614f55cb1492ceb07ec6f8cf6316b49e1901766f8489e33860226e
ebola-22546759770bda96998534821dc1899fe609fe3d95bbf87e3a8831e61b5cbdcd
ebola-c8083a1e7bdb768e717d974c461d5ebe73b2ef406bf5730530ca952d8fadd813
ebola-debb50eb07c9df9f62b7e25910f10da7ced01b186ad9ea309b2d434aa7fd4e1c
ebola-adbc27f45404bfd9c00de865b5f3268c3e2818d65afdeb77b127fdebbdca2d56
ebola-7269fe5e451a73bd91ce0af1f30214d8294e58556525d2abced8ea2f59cd9270
ebola-37bd96e0da796a4f1a79412873eebd4812552a10ccc30e1beb67e1221a3b88b2
ebola-bb558f36e17c55c6a5111cdb0250ccda898b6de733704980e7c56e96269c1e2b
ebola-0a0bfca873c823ebd484858c40811c53fa591452df3c685c39317a0bde26cadb
ebola-88cf07bb51227255c6352f66884730ee6630b8bdc39e8db58126a9fe207113a6
ebola-84c8ef8ebcb64b4d6ba400ccaabe7aeb6f469ca31e5a804aac79fd73cdb4e523
ebola-1bc7780700f01f6c06781766f5ef2a467c74e32f9c9320b1284746a67e936eda
ebola-5b916eb6d614bdd673b97f49ea842c99607c67732f9254ee623d42611461cb5c
ebola-7a983224dcb45a59b39a20fef829c1b92e2abd13867dc23e1d976572305d7e01
ebola-9db789e50a5dd2494dd2f881e0c5678c8f389151306c235f6ddc71c8fe0c78e9
ebola-56ae37a08ef822a317e60ce94e76241e495dff639cd54f7da17e757875d3306b
ebola-75aaa92451140763b7cc13f501330fcc2f4b656a5bd0af5b1d7e110e46c44d22
ebola-5353142d7ac154552577129bcd106c53cdebf6154499d068751880c193220e50
ebola-0e99dc4e69d57afa571419cac72aff8c2d2e58cecfdc958be6b662646aa24677
ebola-484b44670792de2aa891655c2b419c4dda0d68035846e934b049b2d3c3558860
ebola-1ff65aa6a4f36ca8e9bdddb49933a5b167be8bf20536f06a8b14f8e5c750fff6
ebola-f82f85e8180b8d202a9899cdbb6a829f0d6fa525d2c6ed8f35196ee5c72a8823
ebola-5ead8888f4444b00cecd2f146d92f064c51daba0283838a6eb97f21b07210d4c
ebola-67e3640ae2ac5c1d5ca9c40cfd4ddbeecad1ebb32fb884b75ab8465e3d62b9fe
ebola-c27f5a84427839f29d3858b077f72653c2c8c90de9cbd94aacc1357db57fac5e
ebola-aa67f0f5f13c56cb572c029e4d32b2be60360f08e4c4fd4c4b867fe2522e9303
ebola-708b405aab5a5eb4b6109374dce653962f5a80a34c519d9f1bd3a7718566346b
ebola-4d00b3be5bf48513db9d2a074c31c6e11d6d218afbc93a2746c2b5f9becf1b29
ebola-49afd07054dadb7e404147adbb695599f693101b3ab9cf5acbfb68da228bcfbe
ebola-2305e50bca61445851c0bcb0930ea207e0eebdebf1d7705a1756dc084112d367
ebola-ac0bdbcfc44afebe73d6abb0d60ddfdcd76bafde982aad26d78090ecbd6f83c7
ebola-b68e9ee9d6037be85daaf918da28b01ec999c8bca557518c276d3c8a9dfef4c8
ebola-b6394c4200716d9fd01e90e5589041d407e63c4657a19900d8da62801c07f756
ebola-3969ff94ac3602f07504584c14ededd601f3e7953e1b85fd8508ceb06ec0b3d6
ebola-bdec02759ea1b376d362e879e33985e01027ebd505e775740c5c7df716edf289
ebola-60294b2a63766a9b48af09c1691d3a424d26cf8baa1435c408217c6a5b39e1d1
ebola-a5c4ea27c6d03f69bc2480af8de268ff27d60f08e9368f58168271e13d2ac9d9
ebola-18f4caeed0b5667129db14f1c25f7b8bbcddc480b980288ba81b2b584ae432ba
ebola-761e008ae17942186b2b150535fd6fabaf32b7ff81e38dd051f702c5010fb8ed
ebola-144a260ad2f0233593c09e0f735fb5b6ee504e54708436b1d44d9c2ea6f52884
ebola-007196c29e1f6afa0478759f3307793d6d2f335e48baa65d2fdb9fd1cd5e4e26
ebola-30756ad762525195a488111a0137d3aece920d0049445db27626f5ce5d205093
ebola-9bf3a6b53c6d8ef4ff7225305933c3ea95becfcb01e064f78f466d545e68c644
ebola-0327e347c891fc9088415e829d24c7a853fe7daeaa94172eda54ffaa0fb6c467
ebola-2cb3b9799af44881e6f13b0aa8084b8d670a1bf52b17fdc4d9db1b0007892428
ebola-f6cba29a1b164e29c42b74006481c4390b1a9dab007e993a88ad5a8a03773aa1
ebola-fd0c1b605a3453215dc412f13642e7382fee3054ef6eb71015bcaf13dd6d06ed
ebola-5db3bd6f20a345801b4a68f89ff1b5a308ef2fe86f290ea627dd85687388fb3d
ebola-1d1f93f32b015b2fdabb585436b4865e79d8dbd456f33e0d5641d9f3d6024c42
ebola-4d3f9e4aedcebd5d80697942ab121dba4fc793fe8956137dff97c34f21df8906
ebola-fb9d62e6409ff67aae244fb4459550cbd4b8b06c270da99a44cf4b5679b3a26d
ebola-0e3f97052922a8444a30e4853a6ef58608991fbc4b692ad1d536ff86fe1cc8db
ebola-08ea06f5c52f0fbd4fed6d260bf98f552bf0f979b42671764909ed6861a967bd
ebola-d1f91d0d95a763c68e4abafcca6f501c0663a99ede8c7eb5b86885373be42ff5
ebola-09facb19588b35bf8627a73dc613ad73d9514c29e1559c8484fc8805fcc82f3a
ebola-65fdb3ce7f6664b16c0be963f9590286a3a5ab15c6fd39bbefdb5e921e8fda6d
ebola-ae1adeef917b0b73b7f145352c533a6d8b2e3d7afe034574821d9e4a2ca49983
ebola-9e6503708e6e5ce821802508f0a5df7e0acd2c417902477fc40f79bd4c7c670d
ebola-919ebaa0683871218db09b4647ae0ee935a5ad801f6f14d07ae485a9dc083c2f
ebola-d9323c9afb59b83d5c50c17c331660de357cd8139e5ea6660c72ec00b0d51736
ebola-3a7cfc7589ecc152457f7c2c3a6e8c4572f977997e0ecf70f8318184cfbcc10c
ebola-72b9d42f51307b169c3bcdc3c241fe1b493bc71c3027469d2b87a469fe784120
ebola-2cc40faaa86394751449c25c60b83ab99f185115d28741a021e5c73e0b906e50
ebola-a58d3695f2d9b442ee0e58c8300e8a6b9efa2452c56f173e9df5796673c2b67f
ebola-0117b4f6994387b95b0bf771146fabadcdb93989d494e201d660e549d7362a99
ebola-a11475faf648efecc7df720156645794414179329d6be0b61dfdd53a6c8e2159
ebola-23dc72dbae43e84ea66ccfddde84372f5fb59a0e46f7ea185fbd1c6af9286e73
ebola-f3cc9eba2279f8214418adb0e5a3d8c6aa2b7e962e44b2c42e7f97abdfcba25c
ebola-5c82f99e2fdc97466b3b012b8e4d00d4b01f7048588202f9339c3a93c5cc77de
ebola-ead02635d8d4624c5e85c57ebe754df8447f7941e1aba54d00d37cd10a025157
ebola-73a13aaf9bc06de3059ef94a2f7f589e967ebe1d6ffe7ffb7e0f8f496e46d796
ebola-e116db2b818654e162a93045be542632374e1f1fdfbefdd24dd38c13a826ae01
ebola-6d7395466b6cedf29877b75a90edbe3feeb35dbc3dc962447afee80a2f8ea1c3
ebola-2cc4026358fa8d4179cdda66a42ce1b228b6a25c03e7d7598b5c3674da977281
ebola-5b772bfe38e68757305460e49514cbef9b23f0f2f896864cc729922fb4aa340c
ebola-5d8f99864725b1daf940a9e5f9da401c0e37d7f88daf641ee7e54306f9bc2ad4
ebola-eda4dd0eb84416dc55f1756dc6ea84931931ed092b95d39ff6d2bbc4e231bd7a
ebola-019772cf0c3144381bb27b83155296f64d0a2b3498e200331c259f78376c960e
ebola-6a152866da9b5024209ed33bc529564a1507c64af356f26bddc9ecb92b923aef
ebola-e532d846ee27015fd6d8e83510fd4fd2655d27c699ecd88b91e5f7431998756f
ebola-0f7147ee43dfafbc47b2304b39dd7894c1f50f76c287bf253eb5c3beb357bcab
ebola-94244e9b0749f920ebfccf8f72db0dec1ff3d831195d801dae810bc0457196f2
ebola-5f97f24f2f25826664d63db55879055d7d4d0c3df47067d461a494047de9a2c8
ebola-10160da9c8313304046d60c607aa7982ec79ee269efe8548eee6c7fcbfac9a2c
ebola-f36d89d627e978fafad9108eecce434234c64e8a41c537b19ee732c90729aed5
ebola-c44244d74458dd3e105ccfa801f2b770bb56334dfe99b67bfa7333eb9a43aad1
ebola-0a49813915309df039fe740c89ab7f8071158236981cb78713def4236bd4d745
ebola-b20ad8859e0b6b8c3ed392a68dca6cdb4b00f89056e3eec2ba9f5bbb11cba2ce
ebola-afb585c037d098b44fce944074e9f92fecd88c312252dad39006d028f129bbcb
ebola-c467f20e535bc5a72bea8764b540bfbdbf4768ecb642348bdc7cf723ea4368a8
ebola-17b3c34371053f984685fc3f01b3e498fc801c56ad18934feec19f136bb7078b
ebola-613d444e54c838cfbe10f7c0e3688974f45b48bba65d78669c9038dd1eca5325
ebola-f5dc9abcdd8851968ba43991d40da0c2f4c031582c701b443c56d56d08bdae61
ebola-2929f7d2f68db418d07cd1cf9fd96905b4bbc61b6f0bf267a9bebe7c17bcc528
ebola-a373548060857318d7f1a93a9bd768db8d762d974f43713fcdffeb62e36a000a
ebola-095810736223ea24f448c6af571bc27a4f890d666aa0e1984083ea771428a866
ebola-1a338cf7b9e4475737056b72c7e7954b81769d8ad3289cb38b1c4191a10e9f59
ebola-d7d8a70c4b7de2a3f5d77873ecc763b9cc77d28983a500eb46de529e86551051
ebola-f9920d4b0caec4f5a6a978ec96afd918e9bf03f5bb0580d04b92804b18e1e144
ebola-e9f96a5cec144f5da6cf694ec3087559894bdc470069f29c2b7638cf386053be
ebola-1de946fb1e6d99e126a9507d8f10af1e3c9086508263dadb6bdf5c33b86732a7
ebola-3043b15222884456adcf6e06a5cd978824cfcc4a0dd947fc3d0e52d22e435f6b
ebola-8ab09183b2bcbed563abcfde70ee46d852f275b1482c429f065d9ca9af2365bc
ebola-ba8004fd803c6158795bd550267387b663b24311d28c4c589115c87bd884623f
ebola-d426d76d2073e896c2050ed449b0a46dfa93d624e353f650e2fbffdd837d73e3
ebola-721c813a4ce5d3f9839e2c01474c685ee127c7f593d4f35373b3eb59dfffb07d
ebola-0e9008b26e49f6970bc5d7040a6a1025f2ad513100fbab2d199bd38832f4b111
ebola-a798363583797e8e778960284a2dc7e78ca8e971966a2b056992ccce1db49ba4
ebola-43d55882795fbfa096cb6c510f108c763d638b23f6c0221964c37ee04a1d0f89
ebola-470cb2aec2a29fe9a59a63d55812fc6770eb92c09718833d4181eb2212020620
ebola-1ad65731580b081760f76f4fc4bb52b85fc933c7aab81ae9fc8138ae987f0b9e
ebola-e6956858a359e43c1eac4d88ad7217c40e91ef2844016baacb026c0c6a617e39
ebola-0b2910ecc6dcfa3e98650ba5dcfa2ef71c2870ffa01aecb6e3e1b72593816604
ebola-12719bd04e01ac5cc8d49a479d00913ca2f9a557c6db69d8222fa8a69e5b3714
ebola-f03f8cb7f407cd7e63c851fb24e01b0a3f62f7c9a32c24ecb98ef338ba9f0446
ebola-0cd6b5793ee90cd6457ae95cdb376d946e76b79cd6060a77d8e9392f065c0a93
ebola-69011e54413760c68f0420f761250e215405fbbde8d065e86b810654644cd1e3
ebola-6e3342b0b4945075196a79a33cebdd0d2479ba599b0a7692615df289ff5ae323
ebola-6483a13de65757c68d3f4f45c0442507c88fc201a6c31dd618899330e345639d
ebola-a9ce7a65f2f2f37ac7870eff872c6286a54f3994fd52338aa52888b744f12345
ebola-d04f1f26adf04ca744c28a9834608847458704ac478ab046176142ec9f5a299e
ebola-b4451c56c406c3fa3ac27e57313b510097cd364e302667a5ec8016d08cfeea92
ebola-a60e954f8c78d153ab3285142047f6575e9fe12c77001ee766b47a7f23274b88
ebola-c5f3a76ebffce2edd378367a4bb0349497b629f7ae7d002458b5926dff8fcee0
ebola-60d68d64885ca49037acaa5f7bdac24fb8d4cbe55f47487483d720e5ef6d9f30
ebola-e67f565bf94396f441997c013c29fe2360fac1e88a546b776ac102bcfd263f37
ebola-93946181ef41bb8a263fcd0d0e17e453b9f7421febe1ad65950f91b2e7d99b99
ebola-c3a5293a9bc75dfbacb15e833b3382655cadaf528d08189e41387e9e9fef4afb
ebola-b24f20dbe367ea2b52ab57252b0cd6b2c37267797fe29a9ca0bef6001d36c97d
ebola-1e34b8dbe7344258854b6a359358009443409cee5c97db39629754ed5c1bb071
ebola-386e364de13eb117318ec30543b494061969716715c3a512596d2c73916ebc0b
ebola-3162b4ccb41053ada22915b17a359ee6155de90fc7253b1a2809708d10f509c2
ebola-61369fd089adcc2c955edabf3e6d0e6ae638b0842f0b87afb5ef33c2ce7f327c
ebola-aea0e8075a0f724ba85a9cd713c1857b2c1eee1283e9e05805ff6855e7f352ca
ebola-be8c0951750d65a759dc1a153a13ea8ed52018969b564ba323f97143b50a32c2
ebola-118f11288a6bdbf23305b4e94628dfa50829aa61e660d14c72924bb9c6ca0896
ebola-4e61d33132f89ccfcd16e82d757b555426be0718dd58f782fdb74a29344b2282
ebola-2458ba39380584a1ff0ab626cad9bd86429ae91cbc200b33a5aab50d359f9875
ebola-7549f89b9dffc203ef15e760a2b2f1bba2e2a169b2f0f087ac08ce9cf28f7337
ebola-6f1452c2bc9788b7cedf3ac3463a968595d66136735a338771e1d6c137e91e31
ebola-31879ed4171ec2e09a4d3383bda3c0887171f383395cd4f9256d5d7cc8fc418e
ebola-f6bb1c00a73395b1c017737211c7d6b0f0e111203e7762b997c1a3f89ad9ce33
ebola-2ad70b2e47c80f304f3de445b6073bc8cd6a22ad19f03f271a5cc0c18855ccaa
ebola-30c21953977455401d5628bf313911470ff668d3aa1591a20cca7dccdd0a7dce
ebola-3ddf77385b3eb1f0ba22d25507498a7f97da4f5d7a20f8bd454415a825a9d8fa
ebola-140eee4a4193e69444d31eb9459aa2f39c57c1668bd1cf55f81eb9960bfbaa3e
ebola-23df89a3b16ffe0a68679ee2b82548922f57799f52475ec3e9dd005f76c3b83f
ebola-6f3071b68bd6aa9f55e5d7d0ae963374b8d6c2c09e508fe7f773fd7821f45076
ebola-fa0f1ff10c72b37d70ff86079a03d137a4d726ff599cd0ce4e445f4c4a70d17e
ebola-f9d5b2b7f6ff5a13ad3ec5ea150756ec7755ddb475ff480de30b9097e07c6055
ebola-913913728b8852f4e11f8c718ae4d01e3286db15cc6194c44f8707389b62f299
ebola-3873f067c8c9806a925fbd84c6d039ebbd0cc7ff6e856cba65bf569827f1b373
ebola-70e0851c61cd8a359caeefeae6a38cd1417a16458fa6c4100d9a3fbd4275635c
ebola-876b206a5facef6d0d9e0ff72bfd7e9ddbbbbd3427787237a79223d209c92f23
ebola-780f5e529a5dca873b9c265eef0db0266c08c287624a2473bb2f665370b658f3
ebola-53d93c415f2234c1898a8e551416ccad4b032020a9f5bc50b8fecd00898184e9
ebola-8210d7ec943df935f06ba6a9e1e531d145af9749980c6e6fc4cd0575b0fe722a
ebola-62429590b42cc2814d5884146e376208c5fd29b014fdec961adc3b14c739d195
ebola-6adb5d6057e902c94b05b865a1b000ab93d1fa8d85b599dd2a83c57538389698
ebola-fec20cdd205325cb99e2198c10c8b44226e5868cf329fcfe9a770f2a57d821e5
ebola-f77b75dfc45b506cfa465405062ca8911710a123f90f45abb9e8d1e2c12a5211
ebola-5804661d7167b3fcff8ee12ceaf2487ee3d978b01bbabc30b0efbb09e49f5ae4
ebola-5397dd42105b27dbee5120b27ce3500262e327e515a1fb1f1f8e90448a8d8f77
ebola-44fc0d18677b2ce2a4b2b6faacc58d4c4129c6f356d09c607d7e2980542fb4ec
ebola-d69f5ec4561f614d7062adcb837a61fa444468803f0da523eaebdd5a23faeeba
ebola-33e72f77ea4707222ff0cc21b54c862c02559a2f48cfbcf033534790a53113c1
ebola-d3f614594c423bde74e0524e1f5d783f2fcb597053d0ccb8eca75184dffc4b48
ebola-6ddcbd0b094513bb309440a7c1225d01c4d95fcbf40f0278df0bc0eafc5d02e0
ebola-30a0349c7ab4730915e5f763074ceadabc063babe3745804fbe9348326b6dc2d
ebola-c0348525a2e08a68c0a33780f56ef6db380b7fe43b0a14f9a93805a53607e5a9
ebola-5897bfd6a74d9535f1deafdcf005e63b84f58ef25daf509dc823f03a53146bd1
ebola-d8b6ae8a45a09e894ddb3ecac7b2083467adf71cdb8cf8e352abed6649468aaf
ebola-9fe97fe6aa44de0b7092fa6584e73d669a1a816e103cc3b2d4041b4f9e816f87
ebola-5ccf2af6d6a00b6dbebb1ba1227b510aed3be428735e62945e0771f7dff0c88a
ebola-a13350917493aa3abf38c8f3dbd565f54aec38e8dd3929c606008c2938f50eae
ebola-a4b95d551ce55383e6a0068a3fa36ead781c023489778ad84c2e7e4d9a0f9c0f
ebola-16dc6f16bcae83b09c5e74c6265006988409c2816d1b6ec62e0e3dc6fd1c8978
ebola-139140bdf5024666bfef94078f3c40d6c8f917b5ca98165a7721c362e7b2af39
ebola-8d1a07840e6e7842c6c33a639eb38a1b5849b907c717b2931067216a61b606c6
ebola-25b652d85ef5578812da74be4f6910c13a345a1408b1e8ef03418e233e3118ba
ebola-e40fb24d9d13c95850a7f96d75c1ac2ba9d461eaa3168b3a4d10a34ce1fa413e
ebola-23e2a5edbe5702010c1a213eb3ae84a04fe513d490a226aa7929044edc24eba4
ebola-6073d2e066d6700ca794d86b26aeaff8cb1e88eb016c57b218c95e64a8406772
ebola-c320bd64d1c58203974f59beab4096e8c41063b668b15b48557b86f55efa241a
ebola-57aed64eeb4008e1488938e89e630fc871ea2be3599c5336e0b4adf386613a0d
ebola-938ca859e81a1065f721d383d32590370dcd3bb2dc24ee18cb24c6dae1ef7530
ebola-d0d98dbf4a806ce3d513c4bab7899660f7fb3b432e6cce51b7c24ce527c3b8e0
ebola-6858d4cd66d985cadea7f60e97665e08f8f761fd65314cba0da27e3744ce58dc
ebola-7b2b09e7c81633a84a1dd626e84a1da8cdbeadbfb16707e4e0e6d3be5775071e
ebola-77b7ae5ba9dab21f36769b87568be2cb3d1234282abe0c02cd36573585b89e89
ebola-204f7efe912b356d18f7edb5a102a953ac2e80e05f49b0d505803e2636be8f9e
ebola-4a9156243680940c888e74ec405adaecfdff9af864253df6c236db29dbf31a31
ebola-48698609b6d78c8e52ebb35695a62b83be68c9e6050ece5078ec5129ea9cf1ca
ebola-8d48eaba8cb78f4318cf05164fe3511d525ccaf13468acc7453f148862799a6d
ebola-7e549516d5968662a549ccb7f4a3d9567c6286efa20a68fad99ae28829b70a06
ebola-cf8acc132a9f64d77c34f7bc6bee1439f0ad85494ae9213be5625a500635c8a0
ebola-a08b8dfd8effcc4ac02ee166b481d61db6edcc1310a0ca0080708db7b1a0e186
ebola-9e9202f6248889aa015dbe19034d69dfe38e95115d56fdb8e226397b745c266c
ebola-cc9f61315e43dec8b5a11dcd0215c69fc8fb239501cae73db9979a55d19ab322
ebola-71dc2311b3b450ae80e71ec39d870c09371ce8b052cc446501556824c858fe38
ebola-c40992330cb8fe917b0b07fcbf8608f4e68bb7dca0582af8630518bcb52bed57
ebola-f8ba6700a3dc0741a7e0c1b50cfeb1507679e51af6925a4ff67224a80c24ead9
ebola-673b6cf839699032d35d19981ac6772356f6d6c95de2f119f2904721ba2b2609
ebola-0861b94d7d17702759c3526c16fd9737d022f62618d0b3d1e85c0fae2ae03fc1
ebola-1e00e429460833b80afd4e126607e0bc81c2346dcd99e8869a6a06ad0b75c469
ebola-086aa60091ab72627f0a9bffe355f103ccb0f204a9065da70c4b1d1786cc45d8
ebola-b040f890530b669e335dff8dd120f066a33a97459c1e481242f4d17a105c8675
ebola-f77e65e48169b74fbad32f589ed8fca98ebceaf61a924008448830dc1ce88fa1
ebola-2f86381fd3eb94877171ee1ab18b007471fbc6b94dba7dc0dfc3f47ecc55f26c
ebola-58a14c1635db0248c512fc5b51ebea1d3699bc34708229e496a12a17191c1fd4
ebola-edd587573d210c06e4961ae513be2ad7c7d0a20aad507762d91de8f9e92438ed
ebola-a83c4efa4e6ed8f22b7e1c634b6b76bb553307680927cbd27728b577b622181e
ebola-09a78a87b38b5daa4938b15390fe02a26acefca155cfb9098964c233e0aa0955
ebola-ed642478855f4bd4a4b2d0e18da50d96fd4eaf3670e14a3dc9fbf317c3839700
ebola-9966acfb62b0d1131b552250578a986548883a230282f7a4578d6209429afb8c
ebola-c2c44a34351ad3f53e812a7256179ff2d768609b947513b1584f3889ecb77385
ebola-86da5d9c45f6e15c0afdb652498dfd1fe60d3ff2d29f1eab579d6a92d631831b
ebola-6406b9e30557337d8e3e1490b0a0425989c3d7c945adcd597a04adaa76e7bad4
ebola-4f7bb1973575628d92cfb02b1e9bf0e62baaa05e9344293a2f6c0dac548cea74
ebola-69a575e38d78e1f15309772cba8c88fc3a6334f0219ced787bfc67d1a0e5641a
ebola-5f7c503515942fac07965b5a7f893c3de7f2f1cb477a94e42d450ba4c8afc1e5
ebola-5412710fed3d862c8d519c80fc92187b004b2d27d771fbf0d6b157c1ccfa8822
ebola-48e00a3d42c7bb85fff722d9c97fd9fc6c65ebe558ec95e2f9c169b8010edc29
ebola-b52226305bbfc8f1bdcd1c123d9ac6dd1124cb072ab4451dbde7f1df7f1a6a7b
ebola-8e822df2f2f2fc922ed5804fb6bdb36369a367f3820fceed50869c33c07b3fce
ebola-d83f4d3ac74fd3ee6789b60f8036e3289cb4095f70fbbe5ac93784f607a6a4ea
ebola-a3bf4762ebbafb3b84764c02518530b5d7f4cc9590b73ebb576fe4f839da78c4
ebola-32d3722acca39fb7872baeafb85d661ffd4b059550d3146744ebec4ad07eabb5
ebola-448e365dd4758bbfe2d3006b7ce95d38f7661537d199afe300ee8c98cc9132bc
ebola-1198ce90a1f79f88fbf19963712a76709f428018d310e50c31580373c8b0375d
ebola-3a5f192a100c6b75b41031f4c54a60a8d3688f266db6402db6766b02408da919
ebola-16546929e0fcfbf4493add225f3673d859627a701e5d2cfc8e04d9c20367d189
ebola-39cc21ba3c78a0d54ca01bee76ebaaf88b19e92c01d65b0e2b821d71328f7585
ebola-e04cf29621e2d9158472f2ea05fefa052d283c376d5cfe1f55d37f94100636c7
ebola-e9b4496b5dfef681304937eb69f419f7cd4dd3e2dfb1222fab059b1a17a8f05d
ebola-b105d2fa33597743005287b4cc99a3ba3621c29ad11e5d584f117e8e5dcdb28c
ebola-48fd37b30614e9d7ca2f750a043c9eb02c8671e891c4b46013dfd443a408e5f6
ebola-1330ec50a1bd9e9309c84c118993bbdb78d739740e406c2e50ea8ddc0a80788a
ebola-f5927d226cff6694b3ff4e425c75619e1f1c4231e70bd662bed22a2281e5c066
ebola-8251f3862514258b31880087c1bf4061f6f398fbb3f2cc55ad24649adf1da25a
ebola-28ce2d14db016b716e1cb8d79d5551f5ad9a7d33530917fc2b6186156d92f979
ebola-0eadde344a88962f73d22498999bdae3fbfdee328fb2f99830a5902de5bcdf2f
ebola-92bfbd8b106812b295a17978845bd7aa676bedb2c3b79479f947ca5544424551
ebola-ae163991fb90104a9574591b8668c6f44a823026fa0dfa274bcfa9ceefabbecc
ebola-7c5831b402960aa129a435376f036eddfd9fe68eda48a88eda66c0b8c339af5f

list/click  |  time: 2016-04-19 11:13:30 196602  |  # of fields: 4  |  topic_id: 397  |  docno: ebola-3b494b1ad8b7e3671401b5c5d20cb082bf224a17f31eda835376b821e3e3abfa  |  listsource: lemur

highlight  |  time: 2016-04-19 11:14  |  # of fields: 3  |  topic_id: 397  |  docno: ebola-3b494b1ad8b7e3671401b5c5d20cb082bf224a17f31eda835376b821e3e3abfa  |  highlight_string: ebola healthcare impacts costs

query/lemur  |  time: 2016-04-19 11:14:17 180709  |  # of fields: 3  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  query: ebola healthcare impacts costs 

result_size: 300  |  num_tagged:  0
ebola-3b494b1ad8b7e3671401b5c5d20cb082bf224a17f31eda835376b821e3e3abfa
ebola-334bba2cca2807a3d5096678010b6d9f0e6328ad284896fd5866304be5aaa0dc
ebola-9d0a8eed7597c1b520e3c01bba5717bcdd10adcbae666e90ab70861bace6ffe8
ebola-753d3a150a96ccebf1243c46c3a52a9a15503676cfdfe3697f3696a0b31dcffd
ebola-080008f6c58cec3cee9fedbb22e7874e3dfb33116ff5acc2e68ab0040fac4e1c
ebola-f61616659ba37e9f7b89407c4bc818ec2f46dfb3be7b646217a83438988bc9d9
ebola-2d6b7302444b7997fa2b0c56df041febf0cc4eb98e72b22d405730285e0d9782
ebola-f580ecba794cee1f42540b53a62f5b24e4819f3864df17d579e90c52f9d0fc71
ebola-42471be60460935d889f74a6bc6f1674fea651d0a67d8aa8bcbb3d1e8e08c152
ebola-a4afa9ba8873e8038b662957b17832531574408fd50821613b065f323fb189d7
ebola-d509bdb0afc26eed8ed04f6530217a8510eea3aaa2c3cd04cd2cc14fa8ecc7e8
ebola-56e4e42cbaf1933193a5abaf1f1ca3d0254fbae25498e96dd69f36961a852762
ebola-b51bb3f0107100e220f6e3d7a40aab058b82af388c4543b91aa12ad882d23994
ebola-207e580eae1656dd6fa141c07f7ffa24ad0b4be1413e7fd4e6f9ac23b2927987
ebola-1e9df05453557bedb84840932b01e4b57d08ef2ecabdf3c58227ad906ccefd15
ebola-967217a11c602e6a603247b5a91c5119d1cad68af6a0f4f4b6bdb10ca1ffac21
ebola-8450ce3afc7008a4739c858960205f64e9d9b7b6f02d1ad471d6f5659f03a3f4
ebola-6523543ef516a6a973603c172c9b248072d22c2a3dbe9c62e44d89eafbb59456
ebola-534c708a6d7bfcbb9ef0c2829f7c4b3e9755cb00d4eab0ff222521360a5a5695
ebola-21dbfd488c0c46d8eee9fa7224ebe6247ce03032f1d5eb12e9ef7f1d61cda69d
ebola-e6912bf7d799d1db2c2acd15f4a7aac5924598d514c0c2e1823ec51efbf02575
ebola-849d25a28372bdaf22273a797812aed3a5711006ab39c729fb5ea63d54bdf4c9
ebola-77c399d1dedaa9f6d24c88d6fd2628037468bacdcad4b47c889ab4fb7572b4d9
ebola-8656df476773eaef1202d7d27851ecb68e294d210bad1be10729568d0ac0136c
ebola-6420ac8055e10e42a8b91f9070c33620fd6094049b0534020229b6075d8879cd
ebola-7f065ef3bdbfc22b11a0693b604f6a75d237ac106775a0aa7363494fe229f7b0
ebola-8de06206d14ac4a96b72d79f49d4841521cd2a396c965459dd30bac970e812e0
ebola-fa81efe363d222ee556936ffe17a81da5d7a6131d79d1e05b5232d1c026dd535
ebola-1a2719ebc9d4868e44425e90e96ba44b151667efa6aa443bac187fc4240c014d
ebola-c27d4d504920909e578d52b4f02e0074222e37c5f5fbd2c8d2d31232516935a3
ebola-c60ec907f545bb871cd9b30094906a3f8117ad3648f01b3d3f4093b2486b2652
ebola-0f3caa1ded8a6ee9dfd7052ea574bf082ffef67bfd2012761d17b7d21efa476f
ebola-0d87e550a1551f3776117182ae850063d80c39bda0ed05300ede185748c7183b
ebola-a3d6cec81c1ae4558ba85cc5a4b945ea014720994907581854a026513eb97183
ebola-3d611657a8d500e076f071ac379643ff849a338e87d11bdae71acdd4cfbf377b
ebola-1304d27a5aed50aa80d7ab061bb5c1f5eac52b22373523a29ff109df51b7d83b
ebola-aed19ff83ac981718fa08caa1158caf61c00edfac7ccc5786fd2f6f2ff007723
ebola-c203b08b595e032ecafb20aa10bcd8053ca4bd478eab7f3fa96f5e7c857c5a39
ebola-e1e333e149c1892978591d622b73e22038bc918ddc0e13557476b276b9ea995b
ebola-47a3856ee6048e459d1de88edc0a55343e2ad6e103a6154f46bf282f8108c258
ebola-c1452dc742faa1841b759c4f41157669dff179fa001012c5abc6e99d4a52bb2f
ebola-656efed7fd698911699487b736ca92c6995682b5534de107951de63e4fba69b4
ebola-2ed22fbf565006334438f6931c760a3613f59d0f047d97e0dc7caf72d40a2aa3
ebola-70a40ef7ddc055c8e316d6a27f46b8ee98ac1c3701b02b4a70f591173517c086
ebola-645a8af3ace496323fd3328f765a1820a9bc45bff1ebf6fb74372de778d575ba
ebola-f155f4046188598a9cb5a63d80c8d3c0289d99506d4ff7425ed5f2c8ed7ce23e
ebola-2221f29d6183a19f2cabfe096c791291e81cd91dd2f8bc9d05c709c785cf79b6
ebola-c4665c75539a519d14fddb40825b17194d4abd7a6454f6babfba76db757e1509
ebola-cacd9c2a906a7c8cac9faa760332f467847e0e35fe9275a9f506a244e02d9c63
ebola-47f0361cc8a2a20250b6772c7893d044c1fe1b9f3d5716bf9a56c1cc61196b3a
ebola-2d33381c8fdb2147ceb925c4c746489f981118568f4b88825fe3bf9ad504ef98
ebola-abe7801efd195837f19077d5abf538054f92a2b3409c0450b5b31dda23eacd88
ebola-c1cd79bd9fb8eac68bed419f101e6c0d8cdda9430c47ec729ec1370888b2f9a2
ebola-a9953ff579096eae4493f2c60e31f4314d3b0176e1e9c70ab3054ffe7a111475
ebola-439325b73d844294a363aca72c1147399bd6f275a8baf199312ddf37f4234992
ebola-80b5522e53614f55cb1492ceb07ec6f8cf6316b49e1901766f8489e33860226e
ebola-22546759770bda96998534821dc1899fe609fe3d95bbf87e3a8831e61b5cbdcd
ebola-c8083a1e7bdb768e717d974c461d5ebe73b2ef406bf5730530ca952d8fadd813
ebola-debb50eb07c9df9f62b7e25910f10da7ced01b186ad9ea309b2d434aa7fd4e1c
ebola-adbc27f45404bfd9c00de865b5f3268c3e2818d65afdeb77b127fdebbdca2d56
ebola-7269fe5e451a73bd91ce0af1f30214d8294e58556525d2abced8ea2f59cd9270
ebola-37bd96e0da796a4f1a79412873eebd4812552a10ccc30e1beb67e1221a3b88b2
ebola-bb558f36e17c55c6a5111cdb0250ccda898b6de733704980e7c56e96269c1e2b
ebola-0a0bfca873c823ebd484858c40811c53fa591452df3c685c39317a0bde26cadb
ebola-88cf07bb51227255c6352f66884730ee6630b8bdc39e8db58126a9fe207113a6
ebola-84c8ef8ebcb64b4d6ba400ccaabe7aeb6f469ca31e5a804aac79fd73cdb4e523
ebola-1bc7780700f01f6c06781766f5ef2a467c74e32f9c9320b1284746a67e936eda
ebola-5b916eb6d614bdd673b97f49ea842c99607c67732f9254ee623d42611461cb5c
ebola-7a983224dcb45a59b39a20fef829c1b92e2abd13867dc23e1d976572305d7e01
ebola-9db789e50a5dd2494dd2f881e0c5678c8f389151306c235f6ddc71c8fe0c78e9
ebola-56ae37a08ef822a317e60ce94e76241e495dff639cd54f7da17e757875d3306b
ebola-75aaa92451140763b7cc13f501330fcc2f4b656a5bd0af5b1d7e110e46c44d22
ebola-5353142d7ac154552577129bcd106c53cdebf6154499d068751880c193220e50
ebola-0e99dc4e69d57afa571419cac72aff8c2d2e58cecfdc958be6b662646aa24677
ebola-484b44670792de2aa891655c2b419c4dda0d68035846e934b049b2d3c3558860
ebola-1ff65aa6a4f36ca8e9bdddb49933a5b167be8bf20536f06a8b14f8e5c750fff6
ebola-f82f85e8180b8d202a9899cdbb6a829f0d6fa525d2c6ed8f35196ee5c72a8823
ebola-5ead8888f4444b00cecd2f146d92f064c51daba0283838a6eb97f21b07210d4c
ebola-67e3640ae2ac5c1d5ca9c40cfd4ddbeecad1ebb32fb884b75ab8465e3d62b9fe
ebola-c27f5a84427839f29d3858b077f72653c2c8c90de9cbd94aacc1357db57fac5e
ebola-aa67f0f5f13c56cb572c029e4d32b2be60360f08e4c4fd4c4b867fe2522e9303
ebola-708b405aab5a5eb4b6109374dce653962f5a80a34c519d9f1bd3a7718566346b
ebola-4d00b3be5bf48513db9d2a074c31c6e11d6d218afbc93a2746c2b5f9becf1b29
ebola-49afd07054dadb7e404147adbb695599f693101b3ab9cf5acbfb68da228bcfbe
ebola-2305e50bca61445851c0bcb0930ea207e0eebdebf1d7705a1756dc084112d367
ebola-ac0bdbcfc44afebe73d6abb0d60ddfdcd76bafde982aad26d78090ecbd6f83c7
ebola-b68e9ee9d6037be85daaf918da28b01ec999c8bca557518c276d3c8a9dfef4c8
ebola-b6394c4200716d9fd01e90e5589041d407e63c4657a19900d8da62801c07f756
ebola-3969ff94ac3602f07504584c14ededd601f3e7953e1b85fd8508ceb06ec0b3d6
ebola-bdec02759ea1b376d362e879e33985e01027ebd505e775740c5c7df716edf289
ebola-60294b2a63766a9b48af09c1691d3a424d26cf8baa1435c408217c6a5b39e1d1
ebola-a5c4ea27c6d03f69bc2480af8de268ff27d60f08e9368f58168271e13d2ac9d9
ebola-18f4caeed0b5667129db14f1c25f7b8bbcddc480b980288ba81b2b584ae432ba
ebola-761e008ae17942186b2b150535fd6fabaf32b7ff81e38dd051f702c5010fb8ed
ebola-144a260ad2f0233593c09e0f735fb5b6ee504e54708436b1d44d9c2ea6f52884
ebola-007196c29e1f6afa0478759f3307793d6d2f335e48baa65d2fdb9fd1cd5e4e26
ebola-30756ad762525195a488111a0137d3aece920d0049445db27626f5ce5d205093
ebola-9bf3a6b53c6d8ef4ff7225305933c3ea95becfcb01e064f78f466d545e68c644
ebola-0327e347c891fc9088415e829d24c7a853fe7daeaa94172eda54ffaa0fb6c467
ebola-2cb3b9799af44881e6f13b0aa8084b8d670a1bf52b17fdc4d9db1b0007892428
ebola-f6cba29a1b164e29c42b74006481c4390b1a9dab007e993a88ad5a8a03773aa1
ebola-fd0c1b605a3453215dc412f13642e7382fee3054ef6eb71015bcaf13dd6d06ed
ebola-5db3bd6f20a345801b4a68f89ff1b5a308ef2fe86f290ea627dd85687388fb3d
ebola-1d1f93f32b015b2fdabb585436b4865e79d8dbd456f33e0d5641d9f3d6024c42
ebola-4d3f9e4aedcebd5d80697942ab121dba4fc793fe8956137dff97c34f21df8906
ebola-fb9d62e6409ff67aae244fb4459550cbd4b8b06c270da99a44cf4b5679b3a26d
ebola-0e3f97052922a8444a30e4853a6ef58608991fbc4b692ad1d536ff86fe1cc8db
ebola-08ea06f5c52f0fbd4fed6d260bf98f552bf0f979b42671764909ed6861a967bd
ebola-d1f91d0d95a763c68e4abafcca6f501c0663a99ede8c7eb5b86885373be42ff5
ebola-09facb19588b35bf8627a73dc613ad73d9514c29e1559c8484fc8805fcc82f3a
ebola-65fdb3ce7f6664b16c0be963f9590286a3a5ab15c6fd39bbefdb5e921e8fda6d
ebola-ae1adeef917b0b73b7f145352c533a6d8b2e3d7afe034574821d9e4a2ca49983
ebola-9e6503708e6e5ce821802508f0a5df7e0acd2c417902477fc40f79bd4c7c670d
ebola-919ebaa0683871218db09b4647ae0ee935a5ad801f6f14d07ae485a9dc083c2f
ebola-d9323c9afb59b83d5c50c17c331660de357cd8139e5ea6660c72ec00b0d51736
ebola-3a7cfc7589ecc152457f7c2c3a6e8c4572f977997e0ecf70f8318184cfbcc10c
ebola-72b9d42f51307b169c3bcdc3c241fe1b493bc71c3027469d2b87a469fe784120
ebola-2cc40faaa86394751449c25c60b83ab99f185115d28741a021e5c73e0b906e50
ebola-a58d3695f2d9b442ee0e58c8300e8a6b9efa2452c56f173e9df5796673c2b67f
ebola-0117b4f6994387b95b0bf771146fabadcdb93989d494e201d660e549d7362a99
ebola-a11475faf648efecc7df720156645794414179329d6be0b61dfdd53a6c8e2159
ebola-23dc72dbae43e84ea66ccfddde84372f5fb59a0e46f7ea185fbd1c6af9286e73
ebola-f3cc9eba2279f8214418adb0e5a3d8c6aa2b7e962e44b2c42e7f97abdfcba25c
ebola-5c82f99e2fdc97466b3b012b8e4d00d4b01f7048588202f9339c3a93c5cc77de
ebola-ead02635d8d4624c5e85c57ebe754df8447f7941e1aba54d00d37cd10a025157
ebola-73a13aaf9bc06de3059ef94a2f7f589e967ebe1d6ffe7ffb7e0f8f496e46d796
ebola-e116db2b818654e162a93045be542632374e1f1fdfbefdd24dd38c13a826ae01
ebola-6d7395466b6cedf29877b75a90edbe3feeb35dbc3dc962447afee80a2f8ea1c3
ebola-2cc4026358fa8d4179cdda66a42ce1b228b6a25c03e7d7598b5c3674da977281
ebola-5b772bfe38e68757305460e49514cbef9b23f0f2f896864cc729922fb4aa340c
ebola-5d8f99864725b1daf940a9e5f9da401c0e37d7f88daf641ee7e54306f9bc2ad4
ebola-eda4dd0eb84416dc55f1756dc6ea84931931ed092b95d39ff6d2bbc4e231bd7a
ebola-019772cf0c3144381bb27b83155296f64d0a2b3498e200331c259f78376c960e
ebola-6a152866da9b5024209ed33bc529564a1507c64af356f26bddc9ecb92b923aef
ebola-e532d846ee27015fd6d8e83510fd4fd2655d27c699ecd88b91e5f7431998756f
ebola-0f7147ee43dfafbc47b2304b39dd7894c1f50f76c287bf253eb5c3beb357bcab
ebola-94244e9b0749f920ebfccf8f72db0dec1ff3d831195d801dae810bc0457196f2
ebola-5f97f24f2f25826664d63db55879055d7d4d0c3df47067d461a494047de9a2c8
ebola-10160da9c8313304046d60c607aa7982ec79ee269efe8548eee6c7fcbfac9a2c
ebola-f36d89d627e978fafad9108eecce434234c64e8a41c537b19ee732c90729aed5
ebola-c44244d74458dd3e105ccfa801f2b770bb56334dfe99b67bfa7333eb9a43aad1
ebola-0a49813915309df039fe740c89ab7f8071158236981cb78713def4236bd4d745
ebola-b20ad8859e0b6b8c3ed392a68dca6cdb4b00f89056e3eec2ba9f5bbb11cba2ce
ebola-afb585c037d098b44fce944074e9f92fecd88c312252dad39006d028f129bbcb
ebola-c467f20e535bc5a72bea8764b540bfbdbf4768ecb642348bdc7cf723ea4368a8
ebola-17b3c34371053f984685fc3f01b3e498fc801c56ad18934feec19f136bb7078b
ebola-613d444e54c838cfbe10f7c0e3688974f45b48bba65d78669c9038dd1eca5325
ebola-f5dc9abcdd8851968ba43991d40da0c2f4c031582c701b443c56d56d08bdae61
ebola-2929f7d2f68db418d07cd1cf9fd96905b4bbc61b6f0bf267a9bebe7c17bcc528
ebola-a373548060857318d7f1a93a9bd768db8d762d974f43713fcdffeb62e36a000a
ebola-095810736223ea24f448c6af571bc27a4f890d666aa0e1984083ea771428a866
ebola-1a338cf7b9e4475737056b72c7e7954b81769d8ad3289cb38b1c4191a10e9f59
ebola-d7d8a70c4b7de2a3f5d77873ecc763b9cc77d28983a500eb46de529e86551051
ebola-f9920d4b0caec4f5a6a978ec96afd918e9bf03f5bb0580d04b92804b18e1e144
ebola-e9f96a5cec144f5da6cf694ec3087559894bdc470069f29c2b7638cf386053be
ebola-1de946fb1e6d99e126a9507d8f10af1e3c9086508263dadb6bdf5c33b86732a7
ebola-3043b15222884456adcf6e06a5cd978824cfcc4a0dd947fc3d0e52d22e435f6b
ebola-8ab09183b2bcbed563abcfde70ee46d852f275b1482c429f065d9ca9af2365bc
ebola-ba8004fd803c6158795bd550267387b663b24311d28c4c589115c87bd884623f
ebola-d426d76d2073e896c2050ed449b0a46dfa93d624e353f650e2fbffdd837d73e3
ebola-721c813a4ce5d3f9839e2c01474c685ee127c7f593d4f35373b3eb59dfffb07d
ebola-0e9008b26e49f6970bc5d7040a6a1025f2ad513100fbab2d199bd38832f4b111
ebola-a798363583797e8e778960284a2dc7e78ca8e971966a2b056992ccce1db49ba4
ebola-43d55882795fbfa096cb6c510f108c763d638b23f6c0221964c37ee04a1d0f89
ebola-470cb2aec2a29fe9a59a63d55812fc6770eb92c09718833d4181eb2212020620
ebola-1ad65731580b081760f76f4fc4bb52b85fc933c7aab81ae9fc8138ae987f0b9e
ebola-e6956858a359e43c1eac4d88ad7217c40e91ef2844016baacb026c0c6a617e39
ebola-0b2910ecc6dcfa3e98650ba5dcfa2ef71c2870ffa01aecb6e3e1b72593816604
ebola-12719bd04e01ac5cc8d49a479d00913ca2f9a557c6db69d8222fa8a69e5b3714
ebola-f03f8cb7f407cd7e63c851fb24e01b0a3f62f7c9a32c24ecb98ef338ba9f0446
ebola-0cd6b5793ee90cd6457ae95cdb376d946e76b79cd6060a77d8e9392f065c0a93
ebola-69011e54413760c68f0420f761250e215405fbbde8d065e86b810654644cd1e3
ebola-6e3342b0b4945075196a79a33cebdd0d2479ba599b0a7692615df289ff5ae323
ebola-6483a13de65757c68d3f4f45c0442507c88fc201a6c31dd618899330e345639d
ebola-a9ce7a65f2f2f37ac7870eff872c6286a54f3994fd52338aa52888b744f12345
ebola-d04f1f26adf04ca744c28a9834608847458704ac478ab046176142ec9f5a299e
ebola-b4451c56c406c3fa3ac27e57313b510097cd364e302667a5ec8016d08cfeea92
ebola-a60e954f8c78d153ab3285142047f6575e9fe12c77001ee766b47a7f23274b88
ebola-c5f3a76ebffce2edd378367a4bb0349497b629f7ae7d002458b5926dff8fcee0
ebola-60d68d64885ca49037acaa5f7bdac24fb8d4cbe55f47487483d720e5ef6d9f30
ebola-e67f565bf94396f441997c013c29fe2360fac1e88a546b776ac102bcfd263f37
ebola-93946181ef41bb8a263fcd0d0e17e453b9f7421febe1ad65950f91b2e7d99b99
ebola-c3a5293a9bc75dfbacb15e833b3382655cadaf528d08189e41387e9e9fef4afb
ebola-b24f20dbe367ea2b52ab57252b0cd6b2c37267797fe29a9ca0bef6001d36c97d
ebola-1e34b8dbe7344258854b6a359358009443409cee5c97db39629754ed5c1bb071
ebola-386e364de13eb117318ec30543b494061969716715c3a512596d2c73916ebc0b
ebola-3162b4ccb41053ada22915b17a359ee6155de90fc7253b1a2809708d10f509c2
ebola-61369fd089adcc2c955edabf3e6d0e6ae638b0842f0b87afb5ef33c2ce7f327c
ebola-aea0e8075a0f724ba85a9cd713c1857b2c1eee1283e9e05805ff6855e7f352ca
ebola-be8c0951750d65a759dc1a153a13ea8ed52018969b564ba323f97143b50a32c2
ebola-118f11288a6bdbf23305b4e94628dfa50829aa61e660d14c72924bb9c6ca0896
ebola-4e61d33132f89ccfcd16e82d757b555426be0718dd58f782fdb74a29344b2282
ebola-2458ba39380584a1ff0ab626cad9bd86429ae91cbc200b33a5aab50d359f9875
ebola-7549f89b9dffc203ef15e760a2b2f1bba2e2a169b2f0f087ac08ce9cf28f7337
ebola-6f1452c2bc9788b7cedf3ac3463a968595d66136735a338771e1d6c137e91e31
ebola-31879ed4171ec2e09a4d3383bda3c0887171f383395cd4f9256d5d7cc8fc418e
ebola-f6bb1c00a73395b1c017737211c7d6b0f0e111203e7762b997c1a3f89ad9ce33
ebola-2ad70b2e47c80f304f3de445b6073bc8cd6a22ad19f03f271a5cc0c18855ccaa
ebola-30c21953977455401d5628bf313911470ff668d3aa1591a20cca7dccdd0a7dce
ebola-3ddf77385b3eb1f0ba22d25507498a7f97da4f5d7a20f8bd454415a825a9d8fa
ebola-140eee4a4193e69444d31eb9459aa2f39c57c1668bd1cf55f81eb9960bfbaa3e
ebola-23df89a3b16ffe0a68679ee2b82548922f57799f52475ec3e9dd005f76c3b83f
ebola-6f3071b68bd6aa9f55e5d7d0ae963374b8d6c2c09e508fe7f773fd7821f45076
ebola-fa0f1ff10c72b37d70ff86079a03d137a4d726ff599cd0ce4e445f4c4a70d17e
ebola-f9d5b2b7f6ff5a13ad3ec5ea150756ec7755ddb475ff480de30b9097e07c6055
ebola-913913728b8852f4e11f8c718ae4d01e3286db15cc6194c44f8707389b62f299
ebola-3873f067c8c9806a925fbd84c6d039ebbd0cc7ff6e856cba65bf569827f1b373
ebola-70e0851c61cd8a359caeefeae6a38cd1417a16458fa6c4100d9a3fbd4275635c
ebola-876b206a5facef6d0d9e0ff72bfd7e9ddbbbbd3427787237a79223d209c92f23
ebola-780f5e529a5dca873b9c265eef0db0266c08c287624a2473bb2f665370b658f3
ebola-53d93c415f2234c1898a8e551416ccad4b032020a9f5bc50b8fecd00898184e9
ebola-8210d7ec943df935f06ba6a9e1e531d145af9749980c6e6fc4cd0575b0fe722a
ebola-62429590b42cc2814d5884146e376208c5fd29b014fdec961adc3b14c739d195
ebola-6adb5d6057e902c94b05b865a1b000ab93d1fa8d85b599dd2a83c57538389698
ebola-fec20cdd205325cb99e2198c10c8b44226e5868cf329fcfe9a770f2a57d821e5
ebola-f77b75dfc45b506cfa465405062ca8911710a123f90f45abb9e8d1e2c12a5211
ebola-5804661d7167b3fcff8ee12ceaf2487ee3d978b01bbabc30b0efbb09e49f5ae4
ebola-5397dd42105b27dbee5120b27ce3500262e327e515a1fb1f1f8e90448a8d8f77
ebola-44fc0d18677b2ce2a4b2b6faacc58d4c4129c6f356d09c607d7e2980542fb4ec
ebola-d69f5ec4561f614d7062adcb837a61fa444468803f0da523eaebdd5a23faeeba
ebola-33e72f77ea4707222ff0cc21b54c862c02559a2f48cfbcf033534790a53113c1
ebola-d3f614594c423bde74e0524e1f5d783f2fcb597053d0ccb8eca75184dffc4b48
ebola-6ddcbd0b094513bb309440a7c1225d01c4d95fcbf40f0278df0bc0eafc5d02e0
ebola-30a0349c7ab4730915e5f763074ceadabc063babe3745804fbe9348326b6dc2d
ebola-c0348525a2e08a68c0a33780f56ef6db380b7fe43b0a14f9a93805a53607e5a9
ebola-5897bfd6a74d9535f1deafdcf005e63b84f58ef25daf509dc823f03a53146bd1
ebola-d8b6ae8a45a09e894ddb3ecac7b2083467adf71cdb8cf8e352abed6649468aaf
ebola-9fe97fe6aa44de0b7092fa6584e73d669a1a816e103cc3b2d4041b4f9e816f87
ebola-5ccf2af6d6a00b6dbebb1ba1227b510aed3be428735e62945e0771f7dff0c88a
ebola-a13350917493aa3abf38c8f3dbd565f54aec38e8dd3929c606008c2938f50eae
ebola-a4b95d551ce55383e6a0068a3fa36ead781c023489778ad84c2e7e4d9a0f9c0f
ebola-16dc6f16bcae83b09c5e74c6265006988409c2816d1b6ec62e0e3dc6fd1c8978
ebola-139140bdf5024666bfef94078f3c40d6c8f917b5ca98165a7721c362e7b2af39
ebola-8d1a07840e6e7842c6c33a639eb38a1b5849b907c717b2931067216a61b606c6
ebola-25b652d85ef5578812da74be4f6910c13a345a1408b1e8ef03418e233e3118ba
ebola-e40fb24d9d13c95850a7f96d75c1ac2ba9d461eaa3168b3a4d10a34ce1fa413e
ebola-23e2a5edbe5702010c1a213eb3ae84a04fe513d490a226aa7929044edc24eba4
ebola-6073d2e066d6700ca794d86b26aeaff8cb1e88eb016c57b218c95e64a8406772
ebola-c320bd64d1c58203974f59beab4096e8c41063b668b15b48557b86f55efa241a
ebola-57aed64eeb4008e1488938e89e630fc871ea2be3599c5336e0b4adf386613a0d
ebola-938ca859e81a1065f721d383d32590370dcd3bb2dc24ee18cb24c6dae1ef7530
ebola-d0d98dbf4a806ce3d513c4bab7899660f7fb3b432e6cce51b7c24ce527c3b8e0
ebola-6858d4cd66d985cadea7f60e97665e08f8f761fd65314cba0da27e3744ce58dc
ebola-7b2b09e7c81633a84a1dd626e84a1da8cdbeadbfb16707e4e0e6d3be5775071e
ebola-77b7ae5ba9dab21f36769b87568be2cb3d1234282abe0c02cd36573585b89e89
ebola-204f7efe912b356d18f7edb5a102a953ac2e80e05f49b0d505803e2636be8f9e
ebola-4a9156243680940c888e74ec405adaecfdff9af864253df6c236db29dbf31a31
ebola-48698609b6d78c8e52ebb35695a62b83be68c9e6050ece5078ec5129ea9cf1ca
ebola-8d48eaba8cb78f4318cf05164fe3511d525ccaf13468acc7453f148862799a6d
ebola-7e549516d5968662a549ccb7f4a3d9567c6286efa20a68fad99ae28829b70a06
ebola-cf8acc132a9f64d77c34f7bc6bee1439f0ad85494ae9213be5625a500635c8a0
ebola-a08b8dfd8effcc4ac02ee166b481d61db6edcc1310a0ca0080708db7b1a0e186
ebola-9e9202f6248889aa015dbe19034d69dfe38e95115d56fdb8e226397b745c266c
ebola-cc9f61315e43dec8b5a11dcd0215c69fc8fb239501cae73db9979a55d19ab322
ebola-71dc2311b3b450ae80e71ec39d870c09371ce8b052cc446501556824c858fe38
ebola-c40992330cb8fe917b0b07fcbf8608f4e68bb7dca0582af8630518bcb52bed57
ebola-f8ba6700a3dc0741a7e0c1b50cfeb1507679e51af6925a4ff67224a80c24ead9
ebola-673b6cf839699032d35d19981ac6772356f6d6c95de2f119f2904721ba2b2609
ebola-0861b94d7d17702759c3526c16fd9737d022f62618d0b3d1e85c0fae2ae03fc1
ebola-1e00e429460833b80afd4e126607e0bc81c2346dcd99e8869a6a06ad0b75c469
ebola-086aa60091ab72627f0a9bffe355f103ccb0f204a9065da70c4b1d1786cc45d8
ebola-b040f890530b669e335dff8dd120f066a33a97459c1e481242f4d17a105c8675
ebola-f77e65e48169b74fbad32f589ed8fca98ebceaf61a924008448830dc1ce88fa1
ebola-2f86381fd3eb94877171ee1ab18b007471fbc6b94dba7dc0dfc3f47ecc55f26c
ebola-58a14c1635db0248c512fc5b51ebea1d3699bc34708229e496a12a17191c1fd4
ebola-edd587573d210c06e4961ae513be2ad7c7d0a20aad507762d91de8f9e92438ed
ebola-a83c4efa4e6ed8f22b7e1c634b6b76bb553307680927cbd27728b577b622181e
ebola-09a78a87b38b5daa4938b15390fe02a26acefca155cfb9098964c233e0aa0955
ebola-ed642478855f4bd4a4b2d0e18da50d96fd4eaf3670e14a3dc9fbf317c3839700
ebola-9966acfb62b0d1131b552250578a986548883a230282f7a4578d6209429afb8c
ebola-c2c44a34351ad3f53e812a7256179ff2d768609b947513b1584f3889ecb77385
ebola-86da5d9c45f6e15c0afdb652498dfd1fe60d3ff2d29f1eab579d6a92d631831b
ebola-6406b9e30557337d8e3e1490b0a0425989c3d7c945adcd597a04adaa76e7bad4
ebola-4f7bb1973575628d92cfb02b1e9bf0e62baaa05e9344293a2f6c0dac548cea74
ebola-69a575e38d78e1f15309772cba8c88fc3a6334f0219ced787bfc67d1a0e5641a
ebola-5f7c503515942fac07965b5a7f893c3de7f2f1cb477a94e42d450ba4c8afc1e5
ebola-5412710fed3d862c8d519c80fc92187b004b2d27d771fbf0d6b157c1ccfa8822
ebola-48e00a3d42c7bb85fff722d9c97fd9fc6c65ebe558ec95e2f9c169b8010edc29
ebola-b52226305bbfc8f1bdcd1c123d9ac6dd1124cb072ab4451dbde7f1df7f1a6a7b
ebola-8e822df2f2f2fc922ed5804fb6bdb36369a367f3820fceed50869c33c07b3fce
ebola-d83f4d3ac74fd3ee6789b60f8036e3289cb4095f70fbbe5ac93784f607a6a4ea
ebola-a3bf4762ebbafb3b84764c02518530b5d7f4cc9590b73ebb576fe4f839da78c4
ebola-32d3722acca39fb7872baeafb85d661ffd4b059550d3146744ebec4ad07eabb5
ebola-448e365dd4758bbfe2d3006b7ce95d38f7661537d199afe300ee8c98cc9132bc
ebola-1198ce90a1f79f88fbf19963712a76709f428018d310e50c31580373c8b0375d
ebola-3a5f192a100c6b75b41031f4c54a60a8d3688f266db6402db6766b02408da919
ebola-16546929e0fcfbf4493add225f3673d859627a701e5d2cfc8e04d9c20367d189
ebola-39cc21ba3c78a0d54ca01bee76ebaaf88b19e92c01d65b0e2b821d71328f7585
ebola-e04cf29621e2d9158472f2ea05fefa052d283c376d5cfe1f55d37f94100636c7
ebola-e9b4496b5dfef681304937eb69f419f7cd4dd3e2dfb1222fab059b1a17a8f05d
ebola-b105d2fa33597743005287b4cc99a3ba3621c29ad11e5d584f117e8e5dcdb28c
ebola-48fd37b30614e9d7ca2f750a043c9eb02c8671e891c4b46013dfd443a408e5f6
ebola-1330ec50a1bd9e9309c84c118993bbdb78d739740e406c2e50ea8ddc0a80788a
ebola-f5927d226cff6694b3ff4e425c75619e1f1c4231e70bd662bed22a2281e5c066
ebola-8251f3862514258b31880087c1bf4061f6f398fbb3f2cc55ad24649adf1da25a
ebola-28ce2d14db016b716e1cb8d79d5551f5ad9a7d33530917fc2b6186156d92f979
ebola-0eadde344a88962f73d22498999bdae3fbfdee328fb2f99830a5902de5bcdf2f
ebola-92bfbd8b106812b295a17978845bd7aa676bedb2c3b79479f947ca5544424551
ebola-ae163991fb90104a9574591b8668c6f44a823026fa0dfa274bcfa9ceefabbecc
ebola-7c5831b402960aa129a435376f036eddfd9fe68eda48a88eda66c0b8c339af5f

list/click  |  time: 2016-04-19 11:14:38 709350  |  # of fields: 4  |  topic_id: 397  |  docno: ebola-3b494b1ad8b7e3671401b5c5d20cb082bf224a17f31eda835376b821e3e3abfa  |  listsource: lemur

doc/next  |  time: 2016-04-19 11:15:25 425580  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-3b494b1ad8b7e3671401b5c5d20cb082bf224a17f31eda835376b821e3e3abfa

doc/next  |  time: 2016-04-19 11:15:39 819013  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-334bba2cca2807a3d5096678010b6d9f0e6328ad284896fd5866304be5aaa0dc

doc/next  |  time: 2016-04-19 11:15:57 491698  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-9d0a8eed7597c1b520e3c01bba5717bcdd10adcbae666e90ab70861bace6ffe8

doc/next  |  time: 2016-04-19 11:16:09 649888  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-753d3a150a96ccebf1243c46c3a52a9a15503676cfdfe3697f3696a0b31dcffd

doc/next  |  time: 2016-04-19 11:16:18 000681  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-080008f6c58cec3cee9fedbb22e7874e3dfb33116ff5acc2e68ab0040fac4e1c

doc/next  |  time: 2016-04-19 11:16:42 195367  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-f61616659ba37e9f7b89407c4bc818ec2f46dfb3be7b646217a83438988bc9d9

doc/next  |  time: 2016-04-19 11:17:06 536311  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2d6b7302444b7997fa2b0c56df041febf0cc4eb98e72b22d405730285e0d9782

doc/next  |  time: 2016-04-19 11:17:19 853043  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-f580ecba794cee1f42540b53a62f5b24e4819f3864df17d579e90c52f9d0fc71

doc/next  |  time: 2016-04-19 11:17:24 220890  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-42471be60460935d889f74a6bc6f1674fea651d0a67d8aa8bcbb3d1e8e08c152

doc/next  |  time: 2016-04-19 11:17:27 778402  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-a4afa9ba8873e8038b662957b17832531574408fd50821613b065f323fb189d7

doc/next  |  time: 2016-04-19 11:18:26 498711  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-d509bdb0afc26eed8ed04f6530217a8510eea3aaa2c3cd04cd2cc14fa8ecc7e8

doc/next  |  time: 2016-04-19 11:18:36 472417  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-56e4e42cbaf1933193a5abaf1f1ca3d0254fbae25498e96dd69f36961a852762

doc/next  |  time: 2016-04-19 11:18:47 395165  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-b51bb3f0107100e220f6e3d7a40aab058b82af388c4543b91aa12ad882d23994

highlight  |  time: 2016-04-19 11:19  |  # of fields: 3  |  topic_id: 397  |  docno: ebola-207e580eae1656dd6fa141c07f7ffa24ad0b4be1413e7fd4e6f9ac23b2927987  |  highlight_string: ebola healthcare impacts costs insurance

doc/next  |  time: 2016-04-19 11:19:34 652309  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-207e580eae1656dd6fa141c07f7ffa24ad0b4be1413e7fd4e6f9ac23b2927987

doc/next  |  time: 2016-04-19 11:19:51 969663  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1e9df05453557bedb84840932b01e4b57d08ef2ecabdf3c58227ad906ccefd15

doc/next  |  time: 2016-04-19 11:20:19 538987  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-967217a11c602e6a603247b5a91c5119d1cad68af6a0f4f4b6bdb10ca1ffac21

doc/next  |  time: 2016-04-19 11:20:38 927530  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-8450ce3afc7008a4739c858960205f64e9d9b7b6f02d1ad471d6f5659f03a3f4

doc/next  |  time: 2016-04-19 11:29:16 345853  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6523543ef516a6a973603c172c9b248072d22c2a3dbe9c62e44d89eafbb59456

doc/next  |  time: 2016-04-19 11:29:30 411345  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-534c708a6d7bfcbb9ef0c2829f7c4b3e9755cb00d4eab0ff222521360a5a5695

doc/next  |  time: 2016-04-19 11:29:55 401750  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-21dbfd488c0c46d8eee9fa7224ebe6247ce03032f1d5eb12e9ef7f1d61cda69d

doc/next  |  time: 2016-04-19 11:30:05 391244  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-e6912bf7d799d1db2c2acd15f4a7aac5924598d514c0c2e1823ec51efbf02575

doc/next  |  time: 2016-04-19 11:30:42 872518  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-849d25a28372bdaf22273a797812aed3a5711006ab39c729fb5ea63d54bdf4c9

doc/next  |  time: 2016-04-19 11:30:59 953724  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-77c399d1dedaa9f6d24c88d6fd2628037468bacdcad4b47c889ab4fb7572b4d9

doc/next  |  time: 2016-04-19 11:34:37 207383  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-8656df476773eaef1202d7d27851ecb68e294d210bad1be10729568d0ac0136c

doc/next  |  time: 2016-04-19 11:34:52 647106  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6420ac8055e10e42a8b91f9070c33620fd6094049b0534020229b6075d8879cd

doc/next  |  time: 2016-04-19 11:35:29 373719  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-7f065ef3bdbfc22b11a0693b604f6a75d237ac106775a0aa7363494fe229f7b0

doc/next  |  time: 2016-04-19 11:36:28 247712  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-8de06206d14ac4a96b72d79f49d4841521cd2a396c965459dd30bac970e812e0

doc/next  |  time: 2016-04-19 11:37:03 855973  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-fa81efe363d222ee556936ffe17a81da5d7a6131d79d1e05b5232d1c026dd535

doc/next  |  time: 2016-04-19 11:37:48 612604  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1a2719ebc9d4868e44425e90e96ba44b151667efa6aa443bac187fc4240c014d

doc/next  |  time: 2016-04-19 11:38:01 345306  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c27d4d504920909e578d52b4f02e0074222e37c5f5fbd2c8d2d31232516935a3

doc/next  |  time: 2016-04-19 11:38:29 054994  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c60ec907f545bb871cd9b30094906a3f8117ad3648f01b3d3f4093b2486b2652

doc/next  |  time: 2016-04-19 11:38:41 253200  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-0f3caa1ded8a6ee9dfd7052ea574bf082ffef67bfd2012761d17b7d21efa476f

doc/next  |  time: 2016-04-19 11:39:09 460561  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-0d87e550a1551f3776117182ae850063d80c39bda0ed05300ede185748c7183b

doc/next  |  time: 2016-04-19 11:39:57 969668  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-a3d6cec81c1ae4558ba85cc5a4b945ea014720994907581854a026513eb97183

doc/next  |  time: 2016-04-19 11:40:21 614395  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-3d611657a8d500e076f071ac379643ff849a338e87d11bdae71acdd4cfbf377b

doc/next  |  time: 2016-04-19 11:40:49 384173  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1304d27a5aed50aa80d7ab061bb5c1f5eac52b22373523a29ff109df51b7d83b

doc/next  |  time: 2016-04-19 11:41:24 121807  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-aed19ff83ac981718fa08caa1158caf61c00edfac7ccc5786fd2f6f2ff007723

doc/next  |  time: 2016-04-19 11:41:46 153419  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c203b08b595e032ecafb20aa10bcd8053ca4bd478eab7f3fa96f5e7c857c5a39

doc/next  |  time: 2016-04-19 11:42:28 645919  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-e1e333e149c1892978591d622b73e22038bc918ddc0e13557476b276b9ea995b

doc/next  |  time: 2016-04-19 11:42:48 236857  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-47a3856ee6048e459d1de88edc0a55343e2ad6e103a6154f46bf282f8108c258

doc/next  |  time: 2016-04-19 11:45:24 188967  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c1452dc742faa1841b759c4f41157669dff179fa001012c5abc6e99d4a52bb2f

doc/next  |  time: 2016-04-19 11:45:39 362802  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-656efed7fd698911699487b736ca92c6995682b5534de107951de63e4fba69b4

doc/next  |  time: 2016-04-19 11:46:03 872057  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2ed22fbf565006334438f6931c760a3613f59d0f047d97e0dc7caf72d40a2aa3

doc/next  |  time: 2016-04-19 11:47:40 451003  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-70a40ef7ddc055c8e316d6a27f46b8ee98ac1c3701b02b4a70f591173517c086

doc/next  |  time: 2016-04-19 11:48:29 763047  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-645a8af3ace496323fd3328f765a1820a9bc45bff1ebf6fb74372de778d575ba

doc/next  |  time: 2016-04-19 11:48:42 964804  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-f155f4046188598a9cb5a63d80c8d3c0289d99506d4ff7425ed5f2c8ed7ce23e

doc/next  |  time: 2016-04-19 11:49:13 761062  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2221f29d6183a19f2cabfe096c791291e81cd91dd2f8bc9d05c709c785cf79b6

doc/next  |  time: 2016-04-19 11:49:34 908106  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c4665c75539a519d14fddb40825b17194d4abd7a6454f6babfba76db757e1509

doc/next  |  time: 2016-04-19 11:49:48 101336  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-cacd9c2a906a7c8cac9faa760332f467847e0e35fe9275a9f506a244e02d9c63

doc/next  |  time: 2016-04-19 11:50:09 062074  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-47f0361cc8a2a20250b6772c7893d044c1fe1b9f3d5716bf9a56c1cc61196b3a

doc/next  |  time: 2016-04-19 11:50:23 909952  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2d33381c8fdb2147ceb925c4c746489f981118568f4b88825fe3bf9ad504ef98

doc/next  |  time: 2016-04-19 11:50:32 970375  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-abe7801efd195837f19077d5abf538054f92a2b3409c0450b5b31dda23eacd88

doc/next  |  time: 2016-04-19 11:51:07 317702  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c1cd79bd9fb8eac68bed419f101e6c0d8cdda9430c47ec729ec1370888b2f9a2

doc/next  |  time: 2016-04-19 11:51:31 643302  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-a9953ff579096eae4493f2c60e31f4314d3b0176e1e9c70ab3054ffe7a111475

doc/next  |  time: 2016-04-19 11:51:59 045742  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-439325b73d844294a363aca72c1147399bd6f275a8baf199312ddf37f4234992

doc/next  |  time: 2016-04-19 11:56:14 315412  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-80b5522e53614f55cb1492ceb07ec6f8cf6316b49e1901766f8489e33860226e

doc/next  |  time: 2016-04-19 11:56:41 161666  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-22546759770bda96998534821dc1899fe609fe3d95bbf87e3a8831e61b5cbdcd

doc/next  |  time: 2016-04-19 11:56:50 281425  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c8083a1e7bdb768e717d974c461d5ebe73b2ef406bf5730530ca952d8fadd813

doc/next  |  time: 2016-04-19 11:58:01 763455  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-debb50eb07c9df9f62b7e25910f10da7ced01b186ad9ea309b2d434aa7fd4e1c

doc/next  |  time: 2016-04-19 11:58:33 720670  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-adbc27f45404bfd9c00de865b5f3268c3e2818d65afdeb77b127fdebbdca2d56

doc/next  |  time: 2016-04-19 12:00:16 426838  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-7269fe5e451a73bd91ce0af1f30214d8294e58556525d2abced8ea2f59cd9270

doc/next  |  time: 2016-04-19 12:00:49 064588  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-37bd96e0da796a4f1a79412873eebd4812552a10ccc30e1beb67e1221a3b88b2

doc/next  |  time: 2016-04-19 12:02:13 324976  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-bb558f36e17c55c6a5111cdb0250ccda898b6de733704980e7c56e96269c1e2b

doc/next  |  time: 2016-04-19 12:16:07 673145  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-0a0bfca873c823ebd484858c40811c53fa591452df3c685c39317a0bde26cadb

doc/next  |  time: 2016-04-19 12:19:08 767970  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-88cf07bb51227255c6352f66884730ee6630b8bdc39e8db58126a9fe207113a6

doc/next  |  time: 2016-04-19 12:19:57 525789  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-84c8ef8ebcb64b4d6ba400ccaabe7aeb6f469ca31e5a804aac79fd73cdb4e523

doc/next  |  time: 2016-04-19 12:21:28 400781  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1bc7780700f01f6c06781766f5ef2a467c74e32f9c9320b1284746a67e936eda

doc/next  |  time: 2016-04-19 12:21:49 854084  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-5b916eb6d614bdd673b97f49ea842c99607c67732f9254ee623d42611461cb5c

doc/next  |  time: 2016-04-19 12:28:21 626754  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-7a983224dcb45a59b39a20fef829c1b92e2abd13867dc23e1d976572305d7e01

doc/next  |  time: 2016-04-19 12:42:20 763091  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-9db789e50a5dd2494dd2f881e0c5678c8f389151306c235f6ddc71c8fe0c78e9

doc/next  |  time: 2016-04-19 12:45:52 826300  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-56ae37a08ef822a317e60ce94e76241e495dff639cd54f7da17e757875d3306b

doc/next  |  time: 2016-04-19 13:20:44 730377  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-75aaa92451140763b7cc13f501330fcc2f4b656a5bd0af5b1d7e110e46c44d22

doc/next  |  time: 2016-04-19 13:23:59 127014  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-5353142d7ac154552577129bcd106c53cdebf6154499d068751880c193220e50

doc/next  |  time: 2016-04-19 13:24:13 048171  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-0e99dc4e69d57afa571419cac72aff8c2d2e58cecfdc958be6b662646aa24677

doc/next  |  time: 2016-04-19 13:24:31 213742  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-484b44670792de2aa891655c2b419c4dda0d68035846e934b049b2d3c3558860

doc/next  |  time: 2016-04-19 13:26:09 684276  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1ff65aa6a4f36ca8e9bdddb49933a5b167be8bf20536f06a8b14f8e5c750fff6

doc/next  |  time: 2016-04-19 13:35:48 634644  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-f82f85e8180b8d202a9899cdbb6a829f0d6fa525d2c6ed8f35196ee5c72a8823

doc/next  |  time: 2016-04-19 13:37:40 494539  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-5ead8888f4444b00cecd2f146d92f064c51daba0283838a6eb97f21b07210d4c

doc/next  |  time: 2016-04-19 13:41:25 542289  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-67e3640ae2ac5c1d5ca9c40cfd4ddbeecad1ebb32fb884b75ab8465e3d62b9fe

logout  |  time: 2016-04-19 13:55:27 708499

doc/next  |  time: 2016-04-19 14:48:08 888546  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c27f5a84427839f29d3858b077f72653c2c8c90de9cbd94aacc1357db57fac5e

doc/next  |  time: 2016-04-19 14:48:17 633307  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-aa67f0f5f13c56cb572c029e4d32b2be60360f08e4c4fd4c4b867fe2522e9303

doc/next  |  time: 2016-04-19 15:46:40 707227  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-708b405aab5a5eb4b6109374dce653962f5a80a34c519d9f1bd3a7718566346b

subtopic/create  |  time: 2016-04-19 15:47:49 860632  |  # of fields: 4  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola

logout  |  time: 2016-04-19 15:47:57 700243

login  |  time: 2016-04-20 13:16:40 252721

doc/next  |  time: 2016-04-20 13:16:53 657620  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-4d00b3be5bf48513db9d2a074c31c6e11d6d218afbc93a2746c2b5f9becf1b29

subtopic/create  |  time: 2016-04-20 13:18:27 514659  |  # of fields: 4  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 193  |  subtopic_name: Who pays for healthcare

subtopic/create  |  time: 2016-04-20 13:18:44 205397  |  # of fields: 4  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 194  |  subtopic_name: healthcare insurance

subtopic/create  |  time: 2016-04-20 13:18:59 827744  |  # of fields: 4  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 196  |  subtopic_name: provider impacts

highlight  |  time: 2016-04-20 13:19  |  # of fields: 3  |  topic_id: 397  |  docno: ebola-49afd07054dadb7e404147adbb695599f693101b3ab9cf5acbfb68da228bcfbe  |  highlight_string: provider insurance payment costs

query/lemur  |  time: 2016-04-20 13:19:48 559366  |  # of fields: 3  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  query: ebola healthcare impacts costs 

result_size: 300  |  num_tagged:  0
ebola-3b494b1ad8b7e3671401b5c5d20cb082bf224a17f31eda835376b821e3e3abfa
ebola-334bba2cca2807a3d5096678010b6d9f0e6328ad284896fd5866304be5aaa0dc
ebola-9d0a8eed7597c1b520e3c01bba5717bcdd10adcbae666e90ab70861bace6ffe8
ebola-753d3a150a96ccebf1243c46c3a52a9a15503676cfdfe3697f3696a0b31dcffd
ebola-080008f6c58cec3cee9fedbb22e7874e3dfb33116ff5acc2e68ab0040fac4e1c
ebola-f61616659ba37e9f7b89407c4bc818ec2f46dfb3be7b646217a83438988bc9d9
ebola-2d6b7302444b7997fa2b0c56df041febf0cc4eb98e72b22d405730285e0d9782
ebola-f580ecba794cee1f42540b53a62f5b24e4819f3864df17d579e90c52f9d0fc71
ebola-42471be60460935d889f74a6bc6f1674fea651d0a67d8aa8bcbb3d1e8e08c152
ebola-a4afa9ba8873e8038b662957b17832531574408fd50821613b065f323fb189d7
ebola-d509bdb0afc26eed8ed04f6530217a8510eea3aaa2c3cd04cd2cc14fa8ecc7e8
ebola-56e4e42cbaf1933193a5abaf1f1ca3d0254fbae25498e96dd69f36961a852762
ebola-b51bb3f0107100e220f6e3d7a40aab058b82af388c4543b91aa12ad882d23994
ebola-207e580eae1656dd6fa141c07f7ffa24ad0b4be1413e7fd4e6f9ac23b2927987
ebola-1e9df05453557bedb84840932b01e4b57d08ef2ecabdf3c58227ad906ccefd15
ebola-967217a11c602e6a603247b5a91c5119d1cad68af6a0f4f4b6bdb10ca1ffac21
ebola-8450ce3afc7008a4739c858960205f64e9d9b7b6f02d1ad471d6f5659f03a3f4
ebola-6523543ef516a6a973603c172c9b248072d22c2a3dbe9c62e44d89eafbb59456
ebola-534c708a6d7bfcbb9ef0c2829f7c4b3e9755cb00d4eab0ff222521360a5a5695
ebola-21dbfd488c0c46d8eee9fa7224ebe6247ce03032f1d5eb12e9ef7f1d61cda69d
ebola-e6912bf7d799d1db2c2acd15f4a7aac5924598d514c0c2e1823ec51efbf02575
ebola-849d25a28372bdaf22273a797812aed3a5711006ab39c729fb5ea63d54bdf4c9
ebola-77c399d1dedaa9f6d24c88d6fd2628037468bacdcad4b47c889ab4fb7572b4d9
ebola-8656df476773eaef1202d7d27851ecb68e294d210bad1be10729568d0ac0136c
ebola-6420ac8055e10e42a8b91f9070c33620fd6094049b0534020229b6075d8879cd
ebola-7f065ef3bdbfc22b11a0693b604f6a75d237ac106775a0aa7363494fe229f7b0
ebola-8de06206d14ac4a96b72d79f49d4841521cd2a396c965459dd30bac970e812e0
ebola-fa81efe363d222ee556936ffe17a81da5d7a6131d79d1e05b5232d1c026dd535
ebola-1a2719ebc9d4868e44425e90e96ba44b151667efa6aa443bac187fc4240c014d
ebola-c27d4d504920909e578d52b4f02e0074222e37c5f5fbd2c8d2d31232516935a3
ebola-c60ec907f545bb871cd9b30094906a3f8117ad3648f01b3d3f4093b2486b2652
ebola-0f3caa1ded8a6ee9dfd7052ea574bf082ffef67bfd2012761d17b7d21efa476f
ebola-0d87e550a1551f3776117182ae850063d80c39bda0ed05300ede185748c7183b
ebola-a3d6cec81c1ae4558ba85cc5a4b945ea014720994907581854a026513eb97183
ebola-3d611657a8d500e076f071ac379643ff849a338e87d11bdae71acdd4cfbf377b
ebola-1304d27a5aed50aa80d7ab061bb5c1f5eac52b22373523a29ff109df51b7d83b
ebola-aed19ff83ac981718fa08caa1158caf61c00edfac7ccc5786fd2f6f2ff007723
ebola-c203b08b595e032ecafb20aa10bcd8053ca4bd478eab7f3fa96f5e7c857c5a39
ebola-e1e333e149c1892978591d622b73e22038bc918ddc0e13557476b276b9ea995b
ebola-47a3856ee6048e459d1de88edc0a55343e2ad6e103a6154f46bf282f8108c258
ebola-c1452dc742faa1841b759c4f41157669dff179fa001012c5abc6e99d4a52bb2f
ebola-656efed7fd698911699487b736ca92c6995682b5534de107951de63e4fba69b4
ebola-2ed22fbf565006334438f6931c760a3613f59d0f047d97e0dc7caf72d40a2aa3
ebola-70a40ef7ddc055c8e316d6a27f46b8ee98ac1c3701b02b4a70f591173517c086
ebola-645a8af3ace496323fd3328f765a1820a9bc45bff1ebf6fb74372de778d575ba
ebola-f155f4046188598a9cb5a63d80c8d3c0289d99506d4ff7425ed5f2c8ed7ce23e
ebola-2221f29d6183a19f2cabfe096c791291e81cd91dd2f8bc9d05c709c785cf79b6
ebola-c4665c75539a519d14fddb40825b17194d4abd7a6454f6babfba76db757e1509
ebola-cacd9c2a906a7c8cac9faa760332f467847e0e35fe9275a9f506a244e02d9c63
ebola-47f0361cc8a2a20250b6772c7893d044c1fe1b9f3d5716bf9a56c1cc61196b3a
ebola-2d33381c8fdb2147ceb925c4c746489f981118568f4b88825fe3bf9ad504ef98
ebola-abe7801efd195837f19077d5abf538054f92a2b3409c0450b5b31dda23eacd88
ebola-c1cd79bd9fb8eac68bed419f101e6c0d8cdda9430c47ec729ec1370888b2f9a2
ebola-a9953ff579096eae4493f2c60e31f4314d3b0176e1e9c70ab3054ffe7a111475
ebola-439325b73d844294a363aca72c1147399bd6f275a8baf199312ddf37f4234992
ebola-80b5522e53614f55cb1492ceb07ec6f8cf6316b49e1901766f8489e33860226e
ebola-22546759770bda96998534821dc1899fe609fe3d95bbf87e3a8831e61b5cbdcd
ebola-c8083a1e7bdb768e717d974c461d5ebe73b2ef406bf5730530ca952d8fadd813
ebola-debb50eb07c9df9f62b7e25910f10da7ced01b186ad9ea309b2d434aa7fd4e1c
ebola-adbc27f45404bfd9c00de865b5f3268c3e2818d65afdeb77b127fdebbdca2d56
ebola-7269fe5e451a73bd91ce0af1f30214d8294e58556525d2abced8ea2f59cd9270
ebola-37bd96e0da796a4f1a79412873eebd4812552a10ccc30e1beb67e1221a3b88b2
ebola-bb558f36e17c55c6a5111cdb0250ccda898b6de733704980e7c56e96269c1e2b
ebola-0a0bfca873c823ebd484858c40811c53fa591452df3c685c39317a0bde26cadb
ebola-88cf07bb51227255c6352f66884730ee6630b8bdc39e8db58126a9fe207113a6
ebola-84c8ef8ebcb64b4d6ba400ccaabe7aeb6f469ca31e5a804aac79fd73cdb4e523
ebola-1bc7780700f01f6c06781766f5ef2a467c74e32f9c9320b1284746a67e936eda
ebola-5b916eb6d614bdd673b97f49ea842c99607c67732f9254ee623d42611461cb5c
ebola-7a983224dcb45a59b39a20fef829c1b92e2abd13867dc23e1d976572305d7e01
ebola-9db789e50a5dd2494dd2f881e0c5678c8f389151306c235f6ddc71c8fe0c78e9
ebola-56ae37a08ef822a317e60ce94e76241e495dff639cd54f7da17e757875d3306b
ebola-75aaa92451140763b7cc13f501330fcc2f4b656a5bd0af5b1d7e110e46c44d22
ebola-5353142d7ac154552577129bcd106c53cdebf6154499d068751880c193220e50
ebola-0e99dc4e69d57afa571419cac72aff8c2d2e58cecfdc958be6b662646aa24677
ebola-484b44670792de2aa891655c2b419c4dda0d68035846e934b049b2d3c3558860
ebola-1ff65aa6a4f36ca8e9bdddb49933a5b167be8bf20536f06a8b14f8e5c750fff6
ebola-f82f85e8180b8d202a9899cdbb6a829f0d6fa525d2c6ed8f35196ee5c72a8823
ebola-5ead8888f4444b00cecd2f146d92f064c51daba0283838a6eb97f21b07210d4c
ebola-67e3640ae2ac5c1d5ca9c40cfd4ddbeecad1ebb32fb884b75ab8465e3d62b9fe
ebola-c27f5a84427839f29d3858b077f72653c2c8c90de9cbd94aacc1357db57fac5e
ebola-aa67f0f5f13c56cb572c029e4d32b2be60360f08e4c4fd4c4b867fe2522e9303
ebola-708b405aab5a5eb4b6109374dce653962f5a80a34c519d9f1bd3a7718566346b
ebola-4d00b3be5bf48513db9d2a074c31c6e11d6d218afbc93a2746c2b5f9becf1b29
ebola-49afd07054dadb7e404147adbb695599f693101b3ab9cf5acbfb68da228bcfbe
ebola-2305e50bca61445851c0bcb0930ea207e0eebdebf1d7705a1756dc084112d367
ebola-ac0bdbcfc44afebe73d6abb0d60ddfdcd76bafde982aad26d78090ecbd6f83c7
ebola-b68e9ee9d6037be85daaf918da28b01ec999c8bca557518c276d3c8a9dfef4c8
ebola-b6394c4200716d9fd01e90e5589041d407e63c4657a19900d8da62801c07f756
ebola-3969ff94ac3602f07504584c14ededd601f3e7953e1b85fd8508ceb06ec0b3d6
ebola-bdec02759ea1b376d362e879e33985e01027ebd505e775740c5c7df716edf289
ebola-60294b2a63766a9b48af09c1691d3a424d26cf8baa1435c408217c6a5b39e1d1
ebola-a5c4ea27c6d03f69bc2480af8de268ff27d60f08e9368f58168271e13d2ac9d9
ebola-18f4caeed0b5667129db14f1c25f7b8bbcddc480b980288ba81b2b584ae432ba
ebola-761e008ae17942186b2b150535fd6fabaf32b7ff81e38dd051f702c5010fb8ed
ebola-144a260ad2f0233593c09e0f735fb5b6ee504e54708436b1d44d9c2ea6f52884
ebola-007196c29e1f6afa0478759f3307793d6d2f335e48baa65d2fdb9fd1cd5e4e26
ebola-30756ad762525195a488111a0137d3aece920d0049445db27626f5ce5d205093
ebola-9bf3a6b53c6d8ef4ff7225305933c3ea95becfcb01e064f78f466d545e68c644
ebola-0327e347c891fc9088415e829d24c7a853fe7daeaa94172eda54ffaa0fb6c467
ebola-2cb3b9799af44881e6f13b0aa8084b8d670a1bf52b17fdc4d9db1b0007892428
ebola-f6cba29a1b164e29c42b74006481c4390b1a9dab007e993a88ad5a8a03773aa1
ebola-fd0c1b605a3453215dc412f13642e7382fee3054ef6eb71015bcaf13dd6d06ed
ebola-5db3bd6f20a345801b4a68f89ff1b5a308ef2fe86f290ea627dd85687388fb3d
ebola-1d1f93f32b015b2fdabb585436b4865e79d8dbd456f33e0d5641d9f3d6024c42
ebola-4d3f9e4aedcebd5d80697942ab121dba4fc793fe8956137dff97c34f21df8906
ebola-fb9d62e6409ff67aae244fb4459550cbd4b8b06c270da99a44cf4b5679b3a26d
ebola-0e3f97052922a8444a30e4853a6ef58608991fbc4b692ad1d536ff86fe1cc8db
ebola-08ea06f5c52f0fbd4fed6d260bf98f552bf0f979b42671764909ed6861a967bd
ebola-d1f91d0d95a763c68e4abafcca6f501c0663a99ede8c7eb5b86885373be42ff5
ebola-09facb19588b35bf8627a73dc613ad73d9514c29e1559c8484fc8805fcc82f3a
ebola-65fdb3ce7f6664b16c0be963f9590286a3a5ab15c6fd39bbefdb5e921e8fda6d
ebola-ae1adeef917b0b73b7f145352c533a6d8b2e3d7afe034574821d9e4a2ca49983
ebola-9e6503708e6e5ce821802508f0a5df7e0acd2c417902477fc40f79bd4c7c670d
ebola-919ebaa0683871218db09b4647ae0ee935a5ad801f6f14d07ae485a9dc083c2f
ebola-d9323c9afb59b83d5c50c17c331660de357cd8139e5ea6660c72ec00b0d51736
ebola-3a7cfc7589ecc152457f7c2c3a6e8c4572f977997e0ecf70f8318184cfbcc10c
ebola-72b9d42f51307b169c3bcdc3c241fe1b493bc71c3027469d2b87a469fe784120
ebola-2cc40faaa86394751449c25c60b83ab99f185115d28741a021e5c73e0b906e50
ebola-a58d3695f2d9b442ee0e58c8300e8a6b9efa2452c56f173e9df5796673c2b67f
ebola-0117b4f6994387b95b0bf771146fabadcdb93989d494e201d660e549d7362a99
ebola-a11475faf648efecc7df720156645794414179329d6be0b61dfdd53a6c8e2159
ebola-23dc72dbae43e84ea66ccfddde84372f5fb59a0e46f7ea185fbd1c6af9286e73
ebola-f3cc9eba2279f8214418adb0e5a3d8c6aa2b7e962e44b2c42e7f97abdfcba25c
ebola-5c82f99e2fdc97466b3b012b8e4d00d4b01f7048588202f9339c3a93c5cc77de
ebola-ead02635d8d4624c5e85c57ebe754df8447f7941e1aba54d00d37cd10a025157
ebola-73a13aaf9bc06de3059ef94a2f7f589e967ebe1d6ffe7ffb7e0f8f496e46d796
ebola-e116db2b818654e162a93045be542632374e1f1fdfbefdd24dd38c13a826ae01
ebola-6d7395466b6cedf29877b75a90edbe3feeb35dbc3dc962447afee80a2f8ea1c3
ebola-2cc4026358fa8d4179cdda66a42ce1b228b6a25c03e7d7598b5c3674da977281
ebola-5b772bfe38e68757305460e49514cbef9b23f0f2f896864cc729922fb4aa340c
ebola-5d8f99864725b1daf940a9e5f9da401c0e37d7f88daf641ee7e54306f9bc2ad4
ebola-eda4dd0eb84416dc55f1756dc6ea84931931ed092b95d39ff6d2bbc4e231bd7a
ebola-019772cf0c3144381bb27b83155296f64d0a2b3498e200331c259f78376c960e
ebola-6a152866da9b5024209ed33bc529564a1507c64af356f26bddc9ecb92b923aef
ebola-e532d846ee27015fd6d8e83510fd4fd2655d27c699ecd88b91e5f7431998756f
ebola-0f7147ee43dfafbc47b2304b39dd7894c1f50f76c287bf253eb5c3beb357bcab
ebola-94244e9b0749f920ebfccf8f72db0dec1ff3d831195d801dae810bc0457196f2
ebola-5f97f24f2f25826664d63db55879055d7d4d0c3df47067d461a494047de9a2c8
ebola-10160da9c8313304046d60c607aa7982ec79ee269efe8548eee6c7fcbfac9a2c
ebola-f36d89d627e978fafad9108eecce434234c64e8a41c537b19ee732c90729aed5
ebola-c44244d74458dd3e105ccfa801f2b770bb56334dfe99b67bfa7333eb9a43aad1
ebola-0a49813915309df039fe740c89ab7f8071158236981cb78713def4236bd4d745
ebola-b20ad8859e0b6b8c3ed392a68dca6cdb4b00f89056e3eec2ba9f5bbb11cba2ce
ebola-afb585c037d098b44fce944074e9f92fecd88c312252dad39006d028f129bbcb
ebola-c467f20e535bc5a72bea8764b540bfbdbf4768ecb642348bdc7cf723ea4368a8
ebola-17b3c34371053f984685fc3f01b3e498fc801c56ad18934feec19f136bb7078b
ebola-613d444e54c838cfbe10f7c0e3688974f45b48bba65d78669c9038dd1eca5325
ebola-f5dc9abcdd8851968ba43991d40da0c2f4c031582c701b443c56d56d08bdae61
ebola-2929f7d2f68db418d07cd1cf9fd96905b4bbc61b6f0bf267a9bebe7c17bcc528
ebola-a373548060857318d7f1a93a9bd768db8d762d974f43713fcdffeb62e36a000a
ebola-095810736223ea24f448c6af571bc27a4f890d666aa0e1984083ea771428a866
ebola-1a338cf7b9e4475737056b72c7e7954b81769d8ad3289cb38b1c4191a10e9f59
ebola-d7d8a70c4b7de2a3f5d77873ecc763b9cc77d28983a500eb46de529e86551051
ebola-f9920d4b0caec4f5a6a978ec96afd918e9bf03f5bb0580d04b92804b18e1e144
ebola-e9f96a5cec144f5da6cf694ec3087559894bdc470069f29c2b7638cf386053be
ebola-1de946fb1e6d99e126a9507d8f10af1e3c9086508263dadb6bdf5c33b86732a7
ebola-3043b15222884456adcf6e06a5cd978824cfcc4a0dd947fc3d0e52d22e435f6b
ebola-8ab09183b2bcbed563abcfde70ee46d852f275b1482c429f065d9ca9af2365bc
ebola-ba8004fd803c6158795bd550267387b663b24311d28c4c589115c87bd884623f
ebola-d426d76d2073e896c2050ed449b0a46dfa93d624e353f650e2fbffdd837d73e3
ebola-721c813a4ce5d3f9839e2c01474c685ee127c7f593d4f35373b3eb59dfffb07d
ebola-0e9008b26e49f6970bc5d7040a6a1025f2ad513100fbab2d199bd38832f4b111
ebola-a798363583797e8e778960284a2dc7e78ca8e971966a2b056992ccce1db49ba4
ebola-43d55882795fbfa096cb6c510f108c763d638b23f6c0221964c37ee04a1d0f89
ebola-470cb2aec2a29fe9a59a63d55812fc6770eb92c09718833d4181eb2212020620
ebola-1ad65731580b081760f76f4fc4bb52b85fc933c7aab81ae9fc8138ae987f0b9e
ebola-e6956858a359e43c1eac4d88ad7217c40e91ef2844016baacb026c0c6a617e39
ebola-0b2910ecc6dcfa3e98650ba5dcfa2ef71c2870ffa01aecb6e3e1b72593816604
ebola-12719bd04e01ac5cc8d49a479d00913ca2f9a557c6db69d8222fa8a69e5b3714
ebola-f03f8cb7f407cd7e63c851fb24e01b0a3f62f7c9a32c24ecb98ef338ba9f0446
ebola-0cd6b5793ee90cd6457ae95cdb376d946e76b79cd6060a77d8e9392f065c0a93
ebola-69011e54413760c68f0420f761250e215405fbbde8d065e86b810654644cd1e3
ebola-6e3342b0b4945075196a79a33cebdd0d2479ba599b0a7692615df289ff5ae323
ebola-6483a13de65757c68d3f4f45c0442507c88fc201a6c31dd618899330e345639d
ebola-a9ce7a65f2f2f37ac7870eff872c6286a54f3994fd52338aa52888b744f12345
ebola-d04f1f26adf04ca744c28a9834608847458704ac478ab046176142ec9f5a299e
ebola-b4451c56c406c3fa3ac27e57313b510097cd364e302667a5ec8016d08cfeea92
ebola-a60e954f8c78d153ab3285142047f6575e9fe12c77001ee766b47a7f23274b88
ebola-c5f3a76ebffce2edd378367a4bb0349497b629f7ae7d002458b5926dff8fcee0
ebola-60d68d64885ca49037acaa5f7bdac24fb8d4cbe55f47487483d720e5ef6d9f30
ebola-e67f565bf94396f441997c013c29fe2360fac1e88a546b776ac102bcfd263f37
ebola-93946181ef41bb8a263fcd0d0e17e453b9f7421febe1ad65950f91b2e7d99b99
ebola-c3a5293a9bc75dfbacb15e833b3382655cadaf528d08189e41387e9e9fef4afb
ebola-b24f20dbe367ea2b52ab57252b0cd6b2c37267797fe29a9ca0bef6001d36c97d
ebola-1e34b8dbe7344258854b6a359358009443409cee5c97db39629754ed5c1bb071
ebola-386e364de13eb117318ec30543b494061969716715c3a512596d2c73916ebc0b
ebola-3162b4ccb41053ada22915b17a359ee6155de90fc7253b1a2809708d10f509c2
ebola-61369fd089adcc2c955edabf3e6d0e6ae638b0842f0b87afb5ef33c2ce7f327c
ebola-aea0e8075a0f724ba85a9cd713c1857b2c1eee1283e9e05805ff6855e7f352ca
ebola-be8c0951750d65a759dc1a153a13ea8ed52018969b564ba323f97143b50a32c2
ebola-118f11288a6bdbf23305b4e94628dfa50829aa61e660d14c72924bb9c6ca0896
ebola-4e61d33132f89ccfcd16e82d757b555426be0718dd58f782fdb74a29344b2282
ebola-2458ba39380584a1ff0ab626cad9bd86429ae91cbc200b33a5aab50d359f9875
ebola-7549f89b9dffc203ef15e760a2b2f1bba2e2a169b2f0f087ac08ce9cf28f7337
ebola-6f1452c2bc9788b7cedf3ac3463a968595d66136735a338771e1d6c137e91e31
ebola-31879ed4171ec2e09a4d3383bda3c0887171f383395cd4f9256d5d7cc8fc418e
ebola-f6bb1c00a73395b1c017737211c7d6b0f0e111203e7762b997c1a3f89ad9ce33
ebola-2ad70b2e47c80f304f3de445b6073bc8cd6a22ad19f03f271a5cc0c18855ccaa
ebola-30c21953977455401d5628bf313911470ff668d3aa1591a20cca7dccdd0a7dce
ebola-3ddf77385b3eb1f0ba22d25507498a7f97da4f5d7a20f8bd454415a825a9d8fa
ebola-140eee4a4193e69444d31eb9459aa2f39c57c1668bd1cf55f81eb9960bfbaa3e
ebola-23df89a3b16ffe0a68679ee2b82548922f57799f52475ec3e9dd005f76c3b83f
ebola-6f3071b68bd6aa9f55e5d7d0ae963374b8d6c2c09e508fe7f773fd7821f45076
ebola-fa0f1ff10c72b37d70ff86079a03d137a4d726ff599cd0ce4e445f4c4a70d17e
ebola-f9d5b2b7f6ff5a13ad3ec5ea150756ec7755ddb475ff480de30b9097e07c6055
ebola-913913728b8852f4e11f8c718ae4d01e3286db15cc6194c44f8707389b62f299
ebola-3873f067c8c9806a925fbd84c6d039ebbd0cc7ff6e856cba65bf569827f1b373
ebola-70e0851c61cd8a359caeefeae6a38cd1417a16458fa6c4100d9a3fbd4275635c
ebola-876b206a5facef6d0d9e0ff72bfd7e9ddbbbbd3427787237a79223d209c92f23
ebola-780f5e529a5dca873b9c265eef0db0266c08c287624a2473bb2f665370b658f3
ebola-53d93c415f2234c1898a8e551416ccad4b032020a9f5bc50b8fecd00898184e9
ebola-8210d7ec943df935f06ba6a9e1e531d145af9749980c6e6fc4cd0575b0fe722a
ebola-62429590b42cc2814d5884146e376208c5fd29b014fdec961adc3b14c739d195
ebola-6adb5d6057e902c94b05b865a1b000ab93d1fa8d85b599dd2a83c57538389698
ebola-fec20cdd205325cb99e2198c10c8b44226e5868cf329fcfe9a770f2a57d821e5
ebola-f77b75dfc45b506cfa465405062ca8911710a123f90f45abb9e8d1e2c12a5211
ebola-5804661d7167b3fcff8ee12ceaf2487ee3d978b01bbabc30b0efbb09e49f5ae4
ebola-5397dd42105b27dbee5120b27ce3500262e327e515a1fb1f1f8e90448a8d8f77
ebola-44fc0d18677b2ce2a4b2b6faacc58d4c4129c6f356d09c607d7e2980542fb4ec
ebola-d69f5ec4561f614d7062adcb837a61fa444468803f0da523eaebdd5a23faeeba
ebola-33e72f77ea4707222ff0cc21b54c862c02559a2f48cfbcf033534790a53113c1
ebola-d3f614594c423bde74e0524e1f5d783f2fcb597053d0ccb8eca75184dffc4b48
ebola-6ddcbd0b094513bb309440a7c1225d01c4d95fcbf40f0278df0bc0eafc5d02e0
ebola-30a0349c7ab4730915e5f763074ceadabc063babe3745804fbe9348326b6dc2d
ebola-c0348525a2e08a68c0a33780f56ef6db380b7fe43b0a14f9a93805a53607e5a9
ebola-5897bfd6a74d9535f1deafdcf005e63b84f58ef25daf509dc823f03a53146bd1
ebola-d8b6ae8a45a09e894ddb3ecac7b2083467adf71cdb8cf8e352abed6649468aaf
ebola-9fe97fe6aa44de0b7092fa6584e73d669a1a816e103cc3b2d4041b4f9e816f87
ebola-5ccf2af6d6a00b6dbebb1ba1227b510aed3be428735e62945e0771f7dff0c88a
ebola-a13350917493aa3abf38c8f3dbd565f54aec38e8dd3929c606008c2938f50eae
ebola-a4b95d551ce55383e6a0068a3fa36ead781c023489778ad84c2e7e4d9a0f9c0f
ebola-16dc6f16bcae83b09c5e74c6265006988409c2816d1b6ec62e0e3dc6fd1c8978
ebola-139140bdf5024666bfef94078f3c40d6c8f917b5ca98165a7721c362e7b2af39
ebola-8d1a07840e6e7842c6c33a639eb38a1b5849b907c717b2931067216a61b606c6
ebola-25b652d85ef5578812da74be4f6910c13a345a1408b1e8ef03418e233e3118ba
ebola-e40fb24d9d13c95850a7f96d75c1ac2ba9d461eaa3168b3a4d10a34ce1fa413e
ebola-23e2a5edbe5702010c1a213eb3ae84a04fe513d490a226aa7929044edc24eba4
ebola-6073d2e066d6700ca794d86b26aeaff8cb1e88eb016c57b218c95e64a8406772
ebola-c320bd64d1c58203974f59beab4096e8c41063b668b15b48557b86f55efa241a
ebola-57aed64eeb4008e1488938e89e630fc871ea2be3599c5336e0b4adf386613a0d
ebola-938ca859e81a1065f721d383d32590370dcd3bb2dc24ee18cb24c6dae1ef7530
ebola-d0d98dbf4a806ce3d513c4bab7899660f7fb3b432e6cce51b7c24ce527c3b8e0
ebola-6858d4cd66d985cadea7f60e97665e08f8f761fd65314cba0da27e3744ce58dc
ebola-7b2b09e7c81633a84a1dd626e84a1da8cdbeadbfb16707e4e0e6d3be5775071e
ebola-77b7ae5ba9dab21f36769b87568be2cb3d1234282abe0c02cd36573585b89e89
ebola-204f7efe912b356d18f7edb5a102a953ac2e80e05f49b0d505803e2636be8f9e
ebola-4a9156243680940c888e74ec405adaecfdff9af864253df6c236db29dbf31a31
ebola-48698609b6d78c8e52ebb35695a62b83be68c9e6050ece5078ec5129ea9cf1ca
ebola-8d48eaba8cb78f4318cf05164fe3511d525ccaf13468acc7453f148862799a6d
ebola-7e549516d5968662a549ccb7f4a3d9567c6286efa20a68fad99ae28829b70a06
ebola-cf8acc132a9f64d77c34f7bc6bee1439f0ad85494ae9213be5625a500635c8a0
ebola-a08b8dfd8effcc4ac02ee166b481d61db6edcc1310a0ca0080708db7b1a0e186
ebola-9e9202f6248889aa015dbe19034d69dfe38e95115d56fdb8e226397b745c266c
ebola-cc9f61315e43dec8b5a11dcd0215c69fc8fb239501cae73db9979a55d19ab322
ebola-71dc2311b3b450ae80e71ec39d870c09371ce8b052cc446501556824c858fe38
ebola-c40992330cb8fe917b0b07fcbf8608f4e68bb7dca0582af8630518bcb52bed57
ebola-f8ba6700a3dc0741a7e0c1b50cfeb1507679e51af6925a4ff67224a80c24ead9
ebola-673b6cf839699032d35d19981ac6772356f6d6c95de2f119f2904721ba2b2609
ebola-0861b94d7d17702759c3526c16fd9737d022f62618d0b3d1e85c0fae2ae03fc1
ebola-1e00e429460833b80afd4e126607e0bc81c2346dcd99e8869a6a06ad0b75c469
ebola-086aa60091ab72627f0a9bffe355f103ccb0f204a9065da70c4b1d1786cc45d8
ebola-b040f890530b669e335dff8dd120f066a33a97459c1e481242f4d17a105c8675
ebola-f77e65e48169b74fbad32f589ed8fca98ebceaf61a924008448830dc1ce88fa1
ebola-2f86381fd3eb94877171ee1ab18b007471fbc6b94dba7dc0dfc3f47ecc55f26c
ebola-58a14c1635db0248c512fc5b51ebea1d3699bc34708229e496a12a17191c1fd4
ebola-edd587573d210c06e4961ae513be2ad7c7d0a20aad507762d91de8f9e92438ed
ebola-a83c4efa4e6ed8f22b7e1c634b6b76bb553307680927cbd27728b577b622181e
ebola-09a78a87b38b5daa4938b15390fe02a26acefca155cfb9098964c233e0aa0955
ebola-ed642478855f4bd4a4b2d0e18da50d96fd4eaf3670e14a3dc9fbf317c3839700
ebola-9966acfb62b0d1131b552250578a986548883a230282f7a4578d6209429afb8c
ebola-c2c44a34351ad3f53e812a7256179ff2d768609b947513b1584f3889ecb77385
ebola-86da5d9c45f6e15c0afdb652498dfd1fe60d3ff2d29f1eab579d6a92d631831b
ebola-6406b9e30557337d8e3e1490b0a0425989c3d7c945adcd597a04adaa76e7bad4
ebola-4f7bb1973575628d92cfb02b1e9bf0e62baaa05e9344293a2f6c0dac548cea74
ebola-69a575e38d78e1f15309772cba8c88fc3a6334f0219ced787bfc67d1a0e5641a
ebola-5f7c503515942fac07965b5a7f893c3de7f2f1cb477a94e42d450ba4c8afc1e5
ebola-5412710fed3d862c8d519c80fc92187b004b2d27d771fbf0d6b157c1ccfa8822
ebola-48e00a3d42c7bb85fff722d9c97fd9fc6c65ebe558ec95e2f9c169b8010edc29
ebola-b52226305bbfc8f1bdcd1c123d9ac6dd1124cb072ab4451dbde7f1df7f1a6a7b
ebola-8e822df2f2f2fc922ed5804fb6bdb36369a367f3820fceed50869c33c07b3fce
ebola-d83f4d3ac74fd3ee6789b60f8036e3289cb4095f70fbbe5ac93784f607a6a4ea
ebola-a3bf4762ebbafb3b84764c02518530b5d7f4cc9590b73ebb576fe4f839da78c4
ebola-32d3722acca39fb7872baeafb85d661ffd4b059550d3146744ebec4ad07eabb5
ebola-448e365dd4758bbfe2d3006b7ce95d38f7661537d199afe300ee8c98cc9132bc
ebola-1198ce90a1f79f88fbf19963712a76709f428018d310e50c31580373c8b0375d
ebola-3a5f192a100c6b75b41031f4c54a60a8d3688f266db6402db6766b02408da919
ebola-16546929e0fcfbf4493add225f3673d859627a701e5d2cfc8e04d9c20367d189
ebola-39cc21ba3c78a0d54ca01bee76ebaaf88b19e92c01d65b0e2b821d71328f7585
ebola-e04cf29621e2d9158472f2ea05fefa052d283c376d5cfe1f55d37f94100636c7
ebola-e9b4496b5dfef681304937eb69f419f7cd4dd3e2dfb1222fab059b1a17a8f05d
ebola-b105d2fa33597743005287b4cc99a3ba3621c29ad11e5d584f117e8e5dcdb28c
ebola-48fd37b30614e9d7ca2f750a043c9eb02c8671e891c4b46013dfd443a408e5f6
ebola-1330ec50a1bd9e9309c84c118993bbdb78d739740e406c2e50ea8ddc0a80788a
ebola-f5927d226cff6694b3ff4e425c75619e1f1c4231e70bd662bed22a2281e5c066
ebola-8251f3862514258b31880087c1bf4061f6f398fbb3f2cc55ad24649adf1da25a
ebola-28ce2d14db016b716e1cb8d79d5551f5ad9a7d33530917fc2b6186156d92f979
ebola-0eadde344a88962f73d22498999bdae3fbfdee328fb2f99830a5902de5bcdf2f
ebola-92bfbd8b106812b295a17978845bd7aa676bedb2c3b79479f947ca5544424551
ebola-ae163991fb90104a9574591b8668c6f44a823026fa0dfa274bcfa9ceefabbecc
ebola-7c5831b402960aa129a435376f036eddfd9fe68eda48a88eda66c0b8c339af5f

list/click  |  time: 2016-04-20 13:19:54 545828  |  # of fields: 4  |  topic_id: 397  |  docno: ebola-3b494b1ad8b7e3671401b5c5d20cb082bf224a17f31eda835376b821e3e3abfa  |  listsource: lemur

passage/create  |  time: 2016-04-20 13:20:32 043257  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 3548  |  passage_name:   new Gallup poll reveals that healthcare costs, access to care and Ebola are the top three concerns of Americans. Gallup has measured public perceptions of the leading U.S. health problem annually since 1999. This year's results are based on Gallup's annual Health and Healthcare survey, conducted in early November. At the time of the new survey, only one of the four people who had been diagnosed with Ebola in the U.S. was still being treated, and the other two surviving patients had already been declared virus-free. Gallup researchers said that it is a testament to the gravity of the Ebola virus that it still sparks relatively high public concern several weeks after the peak of the U.S. scare. Article     

passage/grade  |  time: 2016-04-20 13:20:38 271703  |  # of fields: 2  |  passage_id: 3548  |  score: 1

doc/next  |  time: 2016-04-20 13:20:49 752302  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-3b494b1ad8b7e3671401b5c5d20cb082bf224a17f31eda835376b821e3e3abfa

doc/duplicate  |  time: 2016-04-20 13:24:50 991010  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-334bba2cca2807a3d5096678010b6d9f0e6328ad284896fd5866304be5aaa0dc

doc/irrelevant  |  time: 2016-04-20 13:42:23 049039  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-9d0a8eed7597c1b520e3c01bba5717bcdd10adcbae666e90ab70861bace6ffe8

doc/irrelevant  |  time: 2016-04-20 13:46:42 874283  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-753d3a150a96ccebf1243c46c3a52a9a15503676cfdfe3697f3696a0b31dcffd

doc/duplicate  |  time: 2016-04-20 13:51:11 199714  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-080008f6c58cec3cee9fedbb22e7874e3dfb33116ff5acc2e68ab0040fac4e1c

passage/create  |  time: 2016-04-20 13:51:50 171754  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 3580  |  passage_name:  But no one predicted the cost of the prep as well as treatment of patients with the virus. The cost of treating Ebola patients at Nebraska Medical Center's biocontainment unit averaged $30,000 a day, according to Jeffrey Gold, M.D., chancellor of the University of Nebraska Medical Center, who testified Tuesday during a House Energy and Commerce oversight and investigations subcommittee hearing.  In the end, Gold estimated it cost the hospital than $1 million to treat two Ebola patients at the Nebraska Medical Center. Those are the direct costs, the Washington Post reported, and doesn't include the cost of taking 10 beds out of service--a figure he estimates is close to $148,000. The hospital is still waiting for reimbursement but Gold urged Congress to approve funding to cover reimbursement for the cost of care that insurance doesn't provide

passage/grade  |  time: 2016-04-20 13:51:59 772405  |  # of fields: 2  |  passage_id: 3580  |  score: 2

doc/next  |  time: 2016-04-20 13:52:47 263164  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-f61616659ba37e9f7b89407c4bc818ec2f46dfb3be7b646217a83438988bc9d9

passage/create  |  time: 2016-04-20 13:53:46 781115  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 3582  |  passage_name:  December 1, 2014 | By Zack Budryk Despite progress in containing Ebola in the United States, some hospitals are reluctant to treat new cases because of the potential cost and stigma of caring for patients who have the deadly virus, the  Washington Post  reports. 

passage/grade  |  time: 2016-04-20 13:53:52 124127  |  # of fields: 2  |  passage_id: 3582  |  score: 2

doc/next  |  time: 2016-04-20 13:54:12 131615  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2d6b7302444b7997fa2b0c56df041febf0cc4eb98e72b22d405730285e0d9782

doc/irrelevant  |  time: 2016-04-20 13:59:54 364733  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-f580ecba794cee1f42540b53a62f5b24e4819f3864df17d579e90c52f9d0fc71

doc/irrelevant  |  time: 2016-04-20 14:00:27 969451  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-42471be60460935d889f74a6bc6f1674fea651d0a67d8aa8bcbb3d1e8e08c152

doc/irrelevant  |  time: 2016-04-20 14:04:56 643054  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-a4afa9ba8873e8038b662957b17832531574408fd50821613b065f323fb189d7

passage/create  |  time: 2016-04-20 14:07:30 574938  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 196  |  subtopic_name: provider impacts  |  passage_id: 3584  |  passage_name:  By Alyssa Sellors     Oct 20, 2014 in Health For most in the healthcare industry, the Ebola outbreak is a complete game changer, and something very few are prepared to deal with. But what does this mean for the healthcare industry as a whole? This past week, news broke that two nurses treating the first person ever diagnosed with Ebola in the U.S. (though contracted in West Africa) became the first two people ever infected organically here in the U.S. Blame unrightfully first came down on the nurses themselves, Nina Pham and Amber Vinson; however, as the story broke, the truth came out and it pointed entirely to improper protocol. Following chain of command from the nurse to the hospital, the true blame though lies with the CDC and their inability to keep up with this U.S. spread of Ebola. The healthcare workers are only doing what they know here in the U.S., and having never been exposed with such a unique and infectious disease, there is real fear among these healthcare workers. According to an article in Forbes this week, “a disproportionate number of people of people sickened with Ebola in West Africa are health care workers,” and Doctors without Borders reports that 16 of its staff has contracted Ebola in this current outbreak alone, with nine already dead. Looking at the numbers, around the world about 400 healthcare staff has contracted Ebola with more than 230 dead. Although these are workers in the thick of the epidemic, it’s not a good sign when the only Ebola patient admitted to a “regular” hospital dies and then ends with infected healthcare workers. Ensuring the protection of healthcare workers is a time consuming and costly undertaking that many are not prepared for, especially in countries like Africa where the disease is spreading like a rampant running wildfire. Though a complicated process, it is an essential one to avoid further errors in here in the U.S. like what happened in Dallas. The CDC is still working on a revision of current safety protocols for dealing with infectious diseases like Ebola, and until then, only a few select hospitals like Emory in Atlanta, Georgia, are handling the few cases. But what should we do about the other hospitals in the country who are not equipped to deal with Ebola? What if a patient walks into an emergency room exhibiting symptoms aligned with Ebola? Do the nurses and doctors turn them away or risk their own lives? Called “hometown healthcare heroes” in an article exploring current Ebola protocol, the nurses in Dallas answered that question by risking their own lives, but is this truly what they signed up for when they pursued their career? While these are all questions that seemingly have no real answer right now, it is time to look at the healthcare workers and assess the impact this outbreak is having on their livelihood and those in training programs now trying to become nurses and doctors. The Washington Times

passage/grade  |  time: 2016-04-20 14:07:33 217734  |  # of fields: 2  |  passage_id: 3584  |  score: 2

passage/create  |  time: 2016-04-20 14:08:06 662609  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 3585  |  passage_name:   “The American Nurses Association and other groups have called for clearer guidelines,” and are disappointed that recommendations are not yet available as the world scrambles for answers. The roles and responsibilities of doctors and nurses are changing faster than the training can change, and it will inevitably have a trickling down effect into the way nurses especially are trained early on. According to U.S. Bureau of Statistics, after completing a Registered Nurse (RN) program, over 58,000 new and replacement RN jobs will be needed by just 2018. However, with this recent Ebola outbreak and worldwide scare especially among the healthcare industry, that number could go up significantly. And what about impact on insurers and insurance costs? CBS news explored this question and conducted an estimate of the costs involved in the treatment of Thomas Duncan (who was uninsured). Their estimate equated to $1,000 an hour, or about $500,000 overall. And that is for just one patient. Since those in Africa have no health insurance like we do here in the U.S., the global impact on insurance has not been felt, but if an outbreak occurs in the U.S., “the industry would have to grapple with other insurance-related considerations, including issues such as workers compensation, general liability and medical malpractice.” It appears time will only tell as we all hold our breaths and wish for the best for those affected. More about	Ebola virus, healthcare workers, Healthcare industry More news from	 	 Comments (1) 

passage/grade  |  time: 2016-04-20 14:08:09 657369  |  # of fields: 2  |  passage_id: 3585  |  score: 2

doc/next  |  time: 2016-04-20 14:08:13 026837  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-d509bdb0afc26eed8ed04f6530217a8510eea3aaa2c3cd04cd2cc14fa8ecc7e8

passage/create  |  time: 2016-04-20 14:08:41 342049  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 194  |  subtopic_name: healthcare insurance  |  passage_id: 3586  |  passage_name:  If an Ebola pandemic hits American soil, the need for increased testing to detect the virus and the high cost to treat people who are infected could hit insurers hard.   Treating people with Ebola is very expensive; the costs for treating Thomas Eric Duncan, who was hospitalized and died from Ebola, are estimated around $1,000 an hour, amounting to almost $500,000 total, as FierceHealthFinance previously reported. However, Duncan was uninsured.  But the Insurance Information Institute, which released a fact sheet on Ebola's impact on the insurance industry, says the "cost of caring for Ebola cases would likely be at the high end of health insurance claims."  Health insurers could be dramatically affected if a large number of people are infected with Ebola. "Many people would need to be tested to see whether they have contracted the virus, and the cost of isolation of those affected could be substantial," it says.  Although it's unknown how many people in the United States could contract Ebola, the World Health Organization projects Ebola will infect 20,000 people in November, and the Centers for Disease Control and Prevention warned it could infect up to 1.4 million by January, FierceHealthcare previously reported

passage/grade  |  time: 2016-04-20 14:08:43 864601  |  # of fields: 2  |  passage_id: 3586  |  score: 2

doc/next  |  time: 2016-04-20 14:08:54 839435  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-56e4e42cbaf1933193a5abaf1f1ca3d0254fbae25498e96dd69f36961a852762

doc/irrelevant  |  time: 2016-04-20 14:10:06 058610  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-b51bb3f0107100e220f6e3d7a40aab058b82af388c4543b91aa12ad882d23994

passage/create  |  time: 2016-04-20 14:13:58 562681  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 3587  |  passage_name:  With just a small number of patients making up a large portion the nation's medical expenses, targeting these "high risk" groups is vital to controlling healthcare costs and reducing utilization. This webinar will examine how health plans are working with hospitals and physician practices to manage these patient populations. Register Today!  MORE ITEMS

passage/grade  |  time: 2016-04-20 14:14:05 218412  |  # of fields: 2  |  passage_id: 3587  |  score: 1

doc/next  |  time: 2016-04-20 14:14:28 016290  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-207e580eae1656dd6fa141c07f7ffa24ad0b4be1413e7fd4e6f9ac23b2927987

doc/irrelevant  |  time: 2016-04-20 14:16:02 629542  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1e9df05453557bedb84840932b01e4b57d08ef2ecabdf3c58227ad906ccefd15

doc/irrelevant  |  time: 2016-04-20 14:16:48 659089  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-967217a11c602e6a603247b5a91c5119d1cad68af6a0f4f4b6bdb10ca1ffac21

doc/irrelevant  |  time: 2016-04-20 14:31:36 922058  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-8450ce3afc7008a4739c858960205f64e9d9b7b6f02d1ad471d6f5659f03a3f4

doc/irrelevant  |  time: 2016-04-20 14:34:10 610078  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6523543ef516a6a973603c172c9b248072d22c2a3dbe9c62e44d89eafbb59456

doc/irrelevant  |  time: 2016-04-20 14:37:41 744356  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-534c708a6d7bfcbb9ef0c2829f7c4b3e9755cb00d4eab0ff222521360a5a5695

doc/irrelevant  |  time: 2016-04-20 14:50:47 855150  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-21dbfd488c0c46d8eee9fa7224ebe6247ce03032f1d5eb12e9ef7f1d61cda69d

doc/irrelevant  |  time: 2016-04-20 15:02:50 785818  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-e6912bf7d799d1db2c2acd15f4a7aac5924598d514c0c2e1823ec51efbf02575

doc/irrelevant  |  time: 2016-04-20 15:19:19 703330  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-849d25a28372bdaf22273a797812aed3a5711006ab39c729fb5ea63d54bdf4c9

passage/create  |  time: 2016-04-20 15:37:02 357146  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 196  |  subtopic_name: provider impacts  |  passage_id: 3652  |  passage_name:  Nurses, meanswhile, are calling on hospitals and healthcare providers to have their backs in case of a worsening outbreak, according to USA Today. "Nurses (everywhere) are more at risk for contracting it because they are taking care of the patient with hands-on, intimate contact," National Nurses United (NNU) Co-president Deborah Burger said. NNU has vocally advocated for hospitals to better prepare nurses to handle Ebola patients.  Ebola concerns will likely increase respect for nurses as the vital role they play--and the risks they deal with--become clear, clinical nurse Theresa Brown, R.N., wrote for CNN, citing the two nurses at Texas Health Presbyterian Hospital who contracted the disease caring for Thomas Eric Duncan, the first patient diagnosed with the virus in America.  In an effort to contain the deadly virus, National Coordinator for Health IT Karen DeSalvo will leave her post immediately to serve as Health and Human Services Secretary Sylvia Mathews Burwell's acting assistant secretary for health, according to FierceHealthIT. DeSalvo will help HHS address "pressing health issues, including becoming a part of the department's team responding to Ebola," a spokesman for her office told FierceHealthIT.  In other related

passage/grade  |  time: 2016-04-20 15:37:04 395559  |  # of fields: 2  |  passage_id: 3652  |  score: 2

doc/next  |  time: 2016-04-20 15:37:11 451465  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-77c399d1dedaa9f6d24c88d6fd2628037468bacdcad4b47c889ab4fb7572b4d9

passage/create  |  time: 2016-04-20 15:48:39 126736  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 196  |  subtopic_name: provider impacts  |  passage_id: 3671  |  passage_name:  Health officials' response to Ebola compared to their reaction to hospital-acquired infections (HAIs) demonstrates a clear double standard, according to an opinion piece in Forbes.  While the Centers for Disease Control and Prevention (CDC) has gone to extensive lengths to prevent the spread of Ebola, recently working with the White House administration to designate 35 hospitals nationwide as treatment centers for any patients who contract the virus, it has not made the same effort for HAIs such as C. diff., writes Forbes contributor Robert Pearl, M.D., the CEO of Permanente Medical Group. This is counterintuitive, Pearl writes, as 2011 alone saw 722,000 HAIs, which caused about 75,000 deaths.  Even in the face of these statistics, Pearl writes, healthcare workers find reasons not to practice proper hand hygiene before and after visiting a patient room. "Healthcare workers tell themselves it is not essential to wash if a patient seems healthy," he writes. "They may rationalize that it's too much trouble or that they don't have the time. But make no mistake, if improper hand hygiene put 14,000 caregivers at risk of dying, the culture and rules of healthcare would change rapidly."  This is particularly glaring amid the demand for personal protective equipment (PPE) to safeguard healthcare workers against Ebola. American health authorities are overwhelming PPE manufacturers, with the CDC ordering nearly $3 million worth of the equipment. Pearl agrees that health leaders must do everything in their power to provide the necessary reosurces for caring for Ebola patients, but the same concern must also apply to efforts to stop HAIs. "No healthcare worker wants to hurt patients, but it happens. And all too often, the healthcare double standard is to blame," he writes.  

passage/grade  |  time: 2016-04-20 15:48:41 887496  |  # of fields: 2  |  passage_id: 3671  |  score: 1

doc/next  |  time: 2016-04-20 15:48:48 935116  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-8656df476773eaef1202d7d27851ecb68e294d210bad1be10729568d0ac0136c

passage/create  |  time: 2016-04-20 16:00:13 804369  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 3685  |  passage_name:  With just a small number of patients making up a large portion the nation's medical expenses, targeting these "high risk" groups is vital to controlling healthcare costs and reducing utilization. This webinar will examine how health plans are working with hospitals and physician practices to manage these patient populations. 

passage/create  |  time: 2016-04-20 16:00:24 639899  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 3686  |  passage_name:  With just a small number of patients making up a large portion the nation's medical expenses, targeting these "high risk" groups is vital to controlling healthcare costs and reducing utilization. This webinar will examine how health plans are working with hospitals and physician practices to manage these patient populations. 

passage/grade  |  time: 2016-04-20 16:00:42 426724  |  # of fields: 2  |  passage_id: 3686  |  score: 1

doc/next  |  time: 2016-04-20 16:00:45 034495  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6420ac8055e10e42a8b91f9070c33620fd6094049b0534020229b6075d8879cd

doc/irrelevant  |  time: 2016-04-20 16:13:15 682847  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-7f065ef3bdbfc22b11a0693b604f6a75d237ac106775a0aa7363494fe229f7b0

doc/irrelevant  |  time: 2016-04-20 16:13:48 289158  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-8de06206d14ac4a96b72d79f49d4841521cd2a396c965459dd30bac970e812e0

doc/irrelevant  |  time: 2016-04-20 16:14:49 467427  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-fa81efe363d222ee556936ffe17a81da5d7a6131d79d1e05b5232d1c026dd535

doc/irrelevant  |  time: 2016-04-20 16:17:44 931895  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1a2719ebc9d4868e44425e90e96ba44b151667efa6aa443bac187fc4240c014d

passage/create  |  time: 2016-04-20 16:18:41 662970  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 3702  |  passage_name:  With just a small number of patients making up a large portion the nation's medical expenses, targeting these "high risk" groups is vital to controlling healthcare costs and reducing utilization. This webinar will examine how health plans are working with hospitals and physician practices to manage these patient populations

passage/grade  |  time: 2016-04-20 16:18:44 995867  |  # of fields: 2  |  passage_id: 3702  |  score: 1

doc/next  |  time: 2016-04-20 16:18:51 651034  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c27d4d504920909e578d52b4f02e0074222e37c5f5fbd2c8d2d31232516935a3

passage/create  |  time: 2016-04-20 16:20:14 784225  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 196  |  subtopic_name: provider impacts  |  passage_id: 3707  |  passage_name:  It will have an impact on the front end, with the newness. But long term, you probably would be grateful that a place like Presbyterian is having this experience up front. People today don't think about patients that have HIV who are in beds down the hallway.  If you want a sound bite, it's this: We'll soon realize this is part of the global environment, that nothing is restrained by political boundaries. Healthcare providers have a responsibility and a calling, and the ability and capacity to respond to this new world that we live in. The hospital that thinks that they're immune, that they'll avoid a serious disease, is delusional.  HLM: Can you discuss the problem with the emergency room software glitch and the miscommunication about the patient's travel history? [The hospital said initially that there was a flaw in the way physicians and nurses interacted with the hospital's electronic health record system; then retracted that statement the next day.)  BB: I think there was effective communication. The hospital followed CDC protocols. I'm intimately familiar with (the Epic EHR system). It's true that Epic does have modules of nursing notes and physician notes. But to say that the physician doesn't have access to the nursing notes or to say that the physician doesn't have access to nurse's notes is erroneous.  1	| 2	| 3	| 4	| 5

passage/grade  |  time: 2016-04-20 16:20:17 961560  |  # of fields: 2  |  passage_id: 3707  |  score: 1

doc/next  |  time: 2016-04-20 16:20:22 250833  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c60ec907f545bb871cd9b30094906a3f8117ad3648f01b3d3f4093b2486b2652

doc/irrelevant  |  time: 2016-04-20 16:23:57 223024  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-0f3caa1ded8a6ee9dfd7052ea574bf082ffef67bfd2012761d17b7d21efa476f

doc/irrelevant  |  time: 2016-04-20 16:25:20 316591  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-0d87e550a1551f3776117182ae850063d80c39bda0ed05300ede185748c7183b

doc/irrelevant  |  time: 2016-04-20 16:25:35 025309  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-a3d6cec81c1ae4558ba85cc5a4b945ea014720994907581854a026513eb97183

doc/irrelevant  |  time: 2016-04-20 16:26:05 654334  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-3d611657a8d500e076f071ac379643ff849a338e87d11bdae71acdd4cfbf377b

doc/irrelevant  |  time: 2016-04-20 16:26:25 881164  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1304d27a5aed50aa80d7ab061bb5c1f5eac52b22373523a29ff109df51b7d83b

doc/irrelevant  |  time: 2016-04-20 16:26:52 847745  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-aed19ff83ac981718fa08caa1158caf61c00edfac7ccc5786fd2f6f2ff007723

doc/irrelevant  |  time: 2016-04-20 16:27:25 542367  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c203b08b595e032ecafb20aa10bcd8053ca4bd478eab7f3fa96f5e7c857c5a39

doc/duplicate  |  time: 2016-04-20 16:27:45 637777  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-e1e333e149c1892978591d622b73e22038bc918ddc0e13557476b276b9ea995b

doc/irrelevant  |  time: 2016-04-20 16:28:31 103374  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-47a3856ee6048e459d1de88edc0a55343e2ad6e103a6154f46bf282f8108c258

doc/duplicate  |  time: 2016-04-20 16:28:58 301280  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c1452dc742faa1841b759c4f41157669dff179fa001012c5abc6e99d4a52bb2f

passage/create  |  time: 2016-04-20 16:29:27 317270  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 193  |  subtopic_name: Who pays for healthcare  |  passage_id: 3718  |  passage_name:  As hospitals scramble to properly prepare for any further outbreaks of the Ebola virus in the United States, they are bumping up against the inevitable barrier: cost. Hospitals are finding that merely preparing for the narrow possibility of treating an Ebola patient can cost them hundreds of thousands of dollars.  The costs can come on quickly, even if a hospital may be treating a patient who is only suspected of having Ebola. That was case at the University of Kansas Medical Center. Its costs included $100,000 for personal protective equipment, $8,000 to $10,000 for heavy plastic sheeting, payments for specialized medical waste removal, and overtime for the nursing staff and other hospital employees.  "There were major categories of costs and expenses above and beyond what we'd necessarily have for any other patient," Chris Ruder, vice president of patient care services at the hospital, told the Kansas City Star. "For example, everything the physicians and nurses wore when they went into the patient's room was completely disposable. And we had six nurses at any one time taking care of that one patient--a twelvefold increase in nursing care instead of the usual one nurse taking care of two patients in the ICU--plus physicians and a dedicated infectious disease team. The ratio of human resource to one patient was exorbitantly higher."  At hospitals in the Lower Hudson Valley region in New York, the cost of preparing for a potential Ebola patient could be $500,000 or more, the Poughkeepsie Journal reported. Nyack Hospital put the price tag of preparation at between $250,000 and $500,000. The cost at Westchester Medical Center is up to $700,000 for the creation of a containment area to safely treat an Ebola patient.  Those hospitals are likely moving to a higher state of alert after reports of a Manhattan emergency room physician who was diagnosed with Ebola after treating infected patients in western Africa. At the same time, hospitals that do not properly prepare for Ebola cases are at risk for taking a financial hit if they must treat a patient and it is not handled well.  To learn more: - 

passage/create  |  time: 2016-04-20 16:29:34 613016  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 3719  |  passage_name:  As hospitals scramble to properly prepare for any further outbreaks of the Ebola virus in the United States, they are bumping up against the inevitable barrier: cost. Hospitals are finding that merely preparing for the narrow possibility of treating an Ebola patient can cost them hundreds of thousands of dollars.  The costs can come on quickly, even if a hospital may be treating a patient who is only suspected of having Ebola. That was case at the University of Kansas Medical Center. Its costs included $100,000 for personal protective equipment, $8,000 to $10,000 for heavy plastic sheeting, payments for specialized medical waste removal, and overtime for the nursing staff and other hospital employees.  "There were major categories of costs and expenses above and beyond what we'd necessarily have for any other patient," Chris Ruder, vice president of patient care services at the hospital, told the Kansas City Star. "For example, everything the physicians and nurses wore when they went into the patient's room was completely disposable. And we had six nurses at any one time taking care of that one patient--a twelvefold increase in nursing care instead of the usual one nurse taking care of two patients in the ICU--plus physicians and a dedicated infectious disease team. The ratio of human resource to one patient was exorbitantly higher."  At hospitals in the Lower Hudson Valley region in New York, the cost of preparing for a potential Ebola patient could be $500,000 or more, the Poughkeepsie Journal reported. Nyack Hospital put the price tag of preparation at between $250,000 and $500,000. The cost at Westchester Medical Center is up to $700,000 for the creation of a containment area to safely treat an Ebola patient.  Those hospitals are likely moving to a higher state of alert after reports of a Manhattan emergency room physician who was diagnosed with Ebola after treating infected patients in western Africa. At the same time, hospitals that do not properly prepare for Ebola cases are at risk for taking a financial hit if they must treat a patient and it is not handled well.  To learn more: - 

passage/grade  |  time: 2016-04-20 16:29:38 089020  |  # of fields: 2  |  passage_id: 3718  |  score: 2

passage/grade  |  time: 2016-04-20 16:29:39 654338  |  # of fields: 2  |  passage_id: 3719  |  score: 2

doc/next  |  time: 2016-04-20 16:29:44 981662  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-656efed7fd698911699487b736ca92c6995682b5534de107951de63e4fba69b4

doc/duplicate  |  time: 2016-04-20 16:30:56 680521  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2ed22fbf565006334438f6931c760a3613f59d0f047d97e0dc7caf72d40a2aa3

doc/irrelevant  |  time: 2016-04-20 16:31:33 557972  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-70a40ef7ddc055c8e316d6a27f46b8ee98ac1c3701b02b4a70f591173517c086

doc/irrelevant  |  time: 2016-04-20 16:31:58 660390  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-645a8af3ace496323fd3328f765a1820a9bc45bff1ebf6fb74372de778d575ba

doc/irrelevant  |  time: 2016-04-20 16:32:15 951204  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-f155f4046188598a9cb5a63d80c8d3c0289d99506d4ff7425ed5f2c8ed7ce23e

passage/create  |  time: 2016-04-20 16:33:09 105300  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 193  |  subtopic_name: Who pays for healthcare  |  passage_id: 3720  |  passage_name:  The short-term fiscal impacts are also large, the bank said, at $113-million (5.1% of GDP) for Liberia; $95-million (2.1% of GDP for Sierra Leone) and $120-million (1.8% of GDP) for Guinea.  âThese economic impacts include the costs of healthcare and forgone productivity of those directly affected but, more importantly, they arise from the aversion behaviour of others in response to the disease,â the report said.  âSlow containment scenarios would almost certainly lead to even greater impacts and corresponding financing gaps in both 2014 and 2015.Governments are mitigating some of these impacts on their budgets through reallocation of resources, but much international support is still needed.â  The death toll of the haemorrhagic fever at last count has reached 3 879 â although the true figure is feared to be as much as four times larger due to under-reporting â and is mostly concentrated in Liberia, Guinea and Sierra Leone.  A man who had contracted the disease in Liberia died in Dallas, Texas on Wednesday and a healthcare worker in Spain this week was the first person in this outbreak to contract the disease outside the African continent.  Slow containment will cost billions

passage/grade  |  time: 2016-04-20 16:33:11 592422  |  # of fields: 2  |  passage_id: 3720  |  score: 2

passage/create  |  time: 2016-04-20 16:33:22 012877  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 3721  |  passage_name:  The short-term fiscal impacts are also large, the bank said, at $113-million (5.1% of GDP) for Liberia; $95-million (2.1% of GDP for Sierra Leone) and $120-million (1.8% of GDP) for Guinea.  âThese economic impacts include the costs of healthcare and forgone productivity of those directly affected but, more importantly, they arise from the aversion behaviour of others in response to the disease,â the report said.  âSlow containment scenarios would almost certainly lead to even greater impacts and corresponding financing gaps in both 2014 and 2015.Governments are mitigating some of these impacts on their budgets through reallocation of resources, but much international support is still needed.â  The death toll of the haemorrhagic fever at last count has reached 3 879 â although the true figure is feared to be as much as four times larger due to under-reporting â and is mostly concentrated in Liberia, Guinea and Sierra Leone.  A man who had contracted the disease in Liberia died in Dallas, Texas on Wednesday and a healthcare worker in Spain this week was the first person in this outbreak to contract the disease outside the African continent.  Slow containment will cost billions

passage/grade  |  time: 2016-04-20 16:33:23 736167  |  # of fields: 2  |  passage_id: 3721  |  score: 2

doc/next  |  time: 2016-04-20 16:33:26 036513  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2221f29d6183a19f2cabfe096c791291e81cd91dd2f8bc9d05c709c785cf79b6

doc/irrelevant  |  time: 2016-04-20 16:33:39 526379  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c4665c75539a519d14fddb40825b17194d4abd7a6454f6babfba76db757e1509

doc/irrelevant  |  time: 2016-04-20 16:33:49 929351  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-cacd9c2a906a7c8cac9faa760332f467847e0e35fe9275a9f506a244e02d9c63

doc/irrelevant  |  time: 2016-04-20 16:34:04 094634  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-47f0361cc8a2a20250b6772c7893d044c1fe1b9f3d5716bf9a56c1cc61196b3a

doc/irrelevant  |  time: 2016-04-20 16:34:21 250522  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2d33381c8fdb2147ceb925c4c746489f981118568f4b88825fe3bf9ad504ef98

query/solr  |  time: 2016-04-20 16:37:51 784087  |  # of fields: 3  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  query: ebola healthcare impacts costs 

result_size: 121  |  num_tagged:  0
ebola-938ca859e81a1065f721d383d32590370dcd3bb2dc24ee18cb24c6dae1ef7530
ebola-a37648f57c315517c2b985473b782b225f59b9f370481c3bfb4b16378022faf2
ebola-b70509a81788c84b140f2f3679b0ee3cad663ada8d6652c4167ad254af0d0c4a
ebola-4d00b3be5bf48513db9d2a074c31c6e11d6d218afbc93a2746c2b5f9becf1b29
ebola-6e5e3f765cabc9543ca49756c5a7e4508f048474235c2f5581fba68c825bdb57
ebola-0e99dc4e69d57afa571419cac72aff8c2d2e58cecfdc958be6b662646aa24677
ebola-bd7650f934e648a6ccef20ddb322cd4bb0e6c9258cf1179f9ea68ca2ac622c91
ebola-8fb9717cbfb923ee492468f532a27e4ee90af6b1598bd1b83fd675bab1896703
ebola-acb8a54be904bfdd119f09a4d48eb36f691f17af7ae1a58bb89cd924a86687ea
ebola-67e3640ae2ac5c1d5ca9c40cfd4ddbeecad1ebb32fb884b75ab8465e3d62b9fe
ebola-2305e50bca61445851c0bcb0930ea207e0eebdebf1d7705a1756dc084112d367
ebola-b309366124416d264a84f6975c98c756298124ef45dba08b1ce7c77417756b64
ebola-123b979f7c8f729f83f1f9996be493748b06e28dbfdf9254a48f17eee748e523
ebola-0c8aeae7eb4df16d028e44fdbb0e4aacec7d11c918344cf6abb9968c00ee3035
ebola-abe7801efd195837f19077d5abf538054f92a2b3409c0450b5b31dda23eacd88
ebola-80b5522e53614f55cb1492ceb07ec6f8cf6316b49e1901766f8489e33860226e
ebola-733ccbeb2eff86be2f4f98934a63de5f35ad4edd5e37e3c6ecf28102843434cd
ebola-6e3342b0b4945075196a79a33cebdd0d2479ba599b0a7692615df289ff5ae323
ebola-5b221b726f692cc054374879ca07e9d6964673568371073190f1a95c4abc3ca8
ebola-3303f1c2bc62e67248c59c5e583aa3d929d67ebfad5d5b76e7b0cab460118fdf
ebola-2db5b83a11e987dd3aaa981028b15815735eec7367df863a625ff0c46371ec96
ebola-7da4f28e5442a3c02048ee455d4f22ffe2422dff381aa11e3c33bd71f5060afd
ebola-296ffb5a36648c95428e2fbf2470560fa3aeb3a796846de2b54418663bc8f02c
ebola-8a2f86edea845778cc9be5a432a05f629a66716e71b568a82c5dc2513c6393a8
ebola-17db671c0479e52d9c4afc372a38b5032cc62a868d285c5b1b25007f60c00671
ebola-d4c3bca83830752bfd2f5b8ceb6d541658f3d95b7549b0faa50241e8783c86e3
ebola-41e6ea15c663279f45ab0333818aa21131c3da264942329dad6deb1620e4a895
ebola-d86f470e2424c3f5bb5a822486e87302028f2ff8af05c2f9418d94fbb70e5799
ebola-13cbf4809a87ce5549ffb7a83a260a17060018fe8f7034e38b7fd4e5f5b33b73
ebola-0e3d72b56edcc245645976da0b9671cad0b1921946b476b6faf3c7f44e7b5497
ebola-4cbd1a41ab654e2af4bdf2dc275bf343fa168105243aeb8c0bc95722a26777a1
ebola-37d0a9c5ca65223bf76add66343265b53f4eed7c17b26ede68fc717adf6ce263
ebola-c4cae61c81158216f9dd163a7e7355d1b7a9a470d3590261d2ac909e7321e784
ebola-2b80550e273557fe9e9a299735b85ab7adbb501f7999b0b50fadbc3eda6b5e60
ebola-7422a609de893023f85bdcd5f583709352fd62c1c44af72a3d9f57dc0607fe0c
ebola-5b5ee514eb64e24b4b5b3890b73ad60e136a2d4ca9bf941a22523a1ea0dcb085
ebola-75b5469b76fcd9c00bcc57970d203d6b27bd20f92f8221db6785757301e823d7
ebola-ae99ae8120bc97b3a8a83058fa42a046656fd480ee17f3a2d28d4682f800de75
ebola-767fe4bc6b27eb7f430a565c605d9a8ed04b141e8884bf8632ac713bb7929698
ebola-e26ee69a087e43614c354bba7ef41c745458cb5dc194493a629f32aed929cf0f
ebola-c97e9c8b9137066ab083de7053a43e861a98726d31064c5c6e836016a61cd1aa
ebola-734a13343843d47f9565b9aa4ce778fef9b9476b854bea78b25f49e451b95eba
ebola-5c9091646451282d1510598f280c05525b25c12b396dde47170e3c157cb70e9f
ebola-2034a31d8132ab60cf0ad7dbb5025b7fb2ee665fe5303ced86e6f3d1030b52f8
ebola-f874dcd33c2eecdf1b1f7c66d12dddebf8486b6133e869c0b8a37a5dcfecec81
ebola-82bf7bc96ec80b0e2f049aac7293604ae89edd35e6be10e588361fad6f3a9dd1
ebola-0bdd30601ccbc10fd82948a76be414479ba65f30149d1c78c9c5f5bbca23a0f3
ebola-e72ef92f4a1b28f599a852ff5e50a7c91235b8ccc01677fc75db20727c811a97
ebola-d203cef33920cf33278baf79443a9c9e9d6154d460c3b20766cf5b71bedc110b
ebola-31002ace7ee9f9c2b3fd382efe0716c5b25abd2b030026db5dcea5a3dbab0f57
ebola-9e12191815f06f79c892cbb46cb22525c1bf9679cd8703f1033b1928e6fe4fd7
ebola-6d3d9eabe153fd2f0ddcc7308187b92c376f0854b10944e3e8a7d9077c0eec45
ebola-3fccb3d80fcad1b7d9ba946efe0d0ed2d3f42a239d1462141ef404e3e490a3ab
ebola-286ebbeb7d28b3ddab4e5d7131dd2c57268acc1b0bfa2088a7aa8197f8738527
ebola-8cafe65fc730eaa638c96787a50fa751785a707201caf99986aaa32c0963b99b
ebola-7f1b2810557035b419a842318811944bed4b1c25143d030cea33930a4af84c97
ebola-610f61527dfefa6d2c6550ad1296bedf305a44ee2a0de126d5285cfe1ae883e3
ebola-bab93ec5cfcef57f5289178fe6d3e905225c432f59131b7c13fe021472d3c44e
ebola-f2336a74d7c36e2115574e94c091cbb64d5aaf74007c49adb37a3e61c4c0f727
ebola-0068844a6581d6edc5f6c3afb8567af652648406954df1dea337b74fcf4281a0
ebola-27414fe3cbd1979b04004140b96897d32c1853f133d5504077b9e8893b5f793f
ebola-913ad2db19c4f446fe633aba0b9f8b933a9055e2d012c9f6c2943cb7ce08a73c
ebola-8fdac686a387ab73c054b1a0c205b2c7c10f8defd9d6537f5ef64ba8453f9f27
ebola-4404cb7c1b80114919386fdee9c81cb712be839723fcc172b49e5c259fd55806
ebola-c09349d4ce8bf6c4145646c0be368d0dd832da1a3a807cec998d8ded2daee7e2
ebola-4bfe4fbfaed81612f279c8bd928825c8cfc375bf7ebb6f371ae97f900f761141
ebola-aed1f77c726a7140f6cac44434ecbcb3d5eafa5540537e00c501c32a134d346f
ebola-418a58fdcdaf756e1819298418d62fccfb5f64b2cd9a7dc646f9f316eca082eb
ebola-e6c6c89a3c43ebbda9e25a4135582a40e44aa54b8876751346d07f750f1e4bf4
ebola-d40a879f17a2a303d5e961b06a823847c4e1dceaf009b957212b9afe0e54348e
ebola-3b7737a91cbf6ab0bc29414a6de5d4d20bd037002e5c07f16a85492c24482eee
ebola-63d4c56dadd60a82d8e36514c5488e0dfe1274586998c68e1e1be47b3763e821
ebola-f4745c90d686c325eb0fd8c2665b7fe90b8b8cfc6992f3fb79e9715fa01ff0f1
ebola-4bf723c3fa5f23c4d3a8b41e9841cae6e784d318a0c8792bc64ff212e8ff401c
ebola-540a92ff1495c4ebe71383bc06797c310113e73851a11933f5b7a5c964a58841
ebola-c717056091c78dd575d9eba22051a625581f67f514662271e97d8d12bf302655
ebola-53d93c415f2234c1898a8e551416ccad4b032020a9f5bc50b8fecd00898184e9
ebola-4e91e3c8d334874737e074ddecd416d903f75b54c9460c512a31b3e0db2205b4
ebola-ca2f5ab4464405be24958c436bb092e96fe0636bb818bae1599b437b7d1e934d
ebola-8967b66c2baf48a8d1a99265f086fc08ce144beb2a86b920bc021127c1447ed4
ebola-962cbec9a83a19ebbcde0345d73f14caf93c35351b4bf33041e9557c4a5a6c0a
ebola-cc2d585655c5ff8ff7c31503c7990520f3e2dcc12e693ac34fef13a5d0482365
ebola-f4724312906109b7990b4ab855300a15ede90baa875f9471fd11b9621d321a76
ebola-b9bf27f95685c0d6f0510910de2bee2f06b5d3ae30202ffa9dcada8ecb91c99e
ebola-131ca4dcdd7e1edd2fa221b8992393d5d9c2213c7323d7a908be7ffcf06cf176
ebola-a6d8f1f7dc878a779721eddfb1b6024182766e266f8c5e2fab6fdf4eede92ed3
ebola-acaa3788d9401097c246f546274308cb18fe844b9d69c7ecb33211679960c744
ebola-e9752cfbc99d42d4f040b1b3f4818383bc88912e8a577fe50307a8a9bb0b50e2
ebola-604da3961905401774bfe1f87d67c00da117bc9a5f9c9737313d33e1497b401d
ebola-e1cdfcb1dea31e8dbd1b58c23efa4d12995cbb375573c1a1bbfcfd32ae0ef70e
ebola-07ac09c14357ed48968885a043ccf091f2745e4f9a0f0787272701d668067083
ebola-c8d5ed9be97e22781d9b7076078cd1764586c1d6458fa6d69ba0ad6cf0f9d916
ebola-e323ea7ff37bdacde9eecaa7d2bee96f3036241a86079a2db17bca23e9496af2
ebola-d08db77ea8b308ba1e66c3426ce98153f014408794b31c2603afe7c15991b047
ebola-1a8b859412ece9fc8b3cee02a8acb65baad3583d187bf2191e4e03108ee85690
ebola-14c1da3de29074d240601d82379cca7cda4b61ba8711ee63407ced75de1e39ab
ebola-e71b662a46f6f9bc31380f527d7b9bfe2e5c47c879a17e917caf6cdc59261a8d
ebola-4da3b74d863cbef98606c04ea2136af8d5cc338931f44a7a5459aaadd632a8a0
ebola-7760ab2466aaab581c9ea9e13a83e1c3562fba3742ca0279c631d88710d6aab8
ebola-2f3965d46c21c165653150d9da5bb66a59e8efa77b8a4dba0c43c8f816fbb15b
ebola-21d11e159be15b3e29739c2109299c73478b10c883ae400f3fb9fda80dc0da25
ebola-94e70fec5c616183a70891769c830f426e19904e4019bdcb166cfbd58a9401d6
ebola-6828004f310bd9186adf7ce85bbf7f12dbe07119fecdd82f7e016bfc9c238cb5
ebola-48a8fc0013375628631f0fff9dd1976fd1681300cb5251f57fc4850e2b53ad85
ebola-32b8081197b72f1fab8f6bd47a93345b575da0eeb41aad0c529622819a394108
ebola-1ad8346fb8ffb6dea1ab53da7cd92009cd353a935d3c2e5e592208ee9d0e64a1
ebola-18dcc79cbef8a3d3a5eafb00008639ea2eaa2bc4bdc6ca209509f82e218629e4
ebola-1bfe8cca6a2d2ddbfb6fdfc0e787f41b0ae0fa720d1f258b9837164ebcd4c74d
ebola-33f2de79b583bd4edd3ba0a5a054589a11e484f81d00d6733908c17626fb461e
ebola-f33f4f00dee3e43c7dcef6260a61b46c85d60ef5b206864a282b31a3d33f26b4
ebola-b057ad1ef2f9f1aac208c76058ad12eb587c4602573b9f4b8dbfc3431e19f2af
ebola-58733538d2e8564a7b45a1d53189e333164207093f8e344f474c4c37bb75caca
ebola-f74ed50667558936a35bd76809767317dd74ce00163667ec6ba92853a5079b09
ebola-830bef3c71e38d353136214e8c11caa9d98c37c94aa795f67ec4117849b0695d
ebola-82415e9d4c5975305951509d21c2458f5c9730447ea8fa3484792d1cc506a3e2
ebola-b276d304c4f5d9090c5c993a50a202392e2770d51c54cd7aaaf8268761f7f109
ebola-04786419b29e5f82c69dbc7a9ac6caaef1e8b1fb94af6c1d4a2d81d64172a152
ebola-988b5e2e9feb01e57787452bdce7979f6c0d1d83ca06b56056557ec203e9840c
ebola-07afc5d141285b8a48cf0e13154b1159d3ae02fdc5435df42f222061dc65f41e
ebola-cf2cc170df28b24ecc031ecf5119fa6bbf4a7d4be509468d473f0434510bb6e9
ebola-5a79542471b3c188eb9f0d027d5b256847c7efa6652ecb30861db823aac193cc

list/click  |  time: 2016-04-20 16:38:07 196103  |  # of fields: 4  |  topic_id: 397  |  docno: ebola-938ca859e81a1065f721d383d32590370dcd3bb2dc24ee18cb24c6dae1ef7530  |  listsource: solr

doc/irrelevant  |  time: 2016-04-20 16:42:06 466714  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-938ca859e81a1065f721d383d32590370dcd3bb2dc24ee18cb24c6dae1ef7530

doc/irrelevant  |  time: 2016-04-20 16:44:25 992844  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-a37648f57c315517c2b985473b782b225f59b9f370481c3bfb4b16378022faf2

doc/irrelevant  |  time: 2016-04-20 16:45:08 765361  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-b70509a81788c84b140f2f3679b0ee3cad663ada8d6652c4167ad254af0d0c4a

doc/irrelevant  |  time: 2016-04-20 16:48:27 486628  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-4d00b3be5bf48513db9d2a074c31c6e11d6d218afbc93a2746c2b5f9becf1b29

logout  |  time: 2016-04-20 16:50:48 803109

login  |  time: 2016-04-21 13:20:00 216010

doc/irrelevant  |  time: 2016-04-21 14:00:30 825946  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6e5e3f765cabc9543ca49756c5a7e4508f048474235c2f5581fba68c825bdb57

doc/irrelevant  |  time: 2016-04-21 14:09:29 555253  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-0e99dc4e69d57afa571419cac72aff8c2d2e58cecfdc958be6b662646aa24677

doc/irrelevant  |  time: 2016-04-21 14:12:48 789624  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-bd7650f934e648a6ccef20ddb322cd4bb0e6c9258cf1179f9ea68ca2ac622c91

passage/create  |  time: 2016-04-21 14:15:44 173070  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 4557  |  passage_name:  The world is facing a water and sanitation crisis, with 2.5 billion people on our planet lacking access to a basic toilet. The global health and economic costs are huge. However, the crisis can be addressed, and there is an important and growing role for private enterprise.  Barbara Frost

passage/grade  |  time: 2016-04-21 14:15:47 467216  |  # of fields: 2  |  passage_id: 3721  |  score: 1

passage/grade  |  time: 2016-04-21 14:15:53 379746  |  # of fields: 2  |  passage_id: 3721  |  score: 2

passage/grade  |  time: 2016-04-21 14:15:55 817333  |  # of fields: 2  |  passage_id: 4557  |  score: 1

doc/next  |  time: 2016-04-21 14:16:10 103474  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-8fb9717cbfb923ee492468f532a27e4ee90af6b1598bd1b83fd675bab1896703

doc/irrelevant  |  time: 2016-04-21 14:24:32 969254  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-acb8a54be904bfdd119f09a4d48eb36f691f17af7ae1a58bb89cd924a86687ea

doc/irrelevant  |  time: 2016-04-21 14:25:01 296300  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-67e3640ae2ac5c1d5ca9c40cfd4ddbeecad1ebb32fb884b75ab8465e3d62b9fe

doc/irrelevant  |  time: 2016-04-21 14:25:24 542030  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2305e50bca61445851c0bcb0930ea207e0eebdebf1d7705a1756dc084112d367

doc/irrelevant  |  time: 2016-04-21 14:25:41 046415  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-b309366124416d264a84f6975c98c756298124ef45dba08b1ce7c77417756b64

doc/irrelevant  |  time: 2016-04-21 14:25:54 455914  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-123b979f7c8f729f83f1f9996be493748b06e28dbfdf9254a48f17eee748e523

doc/irrelevant  |  time: 2016-04-21 14:26:13 557713  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-0c8aeae7eb4df16d028e44fdbb0e4aacec7d11c918344cf6abb9968c00ee3035

doc/irrelevant  |  time: 2016-04-21 14:27:24 261372  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-abe7801efd195837f19077d5abf538054f92a2b3409c0450b5b31dda23eacd88

doc/irrelevant  |  time: 2016-04-21 14:27:47 042034  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-80b5522e53614f55cb1492ceb07ec6f8cf6316b49e1901766f8489e33860226e

doc/irrelevant  |  time: 2016-04-21 14:36:21 504433  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-733ccbeb2eff86be2f4f98934a63de5f35ad4edd5e37e3c6ecf28102843434cd

doc/irrelevant  |  time: 2016-04-21 14:37:05 122653  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6e3342b0b4945075196a79a33cebdd0d2479ba599b0a7692615df289ff5ae323

doc/irrelevant  |  time: 2016-04-21 14:38:51 480628  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-5b221b726f692cc054374879ca07e9d6964673568371073190f1a95c4abc3ca8

doc/irrelevant  |  time: 2016-04-21 14:39:11 582908  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-3303f1c2bc62e67248c59c5e583aa3d929d67ebfad5d5b76e7b0cab460118fdf

doc/irrelevant  |  time: 2016-04-21 15:05:31 242834  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2db5b83a11e987dd3aaa981028b15815735eec7367df863a625ff0c46371ec96

doc/irrelevant  |  time: 2016-04-21 15:05:52 566587  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-7da4f28e5442a3c02048ee455d4f22ffe2422dff381aa11e3c33bd71f5060afd

doc/irrelevant  |  time: 2016-04-21 15:07:46 480836  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-296ffb5a36648c95428e2fbf2470560fa3aeb3a796846de2b54418663bc8f02c

doc/irrelevant  |  time: 2016-04-21 15:08:34 360298  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-8a2f86edea845778cc9be5a432a05f629a66716e71b568a82c5dc2513c6393a8

doc/irrelevant  |  time: 2016-04-21 15:09:35 678260  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-17db671c0479e52d9c4afc372a38b5032cc62a868d285c5b1b25007f60c00671

doc/irrelevant  |  time: 2016-04-21 15:10:05 314679  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-d4c3bca83830752bfd2f5b8ceb6d541658f3d95b7549b0faa50241e8783c86e3

doc/duplicate  |  time: 2016-04-21 15:10:15 276701  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-41e6ea15c663279f45ab0333818aa21131c3da264942329dad6deb1620e4a895

doc/irrelevant  |  time: 2016-04-21 15:10:54 643804  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-d86f470e2424c3f5bb5a822486e87302028f2ff8af05c2f9418d94fbb70e5799

doc/irrelevant  |  time: 2016-04-21 15:21:56 439188  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-13cbf4809a87ce5549ffb7a83a260a17060018fe8f7034e38b7fd4e5f5b33b73

doc/irrelevant  |  time: 2016-04-21 15:34:59 459745  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-0e3d72b56edcc245645976da0b9671cad0b1921946b476b6faf3c7f44e7b5497

doc/irrelevant  |  time: 2016-04-21 15:36:59 818541  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-4cbd1a41ab654e2af4bdf2dc275bf343fa168105243aeb8c0bc95722a26777a1

doc/irrelevant  |  time: 2016-04-21 15:37:57 444964  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-37d0a9c5ca65223bf76add66343265b53f4eed7c17b26ede68fc717adf6ce263

doc/irrelevant  |  time: 2016-04-21 15:38:54 838632  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c4cae61c81158216f9dd163a7e7355d1b7a9a470d3590261d2ac909e7321e784

doc/irrelevant  |  time: 2016-04-21 15:41:06 175180  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2b80550e273557fe9e9a299735b85ab7adbb501f7999b0b50fadbc3eda6b5e60

doc/irrelevant  |  time: 2016-04-21 15:44:20 537240  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-7422a609de893023f85bdcd5f583709352fd62c1c44af72a3d9f57dc0607fe0c

doc/irrelevant  |  time: 2016-04-21 16:00:19 035731  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-5b5ee514eb64e24b4b5b3890b73ad60e136a2d4ca9bf941a22523a1ea0dcb085

doc/irrelevant  |  time: 2016-04-21 16:04:21 254483  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-75b5469b76fcd9c00bcc57970d203d6b27bd20f92f8221db6785757301e823d7

doc/irrelevant  |  time: 2016-04-21 16:05:04 051814  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-ae99ae8120bc97b3a8a83058fa42a046656fd480ee17f3a2d28d4682f800de75

doc/irrelevant  |  time: 2016-04-21 16:05:51 254644  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-767fe4bc6b27eb7f430a565c605d9a8ed04b141e8884bf8632ac713bb7929698

doc/irrelevant  |  time: 2016-04-21 16:06:09 946482  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-e26ee69a087e43614c354bba7ef41c745458cb5dc194493a629f32aed929cf0f

doc/irrelevant  |  time: 2016-04-21 16:06:38 410232  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c97e9c8b9137066ab083de7053a43e861a98726d31064c5c6e836016a61cd1aa

doc/irrelevant  |  time: 2016-04-21 16:08:09 850868  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-734a13343843d47f9565b9aa4ce778fef9b9476b854bea78b25f49e451b95eba

doc/irrelevant  |  time: 2016-04-21 16:09:40 479505  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-5c9091646451282d1510598f280c05525b25c12b396dde47170e3c157cb70e9f

doc/irrelevant  |  time: 2016-04-21 16:14:45 155706  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2034a31d8132ab60cf0ad7dbb5025b7fb2ee665fe5303ced86e6f3d1030b52f8

doc/irrelevant  |  time: 2016-04-21 16:15:50 464376  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-f874dcd33c2eecdf1b1f7c66d12dddebf8486b6133e869c0b8a37a5dcfecec81

doc/irrelevant  |  time: 2016-04-21 16:18:07 568748  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-82bf7bc96ec80b0e2f049aac7293604ae89edd35e6be10e588361fad6f3a9dd1

doc/irrelevant  |  time: 2016-04-21 16:18:21 092929  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-0bdd30601ccbc10fd82948a76be414479ba65f30149d1c78c9c5f5bbca23a0f3

doc/irrelevant  |  time: 2016-04-21 16:18:55 025589  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-e72ef92f4a1b28f599a852ff5e50a7c91235b8ccc01677fc75db20727c811a97

doc/irrelevant  |  time: 2016-04-21 16:20:10 599551  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-d203cef33920cf33278baf79443a9c9e9d6154d460c3b20766cf5b71bedc110b

doc/irrelevant  |  time: 2016-04-21 16:20:37 713019  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-31002ace7ee9f9c2b3fd382efe0716c5b25abd2b030026db5dcea5a3dbab0f57

doc/irrelevant  |  time: 2016-04-21 16:22:08 196120  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-9e12191815f06f79c892cbb46cb22525c1bf9679cd8703f1033b1928e6fe4fd7

highlight  |  time: 2016-04-21 16:22  |  # of fields: 3  |  topic_id: 397  |  docno: ebola-6d3d9eabe153fd2f0ddcc7308187b92c376f0854b10944e3e8a7d9077c0eec45  |  highlight_string: ebola healthcare impacts costs insurance

query/terrier  |  time: 2016-04-21 16:22:35 408705  |  # of fields: 3  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  query: ebola healthcare impacts costs 

result_size: 300  |  num_tagged:  0
ebola-5743ef79d272f9cf13363d96e5121bc8893afb47ca87b1e8a17515710e8d8c85
ebola-b6f0ee2784b7cbd58ebd9f7d8010719f24da785d384fe0c92ee7206a43e03b43
ebola-fc34657d3fba931d21b1d36feaf8577b16673b8d907ef0f88aaa6ad9040dbec9
ebola-f74ed50667558936a35bd76809767317dd74ce00163667ec6ba92853a5079b09
ebola-06392bcb81b78b43a2c2ce6e96f01371c5302e4f30ebaed247980847ac0ec0dd
ebola-3347ae1f6a541d06a1255176059a99ab5d27d1f776fb15f2bc389b68dc8f9bd5
ebola-830bef3c71e38d353136214e8c11caa9d98c37c94aa795f67ec4117849b0695d
ebola-281f5283df05bdda06d74a39b56a068ffff19782e8bbf025da3e5067f61a0249
ebola-e53c99687811a6504ea16ffc3d4d88497ea1226082e6c88a7b2d71cbbb98e271
ebola-bdc8e5e8a72aead87dda1bb370bd5f919bd74d9c9f4308cf89608f2d9e2a4941
ebola-34bf027ea80aaf95d775bb97e5059a4e41ee9f9793190d6c3bc7f8b0557dcea0
ebola-bdcc09541050ce58bd8a5a23dadeb15c458f1177985a7b446970c42b6ebfe336
ebola-cc3d4dff193418ee67f37cd64606d7e62c9b76e82ab8aeb9558bd12298170bf4
ebola-1bfe8cca6a2d2ddbfb6fdfc0e787f41b0ae0fa720d1f258b9837164ebcd4c74d
ebola-d07ce7dbafa17565decb454c195d723887fd578af8043160e910959b08ad18b7
ebola-ed79ea2d77deea0b413a260c6815bc5b3980016440551d71daf348d2e5ea8dbb
ebola-1df0fed8e82815f5b826dbde93bf004321e0699d9718d7f31ba4f0f4a942b156
ebola-920621b1d513e04d83f6393358695fe6ecfe75b8a42052272135afa3ab5591e5
ebola-1a8b859412ece9fc8b3cee02a8acb65baad3583d187bf2191e4e03108ee85690
ebola-1d9a5a7ce9d01e072e4ce5dc1654b39ffe9a124bf2082824dc0e4836c2fd03f3
ebola-57b9da45bd36849d7f04d59edab684f57dc2b604a513a28a57250e85680785c6
ebola-392ff1caddf7d72510bf3a67f578b540742aa27a02622ff00f6a0dbc8a59f08c
ebola-7b16962763b48bd6a916530f3253e5c60a8b98c995b40c97b2556e0e950ae923
ebola-b5775c2aa194a67f80ef115176addd408b671cedf7d26be6b7d24c6af40a75bf
ebola-b276d304c4f5d9090c5c993a50a202392e2770d51c54cd7aaaf8268761f7f109
ebola-51a7a5ee011826cf1f397f7289f771f318f3d70da7120bc96d1f0d0c65e10942
ebola-241fd8e014d6aaa0b25a02955dd24f96d9c2c2293e352957bbd654e53003142c
ebola-d9509927ae3466cbdf6075d372ce89355a960e086d2ac01382f9daaaaf880197
ebola-77a9ffd212c7e193f87075854e8136dfe5bff2f9c3cb961bfda1eaec9e91c264
ebola-10cdcce357bbe558a672a500d0cc96538f79c5ca2de224189f6e7a85ec9eadf9
ebola-9a95f574ab2618329a2c42d32ff14e6f070bb71b8da51bc6eba7e5c8f558d381
ebola-702ccd1b4d58569f29a06b0be7f116cd591a9d7b7c7a86570230af10b213f767
ebola-9abaffe0fb848ed4187ad9eb24280e5d52f94100e152bdbc7f8a331d614ae8da
ebola-6e09292b8d57f7456ab5b157f5606aad44ac38c458d1205ba3eac3d9364454fb
ebola-3b4bafee54dfb413115b8c54c0b2571f4ac7d7f5c4a2bf7e369b37f9326563b8
ebola-38ffe3d9bd513de4d578843bd04bae3fba38f00b4f3f63573406b75e2113a937
ebola-18b22d45ef1893aaa1c0441c2efa7d320d11e234719425166215ba89fe37333c
ebola-1ad8346fb8ffb6dea1ab53da7cd92009cd353a935d3c2e5e592208ee9d0e64a1
ebola-d67966195453f45296e8004f4fda0b8ae0ee35a8d4eb9c99d0530245969d9095
ebola-a458938630261d1fb4b30b0cb11f6ab60cac46650b03806dab3d544925bfa3cf
ebola-b5f547576c69db25af413434a69f240e1b3fb39c8e66c1d7df99729cfe398565
ebola-2ae01e5b7b804016d138fac881f7552c67a6b4293bf4a2f6697022ffb589b53e
ebola-69516d909e4b9114c10b6e57a5294c3fd854009539599fec73a489877a86449b
ebola-9b3f1e9b39d71d24152ffe895ca91a4be1525a2f764ae10da0007bfe49a311b1
ebola-27135681e070340769cd61ac824c5eb626bdece5519db884e0e6c5011acb7c23
ebola-f041d7b2a2532e8fdeebe4cb1828835dedc08b132defba729389533be7564808
ebola-37035bb5d6d3b47bc538bc97690896d989904e0a28e9490c9b4750877634de14
ebola-6165699aa7695629ff00106ef345ef21067a0feebdd13107ebebe1afaca02617
ebola-f2074765f742dbcd80bc3a79bae523fb64df8ae4ac0789d4f3e49bf40067e359
ebola-97d2f6c8b8ea6b79a386c98249075d72f58cddafdbd04453fd382b5003445acd
ebola-27f88a7721e78ba1b0276b6ef27a79ca3bf3bfb847d1ab4260c4547331af6c54
ebola-af11ee18aa262dc0ceb2824a3192fd049d7abd1d4c5653be9badd5d17d75e2d8
ebola-d9c917a7608a16a9f8f702391a9ec6e9bc8b108cc2e6ebf08cbd2eb2256927a9
ebola-ff9d4051c1c8764ee7932db459b3e60690c6d8dedc7567740dc5affe68d50e2f
ebola-543b85340431349f81106753e903b21ea0aec397819057decaaf60ea4ebb43fc
ebola-52058b37b090cd651e3505dedfdb960749d7086a5172d5b3a74987039534862c
ebola-63aa113bfcd57ee648ce27940645eb1422d16e7caca21ab278fb6b18d7251b81
ebola-041c90e3a98ae967c3a2d4bb169de90e5725481e94f145434ad4ef3c54b43e25
ebola-58967bfbe43ec2044421ab983dce8c6abd1ab6e06448db8d1cbc6bba78d6ea2c
ebola-f991ad13d70683b7336dd30301c30c41f8d240d0b5e6f212e4bdbfecf0c6e4fb
ebola-0184a48264924263acf0130e9aa71ac83cfd40366a8dbe647b44ddea723f2da2
ebola-76e9738c9ae7e84b89eec0e2a759ea3212f5b7e4ecb20d081b1452dae0694ef1
ebola-0f1bec4f7110e7d613b1d770cde9bdda7f44e12b75bd49a664bdb4b2cb7a33a4
ebola-477cc321ea023aef558c276730c0bf5cbb9b47967e5012067f623fc11c8570f4
ebola-4b3f302f6723b331e0dbd3cd19d052f773eee9532a28b2599e8c7b75e083e8e0
ebola-980920bd57d564d93289612a4379df1ca3dbef050179a87d54c6ee41d40ae6ee
ebola-1e375684843d3c7373a6622ad0b72bc0f64ac882159e329bcd35c6ac9f41f6da
ebola-71c6a22fba495e5536b094b55342d948607bae4be94f0d35e611b57c69eef803
ebola-3bf8f57682d7e89f8a94a3f2a3874f62273c5730d8d38db039490b5d512f88fd
ebola-d21c44a03c8cb0c01be977bf5247ef0ee2892f64d5b8c50ed92da6360f0dd30c
ebola-66ad1bfe864a6c40e8ff7371fcf6b0edafbc55ceb5816ee288fcd708a550df9a
ebola-dbc71a91fd6df885b816f629237f28692cc532aca06d7a6cfa2739bbb9644960
ebola-1270ec95c1b6cf513c3c750e48757c1399b6efe6a2f8e5e4650de2b8337739a2
ebola-efa38e7a3ab6f91b398cf02404a4861d852adf093c9fd9ba7711dae33c1a75d9
ebola-cc6034d0cbf492871063982bc5e8e8738cfc1579570bf332c62f61e6badf73e2
ebola-1fd7f962a920ed3a44b2145bb2ee8102ea14c71070d0c24ad73438bd9cb194b1
ebola-1468e20e31e83a29579b109f81aa53bbd6194cca3c12ba2835f1d56cae9ae6d5
ebola-0e791f846b45be512f143239f264e8a97605a5428809f8a6f38d470edb8b3c33
ebola-b5e2f68c124fc22ccb35082ce218718e095319e445585d4288fa13ae8f846835
ebola-9c15b88a3d12693bb9d9c4f5f7f560b00b0b8c0885a19dca1c8f8068c7046333
ebola-9c1a0e7063bbe15ff98a821d0f5261b684dd4271a356c6c7a01ce4c38a3f8105
ebola-b768976c8ab9a4a28ddd6c170fc0e227c6335981823ee42dce87f3ad0221e6e2
ebola-bb0a514b92810bc27e11eedb7fdc7aa8ce0fffd5c1da682343cf4795e4b2aa33
ebola-122a72500e33fca655d6f6eb2b814723e2d20fb634789c5d65387522e1ff0121
ebola-2c993894837d1ad36f64efee23a134426d798c2426a0fc8f6df1744db1db57af
ebola-d1508ee46a63fe768a711e42de71ae3cc6b6105d8795b9eac8afc438bc8b1862
ebola-8692ceb9d15f151fcb78d66ff249cbb1e8dc8f4a8f09d078d533727bc5d46848
ebola-6898c3b9c6feefe2d0dd5e9f7ea57a2dc1c61aff8035f479002201c3acad0f66
ebola-99c7f16b18d8a4a662ad8c9c892b0ef9517d8c61a35c4da107d0dfe8f8ffc66e
ebola-11bb550f9b112c595e07d67fac9660850b3bda074a0e00d2fdb6ba86d90af8ef
ebola-77e417930d05eb9015c4676c677f71eb705cd88e883216a7a02f82b997cfb31d
ebola-1450853b2cd5fab717996c0ee6b9a1b05fa2ce1d42f62c002198cecfaa050ca2
ebola-daed996aede35753b6885ff623e5606b9fb50c0639edd214170652b0daf8bf34
ebola-f46955598e4226819415092f2b48161e8458cf56d6970225d98d031f854f5e46
ebola-e70837375726ba4b0b38b3deb1d4ad50b33268ad9e8465504fb52960c89c70ec
ebola-f2ee888c8ab2e8a28482e4781229d0cf37e5af54937361ead6afcbfaba09d0ba
ebola-63e2a12478e319645330eb897b94de8df8e7429589725692ebf560c12f68a06d
ebola-7d6709cf294bae19cb680ca5dee3edf54d7fc8980944acb6070550a42b7c5ae3
ebola-fedfb815fb316021b484b8341f0274528cebadc9fabe12bf058f4faa499e5865
ebola-388a68fb4b1cadf3d6b9990f1e81a83f917ea2b9e272407858d1825b0c3a12e3
ebola-bd2a8ea4d09d5271d6793972f602569a1c769e22bc01093b82c2087a59943d9c
ebola-dcb754c07f8ccbd6bd0626a0b5ff24c8e0d245403a68ac845492e70b57e6bf61
ebola-8303ef7e43383338843d2631c05424816a4c69fae8cc6247b8e8143309d6bde3
ebola-fc3c0e0ce9f52d316514b0166e48b1d14fe5cd00b3a0c2b90e45e5d4369bc84c
ebola-d4fc3786c9601d4ae671a5908b647f2e8c9346c745165964f15d017c82b2af32
ebola-0652a8fc4c3b9b5cfaab84166c97505adbd14bee0e32338a4284539be31e03fa
ebola-1089a7a908f740e390f0d487d846e27393e62aecd69e21c6a928158ea66378a5
ebola-ff4ca47682ec15c1937b033911b8e1666a2cca8c0489087ec1ca926a45741183
ebola-bd2d1acf21d5331e4aa14d67c42cc3c1130f080884eaf685bc00a34d557fb4d3
ebola-385699025e2f483073ca0f2ae3f05c79f4be1ff8ea255ea91244d9a13b6c4982
ebola-15e84e22871d87afed6c34dbf1a8bb1dacb4489d69b367a6399ab84605508733
ebola-f98daf12400c1838169f301d42e1aee735f8ec3b2fb4e3dac49aef645346e12e
ebola-6857ce808451007f370b07f1949d805d2d41af21363f5b93dc93edf94db531e9
ebola-48a967839907533c1e0e37a1e11f450190ebb474ceccc31ffc16e92bd8c9aa7a
ebola-eb4f79d464fbb9d6986259e0b61e02bffa618b312cd38ac4f5cb566ea2426401
ebola-c2d99506a510efa8a909072b5efd8b7e39459dafa1b92eb66770567965f35242
ebola-344e46a32ce379543ad5dd9a311e0753648e02d64e5b0045cf2de7407a4983e1
ebola-673ca580d2e0e072ef6eae123ef5f2afbc33f8faae0cbb5c66ea7e659c3bf50f
ebola-c40c75ac7cda07e6d4be0cc8d164cf75e070b6ee72e91718af15b6d7ec56aa68
ebola-6b3898a02abb1c263f2eb5c1bd36b53e850f04fea1ae1fdffe857bb126aedaa5
ebola-e29d9924a1db4e9baf4ed9f5e62fc1841d3d27df928c2091d1a0e09440ae3be5
ebola-7760ab2466aaab581c9ea9e13a83e1c3562fba3742ca0279c631d88710d6aab8
ebola-84a2932d8d75434096d90d1c617244b00fe97e486763d2f2f6e0dd031fb0d4d7
ebola-e53840347feb9fe648c65ee01d76bea2fc42f9b19f19f9ccc0be73bf5caaeb39
ebola-06f94fdfef657a130129655a7f5ca41efecfb2c90b12d55c7ad97c28cd763859
ebola-f03162e47a1368c11e4107b9d621df50b4b1959ba5311e680739777bb88f7274
ebola-edcf8bb0ccbf3f5c45c2fa3486b5e30ebc805ba1aa64d4ddbfab270035ed0e4e
ebola-467d13356eaa941a4e4490cd0e15f08f90d28981f2b33da6a6a32c4157871872
ebola-58c29256c3510e29c50d6713be7e52390e1cb9c2ee1c218b0e7262619eab3197
ebola-1751eaf8331ef2de873e205c063a6ef68c4034fb0ffa5c0774107c26da7951fd
ebola-d8979c93874b3542c97f6c4730f711c4c25875174271dd65a5526eef40271bc2
ebola-ceeac7f60359d02fe0f984bc2a71d847933cb82e43c325cfd13fb032a516e38e
ebola-dbec10ae1af6177aa874ded3cc086ab8b37c7d844c51c18e569296b3e3c0b6d3
ebola-78dc19fdfbd26627d4efa5b1cb09396bb11ff296a597e1ecd55164ebcc532018
ebola-0d23edececab90abdb5c9cc9f44b5b5419c43a296902e3e1d93eeab4dfc0799f
ebola-195a35d196c8c640178d00d911df06814ef517b2a2b8486cfbb1af831f2343c9
ebola-1ea741d4c95fedf9475dfefd34dc6275df8a5aeb77ff1e0b5800f9f9882ac7b4
ebola-de5ffc8c29b07932c6ba099c839203a514aa9970bc7154efc1bc9cbdc7f7464c
ebola-600e2aaed664cb64b09d080e276ca272edb08caeac7b61a793a9ea2be8706322
ebola-ae778417ae013bf3b9794d5a11ce4455a085bee7ed41ac848ef598c9cd2f02d0
ebola-3c8df2c458e2a241de0ffcbc4806380d52bd78876cf9c1429886bd27ee5ef670
ebola-5e62b50b5df29b86449cf9bb3873083abed4302a118c6d88d0145647a1bf6f60
ebola-57247bf5128ac1e64272db60ec8c3960ef62e1d655ede020ce529b2967f7f556
ebola-bbe918d9b8bbad1e29238445a08dd25a679210fab3e8b7124118c4cc39fae414
ebola-900427b86e8f978b9500a453a5dfd9aa77c0c7226a2f0d716938259d768ca85d
ebola-ace4cb304e02ce6ebc821f134e9252baea80779448913e79246dbbd54bf0342f
ebola-5c4cd1070cd49f011166cac2d1381ffeb92d7613a04b4b74318e06d082f53c25
ebola-70d38b9188ad75a2ae2cf5a2f0ac3221e18c0f4d4679ab575f5df5455f694f5e
ebola-d39fb1a166f175affee5c0924037782d27cc03486057d6452f3cbe7652902f66
ebola-15b12f8ae7cbc490a7fb1e8c7c965434dee49abb3e0c533960f0c265bb5558a1
ebola-cb3a3e6e832fb7f95c5999bee0929dc647894658e120259e2cebe834c18488fd
ebola-636152a5dbbb137321b4a4bc9dfc6e8cebdcbd33b30909702b1f71da0cf86c44
ebola-e4432779e37a590d6f56091fdc65c6bc4632c7f50e84a52dad5afeddae0cd8f3
ebola-c74a6c44911a55b3ee7224796c370ca9beaf1efe2c09bc6b8c15ba36a65b01f3
ebola-f202dd3e3d5321b163a8514a35971001b08538fd18acd7b7dbd94907c8d3b77c
ebola-d3f95cc2eb9ee970d9e69527e4d600ca93327c6b4fedf28526ee2725798ff8b8
ebola-c20cf5fd0073f780fe392051bdd51a04be876ac87c4b3aadd5304ed4f0292ce8
ebola-e1239b26badcb4acc7dc241a2e2b18bdb3cf0aab3d0e6683b7fd0daa57050573
ebola-755d886df29732c34d20c630ff8eff980203db368febd864a4c2ecaa6205fb0f
ebola-ab071e0e98443ff15a95824aff69e8b911bedaeef228bae87838f5b0ee2f6466
ebola-5bccc1fc3dfb6b3caa8ee1cb72a7fd9c874782a1877d2e2bbf6e3a6884e25903
ebola-5648b7e35d3f37b358ba16e50c01b38213e9f85f1a3c740e8213b4e47cd75f73
ebola-d38a02332048547b2d68cecffd96ad7e43a3c66ffa809a6257069e6c1132bf9e
ebola-3f674559bc72c13e2365b253df791a6a0820a9705cf39b6761aab15464e8e182
ebola-28729aab4de202831442c96798a19ff34c76e23f6c9ecd2a5af42ff056661c56
ebola-17c1d5178073d68b9f5ffaf133c899ff72afe657ae00100ab142461bcd2a0a7f
ebola-4117a603193fd8ba8bf70f153965dda66ba6b5132e06c5834732a2a87e665604
ebola-7bc59b270e9f49d1157ce6e032eb5db65c04c770bbfa96a8c1cc936f53d54eaa
ebola-13bb7b0b474d60aee5d48545a4e9816b491ef1b1a0370467bb960de8a2c09890
ebola-ce4b7e8821f767d7299299581b48c64a305a7d33f990d9ff200f061d55ec7e3b
ebola-2a3aa225669fbb65cfedde8b7f641994b08110961c58c92086c0413e8d1fe9dd
ebola-1963b94f9352ecb6710325717e36baf238d8a742fce9e6af63e2573b0979acb3
ebola-10903f932a29047d0c429469dcbb60889149b30ee05730e8e6567e2a4ccd5d2e
ebola-66dd0db2abbe79b2af752ab3c90f3c0adbcfc815baf9bd630bfab1f34ecd8d36
ebola-8268d5925b90f8e61a86f99b94772b6130e37ef3003bce785815ff565f9c3929
ebola-f33f4f00dee3e43c7dcef6260a61b46c85d60ef5b206864a282b31a3d33f26b4
ebola-af339fe6d99a0dcb6c783f2e6311860b9911ca719cc849d870cc66d13ad4278e
ebola-664a981cd140a97b353c00129c8130cca06bee312eebf4249952b2c435483a91
ebola-8967b66c2baf48a8d1a99265f086fc08ce144beb2a86b920bc021127c1447ed4
ebola-2ed26209364254c0850d2523588db0c2252ee0a72e78b3e3fa04cdd63ad8b3ed
ebola-9d344606535bf3e2650b97de6b01709bb208f403249a39667625dd8555043d69
ebola-ac53e14bc1be2709f38382673edca5c6c84e5a3917f5ca8e51bb2883fc5f97e4
ebola-d3019f4f015ad5508d2c2495e0334be2da80c67499fe166fb9e1a0eaf6df35c5
ebola-0e6efd1fbb3bff0a64f1d6c5a25d63122711bf8c40ef43b0d99aab6f0b4a505b
ebola-04786419b29e5f82c69dbc7a9ac6caaef1e8b1fb94af6c1d4a2d81d64172a152
ebola-431cddcf48e8330fb19c1b9119ca2fe963a4aecc4e95ad946fc9a4c220c04d61
ebola-c94f9dc9a8a0630e5d609c8c0e6e0a898ded1bb5f76783384487964abfbff93e
ebola-d78ef579fdbdc2f135b4558340f93de42347f0f916b0037b1cf4c234e3ec0745
ebola-3369375422c1751b6fc0a048f75196bbf3cb4ff08665ba099ddc21b52a178277
ebola-2f9dcebf8be88f14baa0e83879e52cdda29c7dfb7e7d3dd7655983ee0eb5958d
ebola-df09085a450e64b90daaebeff9882c645438dda8a2f140ccb3a701b3e18b95a3
ebola-c64364e85e108d0ac85e8cfaf1fcfb61342a62ff1af1c99f0835fbb76aa77280
ebola-83189beabc397908c9b490db5f11389942b1e6b235a8c09201e798f706b02a7b
ebola-058a70c0f4c145931e3c1065fde68451b90465e67dbee1c777357ffb91f4167e
ebola-6677ac00beb41263b749fc591b29a024fb9e2c3b18bf37c2b514e21ffd9ece6e
ebola-b0e55e7e8e6f43633c17f37323eb8ae6b280d57cd2f753f53377dd00b1f195d4
ebola-1559facae8dea73c6660c16ca5b163a8d49450f743866e814638d0d41381e73c
ebola-7cdcbbcdbffd811fcc580cdfb4303f973ec2eb428f0a9d234aedc8f93421fbaf
ebola-8ad5297197b17314d354f2ddbacc71414012338db333a087db26f905eb2f0e47
ebola-7551e591855d2da7d0ee2e4e11a995f9fda0ed51b04a41482d24ac08d3ae72f5
ebola-c87739365ab592c68fe66add138766a10709028be6d7ea12dedab17b1662cd72
ebola-41ac9ba87572b7849d1686486a4cdc1ee9dcd5f402dd8d20a8da3bdf14547f0c
ebola-2b92c70ac15e457b88bada036ffcc705cbc7addbc8ea3cf64db7c6c3ec5223be
ebola-5e6df09deeede715b936e04f39f47a06c6e323c09ebeb1ffe610f7ec6f75aef5
ebola-ec2d4a9fc387998c415040b04e4bf1fe3306d71bbc728291eed8d770ea4a4ad9
ebola-6db35f28faf7a47668555b0c2a4a472fe8a4a69f05598feb01cbdcc86eba1ad8
ebola-ec27d701fb228c2d31a5338bb103f5aa421995f9a61a79bd150c09eecaa10f46
ebola-b286725e1462977b9828cc83d00cc685691a475667b359711f143b1d6bd7682f
ebola-3d10e5feeba8562f89de45f523e592b0ec1d25d212b81d45f5ce539ebb678ff2
ebola-9d02c374015b050fe72fbca71ba50c1917042f5c91f18b650f951266dee0acd2
ebola-da72b9c7cc83ad71447e6c0cfdb7fc3aa4d2e9c4584e6a1d6d204848af279bae
ebola-a702f1639dfc038c6c180ea96b746bc1ec372c19e265190d6a93e46fe7efa218
ebola-558cee9b4e7a83b661d55c50308352073d3fc3b4bf6004b2427a8ce5f2be31b2
ebola-dff638e46ebb3ce02e4f7196d56a01275f3baa6d8be369d3e0f7bbe7b87bd716
ebola-a854fe0805191060affe49967eb2efcfdb27ad4858d9e7cb74586481cb99d445
ebola-33420653b29f56391304e47ff74d35be516f2fd5abc868c1d8303dd118678226
ebola-acdb46cb4662c327afb99854304d29d32ac857c642704e8a529aebcf5ef6b4c3
ebola-3cd1f699dd0c84ed391defadc9f7f3c9f5033b4a0e170085e149eabd2b02d72f
ebola-418a58fdcdaf756e1819298418d62fccfb5f64b2cd9a7dc646f9f316eca082eb
ebola-bbdad8e225b8437f5914e764e0ed986dbc59fb9f8043afb5ee20823229e4b5db
ebola-fe5f3a0edd4ae03ad1de2a8167f9e5fdbd20237c0ef9b7d8224c0f32ed0b21bd
ebola-018cf9d51bf950fb156d215d9081b18250b4ce108b1f9fe52fb6f0624d8718a4
ebola-2409ae89c78ddc96cc3a783812298bae89bc1f64ce7d1c8a31deb3db1028cfef
ebola-80fe8631699b4720dfe3b42e5a02631fae318a36732c9989f11ab2c47b5127fc
ebola-56f6ec00ab96e823b07d8f510aff6c373bdf485022072490972077afdcaa0ce4
ebola-74d9967284c6bc8d1cb8f8b8aeba80c1b7bbe0007e278222c489f64ff88bb630
ebola-fb04ef3a34d75dc215410f588f5ae5b167bd6ae0ff4227fb1f9b86a25c4b948f
ebola-d7c815db3dc9ee0f73cec42137999a37658419a9b09444b4e1618fc2dae50f0c
ebola-3e10380b31f039e5822ee277e53457ce789eb57c69bb847f5e7490ab9ac85102
ebola-aae48dd159a7c750ed9f180dae1cd8346f8856118eb245f3cb8ff1d1ff5806ec
ebola-79898ac5be0aeae0813af6692ddf71d2a9217d87c9a2b0c4de1b49d6301c6a9c
ebola-d95bc827b36d92b3e24c002f0b1ddcf739da1e5e64996accc53c8e12e62af1c8
ebola-f91140caa87e9462e25fda1d8e55b9b7981832635434e51c8002527851260eb5
ebola-25b048e52584bf34bfbd145fd6cefb26dc7134acdf8ac2aca04f70d74b05706c
ebola-7303e87a98078c85e29ce3275c04691ce789c581c5538240bbd54033be8380de
ebola-57f659352d4a78829baae2e294559b2c5144dc2b5bacbdc67faa12d95308844d
ebola-1d899fe75006d42db631d472c24097e6ccbf35e283fd82d7fa5ee01aab6836db
ebola-3f97461f69af30052565df871902970babb7d74c9b21e280313929000f4a8b7a
ebola-8bf646448c546ce3db38a96f03b93d66ff556f74209322acf728c3013212bda5
ebola-65f9dd2786ac868a7490746e928a96ecb83e1ba45ff7d1475e97a3ffb906cdbc
ebola-890641ad0e3de97c94fe88dba96c86f21850e843b5378898e37673eeb4626fc3
ebola-bd40f2ba775282b5d473991547b523a4759468f193a3ddda618c90b60d9e9c49
ebola-f489c680c64d29901d61a0777db875080c76b6f41f0894180399ee8f34a28dc8
ebola-e6f3d9e8d729c8e5dd90122d4e844a79c602108fe18ed63cbe6cf6ac6bb45847
ebola-2d76fc9db67e31b9452cce3ebca1222695e459877e699b498deb34b693a3080c
ebola-909c01ac309808ce0ca6f27fb9ac2b841b807f450ecdffe85dce3cf229c650e5
ebola-123c4ab05fb16c5b395e456a8c9cca8af9d67f231f122e9c16fc87997b6c967d
ebola-305521f6446e47724018d30b8282e29b9c34568bc0cde4528497d22d54577825
ebola-362a8024fd46e266583faeb7964be5e57f6cc6bb554cb93f66e650b47e8fc0d0
ebola-b34d841bae7b73919d12d8caafb878d026f0360990fc95bb90c6f63aa91e2380
ebola-633256fd49a2688f2322801b8ca721170a382d32206eaa96799d47a971f0cb5b
ebola-53270eecf83edd611dee1bb35cbdb3725c09156b4f07de5c02c068ef00048ae0
ebola-16d85468ec14c09013aac2c02b8febf1c08e440087c971b774d80eff6f6d2e07
ebola-c07b5a606f958128ae67d758ffc0bcd76332013b3cdc73e5fabee37d13aebd65
ebola-60576eb27f3c8cd95efd8cc0b1796f2ba00fbe0dbd446fdc5b388cfb4be0287d
ebola-53e8da52712038c54d5c3b0e37b11843788ee5637fc07c09f2559e507cc89296
ebola-ee615a0a705aaf74c66e161cb367c2217aa77d0f2886418803af447030756beb
ebola-68e4e75e1534f3705e951b612e8d7f6f1b2cd00747d7c58d6c25bad5f4127285
ebola-4b79fe141407c819e6fc57ca3a47d175b85493281b9d955a80688b8bc9820f52
ebola-ae9b1a59d707ba2575b567537121b599bd2a0bb7631a3e41f3e6edba160bbfb5
ebola-dce6b2c954f04f4990f79cd67fd9d23a7589f4a9ea523b935cca07a03c786bf0
ebola-f98f0b95313cbb399e31a1699e68154643026cb767b4a3dabe9bf6f75ca07735
ebola-f8bd136fd38e9e8079c77949a9f8fc716cd0abbc2ea0a0c16859bbdfaf01f6e4
ebola-6cc7a730ce0d489d60ec3f6ab44b12c3e46bb47292f47ab0b0389fad6e8b07ec
ebola-0a8b4e2b4bbdde3b7999c16589236f3e7f2258554621d7cec14e59be98565d3e
ebola-c949af9e6cd7e1af51c347add20fcefdbbc29a5208c520b78ab72018d0e2faff
ebola-392638c8be6cd03f4f23376565d6f0d9aa654ca86ed6aacda2e536f27f8b8f9a
ebola-d63cdaede6f6ba1671678a3d3095df075df880b3213a4c7ddec969151b181cdf
ebola-03ca9abb0cab49a7ed4f6ec8c2246551eaa27f691643a62b8e5efef9b83fa9ac
ebola-d6306da39504265c11057e670b0c4661d8f103a516ce96b1101dd816ba20212f
ebola-4a8eb21ac5d0b2817a1e261bbdb899a7db07eec375d5395b33efc7027da6b427
ebola-65e85e681813aa05910e89cffea5c37b46a161acf83e1b496232d3026c3ee192
ebola-8e2fea9d7611ff39ff7be3d16bcaeff60309affe5ff9f7c8c215a1300a70fe88
ebola-61feae090a94f87c55ac9604907d17702be69bf3f9b5d7a6070098e8a7893d65
ebola-e0ea7c73fe5e495c5bf81cf978b20b6835b20388613494ba509ec806cd0fe807
ebola-bd04b4a9ef38183f9e21163caf48c4288f434d113be8ca59540661b58c27763a
ebola-f81be1691d104346ad63ab9f68feeb7be2048107dc80c0de771e5505ed963c1e
ebola-a855eb611a8d70c92e71f8dfff3dabb254f1f11f21acf0326fcc6930f8d7253e
ebola-f9e9dca3665b660df97d87d2cb36a459d9b10858d6fa379b560ab6c97d0da2cd
ebola-a4ccfc166be9e534bc1c496cb3d1132909030393dec08329cf0ddb41881fa123
ebola-02744f2c7737220269342ec0feb36bc3646ed7f55f4648bc826ac285571505a3
ebola-2da74eea6159e3904f343adad5baa8165d79d7c562d18af5623cab73830f5b78
ebola-cc9afe825bbf60bfe5ea0dfbfa49a960933662f50f3fad4588dff122548b3dd8
ebola-ab24078d3b9610af89a8ddd28f2f6600fa8f52f3d7b94077f4dedeb81984242a
ebola-b7367b795e1b48f924e195224427ac2722904c30266023acdb67fb52bd524618
ebola-183d963e0c29eb2d50252e4eda6906649c7f4cdd9b2b8e1f9f4b80b8a137b777
ebola-16eddcf7d0ca7b247c5e4cf9918f0f284ff6abcf690fd43f5c6bf78b387c03bd
ebola-c2a825fea25f4da2ab5832d12666631bdf35090ed04e4c5af5c0a9ad43f8b39c
ebola-7c328b3bb754ba8bee2ff93686064d5dca933cb280f48ce4f543a5043dcacba4
ebola-51613176d47a09645d44c9a1f701a5ccd7a933cb5983c350c99bdb49e90a45fb
ebola-e66ffe36e6f098f50cd2c2cb0bae78a2b44a74f6e6af0a710df1e4dfdd619da9
ebola-d4f7c83824fcf92d899ef22161b98216ae2dae53ab60550aa6dc797496b280ca
ebola-28c75c7dcfad54fa97f2c40a5c30960dd9dd1cb1e18d7a3e55f168f27ead24ec
ebola-d3d47c929717a97112b23e40f9cb9fe3b36aa90d66ea220e80ec05e681c7f4ba
ebola-c34c802d76df64cbf07f13bf5c02fe11b43ed671c312b92bc5cf2f5fabe6bb98
ebola-85480615dee005ccf07a1be098fe4a5dfab6ba76c3c6a3f64c5df1f29c72c8fd
ebola-ccacb36cf5735bb03524a6db209109ad77f59b2bbe14c0d373d70dccafb35981
ebola-02722a74bae62481bafd0ed7f68d11d9bae5a1655e0f52562a309f4c7483b18b
ebola-3851826392701afc0c5e788ff75f642fd58deb8b7a0227c10128a624ec1c08f5
ebola-4b904aeb0fca7f36168c98f1105fc5645e02fcf55183703ae6693cd2328c52d5

list/click  |  time: 2016-04-21 16:23:02 645243  |  # of fields: 4  |  topic_id: 397  |  docno: ebola-5743ef79d272f9cf13363d96e5121bc8893afb47ca87b1e8a17515710e8d8c85  |  listsource: terrier

doc/irrelevant  |  time: 2016-04-21 16:24:03 812639  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-5743ef79d272f9cf13363d96e5121bc8893afb47ca87b1e8a17515710e8d8c85

doc/irrelevant  |  time: 2016-04-21 16:29:50 875523  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-b6f0ee2784b7cbd58ebd9f7d8010719f24da785d384fe0c92ee7206a43e03b43

doc/irrelevant  |  time: 2016-04-21 16:32:19 590634  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-fc34657d3fba931d21b1d36feaf8577b16673b8d907ef0f88aaa6ad9040dbec9

doc/irrelevant  |  time: 2016-04-21 16:33:52 252365  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-f74ed50667558936a35bd76809767317dd74ce00163667ec6ba92853a5079b09

doc/irrelevant  |  time: 2016-04-21 16:42:23 961116  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-06392bcb81b78b43a2c2ce6e96f01371c5302e4f30ebaed247980847ac0ec0dd

doc/irrelevant  |  time: 2016-04-21 16:43:33 229378  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-3347ae1f6a541d06a1255176059a99ab5d27d1f776fb15f2bc389b68dc8f9bd5

doc/irrelevant  |  time: 2016-04-21 16:43:54 539719  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-830bef3c71e38d353136214e8c11caa9d98c37c94aa795f67ec4117849b0695d

doc/irrelevant  |  time: 2016-04-21 16:43:58 190140  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-281f5283df05bdda06d74a39b56a068ffff19782e8bbf025da3e5067f61a0249

doc/irrelevant  |  time: 2016-04-21 16:44:24 471033  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-e53c99687811a6504ea16ffc3d4d88497ea1226082e6c88a7b2d71cbbb98e271

doc/irrelevant  |  time: 2016-04-21 16:44:32 539442  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-bdc8e5e8a72aead87dda1bb370bd5f919bd74d9c9f4308cf89608f2d9e2a4941

doc/irrelevant  |  time: 2016-04-21 16:44:54 168398  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-34bf027ea80aaf95d775bb97e5059a4e41ee9f9793190d6c3bc7f8b0557dcea0

doc/irrelevant  |  time: 2016-04-21 16:45:47 669167  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-bdcc09541050ce58bd8a5a23dadeb15c458f1177985a7b446970c42b6ebfe336

doc/irrelevant  |  time: 2016-04-21 16:46:34 260982  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-cc3d4dff193418ee67f37cd64606d7e62c9b76e82ab8aeb9558bd12298170bf4

doc/irrelevant  |  time: 2016-04-21 16:46:51 769059  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1bfe8cca6a2d2ddbfb6fdfc0e787f41b0ae0fa720d1f258b9837164ebcd4c74d

doc/irrelevant  |  time: 2016-04-21 16:47:15 085624  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-d07ce7dbafa17565decb454c195d723887fd578af8043160e910959b08ad18b7

doc/irrelevant  |  time: 2016-04-21 16:47:51 645872  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-ed79ea2d77deea0b413a260c6815bc5b3980016440551d71daf348d2e5ea8dbb

doc/irrelevant  |  time: 2016-04-21 16:47:54 620703  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1df0fed8e82815f5b826dbde93bf004321e0699d9718d7f31ba4f0f4a942b156

doc/irrelevant  |  time: 2016-04-21 16:48:19 128644  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-920621b1d513e04d83f6393358695fe6ecfe75b8a42052272135afa3ab5591e5

logout  |  time: 2016-04-21 16:58:41 582319

login  |  time: 2016-04-22 13:26:22 162588

doc/irrelevant  |  time: 2016-04-22 13:34:54 728170  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1a8b859412ece9fc8b3cee02a8acb65baad3583d187bf2191e4e03108ee85690

doc/irrelevant  |  time: 2016-04-22 13:34:58 883509  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1d9a5a7ce9d01e072e4ce5dc1654b39ffe9a124bf2082824dc0e4836c2fd03f3

doc/irrelevant  |  time: 2016-04-22 13:36:01 114199  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-57b9da45bd36849d7f04d59edab684f57dc2b604a513a28a57250e85680785c6

doc/irrelevant  |  time: 2016-04-22 13:36:08 324438  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-392ff1caddf7d72510bf3a67f578b540742aa27a02622ff00f6a0dbc8a59f08c

doc/irrelevant  |  time: 2016-04-22 13:56:23 278562  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-7b16962763b48bd6a916530f3253e5c60a8b98c995b40c97b2556e0e950ae923

doc/irrelevant  |  time: 2016-04-22 14:11:55 738931  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-b5775c2aa194a67f80ef115176addd408b671cedf7d26be6b7d24c6af40a75bf

doc/irrelevant  |  time: 2016-04-22 14:12:02 301639  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-b276d304c4f5d9090c5c993a50a202392e2770d51c54cd7aaaf8268761f7f109

doc/irrelevant  |  time: 2016-04-22 14:31:07 416959  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-51a7a5ee011826cf1f397f7289f771f318f3d70da7120bc96d1f0d0c65e10942

doc/irrelevant  |  time: 2016-04-22 14:31:38 379419  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-241fd8e014d6aaa0b25a02955dd24f96d9c2c2293e352957bbd654e53003142c

doc/irrelevant  |  time: 2016-04-22 14:31:44 261476  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-d9509927ae3466cbdf6075d372ce89355a960e086d2ac01382f9daaaaf880197

doc/irrelevant  |  time: 2016-04-22 14:31:47 110264  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-77a9ffd212c7e193f87075854e8136dfe5bff2f9c3cb961bfda1eaec9e91c264

doc/irrelevant  |  time: 2016-04-22 14:32:07 845040  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-10cdcce357bbe558a672a500d0cc96538f79c5ca2de224189f6e7a85ec9eadf9

doc/irrelevant  |  time: 2016-04-22 14:32:21 252079  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-9a95f574ab2618329a2c42d32ff14e6f070bb71b8da51bc6eba7e5c8f558d381

doc/irrelevant  |  time: 2016-04-22 14:33:38 171718  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-702ccd1b4d58569f29a06b0be7f116cd591a9d7b7c7a86570230af10b213f767

doc/irrelevant  |  time: 2016-04-22 14:34:12 096176  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-9abaffe0fb848ed4187ad9eb24280e5d52f94100e152bdbc7f8a331d614ae8da

doc/irrelevant  |  time: 2016-04-22 14:34:47 137132  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6e09292b8d57f7456ab5b157f5606aad44ac38c458d1205ba3eac3d9364454fb

doc/irrelevant  |  time: 2016-04-22 14:34:56 321450  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-3b4bafee54dfb413115b8c54c0b2571f4ac7d7f5c4a2bf7e369b37f9326563b8

doc/irrelevant  |  time: 2016-04-22 14:35:05 081982  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-38ffe3d9bd513de4d578843bd04bae3fba38f00b4f3f63573406b75e2113a937

doc/irrelevant  |  time: 2016-04-22 14:35:31 298324  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-18b22d45ef1893aaa1c0441c2efa7d320d11e234719425166215ba89fe37333c

doc/irrelevant  |  time: 2016-04-22 14:35:41 173557  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1ad8346fb8ffb6dea1ab53da7cd92009cd353a935d3c2e5e592208ee9d0e64a1

doc/irrelevant  |  time: 2016-04-22 14:35:44 080666  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-d67966195453f45296e8004f4fda0b8ae0ee35a8d4eb9c99d0530245969d9095

doc/irrelevant  |  time: 2016-04-22 14:36:33 221919  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-a458938630261d1fb4b30b0cb11f6ab60cac46650b03806dab3d544925bfa3cf

doc/irrelevant  |  time: 2016-04-22 14:36:43 926612  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-b5f547576c69db25af413434a69f240e1b3fb39c8e66c1d7df99729cfe398565

doc/irrelevant  |  time: 2016-04-22 14:36:49 752741  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2ae01e5b7b804016d138fac881f7552c67a6b4293bf4a2f6697022ffb589b53e

doc/irrelevant  |  time: 2016-04-22 14:36:52 623940  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-69516d909e4b9114c10b6e57a5294c3fd854009539599fec73a489877a86449b

doc/irrelevant  |  time: 2016-04-22 14:37:24 311851  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-9b3f1e9b39d71d24152ffe895ca91a4be1525a2f764ae10da0007bfe49a311b1

doc/irrelevant  |  time: 2016-04-22 14:37:31 899097  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-27135681e070340769cd61ac824c5eb626bdece5519db884e0e6c5011acb7c23

doc/irrelevant  |  time: 2016-04-22 14:37:44 286526  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-f041d7b2a2532e8fdeebe4cb1828835dedc08b132defba729389533be7564808

doc/irrelevant  |  time: 2016-04-22 14:37:49 386646  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-37035bb5d6d3b47bc538bc97690896d989904e0a28e9490c9b4750877634de14

doc/irrelevant  |  time: 2016-04-22 14:38:07 833177  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6165699aa7695629ff00106ef345ef21067a0feebdd13107ebebe1afaca02617

doc/irrelevant  |  time: 2016-04-22 14:38:19 331414  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-f2074765f742dbcd80bc3a79bae523fb64df8ae4ac0789d4f3e49bf40067e359

doc/irrelevant  |  time: 2016-04-22 14:38:21 215971  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-97d2f6c8b8ea6b79a386c98249075d72f58cddafdbd04453fd382b5003445acd

doc/irrelevant  |  time: 2016-04-22 14:38:37 025267  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-27f88a7721e78ba1b0276b6ef27a79ca3bf3bfb847d1ab4260c4547331af6c54

findmore/pink  |  time: 2016-04-22 14:39:08 760056  |  # of fields: 3  |  topic_id: 397  |  subtopic_id: 196  |  subtopic_name: provider impacts

result_size: 292  |  num_tagged:  0
ebola-450922b3b0c40555cb60cf2a345032f520776a00e7fc8a65342eee4173b084b7
ebola-8ed1d6647800fea679d8c47b16e6a93e647b721f9d3d9a92efc5e69ddbfde844
ebola-ae1adeef917b0b73b7f145352c533a6d8b2e3d7afe034574821d9e4a2ca49983
ebola-bdec02759ea1b376d362e879e33985e01027ebd505e775740c5c7df716edf289
ebola-f9920d4b0caec4f5a6a978ec96afd918e9bf03f5bb0580d04b92804b18e1e144
ebola-725f441d549636546f30bde18a30675c6c2ac6f13f3c83e51a3477b7a6699ab9
ebola-30faa0f7dc99271cfaac61ec74e93c32a7f69423aedb5c75d7b309a6d8528986
ebola-440afddb732a2037ad00c43019dc21f55b5b5d14e43fd485c75de192abd67985
ebola-2cc40faaa86394751449c25c60b83ab99f185115d28741a021e5c73e0b906e50
ebola-603d743b182b4e8b5de622d7c3535470374d99d2e760c74473fb845c6fc6d399
ebola-3fe9dbd9356898b648471fc1c5643ec5b49c2e89cbf54f13b8dd4ea343fcbc24
ebola-23d868b6271d4aaa7996670e3014e235a0dcfe92d3ac6125be9aea1199b9f920
ebola-6af35b945234b1517e6870f3bd93d0d8e1c524c3c1888028ca4d40c9da5c4538
ebola-d8a0b9c8282a1cd95207157cee59a851484a4f4adb871b730b73e9177451ab87
ebola-807990172ebcad02d23bf123969c03d9d9e11e55169e33cfa357f3f9dc861c00
ebola-cfc5612e6f275b46ed5ae5e02c34bd85de888c1210d5128ca7d690595454e689
ebola-8fa10d8788bb0f370e18ce2b15f402fe2d3af4f2bc103ebfd7e97d362b86fcc0
ebola-2532b70c05067c97c91b8bd16eb66452213b3d9b2ae25877989206a8cf088d7d
ebola-8d48eaba8cb78f4318cf05164fe3511d525ccaf13468acc7453f148862799a6d
ebola-d9d6331dd0ae1dfdcffd3c6d4f11594f2fc94686caf1d98cc06676aba50183ab
ebola-edd587573d210c06e4961ae513be2ad7c7d0a20aad507762d91de8f9e92438ed
ebola-0861b94d7d17702759c3526c16fd9737d022f62618d0b3d1e85c0fae2ae03fc1
ebola-7e549516d5968662a549ccb7f4a3d9567c6286efa20a68fad99ae28829b70a06
ebola-086aa60091ab72627f0a9bffe355f103ccb0f204a9065da70c4b1d1786cc45d8
ebola-9e9202f6248889aa015dbe19034d69dfe38e95115d56fdb8e226397b745c266c
ebola-cc9f61315e43dec8b5a11dcd0215c69fc8fb239501cae73db9979a55d19ab322
ebola-aa67f0f5f13c56cb572c029e4d32b2be60360f08e4c4fd4c4b867fe2522e9303
ebola-c40992330cb8fe917b0b07fcbf8608f4e68bb7dca0582af8630518bcb52bed57
ebola-6073d2e066d6700ca794d86b26aeaff8cb1e88eb016c57b218c95e64a8406772
ebola-f8ba6700a3dc0741a7e0c1b50cfeb1507679e51af6925a4ff67224a80c24ead9
ebola-47ca36e5db65c0c3ad0b615a0a096f12cbeca3ce6caeeb0d0067dca902480df6
ebola-c320bd64d1c58203974f59beab4096e8c41063b668b15b48557b86f55efa241a
ebola-673b6cf839699032d35d19981ac6772356f6d6c95de2f119f2904721ba2b2609
ebola-48698609b6d78c8e52ebb35695a62b83be68c9e6050ece5078ec5129ea9cf1ca
ebola-87cbfc3e80cffd5fbf2d27fcacbb827c97b0260c973e0e66ff8a7c1477c6b099
ebola-e96605d1494ba2e2fbe85053c98d7ce920da642c8ef5e52bfb730374b6e82f0e
ebola-af9d3de0303035b9218c5b88dbc718c00fc45944134d3075d6d3f94d3db816cf
ebola-5722c910b2f43937a1bb187025bb442a1781d587277d8eba98cec4c5557d1a2f
ebola-23abe01e136b79dcee218960c1cf49519f04d9ed91af20921aef6ef93ed28f05
ebola-249903b38e351c3a961181c28710213c03371539829a34191036303722d9a26c
ebola-efa26af7cd3f58f6ef0849567c472f53f80569a91b6dd4f2c6e239b18879de7b
ebola-204f7efe912b356d18f7edb5a102a953ac2e80e05f49b0d505803e2636be8f9e
ebola-7f97697c3b4324d320a9c5b4dade50c7dec7117bf16b74187e921f37e74d9a66
ebola-58a14c1635db0248c512fc5b51ebea1d3699bc34708229e496a12a17191c1fd4
ebola-61c7fffd8edd250d37e71b20a99e591126e077f970e30765dccfc2bc48bb0e21
ebola-431989a6532308358387f9a618e408d1397f2be7a121cfd1403b965598fb615f
ebola-97a701a4c501d6bdf7afd0914c245a6278c558d8a46df67ebd313dc06fe4a6e5
ebola-d76d487128f90d791c50453d9199645fafc7edc163924767dd9ba115509b8dd7
ebola-672e2a49693bda4c9cb42aef98856441fce0fcb8a9fb4d8d914b7bccb7e09dfe
ebola-ac3d38308ce6da0a948435d36335b2f41c61704b6784d0f1f751ef2161d02087
ebola-e1f6997177feaf2b8a399b9547876697de2b76418ae2f2afebc702b7b4f7c6de
ebola-6bd77f93ed5de506628e2ff79c4356db909ed2de83a152fe92ec2efaec603fbe
ebola-0fb7779c1ec2908eaa3dd4b49ab884b8647193ed46df26a49cbe23649933862c
ebola-3ede7ea0b4a94687a2780e60a38a261e66cb6dcaabfbf2f6b89b761865ef8a0a
ebola-535525610c54bccf029db7eadfcbe6309266ce5a18072ace470790bd4beab8a9
ebola-f1943f0052e1c755c7573dfa957775c66e520c80a200f5f17120d5d5a4b6cbe9
ebola-9f591ffbbd9a0dbdb5a3f63f3c920282845bd111f2b6dfdf66e53ee1dc23274f
ebola-398ce5cb9a62fbb5d98f724ba305143834bac244cf33dc8fad4ca81c56396561
ebola-ccd45d5e55dd12a8a80930cff3833e3fc7189cbfcbeecb54c283bbe8eaf050e5
ebola-ac77140c6cd155105810b55905147eeec1992143624cbda7b2788281db5ec876
ebola-08a0dca4b1557aa78d32401254004917cae69471dd848fae63058628b4c4c62c
ebola-d36ca39b3ecac5d979c5ca6010b122079a5d2f89b7f91add95161c2056bc7bd2
ebola-8647f65f26afcafde77f477e872657033e0f482ac38c8c1ca5e64e73210ff418
ebola-fae55f2bd02e4c4f69491d7b8d91ccae840ca7d700d1a3fcca61552cef638813
ebola-f88f3b9f97a2ad4bf62d4edbb67315ea80221f7811ac2d09a0590963e65f45d7
ebola-74ecfa880f97ee9a6232b1dd39c55a5042f123331b75f14f9d56baf18c1f6413
ebola-c508bca48f3988f590d168f8dcbf89a33675283450626f6a9c50ac9a1718b615
ebola-86b062ae269a4c153045ca7e6386a267f19cea28ae3a5387727bb38066b1a68d
ebola-506354a2d645a9b4fd08332a9ea27be13b9a7c2afc7d26820a13fb0dcd9fded2
ebola-93235f32034d9d96e2fdeca1e677783e3e3ffb63214f895d6b1b49cee7a49a26
ebola-28264645e647c00219f59bf80a836add67fdac302c91a19f494516b7f8f224ea
ebola-5e67155e4d753f02c915a1a0da012b2a689b5bff4686cdb49a8265ee70de6522
ebola-563487279a7f28fc1b849255756e3ab13eb91eed3c0ed216cc4238fbbf4daa87
ebola-1ca5fb5d7b7c781e62a1f149cd4b583d81022ae867038217d854686f38be36d4
ebola-1f80aa898d8337eecf3339b2f74d84967021c7bdc9fe6924e1255bbc5367d3e7
ebola-fc5fb07530cfda98d4d4de1dff6cf9d64e78af6a4e8210cc99926e99651c7b8b
ebola-b78544bd3841f223b688b1993be0c234a4f25314c4fd0b3ef3c6111c2cc9a0a1
ebola-209a4477ca8850f03ea935f01c5e4a58a8aeb5fa76eb356d22fb973e33292fa3
ebola-95b64d91a13fd82843730824725fb05f777348468b9333c840643677a26e1eb3
ebola-3d23db8fccfb2a05655eb75f74868526d65cee83621ae52c82f908eb64c4959f
ebola-6245857e72954ea898fb99ac7956fefaaf005173d63b13ca0b2d9f31a1e4a112
ebola-4ea5d791ebe991d336213055204d92fac3ed9495e1d9b8024e0282e67af8572f
ebola-5096205a32a800ff8df023971abbf0c54984a3e5a38a6a6f0983eec727121b5a
ebola-1b634a2bb0de05d4fc640bfd11bee92f38a0cca7d859f17a9eac90e8150e641a
ebola-f5839834f87dd121eddfeea8ae50636ce585dffab39f3e1cfe7a16f323765a83
ebola-bd10486b5784fe8f65f6c7d125e77e456ecdf27744ff157d758a9a8c540d84e5
ebola-4fbcf76cf68c8be7c49ea4515d792c769540142a87fa6b469121f779546b9393
ebola-01828e2c0786a38b945f8861ec66637ced73d96cdd4dfcc4faa1a21cac877178
ebola-563d90883b52cfcd1792030de57029178bb3e63d0ec6f9cc24ab02bded357f4e
ebola-cde048f03433130b6bb00e39ed94892f7dbf64a3140229cb99e495d675fceae9
ebola-4fb2dd41af29fefe03c376e3c3b2885eccfdfd633f05f7cf90bd8863ab360961
ebola-e681ac8784dcbab575b61e5ddd08bceb18c945b59231201b551fb5d9106e6ae8
ebola-5bb18c44cd8ebe2e4da4ff394bf4da1caa5dee3345f6d7c4cd965c0f01c049ef
ebola-cdd1ac7a3be642bafcfbecc4a5001b11fdd8a96da17b0d6a2b7c1e609c24043b
ebola-431dd14ed408392d9644f62fc48379cb3a71b43c53847474b68243fd98368451
ebola-561405bbf03b4747d1abe4066f07c80653f72195b6685c773d97ce70f1a1455a
ebola-f503fc6077e791bb45a1117697306b93dfcf2a110ed9a6749dee41184ba8ab07
ebola-22e0cadf5b2e2af9a7c32341cda6108f7dff44848972b663e0d8545fb974d93a
ebola-76603c98dfdf58430d940cbd1f3b93e818a0dbc777d56fe177c95f9be6e2ab99
ebola-23ee3ac89230c3be673538c9e9a2d8dca2cb22e7b6e992f487f48db0a382c5e2
ebola-225a5075a2ef166428c0238e57b79c0adcdcf9388f06960a1f633d3fea2e1063
ebola-c31cd5a1c8cbbb33cf538d73627b125b72c3dedffa117a7ed80aa0584a65c4b7
ebola-5bd0adae3d5db84a4e63b9f8233a0d4583ba1b4454484a64eed83e5a0114a952
ebola-faa29194b4a41bc3730c41f4895581a403f072b731e7a192f9253a8162819217
ebola-730f291cbb0f784ea6c87d906131d2a96d9481cd2dc262322afe64450bedb809
ebola-7c61aee05cbdc7c78aef5067ff6ce3142352d2a47838b7d8fb13f0d2cd621ad5
ebola-a0975fdc85b8bbfdcbfbc9c43b1b3fe778c6d0cbacdc6558e35730788a69de65
ebola-b1d7d1ac356b2cf469686ce9a2afceb3e0705f3ed78662d93b22fa3d5998859c
ebola-e0afb68e595959e1d51e23b032a481583c5d356aefac38e787f5fb4c188b18f4
ebola-52d7cf3a766574169e085b2af0c5aaa9677535e2f9eb5036ee9988502c4e9c44
ebola-beb807a355385796b9b99acf4803ecd41556d6fbfde3cb54ff5d681e3c6e0a71
ebola-02a87282f0e1ed86d3f677d59161044292f3a44066cd4db4a4b2e589d07e555b
ebola-5504cf2ecd7ea713b7d08e4122bc9e433c5c6e88a093e5d53deb8240f8e4236c
ebola-becc2ba67410f1ae9c7431a7a4f8ad77dae6ee63686a91da2b23969c01922f1f
ebola-f44d59053915c328ced6ce1f7893f966a594bce45811e8e0f65b3e122dfd2a5a
ebola-2a9c0b2507c32de343ac7278aa4921f32e9d5847bde637d66930925cd41b7d57
ebola-f63fe14e8d7b1cb9472a968883fa4f15711599c0eb7a9aefa1b77a7eaeb68554
ebola-8f1ead9318e5ad6ea3d1d20055c16c8c64b3d4065a08b8b56a530e613a96811e
ebola-27396468c4890be2dc7879452800b22d484e63d5c02d68214fb7620a762359de
ebola-96493e1ff1f749bae56fb040c1494398d9e958be27b5211168a719f7b06d78c3
ebola-2de912d5cddb903da3c19aba7d3b83c362672dd6a917adab55fe3efd84b5d2b3
ebola-49b973c1cb9b8067b5cb899c4da728cfd1395744913315ff88deacbc4327ec3a
ebola-eeefc37d146424a448788a7d5d4c9da87fabf3a305d33e88614a255e29ef2d1b
ebola-64b1619aada88df6f8b3b3d078b2d7b3022c0681e1073f0e61846e7194ba9332
ebola-9f62263de17551bcb7c92def718cad4154894336540eca0d8fcd15a3ae2a8b7d
ebola-d8cc593217aabef3ab823ca750f7b748fe94144dcffb4d905948ff305cdaf138
ebola-06fd128324775d7c1af43f7fe44e7bc37600f391492e8baf278881cddc196374
ebola-3b7728a4e01bc9532e0b9f13dfaa2f01cae42f8d3e74a76e7db698c95dcfa312
ebola-b4464c0599822fbaea43e10aa20277375d2a3b93d9f0320bf44f7afa2207e3a9
ebola-539c0ceef48f08546f7cc7b97bed258d315e2022fb0e84e8802d498d55211d2d
ebola-acebbb0df232077c5f5bdeb9bc2497242155525777a5b09999ebb1c0705abeab
ebola-bef244ed775f480cea46983ea900f23e62560752125142158ec35cca9d05e9a8
ebola-555229f1d26a7f75ba04eb9b507958f16308f400db0a0e12cccaed9543044eaf
ebola-036c264a291302c2f21af7637e377ce469fa7832c98983ee10edd4ea1b899d3d
ebola-d83f4d3ac74fd3ee6789b60f8036e3289cb4095f70fbbe5ac93784f607a6a4ea
ebola-7794e517361ab874e1fa253588cb5456f22fbc993cf9ea0df0135e469ad360af
ebola-a8f9b6755b154ad35698e2f5ea77a3d97e23282964527d1ef49da6ff201b5f3c
ebola-d23bb8f14aadc38afac500123ba81530ef0dce6053fbbec7c7c61f792d73eee2
ebola-4f86458e5b32c90093afe2f348fdd5cd5eb368c89dc217e6cef4a3ee9bb7d0fb
ebola-883ab0ac6f4f77913b23743a2f40e0ecaf3c02682c83c073b18bc85a081a0a1e
ebola-6522500e46bdd730d364af79ffc161a08c9e45c58d9fd0f0219a3f1e0f1f330a
ebola-b578408f93bc5e952d75dc2c4800c7795fa38cf720f9fa24e8b135bddf594c58
ebola-3ceb8380f827698c07a1bd61ccea59cb971e2d91dcd43795d47ec5b9b966f686
ebola-6f4ab2ab15836e6e6d1f898bcf2873056c974c0597bb3e2826c6403f3e763520
ebola-9be576bd970e0694831ded846f1a9c03c1245fb826d0637f73e5eca86ccc0dee
ebola-19fea6ab606ee20c7fb8b726fdd45c7ea49c7ae431166443db5d78fdc368fe6d
ebola-e35c30c7334bec3a7de7b4a4b9286971a10c37f8bd9b75fa006a487010b857f8
ebola-a65b381cce2d48a5fa534fdf6afd59d498c36e7610089404baa07e9215d1084f
ebola-f4a1ecf3d9c1874120723e509158269fe8725b369345979f6b3f8180ee844cf8
ebola-6b5d589712d0f902cd15e64989710a65021da217bd6b0d035ef54b8c8d34391a
ebola-ce2bc52171ac7861dba2f90f5c388b0e8f59310665e00cdd71dc35a331e8b982
ebola-3ebcf5478e7394981e1da34891d29841ca4c2585b8b9de26792aa704af6f0e1d
ebola-28dd5c6eb24b68bed2cdfaa9fa8de4cbc4717c8e5c6b39501d51d3ee5776790b
ebola-ba08ac3912500502856b2c67bd80e7809b26525867230d9f88893f3c0fb95ee8
ebola-cb428a3c70600b644770ec29c43b8e86c14faaa904ce7c0736d0c50d6fdddbf5
ebola-20b155283c087f24d18921e49b1d247f4ac2e604ae26129030699ed7e4b93e29
ebola-279fb510e0ea45e08092c625b82d53ec3057c6d018a5ca20018f29a6c021cbbd
ebola-a9e99931598d5ce59d28366a28000fc645413ec5c02077be73d7cde5446f2324
ebola-b8d8432531d0ec5f29c5bae850c5d5ae37fcfd275743993035184c8cc6f13f85
ebola-a992691b8e74367a3c93385552c835ce742a63b3e165884ab22fdd5056709158
ebola-90587abfbc502b657d6ae0289f4e6ca47e2c14937406399d4e190cb9733a8063
ebola-532c113b5cb564dc3f5e6675e87bc04f6a4ec526a26b343ea0785f05e3d6435e
ebola-f885beb24b8dde69c218a19095b2d08240d8186d93361152fb9994e4dcf6b619
ebola-23b3ea1006c9822174e51afd0af390bf7dab0a69f91d373f0077537786bbe873
ebola-1198ce90a1f79f88fbf19963712a76709f428018d310e50c31580373c8b0375d
ebola-d67524229aae9451704cad53bf48a8c1aaf436dc0a7c3c8c0fc6a042fe707a45
ebola-7e54f579168cec6f9c3b6b40111bad50e0358ebb29c0a218577c31220db5eb27
ebola-db7867d5843ea8a127a6b0ba038ce3f592aaf24f78e37ebf8735caa32cf7bfbd
ebola-6361a002b90382408a52b1c2a241120311e2ccca2b690c8b817dfa2b2e716b1f
ebola-4a4a9e50a0e1868b236f25a75b64f077a272b31240033030ed63a42785e71f51
ebola-2bf3e37860ef00d61225d9ad2f8c1f1860b71c5531bef512823f0f46719818ec
ebola-c8d4c4d621e152cc1578e053ef62b65d27bc10054f6755f1b58a2baf1fa91b86
ebola-0cafb1920abd94cbbd7be29ef727268bf8845edce3680da8fe296767461e8155
ebola-4bbe4b70511afb2dbc9798ada9d5c12a9ab374da2d906719dafcc19684073340
ebola-8c71696cdf5f1a53626e87afd87d54ce9a76a43b689a387522221a11009f28db
ebola-995d65322d7690ea66a190bec5dbbb70b23123309e262ac9fcc978623c7f9f6b
ebola-14017f3879ac389a0476278e3e1d1999e1fc49c3d5e5d6cf6762a62c768e5271
ebola-0445b6d2f5efbb81280f304ee0c308d35310024e3bab11fc3490c54e9eaae1a2
ebola-17f6a09db2d36a5165e30b1e4de395d50e4e0fce7a8b44d5600f22acb18ee3f3
ebola-d22c2e444f8ec2beaea7291ece1af008a49efb7800c9c9cc43ace3cc98581183
ebola-d1fe42c219321c315121929fae29566475efe0182bd381c148151cc33523e778
ebola-0cdeb9a71d505cd9b603c25a0f360e05492dbaeea4b0b24a11f4c85f07601c9d
ebola-4878370931d274b338ec87a101b394a17ec20b7d5521ffdae7dbd930974e97bf
ebola-e115ad8214f5cc2b96abf76ea91a0e19ee5b452875756702ef4f60c4f99e6d65
ebola-4d1cd555ce120340953efa82f4a9902c3f4c4e0c5813d2f4236e650887c74745
ebola-493aa1c655f5cd0f0ba4214c6eff58154bfa47d4d5f651c8d635f8a32bcd846f
ebola-a6fccc89efd3ddf57c11f305f9fc658c8ee9c11f6a305b808dfdd6b96e940d9e
ebola-24307def900eea42f91bff4820ff9417151db6515fc3ca427b7308fefda6a32e
ebola-087b06665597cb1a30d347d23cb2e02610e77a6577b68ff5487ce685478e0f28
ebola-aa9e6d28cab6b4274337ea3e46130cddf3b7553069b8974c1a37474b67ee9df0
ebola-09f1a58add27b87fc4a1bbcd420ee39dea34f17d8a3a714d44dc92f089b43851
ebola-af18f83d1331c5576ee9046e92c97394832f97df11309c0c8879c50390a6d502
ebola-6c40e3d6af5e0e1b27bb50b54ba671bf108178bf13d9c4b4cf7e48235e8c6dd2
ebola-eaae36667d41ca083ccdda910fbe1dbd3b531f32bfd4bb6efce0411512ba7bf9
ebola-3ffcca4fe759d17546077a8009b447ad30f12eff6f548d11d71e84e1694390bf
ebola-52822cf91d8d8d0d3f857bee95d10daa0d40b06987d00e6af61ef12cb5f46ae0
ebola-369becf1fdf972f1771f7b91235c558cd24f2c9eb5f17b60b956835ed1266175
ebola-bb45ec6518673ca16e9f8776fab0e95261e87a622feefd2aaf2bcd5fcc3b2626
ebola-80ec73d3d6cddb3d1f953ba9704b9f8ab14b8d1f0b20e73f98fa2d55a6d2ff5c
ebola-dc3339de2e01e56375c4dff3129d16a14aa0be7030d6086390b38267c51f1bba
ebola-f18ddfea35340f2abb312d8ce56707ddeb730d5c6cc1e19365293ad93deb3dde
ebola-2eb1d3024bfb1b194812bd344db528e4631cfaf7b67246a5fd131b6b31f1ea36
ebola-1c2e6d3d5c8ab66650d84e451511b636e85493086aff2dcb7c84f8397f1ad0af
ebola-7b5253c611472fdaebbf2b9698e289c94744b2d16c54f80eb844087409901b55
ebola-c3811e3db9ec66261dcdd82b8680f50c5fb7b45f85206a2128ab8d098821050d
ebola-95216efaf5f1e9291cce9c08b8574d396754815c97c89dd2ea5f858aafca7d07
ebola-3cc2c84f6822e74a053f77ea10635fbdf1d44cfcceb70757b3a74f32bd40ca17
ebola-35ff1030d868605b05457b473c8652811a4a250a394d21215072b71eb4efe411
ebola-36157f11049e80fe9ae6a142a2e99487fddaf53233ffd3e979af1e8a7541617c
ebola-e1a43cd09edcfce8474b59d8a0523a1c00e55d53478ea097a783b6152ae29c8b
ebola-832da4c80f44ddbc88bc8a237a10b9838c74869904c259aac5cde0ec5136ec01
ebola-f9d4d70f64f645d3633704d70093ab5007ba9ff89bb8cc3951e4a193cb7b80b8
ebola-9aa4edd4413e06a63a5ce8cf06f43d02f5a6ee388495fa471244067bec185cd9
ebola-32492b8d2ad2361573efae3d55b9bd34db18aeef6bed4bf23866e6f4b10d019e
ebola-109d56e62298124ae88f2da2b9a607e43adcd32f308a7df3b6f0e977c51c7dc9
ebola-2f44133e715dc7a4f551aa94ecd542127465cd4be5b10d271cd81d54afc93ebd
ebola-cceac81ea237477759d163e69f6266c95f16eea773a8a0203befaf0f486cedc5
ebola-ab2b5075f6d0b010f31645c38a871beea77c268520cb359458eb0577484da8b1
ebola-8d34257e34a8557038423cd2ecb4d8fe55589daae0c4fa4ffc2da903de8e86ba
ebola-ad9b5d93e9ae1620c3395325e6bf5fe4fcf460d8befd4fbd4a524f62d7f3d1ab
ebola-2e76f17529d19d1e7d837a45602dcba4b857166e790a2b311329f40117f9f7f7
ebola-2cf232c474b645659eaf6aa51cf7cd109afcbda07cfb289ee5583187234393bc
ebola-741bdf71d761d0d5911640fda7f0c52735d85555c611c17420af64ea8febae8b
ebola-ec1fd461dc8739a8ed3634da4c2d44227f2d833cee66a7b42fb595037f785094
ebola-4f6496406471516c1165330609e334a8fa057c68769b1f3e0063ca3c29eee5e2
ebola-d1e5227a8e9f11f8c47b1b0c7f44ace31fdbed52b04cdd4dc1a155d912bb8cb5
ebola-08813bc4d1b33bbabca546609986f164bb23c751b7c7cd0ea5780409a0d247dc
ebola-6d69b5ca24d8cea02f2efb6a937cb6c4192f66ed835d660dad3b7173b613ac4a
ebola-e8d6a58e000f2edaf662edcb28d7ca05d5b12cf0b8b2feb8fabfbf6089f50d18
ebola-b24f20dbe367ea2b52ab57252b0cd6b2c37267797fe29a9ca0bef6001d36c97d
ebola-27a573351ba4d7ffe0edaf300dd922809a6be9d6ad0abf50049dcade0ced0056
ebola-a1205e504fb555bc16b11188a03ef093acacb9b9a7ffd4bb58b5eb6f018b2230
ebola-c04fb97307bc46a73b19643fc98802bbdcf4d9c903fb851fc207c7c7141155fa
ebola-9b0faea1088c75f02267b52576c8c212522f80bcbfe6a35bd551773c1e969edf
ebola-02c992cc58fef48bd61261721a834002e37383ad9b717a7542807bd03c86c645
ebola-64de1c8413d4a431078773fc6529ca66fec901a65e65e5ce9ab1793f4e136ca0
ebola-904d215abb6afef31abc21e33656f2ff9920eabc8701198c2a761c13c577d524
ebola-dacd536b1f02ac35678e620f4c4e31f81de2275f1d4951586730830b66507f8c
ebola-d3a62a0d66acdb6a2722c72a300c2313cf5b7dbd764b65b6cba241e801d597d6
ebola-261f61c5b424d616c0cf2caa870bdd33e2c47342dcdd8ec7e27d78632437726e
ebola-e19a268e05eeccf5ecce97f37e338bd137d969b836d470019b6f7eb22d007997
ebola-af164d3b67a35a7e525efad04eceb03c16c2fdb7e378c69a1d075d77202e35e6
ebola-bd4f469fb9418337eb63508c3d055223c0f95db5dc85f3c0af3c2746f0f6ec5d
ebola-72b5884a6f0d49ebb1547d8bfdc3ce4814a5c4e3dddb2cd5056381a455349fc3
ebola-283b76ef0da57c769c2d9edc7d56370d015e647aa57c1aaf0e99c1e7312f7c67
ebola-754a7bf50929b5fb9618f8e14d7bcfde1e83d99b73e159598d95689aa1171383
ebola-23f0ee5d68c7cbe0542897bb71237dc1e6016f5ddf5daca16fcfb0327f0d8821
ebola-71dc2311b3b450ae80e71ec39d870c09371ce8b052cc446501556824c858fe38
ebola-ef78a5f7dfdedce142978ab325d9745b25ca3e0bf264e8d1acc6ab0b85597d51
ebola-ab6a6894a162dd502251e33d618a3f97fa89cbc40905940e532328d6c98bb89a
ebola-b422df15605e8a05197b7cd6ec3d571caf7224c7edec64305884d41bfed8116f
ebola-460d40624d452956b0d5f0d2a2347b285d1d579f6904d82258f202eaa37618cd
ebola-360a9764b6fbafd8072da0d5344e1347f4ea8b07c70b2568dca5482a28828e6f
ebola-adc4e73828acfa32e2ace67be5183d78362fa7477b9056bb41bc563cea069e5e
ebola-f27dce32a434816fb77c12f87c6a5c8123d6cf0319e87f36df1e817a926a155e
ebola-97b50a28f41ea2355b004b67db24d04d1ab80c585d2d2f2bdf660e0a71ea3745
ebola-0b2910ecc6dcfa3e98650ba5dcfa2ef71c2870ffa01aecb6e3e1b72593816604
ebola-ebf7a8699c39e6fc530d964d6b6b9b78e3aa0182ffd66140b45629038fa7757b
ebola-f121dd1163a224d8bee26ff365d0535e418c9cd33a7fd46ae44933fdea6ebaad
ebola-f7632aeaddedadfd4d8c1fd251d353bcaae459ce6e09abd733bc83b97ecceabe
ebola-f212a8b4d58dfd396f651131a20e615ddad881aa96e87a8335c4c99fdd2bd7b1
ebola-be08214608f2b52a6879a3f1a95e02b77395e5ec5460feff0c016b50c6d05453
ebola-be84973590467f0359973249b5fc70e6aefb197e794319e494e23ec8fd619eb0
ebola-93946181ef41bb8a263fcd0d0e17e453b9f7421febe1ad65950f91b2e7d99b99
ebola-fa406d858c1adc4161ed962028eb45de19c7651ee7a86e85953f794540b4fd30
ebola-1ad65731580b081760f76f4fc4bb52b85fc933c7aab81ae9fc8138ae987f0b9e
ebola-b0028b6653674897917229bf83233a8f3221569805dfa324a03750dfe9f8e842
ebola-57d10c2f19f0f624f3190bfa55f1dfd22d9eb7c2e0e9bf31fa498c17405c44ee
ebola-b224aca4e7039e956e19572cbee293c9bf6b5f11c3635bbbe8e4ad06d43dfe1a
ebola-de9a8f33e7949aa72967c5c54e454d6b3f0dba6996222a952dba8afe218027a2
ebola-81ddb54caed7d665cd3286713575bccaaf4e67e6bde0a6fea1e21066a743b6a9
ebola-a53ccf989df81c0e21d4c20c24d6ccc4ab590192755d0f7224658bf3cbca1e1e
ebola-0117b4f6994387b95b0bf771146fabadcdb93989d494e201d660e549d7362a99
ebola-33ab0a736c450ba6d0b04822edf129362b669a8e23097998af8c726572308e5c
ebola-7a45f142584aad606cfbda6e64b28af489fdd75568b6d637806b4036600216b6
ebola-2387f805421237056ab2e7ee8bde304cf60672863f435efd80fcf3de61f738e4
ebola-56548e7fed0b8559bd455dc7247f7ae91f5dd506923ba745fb0e25e630b83bb7
ebola-89f0c6292b5d591598f698200474d9ff72e9fd89df6d9ca4b665d44cd584ee32
ebola-17d251627636f9e03217915814ffeaa641eb4f7aa9d73d6e222e7076d8c3cbcc
ebola-92edaf6e9feeb3f20c8aafdb04bf53514e1bdc2a445cdb3f15978ec34215b09e
ebola-ba8004fd803c6158795bd550267387b663b24311d28c4c589115c87bd884623f
ebola-9e5a4e5ef7d6704f6fac5da19f96f8140cab6855939ffff189444243e62bd45d
ebola-edf7c2966b7461508b266a8d18dc00e0bf13f044976773efe0a27c0efe17d5ea
ebola-2458ba39380584a1ff0ab626cad9bd86429ae91cbc200b33a5aab50d359f9875
ebola-66604547f8e8e52f165bc43932dc36f4db5808220340e028e58e49198f159321
ebola-ee70b01d80c0e6b73e1b358f7939b279e99483ea202dd3f6e11e58ee5a6d9c41
ebola-8d5e0bb4994dffdcd405de14b9a4988899657ac6f709f042ffe92f073c6d99bf
ebola-ceb11737247e93cd676963bdcaa25a13ea0fd8bab27baff633d82d5570142952
ebola-5f97f24f2f25826664d63db55879055d7d4d0c3df47067d461a494047de9a2c8
ebola-a9ce7a65f2f2f37ac7870eff872c6286a54f3994fd52338aa52888b744f12345
ebola-98a1616e8df6a37bf382a0c452136177d92985172a3e4999568089898cfb86b8
ebola-16b216b350527301fc4fe8b2591e512eeee40ee7c2ad4f31c1dd29ae058d0819

list/click  |  time: 2016-04-22 14:39:28 162027  |  # of fields: 4  |  topic_id: 397  |  docno: ebola-450922b3b0c40555cb60cf2a345032f520776a00e7fc8a65342eee4173b084b7  |  listsource: pink_findmore

doc/irrelevant  |  time: 2016-04-22 14:39:42 004900  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-450922b3b0c40555cb60cf2a345032f520776a00e7fc8a65342eee4173b084b7

doc/irrelevant  |  time: 2016-04-22 14:53:28 202026  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-8ed1d6647800fea679d8c47b16e6a93e647b721f9d3d9a92efc5e69ddbfde844

doc/irrelevant  |  time: 2016-04-22 14:55:13 925282  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-ae1adeef917b0b73b7f145352c533a6d8b2e3d7afe034574821d9e4a2ca49983

doc/irrelevant  |  time: 2016-04-22 14:55:28 140057  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-bdec02759ea1b376d362e879e33985e01027ebd505e775740c5c7df716edf289

doc/duplicate  |  time: 2016-04-22 14:55:38 028620  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-f9920d4b0caec4f5a6a978ec96afd918e9bf03f5bb0580d04b92804b18e1e144

doc/irrelevant  |  time: 2016-04-22 14:55:49 886741  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-725f441d549636546f30bde18a30675c6c2ac6f13f3c83e51a3477b7a6699ab9

doc/irrelevant  |  time: 2016-04-22 14:56:05 312827  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-30faa0f7dc99271cfaac61ec74e93c32a7f69423aedb5c75d7b309a6d8528986

doc/duplicate  |  time: 2016-04-22 14:56:52 380262  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-440afddb732a2037ad00c43019dc21f55b5b5d14e43fd485c75de192abd67985

doc/duplicate  |  time: 2016-04-22 14:56:59 489345  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2cc40faaa86394751449c25c60b83ab99f185115d28741a021e5c73e0b906e50

doc/irrelevant  |  time: 2016-04-22 14:57:14 759554  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-603d743b182b4e8b5de622d7c3535470374d99d2e760c74473fb845c6fc6d399

doc/irrelevant  |  time: 2016-04-22 14:57:27 264202  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-3fe9dbd9356898b648471fc1c5643ec5b49c2e89cbf54f13b8dd4ea343fcbc24

doc/irrelevant  |  time: 2016-04-22 14:57:38 693033  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-23d868b6271d4aaa7996670e3014e235a0dcfe92d3ac6125be9aea1199b9f920

doc/irrelevant  |  time: 2016-04-22 15:12:26 153955  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6af35b945234b1517e6870f3bd93d0d8e1c524c3c1888028ca4d40c9da5c4538

doc/irrelevant  |  time: 2016-04-22 15:12:34 070293  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-d8a0b9c8282a1cd95207157cee59a851484a4f4adb871b730b73e9177451ab87

doc/irrelevant  |  time: 2016-04-22 15:38:59 796316  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-807990172ebcad02d23bf123969c03d9d9e11e55169e33cfa357f3f9dc861c00

doc/irrelevant  |  time: 2016-04-22 15:39:02 381044  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-cfc5612e6f275b46ed5ae5e02c34bd85de888c1210d5128ca7d690595454e689

doc/irrelevant  |  time: 2016-04-22 15:39:11 821370  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-8fa10d8788bb0f370e18ce2b15f402fe2d3af4f2bc103ebfd7e97d362b86fcc0

doc/irrelevant  |  time: 2016-04-22 15:56:27 870320  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2532b70c05067c97c91b8bd16eb66452213b3d9b2ae25877989206a8cf088d7d

doc/irrelevant  |  time: 2016-04-22 15:56:38 244729  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-8d48eaba8cb78f4318cf05164fe3511d525ccaf13468acc7453f148862799a6d

passage/create  |  time: 2016-04-22 15:57:13 202383  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 194  |  subtopic_name: healthcare insurance  |  passage_id: 4965  |  passage_name:   $1 million to Doctors Without Borders and the International Medical Corps to support medical care and clinical safety in the three West African countries where the majority of Ebola-related deaths have occurred. A Kaiser spokesperson indicated that the organization could send more aid as the outbreak progresses.  "

passage/grade  |  time: 2016-04-22 15:57:16 651736  |  # of fields: 2  |  passage_id: 4965  |  score: 1

doc/next  |  time: 2016-04-22 15:57:19 903579  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-d9d6331dd0ae1dfdcffd3c6d4f11594f2fc94686caf1d98cc06676aba50183ab

doc/irrelevant  |  time: 2016-04-22 15:57:27 772454  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-edd587573d210c06e4961ae513be2ad7c7d0a20aad507762d91de8f9e92438ed

doc/irrelevant  |  time: 2016-04-22 15:57:34 463890  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-0861b94d7d17702759c3526c16fd9737d022f62618d0b3d1e85c0fae2ae03fc1

doc/irrelevant  |  time: 2016-04-22 15:57:40 165801  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-7e549516d5968662a549ccb7f4a3d9567c6286efa20a68fad99ae28829b70a06

doc/irrelevant  |  time: 2016-04-22 15:57:45 773858  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-086aa60091ab72627f0a9bffe355f103ccb0f204a9065da70c4b1d1786cc45d8

doc/irrelevant  |  time: 2016-04-22 15:57:52 917074  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-9e9202f6248889aa015dbe19034d69dfe38e95115d56fdb8e226397b745c266c

doc/irrelevant  |  time: 2016-04-22 15:58:00 093627  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-cc9f61315e43dec8b5a11dcd0215c69fc8fb239501cae73db9979a55d19ab322

doc/irrelevant  |  time: 2016-04-22 15:58:07 376116  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-aa67f0f5f13c56cb572c029e4d32b2be60360f08e4c4fd4c4b867fe2522e9303

doc/irrelevant  |  time: 2016-04-22 15:58:14 911460  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c40992330cb8fe917b0b07fcbf8608f4e68bb7dca0582af8630518bcb52bed57

doc/irrelevant  |  time: 2016-04-22 15:58:20 634548  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6073d2e066d6700ca794d86b26aeaff8cb1e88eb016c57b218c95e64a8406772

doc/irrelevant  |  time: 2016-04-22 15:58:25 945505  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-f8ba6700a3dc0741a7e0c1b50cfeb1507679e51af6925a4ff67224a80c24ead9

doc/irrelevant  |  time: 2016-04-22 15:58:42 540074  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-47ca36e5db65c0c3ad0b615a0a096f12cbeca3ce6caeeb0d0067dca902480df6

doc/irrelevant  |  time: 2016-04-22 15:58:49 464498  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c320bd64d1c58203974f59beab4096e8c41063b668b15b48557b86f55efa241a

doc/irrelevant  |  time: 2016-04-22 15:58:55 646763  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-673b6cf839699032d35d19981ac6772356f6d6c95de2f119f2904721ba2b2609

doc/irrelevant  |  time: 2016-04-22 15:59:01 976028  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-48698609b6d78c8e52ebb35695a62b83be68c9e6050ece5078ec5129ea9cf1ca

doc/irrelevant  |  time: 2016-04-22 15:59:16 223061  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-87cbfc3e80cffd5fbf2d27fcacbb827c97b0260c973e0e66ff8a7c1477c6b099

doc/irrelevant  |  time: 2016-04-22 16:05:31 675216  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-e96605d1494ba2e2fbe85053c98d7ce920da642c8ef5e52bfb730374b6e82f0e

doc/irrelevant  |  time: 2016-04-22 16:05:38 128014  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-af9d3de0303035b9218c5b88dbc718c00fc45944134d3075d6d3f94d3db816cf

doc/irrelevant  |  time: 2016-04-22 16:05:45 927396  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-5722c910b2f43937a1bb187025bb442a1781d587277d8eba98cec4c5557d1a2f

doc/irrelevant  |  time: 2016-04-22 16:05:51 447053  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-23abe01e136b79dcee218960c1cf49519f04d9ed91af20921aef6ef93ed28f05

doc/irrelevant  |  time: 2016-04-22 16:05:55 587170  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-249903b38e351c3a961181c28710213c03371539829a34191036303722d9a26c

doc/irrelevant  |  time: 2016-04-22 16:06:04 010563  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-efa26af7cd3f58f6ef0849567c472f53f80569a91b6dd4f2c6e239b18879de7b

doc/irrelevant  |  time: 2016-04-22 16:06:11 456825  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-204f7efe912b356d18f7edb5a102a953ac2e80e05f49b0d505803e2636be8f9e

doc/irrelevant  |  time: 2016-04-22 16:06:17 514145  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-7f97697c3b4324d320a9c5b4dade50c7dec7117bf16b74187e921f37e74d9a66

doc/irrelevant  |  time: 2016-04-22 16:06:27 140017  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-58a14c1635db0248c512fc5b51ebea1d3699bc34708229e496a12a17191c1fd4

doc/irrelevant  |  time: 2016-04-22 16:06:29 451484  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-61c7fffd8edd250d37e71b20a99e591126e077f970e30765dccfc2bc48bb0e21

doc/irrelevant  |  time: 2016-04-22 16:06:33 928438  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-431989a6532308358387f9a618e408d1397f2be7a121cfd1403b965598fb615f

doc/irrelevant  |  time: 2016-04-22 16:06:38 483258  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-97a701a4c501d6bdf7afd0914c245a6278c558d8a46df67ebd313dc06fe4a6e5

doc/irrelevant  |  time: 2016-04-22 16:06:46 912598  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-d76d487128f90d791c50453d9199645fafc7edc163924767dd9ba115509b8dd7

doc/irrelevant  |  time: 2016-04-22 16:06:51 711677  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-672e2a49693bda4c9cb42aef98856441fce0fcb8a9fb4d8d914b7bccb7e09dfe

doc/irrelevant  |  time: 2016-04-22 16:07:05 662050  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-ac3d38308ce6da0a948435d36335b2f41c61704b6784d0f1f751ef2161d02087

doc/irrelevant  |  time: 2016-04-22 16:07:08 006567  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-e1f6997177feaf2b8a399b9547876697de2b76418ae2f2afebc702b7b4f7c6de

findmore/blue  |  time: 2016-04-22 16:07:13 232440  |  # of fields: 3  |  topic_id: 397  |  subtopic_id: 196  |  subtopic_name: provider impacts

result_size: 0  |  num_tagged:  0

findmore/pink  |  time: 2016-04-22 16:08:13 341786  |  # of fields: 3  |  topic_id: 397  |  subtopic_id: 194  |  subtopic_name: healthcare insurance

result_size: 270  |  num_tagged:  0
ebola-6c1711af8abb7218aaafb86b496cb6a68c45391a521b0eee3bb218f73d5d3d87
ebola-30756ad762525195a488111a0137d3aece920d0049445db27626f5ce5d205093
ebola-410e085cc50ccd3dbe80b857c5e5992bc6bc5d57b64c84290d33c3e0d7e4229c
ebola-8251f3862514258b31880087c1bf4061f6f398fbb3f2cc55ad24649adf1da25a
ebola-e67f565bf94396f441997c013c29fe2360fac1e88a546b776ac102bcfd263f37
ebola-6483a13de65757c68d3f4f45c0442507c88fc201a6c31dd618899330e345639d
ebola-23df89a3b16ffe0a68679ee2b82548922f57799f52475ec3e9dd005f76c3b83f
ebola-095810736223ea24f448c6af571bc27a4f890d666aa0e1984083ea771428a866
ebola-db995753f45cfe398894a738d3f8493d60b7a1ba31a7527039f795a5599ea514
ebola-6a152866da9b5024209ed33bc529564a1507c64af356f26bddc9ecb92b923aef
ebola-c9f6e0a9ab84e43cec1a3cc0ea93de9eb00323f9f2c07d349e8cec0dd481cffb
ebola-613d444e54c838cfbe10f7c0e3688974f45b48bba65d78669c9038dd1eca5325
ebola-e41ef172793bf1969c02bd548a28821f6d2ab9373bf6d4a490b29a302e6d71e3
ebola-f6dad867f965846d85c4c571c7eae0953275c5362cf8cf4fe5440e37c1b9d70b
ebola-ce198b39c866eb7fcf7b9dabaa15a64efbce836eb2514878f705cb81b7788433
ebola-c5f3a76ebffce2edd378367a4bb0349497b629f7ae7d002458b5926dff8fcee0
ebola-6d7395466b6cedf29877b75a90edbe3feeb35dbc3dc962447afee80a2f8ea1c3
ebola-a373548060857318d7f1a93a9bd768db8d762d974f43713fcdffeb62e36a000a
ebola-34a6569ccbbe792ffee42bab987f51075e40528ae0f7dbb27dc3f91c89d00885
ebola-22a9ce04dfcb83b81460d5f20e066374bb0435d03c8bdc2849b0b5c9d67ddc06
ebola-b52226305bbfc8f1bdcd1c123d9ac6dd1124cb072ab4451dbde7f1df7f1a6a7b
ebola-18c30a5f74fd6c54831b8c3048ca5f697c040a9379c256547d3a731b049e79e1
ebola-0e9008b26e49f6970bc5d7040a6a1025f2ad513100fbab2d199bd38832f4b111
ebola-a96a6ab441851176acc283dd4303342e429b958bdc370f7b22afdea5fa947c22
ebola-bcb3dc7cd770fde9b74f5bb8006820749cb296c472bb1f9c4b6ad328d3e5a684
ebola-c27f5a84427839f29d3858b077f72653c2c8c90de9cbd94aacc1357db57fac5e
ebola-bfda3c5b8b82e4abe49ea1cbe922a204ae35df567169f3433dd4a467f878e369
ebola-6f3071b68bd6aa9f55e5d7d0ae963374b8d6c2c09e508fe7f773fd7821f45076
ebola-94244e9b0749f920ebfccf8f72db0dec1ff3d831195d801dae810bc0457196f2
ebola-864d9825a93b40a44fd5d136f8cfb63f5b84812559ffec6d30746a150549c484
ebola-b68e9ee9d6037be85daaf918da28b01ec999c8bca557518c276d3c8a9dfef4c8
ebola-a7194923bdccc67c63787929db0e441877b6d82d84d9f3e458ae3759dfc8ee07
ebola-cc32a8689758ca929a12a4405e920e005eaefbc16da1d5f11aa69adc0d1fd43b
ebola-da548f8b5c8dc9e3213fced4f9c69c2d0197ee107d05e71de130909db1ad31fa
ebola-18f56ac8f25a893e2686cbf23237997669df3827383438483c8fc93e6d2e35b7
ebola-eea9fe7a2b00f3c836c5c7d07a0b72c001b8848904bc2d6b791ababb66471743
ebola-62c52e2338d4617fc2f6cd6eb80a528d5a74c10515d497221c2b5737114ec8e2
ebola-fd682ac28e593758927e740e300651d8e3f15383817272a1eb0d03be636c5b21
ebola-1c6f06887dbc833f21625cee259d84ea1edfeb8ef5e74c5cc29ad9c9eefb9715
ebola-4577fe3bfc671a15641cbacced7a3becd094e16c19b6131c55b10c3ab781d877
ebola-7269fe5e451a73bd91ce0af1f30214d8294e58556525d2abced8ea2f59cd9270
ebola-cb503ee98043e09e5711e8d14b252cf21850939917d282a7d49311ae21e04482
ebola-30c21953977455401d5628bf313911470ff668d3aa1591a20cca7dccdd0a7dce
ebola-0296dfe530ae90f157038979a6e7230efd728b142a5c2ab8af157d0c6e2c7d7d
ebola-c5289bf213a627c2e398e65ea503f3414e264a01d3b73ee01486f0ffafc4542a
ebola-ab8ca70270adf5e47c753d8d1cd63e27695fdaf068b340d030139b45de490f2b
ebola-97ace35793b6303f76ff989719d7099d9661166bf485d7a6a83280a9762e2af9
ebola-8e16a80c114e78b56bc1d25992c7aa25ca34a1adff84c52f8ede6fc1e1e2089f
ebola-ba07be15f631b6c8ae6b0d42cbe3cbb244a46aea7df851189597a0a0becd068f
ebola-5d64aa3cc13a1ba562ff07143c9cf1e1b620838a46b671f64af17073b35dd95f
ebola-a1bbdcaf118f90905055696994e41a17fcb3203873c1cd4b284308bde66fdd98
ebola-164be4075902530f8648034fac9785158ddb753a1284a8c8b05e0ab101d116b6
ebola-6adb5d6057e902c94b05b865a1b000ab93d1fa8d85b599dd2a83c57538389698
ebola-66461b8a47800e091613cc8f5d1a8cc9c8b6bff4d7fec200d6ad7b9f059938cd
ebola-e9616420f49067de3c0691d9b27680be08aaee9e148da1bf213bb89d7eb99a13
ebola-fff5f05df081a13be0fe3220f6cd6e8c5f3aeccec3035ba4e0f69d6df92a9764
ebola-bd4b19ca26d45207794d38b00d8a5698a8973680e5bc12a12f06c6bbf61abaab
ebola-6b848c3491561e4847f9fbf9a46531a819d7db55a27746bb3fb37f68ddc904f6
ebola-88cf07bb51227255c6352f66884730ee6630b8bdc39e8db58126a9fe207113a6
ebola-08ea06f5c52f0fbd4fed6d260bf98f552bf0f979b42671764909ed6861a967bd
ebola-0c21f2070e99952774e37966022b51f38ad30f1e121b7e37c82faa0adba520ab
ebola-439325b73d844294a363aca72c1147399bd6f275a8baf199312ddf37f4234992
ebola-a5841fec276e21bda7c0f53273b51dc310741a6b65d121fc567f1de966ab949e
ebola-3e93941e57cf11901d833b4dbd3f716d5670c0ae893ff3214f3398575cdbf1a0
ebola-26b86f957b7eac8af2a61ca946276eb0084236652394010888cc527e7afaaa34
ebola-e861b9d1f2cd44f10824b0795489f2f5f8ff645542e0eb45323c61abcdd097c8
ebola-cb1928a8273e4126225e6d27a60417ec0e495099c41babc602d06f8525b9e96f
ebola-ab931a7fcbacf3b572401787bcf8dfb20fd0198080a0ed96647553bb547f2d19
ebola-3a7cfc7589ecc152457f7c2c3a6e8c4572f977997e0ecf70f8318184cfbcc10c
ebola-cb7ba871850298a0ef3840d0f2618b14d676e71a53ea6c7c337a79215232b259
ebola-d9fefd9970ca3674668b2ba0f9fec8ceee12e601e4662d0a752fcededc30f008
ebola-9b53fa75ee09b1cb1b0f4db268b6dfa87d2e8bf64fa5ae1b25c87de08449b4a6
ebola-6ddffed12bf62e63fb0883ed46db24a90cb6b606cc81a269ee05950a6d797d5e
ebola-575f254c24716f22364b327ca9d121c0a53edbb81da129a9ae32a3312eb4ddb0
ebola-0e3f97052922a8444a30e4853a6ef58608991fbc4b692ad1d536ff86fe1cc8db
ebola-07d90d6f05a0c90da5edf78b4a5b1f401433ce1eed00bbefd2c6bb17343a8a28
ebola-af0f1a905f0428b0b8a4f0d1f30d5e7e484686099c9a8933896c5736821ebe6e
ebola-8906b242a9dabdf9c44e41d93e12bfd549a0cba0d2955042a3cc3869c4e5c303
ebola-5b9899c13bbf84b6c7dffded95a644549acf6470460eac69ea3e05c7afc07bd5
ebola-a58d3695f2d9b442ee0e58c8300e8a6b9efa2452c56f173e9df5796673c2b67f
ebola-0b3e6303e4d56fb67bc14f68054e3e508b40aed22168ce7f2a48d8353ff9b06d
ebola-68c98b91f3194f081332d9133f6090e9f4fd835acdfdf6bde06519e4ec5a3147
ebola-97575f64201202f2429d22f43dfd51b406b84ae5622b072ca6dd6feb413b3242
ebola-c88142bc0181855d4e1bf4a97fb8f53e68b8b982588bf9815c9587fd35888ddd
ebola-35b5ae2eabb70bf83bda1ef48ac461f9d7673f5ff05e3ff0c5e7cd1585ad8fba
ebola-9d5204a2747412d197a0ca90cf5dfe693dd26cef833150da9d06715577af3e4a
ebola-9cd74a745b650965f20c945a1e8ec8c38e1b9da2a21d68191a374b294f88a191
ebola-4e13b8d01e9e91be3d348704a6be782fabea381a5a15862076c5785feba8e42d
ebola-3d5ff69dcdad23193d0a8b655c63a2e72eb153ce6f4c675770a0299fdf573c6e
ebola-e94aa6c4dbaa8c78206f917a3072c2aaf0987ad51c96f117c9d956b2101d703c
ebola-7fc49bbcc6d86fb9583b8bdc9c2f03185ab265036a8cc0980b75888511986c2f
ebola-512030c75ac80f961496f4643621847cb04f54502702a3e32a4f2ec4a6fd16d2
ebola-e954c619fb08507667227cda9622f9f049d5c51bf4e97397bf869c97df4cdccb
ebola-e0e89c3f24f120b39b81dfadcd46decafc54b8a7ec80f6655c6e02b28c22e866
ebola-738904b9d7288852fece10f84e89151c5ca0da52dab7889592f9ffb67fcbf611
ebola-603ee8700ea6c479e708c7c222be78da092812aed3b50bc11febf60d8e40292e
ebola-0555b19891e9e7891e56ad31c737eb4af608f7371502ee0fae532b76df5fa173
ebola-7282d19547fa94fac39ac2e968d47d08c8cf0c747927dc39e47a3c3e2fe11e56
ebola-761e008ae17942186b2b150535fd6fabaf32b7ff81e38dd051f702c5010fb8ed
ebola-60294b2a63766a9b48af09c1691d3a424d26cf8baa1435c408217c6a5b39e1d1
ebola-e378aaf9dae2764eacdbfe599484f0ac4d7c89460dfe9e1c3ca13bc6eccb82df
ebola-f62658f1f8db9df1e7f3327ade737727de3c747f0d32fc5888e32d8353c4384e
ebola-1eadb9c392e2fbd2966d24f5c81bc3766730f9d858c18043334e21e82b71c60b
ebola-7f509178be811d62219a354eb99109af8a1b92c595b7528e6456e8b193e1263c
ebola-08abc8d14486162df83c1c5f6add10e33580b9dab8c5d65f5cb534b6c9ad8ebf
ebola-137e1ee445d4ac9d0da2015635251b035333793e7a342bd8bcf00bbce8278f28
ebola-59562dfd95ccda0dc559fdd4dfe330fa76ef7c5309756d914c60e61701ffe043
ebola-a60e954f8c78d153ab3285142047f6575e9fe12c77001ee766b47a7f23274b88
ebola-0afd9ec7014973274e52f8bc2eea31421b05226135ef6d9bba02329c1ab080e7
ebola-b062a18026fcac187767e1a523b3c054c5f7281032e33bf3d360d5625837fa01
ebola-54621b94e62901ca7e0a52c0d4849922273a1e864568a27bccdfcb3c46bf9356
ebola-90aae038081126d042ea0bfe293b55be45a4ae0a91a60ee614655a1780f85ff4
ebola-7fd8dc3c06bee2818a840164b62424411469b4e059d7631532ef3d05d2e93230
ebola-9715ba2023a6b772371f62b14668ccdb46a388782e2842af416a258232b0a00c
ebola-a7059f80ad11e12a94fcc5c5b6076a6a63294f62c901e2c6aa6e5ca5571ff11a
ebola-3ac03a61b55dc9f0bbae8f3b59cecfba20c5c2825886839f04b78e8328141157
ebola-46f8a0115e45f3e8438561fe2bd22a9ed6053679033cab70532f6ca326470f73
ebola-acf7046df6bb2dccb50d5c199c4b27c0b6e950889242e132be8f18058973a13d
ebola-fc832b1ac354943bcff96092a0485916662faa92181e676893fadea51fcfe0a0
ebola-50d668483fc8b04d60c990b7bda8d522f35704efbcd911b7b30c40940df6763e
ebola-aceb495cb7d42b7548fcc81505d6c089542943bfbd7879096b0939b7ed6e83ef
ebola-f08d5806012e41df6da9155c8ee0fff0693ba433bf2b4e21bafd7fd70c10efc4
ebola-0ee467a4ca8b6b8843fd7cde86f0b4de236db0944fac85b4ce0c49fcf68b0509
ebola-0d1cb9fe40e8251bf26d8c2e21f31f4ed694349076eaec3d6666941968d3285b
ebola-d9323c9afb59b83d5c50c17c331660de357cd8139e5ea6660c72ec00b0d51736
ebola-079ea34fcf395966ee719f7eb5197eeea8071222601c7b748cfa3cd7cbb20fa4
ebola-a98dbd1b1b634de54897760d2dad406e62d7964fcc9d351405c6e1b8bb486711
ebola-ebd23f149e5c4f1b0d70f8d1ff8e15322980888d7008058d45b3eef92c138716
ebola-a6a8096b5e5d7ce95f33b181a0c6fe9c23366504f1f567780a0ced5d6135c9b5
ebola-87c0ace5e804e6728ae15ce699584b0488c54194a7b5ede49cbe1a4279770dd2
ebola-97760eb6d90479ad587c4f6b2b1266ad4785ce12b35f7e2011b8153a05222b53
ebola-0c95cdad7195154f4d6d97f01346b1bef1d7bfe803d859265c2432c1acbae030
ebola-c63f5064ad689142f05c642e2a41f6f3fd60dae421d2d7ac3c7bf3c6bdd7dceb
ebola-019772cf0c3144381bb27b83155296f64d0a2b3498e200331c259f78376c960e
ebola-c1b09c9b46b8a9bdf5b08fd0ed02de147094ce3dcbf82f1639146ce7016748de
ebola-007196c29e1f6afa0478759f3307793d6d2f335e48baa65d2fdb9fd1cd5e4e26
ebola-56ae37a08ef822a317e60ce94e76241e495dff639cd54f7da17e757875d3306b
ebola-ead02635d8d4624c5e85c57ebe754df8447f7941e1aba54d00d37cd10a025157
ebola-995d65322d7690ea66a190bec5dbbb70b23123309e262ac9fcc978623c7f9f6b
ebola-d3f614594c423bde74e0524e1f5d783f2fcb597053d0ccb8eca75184dffc4b48
ebola-17b3c34371053f984685fc3f01b3e498fc801c56ad18934feec19f136bb7078b
ebola-0772a3547d2f0be020e0bb7492fa34cd9fdac62b5d8f778ffd4c8ddfe8411e3e
ebola-e532d846ee27015fd6d8e83510fd4fd2655d27c699ecd88b91e5f7431998756f
ebola-24da49cd7f8ef6f4904155f7efe919b8d4508fd4f1eccc078f0f2f80efc8ece3
ebola-72d42dd8b54ae85ccbe2fe87b202e740d3000492b4e527d4c794b548701e138e
ebola-3f55bb82f8da14eb666a5fe1257a8188a4ee97a7b0aa10dc809155d2ef1e4851
ebola-8bcba43dfdf8865a65652638bac548a51bf1c79c0032b1d41a249de49cf9fdbe
ebola-53d93c415f2234c1898a8e551416ccad4b032020a9f5bc50b8fecd00898184e9
ebola-9f8786af06f82bb0e9746416090049584cd9ccf81c77f75ca563e9b5bd9e156a
ebola-5eff683c7d055e49ca9cc27ed40609296b7d2352b2f76a29a3dfd72004dc01b6
ebola-52e9fed65b33110a0755f2f6db3fc45159b94593f0bc6f259c1905876218dc32
ebola-000d4025ad6ab112aa369ae9ae9d5729b7c90b40716daf2f2b21fec80d3a4715
ebola-7cd0e4a41484c2c8fb051df8cd9fc97c569bc69946ff11682000a8bdc85bf14f
ebola-1a338cf7b9e4475737056b72c7e7954b81769d8ad3289cb38b1c4191a10e9f59
ebola-ee92ab4f529e6efc1bd24dce957b69b985b3138fea451aa8368c24aaa4669cf9
ebola-dbbe9a66d07294bf404c54fe7a5e6b09f735a08a146e023204ab4295e009d040
ebola-708b405aab5a5eb4b6109374dce653962f5a80a34c519d9f1bd3a7718566346b
ebola-adbc27f45404bfd9c00de865b5f3268c3e2818d65afdeb77b127fdebbdca2d56
ebola-5f5ee31b3de83877520cb46ffe63ba5bb1e1deefd68e460a9cc4750ea85c3257
ebola-de4f856065a7f92b8ccf046953b502816bb9f2d77ed970560011c16b5a0ffa77
ebola-3f6210d0863e754dd38096f338b03c820cca9b8a326bd1fe17b5479c0ccc893b
ebola-f16066d836a89ed78c665de329910248b693c940631eea9d9f0adcdffbd80244
ebola-77b887018a657bc57a93e794bab54497c3205aa49455e4d62df358259da9a43a
ebola-15363d94ff79a1fd583117ec93da56d7b19c82def2a6c5b347bfd6fe04770350
ebola-713b4283a8677e3e5e1e42aa4c574cb795fb10cb7cb0eeed293ee2dcbc985e5a
ebola-cbc5d125b6caaddd70c7221a42232f45792a561836c66e42e979e79027340d93
ebola-c5be69c93b3d20d8fa33d05c821fc8aa1646f10b42dd322f20b7ff80b7048240
ebola-b36caf6d76f0a183a00b99dbc481f897d87fdae21228e027832efc8f0bc9ee2e
ebola-a49864cc2d16b7ac6a794a9ee52f4622fe0b66eb64587bfc8b1d4457821bce8a
ebola-84a2d09072353b8dfaae75570661f37e8db7d9975f1d512f6aca47b892ee4d06
ebola-5804661d7167b3fcff8ee12ceaf2487ee3d978b01bbabc30b0efbb09e49f5ae4
ebola-9fe97fe6aa44de0b7092fa6584e73d669a1a816e103cc3b2d4041b4f9e816f87
ebola-e5c740b4e8f727bfbee44c732b6cfdd2509d1f73ab4c0e45d72591c9be701d43
ebola-37ef0dea729071a2c3f6663b32f76855e61814e0336aed560b77195efb3dcf7f
ebola-f6ac42dc7a2ffd9a95a90e9f0745a91a214d62eb68aa01e0ba6565de651cfbd3
ebola-467545eee0abe5ecc247aa77a48f823e34f4db50568809d0e32d046b5f21f35a
ebola-f8d25954b8219328bdfd5acc5411c33b504902b00e58b925c6787db430d94ce3
ebola-144a260ad2f0233593c09e0f735fb5b6ee504e54708436b1d44d9c2ea6f52884
ebola-118f11288a6bdbf23305b4e94628dfa50829aa61e660d14c72924bb9c6ca0896
ebola-b42e4e9f6757f90d00dce78d47a52c5043fdc61fa749393da87c1d4bee4236c1
ebola-16a8bb87464d38a50e1851dff9ab77c52df510aad9aebfc64d20a99d7afe23df
ebola-10eb767107af44c13faea5137544e290d9258a184dbcba834419c551d0eb0e06
ebola-924f4425bec124b3bbc1a28d3e05b88b45aa84f96ae3f7d6bc9e6a268dba00bc
ebola-459b9379351db4a54200e9270fa970b5bca304fbbd7747dd070f1302d1d0c03e
ebola-46dcc623b98c4581edbd174794e2205fa8d8dd7463d408f85bb570e42de85a54
ebola-735bf13d0de22aba9ca5e1408e55786b08c4e7d8bc6e55e74f8c66b6a14ea657
ebola-d04f1f26adf04ca744c28a9834608847458704ac478ab046176142ec9f5a299e
ebola-31879ed4171ec2e09a4d3383bda3c0887171f383395cd4f9256d5d7cc8fc418e
ebola-b3f767c56b822f0752f99c05cd623d60bd9c293b3bb1ed13ba88b87b8d082147
ebola-e6956858a359e43c1eac4d88ad7217c40e91ef2844016baacb026c0c6a617e39
ebola-7d837f82e09196a403520b852041f6ad7be5b4c8af53db1e1467aa9753e2fb33
ebola-c8083a1e7bdb768e717d974c461d5ebe73b2ef406bf5730530ca952d8fadd813
ebola-d7d8a70c4b7de2a3f5d77873ecc763b9cc77d28983a500eb46de529e86551051
ebola-a2c921012a8583f2a38936e1f12f9df88c1a3c46cdf4947ac05c13ca77878c34
ebola-bbc55e647c6f76611a020be873f8816f642ed466928175de7bb3fb9e370ce4a3
ebola-eda4dd0eb84416dc55f1756dc6ea84931931ed092b95d39ff6d2bbc4e231bd7a
ebola-750a7ba77e0d320fa14460211c622a8cdfca8e49e3c6f5fc1b185f7ce49a642c
ebola-3ce57df9e6a26e3ce1a653103c744f778d8c2f7ceeb639a145010601ce847f90
ebola-c1e2cfe86bc18cd9839363f63b24baac0621ed52ae1418e9516b92a6b4c1c5c5
ebola-7e6833068e365adf4e2398bdc08e735708534eedaa42a7c8585c48398c6f0016
ebola-6f4566c69445b758aad12e8fa8c92f5498cfe0793567921d595a68a422e74076
ebola-10160da9c8313304046d60c607aa7982ec79ee269efe8548eee6c7fcbfac9a2c
ebola-46286154616df10192066ba7a9d6bd07318e1a3f0205c4d915235e0537e5d87f
ebola-3a71ae9864915c2826d582460bd7458dcb9ff1804beb9928544a6b16466a899c
ebola-3ac83b348aeb225a5ff3a8360889ee8a6695e534184fd71940193827db0e777c
ebola-7b2b09e7c81633a84a1dd626e84a1da8cdbeadbfb16707e4e0e6d3be5775071e
ebola-9e5c53cf3e8c6202d0e5b15d6497348153875dbf5d8c4eeafdddeabab6bf92d3
ebola-c3637fec59a8ba6b305e7fe46a8ca81eb51566951e7b20652566d6d19b657928
ebola-b1cbd7bf92e1d3f506c86f4630252762f904f2e98a6d6706cd59a7be0fbba9ce
ebola-ffbfaa2b86cf310889226d9db2ad6d2c697a44d2dbab17e35542a71fe99ee7c8
ebola-684803fa6295ccb5031139b0bc7b6132d00a8e9ed9cbe55bc75cd9ddb9e014fe
ebola-97b49f80678ca844929993ac2a5953a73fced5a19eaaeb08e52566d072c3e568
ebola-0343423688635a6fc6b0b30b1fe3663bb3039559442cb7705a7e7f2989140f63
ebola-ba14c70085314010cfeebb52bb9fa66f5817a6e39184f5ec0deab7df78296d3b
ebola-d4a365b1a5fd1e8b93de8026427148c0746a9976d544ea6f0afd941ab6fe6283
ebola-39590251930f1d7758f6a5ae79d92dd110cb5a899c1376f57e2ea6757e5b3599
ebola-567e781a19ee665d71877927bd5c2588b73247aa8d2eede0eda19e2f16ff7455
ebola-a08b8dfd8effcc4ac02ee166b481d61db6edcc1310a0ca0080708db7b1a0e186
ebola-1779c93736c956b31e609dcb01dc269d22393d125a23e6093fdd40bd359b15b9
ebola-573fff947ea3ef70eaa605aa60475f21ca4d727854cebbbf4afb6b51cadcb4de
ebola-f489c680c64d29901d61a0777db875080c76b6f41f0894180399ee8f34a28dc8
ebola-ff2c956bb9a38ac042a81bd9e423b4c439c9521f613eafb041ddc0e03ea0dde4
ebola-a47a52eb28795b7bf8558c23c4b607e022db54f535528230fabbc82c13a0fe52
ebola-cf087bcde390b19289f815aa2a6eedd0f846db0dec4333732af3ec09eef5b94d
ebola-834a8eb78f8c2b218e9c3151cbf2d48fe4f62af16c6a3d501b57f8c5a0d75d24
ebola-0e6d2c777d5c8d8c95a85c3cbc82aa01ac7c0d4cb4db7eff7000876e304087d6
ebola-df05015e31fd446020864ecaa3ae58ad954c2767f28d9c43784a0649e8c93367
ebola-26af01d91dfb58d17f6699a59d34062efd4583867e18632b661b9aadf19e0c93
ebola-7e6798f49e76dd1abda68ecce2b0bf96321c2c01c2db317c871fc25125c3dae5
ebola-c0172ffefa2cb5e19962b0055243d0881920eb99915e0eec403d66bde61c053e
ebola-437a28422daeb80b29e95af70e1fcbc101e014572f913acc6c3aa4c5eb18e414
ebola-b711ac125d884fbc8b5d6e5dcd687dd6c3e6abda5465d09e39bd4a8044cd8261
ebola-f6c62ab1ebe6096004b8ff87baa5269f38466fac9f8dd8240dab18b861a67090
ebola-f99d2c3064a4b2a0a7add345608282605d1a62688ee43ba522506aa2f1b7c032
ebola-8fa2dd4a4e2aec96d9f65b544174ad62c7692eb47b96889c7abf6f881a52d594
ebola-3055ec45e42689705adaeabd6a0b86a1e966b5063f9cc3b155694c12c01c921d
ebola-b0cdb47200ee7bb1c0a8baf5e0a17ff8871d0620672de29bf3e9d2d93850e925
ebola-6a18a2cea3afeb30678c6cb4844d022622d7daf0b651cf720b8cd375a05e2bbe
ebola-cb2c71505099a4b7230cf856300fc7e5449e68fd69302f23cfdf076a318cc906
ebola-ce9212e5faa668ce43fb37e0e2b2932cd12044afd702e7fd7593dbf3c7c5b918
ebola-ea5ae29af51d94a135517d743d9fcd168bb556b85ba3b60385354fa18d14e032
ebola-36d6190e48428821c9c60e0b7da523ceeee6a5cf35ca7438e332986804ef786b
ebola-9707678e2492660941dd97ad093b7990b83bc645914bfcf6e479645e1de47f1a
ebola-08a05a7e7ffee0588db03cac8877c1ae77c77f75d3d6b71fffd6fbbf8a411098
ebola-20242599df7d60f2c760b43366011a6c937308912abc4f63fdf1cfecfe561ef1
ebola-5ead8888f4444b00cecd2f146d92f064c51daba0283838a6eb97f21b07210d4c
ebola-cbc28a4296324b491ea2cc036c129c745f0810cfc41c2349bd0e99b70c9b1a2a
ebola-ae53c29dfddecac5282e36774dd29a13dc5b3bc74e3c86b3416cfd93bd12ce90
ebola-1e72822d66169ce656ad6a1cb3218eaee9fe42f5df370ccd9800afbb147377ba
ebola-5d2f5d65d10f37c5761145ce94f7cf0b1875d7ce26c235762832687f195eacae
ebola-420de77ba1d223be6f5d19deed51da50db707f51cf92e6fb97d2a6ddfd79d04d
ebola-5f5b616510dab6599f54a3e1d22965adae1cd34eb08320425cd0630f4b9df0bd
ebola-8ba96de0fc580c0a2b7356c7e93024c254efb19962d67e9e3e804daafc9ada17
ebola-188da1ad643c4d486795a0a24f5a9cb69c9dcb4a992effed3e731270eb56f176
ebola-667ecc685649eb500586abf7acf7c91651865d88107d2d340a4c19d3228cea3f
ebola-4bf15d525d171e9a35c0116ab29c4af25a53bef830d6ee85171fb148b4d34b58
ebola-9c2fd6b207f8286d8a992bcef642e504dfb65ed108989c8364f7899cbc5c0e98
ebola-2b405a36529a30e22920251e3f650c36e36dcfb7b5d359b1b79a3401446eeab3
ebola-5c82f99e2fdc97466b3b012b8e4d00d4b01f7048588202f9339c3a93c5cc77de
ebola-42b053903970be692423a0825936fb252753c369f93dd22215e5f09e0ee8c630
ebola-fda2d8bd09c35f7c2bf6bf839bd3d1ce9de4278cbb021eb998ddbc3b07dc4bfd
ebola-728c1455fbe26a4f7dadcf95d07019d74c46765b87f2f6099073a91cc74081fd
ebola-fc289aa384b5e82a88eb49217b486c0fac65dd9f0aa8c598b3587606814c5171
ebola-c3597c6954e0cb9b44b8a1047423a8ca9d535a2d23e472999767e6f615e79225
ebola-8cdfe061d5c71525985a8e4380f4d292a88f1a91a0e1ad1c0f081979c03efdcc
ebola-eeaf2383a764b9e5c0dab619ea0f5537e587cb3416343e1e91e5fa0fd6daaecf
ebola-1d1f93f32b015b2fdabb585436b4865e79d8dbd456f33e0d5641d9f3d6024c42
ebola-7368019e15a7905dc94b57caddefa5be3d63aefd9b2a64d47fefc41934726506
ebola-cd2c66bfe4fe2f055df3ffea4184c9781b906b132bd20b49db86f949e09797ea
ebola-7f781cafc7ad600dde5d798f1a0f915a04d5718a5ab61a5dc16ae8cdce2c0bf6

list/click  |  time: 2016-04-22 16:08:33 498188  |  # of fields: 4  |  topic_id: 397  |  docno: ebola-6c1711af8abb7218aaafb86b496cb6a68c45391a521b0eee3bb218f73d5d3d87  |  listsource: pink_findmore

passage/create  |  time: 2016-04-22 16:09:05 094956  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 196  |  subtopic_name: provider impacts  |  passage_id: 4966  |  passage_name:  If an Ebola pandemic hits American soil, the need for increased testing to detect the virus and the high cost to treat people who are infected could hit insurers hard.   Treating people with Ebola is very expensive; the costs for treating Thomas Eric Duncan, who was hospitalized and died from Ebola, are estimated around $1,000 an hour, amounting to almost $500,000 total, as FierceHealthFinance previously reported. However, Duncan was uninsured.  But the Insurance Information Institute, which released a fact sheet on Ebola's impact on the insurance industry, says the "cost of caring for Ebola cases would likely be at the high end of health insurance claims."  Health insurers could be dramatically affected if a large number of people are infected with Ebola. "Many people would need to be tested to see whether they have contracted the virus, and the cost of isolation of those affected could be substantial," it says.  Although it's unknown how many people in the United States could contract Ebola, the World Health Organization projects Ebola will infect 20,000 people in November, and the Centers for Disease Control and Prevention warned it could infect up to 1.4 million by January, FierceHealthcare previously reported.  To learn more: - 

passage/grade  |  time: 2016-04-22 16:09:07 014765  |  # of fields: 2  |  passage_id: 4966  |  score: 2

passage/create  |  time: 2016-04-22 16:09:10 134762  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 194  |  subtopic_name: healthcare insurance  |  passage_id: 4967  |  passage_name:  If an Ebola pandemic hits American soil, the need for increased testing to detect the virus and the high cost to treat people who are infected could hit insurers hard.   Treating people with Ebola is very expensive; the costs for treating Thomas Eric Duncan, who was hospitalized and died from Ebola, are estimated around $1,000 an hour, amounting to almost $500,000 total, as FierceHealthFinance previously reported. However, Duncan was uninsured.  But the Insurance Information Institute, which released a fact sheet on Ebola's impact on the insurance industry, says the "cost of caring for Ebola cases would likely be at the high end of health insurance claims."  Health insurers could be dramatically affected if a large number of people are infected with Ebola. "Many people would need to be tested to see whether they have contracted the virus, and the cost of isolation of those affected could be substantial," it says.  Although it's unknown how many people in the United States could contract Ebola, the World Health Organization projects Ebola will infect 20,000 people in November, and the Centers for Disease Control and Prevention warned it could infect up to 1.4 million by January, FierceHealthcare previously reported.  To learn more: - 

passage/grade  |  time: 2016-04-22 16:09:12 349590  |  # of fields: 2  |  passage_id: 4967  |  score: 2

doc/next  |  time: 2016-04-22 16:09:15 685607  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6c1711af8abb7218aaafb86b496cb6a68c45391a521b0eee3bb218f73d5d3d87

passage/create  |  time: 2016-04-22 16:24:16 462233  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 4968  |  passage_name:  Treating people with Ebola is very expensive; the costs for treating Thomas Eric Duncan, who was hospitalized and died from Ebola, are estimated around $1,000 an hour, amounting to almost $500,000 total, as FierceHealthFinance previously reported. However, Duncan was uninsured.  But the Insurance Information Institute, which released a fact sheet on Ebola's impact on the insurance industry, says the "cost of caring for Ebola cases would likely be at the high end of health insurance claims."  Health insurers could be dramatically affected if a large number of people are infected with Ebola. "Many people would need to be tested to see whether they have contracted the virus, and the cost of isolation of those affected could be substantial," it says.  Although it's unknown how many people in the United States could contract Ebola, the World Health Organization projects Ebola will infect 20,000 people in November, and the Centers for Disease Control and Prevention warned it could infect up to 1.4 million by January, FierceHealthcare previously reported.  

passage/grade  |  time: 2016-04-22 16:24:19 722040  |  # of fields: 2  |  passage_id: 4968  |  score: 2

doc/next  |  time: 2016-04-22 16:24:23 373301  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-30756ad762525195a488111a0137d3aece920d0049445db27626f5ce5d205093

doc/irrelevant  |  time: 2016-04-22 16:34:05 921379  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-410e085cc50ccd3dbe80b857c5e5992bc6bc5d57b64c84290d33c3e0d7e4229c

passage/create  |  time: 2016-04-22 16:34:33 916278  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 194  |  subtopic_name: healthcare insurance  |  passage_id: 4969  |  passage_name:  Along with all the concerns regarding the ongoing Ebola epidemic, here's one many people probably haven't considered: What about health care and life insurance costs if the disease were to become widespread in the U.S.?  Some estimates put the costs of treating Thomas Eric Duncan, the uninsured Liberian national who was hospitalized in Dallas for Ebola and who died there earlier this month, around $1,000 an hour, or close to $500,000 overall.  

passage/grade  |  time: 2016-04-22 16:34:36 698918  |  # of fields: 2  |  passage_id: 4969  |  score: 2

passage/create  |  time: 2016-04-22 16:34:47 296393  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 4970  |  passage_name:  Along with all the concerns regarding the ongoing Ebola epidemic, here's one many people probably haven't considered: What about health care and life insurance costs if the disease were to become widespread in the U.S.?  Some estimates put the costs of treating Thomas Eric Duncan, the uninsured Liberian national who was hospitalized in Dallas for Ebola and who died there earlier this month, around $1,000 an hour, or close to $500,000 overall.  

passage/grade  |  time: 2016-04-22 16:34:49 844446  |  # of fields: 2  |  passage_id: 4970  |  score: 2

doc/next  |  time: 2016-04-22 16:34:56 004822  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-8251f3862514258b31880087c1bf4061f6f398fbb3f2cc55ad24649adf1da25a

doc/irrelevant  |  time: 2016-04-22 16:35:38 648814  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-e67f565bf94396f441997c013c29fe2360fac1e88a546b776ac102bcfd263f37

doc/irrelevant  |  time: 2016-04-22 16:35:51 041120  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6483a13de65757c68d3f4f45c0442507c88fc201a6c31dd618899330e345639d

doc/irrelevant  |  time: 2016-04-22 16:42:26 410120  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-23df89a3b16ffe0a68679ee2b82548922f57799f52475ec3e9dd005f76c3b83f

doc/irrelevant  |  time: 2016-04-22 16:48:29 248812  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-095810736223ea24f448c6af571bc27a4f890d666aa0e1984083ea771428a866

doc/irrelevant  |  time: 2016-04-22 16:48:46 801486  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-db995753f45cfe398894a738d3f8493d60b7a1ba31a7527039f795a5599ea514

doc/irrelevant  |  time: 2016-04-22 16:49:06 476013  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6a152866da9b5024209ed33bc529564a1507c64af356f26bddc9ecb92b923aef

doc/irrelevant  |  time: 2016-04-22 16:49:20 398717  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c9f6e0a9ab84e43cec1a3cc0ea93de9eb00323f9f2c07d349e8cec0dd481cffb

doc/irrelevant  |  time: 2016-04-22 16:49:42 000963  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-613d444e54c838cfbe10f7c0e3688974f45b48bba65d78669c9038dd1eca5325

doc/irrelevant  |  time: 2016-04-22 16:49:54 929738  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-e41ef172793bf1969c02bd548a28821f6d2ab9373bf6d4a490b29a302e6d71e3

doc/duplicate  |  time: 2016-04-22 16:50:04 441217  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-f6dad867f965846d85c4c571c7eae0953275c5362cf8cf4fe5440e37c1b9d70b

doc/irrelevant  |  time: 2016-04-22 16:50:18 061006  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-ce198b39c866eb7fcf7b9dabaa15a64efbce836eb2514878f705cb81b7788433

doc/irrelevant  |  time: 2016-04-22 16:50:35 161064  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c5f3a76ebffce2edd378367a4bb0349497b629f7ae7d002458b5926dff8fcee0

doc/irrelevant  |  time: 2016-04-22 16:50:50 880435  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6d7395466b6cedf29877b75a90edbe3feeb35dbc3dc962447afee80a2f8ea1c3

doc/irrelevant  |  time: 2016-04-22 16:51:01 736681  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-a373548060857318d7f1a93a9bd768db8d762d974f43713fcdffeb62e36a000a

passage/create  |  time: 2016-04-22 16:51:40 320349  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 194  |  subtopic_name: healthcare insurance  |  passage_id: 4971  |  passage_name:  Effect on the Life and Health Insurance Industries  The effects on the Life and Health insurance industries will clearly depend on whether the infected people are insured. Some of those who have died up to now were children and almost certainly did not have life insurance. Even if the Ebola virus spreads to infect tens or even hundreds of thousands of adults in Africa, it is not likely to trigger many life insurance or health insurance claims there. Life insurance coverage in the three most affected countriesâGuinea, Liberia and Sierra Leoneâis extremely low. Indeed, in Swiss Reâs most recent report on life premiums per capita (for 2013), the calculation for all three of these countries is so small that none makes the list. Even in the unlikely event that the Ebola virus spreads to infect tens of thousands of adults in the United States, the financial impact will likely be quite manageable. This is because perhaps one-third of adults in the U.S. have life insurance only through their employment, and the amount is typically equal to one yearâs income. Another one-third have individual life insurance, with the average death benefit in the $200,000 range. In a typical year life insurers pay about 2 million death claims, so another 100,000 would be only 5 percent more than typical. Moreover, most life insurers are well capitalized, and even the largest life insurers have reinsurance to prevent a surge in death claims from imperiling their solvency, so that the net effect would likely be, at most, a reduction in the profit they would otherwise record. The cost of caring for Ebola cases would likely be at the high end of health insurance claims, and the effect on health insurers would depend on the number of people suspected of being infected. Many people would need to be tested to see whether they have contracted the virus, and the cost of isolation of those affected could be substantial. Note that some individuals may have no health insurance, as was the case with the index (first) patient who died of Ebola at a Dallas hospital on October 8. In such cases, treatment costs will likely be borne outside the private health insurance system. 

passage/grade  |  time: 2016-04-22 16:51:42 543483  |  # of fields: 2  |  passage_id: 4971  |  score: 2

doc/next  |  time: 2016-04-22 16:51:50 928548  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-34a6569ccbbe792ffee42bab987f51075e40528ae0f7dbb27dc3f91c89d00885

passage/create  |  time: 2016-04-22 16:52:23 645292  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 194  |  subtopic_name: healthcare insurance  |  passage_id: 4972  |  passage_name:  Kaiser Health Policy News Index: Special Focus On Ebola  Oct 16, 2014	|	Liz Hamel, Jamie Firth, and Mollyann Brodie  With the Ebola outbreak in West Africa and individual cases in the U.S. and Europe making international headlines, the latest Kaiser Health Policy News Index examines Americansâ attention to the Ebola crisis, awareness of key facts about the disease, and views of the U.S. role in addressing Ebola in Africa and at home. Fielded October 8-14, during which time a nurse in Dallas became the second patient diagnosed with Ebola in the U.S.1, the survey finds that Ebola tops the list of news stories followed by the public this month, with U.S. airstrikes against Islamic militants the only other story garnering similar levels of attention. While the vast majority of the public knows the basics of how the virus is transmitted – Â through direct contact with the bodily fluids of someone who is sick with Ebola – fewer are aware that a person with Ebola must be showing symptoms in order to be contagious. Nearly two-thirds say they are at least somewhat worried the U.S. will see a large number of Ebola cases, and about four in ten are worried that they or a family member will contract the disease. Still, a majority believes the most likely scenario is that Ebola will be contained to a small number of cases in the U.S., and most trust their local, state, and federal health authorities to prevent Ebolaâs spread. Most Americans â including majorities of Republicans, Democrats, and Independents â think the U.S. should play a major role in addressing the Ebola outbreak in Africa. Majorities support the U.S. providing financial aid, medical supplies and personnel, and fewer but still a majority support sending troops and military personnel to fight Ebola in Africa, with the publicâs top two reasons for providing such support being to protect the health of Americans and to save lives in the African countries affected. The public is divided about whether the U.S. government is doing enough to fight Ebola abroad and at home.  Attention To News  News coverage of Ebola in Africa and the U.S. topped the list of closely-followed news stories this month. Seven in ten (69 percent) say they followed news about the diagnosis of the first Ebola case in the U.S. âveryâ or âfairlyâ closely, and nearly as many report closely following the Ebola outbreak in West Africa (63 percent, similar to 62 percent last month). Close attention is somewhat heightened on the home front, with a larger share saying they followed the first U.S. Ebola case âveryâ closely (32 percent) compared with the outbreak in West Africa (24 percent).  

passage/grade  |  time: 2016-04-22 16:52:27 390542  |  # of fields: 2  |  passage_id: 4972  |  score: 2

doc/next  |  time: 2016-04-22 16:52:31 202995  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-22a9ce04dfcb83b81460d5f20e066374bb0435d03c8bdc2849b0b5c9d67ddc06

doc/irrelevant  |  time: 2016-04-22 16:52:50 697664  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-b52226305bbfc8f1bdcd1c123d9ac6dd1124cb072ab4451dbde7f1df7f1a6a7b

logout  |  time: 2016-04-22 16:52:55 162108

login  |  time: 2016-04-23 13:44:19 110026

doc/irrelevant  |  time: 2016-04-23 13:45:12 167656  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-18c30a5f74fd6c54831b8c3048ca5f697c040a9379c256547d3a731b049e79e1

doc/irrelevant  |  time: 2016-04-23 13:45:42 202366  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-0e9008b26e49f6970bc5d7040a6a1025f2ad513100fbab2d199bd38832f4b111

doc/irrelevant  |  time: 2016-04-23 13:49:45 705358  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-a96a6ab441851176acc283dd4303342e429b958bdc370f7b22afdea5fa947c22

highlight  |  time: 2016-04-23 13:50  |  # of fields: 3  |  topic_id: 397  |  docno: ebola-bcb3dc7cd770fde9b74f5bb8006820749cb296c472bb1f9c4b6ad328d3e5a684  |  highlight_string: provider impacts, ebola, insurance, pays

doc/irrelevant  |  time: 2016-04-23 13:51:35 479371  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-bcb3dc7cd770fde9b74f5bb8006820749cb296c472bb1f9c4b6ad328d3e5a684

doc/irrelevant  |  time: 2016-04-23 13:51:54 343333  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c27f5a84427839f29d3858b077f72653c2c8c90de9cbd94aacc1357db57fac5e

doc/irrelevant  |  time: 2016-04-23 13:53:55 970562  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-bfda3c5b8b82e4abe49ea1cbe922a204ae35df567169f3433dd4a467f878e369

doc/irrelevant  |  time: 2016-04-23 14:00:12 617136  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6f3071b68bd6aa9f55e5d7d0ae963374b8d6c2c09e508fe7f773fd7821f45076

doc/irrelevant  |  time: 2016-04-23 14:10:48 851063  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-94244e9b0749f920ebfccf8f72db0dec1ff3d831195d801dae810bc0457196f2

doc/irrelevant  |  time: 2016-04-23 14:24:17 366596  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-864d9825a93b40a44fd5d136f8cfb63f5b84812559ffec6d30746a150549c484

passage/create  |  time: 2016-04-23 14:27:08 378219  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 4973  |  passage_name:  Texas Health Presbyterian Hospital may have spent as much as $1,000 an hour in its futile attempt to treat Ebola patient Thomas Eric Duncan, Bloomberg News has reported. Duncan died last week after 11 days of treatment. The costs not only are linked to the intensive care Duncan required, but also the fact that he was also kept under strict isolation--a protocol that disrupted other hospital operations. Altogether, the cost of treating Duncan may have exceeded $500,000, not a penny of which is likely to be recouped because the Liberian national lacked health insurance. Article  Filed Under

passage/grade  |  time: 2016-04-23 14:27:11 906509  |  # of fields: 2  |  passage_id: 4973  |  score: 2

doc/next  |  time: 2016-04-23 14:27:15 074526  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-b68e9ee9d6037be85daaf918da28b01ec999c8bca557518c276d3c8a9dfef4c8

doc/irrelevant  |  time: 2016-04-23 14:30:29 961455  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-a7194923bdccc67c63787929db0e441877b6d82d84d9f3e458ae3759dfc8ee07

doc/irrelevant  |  time: 2016-04-23 14:40:45 046039  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-cc32a8689758ca929a12a4405e920e005eaefbc16da1d5f11aa69adc0d1fd43b

doc/irrelevant  |  time: 2016-04-23 14:40:58 219494  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-da548f8b5c8dc9e3213fced4f9c69c2d0197ee107d05e71de130909db1ad31fa

doc/irrelevant  |  time: 2016-04-23 14:41:13 007175  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-18f56ac8f25a893e2686cbf23237997669df3827383438483c8fc93e6d2e35b7

doc/irrelevant  |  time: 2016-04-23 14:41:31 584349  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-eea9fe7a2b00f3c836c5c7d07a0b72c001b8848904bc2d6b791ababb66471743

doc/duplicate  |  time: 2016-04-23 14:41:44 936112  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-62c52e2338d4617fc2f6cd6eb80a528d5a74c10515d497221c2b5737114ec8e2

doc/irrelevant  |  time: 2016-04-23 14:47:18 794145  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-fd682ac28e593758927e740e300651d8e3f15383817272a1eb0d03be636c5b21

doc/irrelevant  |  time: 2016-04-23 14:47:28 040087  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1c6f06887dbc833f21625cee259d84ea1edfeb8ef5e74c5cc29ad9c9eefb9715

doc/irrelevant  |  time: 2016-04-23 14:47:38 299678  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-4577fe3bfc671a15641cbacced7a3becd094e16c19b6131c55b10c3ab781d877

doc/irrelevant  |  time: 2016-04-23 14:47:48 977294  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-7269fe5e451a73bd91ce0af1f30214d8294e58556525d2abced8ea2f59cd9270

doc/irrelevant  |  time: 2016-04-23 14:48:01 611045  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-cb503ee98043e09e5711e8d14b252cf21850939917d282a7d49311ae21e04482

doc/irrelevant  |  time: 2016-04-23 14:48:11 389375  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-30c21953977455401d5628bf313911470ff668d3aa1591a20cca7dccdd0a7dce

doc/irrelevant  |  time: 2016-04-23 14:48:22 813146  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-0296dfe530ae90f157038979a6e7230efd728b142a5c2ab8af157d0c6e2c7d7d

passage/create  |  time: 2016-04-23 14:48:54 746473  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 4974  |  passage_name:  An ambulance transports Texas Health Presbyterian Hospital nurse Nina Pham on Oct. 16 in Frederick, Md.  Nina Pham, a Dallas nurse who contracted Ebola while caring for the first person in the U.S. to have the virus, is now Ebola-free. Getting a clean bill of health took 13 days in the hospital and an estimated $110,000.  Daily hospital care for Ebola can easily reach $8,500 per day, according to Lockton, a global insurance company in Kansas City, Mo.â$6,000 a day in an intensive care unit, plus $2,500 per day for additional costs, such as physician fees and aggressive support therapy. Costs may even be higher than that, says Eric Justin, Locktonâs chief medical officer, if there are other health complications. That was the case with the U.S.âs first Ebola patient, Thomas Eric Duncan, who was also on dialysis.  Based on a two-week confinement, Lockton estimates that the minimum expense for an intensive care unit alone at any hospital would reach $100,000. Experimental medication expenses or care in a specialized biocontainment facility could easily push costs to $500,000 or more. That doesnât account for potential complications like loss of hearing or vision, bringing disability or long-term health care costs into play.  So who would pay? For now, standard health insurance policies would respond, although itâs unclear exactly how much care they may pay for, says Logan Payne of Locktonâs international practice. Most health-care policies, for example, wouldnât cover experimental treatments, but Justin says patients canât be charged for such drugs as ZMapp, which has been given to several Ebola victims, until after the FDA approves them. Thus, âfor an indeterminate period of time when those experimental drugs are used,â there likely wonât be a cost for the medication, he adds.  Depending on how a person contracted the virus, Payne says workers compensation could cover medical costs. Insurance carriers would have to determine if the exposure to the virus happened while the individual was in the scope of her work. Health-care workers, therefore, would most likely be covered. Aid worker and nurse Nancy Writebol, who got Ebola while she was working in Liberia as part of missionary group SIM, is covered by SIMâs health and workersâ comp plans; SIM plans to pay her $25,000 deductible, according to a SIM executive. NBC and Vice Media are helping pay freelance cameraman Ashoka Mukpoâs medical bills because he contracted Ebola in Liberia while working for the media outlets.  Some insurance companies have already addressed Ebola insurance concerns in recent days. On Allianz Worldwide Careâs (ALV:GR) website, the insurer released a fact sheet that says, âPlease note that all Allianz Worldwide Care policyholders are fully covered for all investigations into, and treatment of, Ebola infection.â And on Cignaâs (CI) website, the company states, âStandard evacuation benefits and procedures (as stated in your plan documents) apply to requests for evacuations of Ebola patients.â  

passage/grade  |  time: 2016-04-23 14:48:57 711812  |  # of fields: 2  |  passage_id: 4974  |  score: 2

doc/next  |  time: 2016-04-23 14:48:59 996069  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c5289bf213a627c2e398e65ea503f3414e264a01d3b73ee01486f0ffafc4542a

doc/irrelevant  |  time: 2016-04-23 14:49:11 543303  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-ab8ca70270adf5e47c753d8d1cd63e27695fdaf068b340d030139b45de490f2b

doc/irrelevant  |  time: 2016-04-23 14:49:26 779480  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-97ace35793b6303f76ff989719d7099d9661166bf485d7a6a83280a9762e2af9

doc/irrelevant  |  time: 2016-04-23 14:49:43 098477  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-8e16a80c114e78b56bc1d25992c7aa25ca34a1adff84c52f8ede6fc1e1e2089f

doc/irrelevant  |  time: 2016-04-23 14:49:51 675055  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-ba07be15f631b6c8ae6b0d42cbe3cbb244a46aea7df851189597a0a0becd068f

doc/irrelevant  |  time: 2016-04-23 14:49:59 987808  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-5d64aa3cc13a1ba562ff07143c9cf1e1b620838a46b671f64af17073b35dd95f

passage/create  |  time: 2016-04-23 14:50:28 671166  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 4975  |  passage_name:  The arrival of Ebola in the United States this year led to an unprecedented medical response involving experimental drugs, round-the-clock care, and layers upon layers of protective gear. And none of it has been cheap.  Nine people have been treated for the virus in the U.S. since August. Seven recovered. The National Institutes of Health Clinical Center, which treated one of them, estimates treatment for patients diagnosed with Ebola costs $50,000 a day. Officials at the University of Nebraska Medical Center, which cared for two patients, put the daily cost at $30,000, and the total at $1.16 million for a single patient. Most patients have been hospitalized for more than two weeks.  The U.S. has shown it can beat Ebola. But who will pay for the expensive care it takes to do it?  It's a tough question, and one that the people holding the bills seem reluctant to answer. Hospitals that have treated patients in Georgia, Nebraska, New York, and Texas did not respond to requests for comment, nor did the governors' offices of these states. NIH was forthcoming about cost of care, but the feds pick up the tab for treatment there.  The topic of payment came up during a Senate Appropriations Committee hearing earlier this month but only briefly. The Obama administration had requested $6.18 billion in emergency funding for Ebola response efforts in the U.S. Missing from the request, said Sen. Mike Johanns, was funding that would cover treatment of patients with Ebola on American soil. The federal government should cover the University of Nebraska Medical Center's costs, he said, because it had asked the medical facility to take in patients.  "We were glad to do it," said the Republican lawmaker from Nebraska. "But it seems at this point some assistance in terms of reimbursement would be appropriate, because treating an Ebola patient is worlds different than treating Mike Johanns who walks in with a severe case of the flu."  Health and Human Services Secretary Sylvia Mathews Burwell said that conversations about payment have so far remained between hospitals and private insurers. "To date, it has not been an issue that has come to us," she said. "If this is something that [Congress] wants to discuss as part of this funding, we're happy to entertain that."  Sen. Barbara Mikulski, D-Md., the Senate Appropriations Committee chair, agreed with Johanns about exploring federal reimbursement options. "It is costly," she said at the hearing, referring to Ebola treatments. But neither the committee nor the panelists had a real solution. "Let's talk about this. Let's keep working on it."  Some hospitals, faced with these costs, are tentatively looking to the feds to foot the bill. New York City health officials said earlier this month that Bellevue Hospital's treatment of one patient with Ebola was expected to be so expensive that they would seek federal funding to help pay the bills. Emory University Hospital in Atlanta, which treated four patients, has asked Congress to approve funding for full reimbursement for Ebola cases. One case, they said, can cost up to $1 million.  "Caring for patients with Ebola virus disease effectively and safely is enormously resource-consuming, far above and beyond usual care," the hospital wrote in a letter to the Senate Appropriations Committee on Nov. 7. Emory officials said payment should be a collaborative effort, using both federal and private sources.  At the time of this writing, there are no reported cases of Ebola in the U.S. But federal health officials have said that as long as the Ebola outbreak in West Africa—which has infected more than 15,300 people and killed 5,459 of them—rages on, there could be more patients. And those patients most likely won't be able to cover hundreds of thousands of dollars in medical bills on their own.  More from

findmore/blue  |  time: 2016-04-23 14:51:00 816130  |  # of fields: 3  |  topic_id: 397  |  subtopic_id: 193  |  subtopic_name: Who pays for healthcare

result_size: 0  |  num_tagged:  0

findmore/blue  |  time: 2016-04-23 14:51:15 480250  |  # of fields: 3  |  topic_id: 397  |  subtopic_id: 194  |  subtopic_name: healthcare insurance

result_size: 0  |  num_tagged:  0

findmore/pink  |  time: 2016-04-23 14:51:23 971129  |  # of fields: 3  |  topic_id: 397  |  subtopic_id: 193  |  subtopic_name: Who pays for healthcare

result_size: 286  |  num_tagged:  0
ebola-735bf13d0de22aba9ca5e1408e55786b08c4e7d8bc6e55e74f8c66b6a14ea657
ebola-d900eef0e972737c731a1f72ab6d975c532667543afd66c9f65f01be65d6fcea
ebola-190a9b8ddecaaba9f73c58be72e617a7ea98eea66005b2b80edcea64f1586c16
ebola-0872d854b6fd4c07ada25dd35096778257469c7ec6d2da1e8203bd9a033d9615
ebola-86da5d9c45f6e15c0afdb652498dfd1fe60d3ff2d29f1eab579d6a92d631831b
ebola-e40fb24d9d13c95850a7f96d75c1ac2ba9d461eaa3168b3a4d10a34ce1fa413e
ebola-8e822df2f2f2fc922ed5804fb6bdb36369a367f3820fceed50869c33c07b3fce
ebola-da2f0ee25572be431b8da81d2d369465e00d1e41418912f3c4e9a700e4d4d3c7
ebola-ead97a4db95901eb2f6f7486e74a3df5aa6108a556f9686442958d3ab5f874e8
ebola-cde40f6642c76305a98ce45eca243f5013773274a7c1819eab4ed3f473bc57b4
ebola-cb0d0db0ea3a491007a52655a638e6098aff666c97b30c8e3c463d4c5b077d09
ebola-21c1155bf784afeb2eb25e67a3170a85343eb5f6ac64de493a614bbef4375775
ebola-dfa937f1671dd2e4a580477b55722417d9517e19c57265f95221ae0083a1651e
ebola-766fefdddad16d870df27d6bca55beb78572c56bcc191292290c7729ac1cc826
ebola-595ea4be3bd4a8939ea1ab7fe93cd72b347b89a479b7758375fc528b617930a7
ebola-86ef0de594fec3874c6df98a44a567efe1690120c22cd99c5db9d3c030b57846
ebola-278b2a44ffc3845af71f8771a7230ff512a32737d365e7ed964bd4a88ea0b132
ebola-0853672e04411d5945d0b84d9f91be349eb94a75ecd445fd24826938cd4dd0f2
ebola-640e3d0a69884b73a59e7f01bda02c2dae67dea45e0523aecc20b62705c0588c
ebola-818c8e25e61d76ec033692ab577a0c939e0b5d4bb82578441add29acc1a6aebe
ebola-8a4cb801ace14c0d89be8f7013204b6db2021ea168fc631b899ae790167b91b5
ebola-a8d2fee9c3683c388e16407dd5a227ce0a63c6fdd091f632cfd3261293bdbb47
ebola-db2de43fbcd5a57acf751a48b06f3f7f1f5ddba1d1289123e608cbca286adc44
ebola-f9027039b9b74dc9e82ddf09ae429ebd00d855871339992a1adc52eeab3451e0
ebola-905973604b7397504868491277c455a5f236e9f15c0c0e697f97349f17e212bc
ebola-553d288a7ce7d9a3770a130882b17be4a68d371ce25f31aff09da03b5e5e25ee
ebola-8630bd0484709cad38ec09f8431a998bb9504c6515cae25f1375143ee64917b9
ebola-ee2b40b8999a5d538b563366a5de5a0f56cd6f4341498b44dabf0ac2fe3978d4
ebola-cdcbbd0032d0b581c54ae92622d2e04c69cca47d843036fb540cf6e72ca73174
ebola-28dcaeb58b3d2f717f1d6e4bfb0483d53a163507bc40a440a6329ee81f62681a
ebola-7122149b0e46d8b272fefafe2e9d64e2489a96c1bf9c7644d08108a3a89c2642
ebola-b8ac12c6ac7f920b0e174ed3da53cff2c5af82fe7871e55c815441fc8d632bfc
ebola-5537fa0e5e3c2c8e1bb06af8b3b10f6574c2c88f783a376538d58ad28e63a28c
ebola-80c781babd712e03d45725e7abdb05d039ece37570c06e3018c1e45f08a9078b
ebola-123b9313ccc2c7612b378b4080bff00d0f09744fc419be05fe7f67866a3695dd
ebola-451a50bc861f2b745797bf4ced022ba72fd2b9a9e8dc5340d7c2d7f3c852866d
ebola-e5f7bcff6b19292659ce2a566fa034dddde32806100944e6815de9b1e07a1672
ebola-db784d5ec2896039cfe35c5bcdde54812f8c7cc73e3ce0cc1f68e9a8245456db
ebola-6a1d469aeaf808baec4558ef95d9009e4347e0957eb8245887a725c146556d43
ebola-2ed08d479a1146e390a930be867539d9de8399d4dc0f7fa2ce772fcf39c1d6b5
ebola-2ed66796470e85d98eafab2be6535fa2a8a00d6f678406b9d76da24e2c2c56fb
ebola-57aed64eeb4008e1488938e89e630fc871ea2be3599c5336e0b4adf386613a0d
ebola-756d210e2de46a793cb44b319005af9ee6568f84c284b0cd4a28286bde53f540
ebola-cf55846747ccc46141b3ed6dd6a9a0ca255ea67b595a9e3666046a58bd0942aa
ebola-2f93cee9e291ee7afa6e74379cf5751623a8b6fc770eaab626b9f2c3b3a233e6
ebola-75aaa92451140763b7cc13f501330fcc2f4b656a5bd0af5b1d7e110e46c44d22
ebola-867253bdb1c189d62fa636f0d6ee3b666a1d7fc78cd047927ea05becfbfc00e2
ebola-e842ece2ab22386987db8b3ae6ea0ba1ed2852fd17c30b86105269fdf65784f9
ebola-cf0814f57d61c65a0f76ebe7bc95fa867be935cd43c9a35b34a888ab5a22b29c
ebola-ce7180bb72edf3d48a2204388493132d4e8467d00cadbdafe8f4b732ea019292
ebola-2d52c7dcfdd0d16d20150546fe1da0328140f20145c7bb9fc8a22c7746f4e164
ebola-cda4194699cff3edb05c5e66588f6cc8f58453e79640ea6772cf3c23897a6144
ebola-9966acfb62b0d1131b552250578a986548883a230282f7a4578d6209429afb8c
ebola-0d2f2cab7b5351f4960c9f6f2a2d58a14be5200ad09ba49bd2e10d8cb022815a
ebola-c5b3b87ca4c52b2f2444fc7077e96672dabefe14560f7a85615e700356312795
ebola-c60bf6235b4a0794683eafc9677675a034114468f10730e35e5c65e8dc63b2bf
ebola-e9bfb04ec5a8b8420314655d5e3a71db5c04dcb93785bde56940b68d5706d7c2
ebola-414f51d90e4cf345ace4523f5075c77d8fe46ec7173537aeaae16352a3103a04
ebola-26ee779b3cb75fc7f2ae405c5c47724a79663e9040287e6a8d333f1dbe434047
ebola-575c42d53c14fb8314842bc4354673167fee0639001c4a753748321cda097c2e
ebola-3003d2d2cc1edd7b2a750a63e6aa7b7d880625acd257c840fedbde4f95a99117
ebola-4b49561d74c4f756b6995fca048a3ac9ac187847f9f63118365c706057547286
ebola-65a24270ebd4ea80ffdd197f46c466e05525d01055cad592e2822e653b7bd04e
ebola-f0566bd450f3440ff050ad18cc2822b59cb437c7b46bf2f8c9e87b4ccea5d53a
ebola-29baa320dc9996f6e315be85902cd03f4512eee04b5beee227c9071549eab6dc
ebola-ac00d9bbae4964df69d99e211c9116ff52e829e3fba52f4f64e217a40969d7d4
ebola-400c279667407f934ff08f67c011b62d796e89cedd950581bc17599f44a60775
ebola-1f9871d66c9354707d2615f6793860971eb16df5885ef8c64d390a10c4df6114
ebola-310cc0e877b49f5c5ecf09ae9c408226c3138c1d385cc3c21fe1975bcc876958
ebola-89f33b7ab466b922de7dd2688c0a1a43edf6988a88509b49279a71731b3fcb6f
ebola-b6056fc159248146ce4cc8da928c64105244be080c8f90cccdfa8b8bd9c30a81
ebola-90367bd553067c9981300a345985ba77fed9348e061bc3f42ec71553fdc4a9ca
ebola-0a9fdb3b463961971ac3cc344621a2fafee3c0370d3633b2eddbe7f2828d3e87
ebola-ee896a9af8706f66dc30df5d7965503ee69e5f0ca1670613cdcf02a8c13fc687
ebola-36a87744f9e923b9107cb4a4cacc669f73bb03a10625d4399f1583b71bf64d3f
ebola-d552fc84ce7551d455e4d3ead3fb7fb665b6830fcda2898c24fdd3f742584191
ebola-4f588c3f015b9879ce863a51b40c1b68af4a31b9fdc98eec4da4c6d7d9bf9eb7
ebola-6364adbecb63a5bafc63b403fa1604994b85bf504d3524a8c718e71e77aa11cd
ebola-f605fe4cdba0b1fbd1712af7b03c10d8c129806fea2edc7eadd7ba0032ba75f0
ebola-67bfbc22c17a6b4c4850f13a8f67b2b1ef8471764e3be1f06c7a9d267210d01e
ebola-c2727cb53b3f7b506881aa1dabb79f17343e6efb75a727bfd20836aa41d179e0
ebola-1980a629539ee6cb8f65ff11f4775bc103701861e5f1d1aba74f1fafce2d3e52
ebola-651d85c6710c6768df6b8cad950cdef7a589875f5eb64615b0edba93c7dc0058
ebola-2656183512bd003defd66a508f50606b25a25f797e9e412b229618209d0a714c
ebola-3ff3c72a4e4bdf4fc09678f1c892ae0cf76abf87f8d7f8e615030d36acc3c16d
ebola-8a62438bec920d7e0015835f25e389c10f54036ddd45937b16d9639dabc42acd
ebola-2f6af56c1cc98e3c99d0ea81a8ecf0c3ec0dac38c9ae5305939f82b94113eba4
ebola-83a77d6343fcd5f9ca9e6fabc31a128bd520a2047313e29124d50a9e2d6cf114
ebola-98e4d310f71a63ec216759fe4d54469db35fba3e13a37a015d9f8ecd928eb4b6
ebola-bf2892fa7e057a99fea4596860eef688596c910c68970e8ecf4650fc483006e2
ebola-4de891d5c3a8f419ab268074ae0ec2b6195499bb101cd2ba3e338e18aa6f948e
ebola-4f39c9a8453da1cfea0993cb8f4d81a66275cff0cefa4b270ee941d5ab040c37
ebola-d0ac9e01a687475f0eb7bda7ff6a191e39cea06940cabe4cfb60d708d312fc99
ebola-7a64bddb528d4579691d978dc0b105238e28cd36b7225eb45a161f4aacd18836
ebola-83eae081d80dabc97a06432b8bfe946d63c4cb23f279c67a1fbe1d3badafe47f
ebola-d5bad72db14f21c845db1ecd541ccd72761d820e3c10924dc64d98ca364fb5b7
ebola-8f7cfa82c36fd8c3ecf32005ac56432423fd128a71939a59c275f79a66eeca0f
ebola-b8f88bff98ca6febc6dcbb42b712427e75726cda2d29c9a9210ce3836ea0a443
ebola-26a1d7cc118122f23032c064692b94f129d3cf7b32af1a6be9ebc06d21c856b0
ebola-fc52b3f61dfdd7abe8c292b253af9a5313d2dd0d0ab85deaee9405ee899fbe4a
ebola-8c27052cb34c4712cc450e8525aae96a17d53bf6333d6fc223a8668d87e932d5
ebola-7a63bf14d5f798bcc2971e254912cda3905c39c165d26c44791667f9de5a7889
ebola-2b993a3c334919af63ef2f6b1ae9ae27ddf4bf78b61e6fbc79502bb1b5deb87c
ebola-7421db2de74b615cea718cecd07557c952fec17a835582af264667991debae7e
ebola-765634e3e8f89f468cd1ca10be84832b7f6829f160342637333ffeaf96abbbd2
ebola-cdd5cc81d20e44695fac738dc7b150cce6e3904ef6474c0c6cb4146a964109c9
ebola-7168cbf5436eeddf05d58c50d182deea60b547437a1da227aff7df2401805241
ebola-fbd2cc3af29aeb97a27cdcd35a1dc27624f17d5f1d66ba33d136bd1d161c2cab
ebola-c041996be745d54c8e3f7d95946f1b92a1d18e7647bc76a4b4dbe99ca83535e8
ebola-0d8b7b4dba84074c2248e89984ace16898ca939f70d935b0bbe62c33840bae40
ebola-9a21ab4175f97b84b359364664f43bff18e25b8a264503546a0bc4a9169760b2
ebola-2d6b4ce3dd058002e48cab32927e57e3541a3209b8345ce9c26269229a7968d0
ebola-4df978a3d108093c7b3352de0a8427acafd2ad303f2439a34f97c9d141a21549
ebola-8d3cc20484cbdb3f2a0a911240977ee8cc896b6726e4ec10f448fe787b14a87a
ebola-713d9180a6c5b9c64297c1681751cb59f86ada1094d16bb4b0cbc04efc24efc1
ebola-1449e4e2fe030352b8f32faf8e21664c383cd81376c3e9c8258639e6a508cd18
ebola-4bd7c5440b2bb0ff2a82a7820513da9d7b7dff04f67a031740780f8807c150bf
ebola-d61029bc9bc677eee1d64e9cef2aaf7c64399119727db7d99a2d21d6b85a27d3
ebola-138f8c11525906de7c356529544c8cf347aa43a490e476d10fb77bb69ce5b542
ebola-1fd5559f681b8292f02eba09b9d0bc8d3f514aa4216a8638a3b2fb1c86def49b
ebola-cb464a1c001e7ff8279092bf0506e05446db89176c60acba26e659c7464e8411
ebola-eb543992da3e377912c0b64b4d037b982a72242a1baa02f25c4b249cfc422774
ebola-6d906ced7ef638a69de696b12db148216756db8bfae2eeffabafa4bb7637e21d
ebola-1abe5e5154d766c9b9cd03a4b5e8310de9d3a17c49c5abcd7ef6a5000ed46c5f
ebola-a396d3d6aad17d8b2a622e22dea38cbcfabce2d8dd91ae077e06dee2bf143967
ebola-d688ecbf325dbf0469efb8933d89cbe20ae5149abb458e1cecdb2c5eec819802
ebola-6606d7a17b31351881ace9013aa8dbbc7904331e66645b55b3d4c46e51ee3df8
ebola-2e35ee63a7ecf6774030be1d845577293d65b3a43147ae943d13dde234d6bcd6
ebola-da2363ee2f60221266102e98f3be42f8fd2ce93b5459658e544698e4d0422a6e
ebola-433cc32e42e1a3f05efcad00446ce63ae777ff45c063c6873ba715a5a2ea56cc
ebola-9b08ce51aa2f7e3bb448679020448abc6c8afe5c18632e9f6e2dad51c22a7ea5
ebola-4cb8eb81af91e754e2481a5f247e6d909fe6c26a2e75b179a5d7d779d235a824
ebola-94a0fb05a363cf8bf9adaaaba7b2e53a5a429ad163f6bc4c689f4d7b6b9bcf4f
ebola-dd6ea906cb9a62ed20c7973a36255b126dc360d802198a5c8b4a8a85e58a1048
ebola-2123d17e4a1b67b7f519d41aded26c33b911d1b5b99283c2941497bd03ae7b6f
ebola-82fdce95fea98a1013f599d647e42f808589281b0f4e7c18404e6da9c4fb1393
ebola-8eba26b748f622c7255539a4993dc3a236117d65212d15a1e4637edb4ea4f93f
ebola-d0d98dbf4a806ce3d513c4bab7899660f7fb3b432e6cce51b7c24ce527c3b8e0
ebola-3b6308687b4aea2c068f9a3176cd28bbb52c7a09f5c5f8d608221d494251c259
ebola-19f12081dd70f741796afec10d6d63f979e134a40827a117e37e0fe2722d2192
ebola-cb1c15fe82abe3ddb4c2cdb0ee55bc873a3371af5223cd21f7dd40e1ffe7d127
ebola-77b7ae5ba9dab21f36769b87568be2cb3d1234282abe0c02cd36573585b89e89
ebola-0eadde344a88962f73d22498999bdae3fbfdee328fb2f99830a5902de5bcdf2f
ebola-c64fde2130b70f764b4d6326c0be7c959fbd4ca9950c50c90a380f81c38974ea
ebola-92102d37be6ec2ad7b51536aa0bcaefd4824d1550cb863b1001212f05a182fd8
ebola-c1b09c9b46b8a9bdf5b08fd0ed02de147094ce3dcbf82f1639146ce7016748de
ebola-c5c7044e32eb2cdc2dd4c3e45634d9ae6600e7be37f7c622c840f50ce608a36c
ebola-33c9eea3e2100960cc872e13a739066a9c5daa244c79a6727c0aef6b00aedfaf
ebola-2653256a6efb4910dbf83edfd52b806c597ea525f1f4c414d3db646dd285f153
ebola-894ddd1581efa201f6b9966213644a1779ccfacff44ec6a54b13ced0a6f88164
ebola-5f2f34e78b3eddb7da5bf48129ff39b73d6ab5a6997cf6a1f8e1925fc02ed30e
ebola-a7efe0646069f6f031b6aaf7fd238668d6f340f2a3793693d13843a93ceaea85
ebola-00f11e46bef1b9469f6bc5eaddda49485893a8b82edd295b2239ad65f02e2c92
ebola-103940a28744c54663e4738dec6d0dfaa2d8d5fb78fd5044d736039802a3db01
ebola-4196b271cad36778dea2b9901a67f9e93ab073bcd7c4eee9aa7e023136a68c51
ebola-b9d38a2d743f6f0dde07789d05480aca36a47a39d4aed6fb18384f48532964dd
ebola-28f1d9765ebc5fe84aefd660608007e9dac0a383dfb78d99f1baf12e8a5f499a
ebola-30538090a055cfdf89f1cc60719f4e1d072f4ce79bbb850f2a63831737f058ce
ebola-d44020b5b0e0e5d48ef62bbb92ddfe9db495e6e7c8bcfe20b8c311468d25e73b
ebola-eec3ea780d4ec88458b1f3ddaba275046aa4cac8e9169b3408dffbe95642f02a
ebola-9fc44b5c9d03188b09694943edfda888228b1f5d09cbba6b2c05128ee24b94e3
ebola-412da949b735ad46dde9c849bce2653b6c5eb52f8f4ced6eec534aaa0c58c07c
ebola-8f94baf70fd42a94fb2aa8883548451bea3600c874b9949401361f708ee264c1
ebola-a5f4a21edc1f51dfefc0dbb49798f4b84c98c26e213a0ce04e7e25a055264989
ebola-ceb7c2f04604a02df690db1341a112bff5c8b1370d8767332d20bd0ddc9c4b02
ebola-5ff637d451605aac0093de91a5b6d7663bad705cc0d27222a5f4bddb4916ba3f
ebola-d2f4f555567bbf09fcdb564da56cc20948853581d74a25371d62711f331cba62
ebola-5e12b75e23946bae9ae0e74e4d653f910751d46bb5fef233570d939d4cd75d5a
ebola-5c8d148ce2a9fbaafee131da2b323e80abbfe7380a823a22ac9aca6e5dbc0c21
ebola-8b0f6ba4711d27449313fb55a1dd794ebd80bfebbcf81f98ec443f604edf12dd
ebola-448e365dd4758bbfe2d3006b7ce95d38f7661537d199afe300ee8c98cc9132bc
ebola-32d3722acca39fb7872baeafb85d661ffd4b059550d3146744ebec4ad07eabb5
ebola-5aee24a120e92204c9627f850a86739882493395a0928e6a5c9a60118a40e6bc
ebola-4fe2f8d75165d328fffcbcb2453c6262a1c46feb406b408d7e3a78e889f1710b
ebola-de7ea8c4a9f7e0f42253d56f4cec77a73744ea2dfab332f1641287823940167b
ebola-e02161b532e6067071690f793a75f2cd089c1fc02dde44c56918f1eb483dad5b
ebola-218adafc8696fdf71923b0f169f8eb7ab96de04d4f14993a204c9cf25df0d574
ebola-980047de0a0f256f523715064b8bbb48b7fe748d9b9279f2b1fc10ee0160f7d3
ebola-b998df140e4c289d28658d8ba9c82c4e50ad576b7f88513a2e236780db695a69
ebola-4f724e0d67e51c56152e1085ad6c317e1e23e94fdb75380fe067f850770a76fb
ebola-2774a3173bec9ad0f877d967059b8d9935cf316e3807319ad676092934e85b1d
ebola-8870df2bfcfbb6203eac2796f2fc39b71649e335471e7b17afe41e533f296e8b
ebola-2e47e7636203508f43da97833feaf357f39e9a37fbe89ec13f3643300d3f81b7
ebola-6f5302d9496e4001dc26cf1b6e6cd2dad212d106c22a5ea47f7f45ed09b5463a
ebola-dc799bbf3129408d962e962c2d206d3a34f89d54775bcd1fcf2de2213f7a23fb
ebola-71171992113d81eac4c70668bf09e42be27864bdc11f0014f828b989ec5bf500
ebola-a01c40e9e40baa81543bd2b9419d421b97d6c3c0618104f04fd43859a4d527aa
ebola-91b0b0ed4d33a22317ce9f5033c3dbb51f531e09a5a39bff836e56f81b9fadc6
ebola-a08d982f2f21cd919f9f9f2781b2a8e6f15ca5c7f173a760899e42dd4a394d22
ebola-4d4686b2b74d4e6e97950d01eff988631047175a492582dc712006905b1d23be
ebola-e72bc99ddc683efdd08808157339524f041d8eff86f45faeced974995bcbdcb4
ebola-e7d4a8b9d9e6fb15b8cc5560730db713f4efc85a4fb1b0f783fcdced0cf1aa28
ebola-2fd5318759234417b1014e32c0d481a868f091d1f765b244c7be1a1995eb4938
ebola-72a173e5de379ae568b26a2a22e45bc1ce2d1029444410c63652062911675b76
ebola-9906746a7b616eaba24e5d3ca4780f0ecdc846d29a384deae56aebef82261976
ebola-8791c4af8426fc731cc937f1da7a1654bbda74ae1eef69a4b15280bf78ae89ce
ebola-8d46f36c7f645e1773f91fbaff75ac7311c9fea7e64deb6ff440bca46ac0d016
ebola-c23ecc2857414fe14444a699fca2743ae0ce275645a10fb6d3964c33b0651ae0
ebola-8dfaceb0da3b49830937c126d3ca3a7ecd25b8427e340d59b82cd27d988d50a4
ebola-aea7ce7ce526ee6a515f9956475239911997acd6a24935c451a7f05cb2b815cf
ebola-17273d4077d41ceef4a8e658c8ca0ed614c6fec0d9c32cd108265712363b1236
ebola-938be846f3d513a1a87dbe1de249b631ca43eacf997a834e6bd075aa536e43d6
ebola-59e5b4d272e862b1dbbf9be4f9bc74def538a7954c08b4295709dc2c3458eaf2
ebola-af493db6f37e0ad8592219cdba12c2d1b61c35d4eb28ddc392bf295aaa8f111a
ebola-e218b70b7d2d8b30bb7c5a3c4785e7ac199a5a0c52a61cc3db5de0627f111e2a
ebola-464fbd5787eea32bb86d5d35a6abdf06611bc2fcecf0d97c880a2a4dda9a0a0d
ebola-58afdda45cf520820eb332c700ece0d05d0297ab224e40e67ae542ac58ab6528
ebola-fd7271b89a591ba814cd805e30949aeb9f975bf68fd26981fb4ec9e49f70caf7
ebola-9268b66d567860d06569c64d45dc407bfb9e774535602edadef3a25180de2230
ebola-3714d02d2088b88f15bf6c6a6fb54b34666548d95ea2cc96298b99849eef6d37
ebola-02b4ad54e74d7f1e814018fe60e9eb2285fc4ef7cae6ddfe5bd00d5a101b0826
ebola-2eb70178b4731417790ae96f6b6a96115ce3d8567502100bfbf3bea1320ab11f
ebola-725081529b8edce8a46a9d493777e71e01dc292f57408548b21b9769046452da
ebola-263fd3b77067d540a4e5a0cceeb404f49f421010f03e91f59897a7f477161a30
ebola-8b1ba36190128d76adf0e32b9cf2ed1f6362a75471089d1d3418672db314c4a6
ebola-d82d78bbb854fba5a9c5079be75330802eb8a3f2580e062319e900c409a0acd4
ebola-f6b45ced0d7ff0457a500a765d025a1a9b32d4effabe6b388041543a4e227bde
ebola-c670cf691be7adfc95073b322dd4428a5f60c9d2a181b907359e1e5cdb4e93ba
ebola-1b3b2912addeaea82898be352bbabada921df34da3e0a3829645304d169be754
ebola-8f3275f40104695312b955aa441c1b4352d64168b69d17dd3886e9b210702ecd
ebola-2728c78d2c0443ea4dc5c68f367c2fbaeb65fbe72df71ed42ee2c6311e4e2b03
ebola-d69b52d2de54888a95638be983dadddad08f09ea5ad50f476902fdab1a7f32a0
ebola-d9eb22fb9283be12587df82a777890c67a95bb0e28c8c3129fe899d1c4fab101
ebola-c77221eda4222e204ea78fbdf2bc8e02c513e278e28e188f2ff2397b9d42df93
ebola-d2b5ffbea92d40a74fc5e218ef7436af1957b40f4468b8c9c2cd78be6711c789
ebola-eb81a0bffb372769d62c9debda4ab3fbfa0e726fd102e8ec21b3cee780a53529
ebola-47d002e207274e8d777b069407837c530c42507f6e2ec0a645bbb00889bcbe78
ebola-39512cecf669cccefc9cb0c45bffc606d0147ba2360f1d646cf89d1ca61e6a06
ebola-11aca23835b9df27398033ee1c7ccd121b1463d032982f76c35c061f1dbc5e38
ebola-af1930e8f473ce752c3e24bc5bf131bfff10ca46142eab1ddb99e16e7a9099fc
ebola-3fcf7c0855a95be0b54449882c1eab16c2831f45a0cebcf61908754e2e722c3d
ebola-5523330cc94da4405a7c678880f35060e6b8d10af6def0e5298e04b7a5561e41
ebola-d5414916be9455dbe58d86ce0418b85aacbad2877562dd6ae02c9968a29d58c4
ebola-b326d349547343008d503a869dbfdf7a06852eee3f7c043beb93e0b728187c75
ebola-97902119de25e9f7497f8c0e96af0ec2db4a5068d4eac0be8dce0e66ef7158ac
ebola-32f39651db3d698e862686320a90fa5d31069402e736a3c3d605f636d3c3ea44
ebola-d5178e23444789c5426cbe77762e3236f36547ea5431dc3853f99c2e148eed7d
ebola-198850572930c54d50cc9b550a82958a32f8fe8d83ae42664fce6a0e67133872
ebola-1df7788d682b219340e6d086bea9786c5b49dd1ae4b8ad2efae71bb9dc8c20eb
ebola-3bb15e87a7126023d1248570b82643abb29e2982fe3790cb7921d9d2cb3a3a66
ebola-fbb45f4868e12c32a069c690014c207ebae430acdbf09d649fb785b9d0a6758a
ebola-8b1df916655b1a13f8d36c08b0171a1dd405d61f962fd5782e65787110fc7187
ebola-c02a5ddf783fdda6b11f0e68986f6d04b45ba6c034026ee4d910b88a5f405746
ebola-c264363b7d68390522cbb3935da3f523eca52462c4a2310d361aaae3192fc0e6
ebola-5f825f6b6e2112c08500803495a2d987bc2d5fe87b0a49cd3a9bdab858c52b4a
ebola-e36d059792d69a56d16d33eac564f6cc64426b8201ec21c51e3ea08d3c71fff6
ebola-76e562acc8f0f35c72d93399389e7dac17c12c5911bc47833c23b4460d0d1a9b
ebola-9a3224c07ad46a0a4e3f127e3dbd28f895ee09c1b8ad8ac20a65bac973ce3d90
ebola-5de46559ea686e0b2c44b7d55ff5c1b2f49a2588b6a8566b4a993d0ddc7f82d6
ebola-0ec592b3b730cd3848bc2d8e2a9a6b765f97164789d357fa67aad061243112db
ebola-de4328cada62e3afe68ea94426ed42d6b71c458b54933bad8861154bb86e04b2
ebola-3c1af937856a07d9ae46b8abe19809f5179aef49ab3dfe7f927d84f007ef2e86
ebola-fcb9a47299c9e6d46515d89be478687c5a5fbbde1f5b35cdb031d46720c947f0
ebola-ede9dc883494a7b483b43b0e662284dbc037bfdd1876185d3504ee3bf6d43738
ebola-0263eacb036cd3890a51cbdc0b5670060c1cfcbc5314496873fda282f6848315
ebola-5b2b9c9d64dcd4197540b3e3c898334502aa4e2c67208dfe6b4afe5729b70581
ebola-794201eef10fd5376f8bd4f35a928bcf1154dbc768a99bec91ac042ebdf627b7
ebola-7497531c8002343b5879613a09b5914fbfebd8616e32326bb95194d61007faae
ebola-a2bc31d25fd14201d0ccf9e420a103ab6a9a71fb31444fa8c40d7711beff5192
ebola-9fd80491c5f347214d532d74c41d537d1a8d55903c995b12d12fabfa44f1ee80
ebola-ea7e1f3705454dce4d9fbe45c0138deff09696b3a88746aaf3821c8869c4b394
ebola-fb02cac0ccfeb135e25a745335176cba7d8b56ce74580082fdbe364e7c2b3f91
ebola-ad0213391964701c1c362815a263d911a23f66a8ff88fc85bef7b24be4dc8b99
ebola-1a7828928ecc99ff296c538a77aba37b66766b5e6de28c5609b54f51adbc3eb1
ebola-74f0eccd0d00cc37e0ff7aa1bcaaffabf1a5ca5c518ffe05bd2a4139506b1b13
ebola-611bb4457a0a09581fb5c922d56b34124bc03f2ebf55867c7feb2a713aa2bc4e
ebola-ba405d093989b04770c10681007b57e85b0fc77276acc56014c4a49cf97f3000
ebola-8b5550a915eee38313d9c153e658957cd7c081351418beec663901a7086e4812
ebola-ecaa51fce44b73d14662f2812287ed89fcfecf6ed656b77a49f6f65d58d01aed
ebola-53719985486eb8225631ed9503fcb38fe611210fd72e9e4016f17e24f12cbab7
ebola-57652b3f3c2f2bebb48973ad983c3e802ff5640ade09fc8bac66c60641ff3eac
ebola-79ea6af3f0fd873a0a2b8db239496aa9671fc254db7dc7af119c80d9cc9175b6
ebola-43a96bc988df03403822f71ff1023ec6e4d73deb802ba82a2265cacb9d39e183
ebola-f43870f1d4e0325be39ce9151c81ca3891446cf64c28d405c7b26c63629c425d
ebola-f0ad7817431b8801f2f15d29440a2352d62421ca56024491c377b1428d96e583
ebola-08f5c4550e2e16d010b9f7b7da8bec5092b49721dea6e1f51ed032aeca3f0696
ebola-3dea130b7708c6d3a6b9cccc6131d196d89d2dcb32deb52c63b354fdf9e40c3d
ebola-b8c9cc4dc456c9f25b3e9efcf323dfa89b0885b64f970ea31856e9faba534dd7
ebola-8165a977c1ae5877a0d43d62abcbbc2578832d9536017929b0cb48f795b2fd89
ebola-1b49bd6157c32793b43df6d3af3ca6d3d24f2b2030c61c8f670eff2f8900640c
ebola-045640b964cc85b3e02f056954b4757b29bc46ecf3bad4136c363a65ff74a91b
ebola-a5842788d2661ced7e03dba1987f42a66349b487fc093288863af2963bc1dc60
ebola-e846e72bd64bf262bffd3fefb911f8fb9a94bd7c3a1d595e3759a0a4e734ee1e
ebola-2a27b257a102dc11ce97c3d6c9d9beca643064be53f0c5680bf30f0610f4fc0f
ebola-ac248415caf50d13a01bcb25f500b1d7d193ecc1b77644cda2765ed4a46d3e48
ebola-85f93920b39807ca4cd4a86b0eda2a94013b206884e236daa86ab372348a4f38

list/click  |  time: 2016-04-23 14:51:52 379648  |  # of fields: 4  |  topic_id: 397  |  docno: ebola-735bf13d0de22aba9ca5e1408e55786b08c4e7d8bc6e55e74f8c66b6a14ea657  |  listsource: pink_findmore

highlight  |  time: 2016-04-23 14:52  |  # of fields: 3  |  topic_id: 397  |  docno: ebola-735bf13d0de22aba9ca5e1408e55786b08c4e7d8bc6e55e74f8c66b6a14ea657  |  highlight_string: ebola, pays, healthcare, insurance

passage/create  |  time: 2016-04-23 14:52:49 038972  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 193  |  subtopic_name: Who pays for healthcare  |  passage_id: 4976  |  passage_name:  Ebola preparation is costly for hospitals  October 26, 2014 | By Ron Shinkman As hospitals scramble to properly prepare for any further outbreaks of the Ebola virus in the United States, they are bumping up against the inevitable barrier: cost. Hospitals are finding that merely preparing for the narrow possibility of treating an Ebola patient can cost them hundreds of thousands of dollars.  The costs can come on quickly, even if a hospital may be treating a patient who is only suspected of having Ebola. That was case at the University of Kansas Medical Center. Its costs included $100,000 for personal protective equipment, $8,000 to $10,000 for heavy plastic sheeting, payments for specialized medical waste removal, and overtime for the nursing staff and other hospital employees.  "There were major categories of costs and expenses above and beyond what we'd necessarily have for any other patient," Chris Ruder, vice president of patient care services at the hospital, told the Kansas City Star. "For example, everything the physicians and nurses wore when they went into the patient's room was completely disposable. And we had six nurses at any one time taking care of that one patient--a twelvefold increase in nursing care instead of the usual one nurse taking care of two patients in the ICU--plus physicians and a dedicated infectious disease team. The ratio of human resource to one patient was exorbitantly higher."  At hospitals in the Lower Hudson Valley region in New York, the cost of preparing for a potential Ebola patient could be $500,000 or more, the Poughkeepsie Journal reported. Nyack Hospital put the price tag of preparation at between $250,000 and $500,000. The cost at Westchester Medical Center is up to $700,000 for the creation of a containment area to safely treat an Ebola patient.  Those hospitals are likely moving to a higher state of alert after reports of a Manhattan emergency room physician who was diagnosed with Ebola after treating infected patients in western Africa. At the same time, hospitals that do not properly prepare for Ebola cases are at risk for taking a financial hit if they must treat a patient and it is not handled well.  To learn more: - 

passage/grade  |  time: 2016-04-23 14:52:51 796368  |  # of fields: 2  |  passage_id: 4976  |  score: 2

passage/create  |  time: 2016-04-23 14:52:56 784315  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 4977  |  passage_name:  Ebola preparation is costly for hospitals  October 26, 2014 | By Ron Shinkman As hospitals scramble to properly prepare for any further outbreaks of the Ebola virus in the United States, they are bumping up against the inevitable barrier: cost. Hospitals are finding that merely preparing for the narrow possibility of treating an Ebola patient can cost them hundreds of thousands of dollars.  The costs can come on quickly, even if a hospital may be treating a patient who is only suspected of having Ebola. That was case at the University of Kansas Medical Center. Its costs included $100,000 for personal protective equipment, $8,000 to $10,000 for heavy plastic sheeting, payments for specialized medical waste removal, and overtime for the nursing staff and other hospital employees.  "There were major categories of costs and expenses above and beyond what we'd necessarily have for any other patient," Chris Ruder, vice president of patient care services at the hospital, told the Kansas City Star. "For example, everything the physicians and nurses wore when they went into the patient's room was completely disposable. And we had six nurses at any one time taking care of that one patient--a twelvefold increase in nursing care instead of the usual one nurse taking care of two patients in the ICU--plus physicians and a dedicated infectious disease team. The ratio of human resource to one patient was exorbitantly higher."  At hospitals in the Lower Hudson Valley region in New York, the cost of preparing for a potential Ebola patient could be $500,000 or more, the Poughkeepsie Journal reported. Nyack Hospital put the price tag of preparation at between $250,000 and $500,000. The cost at Westchester Medical Center is up to $700,000 for the creation of a containment area to safely treat an Ebola patient.  Those hospitals are likely moving to a higher state of alert after reports of a Manhattan emergency room physician who was diagnosed with Ebola after treating infected patients in western Africa. At the same time, hospitals that do not properly prepare for Ebola cases are at risk for taking a financial hit if they must treat a patient and it is not handled well.  To learn more: - 

passage/grade  |  time: 2016-04-23 14:53:00 072980  |  # of fields: 2  |  passage_id: 4977  |  score: 2

doc/next  |  time: 2016-04-23 14:53:04 254446  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-735bf13d0de22aba9ca5e1408e55786b08c4e7d8bc6e55e74f8c66b6a14ea657

passage/create  |  time: 2016-04-23 15:13:55 424435  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 4978  |  passage_name:  Start with a $100,000 order for more personal protective equipment than usual and the price quickly mounted when the University of Kansas Hospital last week cared for a possible Ebola patient.  Add about $8,000 to $10,000 worth of heavy plastic sheeting and materials used to seal off the isolation area from the rest of the hospital.  Count in nursing overtime. Tally extra costs for hazardous waste removal. Figure in communication costs to handle the media. And note that an entire seven-bed intensive care unit â which usually would have been filled with other patients â was devoted to the care of just one person.  âThere were major categories of costs and expenses above and beyond what weâd necessarily have for any other patient,â said Chris Ruder, vice president of patient care services at the hospital.  The Kansas City, Kan., Ebola scare, which turned out to be more of an infectious disease practice event, gave the hospital a clear window into the cost of best-practice care for the infectious and often fatal disease. By using equipment and procedures that the Centers for Disease Control and Prevention has since said are the right things to do, KU Hospital had an expensive 48-hour experience.  The full bill isnât known, but a recap of those stressful days hints at what any medical center might face if a possible Ebola sufferer comes to its doors.  âFor example, everything the physicians and nurses wore when they went into the patientâs room was completely disposable,â Ruder said. âAnd we had six nurses at any one time taking care of that one patient â a twelvefold increase in nursing care instead of the usual one nurse taking care of two patients in the ICU â plus physicians and a dedicated infectious disease team. The ratio of human resource to one patient was exorbitantly higher.â  The expensive, airtight protective suits, hoods, gloves and respirators could only be worn for two to four hours at a stretch before the workers became drenched in sweat. The hospital even bought underwear, socks and booties in all sizes for the workers to wear because they also had to be disposed of after each two- to four-hour service time.  Separately, the International Association of Fire Fighters calculated an average cost of $382.31 for one set of personal protective equipment that would be considered adequate for a first responder to handle a possible Ebola victim.  The association points out that the protective suitâs cost doesnât begin to consider extra costs for throwing away a gurney mattress, blankets or anything else that may carry the virus after a sufferer is transported in an ambulance. Nor does it figure the expense of disinfecting care providers, equipment or vehicles.  Ruder noted that major hospitals, already prepared to handle infectious disease, have many materials and facilities, such as negative-airflow rooms, already on hand. But the emergency construction of separate caregiving zones outside the patientâs isolation room required a temporary sealed tunnel of plastic sheeting and creation of anterooms for workers to put on and take off protective gear and move to the shower.  âWeâve even replaced the ceiling tiles in our negative-airflow rooms with nonporous tiles,â Ruder said.  

passage/grade  |  time: 2016-04-23 15:13:58 200552  |  # of fields: 2  |  passage_id: 4978  |  score: 2

doc/next  |  time: 2016-04-23 15:14:01 421778  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-d900eef0e972737c731a1f72ab6d975c532667543afd66c9f65f01be65d6fcea

doc/duplicate  |  time: 2016-04-23 15:29:10 854159  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-190a9b8ddecaaba9f73c58be72e617a7ea98eea66005b2b80edcea64f1586c16

doc/irrelevant  |  time: 2016-04-23 15:35:53 516336  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-0872d854b6fd4c07ada25dd35096778257469c7ec6d2da1e8203bd9a033d9615

doc/irrelevant  |  time: 2016-04-23 15:54:47 379337  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-86da5d9c45f6e15c0afdb652498dfd1fe60d3ff2d29f1eab579d6a92d631831b

doc/irrelevant  |  time: 2016-04-23 16:08:43 241475  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-e40fb24d9d13c95850a7f96d75c1ac2ba9d461eaa3168b3a4d10a34ce1fa413e

doc/irrelevant  |  time: 2016-04-23 16:09:05 854706  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-8e822df2f2f2fc922ed5804fb6bdb36369a367f3820fceed50869c33c07b3fce

doc/irrelevant  |  time: 2016-04-23 16:18:07 169225  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-da2f0ee25572be431b8da81d2d369465e00d1e41418912f3c4e9a700e4d4d3c7

doc/irrelevant  |  time: 2016-04-23 16:22:31 831630  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-ead97a4db95901eb2f6f7486e74a3df5aa6108a556f9686442958d3ab5f874e8

doc/irrelevant  |  time: 2016-04-23 16:27:52 347063  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-cde40f6642c76305a98ce45eca243f5013773274a7c1819eab4ed3f473bc57b4

doc/irrelevant  |  time: 2016-04-23 16:34:09 538335  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-cb0d0db0ea3a491007a52655a638e6098aff666c97b30c8e3c463d4c5b077d09

doc/irrelevant  |  time: 2016-04-23 18:42:51 734380  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-21c1155bf784afeb2eb25e67a3170a85343eb5f6ac64de493a614bbef4375775

logout  |  time: 2016-04-23 18:42:54 837111

login  |  time: 2016-04-25 10:37:32 665346

highlight  |  time: 2016-04-25 10:39  |  # of fields: 3  |  topic_id: 397  |  docno: ebola-dfa937f1671dd2e4a580477b55722417d9517e19c57265f95221ae0083a1651e  |  highlight_string: ebola, insurance, impacts, healthcare, providers

doc/irrelevant  |  time: 2016-04-25 10:39:31 552744  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-dfa937f1671dd2e4a580477b55722417d9517e19c57265f95221ae0083a1651e

doc/irrelevant  |  time: 2016-04-25 10:39:50 390986  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-766fefdddad16d870df27d6bca55beb78572c56bcc191292290c7729ac1cc826

doc/irrelevant  |  time: 2016-04-25 10:40:13 595468  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-595ea4be3bd4a8939ea1ab7fe93cd72b347b89a479b7758375fc528b617930a7

doc/irrelevant  |  time: 2016-04-25 10:41:04 191459  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-86ef0de594fec3874c6df98a44a567efe1690120c22cd99c5db9d3c030b57846

doc/irrelevant  |  time: 2016-04-25 10:41:48 001579  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-278b2a44ffc3845af71f8771a7230ff512a32737d365e7ed964bd4a88ea0b132

doc/irrelevant  |  time: 2016-04-25 10:42:15 602313  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-0853672e04411d5945d0b84d9f91be349eb94a75ecd445fd24826938cd4dd0f2

doc/irrelevant  |  time: 2016-04-25 10:42:25 548744  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-640e3d0a69884b73a59e7f01bda02c2dae67dea45e0523aecc20b62705c0588c

doc/irrelevant  |  time: 2016-04-25 10:42:38 941931  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-818c8e25e61d76ec033692ab577a0c939e0b5d4bb82578441add29acc1a6aebe

doc/irrelevant  |  time: 2016-04-25 10:42:55 430407  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-8a4cb801ace14c0d89be8f7013204b6db2021ea168fc631b899ae790167b91b5

doc/irrelevant  |  time: 2016-04-25 10:43:07 734066  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-a8d2fee9c3683c388e16407dd5a227ce0a63c6fdd091f632cfd3261293bdbb47

doc/irrelevant  |  time: 2016-04-25 10:43:22 938230  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-db2de43fbcd5a57acf751a48b06f3f7f1f5ddba1d1289123e608cbca286adc44

doc/irrelevant  |  time: 2016-04-25 10:43:35 244263  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-f9027039b9b74dc9e82ddf09ae429ebd00d855871339992a1adc52eeab3451e0

doc/irrelevant  |  time: 2016-04-25 10:43:49 597088  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-905973604b7397504868491277c455a5f236e9f15c0c0e697f97349f17e212bc

doc/duplicate  |  time: 2016-04-25 10:43:57 408371  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-553d288a7ce7d9a3770a130882b17be4a68d371ce25f31aff09da03b5e5e25ee

doc/irrelevant  |  time: 2016-04-25 10:44:07 339899  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-8630bd0484709cad38ec09f8431a998bb9504c6515cae25f1375143ee64917b9

doc/irrelevant  |  time: 2016-04-25 10:44:35 300678  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-ee2b40b8999a5d538b563366a5de5a0f56cd6f4341498b44dabf0ac2fe3978d4

doc/irrelevant  |  time: 2016-04-25 10:44:42 287755  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-cdcbbd0032d0b581c54ae92622d2e04c69cca47d843036fb540cf6e72ca73174

doc/irrelevant  |  time: 2016-04-25 10:45:31 939160  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-28dcaeb58b3d2f717f1d6e4bfb0483d53a163507bc40a440a6329ee81f62681a

doc/irrelevant  |  time: 2016-04-25 10:45:39 283298  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-7122149b0e46d8b272fefafe2e9d64e2489a96c1bf9c7644d08108a3a89c2642

doc/irrelevant  |  time: 2016-04-25 10:45:44 025733  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-b8ac12c6ac7f920b0e174ed3da53cff2c5af82fe7871e55c815441fc8d632bfc

doc/irrelevant  |  time: 2016-04-25 10:45:53 838322  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-5537fa0e5e3c2c8e1bb06af8b3b10f6574c2c88f783a376538d58ad28e63a28c

doc/irrelevant  |  time: 2016-04-25 10:46:05 680908  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-80c781babd712e03d45725e7abdb05d039ece37570c06e3018c1e45f08a9078b

doc/irrelevant  |  time: 2016-04-25 10:46:20 596598  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-123b9313ccc2c7612b378b4080bff00d0f09744fc419be05fe7f67866a3695dd

doc/irrelevant  |  time: 2016-04-25 10:46:29 508916  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-451a50bc861f2b745797bf4ced022ba72fd2b9a9e8dc5340d7c2d7f3c852866d

doc/irrelevant  |  time: 2016-04-25 10:46:33 796432  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-e5f7bcff6b19292659ce2a566fa034dddde32806100944e6815de9b1e07a1672

doc/irrelevant  |  time: 2016-04-25 10:46:37 301357  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-db784d5ec2896039cfe35c5bcdde54812f8c7cc73e3ce0cc1f68e9a8245456db

doc/irrelevant  |  time: 2016-04-25 10:46:41 681061  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6a1d469aeaf808baec4558ef95d9009e4347e0957eb8245887a725c146556d43

passage/create  |  time: 2016-04-25 10:47:39 699730  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 5109  |  passage_name:  That's the model the University of Kansas Hospital tried to replicate in a hurry when it got its first suspected Ebola patient turned up in early October.  The Kansas City, Kansas, hospital emptied out a seven-bed patient care unit and quickly put up $10,000 worth of temporary walls and heavy plastic sheeting to create an isolation suite. It included sealed tunnels that caregivers could use to move between the patient's room and a decontamination area.  The hospital even stockpiled shoes and undergarments for doctors and nurses, who were told to dispose of every stitch as hazardous waste during decontamination.  It took less than 48 hours to determine that the patient didn't have Ebola, but since then even more light construction has been done to make it easier to ramp up in the future.  "

doc/next  |  time: 2016-04-25 10:47:43 635512  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2ed08d479a1146e390a930be867539d9de8399d4dc0f7fa2ce772fcf39c1d6b5

doc/irrelevant  |  time: 2016-04-25 10:47:49 481037  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2ed66796470e85d98eafab2be6535fa2a8a00d6f678406b9d76da24e2c2c56fb

doc/irrelevant  |  time: 2016-04-25 10:48:11 917448  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-57aed64eeb4008e1488938e89e630fc871ea2be3599c5336e0b4adf386613a0d

doc/irrelevant  |  time: 2016-04-25 10:48:23 351102  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-756d210e2de46a793cb44b319005af9ee6568f84c284b0cd4a28286bde53f540

doc/irrelevant  |  time: 2016-04-25 10:48:54 613109  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-cf55846747ccc46141b3ed6dd6a9a0ca255ea67b595a9e3666046a58bd0942aa

doc/irrelevant  |  time: 2016-04-25 10:49:12 587201  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2f93cee9e291ee7afa6e74379cf5751623a8b6fc770eaab626b9f2c3b3a233e6

doc/irrelevant  |  time: 2016-04-25 10:49:51 399879  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-75aaa92451140763b7cc13f501330fcc2f4b656a5bd0af5b1d7e110e46c44d22

passage/create  |  time: 2016-04-25 10:50:31 925428  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 5114  |  passage_name:  CONNECT 5 TWEETLINKEDINCOMMENTEMAILMORE Strong Memorial Hospital spent about $700,000 on renovations and equipment in case it had a patient with Ebola, and it continues to spend $50,000 a month on training to keep a select group of more than 100 staffers ready.  "We anticipated there would be expense," executive vice president and chief operating officer Kathy Parrinello said. "We did not anticipate the degree to which we needed to invest in this."  Parrinello said Thursday the hospital spent the money without a specific promise that it would be made whole by the state or federal government.  "We assumed we'd be able to work something out with expenses," Parrinello said, basing the belief on other experiences. "But nothing definitive was worked out in advance."  Now Strong is among several hospitals in New York and around the country waiting to see how the U.S. Department of Health and Human Services apportions $700 million to pay them back.  A decision on how to distribute that money, part of the fiscal year 2015 omnibus budget bill that includes money for Ebola response, is expected in the next couple of weeks.  On Thursday, Sen. Charles Schumer, D-N.Y., held a conference call with reporters in which he called on HHS to reimburse New York's five Ebola treatment centers as well as community hospitals that had to comply with state preparedness regulations.  Schumer said that the five treatment centers â Strong, Erie County Medical Center, Women and Children's Hospital in Buffalo, Westchester Medical Center and Upstate University Hospital â spent about $4 million. He said the remainder of the state's hospitals spent an average of $40,000.  "If you are a smaller hospital in one of our not-so-large cities in upstate New York, that's a lot of money," he told reporters. "We have 87 hospitals north of New York City and for many of them, $40,000 is a lot of money, especially if it wasn't budgeted for.''  Four medical centers in New York City and the North Shore System Long Island Jewish/Glen Cove Hospital on Long Island are part of the federally designated system. Only one â Bellevue Hospital Center in Manhattan â has treated an Ebola patient.  Schumer said that shouldn't matter. "... The costs of being prepared have been extremely high in order to be ready for a potential patient."  Strong Memorial Hospital, while part of the University of Rochester, is self-supporting and the money spent on Ebola preparedness came from its budget. Parrinello said that $700,000 is a significant amount, and it could put a damper on future projects.  Parrinello said Strong began its preparations in October, when it agreed to be designated by the New York state Department of Health as a treatment center.  "We went into this because there was need in the community and we're the institution that is looked to to be prepared for these things," Parrinello said, citing the regional reach of its specialty services such as the Kessler Burn and Trauma Center and Golisano Children's Hospital. "We understand that's part of our role."  Strong has not had a suspected or confirmed case of Ebola.  The Monroe County Department of Public Health had monitored people who traveled to West African nations, which has been coping with a monthslong epidemic. A Webster nurse who treated patients in Liberia in November and returned home last month was monitored for 21 days by the state health department. She showed no symptoms of the disease.  "While the Ebola headlines have largely faded, the costs of Ebola preparedness have not," Kenneth Raske, president of the Greater New York Hospital Association, said in a statement. "Any one of New York's Ebola treatment centers may be called into action in a moment's notice, and they continue to incur enormous ongoing Ebola training, plant, and equipment expenses.''  Parrinello said an isolation unit with an anteroom and a separate lab area were among the renovations. She said the hospital bought personal protective equipment and trained staff in putting on the gear and taking it off to avoid contamination.  While there doesn't seem to be an obvious immediate return, the investment is paying off. Parrinello said the isolation unit can be used for other patients until it's needed to keep a person sequestered. She said the equipment is not used in everyday care, but it could be used in another type of emergency.  Parrinello expressed appreciation that Schumer was championing the cause at the same time saying the hospital will absorb the expense.  "It would be very appropriate to get reimbursed. But it is a responsibility we assume."  PSINGER@DemocratandChronicle.com  

passage/grade  |  time: 2016-04-25 10:50:35 771290  |  # of fields: 2  |  passage_id: 5114  |  score: 2

passage/grade  |  time: 2016-04-25 10:50:41 681772  |  # of fields: 2  |  passage_id: 5109  |  score: 2

doc/next  |  time: 2016-04-25 10:51:05 831135  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-867253bdb1c189d62fa636f0d6ee3b666a1d7fc78cd047927ea05becfbfc00e2

doc/irrelevant  |  time: 2016-04-25 10:51:19 725485  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-e842ece2ab22386987db8b3ae6ea0ba1ed2852fd17c30b86105269fdf65784f9

doc/irrelevant  |  time: 2016-04-25 10:51:45 281209  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-cf0814f57d61c65a0f76ebe7bc95fa867be935cd43c9a35b34a888ab5a22b29c

doc/irrelevant  |  time: 2016-04-25 10:52:11 412489  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-ce7180bb72edf3d48a2204388493132d4e8467d00cadbdafe8f4b732ea019292

doc/irrelevant  |  time: 2016-04-25 10:52:20 298943  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2d52c7dcfdd0d16d20150546fe1da0328140f20145c7bb9fc8a22c7746f4e164

findmore/blue  |  time: 2016-04-25 10:52:29 301643  |  # of fields: 3  |  topic_id: 397  |  subtopic_id: 193  |  subtopic_name: Who pays for healthcare

result_size: 0  |  num_tagged:  0

findmore/pink  |  time: 2016-04-25 10:52:40 638951  |  # of fields: 3  |  topic_id: 397  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola

result_size: 271  |  num_tagged:  0
ebola-3e93941e57cf11901d833b4dbd3f716d5670c0ae893ff3214f3398575cdbf1a0
ebola-7fc49bbcc6d86fb9583b8bdc9c2f03185ab265036a8cc0980b75888511986c2f
ebola-512030c75ac80f961496f4643621847cb04f54502702a3e32a4f2ec4a6fd16d2
ebola-fa0abee9d45e34bbd2b046dc7d0b5f2388d702d2a670af927c46cfd5f6c5c97d
ebola-a4535e04072fccdb0b10d2be1dd112191fca5e628c632f48ca7ea36894a49666
ebola-81cea2d3019cab6eb79ab6beabf2cb76c2d23ee28cdb73fd1c673af4575da3f8
ebola-2453d59835e2107fbf446589a9a404b480f846ed93554338f53b726816550d14
ebola-f95bd9ba983a2798ba2e277259a9534d971416035d83eb3cc082403cd1e3103b
ebola-e0e89c3f24f120b39b81dfadcd46decafc54b8a7ec80f6655c6e02b28c22e866
ebola-a396d3d6aad17d8b2a622e22dea38cbcfabce2d8dd91ae077e06dee2bf143967
ebola-6606d7a17b31351881ace9013aa8dbbc7904331e66645b55b3d4c46e51ee3df8
ebola-fdb84aa024920f315c6ede307a410e16edf8936197a0073bea57b44343dfaad6
ebola-c61a52356d35ff62e169646c8535a90e3c6ea9ed03f31457f1dbbdebf9fd0419
ebola-a8007d42a060458077600712973bd5123c12a95dd020f60546eefcb076f66d4a
ebola-f30841650154bafc6388f630add2c1d60dd49ff29c2704979d2e0c92d7d8b32f
ebola-e0db16f1168c3b340b9ddfaae8658a2128cb05e4e588c8db554950eb8c3c89e5
ebola-81ea4f25d42d164eeaa005f4ea02fedd5b50125bd767a212605c1e9634aac7c3
ebola-5e12b75e23946bae9ae0e74e4d653f910751d46bb5fef233570d939d4cd75d5a
ebola-5f571050e5d0b60d63f32ce6f21d1b7956ae9b6f20667eb0ba0d6553efd9fd0a
ebola-6f6b413c1dd5193e115a344bdf0b02326f10dbc6962bfb50e2f41cfa72c060a4
ebola-dac6d6822f298f48c9293faf2cb8746b269b8b5a1060021c6d88322cf4d160cd
ebola-dbb9a9e160741ff1bf6aa849fab3e9d69cc9dffa14a5dfb70d5d0dd9565879b5
ebola-4bdb78259b0c1b7dc43eb6388a74a3408555872f6e3dcd17a1a9786be1e45a10
ebola-1796a94c9db78b8dcd00a005f917d9a4d76f3a1eec7488a97cf5ed3e21a56da7
ebola-511630531451ab3a512cd87659521730a9ea39164dc2ca547747714211b477b4
ebola-26f5039bfb8f5ab8a0ed965cb5cb8e400ce12371290b2f794c42107b48d98694
ebola-1f91b5df9262fc9907633654ca2efc739c77eb927e595bcb6e746e5743494699
ebola-b263cd4372d5f073babfbf03044997041d0dbbe8c5517db5e63e75e3dfba2f3f
ebola-d3572e36b98e65ac7cb825dbf530ce389e27d6e407d0b4f09ddc1da52d49d5fc
ebola-7497531c8002343b5879613a09b5914fbfebd8616e32326bb95194d61007faae
ebola-bdebcd62d032e371d1c03718a79a2059a22d0756806172d05cb28ee878884202
ebola-b995130a157cd6814b0ad6baf365924ed540727d3b10b690c89b05b182454bc7
ebola-56df2d2967a03d160dab4457f0f5ec4b8b876c75b54df760077433bac9c4dfe4
ebola-e33a905a4fd1f91cf46e993cd530b6074c1c1eca7a2311cf866bb39f4d86b123
ebola-ae2802f19978ff3cefbebffae2f499da48a222c78761b8aeb23f9f0a054f673d
ebola-c62a7c914c0cdc21e19fd35a804498a57b686e17a20c56ae95be982f2a4f827f
ebola-7dd0e3880faad27d2d98b5143ed0ef59245047ed58d0ae137f2fc14d2a77c984
ebola-472dfcfde07c778daa1aead6f7845be157b0e1bb5cf67b8560d8dc0d56d33402
ebola-1df56ebc6ffd7b30c1a68e5f71601a9c03b064cc5a23b4dceba977ea62e225ae
ebola-1db00abe5fa4c2a1d9c44ddbe08087e1857925ffb6523e0bd775e9f0661a41f0
ebola-a90087f5421fbbf882cf951d8960aab2d6f7822c2219f46d44e7905a544ee004
ebola-5105e5c11849840cc55ce0f3c58c2e8ed47ad0b0105d30d4487e0669d2daeaac
ebola-33126c6e31557e3da3fc4170988c7f6c0be335d00f05569cabb1d27c1075e92a
ebola-45418cbd479d0e55107cca5ea14d50e199d536c05e64eb80a0ce33e633392f8d
ebola-73095a4814941fc31f36bdc1d8c9d5ef9aa430f85a06f649c65b007b60a6b507
ebola-339d324f984a3348763de7a334780123271f7b7e23ccee9d26f7a715673f9e23
ebola-bfa4262b7f0899666066f7b19e64b4acd90b561bd899b7498e9aace3934a5ebc
ebola-9a761f05d251c4f09eebcb9ce68825dcc162ef1946a0cdd5830c62d57708b140
ebola-c23ecc2857414fe14444a699fca2743ae0ce275645a10fb6d3964c33b0651ae0
ebola-3df9f57466a28b51b9dfde109bbef3231abda190fb6399ec0624d854281fd848
ebola-2d676395952d948eba383e7e261f42044c1cf0cc08ae0d244dcc3dec8a7e163e
ebola-41946754fb49b7cc4c5072f949c347035b5f5b211030f0931e8da1df2c4c74dd
ebola-782cd4d616ff1c519951e98e41121e929c12446e7641f3cf79f9fd0f717340ea
ebola-6278b72edcd51c550ca401ff8da41b2c946c742e466e6ec4b04055a10428e2b9
ebola-bf97e40c44aa3b0aefed3b9f656604a3c02accf3daa34a072a85e06931bebbd3
ebola-a00a42a1c656cd67d0221416d3a1be6ca309e29bbf4374cc3dba0c501b5343cf
ebola-d85160d41b3b887264e42ac58037658363f790230ac5f59c332cfcb80e170667
ebola-503109a27c4f3f6d8dfde31d7816b179cd710fd24769064386ef4057399d7367
ebola-87653f92bd9ab80a3fe56e09dee2b8c5729f46ffe2a3a3f5642cf7ce375a4f5f
ebola-be6faef276ee2ddfb5d65b984016777f2417e9fe9afaae21970c23675229eab6
ebola-3f55bb82f8da14eb666a5fe1257a8188a4ee97a7b0aa10dc809155d2ef1e4851
ebola-57e4f390b0263399debbe22dbdfba9414f860b79d38e08bfba05cbd6cd025174
ebola-024616cc8981647179f5ef81a66ea2d81881ea2ed6e7cd86290329d94b72c92d
ebola-acb0714cf90d34a7c0923c1fffd2b609b600095058982fce460c25461a7417cd
ebola-a28ffa62544e42843593ff33e0e0e97d2c46c8108d1bcaf3b32f50c46b65f948
ebola-1856df8c0b74a8c26b38ab27f3b4f6593d9e48ffe0142ef194a7972973833a94
ebola-7ed0519a67aead661ff0c9e6ba8f86c4f98e8afe7da915c797d8517103af6675
ebola-5e9fc4ee9497088ca62ba3268a286a240c122745bf5b88518a897d0f997afd5e
ebola-62158ccf4036152a23eb943d8c27905b7ec81cbfde12b98003f32ff96e7de5f8
ebola-8c9b668393977a662097071e4ed9798874e0782b23ab6b18079581d17275abde
ebola-a6f9725d88b0e6724401828cda00787d81cb40c2b5f80aedb0e8bc166ec0ac65
ebola-0745975295635831338b72df8b5bb702d0b1ffecd07de2397f62be3404be5379
ebola-c80474c6be1dae694c4926b9734ac493d5cd5a429c1e43df8efad172120a6992
ebola-6887bf700cc247c2b523f91d5b044a35dad4d911d53203792e5e6e19b4baa878
ebola-6ed7d7669d89ee66fbc8ae00e858af9561a9ac8d42aa55735fa2c71fa0599374
ebola-c33bd467a206560c7a1c5a53b9347fc501a87c24992a99804d112e9600b38f31
ebola-2728c78d2c0443ea4dc5c68f367c2fbaeb65fbe72df71ed42ee2c6311e4e2b03
ebola-bf71caf93e152299d21bdc5b4b76259103689d4e3f41361b7fc97292a8f31d2d
ebola-286b2bd945f03287cca854b3bfb9de8af8958d206392783fb04d18fda1710043
ebola-60fa62b69225345ce024f7c1064bd4a6d7dfee04fea9419e9ef12039ccb37f00
ebola-f62d4a3e5e653f9f149b947e981e8dc6a77b162b15ccb4b471acd3ea7f6449b7
ebola-af1930e8f473ce752c3e24bc5bf131bfff10ca46142eab1ddb99e16e7a9099fc
ebola-95796753fbdd2bec6a4a3cdb57991ec4d60db6011bf0743a9b1ef2dd44cabffc
ebola-1cf5de07bb53a68eb3a0771e24cb62df591ee84be7d18529d1e98aae846ce44e
ebola-e189448864f37187676a025f61a4e9e3b81b49ca3e00a444245bd720a487bcc3
ebola-86fd570b0d3c3bcdb101fe54ae6dc3ef81e17f16385cfb36fbd9d814bc486634
ebola-1620a8dec76faabc06b60938e07443dd0d5447daf99bd8c9d0ef6e0e64251629
ebola-07d90d6f05a0c90da5edf78b4a5b1f401433ce1eed00bbefd2c6bb17343a8a28
ebola-68c98b91f3194f081332d9133f6090e9f4fd835acdfdf6bde06519e4ec5a3147
ebola-c02d6117a835c95b691dc45b2f557cc939194a284cb0f98e815b6da3ad6014c5
ebola-505b657381b34f80f174b417b0aa0d1db379f7e546c266db9ad517faf7c6383a
ebola-5d24373ab833415b26ed29b39d67e24fe6abe065c0d508fb8425c4504fc0674a
ebola-0fdfd94e8c120557e1bc6ec6677c8e271a96035e170eb9c227cb208491c024e6
ebola-a78447306a1b77c9ac0f99ddfec538f9ec0eefa6483b2cce164c6426d84b739a
ebola-467545eee0abe5ecc247aa77a48f823e34f4db50568809d0e32d046b5f21f35a
ebola-128eeabe64425cd1322c0f5980f83cea6e2b43323fe449a3a852ce0eab7ecae2
ebola-579d1127ac4e46a18753ebbf5fd6b31670216711eaa0fe3fcd5e3151cf56ddc6
ebola-ce9212e5faa668ce43fb37e0e2b2932cd12044afd702e7fd7593dbf3c7c5b918
ebola-7e0d89c88454e839dcaa8157e53c41c3a1279b79f351ec47bd862da9460e3bae
ebola-ea5ae29af51d94a135517d743d9fcd168bb556b85ba3b60385354fa18d14e032
ebola-08397b193d2de6572e82baae9c55890577a21d30ad95ec37cb2150b5f229fc58
ebola-f40e2a5345a74b71d9ac6b9f193fba242f9cc94142a27e7ed95bf145bd8e6572
ebola-eab7586c7b36d6b4585e21cb14dbbaf7c7dfb2adbdb033865f9e683366d92036
ebola-1ec2bcea172e0dd3b24c54dbf749c8adae2726d43990a1fe66246b15a505922a
ebola-bbe23642f6caf2faba0ccb82c0813995388c18ead3042971bfd445c2d0032c3e
ebola-0bb24ca98ea20b3e0657c595371567a9c60a52ef8d5f42c65526ec57463c813f
ebola-eb2b8f58661bbc20a0e863192a99674d7ecd6aa1e5937d00da70b1863cf8426b
ebola-6b7e743fc35cc78adb31818be48629efd723873e7250a593529e4c0b9b917109
ebola-4f2e0890955df6d0499378d59c0a339f2c08fec8a03b8e161e5052487e2c4843
ebola-fa9adcb60b4547c8407b337ce9dab80539713f15af351afe9cbffcbb554e9ca4
ebola-70a3653024391107dcd99faadb89e70ddc2e8fbb4791550e0f8c732d0272751e
ebola-0ccdb4b82bd8229c4dc6615075d0dcb8be51ed141e7eefde8c42beb01e8b3968
ebola-1c1ebe54cc49861a568759bc48b73ae233ed5c0b42b0dbb9c47422fef38a98f7
ebola-d5bad72db14f21c845db1ecd541ccd72761d820e3c10924dc64d98ca364fb5b7
ebola-d7851c2ef5c905dd1345e0ce514a278424de629ca10e529d71ea788db97bc01a
ebola-7d2f38a86ff763f1a6786ed5dabba82cb7394edbd96c5a9bf13420507b2e4b17
ebola-974f93c94e7d82d24ff6d4de6f8d8394b95df56d53c8004ebf91da1ade9f186a
ebola-b154b4391eab78750f52416cbc2ffb1c184a5cb88f0d75892b80c200915d0f18
ebola-ca3f0c7edeac6f4cac1996e4f4499f9bab97e9f60c8bc873ba23dca893792e1c
ebola-ffb41c76210b6b62f940d62eaeec38a4beeef122ecdbb07a35e1d6ca60e3ad54
ebola-bae904d56a3eb537eab6db1ebe537e4fcf186efe3be6236ee2672f5d39a4eff5
ebola-36d62ffc6117f459955e2372bb7dc953ca4f7b246b1bce2440bc772708d76766
ebola-a60e954f8c78d153ab3285142047f6575e9fe12c77001ee766b47a7f23274b88
ebola-2fb5e35b3e52524e83e5c70469207e20f46268c8a7181a57fc0be3ac26914d22
ebola-cc92fe843107e60cc068dcefdce47dcbbe6d5197c837b880056a72a2bedbdf24
ebola-ea6a02e04acf73e209b7f0a435f7260ee92684167f080098924fd953777770d0
ebola-cb051a159a23d5e380f93758a9ddab9547697d5a990fef45a8e2d5285224dfa3
ebola-12f429c13cc7301b8d1a5ac774d5286e6c23f2fb33b866eb9a5fdc43a70bdc79
ebola-24f44caf85c89dd1912d85cfea4f70d085c4378564c8e41c3e96657639922e24
ebola-42fadf3eb8870fb2ad8448b8defa6ac1b114ef9ccce8a81a9655aa18e50c1148
ebola-bbe0be006d14605687063f7264f93dc960914e57bb1a17ef5e24139cb700f6b7
ebola-f9fd1cc26b2d6a8a4f03986750156c89544e5af6ef5aee25d4acee36d77fd038
ebola-50bf8fa4e3ff2566d6c49be7f1cd7bf1eae4127007f4ae0163d1945dd86cc240
ebola-e80f16c2ee9e4ee3b49f86009af4514228ff267060fd45160a82d310efbbf5ee
ebola-11f750659563846025df7d99dd5a6aaba570c4514fd6eb0d8e63bb350aacdb28
ebola-dc4ae690c3ec967091bfc78fe44b4d872267bd8c3379a70bdf94bf66982fa2d9
ebola-47dabc30c4d38ea2dacd5023478d8255b0e506b9d92911e1060ee54c8ab25031
ebola-115cdcb4c577d10eca274d90f0feb340932e83f5afd2819db7be8250304de9f9
ebola-701fcd30660da8cec7a95f40e5a09dcd89b79873f4f38c65bca018ebcd20afff
ebola-9cd74a745b650965f20c945a1e8ec8c38e1b9da2a21d68191a374b294f88a191
ebola-688abd82ba5cd8b8865ee987c549ea4e49698f458a1114b2d7db5b11a5595c3e
ebola-f47a55639f4c5464e23cdf3fdf2639d2b8641025d1103ec41ca139559cb5ea4f
ebola-5ee742e935630ff48e7332d07a4acd9d533c513cf37e6f73d53bc45a795fd821
ebola-8ba96de0fc580c0a2b7356c7e93024c254efb19962d67e9e3e804daafc9ada17
ebola-84d060de53e4ced33b296ca49b7c37b49e76c5378d97efae2b9f71980ec1e30e
ebola-40a1490116bee7d94427d52ca824b703f05475660c262f4b6122cae18486d563
ebola-1a092f2cc3e80523b25b86d19c2e2dee86a3ba1e393fda5c7a2f5b2d508f706e
ebola-9399669bf84dd1e5469d9754c5e5be2cb110bbe12412158cb036f546aa76f766
ebola-db17e185adf261dc947f4601eda0d59ee4515ec6ee5e2506a8f1066ff6e24b1d
ebola-2e20611d432e9fd9f46e10eec0dda1bd0ec434f1f03fdd5158ebf1a8e8fe3e3a
ebola-46f126d449e9e6b2e8d91e3c9af6b36b119461919ccbb2a041d0ed935bba2552
ebola-0c21f2070e99952774e37966022b51f38ad30f1e121b7e37c82faa0adba520ab
ebola-6b735bfe5120716efe3935959331801dcb1ce2eb4ea5711c75d5d58460fd6873
ebola-eff64730fe86217c6b3756c9c9c517756aadab5cd64f5266f36780bc401c7bf8
ebola-710755e9eef51ed104194d1b96b9e259a46e7af26a62650ea03e1dcc83ed7067
ebola-528dafb44eecaa47cfea93975c36681e41dbbea7ca5c631eb7ec17ba16eaa56b
ebola-f5761f1ad2fd247d3eec92ed54ac22fbc64ebce6aa71670fee48abd44e39e9e8
ebola-df05015e31fd446020864ecaa3ae58ad954c2767f28d9c43784a0649e8c93367
ebola-97575f64201202f2429d22f43dfd51b406b84ae5622b072ca6dd6feb413b3242
ebola-01ccd54b936018c5cf60583e714f5c56d3e05ed6f6391d9aa5664ada7efbac99
ebola-6173204cbc8645007be7508c43e2522676e1db96b034ddd0207b7ce8003ef943
ebola-76b654399ac8ba1e5860cb3eac5c139e9a9d6496a4c1794b9843d14610993a6d
ebola-046234111686d4832c1962b4ae874293c0c0b121c159fbdd82319d545adf3abc
ebola-d4cc82c163d695bbf18e0b31c1dab6478043fda87ac3826f2cbf7eaade4827a5
ebola-a83323794552816457bca08e5d2292a263c5bf098de221fbb8b69b111048dd0e
ebola-02c6d70e2ecf9a92769dc452706ed252f5cda08dc045c33db2d363caadb00187
ebola-f2d8d803cf3e063ae0ec406b3a05a6651cba693b6afe64565821b32e2e9252dd
ebola-ee082bf2014f5f1defe83e18caf83a0d4cc173c39055dcebc783a0fa3976eae3
ebola-64d07c4802914018fd24dd7b192b0d01cffb9be315eabc4235b4dfc1fcc13552
ebola-d49368b5339f61ae28e7a2302e56c16b39b7b36363f68234eab85ff6339c73fe
ebola-9f8786af06f82bb0e9746416090049584cd9ccf81c77f75ca563e9b5bd9e156a
ebola-ce44d09230b27c4fc60430ecf9add0f9e3f9f2bf0b4b994d68674ab6b2ee3f6c
ebola-39512cecf669cccefc9cb0c45bffc606d0147ba2360f1d646cf89d1ca61e6a06
ebola-2b56e46a6dd687746e0b6de44bfc6e09db4ede9819ac80eb7d16abdfbb1289b3
ebola-8e2e8dd762e6f15654e8e6bbc4cf320539ece327af0320d2eb2f675ac68432e3
ebola-5eed7beb1ff40623e658f1a10d0e4cc6f737cd1628c6c5a8796e6da6ad7499f5
ebola-48129284c6688c25cd308cbd335cd77588383bdcb9983255302c835b413451a3
ebola-c3637fec59a8ba6b305e7fe46a8ca81eb51566951e7b20652566d6d19b657928
ebola-57b103b802f03602527b8e63bf54cd578e16114481dfb35c6b12dc927f02e562
ebola-80ce3b4efc0e95792b0af3dfd22c0bd7b3a188aad62df6f99e25706155bc9f5e
ebola-82e6eebe3421fda594bdffd05c550be4c46fba2fc18bcdbf331de2091881ca33
ebola-00fb30c4354d0c5421a496ce7091ca1602b5f72bfe8317bfac676592eaa2d9cf
ebola-885c8d935991f92926a93321e4b15c184701b8ded37f23106d0072872c07271e
ebola-2aa6c4da511d6a9451bd51ccd757480f269949ed215c642aa56819947fd58add
ebola-caf6e63c01121ec02c30f85a585490eb22cee30b06c482a6f89d4bc042fdd428
ebola-2d758160e77b9a490061a7a1d38128b84a79d96be86fdd6ba64d279ffd574d27
ebola-eb542a07a79bce05876a196fdeea8c6c1a1a7e7a1f873ece52daf958ba0022f0
ebola-43a8e3ea1a078ed22c32799fdb9552668bea5393b4464cd206bafd6f7a3a0e84
ebola-b3b3a6ec2301f4273b71cb6bbc55039944806b1643a4f6aa6a3c94ca816782d6
ebola-8cfdb0acbdd10203a5f1ed4d504c7f34634f13e3656e1c6272fecaa463edec00
ebola-e72bc99ddc683efdd08808157339524f041d8eff86f45faeced974995bcbdcb4
ebola-0095f0dfe67c571a6719be821c43272994ff1fffbc07e0e52b5a5c5717c969c7
ebola-e83117b4026df49e7bed32c4d782693a5c1a6cdd7a42a29dec1b292c8a055622
ebola-a90a7c8cb47e3d30b62e153e5eae615b36a0d4e1bf5497c725fd5a26db71db22
ebola-43dba7c6224cd217f9fd8c3a36ec182e35f1c3c690f1a680d7de9baf89c6962e
ebola-7f5dc8644c6b53fbe2512b625be1c7a6f844e6de7a9deb362a41195bddcab6af
ebola-727710c8e2b8c53ebc8eafeb09c42e196412fd2d0d5515cab4735099fb2531a4
ebola-bfe516e94b475798b6613c015ae16134d460793c65363a88fb38ee11c9e93f25
ebola-96acef8590a3523f0452d920328ec7ee440a3748123550847d9e0d3a33599140
ebola-c5056a6c26513d4a9856a80e02a97a31f9b9f016155d202521e96df1fb857808
ebola-baf5dbcdd3efff8062ea5f4b1116f6c191bf89e74cdf61ff146c93678c05af3e
ebola-c298dd7e4fdfc852893d410f5dc30ddcdf5c040b6c384b7add43ada06c1af104
ebola-06a4523bb0a5a552ed659e2decac2b3ecbd667daba681a8f1cd57646f1df8f41
ebola-dbfd6b9e9f8242fc6a9c7242a7f96ca3e2eb87d6b4bf1dd46293e6ea974c74df
ebola-16ac8d17cff4cbf825cd827fe35cfd31994521d68700720bdb695cca8b71d985
ebola-9b61d75b66c06aa91575e1fc63de6eca096cde9d4a6dc5f039b212b69a97d1ab
ebola-a020d13824587a8d8c9750dc9d4e3acc2ea92c512d423c5f296de819bf79ed94
ebola-5f852d53681b019adc1b24e861abaa8a93fd553c8447ec858fe9891ed5050f2f
ebola-822fee5ad0388dc7d9ba0de3bdd2441d587fc119648457e3a6adb7bdec8b01cf
ebola-c745d81593b220a07a9cb4fc707c74dc8faa3bdccfdba108cd514a3df8ae97ba
ebola-5a79c562e3fa34bfeb388ecb3ae7f4a193ea71aa11eea5095e11327de997f2b5
ebola-81fc18fc721ce9eb548ffdc69b14cd94dcdcc42f400ba624199860a4398d621e
ebola-b8ac6a9e47aa097bc5fe87bd9b504f62fbd229263399d42128f0bd0a8987fc5b
ebola-42fc3ba69b12b2da0be5c1b7dbd7844e88859fee72f89c46de672d282eaa7627
ebola-22bf4d53449b3619e321341feaee6475c8adf5726804259d5b185b250a9970a3
ebola-51a2537599294613e090e441ae34b2be354898f74234866256d05ed5b1ca7b5d
ebola-0488aea42715fe79da83119ef9d1aa558e2ea53607ef0668ee8dc443bb59a03c
ebola-07f6e9b225ea2c83511d9a2820765902b1e46856618bfe3efe9ae06eb130cc47
ebola-3f267f816d947bdc84e4b8230f007ab02436f9fac9bd7079872d5095436e6e5d
ebola-eaf7354196a068d49ccad33d55631fd4c95d1e442dd7ab57a0d9fd719f53ac7b
ebola-69733a3bdc45948a0369f86b8a90ba38926b4ed7883d7dee103829e0a808ca7b
ebola-c524d55e3d5f2ee97266e415568408143b7bf447412541d9b60b246103ae7987
ebola-2de912d5cddb903da3c19aba7d3b83c362672dd6a917adab55fe3efd84b5d2b3
ebola-de2121ebde5917ff948543339fc8cf26d9e6472c86a43181622b2a64ba4e89ca
ebola-ad0dedba9ba3183534532b19e0c593672af5eef68baf7fe7e69c1e5e225a31ee
ebola-8b2387dd1dff0836f470d6d831fb96bf011712be5eb6566aebf08c19714f7deb
ebola-6f18ac1e5208771f2f0eaebb5abf10db2bc4a122cc59fa0737c05a45e8714a73
ebola-ac28d6c531421b39cb0bb92d2086a4978573bf7ad52b8df4085d900f61e02579
ebola-073fc25a24003b73042a002b9572d18bc610d29267c3a8d560c93ab7ffc3cf74
ebola-a28c7545fdd3f9479776180e197fbca1f5487aa27a134ef8d48ebe7e9e4da88e
ebola-a5b6e74624f271c82cefecb9adebe60cb2b860bc6881860afb9385778035ce00
ebola-13835d92eea6b34bebdb60fc3db2203433c87f379d4ea959bed431f95e91a330
ebola-74c913ff0e4ad16561817d123e25ace50982cd62a8dcffc12b0e7c4be5d41bdf
ebola-8454b9728035b9677e44e16feb76b1288d89968062ddf441d5bf04d446f1828d
ebola-924f4425bec124b3bbc1a28d3e05b88b45aa84f96ae3f7d6bc9e6a268dba00bc
ebola-b64a2f21a963621c2577f63ba53fd9d61ffd7146a422bdcbfd00c8dc313f45f2
ebola-9e0abb181d1f5947eab1d2db029cc3966d213dfe696775454a87ec55c9801766
ebola-b39363af0e4cda3fb7690cc1b9f5a3d1085dd04ecd05c9e6892140ae73f8cd82
ebola-7218197628f35fea101bb0595043e73089b701bf22b37691f9aa6c18c2dcf3e6
ebola-ebe29ef68759d396e7f76b555fb1cfec2281b13044d01cffd91d2fd62ed7e4aa
ebola-238747aacc7ccbb68ee66381479b58f8580ee6676d6664ba79b8a32c2601abb4
ebola-6ece05b00aff0d189e208e5f387b96b0354bb5283f4b1c58dbad6fdcba04653b
ebola-b3f767c56b822f0752f99c05cd623d60bd9c293b3bb1ed13ba88b87b8d082147
ebola-362dfdc1749fd522c223a90bf46087819564f496e531cf46d3e4c3b564182757
ebola-c520547cddb33d4ea68352a6583cb7f746508c69e9f6995413cbecf49ce846a9
ebola-7418fcdbe10e844f8732492ecc1e3aaa2438f4dc92dd157861104e3731fc012d
ebola-941f020924f0c6c8a21f281ed4b882c4f68aa5cf5188774bdca6bc84c55e7d8b
ebola-ad92ea4f8859c9a864a465ae97f84336e10b4e7441bebeb8614e4d017a4b9bdc
ebola-897e1a2209378cf76dac49191bd9f8e6043fa6df8a721e9a577ed149ca0a576a
ebola-7927e85ba3af0dbfbd2ff7431ba910a8827a9d9b398918bae2e51732acfb2cad
ebola-497d28e0fa8612994e87fac96e66288f7be4905b54af0197099ada2147841fa9
ebola-2c63f836937e9e79253a848ee42f16f22f31ffbaa98c17a805242efeecc06672
ebola-1ebd6a466056279fce5e89d3706dc7736d54b4f0017a7946af1d8e3ce6649780
ebola-ab3023788870e30fe9e3c943aeda14f4a82fa95656cd4fb78f448eb343589c92
ebola-ef7b5ffcdc848b7f95adb8f68dbd3bcf19face15e67212c882186b1b734048cb
ebola-40685639506ea5ca12ebaf7396835d579075c95fea7e8f973c6b50989b5df91c
ebola-02fd982cecb3f9e911f9f587a1d9f0ca61ff1280f69837235370be4aecfc94ed
ebola-d5d5dd1d77cd57afda99aeab38a7723799f3b8ddbe44f8e6f02c2bcfb0e902ec
ebola-9ae30620a9de33cf1a54d01ffc764ae7d2d138852f041efc4d11923c543f0fac
ebola-d1793778098ce2fdc70d7bebb22c93b4043ce1322f68f5c0ce0add516bf7b489
ebola-c740d3479a96937b688c85042ff8f458b8b232f357b695e617b77f0ffd099b54
ebola-232cfce3da659ce894c9a13b76aa2625836e532e6e47e5abc331ad56d5e64268
ebola-89776601d5373b3657368856b57d218c03486d19b3fa49efafc6bae3b754f516
ebola-6039417afec661b3bbe1dcc9c1fcbd6204d2e66f9419f2f0afea40b4c8818c4a
ebola-b8792c81e9adcf5aabbe3571c3a4fc3d92313fc3808550be242d26f3bb8140a1
ebola-3c2bbff4b2d2b4ce0c47aac15f50deb16cd82fa5e011cf1a7b8d0b295dfc3ef3
ebola-0ba5f693384fd6d4fd06eb1399d5d139dde1054cdc1ffdb2f90f14ec4930b4aa
ebola-0285b5c964b4a0f7316593b6dd8697e32b65d3e751615dbe8a44f370ce94f97b
ebola-5c9a94916ff51bca50adcf65d5658b19bd87d88fc96b86d69d5ee004c5e524a9
ebola-2581674f1f38530956761af10853b641475659295452a753eead53bd35820963
ebola-5ee4be3b5e7f1f9c1a5f5d5cc114c45f62790b2c5362bfee710956b1abedc7c1

list/click  |  time: 2016-04-25 10:53:03 916078  |  # of fields: 4  |  topic_id: 397  |  docno: ebola-3e93941e57cf11901d833b4dbd3f716d5670c0ae893ff3214f3398575cdbf1a0  |  listsource: pink_findmore

highlight  |  time: 2016-04-25 10:57  |  # of fields: 3  |  topic_id: 397  |  docno: ebola-3e93941e57cf11901d833b4dbd3f716d5670c0ae893ff3214f3398575cdbf1a0  |  highlight_string: costs, ebola, insurance, providers, impact

passage/create  |  time: 2016-04-25 10:58:20 540642  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 5132  |  passage_name:  An ambulance transports Texas Health Presbyterian Hospital nurse Nina Pham on Oct. 16 in Frederick, Md.  Nina Pham, a Dallas nurse who contracted Ebola while caring for the first person in the U.S. to have the virus, is now Ebola-free. Getting a clean bill of health took 13 days in the hospital and an estimated $110,000.  Daily hospital care for Ebola can easily reach $8,500 per day, according to Lockton, a global insurance company in Kansas City, Mo.â$6,000 a day in an intensive care unit, plus $2,500 per day for additional costs, such as physician fees and aggressive support therapy. Costs may even be higher than that, says Eric Justin, Locktonâs chief medical officer, if there are other health complications. That was the case with the U.S.âs first Ebola patient, Thomas Eric Duncan, who was also on dialysis.  Based on a two-week confinement, Lockton estimates that the minimum expense for an intensive care unit alone at any hospital would reach $100,000. Experimental medication expenses or care in a specialized biocontainment facility could easily push costs to $500,000 or more. That doesnât account for potential complications like loss of hearing or vision, bringing disability or long-term health care costs into play.  So who would pay? For now, standard health insurance policies would respond, although itâs unclear exactly how much care they may pay for, says Logan Payne of Locktonâs international practice. Most health-care policies, for example, wouldnât cover experimental treatments, but Justin says patients canât be charged for such drugs as ZMapp, which has been given to several Ebola victims, until after the FDA approves them. Thus, âfor an indeterminate period of time when those experimental drugs are used,â there likely wonât be a cost for the medication, he adds.  Depending on how a person contracted the virus, Payne says workers compensation could cover medical costs. Insurance carriers would have to determine if the exposure to the virus happened while the individual was in the scope of her work. Health-care workers, therefore, would most likely be covered. Aid worker and nurse Nancy Writebol, who got Ebola while she was working in Liberia as part of missionary group SIM, is covered by SIMâs health and workersâ comp plans; SIM plans to pay her $25,000 deductible, according to a SIM executive. NBC and Vice Media are helping pay freelance cameraman Ashoka Mukpoâs medical bills because he contracted Ebola in Liberia while working for the media outlets.  Some insurance companies have already addressed Ebola insurance concerns in recent days. On Allianz Worldwide Careâs (ALV:GR) website, the insurer released a fact sheet that says, âPlease note that all Allianz Worldwide Care policyholders are fully covered for all investigations into, and treatment of, Ebola infection.â And on Cignaâs (CI) website, 

passage/grade  |  time: 2016-04-25 10:58:23 106915  |  # of fields: 2  |  passage_id: 5132  |  score: 2

passage/create  |  time: 2016-04-25 10:58:26 720609  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 193  |  subtopic_name: Who pays for healthcare  |  passage_id: 5133  |  passage_name:  An ambulance transports Texas Health Presbyterian Hospital nurse Nina Pham on Oct. 16 in Frederick, Md.  Nina Pham, a Dallas nurse who contracted Ebola while caring for the first person in the U.S. to have the virus, is now Ebola-free. Getting a clean bill of health took 13 days in the hospital and an estimated $110,000.  Daily hospital care for Ebola can easily reach $8,500 per day, according to Lockton, a global insurance company in Kansas City, Mo.â$6,000 a day in an intensive care unit, plus $2,500 per day for additional costs, such as physician fees and aggressive support therapy. Costs may even be higher than that, says Eric Justin, Locktonâs chief medical officer, if there are other health complications. That was the case with the U.S.âs first Ebola patient, Thomas Eric Duncan, who was also on dialysis.  Based on a two-week confinement, Lockton estimates that the minimum expense for an intensive care unit alone at any hospital would reach $100,000. Experimental medication expenses or care in a specialized biocontainment facility could easily push costs to $500,000 or more. That doesnât account for potential complications like loss of hearing or vision, bringing disability or long-term health care costs into play.  So who would pay? For now, standard health insurance policies would respond, although itâs unclear exactly how much care they may pay for, says Logan Payne of Locktonâs international practice. Most health-care policies, for example, wouldnât cover experimental treatments, but Justin says patients canât be charged for such drugs as ZMapp, which has been given to several Ebola victims, until after the FDA approves them. Thus, âfor an indeterminate period of time when those experimental drugs are used,â there likely wonât be a cost for the medication, he adds.  Depending on how a person contracted the virus, Payne says workers compensation could cover medical costs. Insurance carriers would have to determine if the exposure to the virus happened while the individual was in the scope of her work. Health-care workers, therefore, would most likely be covered. Aid worker and nurse Nancy Writebol, who got Ebola while she was working in Liberia as part of missionary group SIM, is covered by SIMâs health and workersâ comp plans; SIM plans to pay her $25,000 deductible, according to a SIM executive. NBC and Vice Media are helping pay freelance cameraman Ashoka Mukpoâs medical bills because he contracted Ebola in Liberia while working for the media outlets.  Some insurance companies have already addressed Ebola insurance concerns in recent days. On Allianz Worldwide Careâs (ALV:GR) website, the insurer released a fact sheet that says, âPlease note that all Allianz Worldwide Care policyholders are fully covered for all investigations into, and treatment of, Ebola infection.â And on Cignaâs (CI) website, 

passage/grade  |  time: 2016-04-25 10:58:29 644359  |  # of fields: 2  |  passage_id: 5133  |  score: 2

doc/next  |  time: 2016-04-25 10:58:45 678435  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-3e93941e57cf11901d833b4dbd3f716d5670c0ae893ff3214f3398575cdbf1a0

doc/duplicate  |  time: 2016-04-25 10:58:59 293314  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-7fc49bbcc6d86fb9583b8bdc9c2f03185ab265036a8cc0980b75888511986c2f

doc/duplicate  |  time: 2016-04-25 10:59:13 244697  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-512030c75ac80f961496f4643621847cb04f54502702a3e32a4f2ec4a6fd16d2

doc/irrelevant  |  time: 2016-04-25 10:59:20 138193  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-fa0abee9d45e34bbd2b046dc7d0b5f2388d702d2a670af927c46cfd5f6c5c97d

doc/irrelevant  |  time: 2016-04-25 10:59:26 596113  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-a4535e04072fccdb0b10d2be1dd112191fca5e628c632f48ca7ea36894a49666

doc/irrelevant  |  time: 2016-04-25 10:59:30 157474  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-81cea2d3019cab6eb79ab6beabf2cb76c2d23ee28cdb73fd1c673af4575da3f8

doc/irrelevant  |  time: 2016-04-25 10:59:41 198463  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2453d59835e2107fbf446589a9a404b480f846ed93554338f53b726816550d14

doc/irrelevant  |  time: 2016-04-25 10:59:49 657507  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-f95bd9ba983a2798ba2e277259a9534d971416035d83eb3cc082403cd1e3103b

passage/create  |  time: 2016-04-25 10:59:59 504138  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 5138  |  passage_name:  Cost of treating Ebola: $1,000 an hour  October 13, 2014 | By Ron Shinkman Texas Health Presbyterian Hospital may have spent as much as $1,000 an hour in its futile attempt to treat Ebola patient Thomas Eric Duncan, Bloomberg News has reported. Duncan died last week after 11 days of treatment. The costs not only are linked to the intensive care Duncan required, but also the fact that he was also kept under strict isolation--a protocol that disrupted other hospital operations. Altogether, the cost of treating Duncan may have exceeded $500,000, not a penny of which is likely to be recouped because the Liberian national lacked health insurance. Article  Source URL: http://www.fiercehealthfinance.com/story/cost-treating-ebola-patient-1000-hour/2014-10-13

passage/grade  |  time: 2016-04-25 11:00:01 783903  |  # of fields: 2  |  passage_id: 5138  |  score: 2

doc/next  |  time: 2016-04-25 11:00:10 230042  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-e0e89c3f24f120b39b81dfadcd46decafc54b8a7ec80f6655c6e02b28c22e866

doc/irrelevant  |  time: 2016-04-25 11:00:13 601424  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-a396d3d6aad17d8b2a622e22dea38cbcfabce2d8dd91ae077e06dee2bf143967

doc/irrelevant  |  time: 2016-04-25 11:00:22 237652  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6606d7a17b31351881ace9013aa8dbbc7904331e66645b55b3d4c46e51ee3df8

doc/irrelevant  |  time: 2016-04-25 11:00:53 494596  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-fdb84aa024920f315c6ede307a410e16edf8936197a0073bea57b44343dfaad6

doc/irrelevant  |  time: 2016-04-25 11:01:01 240465  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c61a52356d35ff62e169646c8535a90e3c6ea9ed03f31457f1dbbdebf9fd0419

doc/irrelevant  |  time: 2016-04-25 11:01:17 413478  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-a8007d42a060458077600712973bd5123c12a95dd020f60546eefcb076f66d4a

doc/irrelevant  |  time: 2016-04-25 11:01:25 812937  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-f30841650154bafc6388f630add2c1d60dd49ff29c2704979d2e0c92d7d8b32f

doc/irrelevant  |  time: 2016-04-25 11:01:34 566925  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-e0db16f1168c3b340b9ddfaae8658a2128cb05e4e588c8db554950eb8c3c89e5

doc/irrelevant  |  time: 2016-04-25 11:01:49 177141  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-81ea4f25d42d164eeaa005f4ea02fedd5b50125bd767a212605c1e9634aac7c3

doc/irrelevant  |  time: 2016-04-25 11:01:55 753588  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-5e12b75e23946bae9ae0e74e4d653f910751d46bb5fef233570d939d4cd75d5a

doc/irrelevant  |  time: 2016-04-25 11:02:04 537928  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-5f571050e5d0b60d63f32ce6f21d1b7956ae9b6f20667eb0ba0d6553efd9fd0a

doc/irrelevant  |  time: 2016-04-25 11:02:16 300095  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-6f6b413c1dd5193e115a344bdf0b02326f10dbc6962bfb50e2f41cfa72c060a4

doc/irrelevant  |  time: 2016-04-25 11:02:26 317518  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-dac6d6822f298f48c9293faf2cb8746b269b8b5a1060021c6d88322cf4d160cd

doc/irrelevant  |  time: 2016-04-25 11:02:33 459102  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-dbb9a9e160741ff1bf6aa849fab3e9d69cc9dffa14a5dfb70d5d0dd9565879b5

doc/irrelevant  |  time: 2016-04-25 11:11:16 858746  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-4bdb78259b0c1b7dc43eb6388a74a3408555872f6e3dcd17a1a9786be1e45a10

doc/irrelevant  |  time: 2016-04-25 11:11:28 888856  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1796a94c9db78b8dcd00a005f917d9a4d76f3a1eec7488a97cf5ed3e21a56da7

doc/irrelevant  |  time: 2016-04-25 11:11:45 630329  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-511630531451ab3a512cd87659521730a9ea39164dc2ca547747714211b477b4

doc/irrelevant  |  time: 2016-04-25 11:11:59 827180  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-26f5039bfb8f5ab8a0ed965cb5cb8e400ce12371290b2f794c42107b48d98694

doc/irrelevant  |  time: 2016-04-25 11:12:10 814014  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1f91b5df9262fc9907633654ca2efc739c77eb927e595bcb6e746e5743494699

doc/irrelevant  |  time: 2016-04-25 11:12:22 466941  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-b263cd4372d5f073babfbf03044997041d0dbbe8c5517db5e63e75e3dfba2f3f

doc/irrelevant  |  time: 2016-04-25 11:12:31 295717  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-d3572e36b98e65ac7cb825dbf530ce389e27d6e407d0b4f09ddc1da52d49d5fc

doc/irrelevant  |  time: 2016-04-25 11:12:57 069636  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-7497531c8002343b5879613a09b5914fbfebd8616e32326bb95194d61007faae

doc/irrelevant  |  time: 2016-04-25 11:13:06 036741  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-bdebcd62d032e371d1c03718a79a2059a22d0756806172d05cb28ee878884202

doc/irrelevant  |  time: 2016-04-25 11:13:17 223256  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-b995130a157cd6814b0ad6baf365924ed540727d3b10b690c89b05b182454bc7

doc/irrelevant  |  time: 2016-04-25 11:13:32 101307  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-56df2d2967a03d160dab4457f0f5ec4b8b876c75b54df760077433bac9c4dfe4

doc/irrelevant  |  time: 2016-04-25 11:13:45 273514  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-e33a905a4fd1f91cf46e993cd530b6074c1c1eca7a2311cf866bb39f4d86b123

doc/irrelevant  |  time: 2016-04-25 11:14:07 717432  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-ae2802f19978ff3cefbebffae2f499da48a222c78761b8aeb23f9f0a054f673d

doc/irrelevant  |  time: 2016-04-25 11:14:14 555204  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c62a7c914c0cdc21e19fd35a804498a57b686e17a20c56ae95be982f2a4f827f

doc/irrelevant  |  time: 2016-04-25 11:14:22 269324  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-7dd0e3880faad27d2d98b5143ed0ef59245047ed58d0ae137f2fc14d2a77c984

doc/irrelevant  |  time: 2016-04-25 11:14:29 465494  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-472dfcfde07c778daa1aead6f7845be157b0e1bb5cf67b8560d8dc0d56d33402

doc/irrelevant  |  time: 2016-04-25 11:14:39 334378  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1df56ebc6ffd7b30c1a68e5f71601a9c03b064cc5a23b4dceba977ea62e225ae

doc/irrelevant  |  time: 2016-04-25 11:14:50 315761  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-1db00abe5fa4c2a1d9c44ddbe08087e1857925ffb6523e0bd775e9f0661a41f0

doc/irrelevant  |  time: 2016-04-25 11:15:14 787698  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-a90087f5421fbbf882cf951d8960aab2d6f7822c2219f46d44e7905a544ee004

passage/create  |  time: 2016-04-25 11:15:40 539837  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola  |  passage_id: 5160  |  passage_name:  Sylvia Mathews Burwell, the secretary of the federal Department of Health and Human Services, issued a spending plan on Thursday for the nearly $2.8 billion in Ebola funding allocated by Congress, though the plan is too short on detail to know if New York will receive the money advocates have called for.  The majority of the money—$1.77 billion—will go to the Centers for Disease Control and Prevention. Of that, $1.2 billion will go overseas to help combat the epidemic in West Africa, with support for programs such as labs, infection control and waste management.  The rest of the C.D.C. money will be used for domestic initiatives, such as preparing states to respond to an Ebola case, paying for quarantines that were put in place and worker training.  Burwell was directed to provide a "detailed" spending plan 30 days after Congress' $1.1 trillion spending plan became law. That deadline is today but Burwell's proposal provides only top-line numbers.  

passage/grade  |  time: 2016-04-25 11:15:43 556472  |  # of fields: 2  |  passage_id: 5160  |  score: 2

passage/create  |  time: 2016-04-25 11:16:19 774386  |  # of fields: 6  |  topic_id: 397  |  topic_name: healthcare impacts of ebola  |  subtopic_id: 193  |  subtopic_name: Who pays for healthcare  |  passage_id: 5161  |  passage_name:  If the funding is routed through state governments, it would allow the federal government to reimburse hospitals even if they are not federally designated Ebola treatment centers.  "Costs incurred by hospitals to treat ebola and prevent its spread should be reimbursed to the maximum extent possible by the federal government," said Rep. Nita Lowey, the ranking member on the House appropriations committee. "I will work to ensure hospitals are compensated properly for their work during this public health crisis."   H.H.S. will also spend $157 million on research for an Ebola vaccine and other therapeutic candidates such as ZMapp, and $25 million is headed to the Food and Drug Administration.  

passage/grade  |  time: 2016-04-25 11:16:22 167803  |  # of fields: 2  |  passage_id: 5161  |  score: 2

doc/next  |  time: 2016-04-25 11:16:24 444507  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-5105e5c11849840cc55ce0f3c58c2e8ed47ad0b0105d30d4487e0669d2daeaac

doc/irrelevant  |  time: 2016-04-25 11:16:32 129999  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-33126c6e31557e3da3fc4170988c7f6c0be335d00f05569cabb1d27c1075e92a

doc/irrelevant  |  time: 2016-04-25 11:16:40 803576  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-45418cbd479d0e55107cca5ea14d50e199d536c05e64eb80a0ce33e633392f8d

doc/irrelevant  |  time: 2016-04-25 11:16:49 834376  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-73095a4814941fc31f36bdc1d8c9d5ef9aa430f85a06f649c65b007b60a6b507

doc/irrelevant  |  time: 2016-04-25 11:16:55 217758  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-339d324f984a3348763de7a334780123271f7b7e23ccee9d26f7a715673f9e23

doc/irrelevant  |  time: 2016-04-25 11:17:03 904969  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-bfa4262b7f0899666066f7b19e64b4acd90b561bd899b7498e9aace3934a5ebc

doc/irrelevant  |  time: 2016-04-25 11:17:12 813234  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-9a761f05d251c4f09eebcb9ce68825dcc162ef1946a0cdd5830c62d57708b140

doc/irrelevant  |  time: 2016-04-25 11:17:23 013165  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-c23ecc2857414fe14444a699fca2743ae0ce275645a10fb6d3964c33b0651ae0

doc/irrelevant  |  time: 2016-04-25 11:17:29 434246  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-3df9f57466a28b51b9dfde109bbef3231abda190fb6399ec0624d854281fd848

doc/irrelevant  |  time: 2016-04-25 11:17:40 563631  |  # of fields: 2  |  topic_id: 397  |  docno: ebola-2d676395952d948eba383e7e261f42044c1cf0cc08ae0d244dcc3dec8a7e163e

findmore/blue  |  time: 2016-04-25 11:17:53 242814  |  # of fields: 3  |  topic_id: 397  |  subtopic_id: 178  |  subtopic_name: healthcare costs of ebola

result_size: 0  |  num_tagged:  0

topic/create  |  time: 2016-04-25 11:21:44 976215  |  # of fields: 4  |  domain_id: 1  |  domain_name: Ebola  |  topic_id: 417  |  topic_name:  Ebola medical waste

topic/select  |  time: 2016-04-25 11:21:45 077275  |  # of fields: 2  |  topic_id: 417  |  topic_name: Ebola medical waste

query/lemur  |  time: 2016-04-25 11:22:11 175526  |  # of fields: 3  |  topic_id: 417  |  topic_name: Ebola medical waste  |  query: ebola medical waste

result_size: 300  |  num_tagged:  0
ebola-f9299cda6db2203ce2f9476ea9b26a6b9cce371828efbd763fa83eb7e6e150db
ebola-6aad85f9fac9b94b639b774d81664ae861480f50657c7f3da739a419c6e2b37b
ebola-a56c6f151c3bfeb7b43f508d924244f6c3c7a05460d517721d9c1744375fcdd1
ebola-49e38b469f16a2af567d234fb7e04de1f71e91a646e079c02f73f4783ecba0ba
ebola-77091a96d4ac625edee1199df78033413a49694b956dcb5f8948b6c6feeb496a
ebola-c5edfde546768a9330228bcde0171a46a7a67cf654a547adc9b1b30590294e41
ebola-07b05105695e564aba0746b56ce3e745bbe9bd3d6644ea799d69a815a044d09d
ebola-306347d0daf3791561ecbc809ee333c4f1b306d33168d0cc957ac122c8cbbee2
ebola-d65cd5ce5fc1fa9af890f6564b24f6003a3263b610a77cd231a640b6409b59dd
ebola-f2ceca1e829f1202d31674bd9439bdf069fff11ae7eacb2e15447c969f680db3
ebola-e6f1116e939b49f1e484d2e863c4967652a7fb52dafa6319371b5c46b04fa9ee
ebola-22d639ebb2b968b07149bdc561572b9acd6a83762954b55a51a2a2566ff49c54
ebola-16247a95a0a2fcfeb248bafa15826c0fefa77685092d6db7e681e1ddb88ebdb2
ebola-0e05aaefaa744acab64abd6e1a9f7f04857199f4afee4075f62a3843f80ff70e
ebola-c57812f51bdf5852f6679757c813040663bf7646c3be357759f85ba6f7ae35c1
ebola-ea43d97e245053cfc851104648daf68bbccab96d61b86e5d689257de9a4e6668
ebola-e2d0ab4bdf9bfe258b4a3e2146fa74fd81d313db8b7bd9a6a9f8b22f014f979d
ebola-ea48d95a92957b7042affb669fbdad4f69f0ac53cc27f20fba7e560da3f1ebc7
ebola-6889b577976fabec6831d275bf9fb2487f991f318f37217f5668dfcfb364c93b
ebola-27e9b9967565bbaab95f071e7d14267d03ff5b768eecc9252ea07960b0fff579
ebola-f08ab63d91cd3f3804f8594d62acca58c1cb9b3b31d4442058cc62720572344f
ebola-99e0d32acf65f4c29aa425fbc7a0d7b1883320311a0d8de5285421e0f2a7e2d5
ebola-b1bc66b0e46c2bf2b09a3e8dbb191834ba598ea412148cb7281129b55c8343e2
ebola-44d54792969ee477e8f741da64e7ee86a444c6dc322371116fef408933b431d8
ebola-5d7e503bcc861570c472e9ee241df123a9ea712c355f0ef13ab930d1fe3d86df
ebola-008c044f564afa636e57f49d63cff85159554ba089f078fc77945c049d2d4099
ebola-fee73c84cb32df01efaf319f8b7d8a5f0f95b2fac138901786cda2b1a5bd247b
ebola-5cf32a3a76318d3274909f4c3717a95aa29ef0f6cbad776c3a2cce054cd51ffa
ebola-82c2334cce1bbd5b7e02e2621ee4cb37012ae1545a6e13078b35991eea765a5c
ebola-1dd1377a2de0b5f4e1deff23d332c947ca45bbe8dc863aeba4871b9c94f7ba29
ebola-c2e3799889f9227123d7ee568ec200f1ca78ea5520858704687dea484ec1d113
ebola-8215d9a7fa3f20828cafef8f84f2d2df13db8b79c3d2ccd4cb55eafc97c505cb
ebola-d52b344dd81ab636a9ab703a5d64fd25955e24a61e84e834412a4c3a82e7dcb4
ebola-06d0cf0e6165816a9d6f292e3f4ec4c2f12b3a05c02f98a43902ba7f98afcb7e
ebola-db33746749bfe39e7272b133230b8f60767256ea40f4390fa104e411b28cb9ef
ebola-59b9d0abba54950c55e421c0056be42951d91aea55eb29cb6e92e206ebe36e7f
ebola-0cd75de9b194f51adbf1ee78b744132fd6307cd6df9f49d1a72ee913680aed13
ebola-8ae707691026b36bab3c79f675a414a74e9163e96fb01460ee9bfd980a08ef8c
ebola-58428a420e8f57e21650d31946d406492cdf981805b0c74f9fbf3543e4648362
ebola-e912f5e7a8d7577532661034d4b4497b2333b71b7209d7d0cfe3026dc38532bc
ebola-5c23ff9348e5718ee801743d7ce45e63bb93e30e4b49c22929c88a7b3859c836
ebola-781e6e8c82ad1e5e2f8f346f69e8e9701defc7509e057983a84c524bd24d3899
ebola-c973b45a5fb1b43780d3ab1a49b6bbc1ab984cca4b87e41a922c1858e9e5c330
ebola-66b29df52280e4f9fb683300cfabc8bf101d0c2cb3447fdff184e5d2e1c3b5e9
ebola-b96df72d4fc9a2bf3b1d1d44087beb66d3815dc918c1f05c5c71bdbfa2d4e3f7
ebola-5ca63115e384dd7f0a2cc60feadda316a01f061e2f589700b476fc84cdf2aac7
ebola-bb6df3d26b4d71cb3dff3229e62482ad3b424c25a6eff7808e58ac15051ca838
ebola-3f9fc26fd2381c629a98797575df78cddc13761c95e6f59b351fc5336fb0e903
ebola-89841e13c81c777d1409ab921ad3dba6ff8f998fb32d5010c85b17bb6e0ca237
ebola-2daaf7f91339fe4f73be3c5a53c80e59220c5ecec4474f658bca4fd2cdd03684
ebola-85fbbb06a6e03ca7bdece332e9a1820902b0d05f8f288d81e790e965c2e53e53
ebola-5ca94959e81e07712fe34e9b5532bd46a664d50af74600c1cdaf659ca0c29321
ebola-f7a01e636284f54d6b08f0f3a2cc59ab0c311c855e78afebb7dabf211a141614
ebola-3975570851fcf8092e11b9553a29edad22ad3bf67eb9bc4cddb52275641b875b
ebola-5b7ad0559b1dd4d9211ea387d77826f95800261ed97c94872920f900b645efd1
ebola-f09497a6a089ddc1b8965d992d67122ac947a51ef24d1a83ab90cf2d5880012f
ebola-4b88b120b8c06ff46b2c2fbe97147e1bc21972142687d01e98b3e9e4b0e23ac9
ebola-5f8c2554f46c3cd90157b57676e649c3e1965785c2ef6cf57b6544e8b7a3f6cd
ebola-d56f3c65a4d8a47731dd9f60da225abd753c574b81c5b05f808e3ac9fce9c711
ebola-2638d49c8ca993a6b559fa97cd0572bac6e59c7a0c20e97be9726ee0ded1ab24
ebola-4fa8aa0cf552334d823d69c9eab5c49224e2169cfbf71b7bd89fce6c2ef26844
ebola-7c4baeafec00a23e4387a4bcc8d6562d24ab0313f11c562e465d6c8e17a070df
ebola-7cee6d70977d2604c67f43822f3c7d2a390ed1456c6f766b26b28abb2991d87b
ebola-c276320148c13708aed70b61637078328deeeb6bcba4f04bf910230de03a0530
ebola-dfca159b0fb8af489ac7c9310166190bdfc47116de44f548722a86a5f68435b7
ebola-b60093340d124a0021cc656138212c7ebefb890b102399eec38b766367ee3686
ebola-4ea41c17f751353b74791656e45e3c15b68de012e9e588a6e1686b2c041b64a7
ebola-5f458c0da7225e6d95647f6c937bd3aa2cc66eda0c8cb2a6043ce556d622fad9
ebola-063b3c2e0fb2ade0f07ecb0893366ac44c0ab63b210f4b3df995b5868e38c56b
ebola-af3ffa16a42eb3692fc84c811cf9d50fe798f1352682794ba4deed5312e0b988
ebola-4fabd3c1ca1f98fcff9f073fc7dd63aecccdb2d619e74495a2432f90062f53b7
ebola-5c0a3f3a599ddefb91d97544b9e03b258df46642ee1b50e692d2d2fba36d1a27
ebola-fe004c2cb2374883831a3b5095cc4692588519863323fd27a59908345f59b9fc
ebola-aa5812bf96069b34a9c7d51d35284161f8eb24d1abd7ecdc65cb56667beee9cd
ebola-2ff461e540113f6d154f4cfd531d8a42832a463f4304e41eea301f2c18c9097d
ebola-1f5b2440f10dcd56ed9fdf3a184f7d2e9ce0cd6eb7283545055d91030786975e
ebola-06850447074cceb767fd0bc768f0824940e627cc1bba23bd4f1b2c4ad414995b
ebola-bb660bbc1075b644f3efceee27d535685937d3bad12323322ee56b7c3e35f334
ebola-183d930a763db2c747d36ded804d5d51a3a23a8ca03d200327d0ad59c1341b42
ebola-dd7a56319537cdf4389417f1442316605e3091d4c370c208fc225b4e777390cd
ebola-075305f1dffb4d676e26df81ce0a4b9fbb7d2447bad354ff0cd0f4e6514a7dc6
ebola-d52f1376144b27d28749e0480901712299d88bafa9e04a8cfa01cafa5391eedc
ebola-e0ac128dc39bf24030218dea5a184f4f04a840754cec0e3a781ee1a7a8a53a0e
ebola-4c39c2762cc04dc9e1d0d450bef08c2af2b707b84a94d08e6599d8272fc0cab8
ebola-806ae93ca716efcc3b1e0993315414d8cae35a009ac5c8c0da1c20f0caf123cd
ebola-69011e54413760c68f0420f761250e215405fbbde8d065e86b810654644cd1e3
ebola-f6bb1c00a73395b1c017737211c7d6b0f0e111203e7762b997c1a3f89ad9ce33
ebola-821ae4f2028bd0f16a1839639ed3af3cdb3c2ac40950511fd18b470f02126cde
ebola-a8f0d95a4d7c6e15944d9c3ac2659dd26b6e7309045d32779307385cfd5f112e
ebola-bb3940e1a5dfcc1c225787ac2b47151003f9b563c1330c85e2d6b22bd10497cb
ebola-c9fc0a20a440dae2cd1d9f739d755c317c805ae569c162b6c8593dedcc389b86
ebola-b45773ad881cc2ce9d03e0b855c52524ba454a2ef23f3bc160a51ce227c890cc
ebola-28ce2d14db016b716e1cb8d79d5551f5ad9a7d33530917fc2b6186156d92f979
ebola-e9672ab8d937b648b8922584f024f64aa994705aaae3261aeae7c7a6437d920b
ebola-aa5aeb0679a5836a46b6e94d7bc2c6fdfbee05d713a320bc92bfb7ee3094c61b
ebola-e9c25139bc5a128f49f03ae3241f8e305199b235a2c8e8c434ac0ca55a4995c3
ebola-f167aff69312559037f7f8e576804b32a9633be65315aa28cc9327e910a5c582
ebola-c9a650f810a7ba3b2f8f9f59e9c5b2219b2d09cee1f22e05d5c7635525e6605e
ebola-c616a8612856a8b5f434946abef728581ad053afb2b0337842c71a9642334fb3
ebola-079056e19622bddf80364652e538a7847cd8a2f19308cbd01f60084fa9f97720
ebola-07fe8a4ae3908a0c0bd0eff74e57468109ff6071c8194d37c93fb0f2998d0f09
ebola-46273352d8919a3d99b24fec272148858bf26a38952a3e296e6019b25e9b0e36
ebola-b7583987882e911fdf8219eed926d3e040f8a285f202437f37ba252fa7686e62
ebola-ce585a480add131a1e269ba4ac5f58c4311f4503af12ecf58a219eff3d30ab61
ebola-206594c3ab992bd43f988e3dcc6a19dba7142c9546506aefa12ff5ccfb49eecd
ebola-8fd1e418a8ca0d5be7bda38c888ec5da5c3dcedcdaf396ec690a3b8420fbc935
ebola-2834e8249bad50c1290b45b663c5dd797642691381123f2b1100b500528fd3e7
ebola-80bf9c552fd3176a028fcd62a3640e154a2ca7e73fdfcd0d75dbea9207e5792f
ebola-a21b4ce0d224157ef976d6d7e6214b86e85041d7253fc11fba221dce5130d595
ebola-8801e21da2b0b59d7597d62aa8ca1b279ba423664dc8d1d280378fe9df6ab554
ebola-7286d9037b236b5d3e36d1672d4ccffbaf8cfe8091582499d40f38d3dcd8f630
ebola-7a60a5c35ebf8ff096a4ee3019a5ce3a07bd453722412c6a3d2be22070f16fdd
ebola-5353142d7ac154552577129bcd106c53cdebf6154499d068751880c193220e50
ebola-bef376f7302bd609a3e020bca7fa3af9c8b21b91c1bcc2cd59829cc32fc4c537
ebola-9c367824e41305839a585cc161e4d2f3d3eac526b47b26ea0fc663e14f35dddd
ebola-498bf7237066ba35cb2e55bf61721e938aa488fa1db67f5914fd5f41ef08c784
ebola-fc8d1084ef3f5f4a037f0ae50be532241738974a414c0abea119d844b2773a9d
ebola-aea0c48376f572228347dffeee3a8f04a07740fbe8db46fd0cdec638a078e6e3
ebola-0dbf2048ba5e524f1169f49b90bd7b855fe999f44fafca92f9afc8ee17165052
ebola-7dd401fe52aded4c8b3832b64fa006d8903dd5137905469e9a5456572dc0f9e6
ebola-94a8dca870f1a541676a57f79a1f6d9396ddd35521845b39034a24e663722ba1
ebola-9c7dfc6449f535d7a2655b8b550c830fd82a4ac4e3c6b613519887a027e2568f
ebola-30ba32de2c3b2e6fcafc1abfd104d6e31fc25d8df54e328194a09b331effcda0
ebola-e3d7820366d6b6decdb5a805f87b0300f700c1cea8df58aba39b432c7b60e3a7
ebola-30dc294cddab853f68afc8e991e99ff29b3bbedf5e2a6907235f0344fc826ee8
ebola-330615ecb240a22a457490c255df233a7abd1db46d21a439c5146e421a77989f
ebola-3c5dbecccc7b7c18ad69cd98b17c59e25099c8c1d9842de493d9ab7c63c5aa14
ebola-462875face3e6fb25f596aa654bbc96fc5349ccb76b4294b029c4d34cd45a5e8
ebola-6f7e74899432c6621f2ae7547f61157c2cb02dbc482ce4c8aa7d1ea7173bfeef
ebola-bfaf99b5ee4a612211377426bf96b0b33ef26aabaaede1fe7fa83c85f3eb85e0
ebola-53dd6c8864894b50326ef91c80f7bc23ddda0e208f9c31897beed45586d7f8ad
ebola-e21f32c04383e52b375f47ad79eab07a4151cd964b03e1045efaf4c1fafd1a56
ebola-716e389405028ff09b10b49dc54ab0059409d32b7bbabbffbd8ee143f5b0825d
ebola-eb80f354a6dc826c143e6fc93bc4f66cfc3487a188bb3451465037d736a343b3
ebola-76b28a3d8d144f5077273f6d188d9686cd916b8c9a964d5c66d099bf1c5a3a37
ebola-8923735d6c6c94ecab86cce28e721094344b9a569343490a5877bfd2418a952c
ebola-42f458ce0fbc6712bdbf7ab2f9828e65bef869330718a49c80e05d46d07518a8
ebola-6d2fe5f994d6be624f0b988382df138fe49310dfd7fa636cf0730bfe473ed267
ebola-a795f546ed849731fb26d6e6ea7b46b036259e16a6ff7d798ca59c9d6f022c77
ebola-a98909a908080d01ec1fee0c56a5ba1152e3cb9af8c838658efccdccbaf323ce
ebola-3b8b96a0d80991175bd0da1a263224e394266a792b5f54ff4d9e5290eb95c082
ebola-e8f7747a26fda9c2b03ed3191cee0574b8247829b3f072f8b624a9feabf07244
ebola-ba7c100cd1f8abd59c6c6c7a40d8899af5a4731ec41d8e680cbf4274e6731fee
ebola-d5a0b070b9855234237eb4bb63828d535c0f0548f8258dbc91ed351e778c77e0
ebola-7590d9503271e572e725484a22a926111f41f018c1b346a048a9cc40ada1ae27
ebola-723702d9d02c193f742365242c36d87908a737ba53464d95f695f2b0fc818bca
ebola-e556a574f0440b0ce9ac10c81f18150cf1039aebd199bdd5f945032ff2458f8f
ebola-6deaca65160ef13c08f5a63bdf315664425e954aba94ab093c868e5363c00c1e
ebola-1e8c75835944f0c2ca810f970e50418bfbec526b5ef67ac76ec7d49518e30b9b
ebola-019f5bc1104e72b31c72dddc3f2c1df798b91442f9834776ae4c9d3874fe3a98
ebola-99b6bb91b99ee8e1d6a53e59444ffc2f555040972d95e3facea0b0708cbda788
ebola-463eeab0d614458b151198f6428d8b4b58ee88f25d073368c4a64429e3789d00
ebola-9b1477392bd018fbd3132341476a9589753bd50ed5f68f6604d5eaf28548b908
ebola-2879342d75b691cda51ed0f121626456493efbed810d2427852fd05a54e51a77
ebola-5dd5366bd6cb77a61bba35b884866d7ea1395adaf6fd84110477a5390599cfd9
ebola-b654925b5e8ea4b309c7f2f9aad8a2a9250812bb136873d726fa2b2dab182703
ebola-df54f04571da6352f4b9b746f2a1223f7a1bba028467f1903704aaaa43ec2a2f
ebola-4e7b793dccec7711e009aa7ee51076f96c963f60d199b544b4fe96393d72eb1e
ebola-de3f2afda90b3ddb50d238ac9233032389d2376d83d9ab614cc63253253931d1
ebola-d88155ee6c4f6094bcc6b561f6779be895157b2f47211fc0a868b7013739e944
ebola-c3d4e65fd2dbfc2f52cb2bdf4649b93303938a392bb4dafdccd4399143d3ffb6
ebola-c6a2d2cdae4417f8f69aee8708fcbdb355ef5b2836e7e77438db9cdb1239b5fa
ebola-2b4c32c2564ba2e65e9d4e28c699a08376c76735a4098a36b9f523ecf4231521
ebola-5ff32d40b1d20ecd8972637c5c5280e4293fd43314461e64d0ff3ca2e31a1f91
ebola-e80de745b228f2e3cb37a7c6bfcbe6d3cb4733c80d0013a0db7366da2206eaa2
ebola-f0996d9e01397520dac87efbff9d209981876577671bedb032d4efebf7751fee
ebola-d6a5dac80da35b19e20f572f71cf7f3a2756f647d6ed065cd0cb466c99e2c616
ebola-c2f98e5e25bc6e083764b6dbc38cee38350dd20ebd038639927f4f64893045ab
ebola-21013a6ca1f8c009d7eb54220322e1739ec991df646612edf23a7ea9b47747ab
ebola-a667975a94c49eb39bd736f5590a0d044ed3f9d616210bc84e667cbafc212a8d
ebola-e628662d7f375e572184f3bb1f2811e5bfc09a4ffa95ab98dd95f1b5ce08f7f0
ebola-5d2cc7c107e0ea408c0b368eae91316228759d05ac90c4b408572f3eca04d528
ebola-1dda7416e97203d953de85d50c7c912bab66a06d238dc8b14268de0f3673b843
ebola-12ddcfd5a4dcb4e668f858c44bcdbbc6e684727af27b77eb7bb4d000a7355a96
ebola-b1f88afbc5b6b90c82898ca0dbfe12b0d732c9704f2a37b877bab03d97699f63
ebola-16fc03133e51a1f8c2bb86565cb92d1fb0e288ae6f29cb35b7331bb8e2fbb32e
ebola-f8d742cd8bd02254c3137012e1b567a879b31daa857934b4f074dbf3b303293f
ebola-fee73efbedc3835d06ecd3877f23c5fd52810e86d27c516af95c54e74401f3e4
ebola-9cdabe578d1d70023e0c9c41021d3f4c0089ace1489f0b03f14bfa4a61b7d01a
ebola-f565a26cd467ba41da26e9db151b7dfcf51676687d71b509ad23aa8eba814b6c
ebola-721d422868a89436dd92810147834e5d849732a8fef80910a612bc2fcc8d4ddc
ebola-bff2ee2ffe13ef049fc1616572de70180c0744380d4d9a0ef27be2b4eb1fca7d
ebola-0ec89571cfb9f7262a636b3111c05428279c6659903bebc2edc988328e8be794
ebola-7565613fc520be1b18647263139a0ab2a5de0b38dd359cc07b82f50dd0c32898
ebola-8188e174113f0afcf9b82a726a9007a9f8925d393d2048f78905e0fc64771ec8
ebola-87e7a6f7f05a2a7a928212c13b0c8d570fadabaab35b621fe869c0c5c7b40f2e
ebola-4869e9972bb55defa848a404dd5e129f80fbb12abd02f095bd1c3edf7d561f5d
ebola-731a28549740e1bd6421249ab800eaa3252fe874ecd97d34bd602da16df6c157
ebola-1aa35de1bb30a17c731cf2b39f80bea17f226aca65b225138d20e0f14922a221
ebola-702ac937d308ee6fa609aa558a7f91cc29487f1e5410fdef261032faeabae192
ebola-ae66dd3b5269b1840ad145adddddef2c52c295dde9a023e882263840a0139fa4
ebola-9d2819fe3f406e6ceb065db0422938eae44cc148bf404181deb2d632f1be644a
ebola-7fa39a8cdf02a3851ad4d62a8765d402213b468867a6f085d475b01fb433712f
ebola-c868af5d97eb0cf87669732fa33ede12b2258aeb8970a12d5682c05db9a601c5
ebola-0be9ff476e34b20cf549f5101908fe1e9d19124c9ec3e23d4d4b50193493f9c0
ebola-7a3652fe73d71efd818d8193901007f974d85469c1c205ebd6c3a3ea8794a025
ebola-39aba06a5fad8e0541387d744405874a0f5bcf361e4885b129a352fa88f72f95
ebola-760a78c2d773356d5631b243e13b99d8be0d2084c61a23dce5d86d5eb304f1d7
ebola-58a03f560d6588ddfc0a8601505348285506b81de24b04c6240a5b1b9c87dcd9
ebola-33107043576aea5708dda9670d21f8124c4ead98039225a21ba5534a59a198f0
ebola-93d4277013dd1ba4b54c6e93d85ac4d34a53f912612f28e1293402ee886747bc
ebola-e43152ec81ad3da5530154f9f0dd602506906601c8939263b6f0b8f9768bdd27
ebola-db39ddda3cec2a38d5eb5b6c46191371f79454c89a113aa2657f82aaebcc701b
ebola-f64feecfe492dff01e8b387a6753fcf0e7fe826539014f47d93732dbe417000d
ebola-77c399d1dedaa9f6d24c88d6fd2628037468bacdcad4b47c889ab4fb7572b4d9
ebola-d54f0689abddb6d8c904796de338e5886d876c3a350d563673b6189eb12341f1
ebola-8b0feb19d6603b0e19f34deb410de2f4a6c95476748a2bf510008a2c0b06af8e
ebola-d0baaf1906b793d2131468ea021f337c732937a0cbbe680ca98445493125461b
ebola-10a25e6bf2461b7aa9c38ec970dfbc5a649106f36f76419004feba312611d4a7
ebola-6aa07c106ae24198ec2acd4aa6b21991b51acac2eed01a949dbcfbad328e5ca5
ebola-c417794fb15ab65b44aa9aceb6f62e7307f1260372f506f1390f6b3ca547ef7c
ebola-b23ba77cedeeb975b82be34c668341abfe0b95450a12a79e0d94c9253cfff9da
ebola-4b68c3d12b20c550d42b694902290d5a33345fdbf8c10373f9d603008618b92a
ebola-8ed87874c74d5576e2d6cdc079f000bc4ce504a6d8ef3974a1b24963fd6f76b1
ebola-6836b94bfe72c21436df2cbc5e7543ed1e12a021a2872c4754949418704109d3
ebola-bb5e1313a5fecad68bc842a55f826f59a690db285efccf535cae18230488e9bf
ebola-e73b0f354cabad04e765c07946c1d1791e0cc55932f965a064bc2c14b5b1404d
ebola-2ffe3992c178a748ef9a27c0cae1f5a50b0d1b42df7bdc701f4e50d7f1d582d6
ebola-ff2851ebdf57caaf84aaeead096906600aa66dac83bb771afb6d864faa81b8f3
ebola-1280438913c88b2dfa90ff494b59480bb90f3925660d24524549be43eee3b20c
ebola-98b6ffa21c257a67c607a24b520fe64be5a75afa446d199dd3a840b4745fbf0f
ebola-f8b4df496b00628273d8645b2c019c1f42076c76ba295216b6ac017e00840e30
ebola-4312cde355d64f9c07170d56110a821ba9fed5b8d738ca2e8f05166c6721bb8e
ebola-6df4a2c85ecd31b24b5c09378fab10b05264323837ee88b50110e719d084ffa0
ebola-62294689ca96fb1b500688c678abc6d257b3083e8f4eaf74d9296e4885f61162
ebola-f65c788ec7eac2da5cb16b1f847612981d4962ce89ac026cdc836ddce5072a45
ebola-fbe1949a25d5626a86f07aa38f48f8c03e2063d0ab6f4094360b1d8279e1cb0b
ebola-5b5e439f68a5bf2dea8e2baa3451b2b5ab0eae870e23620ad82d989baf872859
ebola-aa1b47e1d48e6612248bdf37ddfda2b3b7e6430d6e7cefe2249476065ed6aed3
ebola-657ca1f647e79a08436960ea446be4f857a1385b59072e3b44e3ec15adda5499
ebola-4cce6df6f586cd064c260df493cd9525d1b3b5a6b982be513c6a3d7a9e4551c6
ebola-bd897746ab9fcb12bcf89282bdc2f7b38154806355f6f2c91351bae7ea0e5c03
ebola-97b42944916ecd1c89ce9104bc4889d21027271197c8f11da3e074046813dc68
ebola-e00e3f740b95134b82a88120dd9dd9c5e5ef51b02abd4c25ecfbd85e05447932
ebola-3f4d06cfca551e0d4ea3f79fcab5d8b6bb91ebfbc19a797d0e3a1145ea735975
ebola-99030cb7dc469ab8f506ae219e97b65aa1ab01f09b943f1c45c427e065d7108c
ebola-84def0fc00f092568120d84c81bf89b1e0eae7f9e37778f0a50f2a146b980632
ebola-001514b128ae3442e210e87bd2ce508d18d9d795974f1528f316b487a0794df9
ebola-2b1e1e748ede9bb2b7b855067e0dfd0d99775bce60279bdb59589ad2a99bc2c5
ebola-8942767a901686ae379f69a3591b4c2f1a12d0919835b230bbccb87d945b6285
ebola-e1fd0b551213b8d9bea037e3398673660ac18476ff925af71e00226c07674bfc
ebola-2a9c58f075cddf7648a52fadc687c39d9209cf86d9ddb6ce655ef0ada754d8a3
ebola-924703feb086a7cc5f345f747fe33f5b62c0565ac67c402bc14f9bc200b3fc98
ebola-eaf2db5b0fcdae4a0efe34c9ddd61425a7b5bda2bdb2872de1d2f3d07927e1a5
ebola-a73ff294d378b989f68ffdd10b33a46e924d2b8b1ed444371c32bf0f33e21560
ebola-3ceac7e6d45feaacc5269f8e47d9a7c47cb8827db06da8e313155d651343333d
ebola-8d568a3a7f7aee64e2903be804a2f3408fb9fdf5dc2a4aa52d9aacd13c2320d9
ebola-dc19f5e22b98753416e067e89b3619e0667d93223a54d4a50850c0902e979228
ebola-8f9320abc7fe162920759303553768e628cdfca5d8d17405978d152ada40b8d7
ebola-2e1cac7ca02d448aeba5f1945d980a26c0112a5ab36b265f49b27a1e77c63b3c
ebola-df83679aebbb40b065e8a0040dab9520989a3b0f0cb93a9dc9abc89e7ab63334
ebola-6ecc0d2d0957a6fdef11d9e9a48ce39ca0d737e43e2d806e53c197f78850bad6
ebola-5d6b6fa5851dff38f1e65763a09ff6b4c4191cf82cf6b4581cf58b510f47a90b
ebola-82d98335e674e3ae5bf709d438070890f0d8308bf91a4b912744611b46170dd0
ebola-6b64deb6540a52056ebcdf4e7672edaaa14133ef300a4baf7af1666fdb15ece1
ebola-ab0e922f6263e41a883972f7e618d9487dc75391c7623ffce0e9bb2cd6f28a01
ebola-00b878fbf71b9da8053aa934e81f040213e61c46523e59835a6d83f1fda3761e
ebola-0f8f03a88b5a4458771bf77536d47e3b9cdf119f82bf24d3c0982331456643d6
ebola-0a1a590d444b62a2f75fab8982cd71f480482369be4860040bc6314cbf6fbeb5
ebola-3318f39c3eb17ac61dbf4a48693bb6ed65e7e949a5b677ca069d25da2d7042b9
ebola-6200284a673332eba4e59def9b404bcf3d909481e497b209739b9a8e49e6e56a
ebola-43c7073d3d9227bfa77541566c215ab7f562b20332447ec9a94770a396efd0cd
ebola-f5542695307ca6ba4965e94a2ab6b5227f05cc3e8882dc91cc15d6beeceb3f4b
ebola-b913482e5e52147b315ba25f958b45c6bfa6bfd37e2f7bbe5af10b78c03f6477
ebola-2a75234f7ab45bf3a8218abb15703626f72541ce388d94d0748e1cb34bddc681
ebola-60dd97d27a3b44c5367d4bf369a1c44b7d150b61f342fbd5c71f5a5bcf5d0fe4
ebola-d4ca18557bdd0aa8e20892b505cf7710d0a7aafe9e2f5a2d8f7ca678a24578ea
ebola-a8f2f2c39882f3b4e5b27b467a488e478e2c0336d544713476d9f18aa7442a86
ebola-0f93c684792c66bb6ccf92ba24a05847fb408e4c2cfcd3f9c2565e1e279b1a70
ebola-f8d2bf481396b361bd34e0f21a7520736d12a5d3ed1054461eb4327c49ecb39c
ebola-aac3016cac07c98f73311a4ae96bf1b9609418479eaefe568ca85888c82dc99b
ebola-2378ebd3eb3187b43dd52b84d4237e2c4fa297fef36ad57e4dac6e9d105002f2
ebola-50a11c93bf37d61d99448915fdb6773e5d066d7badee1372c4eb171e1745fb6d
ebola-bea6d98f7a830c2eb9da8a7f1e0eb539d52fc8831ffd102a6217724e4634b951
ebola-54a959d78d155cc93d59d05d197b0ca1371bbbe8ceba85b5bcafbce75fd30c5e
ebola-98f99fec3b0a554d4dca8ab04007ca6ccbc6c5da24a2b85477df3ea48e19b3a9
ebola-22b92b51ba62546b5fd0b9ede392f9191be1b45ae48644e8fb4a69c537b74751
ebola-cc548091650a6efff3971c3e9691c1b66f1eeaa5cdafa482e2a93338dc88740e
ebola-a627ff40ac133967ddb9f59564047b3e700c3a593af869a83c4fa0d6448eaf3c
ebola-75f355517d2af9e52c8e9dc6370948c047de821d8a0dc74730405904d7c81781
ebola-add9c78ad7442ecedf6cf960299b889f4ba93ae8b0c9220b1017b173673ef602
ebola-046accc4432cb3b60369072f12e4c8d8ff97fe29a114bcf3cb85d7fc4571b2ce
ebola-e9a3ee845233746e007f34e3f76652960b30b59a1728393debaf8f113e68b1f4
ebola-c0a3a37a27c8e3610641a728e5ddb850f73f16aa1defa7147bed50b0cd80616e
ebola-a10ed5e2d62086a856c42ce8c5f7635d6fcfb9bdbdeba12f73a804e1135bb40c
ebola-c4e9f8993bfc98d068aa52be930ec98dd1e249aa0b2531b75fea7a624284d065
ebola-e6632faf48c3e4d39ca8e37b6a32fd712b38a911b260ae062f9a5d57a2c331b0
ebola-eb1bc645842ea6499127a2f370a4525effd1f9bf2402f46f4244a35c37ca5d97
ebola-3016142447a41c282d8cb0cfb891b9a2e47c7ecf807566a9cc26fd760052cac0
ebola-392bec11a4d6a9c6308b7b04e88471d0cb8df192a63ec155f1723e8d2d42314c
ebola-123a0df8d65c640f1477edb3ad964fec6e9627bb322f690ece74b760755d3614
ebola-28b3cd7fa07efc21ee44792ba627cecc2e2fac8f12d0e05d73a6507186287d5e
ebola-7c4a80fd96e30640b4baac3455996b763bae6703a13f93e554372608364aa265
ebola-8088b42d22ec4eb97ee2a40e9bdbfe0942082c4a8cf78aff943ee03fe8910e61
ebola-54e531a8630c8ac95c7b6195f45a3195dd48ae2456207b35f509674f24e4c7fd
ebola-125cc49c5b583a500a473041860cc96a30342d93c97d782aa712c3b3e2764361
ebola-a81037034e0d4702196c010cf8d4a2d11e6ed4607b8dc3337a2ce10b0a4586a3
ebola-9f591ffbbd9a0dbdb5a3f63f3c920282845bd111f2b6dfdf66e53ee1dc23274f
ebola-c7fb0c2567361daf39c1b210970a6853f37b393daefe7e1ddd750a661ccd07e8
ebola-b2f2e426ff4e6219bbef45eda8a5b989759a6be80bb11f876e9682a34c67b961

list/click  |  time: 2016-04-25 11:22:27 477002  |  # of fields: 4  |  topic_id: 417  |  docno: ebola-f9299cda6db2203ce2f9476ea9b26a6b9cce371828efbd763fa83eb7e6e150db  |  listsource: lemur

subtopic/create  |  time: 2016-04-25 11:26:31 817960  |  # of fields: 4  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste

subtopic/create  |  time: 2016-04-25 11:27:15 455160  |  # of fields: 4  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 258  |  subtopic_name: containment of ebola medical waste

subtopic/create  |  time: 2016-04-25 11:28:03 266425  |  # of fields: 4  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 259  |  subtopic_name: cost of ebola medical waste

subtopic/create  |  time: 2016-04-25 11:28:33 561724  |  # of fields: 4  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 260  |  subtopic_name: dangers of ebola medical waste

highlight  |  time: 2016-04-25 11:30  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-f9299cda6db2203ce2f9476ea9b26a6b9cce371828efbd763fa83eb7e6e150db  |  highlight_string: ebola medical waste cost dangers containment disposal

passage/create  |  time: 2016-04-25 11:31:32 279991  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5176  |  passage_name:  (RMW) associated with Ebola because of its highly infectious nature, the unprecedented volume of waste generated by this disease and the prospect of it spreading to pandemic proportions if not strictly contained.  After contacting several hazardous waste handling businesses, some declined to comment on this sensitive issue.  Stericycle, one of the largest hazardous waste handling companies in the U.S., and the one that handled the Ebola medical waste from the Texas Health Presbyterian Hospital where 42 year old Thomas Eric Duncan died from Ebola on October 8, provided the following statement:  “It is Stericycle’s policy not to comment on the delivery of services for specific customers. However, we continue to work closely with our customers as well as federal, state and local agencies to address each potential and new Ebola case. While Stericycle has received national approval to transport Ebola-contaminated wastes, each incident is being handled on a case-by-case basis with extreme emphasis placed on protecting the general public, healthcare workers and our team members,” said Selin Hoboy, Stericycle’s vice president of legislative and regulatory affairs.  The largest Ebola outbreak to date is the ongoing epidemic in West Africa, which is centered in Guinea, Sierra Leone and Liberia. As of November 2, 2014, this outbreak has 13,042 reported cases resulting in 4,818 deaths.  All medical waste must be properly handled and be responsibly disposed of, but medical waste associated with the Ebola Virus Disease (EVD), a Category A infectious disease, is especially challenging for healthcare workers and medical waste disposal companies.  The patient’s profuse sweating and excretions of other bodily fluids cause widespread contamination to virtually everything in the treatment room and the head-to-toe personal protection equipment (PPE) worn by caregivers.  Current efforts to treat an infected person include giving either oral re-hydration therapy or intravenous fluids. The disease has a high risk of death, killing between 25 percent and 90 percent of those infected with the virus, averaging out at 50 percent. This is often due to low blood pressure from fluid loss, and typically follows 6 to 16 days after symptoms appear.  The virus spreads by direct contact with blood or other body fluids of an infected human or animal. Infection may also occur by direct contact with a recently contaminated item or surface. Spread of the disease through the air has not been documented in the natural environment.  The volume of medical waste associated with the disease is staggering. According to the Los Angeles Times, a single Ebola patient in a U.S. hospital will generate eight 55-gallon barrels or 440 gallons of medical waste each day. This includes virtually all material that comes in contact with the patient, like PPE worn by caregivers, bedding, instruments and food related materials. Even furniture, curtains and mattresses must be treated as contaminated.  The Centers for Disease Control (CDC) recommend autoclaving or incineration of Ebola waste to destroy the microbes; however incinerating infected waste is banned in several states and must be transported to other states for incineration.  Transporting Ebola waste by road, rail or plane is also problematic. Under federal Department of Transportation (DOT) guidelines, Ebola waste is designated as a Class A infectious substance capable of causing death or disability, and requires a special permit for transport.  “The Ebola virus itself is not particularly hardy,” CDC director Dr. Thomas Frieden said recently before a Congressional hearing. “It’s killed by bleach, by autoclaving, or by a variety of chemicals.”  The Healthcare Coalition for Emergency Preparedness (HCEP), an organization with the primary mission to raise awareness on healthcare facility operational sustainability during a crisis or emergency, is concerned about preparedness issues related to Ebola.  In a mid-October letter to a U.S. House of Representatives’ oversight hearing examining America’s public health response to the Ebola outbreak, Darrell A. Henry, executive director of HCEP outlined his organization’s recommendations for handling Ebola medical waste. Following are excerpts from that letter:  “We believe that there are simple solutions that can be implemented quickly, including designated treatment centers; utilize mobile triage centers; recommend more conservative protections for healthcare workers; establish protocols for patient movement; disinfect solid and liquid waste on-site as close to the source as possible; and consider deploying mobile waste sterilizers to medical centers.  “Additionally, with healthcare workers on the front lines in the battle to contain Ebola, the need for proper personal protective equipment and infection control protocols is paramount. We know that there is not much information and research on disease transmission in the healthcare setting, including the potential for infectious particles to be suspended in the air around a symptomatic patient. Thus, it only seems appropriate to adopt more conservative measures to protect healthcare providers.  “We are pleased to note that CDC has now clarified that Ebola waste is a Category A infectious material, which the Department of Transportation (DOT) determines is capable of posing an unreasonable risk to health, safety, and property when transported in commerce, and should not be treated like normal regulated medical waste.  “In addition to performing on-site sterilization of Ebola waste before it is removed from the facility, liquid Ebola waste should be disinfected before it is put into a municipal sewer system. CDC notes that the virus can be effectively killed with autoclave sterilization and bleach solutions, stating: “Ebola-associated waste that has been appropriately inactivated or incinerated is no longer infectious.”  “It is important to know that, as recent as 20 to 25 years ago, most hospitals had on-site technology (incineration) to quickly and effectively destroy any contagious waste, but that was discontinued as a result of EPA regulations to reduce toxic emissions,” Henry continued. “Today, just 20 percent of hospitals have on-site technology (autoclaves). Most institutions outsource the treatment of medical waste, trucking it through communities to a central processing center. Nearly all of the top ranked medical institutions utilize on-site sterilization technology, which is readily available and affordable.  “At Emory Medical Center, one of the Ebola patients was producing up to 40 bags of contagious waste per day. If there was an outbreak, it would be unlikely that any truck transporter would have the capability, (i.e. Haz-Mat trucks, drivers, and DOT approved containers, etc.) to safely manage this deadly material. This situation would further be complicated by insurance and regulatory challenges as hospitals are legally liable for the disinfection of any waste they produce,” Henry said.  Sol Fried, president of Cyntox Biohazards Solutions, a company based in New York City that provides nationwide disposal services of medical and biohazardous waste said the company, like most med-waste disposal companies, is not fully prepared to handle Ebola material.  “Our company is not yet certified to pick up Ebola waste products, meaning anything that has come in contact with an Ebola patient,” Fried said. “The State of New Jersey has reached out to us for special training to be certified to pick up anything that has come in contact with Ebola. That is something we are in the process of doing, which will be done over the next week or so. Our employee training should not take more than a day and will take place online.  “At the current level we are not interested in handling Ebola medical waste. I don’t know if it’s worth the money at this time. If it becomes an epidemic then it may interest us, but I don’t see it becoming that. It seems more hysteria than a real need at this time. For small amounts it’s not economically viable for us.  “Most of our customers are contracted over three and five year agreements where we are picking on a weekly or monthly basis and our profit margins are very small. You only get profits in year two or three. So for one pickup of Ebola waste we could be charging lots of money, so it really does not make sense.  “It looks like the state is going to make sure everyone’s medical waste provider is permitted to pick up Ebola waste. That’s something we may have to do because the state is requiring state facilities to contract out to an Ebola certified waste handling company.  “The liabilities for handling Ebola waste are huge as well. We’d have to contact our insurance company prior to going into such an industry and it’s probably very expensive coverage,” Fried speculated.  Training healthcare workers to properly handle Ebola related waste is another major challenge. Many hospitals and med-waste companies rely on Compliance Publishing.Com for the latest information and guidance on Ebola. Alan Rosenauer, publisher of Compliance Publishing Corporation indicated that  Compliance has been helping companies in a variety of industries by developing and maintaining on-line searchable databases of compliance information that make compliance management easier.  “We don’t train companies; rather we provide information and guidance documents which come from organizations like the CDC, DOT and WHO,” Rosenauer explained. “At the Ebola Information Center on our website we provide the latest information to help medical waste companies, hospitals and clinics understand, handle, package and transport Ebola waste properly and safely. We also e-mail the information as well as post it on our website. In fact, we just published information and guidance for transporting bulk contaminated Ebola med-waste which was sent to everyone in the industry.  “Normally we send the information to just our customers, but right now we’re sending it to every medical waste transporter to make sure everyone is fully aware.  “Training can let someone know what the standards are. What the rules on conduct are, especially with Ebola. It’s not that they are not prepared, most of them are, but they don’t know exactly what they have to do to be compliant. Up until recently there was very little guidance on who needed to do what. What are the standards for packaging? What are the standards for transportation? Do you have to get a special permit to transport? Companies may still need a special permit, it’s just that DOT has recently provided guidelines on transporting bulk Category A waste,” Rosenauer concluded.  Much of the so called “Ebola Panic” has been created by the news media and let’s hope that cooler heads prevail and this deadly disease is contained and an effective treatment is found. Now is the time for everyone in the healthcare and waste disposal industries and governments at all levels to work together and concentrate on strict procedures and protocols to prevent the spread of Ebola, including protecting our borders from carriers of this infectious disease.  Published in the December 2014 Edition of American Recycler News  < Prev Next >     

passage/grade  |  time: 2016-04-25 11:31:39 052873  |  # of fields: 2  |  passage_id: 5176  |  score: 2

passage/create  |  time: 2016-04-25 11:31:43 454688  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 258  |  subtopic_name: containment of ebola medical waste  |  passage_id: 5177  |  passage_name:  (RMW) associated with Ebola because of its highly infectious nature, the unprecedented volume of waste generated by this disease and the prospect of it spreading to pandemic proportions if not strictly contained.  After contacting several hazardous waste handling businesses, some declined to comment on this sensitive issue.  Stericycle, one of the largest hazardous waste handling companies in the U.S., and the one that handled the Ebola medical waste from the Texas Health Presbyterian Hospital where 42 year old Thomas Eric Duncan died from Ebola on October 8, provided the following statement:  “It is Stericycle’s policy not to comment on the delivery of services for specific customers. However, we continue to work closely with our customers as well as federal, state and local agencies to address each potential and new Ebola case. While Stericycle has received national approval to transport Ebola-contaminated wastes, each incident is being handled on a case-by-case basis with extreme emphasis placed on protecting the general public, healthcare workers and our team members,” said Selin Hoboy, Stericycle’s vice president of legislative and regulatory affairs.  The largest Ebola outbreak to date is the ongoing epidemic in West Africa, which is centered in Guinea, Sierra Leone and Liberia. As of November 2, 2014, this outbreak has 13,042 reported cases resulting in 4,818 deaths.  All medical waste must be properly handled and be responsibly disposed of, but medical waste associated with the Ebola Virus Disease (EVD), a Category A infectious disease, is especially challenging for healthcare workers and medical waste disposal companies.  The patient’s profuse sweating and excretions of other bodily fluids cause widespread contamination to virtually everything in the treatment room and the head-to-toe personal protection equipment (PPE) worn by caregivers.  Current efforts to treat an infected person include giving either oral re-hydration therapy or intravenous fluids. The disease has a high risk of death, killing between 25 percent and 90 percent of those infected with the virus, averaging out at 50 percent. This is often due to low blood pressure from fluid loss, and typically follows 6 to 16 days after symptoms appear.  The virus spreads by direct contact with blood or other body fluids of an infected human or animal. Infection may also occur by direct contact with a recently contaminated item or surface. Spread of the disease through the air has not been documented in the natural environment.  The volume of medical waste associated with the disease is staggering. According to the Los Angeles Times, a single Ebola patient in a U.S. hospital will generate eight 55-gallon barrels or 440 gallons of medical waste each day. This includes virtually all material that comes in contact with the patient, like PPE worn by caregivers, bedding, instruments and food related materials. Even furniture, curtains and mattresses must be treated as contaminated.  The Centers for Disease Control (CDC) recommend autoclaving or incineration of Ebola waste to destroy the microbes; however incinerating infected waste is banned in several states and must be transported to other states for incineration.  Transporting Ebola waste by road, rail or plane is also problematic. Under federal Department of Transportation (DOT) guidelines, Ebola waste is designated as a Class A infectious substance capable of causing death or disability, and requires a special permit for transport.  “The Ebola virus itself is not particularly hardy,” CDC director Dr. Thomas Frieden said recently before a Congressional hearing. “It’s killed by bleach, by autoclaving, or by a variety of chemicals.”  The Healthcare Coalition for Emergency Preparedness (HCEP), an organization with the primary mission to raise awareness on healthcare facility operational sustainability during a crisis or emergency, is concerned about preparedness issues related to Ebola.  In a mid-October letter to a U.S. House of Representatives’ oversight hearing examining America’s public health response to the Ebola outbreak, Darrell A. Henry, executive director of HCEP outlined his organization’s recommendations for handling Ebola medical waste. Following are excerpts from that letter:  “We believe that there are simple solutions that can be implemented quickly, including designated treatment centers; utilize mobile triage centers; recommend more conservative protections for healthcare workers; establish protocols for patient movement; disinfect solid and liquid waste on-site as close to the source as possible; and consider deploying mobile waste sterilizers to medical centers.  “Additionally, with healthcare workers on the front lines in the battle to contain Ebola, the need for proper personal protective equipment and infection control protocols is paramount. We know that there is not much information and research on disease transmission in the healthcare setting, including the potential for infectious particles to be suspended in the air around a symptomatic patient. Thus, it only seems appropriate to adopt more conservative measures to protect healthcare providers.  “We are pleased to note that CDC has now clarified that Ebola waste is a Category A infectious material, which the Department of Transportation (DOT) determines is capable of posing an unreasonable risk to health, safety, and property when transported in commerce, and should not be treated like normal regulated medical waste.  “In addition to performing on-site sterilization of Ebola waste before it is removed from the facility, liquid Ebola waste should be disinfected before it is put into a municipal sewer system. CDC notes that the virus can be effectively killed with autoclave sterilization and bleach solutions, stating: “Ebola-associated waste that has been appropriately inactivated or incinerated is no longer infectious.”  “It is important to know that, as recent as 20 to 25 years ago, most hospitals had on-site technology (incineration) to quickly and effectively destroy any contagious waste, but that was discontinued as a result of EPA regulations to reduce toxic emissions,” Henry continued. “Today, just 20 percent of hospitals have on-site technology (autoclaves). Most institutions outsource the treatment of medical waste, trucking it through communities to a central processing center. Nearly all of the top ranked medical institutions utilize on-site sterilization technology, which is readily available and affordable.  “At Emory Medical Center, one of the Ebola patients was producing up to 40 bags of contagious waste per day. If there was an outbreak, it would be unlikely that any truck transporter would have the capability, (i.e. Haz-Mat trucks, drivers, and DOT approved containers, etc.) to safely manage this deadly material. This situation would further be complicated by insurance and regulatory challenges as hospitals are legally liable for the disinfection of any waste they produce,” Henry said.  Sol Fried, president of Cyntox Biohazards Solutions, a company based in New York City that provides nationwide disposal services of medical and biohazardous waste said the company, like most med-waste disposal companies, is not fully prepared to handle Ebola material.  “Our company is not yet certified to pick up Ebola waste products, meaning anything that has come in contact with an Ebola patient,” Fried said. “The State of New Jersey has reached out to us for special training to be certified to pick up anything that has come in contact with Ebola. That is something we are in the process of doing, which will be done over the next week or so. Our employee training should not take more than a day and will take place online.  “At the current level we are not interested in handling Ebola medical waste. I don’t know if it’s worth the money at this time. If it becomes an epidemic then it may interest us, but I don’t see it becoming that. It seems more hysteria than a real need at this time. For small amounts it’s not economically viable for us.  “Most of our customers are contracted over three and five year agreements where we are picking on a weekly or monthly basis and our profit margins are very small. You only get profits in year two or three. So for one pickup of Ebola waste we could be charging lots of money, so it really does not make sense.  “It looks like the state is going to make sure everyone’s medical waste provider is permitted to pick up Ebola waste. That’s something we may have to do because the state is requiring state facilities to contract out to an Ebola certified waste handling company.  “The liabilities for handling Ebola waste are huge as well. We’d have to contact our insurance company prior to going into such an industry and it’s probably very expensive coverage,” Fried speculated.  Training healthcare workers to properly handle Ebola related waste is another major challenge. Many hospitals and med-waste companies rely on Compliance Publishing.Com for the latest information and guidance on Ebola. Alan Rosenauer, publisher of Compliance Publishing Corporation indicated that  Compliance has been helping companies in a variety of industries by developing and maintaining on-line searchable databases of compliance information that make compliance management easier.  “We don’t train companies; rather we provide information and guidance documents which come from organizations like the CDC, DOT and WHO,” Rosenauer explained. “At the Ebola Information Center on our website we provide the latest information to help medical waste companies, hospitals and clinics understand, handle, package and transport Ebola waste properly and safely. We also e-mail the information as well as post it on our website. In fact, we just published information and guidance for transporting bulk contaminated Ebola med-waste which was sent to everyone in the industry.  “Normally we send the information to just our customers, but right now we’re sending it to every medical waste transporter to make sure everyone is fully aware.  “Training can let someone know what the standards are. What the rules on conduct are, especially with Ebola. It’s not that they are not prepared, most of them are, but they don’t know exactly what they have to do to be compliant. Up until recently there was very little guidance on who needed to do what. What are the standards for packaging? What are the standards for transportation? Do you have to get a special permit to transport? Companies may still need a special permit, it’s just that DOT has recently provided guidelines on transporting bulk Category A waste,” Rosenauer concluded.  Much of the so called “Ebola Panic” has been created by the news media and let’s hope that cooler heads prevail and this deadly disease is contained and an effective treatment is found. Now is the time for everyone in the healthcare and waste disposal industries and governments at all levels to work together and concentrate on strict procedures and protocols to prevent the spread of Ebola, including protecting our borders from carriers of this infectious disease.  Published in the December 2014 Edition of American Recycler News  < Prev Next >     

passage/grade  |  time: 2016-04-25 11:31:45 479276  |  # of fields: 2  |  passage_id: 5177  |  score: 2

passage/create  |  time: 2016-04-25 11:31:51 432389  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 259  |  subtopic_name: cost of ebola medical waste  |  passage_id: 5179  |  passage_name:  (RMW) associated with Ebola because of its highly infectious nature, the unprecedented volume of waste generated by this disease and the prospect of it spreading to pandemic proportions if not strictly contained.  After contacting several hazardous waste handling businesses, some declined to comment on this sensitive issue.  Stericycle, one of the largest hazardous waste handling companies in the U.S., and the one that handled the Ebola medical waste from the Texas Health Presbyterian Hospital where 42 year old Thomas Eric Duncan died from Ebola on October 8, provided the following statement:  “It is Stericycle’s policy not to comment on the delivery of services for specific customers. However, we continue to work closely with our customers as well as federal, state and local agencies to address each potential and new Ebola case. While Stericycle has received national approval to transport Ebola-contaminated wastes, each incident is being handled on a case-by-case basis with extreme emphasis placed on protecting the general public, healthcare workers and our team members,” said Selin Hoboy, Stericycle’s vice president of legislative and regulatory affairs.  The largest Ebola outbreak to date is the ongoing epidemic in West Africa, which is centered in Guinea, Sierra Leone and Liberia. As of November 2, 2014, this outbreak has 13,042 reported cases resulting in 4,818 deaths.  All medical waste must be properly handled and be responsibly disposed of, but medical waste associated with the Ebola Virus Disease (EVD), a Category A infectious disease, is especially challenging for healthcare workers and medical waste disposal companies.  The patient’s profuse sweating and excretions of other bodily fluids cause widespread contamination to virtually everything in the treatment room and the head-to-toe personal protection equipment (PPE) worn by caregivers.  Current efforts to treat an infected person include giving either oral re-hydration therapy or intravenous fluids. The disease has a high risk of death, killing between 25 percent and 90 percent of those infected with the virus, averaging out at 50 percent. This is often due to low blood pressure from fluid loss, and typically follows 6 to 16 days after symptoms appear.  The virus spreads by direct contact with blood or other body fluids of an infected human or animal. Infection may also occur by direct contact with a recently contaminated item or surface. Spread of the disease through the air has not been documented in the natural environment.  The volume of medical waste associated with the disease is staggering. According to the Los Angeles Times, a single Ebola patient in a U.S. hospital will generate eight 55-gallon barrels or 440 gallons of medical waste each day. This includes virtually all material that comes in contact with the patient, like PPE worn by caregivers, bedding, instruments and food related materials. Even furniture, curtains and mattresses must be treated as contaminated.  The Centers for Disease Control (CDC) recommend autoclaving or incineration of Ebola waste to destroy the microbes; however incinerating infected waste is banned in several states and must be transported to other states for incineration.  Transporting Ebola waste by road, rail or plane is also problematic. Under federal Department of Transportation (DOT) guidelines, Ebola waste is designated as a Class A infectious substance capable of causing death or disability, and requires a special permit for transport.  “The Ebola virus itself is not particularly hardy,” CDC director Dr. Thomas Frieden said recently before a Congressional hearing. “It’s killed by bleach, by autoclaving, or by a variety of chemicals.”  The Healthcare Coalition for Emergency Preparedness (HCEP), an organization with the primary mission to raise awareness on healthcare facility operational sustainability during a crisis or emergency, is concerned about preparedness issues related to Ebola.  In a mid-October letter to a U.S. House of Representatives’ oversight hearing examining America’s public health response to the Ebola outbreak, Darrell A. Henry, executive director of HCEP outlined his organization’s recommendations for handling Ebola medical waste. Following are excerpts from that letter:  “We believe that there are simple solutions that can be implemented quickly, including designated treatment centers; utilize mobile triage centers; recommend more conservative protections for healthcare workers; establish protocols for patient movement; disinfect solid and liquid waste on-site as close to the source as possible; and consider deploying mobile waste sterilizers to medical centers.  “Additionally, with healthcare workers on the front lines in the battle to contain Ebola, the need for proper personal protective equipment and infection control protocols is paramount. We know that there is not much information and research on disease transmission in the healthcare setting, including the potential for infectious particles to be suspended in the air around a symptomatic patient. Thus, it only seems appropriate to adopt more conservative measures to protect healthcare providers.  “We are pleased to note that CDC has now clarified that Ebola waste is a Category A infectious material, which the Department of Transportation (DOT) determines is capable of posing an unreasonable risk to health, safety, and property when transported in commerce, and should not be treated like normal regulated medical waste.  “In addition to performing on-site sterilization of Ebola waste before it is removed from the facility, liquid Ebola waste should be disinfected before it is put into a municipal sewer system. CDC notes that the virus can be effectively killed with autoclave sterilization and bleach solutions, stating: “Ebola-associated waste that has been appropriately inactivated or incinerated is no longer infectious.”  “It is important to know that, as recent as 20 to 25 years ago, most hospitals had on-site technology (incineration) to quickly and effectively destroy any contagious waste, but that was discontinued as a result of EPA regulations to reduce toxic emissions,” Henry continued. “Today, just 20 percent of hospitals have on-site technology (autoclaves). Most institutions outsource the treatment of medical waste, trucking it through communities to a central processing center. Nearly all of the top ranked medical institutions utilize on-site sterilization technology, which is readily available and affordable.  “At Emory Medical Center, one of the Ebola patients was producing up to 40 bags of contagious waste per day. If there was an outbreak, it would be unlikely that any truck transporter would have the capability, (i.e. Haz-Mat trucks, drivers, and DOT approved containers, etc.) to safely manage this deadly material. This situation would further be complicated by insurance and regulatory challenges as hospitals are legally liable for the disinfection of any waste they produce,” Henry said.  Sol Fried, president of Cyntox Biohazards Solutions, a company based in New York City that provides nationwide disposal services of medical and biohazardous waste said the company, like most med-waste disposal companies, is not fully prepared to handle Ebola material.  “Our company is not yet certified to pick up Ebola waste products, meaning anything that has come in contact with an Ebola patient,” Fried said. “The State of New Jersey has reached out to us for special training to be certified to pick up anything that has come in contact with Ebola. That is something we are in the process of doing, which will be done over the next week or so. Our employee training should not take more than a day and will take place online.  “At the current level we are not interested in handling Ebola medical waste. I don’t know if it’s worth the money at this time. If it becomes an epidemic then it may interest us, but I don’t see it becoming that. It seems more hysteria than a real need at this time. For small amounts it’s not economically viable for us.  “Most of our customers are contracted over three and five year agreements where we are picking on a weekly or monthly basis and our profit margins are very small. You only get profits in year two or three. So for one pickup of Ebola waste we could be charging lots of money, so it really does not make sense.  “It looks like the state is going to make sure everyone’s medical waste provider is permitted to pick up Ebola waste. That’s something we may have to do because the state is requiring state facilities to contract out to an Ebola certified waste handling company.  “The liabilities for handling Ebola waste are huge as well. We’d have to contact our insurance company prior to going into such an industry and it’s probably very expensive coverage,” Fried speculated.  Training healthcare workers to properly handle Ebola related waste is another major challenge. Many hospitals and med-waste companies rely on Compliance Publishing.Com for the latest information and guidance on Ebola. Alan Rosenauer, publisher of Compliance Publishing Corporation indicated that  Compliance has been helping companies in a variety of industries by developing and maintaining on-line searchable databases of compliance information that make compliance management easier.  “We don’t train companies; rather we provide information and guidance documents which come from organizations like the CDC, DOT and WHO,” Rosenauer explained. “At the Ebola Information Center on our website we provide the latest information to help medical waste companies, hospitals and clinics understand, handle, package and transport Ebola waste properly and safely. We also e-mail the information as well as post it on our website. In fact, we just published information and guidance for transporting bulk contaminated Ebola med-waste which was sent to everyone in the industry.  “Normally we send the information to just our customers, but right now we’re sending it to every medical waste transporter to make sure everyone is fully aware.  “Training can let someone know what the standards are. What the rules on conduct are, especially with Ebola. It’s not that they are not prepared, most of them are, but they don’t know exactly what they have to do to be compliant. Up until recently there was very little guidance on who needed to do what. What are the standards for packaging? What are the standards for transportation? Do you have to get a special permit to transport? Companies may still need a special permit, it’s just that DOT has recently provided guidelines on transporting bulk Category A waste,” Rosenauer concluded.  Much of the so called “Ebola Panic” has been created by the news media and let’s hope that cooler heads prevail and this deadly disease is contained and an effective treatment is found. Now is the time for everyone in the healthcare and waste disposal industries and governments at all levels to work together and concentrate on strict procedures and protocols to prevent the spread of Ebola, including protecting our borders from carriers of this infectious disease.  Published in the December 2014 Edition of American Recycler News  < Prev Next >     

passage/grade  |  time: 2016-04-25 11:31:53 422936  |  # of fields: 2  |  passage_id: 5179  |  score: 2

passage/create  |  time: 2016-04-25 11:31:55 600613  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 260  |  subtopic_name: dangers of ebola medical waste  |  passage_id: 5180  |  passage_name:  (RMW) associated with Ebola because of its highly infectious nature, the unprecedented volume of waste generated by this disease and the prospect of it spreading to pandemic proportions if not strictly contained.  After contacting several hazardous waste handling businesses, some declined to comment on this sensitive issue.  Stericycle, one of the largest hazardous waste handling companies in the U.S., and the one that handled the Ebola medical waste from the Texas Health Presbyterian Hospital where 42 year old Thomas Eric Duncan died from Ebola on October 8, provided the following statement:  “It is Stericycle’s policy not to comment on the delivery of services for specific customers. However, we continue to work closely with our customers as well as federal, state and local agencies to address each potential and new Ebola case. While Stericycle has received national approval to transport Ebola-contaminated wastes, each incident is being handled on a case-by-case basis with extreme emphasis placed on protecting the general public, healthcare workers and our team members,” said Selin Hoboy, Stericycle’s vice president of legislative and regulatory affairs.  The largest Ebola outbreak to date is the ongoing epidemic in West Africa, which is centered in Guinea, Sierra Leone and Liberia. As of November 2, 2014, this outbreak has 13,042 reported cases resulting in 4,818 deaths.  All medical waste must be properly handled and be responsibly disposed of, but medical waste associated with the Ebola Virus Disease (EVD), a Category A infectious disease, is especially challenging for healthcare workers and medical waste disposal companies.  The patient’s profuse sweating and excretions of other bodily fluids cause widespread contamination to virtually everything in the treatment room and the head-to-toe personal protection equipment (PPE) worn by caregivers.  Current efforts to treat an infected person include giving either oral re-hydration therapy or intravenous fluids. The disease has a high risk of death, killing between 25 percent and 90 percent of those infected with the virus, averaging out at 50 percent. This is often due to low blood pressure from fluid loss, and typically follows 6 to 16 days after symptoms appear.  The virus spreads by direct contact with blood or other body fluids of an infected human or animal. Infection may also occur by direct contact with a recently contaminated item or surface. Spread of the disease through the air has not been documented in the natural environment.  The volume of medical waste associated with the disease is staggering. According to the Los Angeles Times, a single Ebola patient in a U.S. hospital will generate eight 55-gallon barrels or 440 gallons of medical waste each day. This includes virtually all material that comes in contact with the patient, like PPE worn by caregivers, bedding, instruments and food related materials. Even furniture, curtains and mattresses must be treated as contaminated.  The Centers for Disease Control (CDC) recommend autoclaving or incineration of Ebola waste to destroy the microbes; however incinerating infected waste is banned in several states and must be transported to other states for incineration.  Transporting Ebola waste by road, rail or plane is also problematic. Under federal Department of Transportation (DOT) guidelines, Ebola waste is designated as a Class A infectious substance capable of causing death or disability, and requires a special permit for transport.  “The Ebola virus itself is not particularly hardy,” CDC director Dr. Thomas Frieden said recently before a Congressional hearing. “It’s killed by bleach, by autoclaving, or by a variety of chemicals.”  The Healthcare Coalition for Emergency Preparedness (HCEP), an organization with the primary mission to raise awareness on healthcare facility operational sustainability during a crisis or emergency, is concerned about preparedness issues related to Ebola.  In a mid-October letter to a U.S. House of Representatives’ oversight hearing examining America’s public health response to the Ebola outbreak, Darrell A. Henry, executive director of HCEP outlined his organization’s recommendations for handling Ebola medical waste. Following are excerpts from that letter:  “We believe that there are simple solutions that can be implemented quickly, including designated treatment centers; utilize mobile triage centers; recommend more conservative protections for healthcare workers; establish protocols for patient movement; disinfect solid and liquid waste on-site as close to the source as possible; and consider deploying mobile waste sterilizers to medical centers.  “Additionally, with healthcare workers on the front lines in the battle to contain Ebola, the need for proper personal protective equipment and infection control protocols is paramount. We know that there is not much information and research on disease transmission in the healthcare setting, including the potential for infectious particles to be suspended in the air around a symptomatic patient. Thus, it only seems appropriate to adopt more conservative measures to protect healthcare providers.  “We are pleased to note that CDC has now clarified that Ebola waste is a Category A infectious material, which the Department of Transportation (DOT) determines is capable of posing an unreasonable risk to health, safety, and property when transported in commerce, and should not be treated like normal regulated medical waste.  “In addition to performing on-site sterilization of Ebola waste before it is removed from the facility, liquid Ebola waste should be disinfected before it is put into a municipal sewer system. CDC notes that the virus can be effectively killed with autoclave sterilization and bleach solutions, stating: “Ebola-associated waste that has been appropriately inactivated or incinerated is no longer infectious.”  “It is important to know that, as recent as 20 to 25 years ago, most hospitals had on-site technology (incineration) to quickly and effectively destroy any contagious waste, but that was discontinued as a result of EPA regulations to reduce toxic emissions,” Henry continued. “Today, just 20 percent of hospitals have on-site technology (autoclaves). Most institutions outsource the treatment of medical waste, trucking it through communities to a central processing center. Nearly all of the top ranked medical institutions utilize on-site sterilization technology, which is readily available and affordable.  “At Emory Medical Center, one of the Ebola patients was producing up to 40 bags of contagious waste per day. If there was an outbreak, it would be unlikely that any truck transporter would have the capability, (i.e. Haz-Mat trucks, drivers, and DOT approved containers, etc.) to safely manage this deadly material. This situation would further be complicated by insurance and regulatory challenges as hospitals are legally liable for the disinfection of any waste they produce,” Henry said.  Sol Fried, president of Cyntox Biohazards Solutions, a company based in New York City that provides nationwide disposal services of medical and biohazardous waste said the company, like most med-waste disposal companies, is not fully prepared to handle Ebola material.  “Our company is not yet certified to pick up Ebola waste products, meaning anything that has come in contact with an Ebola patient,” Fried said. “The State of New Jersey has reached out to us for special training to be certified to pick up anything that has come in contact with Ebola. That is something we are in the process of doing, which will be done over the next week or so. Our employee training should not take more than a day and will take place online.  “At the current level we are not interested in handling Ebola medical waste. I don’t know if it’s worth the money at this time. If it becomes an epidemic then it may interest us, but I don’t see it becoming that. It seems more hysteria than a real need at this time. For small amounts it’s not economically viable for us.  “Most of our customers are contracted over three and five year agreements where we are picking on a weekly or monthly basis and our profit margins are very small. You only get profits in year two or three. So for one pickup of Ebola waste we could be charging lots of money, so it really does not make sense.  “It looks like the state is going to make sure everyone’s medical waste provider is permitted to pick up Ebola waste. That’s something we may have to do because the state is requiring state facilities to contract out to an Ebola certified waste handling company.  “The liabilities for handling Ebola waste are huge as well. We’d have to contact our insurance company prior to going into such an industry and it’s probably very expensive coverage,” Fried speculated.  Training healthcare workers to properly handle Ebola related waste is another major challenge. Many hospitals and med-waste companies rely on Compliance Publishing.Com for the latest information and guidance on Ebola. Alan Rosenauer, publisher of Compliance Publishing Corporation indicated that  Compliance has been helping companies in a variety of industries by developing and maintaining on-line searchable databases of compliance information that make compliance management easier.  “We don’t train companies; rather we provide information and guidance documents which come from organizations like the CDC, DOT and WHO,” Rosenauer explained. “At the Ebola Information Center on our website we provide the latest information to help medical waste companies, hospitals and clinics understand, handle, package and transport Ebola waste properly and safely. We also e-mail the information as well as post it on our website. In fact, we just published information and guidance for transporting bulk contaminated Ebola med-waste which was sent to everyone in the industry.  “Normally we send the information to just our customers, but right now we’re sending it to every medical waste transporter to make sure everyone is fully aware.  “Training can let someone know what the standards are. What the rules on conduct are, especially with Ebola. It’s not that they are not prepared, most of them are, but they don’t know exactly what they have to do to be compliant. Up until recently there was very little guidance on who needed to do what. What are the standards for packaging? What are the standards for transportation? Do you have to get a special permit to transport? Companies may still need a special permit, it’s just that DOT has recently provided guidelines on transporting bulk Category A waste,” Rosenauer concluded.  Much of the so called “Ebola Panic” has been created by the news media and let’s hope that cooler heads prevail and this deadly disease is contained and an effective treatment is found. Now is the time for everyone in the healthcare and waste disposal industries and governments at all levels to work together and concentrate on strict procedures and protocols to prevent the spread of Ebola, including protecting our borders from carriers of this infectious disease.  Published in the December 2014 Edition of American Recycler News  < Prev Next >     

passage/grade  |  time: 2016-04-25 11:31:58 145099  |  # of fields: 2  |  passage_id: 5180  |  score: 2

doc/next  |  time: 2016-04-25 11:32:00 925904  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f9299cda6db2203ce2f9476ea9b26a6b9cce371828efbd763fa83eb7e6e150db

passage/create  |  time: 2016-04-25 11:32:49 115952  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5182  |  passage_name:  While the Ebola virus itself is not particularly hardy and can easily be killed by household disinfectant, bleach, heat, sunlight, alcohol and  autoclaving - the technical term for what is sometimes called steam sterilisation, it becomes an enormous tasks to kill it on everything it had touched.   Caring for Ebola patients produces a mountain of potentially contaminated material. The disease causes substantial sweating, bleeding and vomiting and the virus can, via these bodily fluids, easily be transferred to medical equipment as well as protective gear worn by medical personnel.   The Los Angeles Times and others have reported that one Ebola patient treated in a US hospital would generate eight 55-gallon barrels of medical waste per day.  As Ebola can be spread through direct contact with surfaces or equipment, including bed linen, which have been contaminated with infected body fluids, these must all be sterilised or destroyed after use.  Read: Ebola can jump from animals to people in Africa   Surprisingly, according to the World Health Organisation (WHO), Ebola waste can be effectively disposed of using standard procedures for medical waste: the virus is not thought to be particularly hardy and can be eliminated relatively easily with heat, alcohol-based products and bleach.  However, because the virus is so highly virulent, and because its persistence in the environment outside the human body has not been extensively studied, many authorities – such as the Centers for Disease Control and Prevention (CDC) in the United States – consider that only high-temperature destruction of waste, preferably by incineration, is acceptable.  But not all hospitals, even in first world contexts, are equipped with appropriate incineration facilities, which may require transporting waste to the few that do.  Image: A hazmat worker with the US Protect Environmental Agency places an item into one of the waste barrels at The Village Bend East apartment complex in Dallas, Texas where a second health care worker who has tested positive for the Ebola virus resides on October 15, 2014. Nurse Amber Vinson joins Nina Pham as health workers who have contracted the Ebola virus at Texas Heath Presbyterian Hospital while treating patient Thomas Eric Duncan, who has since died. Photo by Mike Stone/Getty

passage/grade  |  time: 2016-04-25 11:32:52 704681  |  # of fields: 2  |  passage_id: 5182  |  score: 2

doc/next  |  time: 2016-04-25 11:33:08 796290  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6aad85f9fac9b94b639b774d81664ae861480f50657c7f3da739a419c6e2b37b

doc/irrelevant  |  time: 2016-04-25 11:33:19 845382  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a56c6f151c3bfeb7b43f508d924244f6c3c7a05460d517721d9c1744375fcdd1

doc/duplicate  |  time: 2016-04-25 11:33:33 638115  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-49e38b469f16a2af567d234fb7e04de1f71e91a646e079c02f73f4783ecba0ba

passage/create  |  time: 2016-04-25 11:34:13 766516  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 259  |  subtopic_name: cost of ebola medical waste  |  passage_id: 5183  |  passage_name:  Key Points  The safe handling and in-hospital management of waste generated through the care of patients with Ebola is based on three main principles.  Safe containment and packaging of waste should be performed as close as possible to the point of generation. Staff should avoid opening containers to manipulate the waste after primary containment. Limit the number of personnel entering the Ebola patient care area and those handling generated waste before and after primary containment. Always use appropriate personal protective equipment (PPE) and procedures for handling waste until onsite inactivation or transport away from the hospital for offsite inactivation. Preparing a Waste Management Plan as Part of Ebola Patient Care  Comply with your State and local regulations for handling, storage, treatment, and disposal of Ebola-associated waste. Determine whether Ebola-associated waste will be inactivated onsite at the hospital or transported offsite for inactivation. Identify a dedicated waste management team with specific training on standardized procedures for waste handling, including wearing appropriate PPE, and protocols for safely bagging and packaging waste, storing waste, and transporting packaged waste. Onsite inactivation: Ebola-associated waste may be inactivated through incineration or by autoclaving using properly maintained equipment with appropriate biological indicators. Offsite inactivation: Comply with regulations for packaging, transport and disposal of Ebola-associated waste. When selecting emergency department triage areas for the evaluation of patients with possible Ebola, a designated area should be identified for waste storage pending a determination of whether the patient has Ebola or not. The storage space should meet all applicable fire codes and principles of maintaining a clutter-free, safe environment. Waste bags should never be over-filled. Bags should be closed when two thirds full. If stored within the patient room, all filled solid waste bags and sharps containers should undergo primary closure procedures as outlined below. If stored outside the patient room, all filled solid waste bags and sharps containers should undergo both primary and secondary closure, and be removed as outlined below. Be sure healthcare personnel and environmental services staff handling waste are trained to wear recommended PPE (same used for patient care) and follow appropriate putting on and taking off procedures. Use the OSHA PPE Selection Matrix for Occupational Exposure to Ebola Virus [PDF - 3 pages] to guide selection of appropriate PPE for environmental services and waste collection workers handling, transporting, and disposing of waste. Handling and primary packaging of waste should occur in the patient room and the area where PPE is removed and be performed by the primary healthcare workers (i.e., doctors and nurses) wearing PPE as designated in the guidance for hospitals. Supplies for Hand Hygiene, Cleaning and Disinfection, and Packaging Waste  Leak-proof labeled biohazard bags: The film bags must have a minimum film thickness of 1.5 mils (0.0015 inch) and be 175 liters or smaller (46 gallons). Reference U.S. Department of Transportation (DOT) HMR requirements Approved sharps waste container Waste container in patientâs room Transport cart Absorbent disposable towels EPA-registered hospital disinfectant for use against the Ebola virus Select a hospital grade disinfectant available as wipe, spray, pull-top, or refill bottles (depending on application) with a label claim for one of the non-enveloped viruses (e.g., norovirus, rotavirus, adenovirus, poliovirus) to disinfect hospital environmental surfaces. Disposable cleaning cloths Alcohol-based hand rub (ABHR) that is at least 60% alcohol Rigid outer receptacle that conforms to U.S. DOT HMR requirements for transport of Category A DOT waste provided by approved waste vendor Note: Outer package must be either a rigid United Nations Standard- or DOT-approved non-bulk packaging. If the outer packaging is fabricated from fiberboard, it must be a minimum of triple wall and contain a 6 mil polyethylene liner. Reference DOT Guidance for Preparing Packages of Ebola Contaminated Waste for Transportation and Disposal. Waste should be packaged with an installed liner provided by the waste vendor. Absorbent material sufficient to absorb potential free liquid (if any) should be placed in the bottom of the rigid outer packaging or the liner of the fiberboard outer packaging. 

passage/grade  |  time: 2016-04-25 11:34:16 220959  |  # of fields: 2  |  passage_id: 5183  |  score: 2

passage/create  |  time: 2016-04-25 11:34:35 426834  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5185  |  passage_name:  Secondary Packaging and Removal of Waste  The healthcare workers (i.e., doctors and nurses) caring for the patient and wearing PPE as designated in the guidance for hospitals should spray or wipe the outside surfaces of double-bagged waste with an EPA-registered hospital disinfectant immediately before removing waste from the room. Upon removing the double-bagged waste from the patientâs room, the healthcare worker should place the double-bagged waste in a designated transport cart (for onsite inactivation or a rigid outer receptacle (with absorbent material and liner as described above, for offsite inactivation). The designated container should be located at the periphery of the area for taking off PPE so that removal from the area is efficient and does not create a risk of recontamination of the outer container. Environmental services personnel removing the waste from the care area should only handle the outer container/transport cart and should never open the container or handle the double-bagged waste. PPE should be used according to the OSHA PPE Selection Matrix for Occupational Exposure to Ebola Virus [PDF - 3 pages]. For onsite inactivation, environmental services personnel wearing appropriate PPE according to the OSHA PPE Selection Matrix for Occupational Exposure to Ebola Virus [PDF - 3 pages] should: Safely transfer waste in a transport cart to dedicated waste autoclave room or secured storage location. Refer to http://www.cdc.gov/vhf/ebola/hcp/survivability-ebola-medical-waste.html for guidance on inactivation of Ebola virus in waste. For offsite inactivation, refer to U.S. DOT Guidance for Transporting Ebola Contaminated Items, a Category A Infectious Substance: Before removal from the area, the healthcare workers wearing appropriate PPE should close the liner (either by zip tie or similar means of closure as specified by the manufacturer of the packaging), and close the outer lid and packaging. Disinfect the entire exterior surface of the container with an EPA-registered hospital disinfectant (wipe or spray). Environmental services personnel wearing appropriate PPE according to the OSHA PPE Selection Matrix for Occupational Exposure to Ebola Virus [PDF - 3 pages] should secure the outer lid and packaging and apply the special Category A DOT Waste labels provided and as directed by the manufacturer of the packaging. Safely transport to a designated and secure storage area that is preferably isolated and with limited access for approved waste vendor pickup. Procedures for Handling Liquid Waste (Body Fluids Including Blood, Urine, Vomit, Feces)  Consult with State or local regulations regarding pretreatment of waste. Sanitary sewers may be used for the safe disposal of patient waste. Reference CDCâs Interim Guidance for Environmental Infection Control in Hospitals for Ebola Virus; WHO Infection prevention and control guidance for care of patients in health-care settings, with focus on Ebola, 2014 [PDF - 24 pages].  Primary handling of liquid waste should occur in the patientâs room and be performed by the primary healthcare workers (i.e., doctors and nurses) wearing recommended PPE as designated in the guidance for hospitals. Pour waste, avoiding splashing by pouring from a low level, into the toilet. Close the lid first, and then flush toilet. Clean and disinfect flush handles, toilet seat, and lid surfaces with EPA-registered hospital disinfectant/cleaner. Discard cleaning cloths in biohazard bags. Discard emesis and portable toileting containers as solid waste. Follow recommended procedures for disinfecting visibly soiled PPE and removal of PPE. Handling Spills: Basic principles for spills of blood and other potentially infectious materials are outlined in the U.S. Occupational Safety and Health Administration (OSHA) Bloodborne Pathogen Standard, 29 CFR 1910.1030 and guidance for Bloodborne Pathogens and Needlestick Prevention.  Spills should be managed by the doctors and nurses caring for the Ebola patient and by wearing recommended PPE as designated in the guidance for hospitals. Isolate the area of the spill; do not let other individuals access the area until disinfection is completed. Place absorbent material on the spill (a solidifier agent can be used). Pour the EPA-registered disinfectant over the spill and allow sufficient contact time (according to manufacturerâs instructions for treating spills). Use disposable absorbent towels to remove bulk spill material. Dispose of the towels in a biohazard bag as specified above. Apply the EPA-registered hospital disinfectant to the cleaned surface and allow the specified contact time. Use disposable cleaning cloths or wipes to wipe the treated area. Follow handling of solid waste protocol as described above to discard materials used for containing the spill and for cleaning and disinfection. Follow recommended procedures for disinfecting visibly soiled PPE and taking off PPE. Resources

passage/grade  |  time: 2016-04-25 11:34:38 927587  |  # of fields: 2  |  passage_id: 5185  |  score: 2

doc/next  |  time: 2016-04-25 11:34:40 699741  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-77091a96d4ac625edee1199df78033413a49694b956dcb5f8948b6c6feeb496a

passage/create  |  time: 2016-04-25 11:35:04 585869  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 258  |  subtopic_name: containment of ebola medical waste  |  passage_id: 5186  |  passage_name:  1. How should hospitals handle bed linens and towels that may be contaminated with viral particles? Most hospitals contract with medical waste laundry services that clean soiled linens offsite. The Centers for Disease Control and Prevention's Ebola page, updated Aug. 1, has two answers:  "… discard all linens, non-fluid-impermeable pillows or mattresses, and textile privacy curtains as a regulated medical waste." "…materials should be placed in leak-proof containment and discarded as regulated medical waste. To minimize contamination of the exterior of the waste bag, place this bag in a rigid waste receptacle designed for this use. Incineration as a waste treatment process is effective in eliminating viral infectivity and provides waste minimization. However, check with your state's regulated medical waste program for more guidance and coordinate your waste management activities for the patient's isolation area with your medical waste contractor." But what should hospitals do with such materials for other patients? And what are laundry processing companies doing to assure that their workers are not infected while handling infected materials?  2. How should toilet waste from suspected Ebola patients be disposed? At Nebraska Medical Center, where Rick Sacra, MD, a Massachusetts physician infected with Ebola while working in a Liberian hospital last month, toilet wastes were treated with a disinfectant in the toilet for 10 minutes before being flushed into the sewer treatment system according to an article in the Nebraska World-Herald. The CDC, however, says human

passage/grade  |  time: 2016-04-25 11:35:06 782291  |  # of fields: 2  |  passage_id: 5186  |  score: 2

doc/next  |  time: 2016-04-25 11:35:20 051958  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c5edfde546768a9330228bcde0171a46a7a67cf654a547adc9b1b30590294e41

doc/irrelevant  |  time: 2016-04-25 11:35:37 248960  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-07b05105695e564aba0746b56ce3e745bbe9bd3d6644ea799d69a815a044d09d

passage/create  |  time: 2016-04-25 11:36:21 237666  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 258  |  subtopic_name: containment of ebola medical waste  |  passage_id: 5188  |  passage_name:  Multisociety Statement on Processing Biohazardous Medical Waste      	 The recent outbreak of Ebola virus disease has raised questions about the correct handling of Ebola contaminated biohazardous medical waste. This joint advisory statement is intended to provide guidance to personnel and health care organizations for handling biohazardous medical waste, including waste contaminated with the Ebola virus.  This statement addresses the use of sterilizers for processing biohazardous waste in the health care facility. This document does not address transportation of biohazardous waste, or processing of contaminated reusable medical devices and textiles.  Recognizing that sterilization modalities other than moist heat may be used for processing biohazardous waste, the term “sterilizer” is used rather than “autoclave” as used in other guidelines.  This is an evolving issue and healthcare professionals should review current research and incorporate new evidence into practice to mitigate occupational and patient risk associated with handling biohazardous medical waste.  AAMI, AORN, APIC, AST and IAHCSMM recommend that:  Health care organizations should not circumvent established protocols for handling biohazardous medical waste. Biohazardous medical waste should not be brought into clean areas where processing reusable medical devices is performed. Biohazardous medical waste should not be inactivated in a sterilizer that is used for processing reusable medical devices. Sterilizers used to inactivate biohazardous medical waste should be designed and validated for that particular purpose. Organizations should work with infection preventionists and keep abreast of evolving professional and regulatory guidelines for handling biohazardous medical waste. 

passage/grade  |  time: 2016-04-25 11:36:23 807701  |  # of fields: 2  |  passage_id: 5188  |  score: 2

doc/next  |  time: 2016-04-25 11:36:26 846677  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-306347d0daf3791561ecbc809ee333c4f1b306d33168d0cc957ac122c8cbbee2

passage/create  |  time: 2016-04-25 11:37:26 846689  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 260  |  subtopic_name: dangers of ebola medical waste  |  passage_id: 5190  |  passage_name:  CHICAGO â U.S. hospitals may be unprepared to safely dispose of the infectious waste generated by any Ebola virus disease patient to arrive unannounced in the country, potentially putting the wider community at risk, biosafety experts said.  Waste management companies are refusing to haul away the soiled sheets and virus-spattered protective gear associated with treating the disease, citing federal guidelines that require Ebola-related waste to be handled in special packaging by people with hazardous materials training, infectious disease and biosafety experts told Reuters.  Many U.S. hospitals are unaware of the regulatory snafu, which experts say could threaten their ability to treat any person who develops Ebola in the U.S. after coming from an infected region. It can take as long as 21 days to develop Ebola symptoms after exposure.  The issue created problems for Emory University Hospital in Atlanta, the first institution to care for Ebola patients here. As Emory was treating two U.S. missionaries who were evacuated from West Africa in August, their waste hauler, Stericycle, initially refused to handle it. Stericycle declined comment.  Ebola symptoms can include copious amounts of vomiting and diarrhea, and nurses and doctors at Emory donned full hazmat suits to protect themselves. Bags of waste quickly began to pile up.  “At its peak, we were up to 40 bags a day of medical waste, which took a huge tax on our waste management system,” Emory’s Dr. Aneesh Mehta told colleagues at a medical meeting earlier this month.  Emory sent staff to Home Depot to buy as many 32-gallon (120-liter) rubber waste containers with lids that they could get their hands on. Emory kept the waste in a special containment area for six days until its Atlanta neighbor, the U.S. Centers for Disease Control and Prevention, helped broker an agreement with Stericycle.  While U.S. hospitals may be prepared clinically to care for a patient with Ebola, Emory’s experience shows that logistically they are far from ready, biosafety experts said.  “Our waste management obstacles and the logistics we had to put in place were amazing,” Patricia Olinger, director of environmental health and safety at Emory, said in an interview.  

passage/grade  |  time: 2016-04-25 11:37:29 687159  |  # of fields: 2  |  passage_id: 5190  |  score: 2

doc/next  |  time: 2016-04-25 11:37:31 303509  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d65cd5ce5fc1fa9af890f6564b24f6003a3263b610a77cd231a640b6409b59dd

passage/create  |  time: 2016-04-25 11:38:12 296866  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 258  |  subtopic_name: containment of ebola medical waste  |  passage_id: 5192  |  passage_name:  Waste generated in the care of PUIs or patients with confirmed EVD is subject to procedures set forth by local, state, and federal regulations. Basic principles for spills of blood and other potentially infectious materials are outlined in the U.S. Occupational Safety and Health Administration (OSHA) Bloodborne Pathogens Standard (29 CFR 1910.1030).  Waste contaminated (or suspected to be contaminated) with Ebola virus is a Category A infectious substance regulated as a hazardous material under the U.S. Department of Transportation (DOT) Hazardous Materials Regulations (HMR; 49 CFR, Parts 171-180). Requirements in the HMR apply to any material DOT determines is capable of posing an unreasonable risk to health, safety, and property when transported in commerce1. For off-site commercial transport of Ebola-associated waste, strict compliance with the HMR is required. If a person requires a variance to the HMR, that person must apply for a Special Permit under 49 CFR Â§ 107.105. DOT may grant a special permit if the applicant can demonstrate an alternative packaging will achieve a safety level that is (1) at least equal to the safety level required under the HMR, or (2) consistent with the public interest if a required safety level does not exist. DOT has granted multiple special permits authorizing the transportation in commerce of certain Ebola-associated waste. Ebola-associated waste that has been appropriately incinerated, autoclaved, or otherwise inactivated is not infectious, does not pose a health risk, and is not considered to be regulated medical waste or a hazardous material under federal law. Therefore, such waste no longer is considered a Category A infectious substance and is not subject to the requirements of the HMR. Inactivation or incineration of Ebola-associated waste within a hospital system may be subject to state, local, and OSHA regulations. On-site inactivation Ebola-associated waste may be inactivated through the use of appropriate autoclaves. Other methods of inactivation (e.g., chemical inactivation) have not been standardized and would need to consider worker safety issues, as well as the potential for triggering other federal safety regulations. On-site incineration Ebola-associated waste may be incinerated. The products of incineration (i.e., the ash) can be transported and disposed of in accordance with state and local regulations and standard protocols for hospital waste disposal. Ebola-associated waste disposal is subject to state and local regulations. Ebola-associated waste that has been appropriately inactivated or incinerated is not infectious and is not considered to be regulated medical waste or a hazardous material under federal law. Relevant CDC guidance

passage/grade  |  time: 2016-04-25 11:38:14 836618  |  # of fields: 2  |  passage_id: 5192  |  score: 2

doc/next  |  time: 2016-04-25 11:38:16 905220  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f2ceca1e829f1202d31674bd9439bdf069fff11ae7eacb2e15447c969f680db3

passage/create  |  time: 2016-04-25 11:38:51 238884  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 260  |  subtopic_name: dangers of ebola medical waste  |  passage_id: 5193  |  passage_name:  US hospitals may be unprepared to safely dispose of the infectious waste generated by any Ebola virus disease patient to arrive unannounced in the country, potentially putting the wider community at risk, biosafety experts said. Waste management companies are refusing to haul away the soiled sheets and virus-spattered protective gear associated with treating the disease, citing federal guidelines that require Ebola-related waste to be handled in special packaging by people with hazardous materials training, infectious disease and biosafety experts told Reuters. Many US hospitals are unaware of the regulatory snafu, which experts say could threaten their ability to treat any person who develops Ebola in the US after coming from an infected region. It can take as long as 21 days to develop Ebola symptoms after exposure. The issue created problems for Emory University Hospital in Atlanta, the first institution to care for Ebola patients here. As Emory was treating two US missionaries who were evacuated from West Africa in August, their waste hauler, Stericycle, initially refused to handle it. Stericycle declined comment. Ebola symptoms can include copious amounts of vomiting and diarrhoea, and nurses and doctors at Emory donned full hazmat suits to protect themselves. Bags of waste quickly began to pile up. “At its peak, we were up to 40 bags a day of medical waste, which took a huge tax on our waste management system,” Emory’s Dr. Aneesh Mehta told colleagues at a medical meeting earlier this month. Emory sent staff to Home Depot to buy as many 32-gallon rubber waste containers with lids that they could get their hands on. Emory kept the waste in a special containment area for six days until its Atlanta neighbor, the US Centers for Disease Control and Prevention, helped broker an agreement with Stericycle. While US hospitals may be prepared clinically to care for a patient with Ebola, Emory’s experience shows that logistically they are far from ready, biosafety experts said. “Our waste management obstacles and the logistics we had to put in place were amazing,” Patricia Olinger, director of environmental health and safety at Emory, said in an interview. The worst Ebola outbreak on record is now projected to infect as many as 20,000 people in West Africa by November, while US officials have said that number could rise above 550,000 by mid-January without an international intervention to contain its spread. Experts say it is only a matter of time before at least some infected patients are diagnosed in US hospitals, most likely walking into the emergency department seeking treatment. Already there have been several scares. As of Sept. 8, as many as 10 patients have been tested by US hospitals for suspected Ebola cases, Dr. Barbara Knust, team leader for the CDC’s Ebola response, said at a medical meeting this month. All tested negative. The CDC has issued detailed guidelines on how hospitals can care for such patients, but their recommendations for handling Ebola waste differs from the US Department of Transportation, which regulates the transportation of infectious waste. CDC advises hospitals to place Ebola-infected items in leak-proof containers and discard them as they would other biohazards that fall into the category of “regulated medical waste.” According to DOT guidelines, items in this category can’t be in a form that can cause human harm. The DOT classifies Ebola as a Category A agent, or one that is potentially life-threatening. DOT regulations say transporting Category A items requires special packaging and hazmat training. CDC spokesman Tom Skinner said the agency isn’t aware of any packaging that is approved for handling Ebola waste. As a result, conventional waste management contractors believe they can’t legally haul Ebola waste, said Thomas Metzger, communication director for the National Waste & Recycling Association trade group. Part of Emory’s solution was to bring in one of the university’s large-capacity sterilizers called an autoclave, which uses pressurized steam to neutralize infectious agents, before handing the waste off to its disposal contractor for incineration. Few hospitals have the ability to autoclave medical waste from Ebola patients on site. “For this reason, it would be very difficult for a hospital to agree to care for Ebola cases - this desperately needs a fix,” said Dr Jeffrey Duchin, chair of the Infectious Diseases Society of America’s Public Health Committee. Dr. Gavin Macgregor-Skinner, an expert on public health preparedness at Pennsylvania State University, said there’s “no way in the world” that US hospitals are ready to treat patients with highly infectious diseases like Ebola. “Where they come undone every time is the management of their liquid and solid waste,” said Macgregor-Skinner, who recently trained healthcare workers in Nigeria on behalf of the Elizabeth R. Griffin Research Foundation. Skinner said the CDC is working with DOT to resolve the issue. He said the CDC views its disposal guidelines as appropriate, and that they have been proven to prevent infection in the handling of waste from HIV, hepatitis, and tuberculosis patients. Joe Delcambre, a spokesman for DOT’s Pipeline and Hazardous Materials Safety Administration, could not say whether requiring hospitals to first sterilize Ebola waste would resolve the issue for waste haulers. He did confirm that DOT is meeting with CDC. Metzger said his members are also meeting with officials from the DOT, the CDC and the Environmental Protection Agency to sort out the issue. Until the matter is resolved, however, “We’re bound by those regulations,” he said.  

passage/grade  |  time: 2016-04-25 11:38:53 151072  |  # of fields: 2  |  passage_id: 5193  |  score: 2

doc/next  |  time: 2016-04-25 11:38:54 746627  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e6f1116e939b49f1e484d2e863c4967652a7fb52dafa6319371b5c46b04fa9ee

passage/create  |  time: 2016-04-25 11:39:21 143134  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5197  |  passage_name:  This document is intended to provide hospitals and healthcare providers with key information about the safe handling, transport, and disposal of waste generated from the care of patients under investigation (PUIs) for or with confirmed Ebola virus disease (EVD).  Waste generated in the care of PUIs or patients with confirmed EVD is subject to procedures set forth by local, state and Federal regulations. Basic principles for spills of blood and other potentially infectious materials are outlined in the U.S. Occupational Safety and Health Administration (OSHA) Bloodborne Pathogen standard, 29 CFR 1910.1030. Waste contaminated (or suspected to be contaminated) with Ebola virus is a Category A infectious substance regulated as a hazardous material under the U.S. Department of Transportation (DOT) Hazardous Materials Regulations (HMR; 49 C.F.R., Parts 171-180). Requirements in the HMR apply to any material DOT determines is capable of posing an unreasonable risk to health, safety, and property when transported in commerce1. For off-site commercial transport of Ebola-associated waste, strict compliance with the HMR is required. If a person requires a variance to the HMR, that person must apply for a Special Permit under 49 CFR Â§ 107.105. DOT may grant a special permit if the applicant can demonstrate an alternative packaging will achieve a safety level that is: (1) at least equal to the safety level required under the HMR, or (2) consistent with the public interest if a required safety level does not exist. DOT has granted multiple special permits authorizing the transportation in commerce of certain Ebola-associated waste. Ebola-associated waste that has been appropriately incinerated, autoclaved, or otherwise inactivated is not infectious, does not pose a health risk, and is not considered to be regulated medical waste or a hazardous material under Federal law. Therefore, such waste no longer is considered a Category A infectious substance and is not subject to the requirements of the HMR. Inactivation or incineration of Ebola-associated waste within a hospital system may be subject to state, local and OSHA regulations. On-site inactivation Ebola-associated waste may be inactivated through the use of appropriate autoclaves. Other methods of inactivation (e.g., chemical inactivation) have not been standardized and would need to consider worker safety issues, as well as the potential for triggering other Federal safety regulations. On-site incineration Ebola-associated waste may be incinerated. The products of incineration (i.e., the ash) can be transported and disposed of in accordance with state and local regulations and standard protocols for hospital waste disposal. Ebola-associated waste disposal is subject to state and local regulations. Ebola-associated waste that has been appropriately inactivated or incinerated is not infectious and is not considered to be regulated medical waste or a hazardous material under Federal law. Relevant CDC guidance

passage/grade  |  time: 2016-04-25 11:39:26 749364  |  # of fields: 2  |  passage_id: 5197  |  score: 2

doc/next  |  time: 2016-04-25 11:39:29 101213  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-22d639ebb2b968b07149bdc561572b9acd6a83762954b55a51a2a2566ff49c54

passage/create  |  time: 2016-04-25 11:39:52 072220  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 259  |  subtopic_name: cost of ebola medical waste  |  passage_id: 5198  |  passage_name:  Filed Under: Tech & Science, Ebola, Viruses, health Medical health experts are days away from deciding how to properly dispose of waste generated by people sick with the Ebola virus, Reuters reports. Since the first patient to be diagnosed with Ebola on American soil is being cared for at a hospital in Dallas, the issue is no longer academic.  Most American hospitals don’t contain incinerators or large autoclaves (oven-like devices) capable of decontaminating the large amount of soiled linens and other waste associated with Ebola patients, said Dr. Jeffrey Duchin, chair of the Infectious Diseases Society of America’s Public Health Committee.  Duchin told Reuters he doesn’t know if Texas Health Presbyterian Hospital in Dallas has its own incinerator or large autoclave, but if it doesn’t, “they are going to have to find a temporary solution for managing infectious waste. That puts the hospital in a very difficult situation.”  Try Newsweek for only $1.25 per week  Texas Health Presbyterian didn’t immediately respond to a request for comment. The hospital says on its website that it has an autoclave for disinfecting surgical equipment, but it’s not clear if that could be used to treat medical waste. It doesn’t appear to have an incinerator—the hospital says it ships waste off-site for incineration.  Properly sterilizing Ebola medical waste before shipping it to a center that does have an incinerator or an autoclave is important for safety but also to prevent the material from being used for nefarious purposes, experts say.  The Centers for Disease Control and Prevention (CDC) advises hospitals to put such waste into leak-proof containers and have it shipped as a type of material known as “regulated medical waste.” But the federal Department of Transportation “deems Ebola a Category A infectious agent, meaning it is capable of killing people and animals, and not ‘regulated medical waste,’ a category in which pathogens are not capable of causing harm,” Reuters said.  A decision to clear up this inconsistency is expected within days.  Thomas Ksiazek, a professor at the University of Texas Medical Branch at Galveston who has done extensive research on Ebola, says he doesn’t see the big deal.  Ebola medical waste “can be readily taken care of with most disinfectants, without a doubt,” says Ksiazek, who used to be the head of the CDC’s Special Pathogens Branch and dealt with the containment of viruses like Ebola on a daily basis. Shipping waste in sealed containers, as with other medical waste for incineration or disinfection in an autoclave, shouldn’t pose a safety risk at all, he tells Newsweek.  He also notes that fears about Ebola spreading are overblown because it is easy to contain by isolating patients and using established sterile techniques. “I am not concerned at all” about Ebola spreading in the United States, Ksiazek says.   

passage/grade  |  time: 2016-04-25 11:39:54 290088  |  # of fields: 2  |  passage_id: 5198  |  score: 2

doc/next  |  time: 2016-04-25 11:39:56 105300  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-16247a95a0a2fcfeb248bafa15826c0fefa77685092d6db7e681e1ddb88ebdb2

passage/create  |  time: 2016-04-25 11:40:16 951139  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5200  |  passage_name:  The Nebraska Biocontainment Unit, located at the Nebraska Medical Center, shares best practices for Ebola waste removal, in a commentary published in in the December issue of the American Journal of Infection Control.  One of the key areas of concern related to the treatment of Ebola patients in the United States is waste removal. According to the case study, Ebola patients treated by the Nebraska team produced about 23 cubic feet – more than 50 pounds – of solid waste per day, most of which was personal protective equipment (PPE) worn by healthcare workers. Additionally, the patients produced approximately 2.3 gallons of liquid waste per day.  According to the U.S. Department of Transportation, which regulates hazardous material, Ebola waste is considered category A – meaning the waste is known or expected to contain a pathogen that is capable of causing fatal disease. Waste in this category requires many steps, and even a special permit, to ensure safe disposal.  The Nebraska Biocontainment Unit developed a strategy to convert the category A waste into category B medical waste, to enable safe disposal. This was done by transferring all solid waste, including PPE, patient linens, scrubs, towels, etc., to a pass-through autoclave system. After it was sterilized by the autoclave, the waste was placed in biohazard bags and into rigid packaging to be disposed of as category B medical waste.  Liquid waste produced by the Ebola patient was disposed of into a toilet with hospital-grade disinfectant and held for 2.5 times the recommended time before flushing the waste. This method was fully vetted by numerous stakeholders and surpasses the CDC guidance regarding Ebola liquid waste removal.  This case study seeks to provide other hospitals and facilities with guidance on the best practices associated with Ebola waste removal.    Reference: Lowe J, Gibbs S, Schwedhelm S, Nguyen J and Smith P. Nebraska Biocontainment Unit perspective on disposal of Ebola medical waste. American Journal of Infection Control. Volume 42, Issue 12. December 2014.  

passage/grade  |  time: 2016-04-25 11:40:19 339610  |  # of fields: 2  |  passage_id: 5200  |  score: 2

doc/next  |  time: 2016-04-25 11:40:22 858475  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-0e05aaefaa744acab64abd6e1a9f7f04857199f4afee4075f62a3843f80ff70e

passage/create  |  time: 2016-04-25 11:41:30 605981  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5201  |  passage_name:  Key Points:  Effective disinfectant product(s): Currently, no EPA-registered hospital disinfectant products will have a statement on the label that specifically says it can kill Ebola virus. Â Use an Environmental Protection Agency (EPA)-registered hospital disinfectants with label claims for hospital disinfection (or the equivalent microbial pathogen claims) and claims against non-enveloped viruses (e.g., norovirus, rotavirus, adenovirus, poliovirus). Â These products are broadly antiviral and capable of inactivating both enveloped and non-enveloped viruses including Ebola virus. Â These disinfectants should be used in accordance with the manufacturerâs labeled instructions. Â   One simple way to identify an appropriate product effective against Ebola virus is to use a product included in EPAâs List L: Disinfectants for Use Against the Ebola Virus.  Level of cleaning and decontamination: Once a person has been confirmed to have Ebola, the way to decontaminate the residence depends on the personâs symptoms at the time they were in the residence: Cleaning by residents - If the person with Ebola only had a fever with no gastrointestinal (e.g., diarrhea, vomiting) or hemorrhagic (bleeding) symptoms while he or she was in the residence, the person should not be contaminating their environment. The remaining members of the residence can clean and launder as normal using detergent and/or disinfectant. Cleaning by contract company - If the person with Ebola had a fever AND diarrhea, vomiting, and/or unexplained bleeding, public health and/or assigned authorities may need to contact a contract company who will assess the residence to determine the proper decontamination and disposal procedures. Remaining members of the residence should avoid contaminated rooms and areas until after the completion of the assessment and decontamination. Which contract companies can conduct the cleaning?: Companies with experience in cleaning biohazard and crimes scenes. OSHA provides guidance for cleaning and decontaminating in non-healthcare settings. Any contract company conducting such work must comply with the its stateâs Ebola policies and with OSHA standards for, among others that may apply, bloodborne pathogens (29 CFR 1910.1030), personal protective equipment (PPE) (29 CFR 1910.132), respiratory protection (29 CFR 1910.134), and hazard communication (29 CFR 1910.1200) (e.g., for chemical hazards). In states that operate their own occupational safety and health programs, different or additional requirements may exist. Transport of waste: Transportation of Ebola-contaminated waste (i.e., materials that cannot be decontaminated and were in contact with the person with Ebola having fever AND diarrhea, vomiting, and/or unexplained bleeding) must be packaged and transported in accordance with regulations on the transportation of Ebola contaminated items provided by the U.S. Department of Transportation (DOT): U.S. DOT Hazardous Materials Regulation for Category A Infectious Substance. If a contract company is handling the waste, requirements in OSHA standards, including Bloodborne Pathogens (29 CFR 1910.1030) may also apply. Definitions:  Contract company: A company hired to complete a needed task. In regards to decontaminating residences of Ebola virus, the contract company will be specialized in decontaminating, handling, and discarding of toxic chemicals, infectious agents, etc. with experience in cleaning biohazard or crime scenes and comply with all health and safety regulations. These companies may be certified through such associations as the National Institute of Decontamination Specialists (NIDS), Institute of Inspection, Cleaning and Restoration Certification (IICRC), American Bio Recovery Association (ABRA), or complete training as outline in the OSHA Hazardous Waste Operations and Emergency Response Standard (HAZWOPER). Disinfection product: A product that will make certain biological agents inactive. Specific to Ebola, use an EPA-registered hospital disinfectant or one with the equivalent microbial pathogen claims that also have a label claim against a non-enveloped virus. Such products are included in EPAâs List L: Disinfectants for Use Against the Ebola Virus. Personal Protective Equipment (PPE): Equipment worn to prevent exposure to hazardous substances (e.g., chemicals, infectious agents, particles). Â For Ebola decontamination, the level of PPE will vary due to the contamination level and chemicals used for cleaning and decontaminating. Refer to the OSHA PPE Selection Matrix for Occupational Exposure to Ebola Virus for appropriate PPE and related recommendations in the CDC âGuidance on Personal Protective Equipment To Be Used by Healthcare Workers During Management of Patients with Ebola Virus Disease in U.S. Hospitals, Including Procedures for Putting On (Donning) and Removing (Doffing).â Decontamination and waste disposal â Determined by the symptoms of the person confirmed with Ebola while they were within the residence  (1) Remaining members of residences where a person with Ebola only had a fever with no gastrointestinal (e.g., diarrhea, vomiting) or hemorrhagic (bleeding) symptoms, can clean and launder as normal because the individual should not be contaminating their environment.  (2) Remaining members of residences where a person with Ebola had a fever AND diarrhea, vomiting, and/or unexplained bleeding should have local public health and/or assigned authorities for Ebola emergency response managing the decontamination and waste disposal through a contract company. Members of the residence (or property owners, if the residence is rented) should not handle contaminated materials; do not touch any body fluids or soiled surfaces and materials.  The public health authorities can assist in finding a qualified contract company. Any contract company conducting such work must comply with the its stateâs Ebola policies and with OSHA standards for, among others that may apply, bloodborne pathogens (29 CFR 1910.1030), personal protective equipment (PPE) (29 CFR 1910.132), respiratory protection (29 CFR 1910.134), and hazard communication (29 CFR 1910.1200) (e.g., for chemical hazards). In states that operate their own occupational safety and health programs, different or additional requirements may exist. The contract company will assess the residence to determine the proper decontamination and disposal procedures. Only areas/rooms with contamination from diarrhea, vomiting, unexplained bleeding, and/or other body fluids, will need to be cleaned and disinfected.  

passage/grade  |  time: 2016-04-25 11:41:32 876706  |  # of fields: 2  |  passage_id: 5201  |  score: 2

doc/next  |  time: 2016-04-25 11:41:34 622476  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c57812f51bdf5852f6679757c813040663bf7646c3be357759f85ba6f7ae35c1

doc/duplicate  |  time: 2016-04-25 11:41:43 455386  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ea43d97e245053cfc851104648daf68bbccab96d61b86e5d689257de9a4e6668

doc/irrelevant  |  time: 2016-04-25 11:42:41 570695  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e2d0ab4bdf9bfe258b4a3e2146fa74fd81d313db8b7bd9a6a9f8b22f014f979d

passage/create  |  time: 2016-04-25 11:43:17 210682  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 260  |  subtopic_name: dangers of ebola medical waste  |  passage_id: 5205  |  passage_name:  One Ebola patient treated in a U.S. hospital will generate eight 55-gallon barrels of medical waste a day Incineration is recommended for Ebola medical waste, but it's illegal in California and other states Southern California hospital group on Ebola: 'We fully expect that it's coming our way' A single Ebola patient treated in a U.S. hospital will generate eight 55-gallon barrels of medical waste each day.  Protective gloves, gowns, masks and booties are donned and doffed by all who approach the patient's bedside and then discarded. Disposable medical instruments, packaging, bed linens, cups, plates, tissues, towels, pillowcases and anything that is used to clean up after the patient must be thrown away.  Even curtains, privacy screens and mattresses eventually must be treated as contaminated medical waste and disposed of.  Dealing with this collection of pathogen-filled debris without triggering new infections is a legal and logistical challenge for every U.S. hospital now preparing for a potential visit by the virus.  In California and other states, it is an even worse waste-management nightmare.  

passage/grade  |  time: 2016-04-25 11:43:18 852205  |  # of fields: 2  |  passage_id: 5205  |  score: 2

doc/next  |  time: 2016-04-25 11:43:21 320298  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ea48d95a92957b7042affb669fbdad4f69f0ac53cc27f20fba7e560da3f1ebc7

doc/irrelevant  |  time: 2016-04-25 11:43:36 015939  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6889b577976fabec6831d275bf9fb2487f991f318f37217f5668dfcfb364c93b

doc/duplicate  |  time: 2016-04-25 11:43:45 561322  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-27e9b9967565bbaab95f071e7d14267d03ff5b768eecc9252ea07960b0fff579

doc/irrelevant  |  time: 2016-04-25 11:43:55 035572  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f08ab63d91cd3f3804f8594d62acca58c1cb9b3b31d4442058cc62720572344f

doc/irrelevant  |  time: 2016-04-25 11:44:09 948621  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-99e0d32acf65f4c29aa425fbc7a0d7b1883320311a0d8de5285421e0f2a7e2d5

passage/create  |  time: 2016-04-25 11:45:25 496880  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5208  |  passage_name:  Cleaning and Storage  Make sure that all sharps, vials, and ampoules have been disposed of in a sharps container Make sure buckets, cleaning, and medical materials are stored in their proper places Do not leave items lying around on the floor Other Cleaning Guidelines  Always clean patient care areas in a systematic fashion: dirtiest areas should be cleaned first followed by more clean areas. Always use wet towels when cleaning the floor in patient care areas. Do not dry sweep. Sweeping can cause infectious droplets to go into the air. Always use disposable towels and mops to clean. Always pour chlorine onto disposable towels. Never dip disposable towels into a bucket of chlorine; dipping a dirty towel into a clean chlorine solution will make the solution less effective. 

passage/grade  |  time: 2016-04-25 11:45:29 053243  |  # of fields: 2  |  passage_id: 5208  |  score: 2

doc/next  |  time: 2016-04-25 11:45:30 970828  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b1bc66b0e46c2bf2b09a3e8dbb191834ba598ea412148cb7281129b55c8343e2

doc/irrelevant  |  time: 2016-04-25 11:45:49 332737  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-44d54792969ee477e8f741da64e7ee86a444c6dc322371116fef408933b431d8

doc/irrelevant  |  time: 2016-04-25 11:46:28 415086  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5d7e503bcc861570c472e9ee241df123a9ea712c355f0ef13ab930d1fe3d86df

passage/create  |  time: 2016-04-25 11:47:05 391117  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 258  |  subtopic_name: containment of ebola medical waste  |  passage_id: 5211  |  passage_name:  Ebola virus is transmitted through:  Direct, unprotected contact (i.e., with broken skin, eyes, nose or mouth) with blood or other body fluids (e.g., , feces, vomit, urine, saliva, sweat, breast milk, tears, vaginal fluid, and semen) of an infected patient who is actively ill Needle stick injuries from needles and syringes that have been contaminated with infected blood or other body fluids and tissue from an infected patient who is actively ill Unprotected contact with medical equipment contaminated with blood or body fluids from an infected patient who is actively ill Direct, unprotected contact with the body of someone who has died from Ebola The World Health Organization recommends that human wastes, including waste from Ebola patients such as vomitus and feces, be either disposed of through a sanitary sewer or be buried in a pit toilet or latrine with no additional contact or treatment.4,5,6 There has been no evidence to date that Ebola can be transmitted via exposure to sewage.7 The WHO has established guidelines for hygiene and PPE to prevent exposure to potential pathogens when working with untreated sewage.4,5 In the United States, human waste (i.e., excreta), blood, and other potentially infectious materials are routinely released into sanitary sewers. Wastewater handling processes in the United States are designed to inactivate and remove pathogens, such as Ebola. Workers should follow the guidelines below to prevent exposure to human pathogens, including Ebola virus, when working with untreated wastewater.  Personal Protective Equipment (PPE)  Workers handling human waste or sewage should be provided hand washing facilities at the worksite, PPE (described below), and training on how to use this PPE. The training should specifically address methods for the correct and safe removal of PPE to prevent workers from contaminating themselves or others during its removal. Trained workers should demonstrate both knowledge of the appropriate PPE they will be expected to wear and proficiency in its use. If using a respirator, the worker should be part of a respiratory protection program that includes medical clearance and fit-testing under OSHAâs PPE standard (29 CFR 1910.132). Workers should wash hands with soap and water immediately after removing PPE. Leak-proof infectious waste containers should be provided for discarding used PPE. Guidelines for dealing with potentially infectious waste can be found at http://www.cdc.gov/vhf/ebola/hcp/medical-waste-management.html and https://www.osha.gov/Publications/OSHA_FS-3756.pdf  The following PPE is recommended for workers handling untreated sewage:  Goggles or face shield: to protect eyes from splashes of untreated sewage Face mask (e.g., surgical mask): to protect nose and mouth from splashes of human waste. If undertaking cleaning processes that generate aerosols, a NIOSH-approved N-95 respirator should be used. Impermeable or fluid-resistant coveralls: to keep untreated sewage off clothing Waterproof gloves (such as heavy-duty rubber outer gloves with nitrile inner gloves) to prevent exposure of hands to untreated sewage Rubber boots: to prevent exposure of feet to untreated sewage. Basic Hygiene Practices  Wash skin with soap and water immediately after handling sewage, or any materials that have been in contact with sewage. Avoid touching face, mouth, eyes, nose, or open sores and cuts while handling sewage, or any materials that have been in contact with sewage. Wash hands with soap and water before eating or drinking after handling sewage. Remove soiled work clothes and do not take home to launder. Launder clothing at work or use a uniform service. Eat in designated areas away from untreated sewage. Do not smoke or chew tobacco or gum while handling human waste or sewage, or any materials that have been in contact with human waste or sewage. Cover open sores, cuts, and wounds with clean, dry bandages. References  

passage/grade  |  time: 2016-04-25 11:47:07 008593  |  # of fields: 2  |  passage_id: 5211  |  score: 2

doc/next  |  time: 2016-04-25 11:47:08 992632  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-008c044f564afa636e57f49d63cff85159554ba089f078fc77945c049d2d4099

doc/duplicate  |  time: 2016-04-25 11:47:28 963608  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fee73c84cb32df01efaf319f8b7d8a5f0f95b2fac138901786cda2b1a5bd247b

doc/duplicate  |  time: 2016-04-25 11:47:36 982421  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5cf32a3a76318d3274909f4c3717a95aa29ef0f6cbad776c3a2cce054cd51ffa

passage/create  |  time: 2016-04-25 11:48:31 965348  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5212  |  passage_name:  Recommendations for contract companies about disinfectants, training requirements, PPE, and waste removal  Recommendations for the contract company to follow are described in CDC's Interim Guidance for Environmental Infection Control in Hospitals for Ebola Virus and OSHA Fact Sheet 3756 on Cleaning and Decontamination of Ebola on Surfaces â Guidance for Workers and Employers in Non-Healthcare/ Non-Laboratory Settings.  For nonporous surfaces (door handles, tile floors), use an EPA-registered hospital disinfectant or a disinfectant with equivalent microbial pathogen claims according to manufacturerâs instructions with a label claim against a nonenveloped virus, such as norovirus, rotavirus, adenovirus, or poliovirus. One simple way to identify an appropriate product effective against Ebola virus is to use a product included in EPAâs List L: Disinfectants for Use Against the Ebola Virus. Any EPA-registered disinfectant that is effective against a nonenveloped virus will also be effective against Ebola virus.Â  Porous materials (linens, carpet, mattress, pillows) should be properly contained and disposed of according to regulations set by the state where the waste is located. Store the properly contained contaminated material in a room that is not being used until it can be collected for disposal. Additional CDC recommendations for Ebola Medical Waste Management provides further information about safe handling and disposal of medical waste from patients under investigation or patients with confirmed EVD. Waste contaminated with Ebola virus must be packaged and transported in accordance to U.S. DOT Hazardous Materials Regulations (HMR, 49 CFR, Parts 171-180). If a contract company is handling the waste

passage/grade  |  time: 2016-04-25 11:48:35 293631  |  # of fields: 2  |  passage_id: 5212  |  score: 2

doc/next  |  time: 2016-04-25 11:48:37 835030  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-82c2334cce1bbd5b7e02e2621ee4cb37012ae1545a6e13078b35991eea765a5c

passage/create  |  time: 2016-04-25 11:49:01 829425  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5214  |  passage_name:  Representational image. Agencies Waste management companies are refusing to haul away the soiled sheets and virus-spattered protective gear associated with treating the disease, citing federal guidelines that require Ebola-related waste to be handled in special packaging by people with hazardous materials training, infectious disease and biosafety experts told Reuters. Many US hospitals are unaware of the regulatory snafu, which experts say could threaten their ability to treat any person who develops Ebola in the US after coming from an infected region. It can take as long as 21 days to develop Ebola symptoms after exposure. The issue created problems for Emory University Hospital in Atlanta, the first institution to care for Ebola patients here. As Emory was treating two US missionaries who were evacuated from West Africa in August, their waste hauler, Stericycle, initially refused to handle it. Stericycle declined comment. Ebola symptoms can include copious amounts of vomiting and diarrhea, and nurses and doctors at Emory donned full hazmat suits to protect themselves. Bags of waste quickly began to pile up. "At its peak, we were up to 40 bags a day of medical waste, which took a huge tax on our waste management system," Emory's Dr. Aneesh Mehta told colleagues at a medical meeting earlier this month. Emory sent staff to Home Depot to buy as many 32-gallon rubber waste containers with lids that they could get their hands on. Emory kept the waste in a special containment area for six days until its Atlanta neighbor, the US Centers for Disease Control and Prevention, helped broker an agreement with Stericycle. While US hospitals may be prepared clinically to care for a patient with Ebola, Emory's experience shows that logistically they are far from ready, biosafety experts said. "Our waste management obstacles and the logistics we had to put in place were amazing," Patricia Olinger, director of environmental health and safety at Emory, said in an interview. The worst Ebola outbreak on record is now projected to infect as many as 20,000 people in West Africa by November, while US officials have said that number could rise above 5,50,000 by mid-January without an international intervention to contain its spread. Experts say it is only a matter of time before at least some infected patients are diagnosed in US hospitals, most likely walking into the emergency department seeking treatment. Already there have been several scares. As of 8 September, as many as 10 patients have been tested by US hospitals for suspected Ebola cases, Dr Barbara Knust, team leader for the CDC's Ebola response, said at a medical meeting this month. All tested negative. The CDC has issued detailed guidelines on how hospitals can care for such patients, but their recommendations for handling Ebola waste differs from the US Department of Transportation, which regulates the transportation of infectious waste. CDC advises hospitals to place Ebola-infected items in leak-proof containers and discard them as they would other biohazards that fall into the category of "regulated medical waste." According to DOT guidelines, items in this category can't be in a form that can cause human harm. The DOT classifies Ebola as a Category A agent, or one that is potentially life-threatening. DOT regulations say transporting Category A items requires special packaging and hazmat training. CDC spokesman Tom Skinner said the agency isn't aware of any packaging that is approved for handling Ebola waste. As a result, conventional waste management contractors believe they can't legally haul Ebola waste, said Thomas Metzger, communication director for the National Waste & Recycling Association trade group. TEMPORARY FIX Part of Emory's solution was to bring in one of the university's large-capacity sterilisers called an autoclave, which uses pressurised steam to neutralise infectious agents, before handing the waste off to its disposal contractor for incineration. Few hospitals have the ability to autoclave medical waste from Ebola patients on site. "For this reason, it would be very difficult for a hospital to agree to care for Ebola cases - this desperately needs a fix," said Dr Jeffrey Duchin, chair of the Infectious Diseases Society of America's Public Health Committee. Dr Gavin Macgregor-Skinner, an expert on public health preparedness at Pennsylvania State University, said there's "no way in the world" that US hospitals are ready to treat patients with highly infectious diseases like Ebola. "Where they come undone every time is the management of their liquid and solid waste," said Macgregor-Skinner, who recently trained healthcare workers in Nigeria on behalf of the Elizabeth R Griffin Research Foundation. Skinner said the CDC is working with DOT to resolve the issue. He said the CDC views its disposal guidelines as appropriate, and that they have been proven to prevent infection in the handling of waste from HIV, hepatitis, and tuberculosis patients. Joe Delcambre, a spokesman for DOT's Pipeline and Hazardous Materials Safety Administration, could not say whether requiring hospitals to first sterilize Ebola waste would resolve the issue for waste haulers. He did confirm that DOT is meeting with CDC. Metzger said his members are also meeting with officials from the DOT, the CDC and the Environmental Protection Agency to sort out the issue. Until the matter is resolved, however, "We're bound by those regulations," he said. Reuters

passage/grade  |  time: 2016-04-25 11:49:03 668523  |  # of fields: 2  |  passage_id: 5214  |  score: 2

doc/next  |  time: 2016-04-25 11:49:29 972833  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1dd1377a2de0b5f4e1deff23d332c947ca45bbe8dc863aeba4871b9c94f7ba29

passage/create  |  time: 2016-04-25 11:50:16 787562  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 258  |  subtopic_name: containment of ebola medical waste  |  passage_id: 5216  |  passage_name:  While the Ebola virus itself is not particularly hardy and can easily be killed by household disinfectant, bleach, heat, sunlight, alcohol and  autoclaving - the technical term for what is sometimes called steam sterilisation, it becomes an enormous tasks to kill it on everything it had touched.   Caring for Ebola patients produces a mountain of potentially contaminated material. The disease causes substantial sweating, bleeding and vomiting and the virus can, via these bodily fluids, easily be transferred to medical equipment as well as protective gear worn by medical personnel.   The Los Angeles Times and others have reported that one Ebola patient treated in a US hospital would generate eight 55-gallon barrels of medical waste per day.  As Ebola can be spread through direct contact with surfaces or equipment, including bed linen, which have been contaminated with infected body fluids, these must all be sterilised or destroyed after use.  Surprisingly, according to the World Health Organisation (WHO), Ebola waste can be effectively disposed of using standard procedures for medical waste: the virus is not thought to be particularly hardy and can be eliminated relatively easily with heat, alcohol-based products and bleach.  However, because the virus is so highly virulent, and because its persistence in the environment outside the human body has not been extensively studied, many authorities – such as the Centers for Disease Control and Prevention (CDC) in the United States – consider that only high-temperature destruction of waste, preferably by incineration, is acceptable.  But not all hospitals, even in first world contexts, are equipped with appropriate incineration facilities, which may require transporting waste to the few that do.  Strict PPE and training needed to handle Ebola waste  The same personal protective equipment (PPE) worn by medical personnel caring for Ebola patients is required for people handling waste materials and cleaning hospital rooms: at a minimum, disposable gloves, a fluid-resistant gown, eye protection (preferably goggles) to prevent splashes, a face mask and closed impermeable shoes – to protect against viral contaminants as well as contact with the disinfectants used.  Waste disposal personnel also go through rigorous training to prepare them for their task.  Sharp, hard objects like needles and tubing that has been in contact with body fluids should be placed inside puncture-resistant waste containers.  Solid, non-sharp, infectious waste must be placed in leak-proof waste bags and covered bins. Bins should never be carried against the body, for example on the shoulder.  Ebola waste should be incinerated – but can also be buried  Destroying medical waste in an industry-standard incinerator is the preferred end-point according to the CDC. Waste may also be rendered harmless in an autoclave  - a chamber that subjects the waste to steam at high pressure and temperature.  However, in settings where safe complete incineration may not be available, the WHO recommends burying waste.  Solid waste should be placed in a pit 2 metres deep and filled to a depth of 1-1.5 m. After each wasteload, the waste is covered with a layer of soil 10-15 cm deep. The area designated for the final treatment and disposal of waste should have controlled access to prevent entry by animals, untrained personnel or children.  The WHO states that waste such as faeces, urine and vomit, and liquid waste from washing, can be disposed of in the sewerage system or even a pit latrine, with no further treatment necessary.  All surfaces of the hospital room housing an Ebola patient must be carefully cleaned, at least once a day.  The Ebola virus, while being highly infectious, is not believed to be particularly persistent in the environment outside the body. Thus it is easily destroyed by many standard disinfectants (including bleach). However, given Ebola’s virulence, the CDC recommends cleaning with disinfectants usually used to kill “tougher” viruses like polio and flu.  Surprisingly, the WHO states that bed linen used by Ebola patients can be

passage/grade  |  time: 2016-04-25 11:50:18 705800  |  # of fields: 2  |  passage_id: 5216  |  score: 2

doc/next  |  time: 2016-04-25 11:50:20 861511  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c2e3799889f9227123d7ee568ec200f1ca78ea5520858704687dea484ec1d113

passage/create  |  time: 2016-04-25 11:54:02 004928  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 258  |  subtopic_name: containment of ebola medical waste  |  passage_id: 5219  |  passage_name:  A number of things came up that surprised us and that we felt really needed to be shared with our colleagues,” he says.  The first of those was the sheer volume of waste generated by each Ebola patient. The group calculated that each patient treated at the Nebraska facility created about 1,010 pounds of solid waste, most of it in the form of personal protective equipment (PPE) — the hoods, face shields, suits and foot covers that doctors and nurses wear. That equipment, as well as towels and linens used for bedding, created around four to eight large bags of waste a day.  Lowe says that the group decided to treat liquid waste generated by the patients even more stringently than required by the CDC. “The lion’s share of calls we took from groups both within our facility and from outside the facility were concerns about exactly what we were doing with all that liquid waste,” he says.  CDC guidelines say that normal waste treatment chemicals in toilets are sufficient to kill Ebola. But the unit’s director Philip Smith and Lowe had two concerns. In the event that the toilets backed up, potentially infectious material could flood into the patient rooms and possibly into other pipes in the hospital as well. Public health groups also wanted assurances that the waste would not be contaminating facilities outside of the hospital. So Smith decided to take extra measures by treating the toilets in the patient’s room with hospital-grade disinfectant. Normally it takes four minutes to sterilize the waste, but to be safe, all Ebola patients’ waste was held in this sterilizing solution for 2.5 times the recommended time before it was flushed.  Flushing, says Smith, is preferable to storing the waste in a separate container and then autoclaving the contents. “You could end up having containers full of liquid that are difficult and hazardous to work with,” he says.  The bags of solid waste, meanwhile, were tied and taped closed, then doused with bleach and handled in very strict ways by workers in full PPE. The Nebraska biocontainment unit is intentionally designed to have its own decontaminating autoclave inside the unit, so soiled waste does not have to be removed from the premises. While Ebola-related waste requires special sterilization and decontamination procedures, it can be turned into normal medical waste that can be disposed of in the hopsital’s normal ways.  MORE: 12 Answers to Ebola’s Hard Questions  To do that, health care workers send the bags into a sterilizing room. Each bag is handled at arm’s length so the workers don’t get contaminated by virus that may be on the bag and so that workers who may have virus on their PPE don’t contaminate the bags further. The bags are then treated with high temperatures and sterilizing chemicals. Once decontaminated, the bags are placed into another bag and into a watertight container and marked as biohazardous material. In this state, the waste can be disposed of as any other hospital waste in the proper medical waste removal sites.  So far, those strategies are working. Two Ebola patients, Ashoka Mukpo and Dr. Richard Sacra, were treated there and recovered, and no health care workers were infected with the virus.  

passage/grade  |  time: 2016-04-25 11:54:04 602836  |  # of fields: 2  |  passage_id: 5219  |  score: 2

doc/next  |  time: 2016-04-25 11:54:10 738178  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8215d9a7fa3f20828cafef8f84f2d2df13db8b79c3d2ccd4cb55eafc97c505cb

passage/create  |  time: 2016-04-25 11:55:06 883964  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 258  |  subtopic_name: containment of ebola medical waste  |  passage_id: 5222  |  passage_name:  Background  The Ebola virus is an âenveloped virusâ; meaning, the core of the virus is surrounded by a lipoprotein outer layer. Enveloped viruses such as Ebola are more susceptible to destruction with a number of physical and chemical agents than viruses without lipoprotein envelopes (Figure 1). Â   For the purposes of this document, any waste generated in the care of patients with known or suspected Ebola is considered a Category A infectious substance.  Physical Agents/Heat  Physical agents that can eradicate Ebola virus include heat, sunlight, ultraviolet light, E-Beam, and Gamma Rays.1 Â   Killing Ebola virus on materials it is suspected to be on or attached to can done by heating:  To 60Â°C (140Â°F) for 60 minutes; To 72-80Â°C (162Â° - 176Â°F) for 30 minutes; or Submersing the material in boiling water for five minutes.2 This can be achieved by submitting materials suspected of being contaminated with Ebola to treatment in an autoclave under a âvalidated waste cycleâ to 121Â°C (250Â°F) for at least 30 minutes depending on the load and packaging, which is more than enough heat and time to kill the virus. Autoclave runs should include a process control to show that the cycle was performed effectively. The Autoclave cycles should be checked at some frequency with biological indicator (spores) as a quality assurance measure to show that the waste cycles is achieving desired results.  Other heat treatments include incineration. Incinerators run at extremely high temperatures, well above the relatively low temperatures needed to kill Ebola virus. Incineration would be the best method for large or bulky items, such as mattresses. Incineration that reduces waste to ash at any temperature kills Ebola virus.3 The ash produced via incineration is NOT hazardous with respect to microbial pathogens.  Chemical Agents  Ebola virus can also be killed by many common chemical agents. Chemical agents that will kill the virus include bleach, detergents, solvents, alcohols, ammonia, aldehydes, halogens, peracetic acid, peroxides, phenolics, and quaternary ammonium compounds.4  Ebola virus can be killed with hospital-grade disinfectants (such as household bleach) when used according to the label instructions. A U.S. Environmental Protection Agency-registered hospital disinfectant with a label claim for a non-enveloped virus (e.g., norovirus, rotavirus, adenovirus, poliovirus) can be used to disinfect environmental surfaces in rooms of patients with suspected or confirmed Ebola virus infection. Please see EPAâs Disinfectants for Use Against the Ebola Virus.  Additional Information  There is limited evidence of Ebola virus transmission through the environment or an inanimate object that may be contaminated during patient care with infectious organisms and serve in their transmission (e.g., bed rails, door knobs, laundry).5 Ebola virus has not been found on surfaces in the absence of visible blood in the patient care environment.6 Frequently touched surfaces should be cleaned and disinfected on a regular basis to help reduce the risk of contact with contaminated surfaces. In addition, spills of biological fluids should be immediately cleaned and disinfected. Disinfectants should also be added to the bagged waste.  â Figure 1. Decreasing order of resistance of microorganisms to disinfection and sterilization. Resistant to disinfection sterilization processes---Prions (e.g., Creutzfeldt-Jakob Disease)-Bacterial spores (Bacillus atrophaeus)--Coccidia (Cryptosporidium)--Mycobacteria (M. tuberculosis, M. terrae)--Non-enveloped viruses (polio, coxsackie, norovirus)--Fungi (Aspergillus, Candida)--Vegetative bacteria (S. aureus, P. aeruginosa--Enveloped viruses (Ebola, HIV, herpes, hepatitis B)---Susceptible. Modified from Russell (1998) and Favero (2001).  

passage/grade  |  time: 2016-04-25 11:55:08 711625  |  # of fields: 2  |  passage_id: 5222  |  score: 2

doc/next  |  time: 2016-04-25 11:55:10 349310  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d52b344dd81ab636a9ab703a5d64fd25955e24a61e84e834412a4c3a82e7dcb4

doc/irrelevant  |  time: 2016-04-25 11:55:29 527524  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-06d0cf0e6165816a9d6f292e3f4ec4c2f12b3a05c02f98a43902ba7f98afcb7e

passage/create  |  time: 2016-04-25 11:56:06 865314  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 260  |  subtopic_name: dangers of ebola medical waste  |  passage_id: 5226  |  passage_name:  Ashes from Ebola victim's apartment in Dallas remain in limbo  Ebola FILE - In this Oct. 3, 2014, file photo, a hazardous material cleaner removes a blue barrel from the Dallas apartment where Thomas Eric Duncan, the Ebola patient who traveled from Liberia to Dallas, stayed. The apartment contents were incinerated but nearly a month later, the ashes sit in limbo at a facility in Port Arthur, Texas, as Louisiana officials fight to keep it out of a landfill there. (AP Photo/LM Otero, File) (AP Photo/LM Otero, File) Print The Associated Press	By	The Associated Press	The Associated Press	 on November 01, 2014 at 7:20 AM, updated November 01, 2014 at 7:31 AM View/Post Comments It took a crew 38 hours to clear out the Dallas apartment where Thomas Eric Duncan was staying before he was diagnosed Sept. 30 with Ebola. Hazmat suit-clad workers piled shoes, carpets, mattresses, bed sheets, clothes and kids' backpacks into 140 55-gallon drums. Only a few items were salvaged: a computer hard drive, legal documents, family photos, an old Bible belonging to Duncan's grandmother.  The drums were packed, decontaminated and then carted away by Cleaning Guys environmental services employees. The contents were incinerated. But nearly a month later, the ashes sit in limbo at a facility in Port Arthur, Texas, according to Veolia North America, the company that owns the facility, as Louisiana officials fight to keep it out of a landfill there.  While the Centers for Disease Control and Prevention says incinerated Ebola waste poses no danger, Louisiana officials earlier this month asked a judge to block Duncan's waste from entering the state, saying they wanted to determine for themselves that it was not dangerous. On Friday, state officials announced that Veolia has agreed to keep the ash out of the state's landfill.  Louisiana Attorney General Buddy Caldwell said in a statement that the agreement "ends this chapter in the controversy of transportation and disposal of Ebola waste."  But the unresolved fate of the ashes highlights the problem U.S. hospitals and communities could face in disposing of their own Ebola-related refuse.  Hospitals routinely deal with hazardous medical waste, sealing, transporting and disposing of vials of HIV-infected blood or boxes of used syringes. But Ebola waste is more problematic because of the intense fear of the virus and the sheer amount of the waste, which could include patients' clothes, their mattresses and scores of protective outfits worn and discarded by medical workers.  According to the American Hospital Association, a typical hospital patient produces roughly three pounds of waste a day, much of it not considered hazardous. However, an Ebola patient could generate eight 55-gallon drums of waste, all of it treated as highly infectious.  By contrast, there isn't much debate about what to do with ashes of Ebola waste, said Julie Damond, a spokeswoman for Doctors Without Borders in Dakar, Senegal. Such waste is routinely incinerated.  "We know that the virus doesn't survive heat more than about 60 degrees (Celsius) for several minutes and it is very sensitive to detergents such as chlorine. So we use both to get rid of it," she said.  In the U.S., Ebola waste is categorized as a Class A infectious substance under federal transportation guidelines, meaning it can cause death or permanent disability. But traditional packaging requirements for Class A waste make it hard to transport such large volumes. Class A material, often needles and blood vials, are packaged inside two small water-tight containers and then placed inside a third container for transport. CDC guidelines call for Ebola-related waste to be decontaminated and bagged, then bagged a second time and placed into 55-gallon drums.  Of 123 hospitals of various sizes across the country contacted by Associated Press reporters, three said they lacked a plan for Ebola, and several others said their plans were evolving. Eleven said they had on-site incinerators for waste disposal. More than a hundred said they relied on outside contractors.  But some companies have said they can't or won't pick up Ebola waste.  After Duncan's diagnosis, Dallas County spokeswoman Lauren Trimble said the county contacted seven vendors to clean out the apartment. Cleaning Guys was "the only vendor that was responsive and met the guidelines" for that kind of waste disposal.  Clay Jenkins, the Dallas County judge overseeing the Ebola response, said fear, as well as logistics, caused some companies to balk.  "Any time we move away from science and into fear and panic, we're making it harder for our first responders to do their jobs," Jenkins said. "The idea that you can't take ash, or waste disposal companies that deal with medical waste won't handle Ebola waste — it's just crazy for people to be afraid of ashes."  Last week, the Department of Transportation developed a new permit to help solve at least the logistics part of the problem, allowing qualified companies to pick up and transport Ebola-contaminated waste from any location, be it hospital or an apartment, in place of the usual site-specific permits.  The new permits were designed to help avoid scenarios that played out in Duncan's apartment and at Atlanta's Emory University Hospital shortly after its first Ebola patients arrived in August, when the company contracted to collect its Class A medical waste refused to take the Ebola waste.  "We had some really unexpected adventures in waste management," Dr. Aneesh Mehta, the hospital's assistant director of transplant and infectious diseases, told the American Society of Microbiology in September. "We had a buildup. We in fact went to Home Depot and bought up every large trash can/sealed canister we could get and kept them in a separate room until we renegotiated our contract with our waste-management company."  That company, Stericycle, would not comment on its contract with Emory, but said in a statement it has received national approval to transport Ebola waste and is working with authorities "to address each potential and new Ebola case."  South Carolina-based Advanced Environmental Options Inc. was granted an emergency DOT permit last week to haul away Ebola waste across the Carolinas, Georgia, Tennessee, Alabama, Virginia, Kentucky and Florida. Account manager Dana West said the company can handle large volumes of hazardous waste in a variety of scenarios.  "Our client list includes government agencies, universities, schools, private industries. We do medical waste, crime scene cleanup, meth labs — you name it, we've done it," West said.  But where Ebola waste will go after it is treated is still unclear.  While Louisiana fights on, Missouri Attorney General Chris Koster has reached an agreement with a sterilization company blocking it from handling Ebola waste at its St. Louis facility.  Linda Greene, who sits on the Association for Professionals in Infection Control and Epidemiology Regulatory Review Panel, said the new DOT permits provide a measure of security for hospitals wondering whether their existing contractors would handle Ebola waste. But protocols are still evolving.  "You start putting plans in place for something you haven't dealt with before and begin asking all these questions," Green said. "There's a lot of discussion and problem solving that still has to occur."  ___  Associated Press reporters Lauran Neergaard in Washington, Nomaan Merchant in Dallas and Melinda Deslatte in Baton Rouge, La., contributed to this report.  View/Post Comments Related Stories

passage/grade  |  time: 2016-04-25 11:56:09 482488  |  # of fields: 2  |  passage_id: 5226  |  score: 2

doc/next  |  time: 2016-04-25 11:56:10 582060  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-db33746749bfe39e7272b133230b8f60767256ea40f4390fa104e411b28cb9ef

doc/duplicate  |  time: 2016-04-25 11:56:36 279148  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-59b9d0abba54950c55e421c0056be42951d91aea55eb29cb6e92e206ebe36e7f

doc/irrelevant  |  time: 2016-04-25 11:57:26 798854  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-0cd75de9b194f51adbf1ee78b744132fd6307cd6df9f49d1a72ee913680aed13

doc/irrelevant  |  time: 2016-04-25 12:42:42 976704  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8ae707691026b36bab3c79f675a414a74e9163e96fb01460ee9bfd980a08ef8c

passage/create  |  time: 2016-04-25 12:43:27 798519  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 258  |  subtopic_name: containment of ebola medical waste  |  passage_id: 5235  |  passage_name:  Due to conflicting regulations from the U.S. Centers for Disease Control and Prevention and the Department of Transportation on how to dispose of waste materials from patients being treated for the Ebola virus, some waste management companies will not remove medical materials used to treat those patients.  This conflict in disposal mandates could not only prevent hospitals from successfully treating patients that show symptoms of Ebola, but also put the hospital's surrounding communities at risk.  Because of federal transportation guidelines that require these items to be taken away by people with special hazardous materials training, Reuters reported Sept. 24 that Stericycle, the waste management company for Atlanta's Emory University Hospital, would not initially handle the waste generated in treating the Ebola-infected patients. Emory was the first hospital to care for Ebola patients in the U.S. during the current outbreak.  The hospital had 40 bags of hazardous waste at the peak of its treatment of the Ebola-infected patients, according to Emory's Dr. Aneesh Mehta. At one point, the staff had to buy as many 32-gallon containers with lids as possible from Home Depot to contain the waste until Atlanta-based Centers for Disease Control and Prevention helped Emory make a deal with Stericycle.  The number of people infected with Ebola in the West African countries of Liberia and Sierra Leone could reach anywhere from 550,000 to 1.4 million by mid-January, the CDC recently reported. Four Americans since August have been flown from West Africa to the U.S. where they were treated for Ebola. With the Ebola outbreak continuing to spread in Africa, it is likely that more infected patients will be diagnosed in U.S. hospitals, experts say. As many as 10 patients have been tested in U.S. hospitals for showing possible signs of an Ebola infection.  The CDC and the U.S. Department of Transportation, which regulates the transportation of infectious waste, have different guidelines for removing Ebola waste.  The CDC tells hospitals to discard Ebola waste as they would other waste considered "regulated medical waste," while the DOT requires that Ebola waste be put in special packaging and removed by those with special training, according to Reuters. Since there may not be packaging approved for handling Ebola waste, many waste management companies don't think they are legally allowed to transport the waste, which is why hospitals may be having difficulty with its removal.  Emory has been able to sterilize the waste with one of the university's autoclaves before letting a waste management company take it away, but not every hospital has access to one of these machines on-site. "For this reason, it would be very difficult for a hospital to agree to care for Ebola cases - this desperately needs a fix," Dr. Jeffrey Duchin, chair of the Infectious Diseases Society of America's Public Health Committee, told Reuters.  

passage/grade  |  time: 2016-04-25 12:43:30 075455  |  # of fields: 2  |  passage_id: 5235  |  score: 2

doc/next  |  time: 2016-04-25 12:43:32 921623  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-58428a420e8f57e21650d31946d406492cdf981805b0c74f9fbf3543e4648362

doc/irrelevant  |  time: 2016-04-25 12:44:10 758677  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e912f5e7a8d7577532661034d4b4497b2333b71b7209d7d0cfe3026dc38532bc

doc/irrelevant  |  time: 2016-04-25 12:44:51 737240  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5c23ff9348e5718ee801743d7ce45e63bb93e30e4b49c22929c88a7b3859c836

doc/irrelevant  |  time: 2016-04-25 12:45:03 971489  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-781e6e8c82ad1e5e2f8f346f69e8e9701defc7509e057983a84c524bd24d3899

doc/duplicate  |  time: 2016-04-25 12:45:08 629373  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c973b45a5fb1b43780d3ab1a49b6bbc1ab984cca4b87e41a922c1858e9e5c330

doc/duplicate  |  time: 2016-04-25 12:45:11 059099  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-66b29df52280e4f9fb683300cfabc8bf101d0c2cb3447fdff184e5d2e1c3b5e9

doc/irrelevant  |  time: 2016-04-25 12:45:26 959542  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b96df72d4fc9a2bf3b1d1d44087beb66d3815dc918c1f05c5c71bdbfa2d4e3f7

doc/irrelevant  |  time: 2016-04-25 12:45:42 732091  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5ca63115e384dd7f0a2cc60feadda316a01f061e2f589700b476fc84cdf2aac7

doc/irrelevant  |  time: 2016-04-25 12:46:12 165406  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-bb6df3d26b4d71cb3dff3229e62482ad3b424c25a6eff7808e58ac15051ca838

doc/irrelevant  |  time: 2016-04-25 12:46:26 297120  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3f9fc26fd2381c629a98797575df78cddc13761c95e6f59b351fc5336fb0e903

doc/duplicate  |  time: 2016-04-25 12:46:39 249849  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-89841e13c81c777d1409ab921ad3dba6ff8f998fb32d5010c85b17bb6e0ca237

doc/duplicate  |  time: 2016-04-25 12:46:49 197430  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2daaf7f91339fe4f73be3c5a53c80e59220c5ecec4474f658bca4fd2cdd03684

doc/irrelevant  |  time: 2016-04-25 12:47:19 607156  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-85fbbb06a6e03ca7bdece332e9a1820902b0d05f8f288d81e790e965c2e53e53

query/solr  |  time: 2016-04-25 12:54:58 575233  |  # of fields: 3  |  topic_id: 417  |  topic_name: Ebola medical waste  |  query: ebola medical waste

result_size: 260  |  num_tagged:  0
ebola-286d50db2a8dd2d4b965d0e63f3914edc19175d6b05e4be3ee515360f8cda194
ebola-2a05c1eb5f64a91f3ab926f78434a9de951b4b2ba8754fecb899b6223c653559
ebola-e9672ab8d937b648b8922584f024f64aa994705aaae3261aeae7c7a6437d920b
ebola-5353142d7ac154552577129bcd106c53cdebf6154499d068751880c193220e50
ebola-60b80408b001eca49e2258c7c0bc927e4219b804c5eeb09ab57bf133b514ad03
ebola-16fc03133e51a1f8c2bb86565cb92d1fb0e288ae6f29cb35b7331bb8e2fbb32e
ebola-3975570851fcf8092e11b9553a29edad22ad3bf67eb9bc4cddb52275641b875b
ebola-19df3cf50947fea1873864be5add334e71582943b9f2a776e917ef6db8b50b74
ebola-c9a650f810a7ba3b2f8f9f59e9c5b2219b2d09cee1f22e05d5c7635525e6605e
ebola-c276320148c13708aed70b61637078328deeeb6bcba4f04bf910230de03a0530
ebola-9cdabe578d1d70023e0c9c41021d3f4c0089ace1489f0b03f14bfa4a61b7d01a
ebola-65d7aad04c34ccd096f98fea194e47fb367d731784b254926f5e49c4baeac835
ebola-65a908266a4647bc62bbff2243f6411e310b7ac3b05536ab63c1d8d3d097ff38
ebola-c27ca266153fb7e8c8308620449a8d8cf228c6c72f796a3fb71d3e978cdc67c2
ebola-7f9ccf79f560eb4aeacd4630ff4efc76da49b4631faa98362b37620e40935c0d
ebola-acd5938a4abcb0f11aa208e8adbb3367daaaa4406d0af0b97baff4865aa3669e
ebola-8801e21da2b0b59d7597d62aa8ca1b279ba423664dc8d1d280378fe9df6ab554
ebola-2638d49c8ca993a6b559fa97cd0572bac6e59c7a0c20e97be9726ee0ded1ab24
ebola-94a8dca870f1a541676a57f79a1f6d9396ddd35521845b39034a24e663722ba1
ebola-0ec89571cfb9f7262a636b3111c05428279c6659903bebc2edc988328e8be794
ebola-46273352d8919a3d99b24fec272148858bf26a38952a3e296e6019b25e9b0e36
ebola-a667975a94c49eb39bd736f5590a0d044ed3f9d616210bc84e667cbafc212a8d
ebola-7cee6d70977d2604c67f43822f3c7d2a390ed1456c6f766b26b28abb2991d87b
ebola-ff2851ebdf57caaf84aaeead096906600aa66dac83bb771afb6d864faa81b8f3
ebola-d88155ee6c4f6094bcc6b561f6779be895157b2f47211fc0a868b7013739e944
ebola-5b5e439f68a5bf2dea8e2baa3451b2b5ab0eae870e23620ad82d989baf872859
ebola-498bf7237066ba35cb2e55bf61721e938aa488fa1db67f5914fd5f41ef08c784
ebola-e21f32c04383e52b375f47ad79eab07a4151cd964b03e1045efaf4c1fafd1a56
ebola-c868af5d97eb0cf87669732fa33ede12b2258aeb8970a12d5682c05db9a601c5
ebola-8942767a901686ae379f69a3591b4c2f1a12d0919835b230bbccb87d945b6285
ebola-dfca159b0fb8af489ac7c9310166190bdfc47116de44f548722a86a5f68435b7
ebola-5ca94959e81e07712fe34e9b5532bd46a664d50af74600c1cdaf659ca0c29321
ebola-702ac937d308ee6fa609aa558a7f91cc29487f1e5410fdef261032faeabae192
ebola-bb3940e1a5dfcc1c225787ac2b47151003f9b563c1330c85e2d6b22bd10497cb
ebola-fe004c2cb2374883831a3b5095cc4692588519863323fd27a59908345f59b9fc
ebola-f7a01e636284f54d6b08f0f3a2cc59ab0c311c855e78afebb7dabf211a141614
ebola-e0ac128dc39bf24030218dea5a184f4f04a840754cec0e3a781ee1a7a8a53a0e
ebola-dd7a56319537cdf4389417f1442316605e3091d4c370c208fc225b4e777390cd
ebola-5c0a3f3a599ddefb91d97544b9e03b258df46642ee1b50e692d2d2fba36d1a27
ebola-5b7ad0559b1dd4d9211ea387d77826f95800261ed97c94872920f900b645efd1
ebola-2dbe392c7ec530d271cd858678f2fa5ba1e6f1c494c0d3e96b9c3a0c6993dc24
ebola-f5542695307ca6ba4965e94a2ab6b5227f05cc3e8882dc91cc15d6beeceb3f4b
ebola-20c5c7e953c297b8ddc4436d7191237595bc37d82a5b957efb18573196631221
ebola-12ddcfd5a4dcb4e668f858c44bcdbbc6e684727af27b77eb7bb4d000a7355a96
ebola-d4ea5d9383c7720bba9021b30015bb39173398dfeda3383a20155cecbfc7cf56
ebola-ce585a480add131a1e269ba4ac5f58c4311f4503af12ecf58a219eff3d30ab61
ebola-fbe1949a25d5626a86f07aa38f48f8c03e2063d0ab6f4094360b1d8279e1cb0b
ebola-7a60a5c35ebf8ff096a4ee3019a5ce3a07bd453722412c6a3d2be22070f16fdd
ebola-7fa39a8cdf02a3851ad4d62a8765d402213b468867a6f085d475b01fb433712f
ebola-4b68c3d12b20c550d42b694902290d5a33345fdbf8c10373f9d603008618b92a
ebola-33107043576aea5708dda9670d21f8124c4ead98039225a21ba5534a59a198f0
ebola-0f93c684792c66bb6ccf92ba24a05847fb408e4c2cfcd3f9c2565e1e279b1a70
ebola-2b1e1e748ede9bb2b7b855067e0dfd0d99775bce60279bdb59589ad2a99bc2c5
ebola-731a28549740e1bd6421249ab800eaa3252fe874ecd97d34bd602da16df6c157
ebola-d52f1376144b27d28749e0480901712299d88bafa9e04a8cfa01cafa5391eedc
ebola-9b7aab16aa6f9cb2a3f19cdb640a345e20750de0c5f889cfef5a0bb6e5888e51
ebola-cb18ea5180655cd78f90ed8670a9851ca27a87ce5f80abf3950ca7d7c3c898c5
ebola-5f8c2554f46c3cd90157b57676e649c3e1965785c2ef6cf57b6544e8b7a3f6cd
ebola-046accc4432cb3b60369072f12e4c8d8ff97fe29a114bcf3cb85d7fc4571b2ce
ebola-54a959d78d155cc93d59d05d197b0ca1371bbbe8ceba85b5bcafbce75fd30c5e
ebola-ca13b2d2a2e04c1061afba125024e5a8725211d7e8b072655948905c3bddec38
ebola-f17725a979c5fa6cd545f38a561053b91c8fa4885fafe99a7b2dc3ec86c21346
ebola-02b4d0afb99017ee4fb35f3f1ea269c159b1d0e67cc87568343241d3834c0e49
ebola-b4464e2ca5151918ad0074dab1d7339d098ff46f369291373e6764b354d10dac
ebola-5c53597ecd01e8effa09d18a8917cffb877b8aa3e424f20c6ae784bd46ad2d45
ebola-1ad53754ce1b807f49f51f87c577344ee3c41bdca8a22dc7e008f01caa31d06b
ebola-5db16fff95620f7b0cd43ef9da7d293672f6869e887be7cbfd7ead88e7d6ebe3
ebola-e6d2811aa9b9a97661eed07052831850aac25261c78c26f2071ba3ef36a62298
ebola-eca8ea528c8197bb96cdb3d28250a82a5a75389d0614b5b3cdbb6721768fb2c1
ebola-06566b3aefacd68487a038028035703623049c25d22151b443ac980b13886523
ebola-63b9802e2c19e798b9b6d4bbe648759118852c516f4de27c662c7dacc3a5e1e8
ebola-a32f11619522874a116f9e712a67a09efb634e4a4b7f6f5b10bb1392f6c4b434
ebola-b677347bc63ea926d6883ac8f79831afbcb8ba167e79e410e339f53b3366c6a8
ebola-59bf890f6ed4574cf6e7850f8ee6c3731abb45d9e4ab7ae52e50d9f5ab08fd69
ebola-07fe8a4ae3908a0c0bd0eff74e57468109ff6071c8194d37c93fb0f2998d0f09
ebola-45466baa59da233bfa1f7d332fe2b97751a4620ca2702a1c420771afff6bfe7f
ebola-6d2fe5f994d6be624f0b988382df138fe49310dfd7fa636cf0730bfe473ed267
ebola-e556a574f0440b0ce9ac10c81f18150cf1039aebd199bdd5f945032ff2458f8f
ebola-df1706a1c8ef8d1e39d883e06baf59ddbac4b4857d870d4fad65ec3f95133259
ebola-5358caa9c25be6f3ee75f4f7b54c069ac7743a59b7d236a234ec44f252908b21
ebola-8029279d3987506bcb3315ef3c5b9f8aa6ec54ed691f85d2914425278acb86e5
ebola-d2622f6d79837a67992c70324724b19e7702ec837bb631f8227e6dd432c28828
ebola-66598ed051c3b2c25ef7a77b0bd7e8c6644422b1828abd6ca3a498874258b6c9
ebola-e628662d7f375e572184f3bb1f2811e5bfc09a4ffa95ab98dd95f1b5ce08f7f0
ebola-63b8d52f3b0e94f5cf3cb7b38e2cc7d7adfb63934cee6ac91598060a1aa57358
ebola-dbbc05ed7b5d532ee134442a04872a471716922aa1c3f292c200ea2191b454bb
ebola-b804d7d02abbbb0e1a990022f25d72cbd1156dd6d039a663510abd6b5be2b623
ebola-7cd31c12d7c31f44e48f253bb53b52c59f63a994216833b96d133a46821eb23b
ebola-bd23f9a1101841b5332d2057b20e11a50544d54a000dfc779035701d96c7958b
ebola-4620272bbe895f0aad3512d9b5707f459e6cb8ccc4adf392b00ef78f244e9804
ebola-32c2cc1ac72bdb87df159f958786e34dcf3fde9da14855f626724754694d26d9
ebola-336d2d0d6529f099b55456340253d12bcaba77605ed20597cabe03124b514468
ebola-b1e7bfe893196660026dde38600744bf4faf40c230b566e601a228524809600e
ebola-afd035eacdcee79f6d6cd8f8474256a578386ea44dd11d6200d31401e5d82874
ebola-0fb29f7e93b6c764fc55f96a72255c1d0571d556efbeb2b3f364c7b39b51b332
ebola-dd99c376c6250896fa98c890a29584e0e545adcdca2a8bcae349d1a1f43c11c9
ebola-2c8c994aefa2eecaadb13a6a8b86f11d21e676f1b00d4d7396694b9e6dfc80e7
ebola-b854225329055207b644236bb0c9f2f4f8259a6498c112cd50a577120ab55af8
ebola-0097b3acb6db3846f1f605004021399ccdc9ccae8f9d8cce69ad926c818e3f8d
ebola-fa7ed115d9d490d7b768e81a5b356d73eb3655efb8a88310f61b043d5ec778e9
ebola-6283bf5cc5cd8c72a392edbe6d19bda82d7bffd6a759030d88ecfc09af9a5cb2
ebola-90fadc1c594a3cb3a09d8a70e945f4cea61b5f37db2719989f3d3532a830c4b4
ebola-a85ab1bd2168b578cb44d85977c80054812bbc69f256607a158ed9456042279f
ebola-aa955d77efb927b310950f9108253762a07bb22f1f9d5dbafc1cd03d02af658c
ebola-7a282ca5839fae0ed29092b1b60fa33b7468ceaba420aff4031964b88469a5d7
ebola-230d5992abccb5a5f7db441083eb7be132204b9dde3868b204235c18d644e1ed
ebola-8fd1e418a8ca0d5be7bda38c888ec5da5c3dcedcdaf396ec690a3b8420fbc935
ebola-e8f7747a26fda9c2b03ed3191cee0574b8247829b3f072f8b624a9feabf07244
ebola-dd6112d8a0915e01c4f44c98058431731a74b90bb316a67d633a4d14101ece2a
ebola-e2ce0aca02f38aaeb23e5f320eb69e18142780ebbb4dfeb8a689b6eb887e4600
ebola-10d7604f4a8aefd10a43ecab84b79ea519954eb20a716a7b1fe964a863efae07
ebola-54e531a8630c8ac95c7b6195f45a3195dd48ae2456207b35f509674f24e4c7fd
ebola-47aab74360c3ee9457abdad8ee5a985800cc9455fadfe5328412a55821dd809c
ebola-f5791d37728207016a35e9e47c4a4695e14a20a066cecc8cc664290792f2c102
ebola-4bd7c5440b2bb0ff2a82a7820513da9d7b7dff04f67a031740780f8807c150bf
ebola-d61029bc9bc677eee1d64e9cef2aaf7c64399119727db7d99a2d21d6b85a27d3
ebola-390dba64eedbbd864d5fb5ec20f40811431af8cdcfbc507c10e8b80efe7e9d31
ebola-5050f8d631d6756584364b60dd0e6057cdce2b3a322bc016436538a361db1157
ebola-d11c80f7a2112ac9dcc28d3e835301e1bd81b63a43b4bb7ff653dabd367d4412
ebola-416b79978a4e599790f3905bfc8b13d3803d587dffc74ff0342c6b0216181f79
ebola-58de07b52d99ab6c34d6b679ec056836f29a17379a6201a1c8f874d8406a09e6
ebola-8c93602bc2dee1722ccfe994e905ae8137621ca55b095da4c697d3317a6e4380
ebola-ffe18fc8ceeec2610dfff31f13a8175a5361c7543b3b76b9d3d75a706c3c4ce1
ebola-d1d230a0066f2698bd0e017ec09b08e6943492c037fb5eca882a1e39e887492a
ebola-5300db87c132ca277609a5e3a002223bc5ca8c36f4154bc562af686a5f5342c8
ebola-0a6293b8d994f074267b263151b5786612cf1fa2fb530153a9f30f771cd93f3d
ebola-ef0abb17c693eff5772d880b7135d8a23eda37b2749674d021cb17cf70d3e63b
ebola-1e3e1652da39a25fc6831f8fbc76ca8e10c584886c9a4218c3564e862ef7d074
ebola-5ae35f5383ef2f99dbd0d2ff7f7166acbb8917a86089858d8fc15652d4682c66
ebola-4b4a64615b9e1fb6e14e8b24102c1c3758874d4dd55b9193fe220ff491c803ae
ebola-26f68a078fc10ff78f8a76557dcfb99512604874dbd5159382b0c489b61ba844
ebola-32cebb6a5122d675b6c852f80a11dc11160a135e933214b3c60f8596d1af1b94
ebola-9ac3977a6d1b829125d4c1c09ec16a156accf915a540f06f43e2f3f01ff2aac7
ebola-e6630ecf19dbdf613f1ec7061feedd23be80def08840968b2232ab8da134b1ac
ebola-ac56905097da0f4a0241023a0ea024167d267ae1e0e14b74859f7b428c419b79
ebola-ed94baefb60a8eaf5d3d8908d489c99d50f22eec4f76dea1e7b53d5b55a04e0d
ebola-1167139f2e599a41638b64ef6a0c095ae5be808309de18ae9ad9e48c464c2827
ebola-bf848e5db5992bcfd9fdecedad95ee6e6df07a1de3ae60861ca04474944fde40
ebola-5f458c0da7225e6d95647f6c937bd3aa2cc66eda0c8cb2a6043ce556d622fad9
ebola-aa91b0ed4af89de31807c7e5073fce934322f81b3bfd114f549195131bde574f
ebola-35b717c8be8e32f8cb328caf55af72178a10a7b32e3e4ba8da6b694d4f3f601f
ebola-390aca948fe2cc10548b65fd1648b8ab37f2155fe5223bff743749afab4e6571
ebola-4c263cfca756fd01ffcd24ead08909fb84201a0c37b2437d8d1491334e14a1d2
ebola-3f341c688d116eaa0475367e7acc3e08d6275905d05422cfcfd890011d23e88a
ebola-7f171e9ac473e95026f412105f4d14bb3a0a8fa4af8cf0199f0d22c465ea2bc8
ebola-ec45d548d007b4e12d5c03304ed3553c358899daf3756a615c6762b3fde25f7d
ebola-caa7cbd716795f873c72600deb97571e88a9d37ba5aa4c9a69f1962264e84cdc
ebola-1155aafabd1e97a8e54763f1b5a071769e6b3b291091878b46a06fd4c680d7d1
ebola-e77ff9888cd037406458b9786b986c10e169e83142320b260dc54d86f6096aa8
ebola-c8124d4e8ba6487eb62ac255cb38b379a829b9dd2ade2e775009275ebd1c2c08
ebola-2e4da28759151b1b2d4686eed853b5a7bae5f3afffcc822f0ed39c191fbf752d
ebola-5a39aa167b4ffc2c3de8d91aba5cab6b4acf85cf3d68b7d8f97a94ff22edd6c1
ebola-0f731a9b5ea38fe7cc389c2d1acc06ced2e9810fd2ff2994bd181928106cd7fc
ebola-b012e8b5477e3214032eaa00ea4530ea69493c9a2a62fa42254166ac6c71fe55
ebola-d028233cd38b37d918ace0a7aad12e527b5682e5ceef2fe20bd0e62a27d795c1
ebola-2c1243329787c1905476f63019b94d14b8a0b9d20e0f5f953865832b87abd8fa
ebola-d9c662802d3560d6c06833fb525e853f2e7f166fcdfad7d644aa9ce8ed48f3ea
ebola-68a6df93367d88793e75998f62d3f1f2e84970e07a66e970fb7f017cefee955a
ebola-07de4b5b02f80632e5347f451f9b9b46252150abac7b40b76b1130009b41d57a
ebola-807deccabecbee71f569df23d02ada0374ba3356f7ecb02f4ffd7efd9461e465
ebola-d26bd844df56d424ae7a3c5eb08cd2a992b3a4d9de9bbd32b4097ecad909671e
ebola-c93ec439f1590ee1cd7133659d2a35ffd94fb4be659175f853411590ac5b67d2
ebola-20b2e21e1ecf8d391c08f6b8fb6a78ee2a4f4ff7357d1ace5d636804f0877e89
ebola-0bf3fc77fe884ab00a99d7788c29a0ff82936f23a5cd6c5f52543b6c23d8895d
ebola-3a695fcae50226eb181ca97a0216122ab4a32f70aca8c69ca938c05af2dfccad
ebola-131ca4dcdd7e1edd2fa221b8992393d5d9c2213c7323d7a908be7ffcf06cf176
ebola-c54e8ca7b4ab5791f8fbc31f8527150177822e29b3eb2d9d3a4228ba1af76d06
ebola-25901658320f717de9d6e6d89a84505ba4c6a5d7622ea291a87c7bd374aa830c
ebola-8e8e567ad89c9fbf27c96be92373f18ad274122572eb688c38532f34d49d3a34
ebola-c066b38bfed69276dc153282d56bf5f27b2d820050d3e2656d023c811a0e066e
ebola-9dfc9688858d90fcf56997501d273c49c5359fa3ee66fd792e3f43491a35fa22
ebola-b302abf73d8bafd590f5956f5f663891249a9a7994704795bbb57825c30d50a9
ebola-564cc5c585fbd6964610ebc28aa32c848ea7008860e39cce6226115615f6ee6f
ebola-a16f692eb9463144873c7fa7bfef90c8dfcb6ee8ee2c1ac4c8d9ca34c6b80150
ebola-41ab12bcd6c941bcf9c0a024eddbc6ec5c43fc5cf2d61ce326fb57f34615808b
ebola-9185911f81de1e094d61c41fc3344498c56bf661da23b21b8103dffb81166e13
ebola-b7583987882e911fdf8219eed926d3e040f8a285f202437f37ba252fa7686e62
ebola-de3f2afda90b3ddb50d238ac9233032389d2376d83d9ab614cc63253253931d1
ebola-9f591ffbbd9a0dbdb5a3f63f3c920282845bd111f2b6dfdf66e53ee1dc23274f
ebola-c1b5bbd585bf19e49a1b70bc031e8d2b2b7ea2229720a2d1f6d68a86371e3bb3
ebola-6030bcf7a076b03dc371bbab4c8136e19e3375010ee8e5b01d1d705b32d08e5b
ebola-f8d8d6a33cff55d0a8c906353650f9c3bceb2946025babd51ed579ef220a1f40
ebola-06a887277173be72b8524d3635525c273b8e8ca33db4b8b6c82d78246be0deea
ebola-7c035414e5a2102ba4b4ff6a1bae1a844035b7b86ccd3241291514866402dbad
ebola-4b830ebe77ef370899db539f8938154fbeb4ccd6dd306c203dfc07d60fc18b6b
ebola-8923735d6c6c94ecab86cce28e721094344b9a569343490a5877bfd2418a952c
ebola-6949345af5778846537d747f599f5a3cf87010e31208c88b7c44644f76ee1bae
ebola-3a7a4477c76d92daf86d71ae98b308ed7b02c6d4116613b7fe82b22e2000c4c7
ebola-51455d1cad7c618dfec0793fce7bbf54e5166cd1204ab2218ab62447cb6d13ed
ebola-9057fbe29a534b277cd42d2c489ade073390d81790c67bdbb7b86f0f866703b5
ebola-114ec3287575043b9c649f5142f41bad6ab5a0cf695aa63de27184a82a2c20f2
ebola-b1963e91373832e5da4a7e53a394e4a72786725affd226c83227a6dbd92cef68
ebola-5d891b58dac73e7423a0803343ca18254fef4b191468a90fbdfcdb2a2fd85032
ebola-46669037a58636793d715e290bb863b87125a320400af019cff57dc9404f9bd1
ebola-87dd9b48d3d2faef7122728f0acf3122e5440f1b4c8265254e999f66b184d6ab
ebola-fc8d1084ef3f5f4a037f0ae50be532241738974a414c0abea119d844b2773a9d
ebola-19f3e75f8112707c1b1ef5e55259245c3a76392cb24cce5a199de4015babc521
ebola-55eae7ceb81c31181207513d73084e508069a52be2cb9ab70ce31f5dc1151fa7
ebola-f565a26cd467ba41da26e9db151b7dfcf51676687d71b509ad23aa8eba814b6c
ebola-69011e54413760c68f0420f761250e215405fbbde8d065e86b810654644cd1e3
ebola-f6bb1c00a73395b1c017737211c7d6b0f0e111203e7762b997c1a3f89ad9ce33
ebola-28ce2d14db016b716e1cb8d79d5551f5ad9a7d33530917fc2b6186156d92f979
ebola-e80de745b228f2e3cb37a7c6bfcbe6d3cb4733c80d0013a0db7366da2206eaa2
ebola-06c52574e1a17bbb09f1b6f66980d883edd62d576d861c2e2368efa4f739967b
ebola-9454dfabe6d2c7ea84e9200b736ca3225eb72cff6fac8b9513053c6120827ed6
ebola-4a0ba3c009f44fd5b68a176a79617b8e9ae9aa33e91ceef93786e4507fecbfd7
ebola-8dd00b84667fec66aa5cae408f5dce20d269e9a519e06f1e9fe2a1f6f0a48701
ebola-aea0c48376f572228347dffeee3a8f04a07740fbe8db46fd0cdec638a078e6e3
ebola-721d422868a89436dd92810147834e5d849732a8fef80910a612bc2fcc8d4ddc
ebola-bff2ee2ffe13ef049fc1616572de70180c0744380d4d9a0ef27be2b4eb1fca7d
ebola-849cb4447dbaebbd5bc42cc3bc1fa744e19944489ccd0d14c00725a01a348192
ebola-6e5e3f765cabc9543ca49756c5a7e4508f048474235c2f5581fba68c825bdb57
ebola-f1633bcedac707ff862725d082e1dcd97aeaca7866812fcf9db9bcf3c6c6bf4c
ebola-2b4c32c2564ba2e65e9d4e28c699a08376c76735a4098a36b9f523ecf4231521
ebola-555f7d79cd1f103ec9ba47a80afaa69de76f1c102084ee5d6b8c4ee9c3420b9b
ebola-9de56195d3d5089924bce8bfdedec8ede72fca414005db523503234411053708
ebola-85a589aa086cc4b4ca7c19a6c00918e6bc59026f994b4688bb5226c7aa2528b4
ebola-621e356f230784e0d089e271fa8f8d71ef79de85647e9156ce3591cd5c42b899
ebola-bb61dfb8de582fe3ea5f21f8d3f45292e575e8f3c653f150dfb17d4dbdbb9099
ebola-dca8083ca67d9f8a15d3c91d32060e27ff2f8fa53c458748dde4fbb71ab768b4
ebola-2ca91bca7a90f87cb9500b88c28593c980e0d687cadc3004529e2a6a71113020
ebola-a8f2f2c39882f3b4e5b27b467a488e478e2c0336d544713476d9f18aa7442a86
ebola-1849ad6bc642253e3d708e4142f9caae6c10e454edc29c1c1393f2efe61f984a
ebola-c826d7e45ebb9491d29a2588a921e1a1c3eff851ab933d7dd643b266b31bc97c
ebola-c39324a4e7975cb2ef741def6ebbbd5dbbbc012d91092ce3a4a9f89e07ec676d
ebola-e9a3ee845233746e007f34e3f76652960b30b59a1728393debaf8f113e68b1f4
ebola-611354ceddfd8e37e740d14b2dfb1500a20453647d01ab057f7b32173e6e3bd0
ebola-34b921fa7b4232356ceeb5025614ea71143d2dede794c96120f8843f307c80d1
ebola-2a45598584934234f7c00e08f29a846e9649ca9e578111e5021e5970c877ef9a
ebola-36308a223e75abfb571e1c4c31910d32f0e1170b5fd8f5232e48905edf504858
ebola-9e379914d624909ddffd355a7da1b58528882ef6559a0c851fad0d1e45d21ad6
ebola-d2800481889af9bc84d21d765f910829ecd5ddb04a73b365c6154d15b7be0470
ebola-f126bd2a3f5f9d3337a9c34c9a38e2df1c66d4eb52db8236861f391d54de6cc4
ebola-ecac88f136ac4b862cd2fd51a3ae972c10c0f5999adb861901fd4ea9426885d8
ebola-3a478cccc2a676e5e5730da97e5c5233e0cc1917065a25415e0b6e5a06c853a5
ebola-3d19c5f694fbef0ec66b91a607fa922725b08b62aa69b3237f7b6a26d19d62d8
ebola-b23ba77cedeeb975b82be34c668341abfe0b95450a12a79e0d94c9253cfff9da
ebola-063b3c2e0fb2ade0f07ecb0893366ac44c0ab63b210f4b3df995b5868e38c56b
ebola-08ca21ee257547b3c6e1067b01a044f5ae6cdba80a312117d863b6c44fc756c8
ebola-0f8f03a88b5a4458771bf77536d47e3b9cdf119f82bf24d3c0982331456643d6
ebola-81d8336a4c6bc84752d89ed7249715c4cf669d1609b18306a2cf2ac393973048
ebola-44025d21917f05f68fa2fc59ed72b6855e30795722e9672196b0bd1c3a91f376
ebola-e73b0f354cabad04e765c07946c1d1791e0cc55932f965a064bc2c14b5b1404d
ebola-28fce575fb5c018fcdc67fe9e6c44e31e5b3c046daf7f42f3a87ba224e3386f8
ebola-b19fa3620a708d3d694fd4ed3e08892d52c6310534f7fc742d84de363a600912
ebola-88e647ebe7f0c8393b2bb8ce59114bb8950403f94fdcf85a5d124dd7351657e8
ebola-b9f4a21016d29fc12182ffd6bedd327228ccb24796527fe15a044b918a41f594
ebola-9c7dfc6449f535d7a2655b8b550c830fd82a4ac4e3c6b613519887a027e2568f
ebola-7de76f8b7a2296645d8968132fc2f87329ca01e1c63496a8617b3263f0270b8d
ebola-d08fbe5291c84a6dbd08ac042cfb094ba824826e246a07d33ec8e4f2d85e156a
ebola-c1dd94d538b40e7199b6f60d71d3602359231d7eab2edabf1b5b480fe61a3537
ebola-965497a0af33db3df4d8ab4bf4f1a65c7f4e1edc3a3011c5a9757f0f99733710
ebola-a05c9f8b309682ad26815e83ac79907d1a6bd8e402bc8e51eed8b960dff2d25a
ebola-b7ba6ef607eb483227ec38fce989863fa624a42ac53f792a05f1879452d3f934
ebola-7a3652fe73d71efd818d8193901007f974d85469c1c205ebd6c3a3ea8794a025
ebola-0be9ff476e34b20cf549f5101908fe1e9d19124c9ec3e23d4d4b50193493f9c0
ebola-9e1485db76282d31fdadba7241b2fbe24cc3cfe3ed58e74b84125cb91c056c6c
ebola-e42b5fb102b4890ccc8911ee2fa24e32f753e91df3c4ae198859ae9a252afb81
ebola-f7168637bee06d906f70029086575e82edca10c12f795889dc0d9e601216fb66
ebola-8aefa71abc41c81f5d3b1333d244dd9a0905f20e4cf44c13437929baf82ad993

list/click  |  time: 2016-04-25 12:55:21 869169  |  # of fields: 4  |  topic_id: 417  |  docno: ebola-286d50db2a8dd2d4b965d0e63f3914edc19175d6b05e4be3ee515360f8cda194  |  listsource: solr

highlight  |  time: 2016-04-25 12:56  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-286d50db2a8dd2d4b965d0e63f3914edc19175d6b05e4be3ee515360f8cda194  |  highlight_string: ebola, medical waste, cost, containment, disposal

doc/irrelevant  |  time: 2016-04-25 12:56:25 926463  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-286d50db2a8dd2d4b965d0e63f3914edc19175d6b05e4be3ee515360f8cda194

doc/irrelevant  |  time: 2016-04-25 12:56:51 664389  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2a05c1eb5f64a91f3ab926f78434a9de951b4b2ba8754fecb899b6223c653559

doc/irrelevant  |  time: 2016-04-25 12:57:23 293911  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e9672ab8d937b648b8922584f024f64aa994705aaae3261aeae7c7a6437d920b

doc/duplicate  |  time: 2016-04-25 12:57:43 116826  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5353142d7ac154552577129bcd106c53cdebf6154499d068751880c193220e50

doc/irrelevant  |  time: 2016-04-25 12:57:46 658257  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-60b80408b001eca49e2258c7c0bc927e4219b804c5eeb09ab57bf133b514ad03

doc/irrelevant  |  time: 2016-04-25 12:58:02 466259  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-16fc03133e51a1f8c2bb86565cb92d1fb0e288ae6f29cb35b7331bb8e2fbb32e

doc/irrelevant  |  time: 2016-04-25 12:58:32 372416  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3975570851fcf8092e11b9553a29edad22ad3bf67eb9bc4cddb52275641b875b

doc/irrelevant  |  time: 2016-04-25 12:59:00 483945  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-19df3cf50947fea1873864be5add334e71582943b9f2a776e917ef6db8b50b74

doc/duplicate  |  time: 2016-04-25 12:59:25 331180  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c9a650f810a7ba3b2f8f9f59e9c5b2219b2d09cee1f22e05d5c7635525e6605e

doc/duplicate  |  time: 2016-04-25 12:59:30 336612  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c276320148c13708aed70b61637078328deeeb6bcba4f04bf910230de03a0530

doc/irrelevant  |  time: 2016-04-25 12:59:38 796430  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9cdabe578d1d70023e0c9c41021d3f4c0089ace1489f0b03f14bfa4a61b7d01a

doc/irrelevant  |  time: 2016-04-25 13:00:01 635350  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-65d7aad04c34ccd096f98fea194e47fb367d731784b254926f5e49c4baeac835

doc/irrelevant  |  time: 2016-04-25 13:00:13 531467  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-65a908266a4647bc62bbff2243f6411e310b7ac3b05536ab63c1d8d3d097ff38

passage/create  |  time: 2016-04-25 13:01:21 527547  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5272  |  passage_name:  The world’s top health agencies have issued strict protocols on the disposal of solid waste from Ebola Patients. The University of Pittsburgh’s Kyle Bibby said there’s also some guidance on the disposal of liquid medical waste.  “The World Health Organization first issued a statement that it was appropriate to dispose of liquid waste from Ebola patients directly in sanitary sewers or pit latrine without any other treatment. And then the Centers for Disease Control in the U.S. followed that guidance and continues to follow that guidance,” he said.  But when several people in the U.S. were treated for Ebola some questioned whether that guidance offered enough protection.  “There was lots of concern from sewage workers about going down into sewers. Would they be exposed to Ebola? What’s an appropriate personal protective care? So the Centers for Disease Control stated that Ebola survives on the order of minutes in water and is almost instantly or very, very rapidly inactivated. And when we looked to the literature we didn’t find any evidence of that,” he said.  Bibby is an associate professor of civil and environmental engineering. He and colleagues at the University of Pittsburgh and Drexel University did not say the CDC is wrong. They just said that there’s an apparent lack of evidence.  The guidance may be based on the type of virus Ebola is – an enveloped virus. That means it has a membrane or wrapping, which actually comes from an infected cell. But Bibby said enveloped viruses usually don’t fair too well when exposed to liquids. Take the AIDS virus.  “For example, some of the studies that have been done, like on HIV, found that HIV’s survival in water is negligible. It dies very, very quickly. And HIV is an enveloped virus and I think that this is probably one of the lines of evidence that’s been used,” said Bibby.  The National Science Foundation has awarded the researchers a $100,000 grant to study the issue further.  Bibby said, “We don’t have firm guidance and guidelines on disposal of infectious liquid waste, period. And whether that’s from a hospital or funeral homes or other places, other medical facilities, there’s not sort of a concrete guideline on how to dispose of all this.”  Researchers will use viruses that are physically similar to Ebola and test their survival rates in water and wastewater.   

passage/grade  |  time: 2016-04-25 13:01:26 555314  |  # of fields: 2  |  passage_id: 5272  |  score: 2

doc/next  |  time: 2016-04-25 13:01:29 480539  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c27ca266153fb7e8c8308620449a8d8cf228c6c72f796a3fb71d3e978cdc67c2

doc/irrelevant  |  time: 2016-04-25 13:01:51 003795  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7f9ccf79f560eb4aeacd4630ff4efc76da49b4631faa98362b37620e40935c0d

doc/irrelevant  |  time: 2016-04-25 13:02:03 759028  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-acd5938a4abcb0f11aa208e8adbb3367daaaa4406d0af0b97baff4865aa3669e

passage/create  |  time: 2016-04-25 13:02:42 917559  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5276  |  passage_name:  New York  â With support from the United Nations Development Programme (UNDP) and the Global Environment Facility (GEF), Sierra Leone has begun to use new, environmentally-friendly sterilizing equipment to help dispose of the vast amounts of contaminated protective equipment and infectious waste generated in treating Ebola patients.  The sterilizing machine, known as an autoclave, decontaminates used medical equipment and waste such as syringes, personal protective suits and gloves through several cycles of high-pressure steam and vacuuming, allowing for their safe disposal.  It is the first of its kind in any of the Ebola-affected countries and is now functioning at the Ebola Treatment Units (ETU) at Police Training School Treatment Centre Two in Hastings and No. 34 Military Hospital in Freetown.  âThis isnât just a massive step ahead in terms of helping medical teams deal with the Ebola virus and ending the disease. It should also be a best practice for disposing of medical waste in general,â said Magdy MartÃ­nez-SolimÃ¡n, Director of the Bureau for Policy and Programme Support at UNDP.  âThis is an investment in the future which Ebola-affected countries will benefit from long after the crisis has ended,â he added. The highly infectious nature of the Ebola virus means that special full-body suits that health workers, burial teams and other responders use have to be sterilized, or destroyed after a single use.  Autoclaves present an alternative to burning waste in open pits, barrels, or inexpensive incinerators without air pollution control equipment, which produce dangerous fumes and expose workers to flames.  âIt is our responsibility to help medical teams manage public health risks and the environment responsibly,â said David McLachlan-Karr, the UN Resident Coordinator and UNDP Resident Representative in Sierra Leone. âWeâve seen the autoclaves at work and they are definitely going to improve the quality of life for communities living in the vicinity.â  With autoclaves, medical waste is processed in safe barrels designed to minimize contact and comes out as a dry and sterile plastic mass less than half the initial volume. The equipment requires electricity and water for the internal steam generator, and a small drain for releasing sterilized liquids and steam.  âItâs very easy to use,â said Private Kargbo Kanbeh, public health officer for 34 Military Hospital. âI know itâs just about two things: temperature, pressure, temperature, pressure. Everything is manual. Itâs very good for Africa. Itâs very fast.â  The autoclave was designed under a UNDP/GEF project and is manufactured by a South African company, Mediclave to prevent the spread of HIV/AIDS, hepatitis B and C, tuberculosis and other diseases that can be transmitted through infectious waste.  UNDP is working to roll out the technology to 11 treatment centers across Sierra Leone and plans to send some units to Guinea and Liberia, the other two most-affected countries. The initiative, worth USD 4 million, is partially cost-shared by the Government of South Korea.  

passage/grade  |  time: 2016-04-25 13:02:45 632019  |  # of fields: 2  |  passage_id: 5276  |  score: 2

doc/next  |  time: 2016-04-25 13:02:48 499546  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8801e21da2b0b59d7597d62aa8ca1b279ba423664dc8d1d280378fe9df6ab554

doc/irrelevant  |  time: 2016-04-25 13:03:08 105699  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2638d49c8ca993a6b559fa97cd0572bac6e59c7a0c20e97be9726ee0ded1ab24

doc/irrelevant  |  time: 2016-04-25 13:03:28 989505  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-94a8dca870f1a541676a57f79a1f6d9396ddd35521845b39034a24e663722ba1

doc/duplicate  |  time: 2016-04-25 13:03:38 798354  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-0ec89571cfb9f7262a636b3111c05428279c6659903bebc2edc988328e8be794

doc/duplicate  |  time: 2016-04-25 13:03:45 304941  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-46273352d8919a3d99b24fec272148858bf26a38952a3e296e6019b25e9b0e36

doc/irrelevant  |  time: 2016-04-25 13:04:27 395963  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a667975a94c49eb39bd736f5590a0d044ed3f9d616210bc84e667cbafc212a8d

doc/irrelevant  |  time: 2016-04-25 13:04:35 890078  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7cee6d70977d2604c67f43822f3c7d2a390ed1456c6f766b26b28abb2991d87b

doc/duplicate  |  time: 2016-04-25 13:04:50 848329  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ff2851ebdf57caaf84aaeead096906600aa66dac83bb771afb6d864faa81b8f3

doc/irrelevant  |  time: 2016-04-25 13:05:07 747500  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d88155ee6c4f6094bcc6b561f6779be895157b2f47211fc0a868b7013739e944

doc/irrelevant  |  time: 2016-04-25 13:05:35 951801  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5b5e439f68a5bf2dea8e2baa3451b2b5ab0eae870e23620ad82d989baf872859

doc/irrelevant  |  time: 2016-04-25 13:05:39 961298  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-498bf7237066ba35cb2e55bf61721e938aa488fa1db67f5914fd5f41ef08c784

doc/irrelevant  |  time: 2016-04-25 13:05:45 607529  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e21f32c04383e52b375f47ad79eab07a4151cd964b03e1045efaf4c1fafd1a56

doc/irrelevant  |  time: 2016-04-25 13:05:51 331072  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c868af5d97eb0cf87669732fa33ede12b2258aeb8970a12d5682c05db9a601c5

doc/irrelevant  |  time: 2016-04-25 13:05:59 587744  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8942767a901686ae379f69a3591b4c2f1a12d0919835b230bbccb87d945b6285

passage/create  |  time: 2016-04-25 13:06:35 964527  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5283  |  passage_name:  Ebola waste disposal a thorny issue  October 6 2014 at 09:09am  By Sharon Begley Comment on this story iol scitech nov 21 ebolaREUTERSUnder the emergency use designation, certain laboratories in the United States and other countries have been authorised to use the test for a limited period to detect the type of Ebola that has been spreading in West Africa. New York - Handling medical waste generated by an Ebola patient proved to be one of the contingencies that US hospitals were unprepared for, a top US health official said, adding that it “took longer than we would have wished” to fix the problem.  The US Centres for Disease Control and Prevention (CDC) thought the disposal issue was resolved on September 26, just two days before the first Ebola patient diagnosed in the United States was admitted to a Dallas hospital after initially being turned away.  “But it wasn't,” said Dr. Thomas Frieden, director of CDC told reporters at a news conference.  In short, conflicting classifications on Ebola waste forced the hospital to wait for the US Department of Transportation to issue a special permit before it could move the material.  The permit finally came through on Friday, allowing Texas Health Presbyterian Hospital, which is caring for patient Thomas Duncan to transport and dispose of medical waste such as vomit and diarrhoea generated during his stay.  While waiting, the Dallas hospital has held the waste at the unit where Duncan is in isolation, said Dr. David Lakey, commissioner of the Texas Department of State Health Services.  County officials have contracted with a disposal company that has received approval to transport the waste, Lakey said on Saturday, but is waiting until after the weekend to remove the items from the hospital.  Conflicting US regulations on transporting such waste caused officials to scramble even before the Dallas Ebola case.  Few US hospitals are equipped with incinerators or large sterilisers called autoclaves needed to safely handle soiled linens, contaminated syringes and virus-spattered protective gear generated from the care of an Ebola patient. The waste needs to be treated before it can travel over public roads.  The CDC advises hospitals to treat items infected with the Ebola virus in leak-proof containers and discard them as they would other regulated medical waste.  However, the Transportation Department classifies Ebola as a Category A infectious agent, meaning it is capable of killing people, rather than as regulated medical waste, which includes non-lethal pathogens. - Reuters  Hungry for more scitech news? Sign up for our daily newsletter  

passage/grade  |  time: 2016-04-25 13:06:39 754543  |  # of fields: 2  |  passage_id: 5283  |  score: 2

doc/next  |  time: 2016-04-25 13:06:41 108613  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-dfca159b0fb8af489ac7c9310166190bdfc47116de44f548722a86a5f68435b7

passage/create  |  time: 2016-04-25 13:07:29 808411  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5287  |  passage_name:  Daniel Bausch is an Ebola expert, and he’s got bad news for you: It’s time to start thinking about medical waste associated with Ebola care.  Patients with this debilitating virus produce 440 gallons of medical waste daily, including instruments, gowns, gloves, body fluids, sheets, mattresses and more. That’s a substantial amount of medical waste in any situation, but it’s especially daunting in this case because it needs to be disposed of extremely cautiously, to avoid the risk of spreading infection. What do you do with a problem like Ebola waste? Because you don’t want to toss it in the garbage.  Somewhat surprisingly, says Bausch, the United States actually faces bigger problems when it comes to safely disposing of Ebola waste, which is simply burned in large pits in Africa: “In the United States, of course, we are somewhat beholden to higher tech solutions, which in some ways are a little bit more problematic in terms of treating all that waste, and we need autoclaves or incinerators that can handle that sort of thing. It’s not the actual inactivation that’s particularly difficult; it’s just the process of getting the waste from, of course, the frontline of care and interaction with the patients safely to the place where it can be incinerated or autoclaved.”  The problem in the United States is ironically compounded by the increased access to medical care, and the higher quality of medical services, available. In the United States, patients are treated by medical teams with access to a huge volume of supplies they use for protection, including masks, gowns, booties, and gloves, along with sanitizers and other tools. Moreover, patients receive extensive medical interventions that generate waste like needles, tubing, medical tape, empty IV bags, and more. The very care that has helped most of the handful of Ebola patients in the United States conquer the disease has contributed to the huge amount of waste generated, highlighting a critical hole in U.S. medical infrastructure — while African hospitals may have lacked the supplies and personnel needed to supply aid to Ebola patients, they’re at least prepared to handle the waste.  The CDC just issued guidelines to help clinicians and administrators decide upon how to handle Ebola waste, but The New York Times notes that many facilities don’t have the autoclave, and incinerator, capacity to handle medical waste on this scale. Some states prohibit the burning of medical waste altogether, or have barred incineration of Ebola waste, leading to the transport of waste across state borders to facilities that can handle it, which poses its own risks; with every mile added to transport, there’s a greater risk of spreading disease to previously unexposed communities.  Surprisingly, defenders of burning the waste come from surprising corners. Environmentals like Allen Hershkowitz, National Resources Defense Council senior scientist, point out that: “There’s no pollutant that’s going to come out of a waste incinerator that’s more dangerous than the Ebola virus. When you’re dealing with pathogenic and biological hazards, sometimes the safest thing to do is combustion.”  The argument in defense of incineration can be bolstered by the fact that medical waste companies specialize in high-efficiency incineration with equipment designed to minimize and trap byproducts of combustion, reducing overall pollution considerably. Fears about Ebola, rather than genuine environmental or public health concerns, are driving the decision to push against incineration of ebola waste in many regions, but eventually, the United States is going to have to face facts: The mounting waste that accumulates in facilities where Ebola patients receive treatments needs to be disposed of safely, and promptly.  

passage/grade  |  time: 2016-04-25 13:07:33 342666  |  # of fields: 2  |  passage_id: 5287  |  score: 2

doc/next  |  time: 2016-04-25 13:07:36 399349  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5ca94959e81e07712fe34e9b5532bd46a664d50af74600c1cdaf659ca0c29321

doc/irrelevant  |  time: 2016-04-25 13:08:17 464029  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-702ac937d308ee6fa609aa558a7f91cc29487f1e5410fdef261032faeabae192

passage/create  |  time: 2016-04-25 13:08:45 935370  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5289  |  passage_name:  The U.S. government is days away from settling the critical question of how hospitals should handle and dispose of medical waste from Ebola patients, reports News Daily.  Currently, conflicting regulations over how Ebola waste should be transported could make it very difficult for U.S. hospitals to safely care for patients.  "Most U.S. hospitals are not equipped with incinerators or large sterilizers called autoclaves that could accommodate the large amounts of soiled linens and clothes, and contaminated syringes and protective gear," said Jeffrey Duchin, chair of the Infectious Diseases Society of America's Public Health Committee.  Sterilizing Ebola waste before it is transported is important not only to protect waste haulers, but to guard against someone using the waste "for nefarious purposes," said Sean Kaufman, ‎president of Behavioral-Based Improvement Solutions, an Atlanta-based biosafety firm.  Cynthia Quarterman, administrator of the U.S. Department of Transportation's Pipeline and Hazardous Material Safety Administration, which oversees dangerous shipments, said her agency is "working on how we can clarify even further for hospitals, for the public, what the appropriate transportation should be."  The U.S. Centers for Disease Control and Prevention (CDC) advises hospitals to treat items infected with the Ebola virus in leak-proof containers and discard them as they would other biohazards that fall into the category of "regulated medical waste."  But the D.O.T. considers Ebola a Category A infectious agent, meaning it is capable of killing people and animals, and not "regulated medical waste," a category in which pathogens are not capable of causing harm.  Waste management contractors who normally handle hazardous hospital waste say they cannot legally haul the material, which leaves hospitals stuck without a way to dispose of the waste.  When Emory University Hospital in Atlanta was preparing to care for two U.S. missionaries infected with Ebola in West Africa in its high-security biocontainment unit, their waste hauler, Stericycle, initially refused to handle it. Bags of Ebola waste quickly began piling up until the hospital worked out the issues.  C.D.C. spokesman Tom Skinner said the waste management problem has not been resolved yet, but he has said previously that the C.D.C. is meeting with officials at the D.O.T. to resolve the matter. Duchin said he has heard that the discussion "has been elevated at the fed to decision makers who can solve the problem."  Texas Health Presbyterian Hospital in Dallas is currently treating the first Ebola patient to be diagnosed on U.S. soil.  "The C.D.C. and D.O.T. will likely issue joint decision soon," said a D.O.T. official.  Related  

passage/grade  |  time: 2016-04-25 13:08:47 823417  |  # of fields: 2  |  passage_id: 5289  |  score: 2

doc/next  |  time: 2016-04-25 13:08:50 612188  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-bb3940e1a5dfcc1c225787ac2b47151003f9b563c1330c85e2d6b22bd10497cb

passage/create  |  time: 2016-04-25 13:09:16 694371  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 258  |  subtopic_name: containment of ebola medical waste  |  passage_id: 5290  |  passage_name:  Dr. Edward Goodman, epidemiologist at Texas Health Presbyterian Hospital Dallas, speaks about the nature and treatment of the Ebola virus during a news conference at Texas Health Presbyterian Hospital Dallas, on Wednesday. (Photo: AP) Washington: The United States is days away from settling the critical question of how hospitals should handle and dispose of medical waste from Ebola patients, a government official said on Wednesday.  Experts have warned that conflicting U.S. regulations over how such waste should be transported could make it very difficult for U.S. hospitals to safely care for patients with Ebola, a messy disease that causes diarrhea, vomiting and in some cases, bleeding from the eyes and ears.  Safely handling such waste presents a dual challenge for regulators, who want to both prevent the accidental spread of the deadly disease and avert any deliberate attempts to use it as a bioweapon.  Most U.S. hospitals are not equipped with incinerators or large sterilizers called autoclaves that could accommodate the large amounts of soiled linens, contaminated syringes and virus-spattered protective gear generated from the care of an Ebola patient, said Dr. Jeffrey Duchin, chair of the Infectious Diseases Society of America's Public Health Committee.  Sterilizing Ebola waste before it is transported is important not only to protect waste haulers but to guard against someone using the waste "for nefarious purposes," said Sean Kaufman, ‎president of Behavioral-Based Improvement Solutions, an Atlanta-based biosafety firm. "It's not just a safety issue," he said.  The matter, which was first reported by Reuters last month, may pose a significant challenge for Texas Health Presbyterian Hospital in Dallas, which is now treating the first Ebola patient to be diagnosed on U.S. soil.  Duchin said he is not aware of whether the hospital has its own incinerator or large autoclave, but if it does not, "they are going to have to find a temporary solution for managing infectious waste. That puts the hospital in a very difficult situation."  Cynthia Quarterman, administrator of the U.S. Department of Transportation's Pipeline and Hazardous Material Safety Administration, which oversees dangerous shipments, said her agency is "working on how we can clarify even further for hospitals, for the public, what the appropriate transportation should be."  

passage/grade  |  time: 2016-04-25 13:09:19 177057  |  # of fields: 2  |  passage_id: 5290  |  score: 2

doc/next  |  time: 2016-04-25 13:09:21 693057  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fe004c2cb2374883831a3b5095cc4692588519863323fd27a59908345f59b9fc

doc/duplicate  |  time: 2016-04-25 13:09:30 694936  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f7a01e636284f54d6b08f0f3a2cc59ab0c311c855e78afebb7dabf211a141614

doc/duplicate  |  time: 2016-04-25 13:09:36 664463  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e0ac128dc39bf24030218dea5a184f4f04a840754cec0e3a781ee1a7a8a53a0e

doc/duplicate  |  time: 2016-04-25 13:09:51 988870  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-dd7a56319537cdf4389417f1442316605e3091d4c370c208fc225b4e777390cd

doc/duplicate  |  time: 2016-04-25 13:10:01 651542  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5c0a3f3a599ddefb91d97544b9e03b258df46642ee1b50e692d2d2fba36d1a27

passage/create  |  time: 2016-04-25 13:10:18 730612  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 258  |  subtopic_name: containment of ebola medical waste  |  passage_id: 5291  |  passage_name:  Officials at the University of Nebraska, which treated Ebola patients, issues a case study in how to get rid of Ebola waste  When treating Ebola patients, hospitals have more than their patients and workers to protect. It’s their responsibility to properly dispose of anything involved in caring for the patients that might be contaminated—and that includes liquid waste, protective equipment, anything used in the lab, linens, towels, pillows, mattresses and even the curtains used in the patient’s room.  In the latest issue of the American Journal of Infection Control, John Lowe, associate director of research from the Nebraska Biocontainment Unit at the Nebraska Medical Center, describes how the team there disposed of waste generated while two patients recovered from their infections there. Some of the procedures in place, Lowe says, go beyond the guidelines set by the Centers for Disease Control and Prevention (CDC). The report will undoubtedly be studied by the 35 hospitals that the CDC designated on Dec. 2 as Ebola treatment centers across the nation.  “A number of things came up that surprised us and that we felt really needed to be shared with our colleagues,” he says.  The first of those was the sheer volume of waste generated by each Ebola patient. The group calculated that each patient treated at the Nebraska facility created about 1,010 pounds of solid waste, most of it in the form of personal protective equipment (PPE) — the hoods, face shields, suits and foot covers that doctors and nurses wear. That equipment, as well as towels and linens used for bedding, created around four to eight large bags of waste a day.  Lowe says that the group decided to treat liquid waste generated by the patients even more stringently than required by the CDC. “The lion’s share of calls we took from groups both within our facility and from outside the facility were concerns about exactly what we were doing with all that liquid waste,” he says.  CDC guidelines say that normal waste treatment chemicals in toilets are sufficient to kill Ebola. But the unit’s director Philip Smith and Lowe had two concerns. In the event that the toilets backed up, potentially infectious material could flood into the patient rooms and possibly into other pipes in the hospital as well. Public health groups also wanted assurances that the waste would not be contaminating facilities outside of the hospital. So Smith decided to take extra measures by treating the toilets in the patient’s room with hospital-grade disinfectant. Normally it takes four minutes to sterilize the waste, but to be safe, all Ebola patients’ waste was held in this sterilizing solution for 2.5 times the recommended time before it was flushed.  Flushing, says Smith, is preferable to storing the waste in a separate container and then autoclaving the contents. “You could end up having containers full of liquid that are difficult and hazardous to work with,” he says.  The bags of solid waste, meanwhile, were tied and taped closed, then doused with bleach and handled in very strict ways by workers in full PPE. The Nebraska biocontainment unit is intentionally designed to have its own decontaminating autoclave inside the unit, so soiled waste does not have to be removed from the premises. While Ebola-related waste requires special sterilization and decontamination procedures, it can be turned into normal medical waste that can be disposed of in the hopsital’s normal ways.  

passage/grade  |  time: 2016-04-25 13:10:20 584825  |  # of fields: 2  |  passage_id: 5291  |  score: 2

doc/next  |  time: 2016-04-25 13:10:22 685187  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5b7ad0559b1dd4d9211ea387d77826f95800261ed97c94872920f900b645efd1

doc/irrelevant  |  time: 2016-04-25 13:10:40 782848  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2dbe392c7ec530d271cd858678f2fa5ba1e6f1c494c0d3e96b9c3a0c6993dc24

passage/create  |  time: 2016-04-25 13:11:25 716845  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5293  |  passage_name:  U.S. Department of Transportation Approves Special Permit for the Safe Transport of Ebola Infected Medical Waste for Disposal  WASHINGTONâThis afternoon, the U.S. Department of Transportationâs Pipeline and Hazardous Materials Safety Administration (PHMSA) in coordination with the Centers for Disease Control and Prevention (CDC) announced that it has issued an emergency special permit allowing a Lake Forest, Ill.-based company to transport large quantities of Ebola-contaminated waste from Texas Health Presbyterian Hospital Dallas for disposal.  The special permit will cover all of Texas, not just waste originating at Texas Health Presbyterian Hospital Dallas, which is beneficial should another diagnosed case present itself in the state.Â  The special permit also extends to the removal of household hazardous material, including the patientâs home.Â  Special permits are issued to individual companies to ensure that each holder is fit to conduct the activity authorized. PHMSA has been in proactive discussions with CDC to prepare guidance to address emerging issues elsewhere in the United States should they develop.  The special permit issued today offers Stericycle, Inc. two alternative options for packaging the waste material prior to transport. Both options require a series of inner and outer packaging and the application of a CDC-authorized disinfectant to the inner packaging. The special permit also provides instructions for operation controls during transport, and requires the carrier to maintain a written spill response plan with guidelines for protecting employees and decontaminating any released material in the event of an accident.Â  For more information about the special permit, please click here.  The Hazardous Materials Regulations authorizes the issuance of special permits that allow a company or individual to package or ship hazardous materials in a manner that varies from existing regulations but maintains an equivalent level of safety. Solid materials contaminated with the Ebola virus are classified as Category A infectious substances according to the Hazardous Materials Regulations. Current safety regulations governing the transport of Category A infectious substances require packaging that may not be always suited for the transport of larger quantities of contaminated waste.Â  The treatment of Ebola patients creates a relatively large quantity of contaminated medical waste.  While the U.S. Department of Transportationâs PHMSA approves the special permit to Stericycle, the contract for services is between the company and Texas Health Presbyterian Hospital Dallas.Â  All questions related to the terms of the contract and operational logistics such as the costs, the times of pick up, disposal locations, the volume of materials, etc. should be answered by the state of Texas health officials or the hospital.  ###  DOT 94-14

passage/grade  |  time: 2016-04-25 13:11:29 284351  |  # of fields: 2  |  passage_id: 5293  |  score: 2

doc/next  |  time: 2016-04-25 13:11:31 549490  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f5542695307ca6ba4965e94a2ab6b5227f05cc3e8882dc91cc15d6beeceb3f4b

doc/irrelevant  |  time: 2016-04-25 13:11:38 193282  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-20c5c7e953c297b8ddc4436d7191237595bc37d82a5b957efb18573196631221

doc/irrelevant  |  time: 2016-04-25 13:11:42 989199  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-12ddcfd5a4dcb4e668f858c44bcdbbc6e684727af27b77eb7bb4d000a7355a96

doc/irrelevant  |  time: 2016-04-25 13:11:56 072252  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d4ea5d9383c7720bba9021b30015bb39173398dfeda3383a20155cecbfc7cf56

doc/irrelevant  |  time: 2016-04-25 13:12:06 786409  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ce585a480add131a1e269ba4ac5f58c4311f4503af12ecf58a219eff3d30ab61

doc/irrelevant  |  time: 2016-04-25 13:12:12 901999  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fbe1949a25d5626a86f07aa38f48f8c03e2063d0ab6f4094360b1d8279e1cb0b

doc/irrelevant  |  time: 2016-04-25 13:12:22 732762  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7a60a5c35ebf8ff096a4ee3019a5ce3a07bd453722412c6a3d2be22070f16fdd

doc/irrelevant  |  time: 2016-04-25 13:12:48 057445  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7fa39a8cdf02a3851ad4d62a8765d402213b468867a6f085d475b01fb433712f

doc/irrelevant  |  time: 2016-04-25 13:12:52 353218  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4b68c3d12b20c550d42b694902290d5a33345fdbf8c10373f9d603008618b92a

doc/irrelevant  |  time: 2016-04-25 13:12:57 027139  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-33107043576aea5708dda9670d21f8124c4ead98039225a21ba5534a59a198f0

query/terrier  |  time: 2016-04-25 13:13:38 625627  |  # of fields: 3  |  topic_id: 417  |  topic_name: Ebola medical waste  |  query: ebola medical waste

result_size: 300  |  num_tagged:  0
ebola-9a95f574ab2618329a2c42d32ff14e6f070bb71b8da51bc6eba7e5c8f558d381
ebola-5743ef79d272f9cf13363d96e5121bc8893afb47ca87b1e8a17515710e8d8c85
ebola-830bef3c71e38d353136214e8c11caa9d98c37c94aa795f67ec4117849b0695d
ebola-3347ae1f6a541d06a1255176059a99ab5d27d1f776fb15f2bc389b68dc8f9bd5
ebola-1df0fed8e82815f5b826dbde93bf004321e0699d9718d7f31ba4f0f4a942b156
ebola-38ffe3d9bd513de4d578843bd04bae3fba38f00b4f3f63573406b75e2113a937
ebola-281f5283df05bdda06d74a39b56a068ffff19782e8bbf025da3e5067f61a0249
ebola-f74ed50667558936a35bd76809767317dd74ce00163667ec6ba92853a5079b09
ebola-d9509927ae3466cbdf6075d372ce89355a960e086d2ac01382f9daaaaf880197
ebola-bdc8e5e8a72aead87dda1bb370bd5f919bd74d9c9f4308cf89608f2d9e2a4941
ebola-37035bb5d6d3b47bc538bc97690896d989904e0a28e9490c9b4750877634de14
ebola-1bfe8cca6a2d2ddbfb6fdfc0e787f41b0ae0fa720d1f258b9837164ebcd4c74d
ebola-d07ce7dbafa17565decb454c195d723887fd578af8043160e910959b08ad18b7
ebola-bdcc09541050ce58bd8a5a23dadeb15c458f1177985a7b446970c42b6ebfe336
ebola-fc34657d3fba931d21b1d36feaf8577b16673b8d907ef0f88aaa6ad9040dbec9
ebola-10cdcce357bbe558a672a500d0cc96538f79c5ca2de224189f6e7a85ec9eadf9
ebola-18b22d45ef1893aaa1c0441c2efa7d320d11e234719425166215ba89fe37333c
ebola-1d9a5a7ce9d01e072e4ce5dc1654b39ffe9a124bf2082824dc0e4836c2fd03f3
ebola-06392bcb81b78b43a2c2ce6e96f01371c5302e4f30ebaed247980847ac0ec0dd
ebola-9abaffe0fb848ed4187ad9eb24280e5d52f94100e152bdbc7f8a331d614ae8da
ebola-ed79ea2d77deea0b413a260c6815bc5b3980016440551d71daf348d2e5ea8dbb
ebola-d67966195453f45296e8004f4fda0b8ae0ee35a8d4eb9c99d0530245969d9095
ebola-241fd8e014d6aaa0b25a02955dd24f96d9c2c2293e352957bbd654e53003142c
ebola-b276d304c4f5d9090c5c993a50a202392e2770d51c54cd7aaaf8268761f7f109
ebola-3b4bafee54dfb413115b8c54c0b2571f4ac7d7f5c4a2bf7e369b37f9326563b8
ebola-920621b1d513e04d83f6393358695fe6ecfe75b8a42052272135afa3ab5591e5
ebola-2ae01e5b7b804016d138fac881f7552c67a6b4293bf4a2f6697022ffb589b53e
ebola-af11ee18aa262dc0ceb2824a3192fd049d7abd1d4c5653be9badd5d17d75e2d8
ebola-27135681e070340769cd61ac824c5eb626bdece5519db884e0e6c5011acb7c23
ebola-f03162e47a1368c11e4107b9d621df50b4b1959ba5311e680739777bb88f7274
ebola-9b3f1e9b39d71d24152ffe895ca91a4be1525a2f764ae10da0007bfe49a311b1
ebola-57b9da45bd36849d7f04d59edab684f57dc2b604a513a28a57250e85680785c6
ebola-702ccd1b4d58569f29a06b0be7f116cd591a9d7b7c7a86570230af10b213f767
ebola-a458938630261d1fb4b30b0cb11f6ab60cac46650b03806dab3d544925bfa3cf
ebola-f041d7b2a2532e8fdeebe4cb1828835dedc08b132defba729389533be7564808
ebola-b6f0ee2784b7cbd58ebd9f7d8010719f24da785d384fe0c92ee7206a43e03b43
ebola-cc3d4dff193418ee67f37cd64606d7e62c9b76e82ab8aeb9558bd12298170bf4
ebola-6165699aa7695629ff00106ef345ef21067a0feebdd13107ebebe1afaca02617
ebola-97d2f6c8b8ea6b79a386c98249075d72f58cddafdbd04453fd382b5003445acd
ebola-77a9ffd212c7e193f87075854e8136dfe5bff2f9c3cb961bfda1eaec9e91c264
ebola-d9c917a7608a16a9f8f702391a9ec6e9bc8b108cc2e6ebf08cbd2eb2256927a9
ebola-ff9d4051c1c8764ee7932db459b3e60690c6d8dedc7567740dc5affe68d50e2f
ebola-543b85340431349f81106753e903b21ea0aec397819057decaaf60ea4ebb43fc
ebola-52058b37b090cd651e3505dedfdb960749d7086a5172d5b3a74987039534862c
ebola-63aa113bfcd57ee648ce27940645eb1422d16e7caca21ab278fb6b18d7251b81
ebola-041c90e3a98ae967c3a2d4bb169de90e5725481e94f145434ad4ef3c54b43e25
ebola-e29d9924a1db4e9baf4ed9f5e62fc1841d3d27df928c2091d1a0e09440ae3be5
ebola-1ad8346fb8ffb6dea1ab53da7cd92009cd353a935d3c2e5e592208ee9d0e64a1
ebola-58967bfbe43ec2044421ab983dce8c6abd1ab6e06448db8d1cbc6bba78d6ea2c
ebola-f991ad13d70683b7336dd30301c30c41f8d240d0b5e6f212e4bdbfecf0c6e4fb
ebola-0184a48264924263acf0130e9aa71ac83cfd40366a8dbe647b44ddea723f2da2
ebola-76e9738c9ae7e84b89eec0e2a759ea3212f5b7e4ecb20d081b1452dae0694ef1
ebola-477cc321ea023aef558c276730c0bf5cbb9b47967e5012067f623fc11c8570f4
ebola-4b3f302f6723b331e0dbd3cd19d052f773eee9532a28b2599e8c7b75e083e8e0
ebola-71c6a22fba495e5536b094b55342d948607bae4be94f0d35e611b57c69eef803
ebola-3bf8f57682d7e89f8a94a3f2a3874f62273c5730d8d38db039490b5d512f88fd
ebola-195a35d196c8c640178d00d911df06814ef517b2a2b8486cfbb1af831f2343c9
ebola-d21c44a03c8cb0c01be977bf5247ef0ee2892f64d5b8c50ed92da6360f0dd30c
ebola-66ad1bfe864a6c40e8ff7371fcf6b0edafbc55ceb5816ee288fcd708a550df9a
ebola-1270ec95c1b6cf513c3c750e48757c1399b6efe6a2f8e5e4650de2b8337739a2
ebola-51a7a5ee011826cf1f397f7289f771f318f3d70da7120bc96d1f0d0c65e10942
ebola-1468e20e31e83a29579b109f81aa53bbd6194cca3c12ba2835f1d56cae9ae6d5
ebola-0e791f846b45be512f143239f264e8a97605a5428809f8a6f38d470edb8b3c33
ebola-b5e2f68c124fc22ccb35082ce218718e095319e445585d4288fa13ae8f846835
ebola-9c15b88a3d12693bb9d9c4f5f7f560b00b0b8c0885a19dca1c8f8068c7046333
ebola-9c1a0e7063bbe15ff98a821d0f5261b684dd4271a356c6c7a01ce4c38a3f8105
ebola-b768976c8ab9a4a28ddd6c170fc0e227c6335981823ee42dce87f3ad0221e6e2
ebola-bb0a514b92810bc27e11eedb7fdc7aa8ce0fffd5c1da682343cf4795e4b2aa33
ebola-122a72500e33fca655d6f6eb2b814723e2d20fb634789c5d65387522e1ff0121
ebola-8967b66c2baf48a8d1a99265f086fc08ce144beb2a86b920bc021127c1447ed4
ebola-8692ceb9d15f151fcb78d66ff249cbb1e8dc8f4a8f09d078d533727bc5d46848
ebola-6898c3b9c6feefe2d0dd5e9f7ea57a2dc1c61aff8035f479002201c3acad0f66
ebola-980920bd57d564d93289612a4379df1ca3dbef050179a87d54c6ee41d40ae6ee
ebola-dbc71a91fd6df885b816f629237f28692cc532aca06d7a6cfa2739bbb9644960
ebola-99c7f16b18d8a4a662ad8c9c892b0ef9517d8c61a35c4da107d0dfe8f8ffc66e
ebola-efa38e7a3ab6f91b398cf02404a4861d852adf093c9fd9ba7711dae33c1a75d9
ebola-cc6034d0cbf492871063982bc5e8e8738cfc1579570bf332c62f61e6badf73e2
ebola-77e417930d05eb9015c4676c677f71eb705cd88e883216a7a02f82b997cfb31d
ebola-11bb550f9b112c595e07d67fac9660850b3bda074a0e00d2fdb6ba86d90af8ef
ebola-1fd7f962a920ed3a44b2145bb2ee8102ea14c71070d0c24ad73438bd9cb194b1
ebola-1450853b2cd5fab717996c0ee6b9a1b05fa2ce1d42f62c002198cecfaa050ca2
ebola-daed996aede35753b6885ff623e5606b9fb50c0639edd214170652b0daf8bf34
ebola-e70837375726ba4b0b38b3deb1d4ad50b33268ad9e8465504fb52960c89c70ec
ebola-f46955598e4226819415092f2b48161e8458cf56d6970225d98d031f854f5e46
ebola-f2ee888c8ab2e8a28482e4781229d0cf37e5af54937361ead6afcbfaba09d0ba
ebola-63e2a12478e319645330eb897b94de8df8e7429589725692ebf560c12f68a06d
ebola-7d6709cf294bae19cb680ca5dee3edf54d7fc8980944acb6070550a42b7c5ae3
ebola-fedfb815fb316021b484b8341f0274528cebadc9fabe12bf058f4faa499e5865
ebola-388a68fb4b1cadf3d6b9990f1e81a83f917ea2b9e272407858d1825b0c3a12e3
ebola-bd2a8ea4d09d5271d6793972f602569a1c769e22bc01093b82c2087a59943d9c
ebola-dcb754c07f8ccbd6bd0626a0b5ff24c8e0d245403a68ac845492e70b57e6bf61
ebola-8303ef7e43383338843d2631c05424816a4c69fae8cc6247b8e8143309d6bde3
ebola-fc3c0e0ce9f52d316514b0166e48b1d14fe5cd00b3a0c2b90e45e5d4369bc84c
ebola-d4fc3786c9601d4ae671a5908b647f2e8c9346c745165964f15d017c82b2af32
ebola-0652a8fc4c3b9b5cfaab84166c97505adbd14bee0e32338a4284539be31e03fa
ebola-bd2d1acf21d5331e4aa14d67c42cc3c1130f080884eaf685bc00a34d557fb4d3
ebola-385699025e2f483073ca0f2ae3f05c79f4be1ff8ea255ea91244d9a13b6c4982
ebola-f98daf12400c1838169f301d42e1aee735f8ec3b2fb4e3dac49aef645346e12e
ebola-6857ce808451007f370b07f1949d805d2d41af21363f5b93dc93edf94db531e9
ebola-48a967839907533c1e0e37a1e11f450190ebb474ceccc31ffc16e92bd8c9aa7a
ebola-eb4f79d464fbb9d6986259e0b61e02bffa618b312cd38ac4f5cb566ea2426401
ebola-f2074765f742dbcd80bc3a79bae523fb64df8ae4ac0789d4f3e49bf40067e359
ebola-c2d99506a510efa8a909072b5efd8b7e39459dafa1b92eb66770567965f35242
ebola-344e46a32ce379543ad5dd9a311e0753648e02d64e5b0045cf2de7407a4983e1
ebola-673ca580d2e0e072ef6eae123ef5f2afbc33f8faae0cbb5c66ea7e659c3bf50f
ebola-c40c75ac7cda07e6d4be0cc8d164cf75e070b6ee72e91718af15b6d7ec56aa68
ebola-1a8b859412ece9fc8b3cee02a8acb65baad3583d187bf2191e4e03108ee85690
ebola-3f674559bc72c13e2365b253df791a6a0820a9705cf39b6761aab15464e8e182
ebola-d3f95cc2eb9ee970d9e69527e4d600ca93327c6b4fedf28526ee2725798ff8b8
ebola-e53c99687811a6504ea16ffc3d4d88497ea1226082e6c88a7b2d71cbbb98e271
ebola-e53840347feb9fe648c65ee01d76bea2fc42f9b19f19f9ccc0be73bf5caaeb39
ebola-b5f547576c69db25af413434a69f240e1b3fb39c8e66c1d7df99729cfe398565
ebola-467d13356eaa941a4e4490cd0e15f08f90d28981f2b33da6a6a32c4157871872
ebola-58c29256c3510e29c50d6713be7e52390e1cb9c2ee1c218b0e7262619eab3197
ebola-1751eaf8331ef2de873e205c063a6ef68c4034fb0ffa5c0774107c26da7951fd
ebola-b5775c2aa194a67f80ef115176addd408b671cedf7d26be6b7d24c6af40a75bf
ebola-8268d5925b90f8e61a86f99b94772b6130e37ef3003bce785815ff565f9c3929
ebola-78dc19fdfbd26627d4efa5b1cb09396bb11ff296a597e1ecd55164ebcc532018
ebola-755d886df29732c34d20c630ff8eff980203db368febd864a4c2ecaa6205fb0f
ebola-d8979c93874b3542c97f6c4730f711c4c25875174271dd65a5526eef40271bc2
ebola-69516d909e4b9114c10b6e57a5294c3fd854009539599fec73a489877a86449b
ebola-d1508ee46a63fe768a711e42de71ae3cc6b6105d8795b9eac8afc438bc8b1862
ebola-13bb7b0b474d60aee5d48545a4e9816b491ef1b1a0370467bb960de8a2c09890
ebola-0f1bec4f7110e7d613b1d770cde9bdda7f44e12b75bd49a664bdb4b2cb7a33a4
ebola-ff4ca47682ec15c1937b033911b8e1666a2cca8c0489087ec1ca926a45741183
ebola-34bf027ea80aaf95d775bb97e5059a4e41ee9f9793190d6c3bc7f8b0557dcea0
ebola-27f88a7721e78ba1b0276b6ef27a79ca3bf3bfb847d1ab4260c4547331af6c54
ebola-17c1d5178073d68b9f5ffaf133c899ff72afe657ae00100ab142461bcd2a0a7f
ebola-ae778417ae013bf3b9794d5a11ce4455a085bee7ed41ac848ef598c9cd2f02d0
ebola-5e62b50b5df29b86449cf9bb3873083abed4302a118c6d88d0145647a1bf6f60
ebola-57247bf5128ac1e64272db60ec8c3960ef62e1d655ede020ce529b2967f7f556
ebola-cb3a3e6e832fb7f95c5999bee0929dc647894658e120259e2cebe834c18488fd
ebola-bbe918d9b8bbad1e29238445a08dd25a679210fab3e8b7124118c4cc39fae414
ebola-900427b86e8f978b9500a453a5dfd9aa77c0c7226a2f0d716938259d768ca85d
ebola-ace4cb304e02ce6ebc821f134e9252baea80779448913e79246dbbd54bf0342f
ebola-2c993894837d1ad36f64efee23a134426d798c2426a0fc8f6df1744db1db57af
ebola-e1239b26badcb4acc7dc241a2e2b18bdb3cf0aab3d0e6683b7fd0daa57050573
ebola-2a3aa225669fbb65cfedde8b7f641994b08110961c58c92086c0413e8d1fe9dd
ebola-e4432779e37a590d6f56091fdc65c6bc4632c7f50e84a52dad5afeddae0cd8f3
ebola-28729aab4de202831442c96798a19ff34c76e23f6c9ecd2a5af42ff056661c56
ebola-f202dd3e3d5321b163a8514a35971001b08538fd18acd7b7dbd94907c8d3b77c
ebola-c20cf5fd0073f780fe392051bdd51a04be876ac87c4b3aadd5304ed4f0292ce8
ebola-ab071e0e98443ff15a95824aff69e8b911bedaeef228bae87838f5b0ee2f6466
ebola-5bccc1fc3dfb6b3caa8ee1cb72a7fd9c874782a1877d2e2bbf6e3a6884e25903
ebola-73bcdc37764f34c21633860c1c18dd8339783736e4cfabcaf067b8c39bb2902e
ebola-5648b7e35d3f37b358ba16e50c01b38213e9f85f1a3c740e8213b4e47cd75f73
ebola-7b16962763b48bd6a916530f3253e5c60a8b98c995b40c97b2556e0e950ae923
ebola-da72b9c7cc83ad71447e6c0cfdb7fc3aa4d2e9c4584e6a1d6d204848af279bae
ebola-edcf8bb0ccbf3f5c45c2fa3486b5e30ebc805ba1aa64d4ddbfab270035ed0e4e
ebola-1ea741d4c95fedf9475dfefd34dc6275df8a5aeb77ff1e0b5800f9f9882ac7b4
ebola-018cf9d51bf950fb156d215d9081b18250b4ce108b1f9fe52fb6f0624d8718a4
ebola-70d38b9188ad75a2ae2cf5a2f0ac3221e18c0f4d4679ab575f5df5455f694f5e
ebola-6b3898a02abb1c263f2eb5c1bd36b53e850f04fea1ae1fdffe857bb126aedaa5
ebola-7760ab2466aaab581c9ea9e13a83e1c3562fba3742ca0279c631d88710d6aab8
ebola-1e375684843d3c7373a6622ad0b72bc0f64ac882159e329bcd35c6ac9f41f6da
ebola-07e4b1dd636b31ad8e0ae18df21ca6f52017f88f322950cfbef21efcff845137
ebola-d78ef579fdbdc2f135b4558340f93de42347f0f916b0037b1cf4c234e3ec0745
ebola-83189beabc397908c9b490db5f11389942b1e6b235a8c09201e798f706b02a7b
ebola-636152a5dbbb137321b4a4bc9dfc6e8cebdcbd33b30909702b1f71da0cf86c44
ebola-cbbbb7b7187394391b4b5d5cee20232d896bb734197d69d58762410d534f28b0
ebola-bd04b4a9ef38183f9e21163caf48c4288f434d113be8ca59540661b58c27763a
ebola-d38a02332048547b2d68cecffd96ad7e43a3c66ffa809a6257069e6c1132bf9e
ebola-3c8df2c458e2a241de0ffcbc4806380d52bd78876cf9c1429886bd27ee5ef670
ebola-84a2932d8d75434096d90d1c617244b00fe97e486763d2f2f6e0dd031fb0d4d7
ebola-0e6efd1fbb3bff0a64f1d6c5a25d63122711bf8c40ef43b0d99aab6f0b4a505b
ebola-66dd0db2abbe79b2af752ab3c90f3c0adbcfc815baf9bd630bfab1f34ecd8d36
ebola-392ff1caddf7d72510bf3a67f578b540742aa27a02622ff00f6a0dbc8a59f08c
ebola-15e84e22871d87afed6c34dbf1a8bb1dacb4489d69b367a6399ab84605508733
ebola-af339fe6d99a0dcb6c783f2e6311860b9911ca719cc849d870cc66d13ad4278e
ebola-664a981cd140a97b353c00129c8130cca06bee312eebf4249952b2c435483a91
ebola-fb04ef3a34d75dc215410f588f5ae5b167bd6ae0ff4227fb1f9b86a25c4b948f
ebola-c94f9dc9a8a0630e5d609c8c0e6e0a898ded1bb5f76783384487964abfbff93e
ebola-ce4b7e8821f767d7299299581b48c64a305a7d33f990d9ff200f061d55ec7e3b
ebola-558cee9b4e7a83b661d55c50308352073d3fc3b4bf6004b2427a8ce5f2be31b2
ebola-431cddcf48e8330fb19c1b9119ca2fe963a4aecc4e95ad946fc9a4c220c04d61
ebola-c64364e85e108d0ac85e8cfaf1fcfb61342a62ff1af1c99f0835fbb76aa77280
ebola-d39fb1a166f175affee5c0924037782d27cc03486057d6452f3cbe7652902f66
ebola-ceeac7f60359d02fe0f984bc2a71d847933cb82e43c325cfd13fb032a516e38e
ebola-74d9967284c6bc8d1cb8f8b8aeba80c1b7bbe0007e278222c489f64ff88bb630
ebola-8bf646448c546ce3db38a96f03b93d66ff556f74209322acf728c3013212bda5
ebola-b92ce07efe2d07413cae9d4102a406e6cbb31b481f7aec7dac0ddd20a6bb9b56
ebola-c949af9e6cd7e1af51c347add20fcefdbbc29a5208c520b78ab72018d0e2faff
ebola-6677ac00beb41263b749fc591b29a024fb9e2c3b18bf37c2b514e21ffd9ece6e
ebola-7cdcbbcdbffd811fcc580cdfb4303f973ec2eb428f0a9d234aedc8f93421fbaf
ebola-8ad5297197b17314d354f2ddbacc71414012338db333a087db26f905eb2f0e47
ebola-c87739365ab592c68fe66add138766a10709028be6d7ea12dedab17b1662cd72
ebola-7551e591855d2da7d0ee2e4e11a995f9fda0ed51b04a41482d24ac08d3ae72f5
ebola-60576eb27f3c8cd95efd8cc0b1796f2ba00fbe0dbd446fdc5b388cfb4be0287d
ebola-41ac9ba87572b7849d1686486a4cdc1ee9dcd5f402dd8d20a8da3bdf14547f0c
ebola-2b92c70ac15e457b88bada036ffcc705cbc7addbc8ea3cf64db7c6c3ec5223be
ebola-5e6df09deeede715b936e04f39f47a06c6e323c09ebeb1ffe610f7ec6f75aef5
ebola-47bda361a0fd01a6204dcc315cd85199cae4105f81bd6e16b0efa6d523044455
ebola-ec2d4a9fc387998c415040b04e4bf1fe3306d71bbc728291eed8d770ea4a4ad9
ebola-6db35f28faf7a47668555b0c2a4a472fe8a4a69f05598feb01cbdcc86eba1ad8
ebola-ec27d701fb228c2d31a5338bb103f5aa421995f9a61a79bd150c09eecaa10f46
ebola-b286725e1462977b9828cc83d00cc685691a475667b359711f143b1d6bd7682f
ebola-e0ea7c73fe5e495c5bf81cf978b20b6835b20388613494ba509ec806cd0fe807
ebola-10903f932a29047d0c429469dcbb60889149b30ee05730e8e6567e2a4ccd5d2e
ebola-633256fd49a2688f2322801b8ca721170a382d32206eaa96799d47a971f0cb5b
ebola-e6f3d9e8d729c8e5dd90122d4e844a79c602108fe18ed63cbe6cf6ac6bb45847
ebola-a854fe0805191060affe49967eb2efcfdb27ad4858d9e7cb74586481cb99d445
ebola-3cd1f699dd0c84ed391defadc9f7f3c9f5033b4a0e170085e149eabd2b02d72f
ebola-53270eecf83edd611dee1bb35cbdb3725c09156b4f07de5c02c068ef00048ae0
ebola-9c3154e377701668946022ee60f8fa99fef77c0d62642a3769e1c57f6e33e8d0
ebola-2409ae89c78ddc96cc3a783812298bae89bc1f64ce7d1c8a31deb3db1028cfef
ebola-9bc2b98cb6bf87a6f226546f25d1162c2f3085f083b5e81949ba8a9aaebaebad
ebola-c07b5a606f958128ae67d758ffc0bcd76332013b3cdc73e5fabee37d13aebd65
ebola-02744f2c7737220269342ec0feb36bc3646ed7f55f4648bc826ac285571505a3
ebola-ac78b1f64b75e9e629ce1c8c848e2bfedc80cf0f8e6da1ce5ab24415ab35d4fe
ebola-d7c815db3dc9ee0f73cec42137999a37658419a9b09444b4e1618fc2dae50f0c
ebola-3e10380b31f039e5822ee277e53457ce789eb57c69bb847f5e7490ab9ac85102
ebola-5c4cd1070cd49f011166cac2d1381ffeb92d7613a04b4b74318e06d082f53c25
ebola-d95bc827b36d92b3e24c002f0b1ddcf739da1e5e64996accc53c8e12e62af1c8
ebola-f91140caa87e9462e25fda1d8e55b9b7981832635434e51c8002527851260eb5
ebola-3369375422c1751b6fc0a048f75196bbf3cb4ff08665ba099ddc21b52a178277
ebola-c2a825fea25f4da2ab5832d12666631bdf35090ed04e4c5af5c0a9ad43f8b39c
ebola-25b048e52584bf34bfbd145fd6cefb26dc7134acdf8ac2aca04f70d74b05706c
ebola-6cc7a730ce0d489d60ec3f6ab44b12c3e46bb47292f47ab0b0389fad6e8b07ec
ebola-2f9dcebf8be88f14baa0e83879e52cdda29c7dfb7e7d3dd7655983ee0eb5958d
ebola-65e85e681813aa05910e89cffea5c37b46a161acf83e1b496232d3026c3ee192
ebola-df09085a450e64b90daaebeff9882c645438dda8a2f140ccb3a701b3e18b95a3
ebola-2d76fc9db67e31b9452cce3ebca1222695e459877e699b498deb34b693a3080c
ebola-26aa664e494e601a4fd93653750d3710d91a3713811f9e58b9f8e8c2e7c3b6c9
ebola-ad3c3dae61c3aa03c32c88f054c707c43b4fb4ea233f19ebca64f73ab5e8d0cd
ebola-909c01ac309808ce0ca6f27fb9ac2b841b807f450ecdffe85dce3cf229c650e5
ebola-123c4ab05fb16c5b395e456a8c9cca8af9d67f231f122e9c16fc87997b6c967d
ebola-305521f6446e47724018d30b8282e29b9c34568bc0cde4528497d22d54577825
ebola-362a8024fd46e266583faeb7964be5e57f6cc6bb554cb93f66e650b47e8fc0d0
ebola-b34d841bae7b73919d12d8caafb878d026f0360990fc95bb90c6f63aa91e2380
ebola-8452dfe090401e5eeabea21277650cdb8c85b5cc06c73d265e90d2b25824655f
ebola-9a827edd930e1f185ffeccdafdced3b953e6c26f5fd0c0a8a4a42c367c31dca5
ebola-2da74eea6159e3904f343adad5baa8165d79d7c562d18af5623cab73830f5b78
ebola-fa5b627f05f92ec5f2fd6255ff2f01cd3bee43a77044f4758f7585ddae681701
ebola-890641ad0e3de97c94fe88dba96c86f21850e843b5378898e37673eeb4626fc3
ebola-792cd7e78f0da81c4a8222e6118a0c4c045e740f96f5fb00374df2eacd46fa7c
ebola-bd40f2ba775282b5d473991547b523a4759468f193a3ddda618c90b60d9e9c49
ebola-53e8da52712038c54d5c3b0e37b11843788ee5637fc07c09f2559e507cc89296
ebola-7c934fee15864b484a1e84885ed9ea96c1f267fc03545867785319dd967ace3b
ebola-68e4e75e1534f3705e951b612e8d7f6f1b2cd00747d7c58d6c25bad5f4127285
ebola-a702f1639dfc038c6c180ea96b746bc1ec372c19e265190d6a93e46fe7efa218
ebola-f4724312906109b7990b4ab855300a15ede90baa875f9471fd11b9621d321a76
ebola-db2000744733863f377ff4fb6c1e1dd87bb3e3a7dc617da82fc4f7c4c2a0d0f4
ebola-7bc59b270e9f49d1157ce6e032eb5db65c04c770bbfa96a8c1cc936f53d54eaa
ebola-57a0d10642fa33f7db3427ee34045e2dae163602f6511ccaaa43659407c4667f
ebola-d67b8c9d010f16de1d22b002b3d54487e1bd6dc08cdf29bae674f3b2641c39a4
ebola-33420653b29f56391304e47ff74d35be516f2fd5abc868c1d8303dd118678226
ebola-058a70c0f4c145931e3c1065fde68451b90465e67dbee1c777357ffb91f4167e
ebola-0d23edececab90abdb5c9cc9f44b5b5419c43a296902e3e1d93eeab4dfc0799f
ebola-03ca9abb0cab49a7ed4f6ec8c2246551eaa27f691643a62b8e5efef9b83fa9ac
ebola-9d02c374015b050fe72fbca71ba50c1917042f5c91f18b650f951266dee0acd2
ebola-c74a6c44911a55b3ee7224796c370ca9beaf1efe2c09bc6b8c15ba36a65b01f3
ebola-e80bb50a6dc28e6c23b0d3145087aa2248b97f6cee207e619cb01e019744849f
ebola-ccacb36cf5735bb03524a6db209109ad77f59b2bbe14c0d373d70dccafb35981
ebola-ace1ef5b1217bf7a326791b6c0770fd22bd72d7ce3e7c0793016b463ec757f3d
ebola-82e9ffa1281ebc902025aef106e71913e7dfe2dcec4513ca8673321d7badbf59
ebola-1559facae8dea73c6660c16ca5b163a8d49450f743866e814638d0d41381e73c
ebola-3a892deffc6885ca7f6cd69cbf80885fb9650a89f8dbe7d9ddcd609d9f4481d2
ebola-aae48dd159a7c750ed9f180dae1cd8346f8856118eb245f3cb8ff1d1ff5806ec
ebola-51613176d47a09645d44c9a1f701a5ccd7a933cb5983c350c99bdb49e90a45fb
ebola-d547ce463baa68a4b5e653849fa9d5d27a5e968d733f6300cdd4dbcf8efab357
ebola-fe5f3a0edd4ae03ad1de2a8167f9e5fdbd20237c0ef9b7d8224c0f32ed0b21bd
ebola-6156b820d7bdade9af11d735b4fbf24ebd47818a342d3efb6a075cbcd62cf905
ebola-c34c802d76df64cbf07f13bf5c02fe11b43ed671c312b92bc5cf2f5fabe6bb98
ebola-352f4ea03863ee58ade26be8d514a7840a663751117e4967d31ea2f4abbe6d66
ebola-3f97461f69af30052565df871902970babb7d74c9b21e280313929000f4a8b7a
ebola-15de067d232f10507e375ba70fbe75ce4e8af3c72b2906258fbca95ef1725467
ebola-32a79b61941215ff0898686ec8cdf5436d3f635c46b78e85056b0c1ea0e426da
ebola-a693ea1fefcc92bf4c150d25bc87b533c0809b5c67ff398e2e2250e0897b4263
ebola-9cabfdc0e65b76ab681c544e69d3ad2e96f688eee117ed59eb91d0527c6b2327
ebola-a41c635ddc15b071764922a50acc2a47900c0cde6b396ed3817c5f093a301d35
ebola-37082d0c6c47d8bf54c6a62cea0ef1b81ca26a95cdbc98555d0bb22768a58bfd
ebola-27b95b2bc0f44ec86d126330e2cf2a19733e632c82d3a3d19738a305640ae79d
ebola-7bd28e9fd217e91ab2deb9ce5791eabc207874551b5b0fb60010d73cbc507109
ebola-5ae1dd69dd6f95bbe73a0d43f81705510af3745b692b3716dc4ddb7217c12e98
ebola-6d7206430b363f258504d4299ba98bc8f1f834f0831295aa242fdc741e532df3
ebola-ee615a0a705aaf74c66e161cb367c2217aa77d0f2886418803af447030756beb
ebola-35f00d8584eb9a2386ca740cba815331b05d067d2ab60bf843f674e34a8c5c4c
ebola-ae9b1a59d707ba2575b567537121b599bd2a0bb7631a3e41f3e6edba160bbfb5
ebola-631241dc462ef5f98c8bbde262ca155c0376a0edd4020ac54664d62f794fa862
ebola-8185128caa73db572ebb8bec4cdf505338db6ecba2f349a01fb963c30e5f0aef
ebola-0fe2c50af10180af856df93afc734619885a5d42a182ac05f7500350f1d14688
ebola-dce6b2c954f04f4990f79cd67fd9d23a7589f4a9ea523b935cca07a03c786bf0
ebola-dbec10ae1af6177aa874ded3cc086ab8b37c7d844c51c18e569296b3e3c0b6d3
ebola-9d344606535bf3e2650b97de6b01709bb208f403249a39667625dd8555043d69
ebola-28c75c7dcfad54fa97f2c40a5c30960dd9dd1cb1e18d7a3e55f168f27ead24ec
ebola-6e09292b8d57f7456ab5b157f5606aad44ac38c458d1205ba3eac3d9364454fb
ebola-0a8b4e2b4bbdde3b7999c16589236f3e7f2258554621d7cec14e59be98565d3e
ebola-a731860fa4fb5422900ad0b9d65bd9628f87ea7d2bf73afba3244df4db988393
ebola-b5dca38f0fff9fdf89295ce7cb8c218e1832522e9bf44bb435dad22c9ccca49f
ebola-392638c8be6cd03f4f23376565d6f0d9aa654ca86ed6aacda2e536f27f8b8f9a
ebola-d63cdaede6f6ba1671678a3d3095df075df880b3213a4c7ddec969151b181cdf
ebola-21828c86756f321aa27efa0b6e712529ea76144807cc4d19fb53e4a2c28d7b47
ebola-a32240fe51a8d1354bcde7d15c8565a85229ff0400476554e72ecfa9f9b23d1f
ebola-4a8eb21ac5d0b2817a1e261bbdb899a7db07eec375d5395b33efc7027da6b427
ebola-2ed26209364254c0850d2523588db0c2252ee0a72e78b3e3fa04cdd63ad8b3ed
ebola-3d10e5feeba8562f89de45f523e592b0ec1d25d212b81d45f5ce539ebb678ff2
ebola-7a701cfd108fe7e211d8e2561cb6d0cbc32f6153abb75106bac35032f7924e86
ebola-3de13958f9532fff1bbf2b015cc0c693f879fd2169c2a93d3693e83c1854e86b
ebola-18986bc0a6ee6c86abd6bb3a04139ac87e2a7436cb28bc3f3975371c27bb8850
ebola-16d85468ec14c09013aac2c02b8febf1c08e440087c971b774d80eff6f6d2e07

list/click  |  time: 2016-04-25 13:13:56 241851  |  # of fields: 4  |  topic_id: 417  |  docno: ebola-9a95f574ab2618329a2c42d32ff14e6f070bb71b8da51bc6eba7e5c8f558d381  |  listsource: terrier

highlight  |  time: 2016-04-25 13:14  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-9a95f574ab2618329a2c42d32ff14e6f070bb71b8da51bc6eba7e5c8f558d381  |  highlight_string: ebola, medical waste, cost, containment, disposal

doc/irrelevant  |  time: 2016-04-25 13:14:38 221154  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9a95f574ab2618329a2c42d32ff14e6f070bb71b8da51bc6eba7e5c8f558d381

doc/irrelevant  |  time: 2016-04-25 13:14:41 818805  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5743ef79d272f9cf13363d96e5121bc8893afb47ca87b1e8a17515710e8d8c85

doc/irrelevant  |  time: 2016-04-25 13:14:58 379068  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-830bef3c71e38d353136214e8c11caa9d98c37c94aa795f67ec4117849b0695d

doc/irrelevant  |  time: 2016-04-25 13:15:03 475522  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3347ae1f6a541d06a1255176059a99ab5d27d1f776fb15f2bc389b68dc8f9bd5

doc/irrelevant  |  time: 2016-04-25 13:15:06 749718  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1df0fed8e82815f5b826dbde93bf004321e0699d9718d7f31ba4f0f4a942b156

doc/irrelevant  |  time: 2016-04-25 13:15:44 127378  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-38ffe3d9bd513de4d578843bd04bae3fba38f00b4f3f63573406b75e2113a937

doc/irrelevant  |  time: 2016-04-25 13:15:47 246874  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-281f5283df05bdda06d74a39b56a068ffff19782e8bbf025da3e5067f61a0249

doc/irrelevant  |  time: 2016-04-25 13:16:20 957903  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f74ed50667558936a35bd76809767317dd74ce00163667ec6ba92853a5079b09

doc/irrelevant  |  time: 2016-04-25 13:16:25 141616  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d9509927ae3466cbdf6075d372ce89355a960e086d2ac01382f9daaaaf880197

doc/irrelevant  |  time: 2016-04-25 13:16:27 895252  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-bdc8e5e8a72aead87dda1bb370bd5f919bd74d9c9f4308cf89608f2d9e2a4941

doc/irrelevant  |  time: 2016-04-25 13:16:30 959529  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-37035bb5d6d3b47bc538bc97690896d989904e0a28e9490c9b4750877634de14

doc/irrelevant  |  time: 2016-04-25 13:17:08 155771  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1bfe8cca6a2d2ddbfb6fdfc0e787f41b0ae0fa720d1f258b9837164ebcd4c74d

doc/irrelevant  |  time: 2016-04-25 13:17:18 322607  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d07ce7dbafa17565decb454c195d723887fd578af8043160e910959b08ad18b7

doc/irrelevant  |  time: 2016-04-25 13:20:41 608469  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-bdcc09541050ce58bd8a5a23dadeb15c458f1177985a7b446970c42b6ebfe336

doc/irrelevant  |  time: 2016-04-25 13:22:41 129722  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fc34657d3fba931d21b1d36feaf8577b16673b8d907ef0f88aaa6ad9040dbec9

doc/irrelevant  |  time: 2016-04-25 13:24:16 887265  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-10cdcce357bbe558a672a500d0cc96538f79c5ca2de224189f6e7a85ec9eadf9

doc/irrelevant  |  time: 2016-04-25 13:25:06 950224  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-18b22d45ef1893aaa1c0441c2efa7d320d11e234719425166215ba89fe37333c

doc/irrelevant  |  time: 2016-04-25 13:25:09 468388  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1d9a5a7ce9d01e072e4ce5dc1654b39ffe9a124bf2082824dc0e4836c2fd03f3

doc/irrelevant  |  time: 2016-04-25 13:26:27 838139  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-06392bcb81b78b43a2c2ce6e96f01371c5302e4f30ebaed247980847ac0ec0dd

doc/irrelevant  |  time: 2016-04-25 13:27:48 504270  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9abaffe0fb848ed4187ad9eb24280e5d52f94100e152bdbc7f8a331d614ae8da

doc/irrelevant  |  time: 2016-04-25 13:28:47 903644  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ed79ea2d77deea0b413a260c6815bc5b3980016440551d71daf348d2e5ea8dbb

doc/irrelevant  |  time: 2016-04-25 13:28:59 391711  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d67966195453f45296e8004f4fda0b8ae0ee35a8d4eb9c99d0530245969d9095

doc/irrelevant  |  time: 2016-04-25 13:31:21 137726  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-241fd8e014d6aaa0b25a02955dd24f96d9c2c2293e352957bbd654e53003142c

doc/irrelevant  |  time: 2016-04-25 13:31:24 625286  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b276d304c4f5d9090c5c993a50a202392e2770d51c54cd7aaaf8268761f7f109

doc/irrelevant  |  time: 2016-04-25 13:36:49 912133  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3b4bafee54dfb413115b8c54c0b2571f4ac7d7f5c4a2bf7e369b37f9326563b8

doc/irrelevant  |  time: 2016-04-25 13:37:19 396233  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-920621b1d513e04d83f6393358695fe6ecfe75b8a42052272135afa3ab5591e5

doc/irrelevant  |  time: 2016-04-25 13:37:24 102147  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2ae01e5b7b804016d138fac881f7552c67a6b4293bf4a2f6697022ffb589b53e

doc/irrelevant  |  time: 2016-04-25 13:37:33 493191  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-af11ee18aa262dc0ceb2824a3192fd049d7abd1d4c5653be9badd5d17d75e2d8

doc/irrelevant  |  time: 2016-04-25 13:38:15 079628  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-27135681e070340769cd61ac824c5eb626bdece5519db884e0e6c5011acb7c23

doc/irrelevant  |  time: 2016-04-25 13:39:05 714080  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f03162e47a1368c11e4107b9d621df50b4b1959ba5311e680739777bb88f7274

doc/irrelevant  |  time: 2016-04-25 13:40:49 844168  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9b3f1e9b39d71d24152ffe895ca91a4be1525a2f764ae10da0007bfe49a311b1

doc/irrelevant  |  time: 2016-04-25 13:41:30 164543  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-57b9da45bd36849d7f04d59edab684f57dc2b604a513a28a57250e85680785c6

doc/irrelevant  |  time: 2016-04-25 13:42:20 320000  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-702ccd1b4d58569f29a06b0be7f116cd591a9d7b7c7a86570230af10b213f767

doc/irrelevant  |  time: 2016-04-25 13:44:23 358194  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a458938630261d1fb4b30b0cb11f6ab60cac46650b03806dab3d544925bfa3cf

doc/irrelevant  |  time: 2016-04-25 13:46:13 365443  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f041d7b2a2532e8fdeebe4cb1828835dedc08b132defba729389533be7564808

doc/irrelevant  |  time: 2016-04-25 13:47:28 994560  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b6f0ee2784b7cbd58ebd9f7d8010719f24da785d384fe0c92ee7206a43e03b43

doc/irrelevant  |  time: 2016-04-25 13:49:10 602744  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-cc3d4dff193418ee67f37cd64606d7e62c9b76e82ab8aeb9558bd12298170bf4

doc/irrelevant  |  time: 2016-04-25 13:50:40 477069  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6165699aa7695629ff00106ef345ef21067a0feebdd13107ebebe1afaca02617

doc/irrelevant  |  time: 2016-04-25 14:04:58 018894  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-97d2f6c8b8ea6b79a386c98249075d72f58cddafdbd04453fd382b5003445acd

doc/irrelevant  |  time: 2016-04-25 14:05:00 396766  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-77a9ffd212c7e193f87075854e8136dfe5bff2f9c3cb961bfda1eaec9e91c264

doc/irrelevant  |  time: 2016-04-25 14:05:02 856426  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d9c917a7608a16a9f8f702391a9ec6e9bc8b108cc2e6ebf08cbd2eb2256927a9

doc/irrelevant  |  time: 2016-04-25 14:05:04 776553  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ff9d4051c1c8764ee7932db459b3e60690c6d8dedc7567740dc5affe68d50e2f

doc/irrelevant  |  time: 2016-04-25 14:05:06 518840  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-543b85340431349f81106753e903b21ea0aec397819057decaaf60ea4ebb43fc

doc/irrelevant  |  time: 2016-04-25 14:05:08 488885  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-52058b37b090cd651e3505dedfdb960749d7086a5172d5b3a74987039534862c

doc/irrelevant  |  time: 2016-04-25 14:05:10 381669  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-63aa113bfcd57ee648ce27940645eb1422d16e7caca21ab278fb6b18d7251b81

doc/irrelevant  |  time: 2016-04-25 14:05:12 096455  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-041c90e3a98ae967c3a2d4bb169de90e5725481e94f145434ad4ef3c54b43e25

doc/irrelevant  |  time: 2016-04-25 14:05:25 234876  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e29d9924a1db4e9baf4ed9f5e62fc1841d3d27df928c2091d1a0e09440ae3be5

doc/irrelevant  |  time: 2016-04-25 14:05:29 703279  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1ad8346fb8ffb6dea1ab53da7cd92009cd353a935d3c2e5e592208ee9d0e64a1

doc/irrelevant  |  time: 2016-04-25 14:05:32 108378  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-58967bfbe43ec2044421ab983dce8c6abd1ab6e06448db8d1cbc6bba78d6ea2c

doc/irrelevant  |  time: 2016-04-25 14:05:36 094059  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f991ad13d70683b7336dd30301c30c41f8d240d0b5e6f212e4bdbfecf0c6e4fb

doc/irrelevant  |  time: 2016-04-25 14:05:38 638217  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-0184a48264924263acf0130e9aa71ac83cfd40366a8dbe647b44ddea723f2da2

findmore/pink  |  time: 2016-04-25 14:06:07 273050  |  # of fields: 3  |  topic_id: 417  |  subtopic_id: 260  |  subtopic_name: dangers of ebola medical waste

result_size: 261  |  num_tagged:  0
ebola-063b3c2e0fb2ade0f07ecb0893366ac44c0ab63b210f4b3df995b5868e38c56b
ebola-f09497a6a089ddc1b8965d992d67122ac947a51ef24d1a83ab90cf2d5880012f
ebola-b45773ad881cc2ce9d03e0b855c52524ba454a2ef23f3bc160a51ce227c890cc
ebola-d56f3c65a4d8a47731dd9f60da225abd753c574b81c5b05f808e3ac9fce9c711
ebola-079056e19622bddf80364652e538a7847cd8a2f19308cbd01f60084fa9f97720
ebola-b60093340d124a0021cc656138212c7ebefb890b102399eec38b766367ee3686
ebola-7c4baeafec00a23e4387a4bcc8d6562d24ab0313f11c562e465d6c8e17a070df
ebola-2ff461e540113f6d154f4cfd531d8a42832a463f4304e41eea301f2c18c9097d
ebola-bb660bbc1075b644f3efceee27d535685937d3bad12323322ee56b7c3e35f334
ebola-4c39c2762cc04dc9e1d0d450bef08c2af2b707b84a94d08e6599d8272fc0cab8
ebola-4caa27f6b9d7dc160db6db0258a6967c9a86a28f7683a4abd7f613ad9ccf4e07
ebola-5f8c2554f46c3cd90157b57676e649c3e1965785c2ef6cf57b6544e8b7a3f6cd
ebola-54a959d78d155cc93d59d05d197b0ca1371bbbe8ceba85b5bcafbce75fd30c5e
ebola-046accc4432cb3b60369072f12e4c8d8ff97fe29a114bcf3cb85d7fc4571b2ce
ebola-821ae4f2028bd0f16a1839639ed3af3cdb3c2ac40950511fd18b470f02126cde
ebola-b23ba77cedeeb975b82be34c668341abfe0b95450a12a79e0d94c9253cfff9da
ebola-2ea29a96f8d30710fe7856ff6f4ae557ff88eb1da57ca330c55e5f448887469e
ebola-ea4ef3f5131f0423abb49423eb9faac9c7b804e73eb437e66515ca90e1d5c82d
ebola-a6368021416d0f304b469f2ff404e6e55e2246ef7f4c23491e36938e462e9b3e
ebola-7dd401fe52aded4c8b3832b64fa006d8903dd5137905469e9a5456572dc0f9e6
ebola-d92b32f7c8f2a3bdf3be76e0dceadd00ab5fbd7670e56835c8a149b9bb6210ff
ebola-456a02322ea0444108da61ae49bc59b15280650cde7b11e92468f9596b8a29b1
ebola-7567fb0f212150d9c0dd8ceafe1f7ad970c72dabf3297e35d92ef91160b9d502
ebola-3f212236831e54dda8d2a5d62aeda403c4428bd8d95026c2e8806d0169d0e4f6
ebola-b5190622145195f6d0c5344a543aa7d61603901bd5fbf8485729a8bc5249d91e
ebola-56b0efab90b52843309aaba373493d9acd3f0f2daf94008fdeb635d5916590d3
ebola-72f7e1872f48a046de99b4d96313858cbe1a78bf4c0602452fded2f38b94eddd
ebola-9e191030bf986219effc443c2a9fae155973f52019dc98cb9a8313774efbb9d2
ebola-d52f1376144b27d28749e0480901712299d88bafa9e04a8cfa01cafa5391eedc
ebola-573efd6396dada3cb91340afb588c2405e960762ee88110436f718f50bf3b9b2
ebola-d07a17efda93708ff9a4e61726bc26f6d90e334a324834fb6e1a3127b8aa10a6
ebola-863341133ca55a733b13f8a779fc0fb0f2792972d90de07002db5efd98334af9
ebola-71f8bbfe73d3f0782b342b5734d49707ab58a1aa54934925dd1e5c823898d8d4
ebola-f2d678ed1c6444eb1aff38bdcf7d5e655095e69ea01eef0d9ec4b64df0667cc3
ebola-4bfc1fe364ec1961b73afcf2788182a2bee850fb5ac85f42d17d77c96539ebea
ebola-1cc08ead8f515e55dad4897bccac64c66f280b67acae7da5a49b377bb405fb98
ebola-2685c52d2898acb110685780d7144b46f636274e0e569f73852c6910cf7dcdbb
ebola-be8d6b8c844ce094c7e7388aee5af6ae3df23ba2e09b7fe5570b27b3301ccefe
ebola-913f3363db97c017248d6c89adb1c92f60e4ee3867b6b829068b48f6ff1411e9
ebola-f5415af96c2c712770382b02810c5855228768467a8effeeceec34b1917460a8
ebola-c59a6418c3eea466d036ba4f74adb71f013e005a32355e955a35c7290611e874
ebola-df5f32c9a89e04637945416680d382106006ce22bded7f976961e18c4fd06754
ebola-7886aa61c96db162cd7636c0ca3dbbcb778b1f912f749f151dd09a67bc9ca605
ebola-459b45a883d91bd84924ae61b49a5bf0e967a208f2ad877b930b4c0986ca5da2
ebola-3add008ed448f4ffa6f1ff958242a74f32452470895d0a3c9ddb7fe753960269
ebola-29fe93b4541ac1db7adc4dae34faf159c58f26e5970ac924cc99c01723f44517
ebola-8dc1ec5b18f1206e8fc59098b52f3154013d8f71aad501069a2a5bf0613aa099
ebola-926046b81a793f71fdb246473c9102353b1cccc0bbbaf6f84685fa8777855ee7
ebola-a1fd0136df1e95155ec1f4499545205639d0ad0c6bb5f74bba7cf76c60e3c45d
ebola-065486329a06c8762e80057f0e1b94e45c4fab24d9927716acdb3b4e2e47332a
ebola-f1d643ce81a3b2330c2c62bcf55b2e9650a5cc9a4be96d4cf649d9f7e0767d3a
ebola-c9e29bf436ce9926248b3474995d5f12c3d91eeab212bd0fdd61277c24d42fac
ebola-d18403321f6e0f5a1f0a03030d6fd6eb50f83baebcd5a241712741f63c0ce524
ebola-de926aef40403887fe2b87a8c5b049a8a0e4f6ffc2abe039af65b746a049079e
ebola-f567377d39a3ea72fb12ff36b6783a0db3bf4de6963e8414b685e339155bff2a
ebola-5d6b6fa5851dff38f1e65763a09ff6b4c4191cf82cf6b4581cf58b510f47a90b
ebola-afdc21148809fcbaa325bf86276ed26a27fa393ad95439786e2fb49562c124f7
ebola-2c4f6307df38581d02e705c014340cf58ad9339c8a611c5eae8478397bee0d56
ebola-9e6ff11cbc79cec4ffec7c3624700b169737d11e211b6c6e046191a30bfc7b92
ebola-d54bdbbee94c8fe8ac1a0e0530d53191446d5d64034de431f8de95e1eb44f846
ebola-061f0529227d824507b979d7795ab8246e228e1577d889b6939d869a7257e094
ebola-c203b08b595e032ecafb20aa10bcd8053ca4bd478eab7f3fa96f5e7c857c5a39
ebola-1c4eae2db553f2ccf557e72b8287078de8b2bba34359bc37e6336417483b4848
ebola-a840c20f4a05aec16fb9cb5f1e24beada6555f3448c702728bc5c4dab1ee38ec
ebola-b20ad8859e0b6b8c3ed392a68dca6cdb4b00f89056e3eec2ba9f5bbb11cba2ce
ebola-bbabe9745e03cdc03ae5351ff4e59144b8ad90af68e8595c333daeb0e90cff79
ebola-c706111b47bfa76422f3dc6f3455bb92f9f28af1f3ff9db2f628da38bd02813a
ebola-d9e595cefa56ea33c370f9cbafde9860b3b4563b72f8df9999cdb226cf5db6e7
ebola-7cc286cddd125138c96329d27b5b3c5ad508b4b8356526e660133d48782df85f
ebola-c84b70f7a40a164556199ac081e1da29678f08e61dbf5e7db0b06b49de3a7629
ebola-80b7592c05903455e41d161b61df15ea85e718fd5fc3d86c2b3c029ead75d738
ebola-9bd2ed9cf489adf3d48ba3eb3fe64ddbc15172ba4f883d251edb0c7c412e5a3d
ebola-de38cfd634dd9ef2a62191f2927c7c328c6c8d66c5d31332afa8370aeaf9be1f
ebola-7b4a42c42afab7ead9fbb1e7e07fb775ed116b94f544d1fd04e17fe62accb1e5
ebola-4fd5f45af6a7db6c5147f305600c09e62f3b41153791c2657c8b9874a4f9778a
ebola-3b567321a937d2d4abd2384e6edf2eee5c11bb61af45fdfabed45d7f1639ed71
ebola-717d47f3cbeaaef6d7f843a1a756cadd4d05ce607edb420598a480f0c0cf4923
ebola-8b24b315cef0788ec68e7feaf97903efff4f61006b949f31a9c3cc394dbbfb00
ebola-fcf6a0aaf3205db46fb21dd48f32c04aada450b432dad3021ff92003be5002ea
ebola-92c1850de5b9832b4e53282f460e3dc96e5be90db0a9c554898a7868dd561098
ebola-cb32379110b1ef7c0d9ba82e94e6d3f0887d488455346b02564865cede6a0503
ebola-96b8b7e11b301dfdd931f5ff356fde5c00190c4392f7183e412a9cca956537b1
ebola-af3ed6bbe3bb4bc4b7beefec4fd162020d83dbb10e224228a0294a1906cd0b3f
ebola-52a50b5f8a38382dfc068742cd4d0568f2b5a1a1b2a0fc32c3c27e404169b397
ebola-7c4a80fd96e30640b4baac3455996b763bae6703a13f93e554372608364aa265
ebola-129fb9fb9b17bf0aea38e5dc1c99a6dbe04996237ea1c1e2fdfb95037f7a29f8
ebola-e31d790a7383ea9e89fe28074d6b1f9f225e2b5e067d847200865088ebd86851
ebola-9757a26707187190319b2ddebc6d6dca4bdae696623a4843262e422230a7b8c6
ebola-07cd5592a136d0fca49ccca1f936bda5d872c2b01f0528b50e21a3247eb862e8
ebola-d58f8fd30bcea666ce854e6ad3a27afe4203e5052c522316826613681c46371a
ebola-07fe8a4ae3908a0c0bd0eff74e57468109ff6071c8194d37c93fb0f2998d0f09
ebola-eb81a0bffb372769d62c9debda4ab3fbfa0e726fd102e8ec21b3cee780a53529
ebola-3f868e3f8ee5c125351aa11178b2da3abdee86def8ee5bf01be642fbc242e2e6
ebola-9abe2c3e38c1449f08c9fe615ffd3223a4f80ff9c462cb4ae1b5f6658afaa4dd
ebola-3b907745aeed7a09d14461395b12bda46c7b96e79b87b305d6933b154718b1e2
ebola-709e8257d8c5cac244aba38b3b8829350cc05909f89e71a61e7dcdc7f2dec06c
ebola-42d14b5109d02cdd8041c5706f8c2388ade3d63bd0e73eae9c173215df4cfb52
ebola-7a871e5cd556923f885b394c9ed96717f2d5d123cd159a3e5fe66c33df2afa21
ebola-84a85a180f1a0ed2c0da88f6ccb68f0fdc94b4bc842a49b0d3825f532b235ebd
ebola-c7627fc3a2c6e99a45775ab325e2e7c379145255ef81194c87e7a6a2ad1a776b
ebola-355711ed73d106b818881b5f16fbd29b487e86e9be0e35c5b555b96868e12d24
ebola-6ebacb5b9309bd1092d8795bfa5a42fbd1761c353fc8ffe1422ee04431874315
ebola-9963e575b0613a5739c4e19835fc0fcd55f05ce109b0a9991c2e9c8b0a33cabd
ebola-c28597b587e6c3a240f0b00432623dbfea70e5b06ea86174e68a42d49337c8c3
ebola-ed40962f29f32c7649095728bf60548ed35f0118d1e5a42460132df7022b4df6
ebola-319af5118f75860de36da842128077e17719dd22bd45aed5f4a7ea8e15e760c0
ebola-949dd7ecc1b4242d08bade5f16bf691319ea865fba77d640e6383c5ba69cb504
ebola-8260e002b524d9c376df40e984dcd594921d15d976eab6bb412f839aaf2071ea
ebola-af747ba32f0818acb8ae9201560f453a6c41c7907701c981de49f58fa672773d
ebola-f4398c288b570ea2743b25c2bbfefdcf8b1449614498b3df484a9af9d8102836
ebola-e1daf9000b3cd99c22dc9a170c02a09b120f519cff801ed88c40babe0411848a
ebola-7db04d4279ce1d7b860cfd810b4f0c72e86ae3b06f0eb008f9b65ef3a60ce154
ebola-5ca096f9f3ec6cff7900f683e2b6da77193acde926428ff74e82852386ba333a
ebola-8a137793d0e534753d54c5ed6c76ac01d256e99a5319b327d202be31a4fd2ee9
ebola-9ef5e6489d32f26d5d2f52332d7a3da7ee280584f572b5cb68ba20088ae5b1af
ebola-784ac16e5cee4a6d052b7bdec3d5ec9fcb666a488823d71faabe04fe1174f4ea
ebola-6af020be19bbc532cf4f0c666c3fd9dfd3e01bb9d23626ca3f0bcd5c2fb661b5
ebola-a05c9f8b309682ad26815e83ac79907d1a6bd8e402bc8e51eed8b960dff2d25a
ebola-a45b451a64a3a26283b8c27b7d52eb279d34023ebae072342a8b1e1c33db88fa
ebola-c27633c193e58fe22a6ba7246b442858c4ee059182787ac59a0873e2ba3d2f7d
ebola-993b812df80c7c3686a899b4f92b1a3c74f0a47700f6fce14759ceddaad2195b
ebola-b08ba1709d80bc064e7361cd4b5c7fa4d408882e72c443207f991b8797322fcf
ebola-d25166b72bd4e896888fb3ea16e6080b0c081ae05e182437c8393d12c15936e8
ebola-a76ee9bc542ba4a758d0f439ed7c38223b7abe2c0c4883d069df13126cbef701
ebola-b90d6da5eaf31f9328ba66124dc5af35cc6742d2ccaced260d739d0aa49c054a
ebola-0a3a156d558e9ca4de50c9b6f5ae223e5850d93f2029f0e75c6993180d744363
ebola-2fbbd51f3397899cf02d6e943f9af60a8ce3ca0d2bf6b806aa6de4df0c64b3f7
ebola-c6e7405aaaee4caf29ed9bd5c12bd5f12f8d57d4d1a9aa14dc80594344da92c2
ebola-8b19886df8ba3f05ab0f000635ab6e897866af1d93a99d2c1e7477022e108497
ebola-45baf16a2a05e30eb71bfddc3b0569c34ae67db77b087643d4923ca5d7c5e8df
ebola-69e26972fcf2cd3582f3c8724ab42dd9c3f25e568cd969bf92996e16462d2d10
ebola-6adca758784ee5637ead98c0986da8f48879a23ee92394af8b7680d6df419241
ebola-05bb4c33f61d6967783f73967bc78a6659fc1295014621e2063e15b5ae591deb
ebola-9adf54af4a5cf321e2c546624b1a4ea288e844adc839dc3fc21bf1b0fe335ffd
ebola-e160066712eabd2f04600d2bb244035431a9e7c6f1f9050b49b65652a3a569f2
ebola-9172eeb773204d8659e5dd14efb93a51b71e28e5ee9a32263d8adbc8cf646e69
ebola-7ef3e872acc7763c140540b9e9f09b9c55826c51fb6147b4cfc231aba3563cee
ebola-20f0d5e4d9993c3c6e3b10875d6a40b3b47211a764b053f79cc9d352cd00128a
ebola-c10dbcfe64dabb1d2ce17d8ac8843afd2b65ab7d538b1a872ff7dd1427ad6bd8
ebola-fed58223b85a57340b6d437f9e842c6430409ddffebb161fd28786d2f3a5eac2
ebola-3a5332dd5a6e290bc9134e77d14842af820708c6458fde1dc01c2226cf5d4f01
ebola-7409ca890a3a8127b5ea1825fde0e2ddcb3a2e6691f49fdf36beef0a5937857b
ebola-1810c09f3c6a215d8a3c205ac4ce5e8f53742bbfdc8e0024a939fbd15084f91b
ebola-7b6069901e2ba2c98f458c67f7bfa1b02e49cfa87d83e0d04129d6bce712e657
ebola-05e77eca0aea976edc5f817204a5cbed11ae3a01b86905fc0bf140699cc4e638
ebola-ca4c380a35d0c11658fa9adb3d6097664d576348d0718887f968ff71247779c1
ebola-4fc07f1fc9435028a027506a6f41309cf2bfecb74eacd01eb758f3c28f50ba0c
ebola-9099afe44970dd6019c009bfe3df689bbee7089615abdc3650aba56be110f826
ebola-69bee4f176804c518df412f5d0d20c077fa3ced9e55965d0af2d8b9ca506a6a1
ebola-964433db59630714e1c559aa916d8521ba53b5fd7289e6391f535db13ed961f0
ebola-9c6bed9458d528b6d1a18cba2813e9c64a4da8ff7103f417568d12d751725ad1
ebola-8ce4371de71d9a2a30125ae41be630af40dcd1ea7870085ee0001f87b551d9a0
ebola-da850757931e883981ace85b125d3e459e8396dae7b96117d90f218b5ddd63b8
ebola-5556501a827fa0bf9aa1562d6661d561dfafd8c8509de046eafb8bc8d536fd96
ebola-fe8392df698917e9f910b570ecbbc08c80f78731bceab7c5d60169225f526f98
ebola-91439d8837178ee420287aeaf3c42de1545c6ecac9dd56a8337c9bb468a49c02
ebola-51a8f5797214382f6de0b3d5636b144b3477fd3e20da382ac7606d80a91f15ba
ebola-f6a9f95fa14e7ceb554ed01501955263dc501e800e828597ea7931c6577684ff
ebola-a20aede5a408cb0b17d9007d5751df71c532cdabd0a14d146ee7d11939b57fb4
ebola-6200284a673332eba4e59def9b404bcf3d909481e497b209739b9a8e49e6e56a
ebola-5abdb1ea28ee3cec01ad9457d2ad03d78c258a6b4d63425c11c0277f3e96ae48
ebola-8ed438390e361a7df721283f666002b5f78f505f99a346de7de4ba8fd81a116e
ebola-9ec8bdc3a0750d45166d50a425062acb14fbb896f24a523e4e5167ffe276d07d
ebola-f783c4e513344a5217938133fc665e3c361c1b3dcdfbbc7c0ce50a907ca9be56
ebola-a9892e033ccb7545c4cc525e2b6f29a217ac0940ed26e357177d8b0406b90037
ebola-267c0e4aabc53aebe9edddc497cbb9b89b66a8b212c668c05c420f075a3d454a
ebola-fa33da01cccb6fba579ed6b358238dafbc8a894713b1de46aa3fadc90a7f5ff5
ebola-91ca04396b201366db37a913e4426d2d88eb1ef4b9e7b94f5e58be8b85cd0054
ebola-72b3b2a2a1eb4c00aa16225cba8781ee06dcc2b42cfe57e53db04ef05ab8cb4f
ebola-85a24359a00ef88fc2684185a7ddc7ba680d9e268cce161d2c622ff28b360a54
ebola-9cd728c7b1ca7a344bf86e53be716d208d14ec2d3e9f576a78e0c7ec8aa21c3b
ebola-161580a42461d3e6b72ede7228475dd75e6ef432558f978750cfb9a7bb5fc729
ebola-b71da5915a5f1c8b0dc3ed68f9f5892cb4b79c5e6fba17ad597a38e369eed996
ebola-676a89034c1a0a6e2e1e38d0b7953be31772f896dcb2a35195a14675e4fbaf51
ebola-58ac47323bf9997f66107a449f4127552cc02c427e537a94096633659ae983bd
ebola-3c09a1971605fd1f66b12b9726e71d9800e6911ab2c23f086c6547f8000537fb
ebola-10ab899686dd8f158bac0f89d122c3b33fcacf6b93b3f1f53cb83571a55b2c7d
ebola-d98675f9aaebc128d93f877567936c5e8de3d9eeeb5a37064dabad9a5a2767f1
ebola-93478c315ffbd3e234c3e5a06228f529e1f4f9e0a893da68c8cbd84adf90b456
ebola-eee27ff8db871b890a8ab44dde2ad907c61bb8149b59aafa164bb4530e6bcdd0
ebola-2c69612e2edcef08f3b5a0e26f8348682c88a9dc957761e615123ac8abef1911
ebola-7ed3c6d1898a695a20bec79922018265dcbe6b2f0759f5d14eaf40f710db9c83
ebola-75f355517d2af9e52c8e9dc6370948c047de821d8a0dc74730405904d7c81781
ebola-64d714d5d73797e06aea7b0d7522452811443d6753e229607fd3edd4bb4d7d0f
ebola-6c5bba0303a90b4ae0ba5d367c40ee85ed96bb2621789d64a8a09ea83cc047f1
ebola-4075621c4edbef3b4230a9e737251dff11420fdb547f3bd968fd96417ca0b58a
ebola-2255509c7a87b836fefd8cb0f6ca5ac86b1412f6e62805d511dfdb2126866dd1
ebola-79bf1ffa41f931ac5cbdf2f30c4be3b8bc0ad43226be8fa6b88e5d360c416fab
ebola-b98e93ab7257c9873519c374f1ebbf5879fe3215ee63523dded0aa7ab3584492
ebola-fed95da043871c8e321fb6e6f98ec37ce666b8c305c9675122fb8dc813b13c3b
ebola-390dc7e263b45052ffecf23b298daf573f1cb22fa67dd3ca601fe9a483a4b6f8
ebola-5d1261870c4afd06966c1339b2be7c1d1435fea1d53551bb79b4a86fc900bc0c
ebola-b554a1aa8c976bf48f46142fcbc945fcf0c3c4ffe8290ec02227a54cbc0c7cfb
ebola-217ca56522455f7fd0518fd96d42cb8f7c0dce26dec58e42b7448e7893e3229a
ebola-25b42d2f5be98ebc2c6a237da93c3da2240b9e20c5f475f4024dbe4501f6eb71
ebola-1212116604e1b9aad91f9f0bc7ed5cca7c97603c1643613ae44f81e7e5ed963e
ebola-bb3dffb9c5f9c8e0e790f536c51aa01b273973450fcd7e543f8e8f9184abf30a
ebola-8457b4056fd922dbd5edad0f4c06a8b2c76bd894b942040020e36352a6d6598a
ebola-b5f5d5d331ee9f016710d179c622178e9e31fe4966ae766f81988247c14ce6a9
ebola-fccc3dbd60610b936f1431e0d45fdf38cae8f59819cf47cae80de6b2edc28361
ebola-a61a67cfa34d0fcbb7edf87a5351a4e6adad857f2866ea4e5c05e3238f9797ca
ebola-e7514c7f6130d78944e34541f50490bd9c5c472b30973e3bf26f327393194bb8
ebola-f611fb07d1314b9cf6a5acf98cba86aef4f3ba0bea1316a2c99856da5da1cdb1
ebola-775b5a710a5392771dd56929d7b9f901677d1d04088e022a21084c4adc48d59b
ebola-029759de88aff60f9b5e6550c1a376b331aa7f7a3dd786792c9ad123726fa39e
ebola-d619c5c0ac29a5f4a7ae165be940564e6f28082c2087c7effb32ffd17a92a7de
ebola-d37cf4fcaf74e243b33466765e0d54d12d046d52c92bf83f917c81d9d97b3be8
ebola-5e2abc5773a07c6b0c0f1521dff18ab54a0af815c0e24f15ca436a87c3c4be83
ebola-e61cd7c02944e7374d2cc984d0032756136caf4f0f425422c8de8355f5efb92d
ebola-353484c6119a71a188bab133377ca24fbd9752f2efb3e14511d0341d26471583
ebola-f20ae0c81a4e1a42e1f74a9bd92f314978e37a3666d12b762c0cd5217eb7c219
ebola-9fbdde79df98c2c292b8c31dec036adc357534631717e11f699e8dbfa8558c92
ebola-cb5c7796f34781d5e1d2380509358101c7588aa84c577ae45d175d10ae9c3295
ebola-2c1f820040bfbfac39c93940cb729cd8fcd08bc26aed41c574e4b1acffcca7de
ebola-ab61ea287a2cc6417325ac942c046a9e66da18bea21e9d21baaa8f455c024e9c
ebola-b7058ddd12dcc759eed3909de9e9c1420edb9b1278f630c8872541e4903caef5
ebola-ac260b9c0ae350ddbf14f56ce07df270ad2c048e6515e67690c5123d0d19afe6
ebola-2351d62f523808ed7a46ce02efb2171ce8f07ab312ff833b988850d0d46efa66
ebola-6d50bf330c11dbbfd979e34f1c3d0d0b0cc67d61d4cd64e211bee53c1ab12b07
ebola-2439835836f6c46e36b5328b4c815f411a9e23435544e54bd7544f1846598239
ebola-7c85d1056337e5dd1cee9fde0bbaa059eea94807f4156fd135e7b5dfbb4ded64
ebola-c04a581876ba185d17425b72eb1aa0416a35c1bf6c79b6ade7c62efb9c9e5f18
ebola-bf3aef9ec525cbccc04ba34aa85d3133e35491405101a5ed268502bc6cbe4c0d
ebola-8dc3f7add2158b27821e5153791187b011ccd52a6645186a76c7e385a11b5b64
ebola-c32e75567f5a8c535a63c1a61dded0a643dcf6bf006969d10dd6d0c30c95eeb3
ebola-18a6c279cd64cda13f556e9f3df1a161a84dc22f611c18b76714f1d9961b617e
ebola-836f0c172a76f826383afebdfdd103abb78ebd6bea7320944b9c3c23520225e0
ebola-9a36392b875244b868beb6cc841958bcb4e9ef2288e52c9d48b26b68edfa3b5f
ebola-f79b9f7cff8d441926eba8da3e30c91b50283a6d32dd14ec4ad2d8b27797a31d
ebola-def070efdf7ffa7b83fc354d6a7d2a720cc7f4b8702d95ecb8a03b6c5ea05006
ebola-efe8619c1de2769e934cb458d50e954e752c4baa1750f4b3998011a00dc4afe4
ebola-40e9e45e1584ca132636d1dae6cbea1d6196c5ce7d79b83467deb81822abf575
ebola-dc8f8941ad50e0963b3fd9d470a3d826095f81a08cc89b3a60f0ba3beb058d9e
ebola-cc03bb3ee6cf198f433c9c9e0ce67d6ad978985eca88b6f76b04c6362ea5eeff
ebola-211a0a70cfecac375e6a9f306cf3862fc5fe64d390561207aa875e6fe5b73a30
ebola-d52c8d4ba224fa74b739de859781ab75602701539079401911618a13207ccdaa
ebola-e43108ca1ec377cca12302199201795bc62f479c83f1c7f0fa40bbfe314c785c
ebola-05ea842a08ebab4f5618b2d5504d84e6a6bd3cce5671f97de7d49c6fa3efcddf
ebola-8f50ddf4440860761b0c9d088b8998e767977911bc29e385af8d882df959804c
ebola-a33d6470bbb6c578f86380dd1e2584cd77bcf911308f91d59bb66c5c0cc94c78
ebola-acaf96465f5c0fb2d9986554ef59f1f2b58de60e3715ad70c4c34e24effa2e14
ebola-2048eb9c9cb2a635ab1e2ea6ddb345c70be6bb13aa50e2e62c0fcf47ea9d8cd7
ebola-e9462221a1b573ecb30fc393e77911b22e5c6e4dea93760f0c15f4d999585d8b
ebola-2ae72db3a7d3e06474b06be0be71a205e03b0ce3320f3d1004675d3fdbaa70f3
ebola-84c11e5173f89385e0b4afd41c4ca3623fbdf3ee45faea48fe02354dbbd68924
ebola-efa805268b6829482efdbae09fd9cbee76b6f93afb8e63faa0b8ad2c6223e760
ebola-eab9087eb986a120060eda3af1d88c79887bd0552ddf7798ea2a2365035c0747
ebola-0e7cde7979ee728fc92498e0b8eba16226b62c02ebf5bd6bceacdf0772f81671
ebola-0fa131085a890cf4feb0924b8d5ecf213c3e8aba02813630543bdea79bed9989
ebola-fc36ddbcc0ccb94dc94461a31c186c77d4eafd6729a5a75bd095f1f28c7fb5e1
ebola-20de82ee19bbed43504eb7a3f352a609f05fe507de7f8b41d5caf762923a3c4d
ebola-a9a8a6d0459c55905f5cc6631422f5163e666cbd48c2c31371787459d3b9907d
ebola-0dd99a8c3384a1741d2e918c7e4859ef92abc7fe9cdea6bb6960bebce93ae45b
ebola-714c2dd715d6553507322a0c2a69a4086e2e4d12be6b961ea1d96b26c2b6557e
ebola-15e2646d4afcb0919d9df0c19eab246255c99290032b6a9b8a4465cb7d26f21a
ebola-561c2d1979eaec7ab23fb691d4498f96399c5381acf71ea19b102a71449dd5b1
ebola-0258327307a331f7b266636d8c8be2569658924d63303c41569b9dbe21d64655
ebola-95557a78f8ff19f8ac2a92364af9947defee33ec2ff1e8e3c6ed56469ba004be
ebola-f422e7124a415662eef89e5f030ca67fca4bc5bf476d353e005821fdba0beaf1
ebola-93b16479787e10062705027e76adc2ff542f492abc55945589a691c9d10d1c0a
ebola-f4d1d6423e761534976d9201fc0f46e9c3f6da675e24fbf64ab10cce7bfb7cf2

list/click  |  time: 2016-04-25 14:06:34 711825  |  # of fields: 4  |  topic_id: 417  |  docno: ebola-063b3c2e0fb2ade0f07ecb0893366ac44c0ab63b210f4b3df995b5868e38c56b  |  listsource: pink_findmore

highlight  |  time: 2016-04-25 14:06  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-063b3c2e0fb2ade0f07ecb0893366ac44c0ab63b210f4b3df995b5868e38c56b  |  highlight_string: ebola, medical waste, cost, containment, disposal

passage/create  |  time: 2016-04-25 14:21:10 689771  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 258  |  subtopic_name: containment of ebola medical waste  |  passage_id: 5351  |  passage_name:  U.S. hospitals unprepared to handle Ebola waste   Email  print The total Ebola virus case toll could reach 1.4 million in the next four months, the Centers for Disease Control warned Tuesday.  By Julie Steenhuysen Reuters 7:29 a.m. CDT, September 24, 2014  U.S. hospitals may be unprepared to safely dispose of the infectious waste generated by any Ebola virus disease patient to arrive unannounced in the country, potentially putting the wider community at risk, biosafety experts said.  Waste management companies are refusing to haul away the soiled sheets and virus-spattered protective gear associated with treating the disease, citing federal guidelines that require Ebola-related waste to be handled in special packaging by people with hazardous materials training, infectious disease and biosafety experts told Reuters.  Many U.S. hospitals are unaware of the regulatory snafu, which experts say could threaten their ability to treat any person who develops Ebola in the U.S. after coming from an infected region. It can take as long as 21 days to develop Ebola symptoms after exposure.  Related CDC: Ebola Cases Could Reach 1.4 Million VIDEO:  CDC: Ebola Cases Could Reach 1.4 Million Ebola death toll passes 2,800 but 'contained' in Senegal, Nigeria: WHO STORY:  Ebola death toll passes 2,800 but 'contained' in Senegal, Nigeria: WHO The issue created problems for Emory University Hospital in Atlanta, the first institution to care for Ebola patients here. As Emory was treating two U.S. missionaries who were evacuated from West Africa in August, their waste hauler, Stericycle, initially refused to handle it. Stericycle declined comment.  Ebola symptoms can include copious amounts of vomiting and diarrhoea, and nurses and doctors at Emory donned full hazmat suits to protect themselves. Bags of waste quickly began to pile up.  "At its peak, we were up to 40 bags a day of medical waste, which took a huge tax on our waste management system," Emory's Dr. Aneesh Mehta told colleagues at a medical meeting earlier this month.  Emory sent staff to Home Depot to buy as many 32-gallon rubber waste containers with lids that they could get their hands on. Emory kept the waste in a special containment area for six days until its Atlanta neighbor, the U.S. Centers for Disease Control and Prevention, helped broker an agreement with Stericycle.  While U.S. hospitals may be prepared clinically to care for a patient with Ebola, Emory's experience shows that logistically they are far from ready, biosafety experts said.  "Our waste management obstacles and the logistics we had to put in place were amazing," Patricia Olinger, director of environmental health and safety at Emory, said in an interview.  NOT IF, BUT WHEN  The worst Ebola outbreak on record is now projected to infect as many as 20,000 people in West Africa by November, while U.S. officials have said that number could rise above 550,000 by mid-January without an international intervention to contain its spread. Experts say it is only a matter of time before at least some infected patients are diagnosed in U.S. hospitals, most likely walking into the emergency department seeking treatment.  Already there have been several scares. As of Sept. 8, as many as 10 patients have been tested by U.S. hospitals for suspected Ebola cases, Dr. Barbara Knust, team leader for the CDC's Ebola response, said at a medical meeting this month. All tested negative.  The CDC has issued detailed guidelines on how hospitals can care for such patients, but their recommendations for handling Ebola waste differs from the U.S. Department of Transportation, which regulates the transportation of infectious waste.  CDC advises hospitals to place Ebola-infected items in leak-proof containers and discard them as they would other biohazards that fall into the category of "regulated medical waste." According to DOT guidelines, items in this category can't be in a form that can cause human harm. The DOT classifies Ebola as a Category A agent, or one that is potentially life-threatening.  DOT regulations say transporting Category A items requires special packaging and hazmat training.  CDC spokesman Tom Skinner said the agency isn't aware of any packaging that is approved for handling Ebola waste.  As a result, conventional waste management contractors believe they can't legally haul Ebola waste, said Thomas Metzger, communication director for the National Waste & Recycling Association trade group.  A TEMPORARY FIX  Part of Emory's solution was to bring in one of the university's large-capacity sterilizers called an autoclave, which uses pressurized steam to neutralize infectious agents, before handing the waste off to its disposal contractor for incineration.  Few hospitals have the ability to autoclave medical waste from Ebola patients on site.  "For this reason, it would be very difficult for a hospital to agree to care for Ebola cases - this desperately needs a fix," said Dr Jeffrey Duchin, chair of the Infectious Diseases Society of America's Public Health Committee.  Dr. Gavin Macgregor-Skinner, an expert on public health preparedness at Pennsylvania State University, said there's "no way in the world" that U.S. hospitals are ready to treat patients with highly infectious diseases like Ebola.  "Where they come undone every time is the management of their liquid and solid waste," said Macgregor-Skinner, who recently trained healthcare workers in Nigeria on behalf of the Elizabeth R. Griffin Research Foundation.  Skinner said the CDC is working with DOT to resolve the issue. He said the CDC views its disposal guidelines as appropriate, and that they have been proven to prevent infection in the handling of waste from HIV, hepatitis, and tuberculosis patients.  Joe Delcambre, a spokesman for DOT's Pipeline and Hazardous Materials Safety Administration, could not say whether requiring hospitals to first sterilize Ebola waste would resolve the issue for waste haulers. He did confirm that DOT is meeting with CDC.  Metzger said his members are also meeting with officials from the DOT, the CDC and the Environmental Protection Agency to sort out the issue.  

passage/grade  |  time: 2016-04-25 14:21:13 408078  |  # of fields: 2  |  passage_id: 5351  |  score: 2

doc/next  |  time: 2016-04-25 14:21:17 205053  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-063b3c2e0fb2ade0f07ecb0893366ac44c0ab63b210f4b3df995b5868e38c56b

doc/irrelevant  |  time: 2016-04-25 14:21:58 669813  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f09497a6a089ddc1b8965d992d67122ac947a51ef24d1a83ab90cf2d5880012f

doc/irrelevant  |  time: 2016-04-25 14:22:03 598420  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b45773ad881cc2ce9d03e0b855c52524ba454a2ef23f3bc160a51ce227c890cc

doc/irrelevant  |  time: 2016-04-25 14:22:21 472003  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d56f3c65a4d8a47731dd9f60da225abd753c574b81c5b05f808e3ac9fce9c711

doc/duplicate  |  time: 2016-04-25 14:22:29 904049  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-079056e19622bddf80364652e538a7847cd8a2f19308cbd01f60084fa9f97720

doc/irrelevant  |  time: 2016-04-25 14:22:54 139951  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b60093340d124a0021cc656138212c7ebefb890b102399eec38b766367ee3686

doc/duplicate  |  time: 2016-04-25 14:23:02 548303  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7c4baeafec00a23e4387a4bcc8d6562d24ab0313f11c562e465d6c8e17a070df

doc/duplicate  |  time: 2016-04-25 14:23:07 133943  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2ff461e540113f6d154f4cfd531d8a42832a463f4304e41eea301f2c18c9097d

doc/irrelevant  |  time: 2016-04-25 14:29:05 611192  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-bb660bbc1075b644f3efceee27d535685937d3bad12323322ee56b7c3e35f334

doc/irrelevant  |  time: 2016-04-25 14:33:08 325670  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4c39c2762cc04dc9e1d0d450bef08c2af2b707b84a94d08e6599d8272fc0cab8

doc/duplicate  |  time: 2016-04-25 14:33:17 778282  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4caa27f6b9d7dc160db6db0258a6967c9a86a28f7683a4abd7f613ad9ccf4e07

doc/duplicate  |  time: 2016-04-25 14:33:29 605177  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5f8c2554f46c3cd90157b57676e649c3e1965785c2ef6cf57b6544e8b7a3f6cd

passage/create  |  time: 2016-04-25 14:34:00 020331  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 258  |  subtopic_name: containment of ebola medical waste  |  passage_id: 5359  |  passage_name:  JEFFERSON CITY, Mo. (AP) _ Missouri Attorney General Chris Koster is seeking to block a sterilization company from handling any medical waste contaminated with Ebola at its St. Louis facility.  Koster said Friday he has asked a St. Louis Circuit judge to grant a temporary restraining order against Stericycle Inc. He says treating waste potentially infected with Ebola poses a threat to workers at the facility.  Calls from The Associated Press to Stericycle were not immediately returned Friday.  Stericycle received a federal permit earlier this month to remove waste from the Texas hospital and home where a man with Ebola virus stayed before dying.  Koster’s court filing also alleges that the St. Louis Stericycle violated the waste management law in the past by failing to properly test and operate its equipment or track infectious materials.  

passage/grade  |  time: 2016-04-25 14:34:02 408492  |  # of fields: 2  |  passage_id: 5359  |  score: 2

doc/next  |  time: 2016-04-25 14:34:05 993905  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-54a959d78d155cc93d59d05d197b0ca1371bbbe8ceba85b5bcafbce75fd30c5e

doc/duplicate  |  time: 2016-04-25 14:34:13 038489  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-046accc4432cb3b60369072f12e4c8d8ff97fe29a114bcf3cb85d7fc4571b2ce

doc/irrelevant  |  time: 2016-04-25 14:34:22 218894  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-821ae4f2028bd0f16a1839639ed3af3cdb3c2ac40950511fd18b470f02126cde

doc/irrelevant  |  time: 2016-04-25 14:34:42 283992  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b23ba77cedeeb975b82be34c668341abfe0b95450a12a79e0d94c9253cfff9da

doc/irrelevant  |  time: 2016-04-25 14:34:49 189551  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2ea29a96f8d30710fe7856ff6f4ae557ff88eb1da57ca330c55e5f448887469e

doc/irrelevant  |  time: 2016-04-25 14:34:58 850315  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ea4ef3f5131f0423abb49423eb9faac9c7b804e73eb437e66515ca90e1d5c82d

doc/irrelevant  |  time: 2016-04-25 14:35:12 746464  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a6368021416d0f304b469f2ff404e6e55e2246ef7f4c23491e36938e462e9b3e

doc/irrelevant  |  time: 2016-04-25 14:35:25 874722  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7dd401fe52aded4c8b3832b64fa006d8903dd5137905469e9a5456572dc0f9e6

doc/irrelevant  |  time: 2016-04-25 14:35:33 444081  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d92b32f7c8f2a3bdf3be76e0dceadd00ab5fbd7670e56835c8a149b9bb6210ff

doc/irrelevant  |  time: 2016-04-25 14:35:38 295795  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-456a02322ea0444108da61ae49bc59b15280650cde7b11e92468f9596b8a29b1

doc/irrelevant  |  time: 2016-04-25 14:35:48 289148  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7567fb0f212150d9c0dd8ceafe1f7ad970c72dabf3297e35d92ef91160b9d502

doc/irrelevant  |  time: 2016-04-25 14:35:55 610799  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3f212236831e54dda8d2a5d62aeda403c4428bd8d95026c2e8806d0169d0e4f6

doc/irrelevant  |  time: 2016-04-25 14:36:25 608445  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b5190622145195f6d0c5344a543aa7d61603901bd5fbf8485729a8bc5249d91e

doc/irrelevant  |  time: 2016-04-25 14:36:32 413491  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-56b0efab90b52843309aaba373493d9acd3f0f2daf94008fdeb635d5916590d3

doc/irrelevant  |  time: 2016-04-25 14:36:37 612033  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-72f7e1872f48a046de99b4d96313858cbe1a78bf4c0602452fded2f38b94eddd

doc/irrelevant  |  time: 2016-04-25 14:36:45 063703  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9e191030bf986219effc443c2a9fae155973f52019dc98cb9a8313774efbb9d2

passage/create  |  time: 2016-04-25 14:37:21 385920  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 260  |  subtopic_name: dangers of ebola medical waste  |  passage_id: 5365  |  passage_name:  Exclusive: U.S. nears solution for safe disposal of Ebola waste  By Daryl Shane De Mesa / Oct 02, 2014 01:56 AM EDT Tags : ebola, texas  Exclusive: U.S. nears solution for safe disposal of Ebola waste (Photo : Reuters/Mike Stone) A general view of Texas Health Presbyterian Hospital in Dallas, Texas October 1, 2014. (Reuters) - The United States is days away from settling the critical question of how hospitals should handle and dispose of medical waste from Ebola patients, a government official said on Wednesday.  Experts have warned that conflicting U.S. regulations over how such waste should be transported could make it very difficult for U.S. hospitals to safely care for patients with Ebola, a messy disease that causes diarrhea, vomiting and in some cases, bleeding from the eyes and ears.  Like Us on Facebook  Safely handling such waste presents a dual challenge for regulators, who want to both prevent the accidental spread of the deadly disease and avert any deliberate attempts to use it as a bioweapon.  Most U.S. hospitals are not equipped with incinerators or large sterilizers called autoclaves that could accommodate the large amounts of soiled linens, contaminated syringes and virus-spattered protective gear generated from the care of an Ebola patient, said Dr. Jeffrey Duchin, chair of the Infectious Diseases Society of America's Public Health Committee.  Sterilizing Ebola waste before it is transported is important not only to protect waste haulers but to guard against someone using the waste "for nefarious purposes," said Sean Kaufman, ‎president of Behavioral-Based Improvement Solutions, an Atlanta-based biosafety firm. "It's not just a safety issue," he said.  The matter, which was first reported by Reuters last month, may pose a significant challenge for Texas Health Presbyterian Hospital in Dallas, which is now treating the first Ebola patient to be diagnosed on U.S. soil.  Duchin said he is not aware of whether the hospital has its own incinerator or large autoclave, but if it does not, "they are going to have to find a temporary solution for managing infectious waste. That puts the hospital in a very difficult situation."  Cynthia Quarterman, administrator of the U.S. Department of Transportation's Pipeline and Hazardous Material Safety Administration, which oversees dangerous shipments, said her agency is "working on how we can clarify even further for hospitals, for the public, what the appropriate transportation should be."  Another official said that news could come within days.  The issue centers on guidance over handling Ebola-contaminated waste. The U.S. Centers for Disease Control and Prevention advises hospitals to treat items infected with the Ebola virus in leak-proof containers and discard them as they would other biohazards that fall into the category of "regulated medical waste."  But the DOT deems Ebola a Category A infectious agent, meaning it is capable of killing people and animals, and not "regulated medical waste," a category in which pathogens are not capable of causing harm.  Waste management contractors who normally handle hazardous hospital waste say they cannot legally haul the material, which leaves hospitals stuck without a way to dispose of the waste.  Already the issue has created problems. When Emory University Hospital in Atlanta was preparing to care for two U.S. missionaries infected with Ebola in West Africa in its high-security biocontainment unit, their waste hauler, Stericycle, initially refused to handle it.  Bags of Ebola waste quickly began piling up until the hospital worked out the issues with the help of the U.S. Centers for Disease Control and Prevention.  CDC spokesman Tom Skinner said the waste management problem has not been resolved yet, but he has said previously that the CDC is meeting with officials at the DOT to resolve the matter.  Duchin said he has heard that the discussion "has been elevated at the fed to decision makers who can solve the problem."  A DOT official said the CDC and DOT will likely issue joint guidance by next week.  (

passage/grade  |  time: 2016-04-25 14:37:24 105841  |  # of fields: 2  |  passage_id: 5365  |  score: 2

doc/next  |  time: 2016-04-25 14:37:26 070239  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d52f1376144b27d28749e0480901712299d88bafa9e04a8cfa01cafa5391eedc

doc/irrelevant  |  time: 2016-04-25 14:37:28 879604  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-573efd6396dada3cb91340afb588c2405e960762ee88110436f718f50bf3b9b2

doc/irrelevant  |  time: 2016-04-25 14:37:35 411824  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d07a17efda93708ff9a4e61726bc26f6d90e334a324834fb6e1a3127b8aa10a6

doc/irrelevant  |  time: 2016-04-25 14:37:40 910893  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-863341133ca55a733b13f8a779fc0fb0f2792972d90de07002db5efd98334af9

doc/irrelevant  |  time: 2016-04-25 14:37:46 905780  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-71f8bbfe73d3f0782b342b5734d49707ab58a1aa54934925dd1e5c823898d8d4

doc/irrelevant  |  time: 2016-04-25 14:37:52 279110  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f2d678ed1c6444eb1aff38bdcf7d5e655095e69ea01eef0d9ec4b64df0667cc3

doc/irrelevant  |  time: 2016-04-25 14:37:57 212822  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4bfc1fe364ec1961b73afcf2788182a2bee850fb5ac85f42d17d77c96539ebea

doc/irrelevant  |  time: 2016-04-25 14:38:03 853026  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1cc08ead8f515e55dad4897bccac64c66f280b67acae7da5a49b377bb405fb98

doc/irrelevant  |  time: 2016-04-25 14:38:12 351172  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2685c52d2898acb110685780d7144b46f636274e0e569f73852c6910cf7dcdbb

doc/irrelevant  |  time: 2016-04-25 14:38:16 069046  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-be8d6b8c844ce094c7e7388aee5af6ae3df23ba2e09b7fe5570b27b3301ccefe

doc/irrelevant  |  time: 2016-04-25 14:38:18 616430  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-913f3363db97c017248d6c89adb1c92f60e4ee3867b6b829068b48f6ff1411e9

doc/irrelevant  |  time: 2016-04-25 14:38:22 516473  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f5415af96c2c712770382b02810c5855228768467a8effeeceec34b1917460a8

doc/irrelevant  |  time: 2016-04-25 14:38:30 043318  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c59a6418c3eea466d036ba4f74adb71f013e005a32355e955a35c7290611e874

doc/irrelevant  |  time: 2016-04-25 14:38:36 173013  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-df5f32c9a89e04637945416680d382106006ce22bded7f976961e18c4fd06754

doc/irrelevant  |  time: 2016-04-25 14:38:44 781218  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7886aa61c96db162cd7636c0ca3dbbcb778b1f912f749f151dd09a67bc9ca605

doc/irrelevant  |  time: 2016-04-25 14:38:51 831156  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-459b45a883d91bd84924ae61b49a5bf0e967a208f2ad877b930b4c0986ca5da2

doc/irrelevant  |  time: 2016-04-25 14:38:59 119997  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3add008ed448f4ffa6f1ff958242a74f32452470895d0a3c9ddb7fe753960269

doc/irrelevant  |  time: 2016-04-25 14:39:03 943489  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-29fe93b4541ac1db7adc4dae34faf159c58f26e5970ac924cc99c01723f44517

doc/irrelevant  |  time: 2016-04-25 14:39:09 228033  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8dc1ec5b18f1206e8fc59098b52f3154013d8f71aad501069a2a5bf0613aa099

doc/irrelevant  |  time: 2016-04-25 14:39:15 965873  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-926046b81a793f71fdb246473c9102353b1cccc0bbbaf6f84685fa8777855ee7

doc/irrelevant  |  time: 2016-04-25 14:39:20 808462  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a1fd0136df1e95155ec1f4499545205639d0ad0c6bb5f74bba7cf76c60e3c45d

passage/create  |  time: 2016-04-25 14:39:44 927234  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5368  |  passage_name:  NEW ORLEANS - A Louisiana waste disposal facility says it will not accept the ashes generated when a Texas Ebola victim's belongings were incinerated, at least not until state officials agree that it would pose no threat to the public.  Chemical Waste Management Inc.-Lake Charles said in news release Monday that it is permitted to accept such material and that it poses no threat to the environment or human health.  But, the company says, "we do not want to make an already complicated situation, more complicated."  Louisiana Attorney General Buddy Caldwell says he plans to go to court to block the transport of the waste to the Calcasieu Parish facility.  Centers for Disease Control and Prevention Director Dr. Thomas Frieden said during a news conference that the virus is not considered to be hardy in the environment and that incineration and chemical treatment of the infected waste is sufficient to remove any risk.  

passage/grade  |  time: 2016-04-25 14:39:48 940335  |  # of fields: 2  |  passage_id: 5368  |  score: 2

findmore/blue  |  time: 2016-04-25 14:40:04 557380  |  # of fields: 3  |  topic_id: 417  |  subtopic_id: 260  |  subtopic_name: dangers of ebola medical waste

result_size: 0  |  num_tagged:  0

findmore/pink  |  time: 2016-04-25 14:40:16 408505  |  # of fields: 3  |  topic_id: 417  |  subtopic_id: 259  |  subtopic_name: cost of ebola medical waste

result_size: 240  |  num_tagged:  0
ebola-7286d9037b236b5d3e36d1672d4ccffbaf8cfe8091582499d40f38d3dcd8f630
ebola-a795f546ed849731fb26d6e6ea7b46b036259e16a6ff7d798ca59c9d6f022c77
ebola-bfaf99b5ee4a612211377426bf96b0b33ef26aabaaede1fe7fa83c85f3eb85e0
ebola-5139c0f38416c331db6ccd4471aa319f92006745c18042e3998967f94680c52c
ebola-fe2f91abd2025791e61f6bd89ac76efa0234db7f677f7ce0d8cc9ab837707870
ebola-75c760fdbc95e2373ed8f3acf38894e03a09e3f123bfb093fe6237deb84a50ac
ebola-8a137793d0e534753d54c5ed6c76ac01d256e99a5319b327d202be31a4fd2ee9
ebola-69011e54413760c68f0420f761250e215405fbbde8d065e86b810654644cd1e3
ebola-f6bb1c00a73395b1c017737211c7d6b0f0e111203e7762b997c1a3f89ad9ce33
ebola-28ce2d14db016b716e1cb8d79d5551f5ad9a7d33530917fc2b6186156d92f979
ebola-7a871e5cd556923f885b394c9ed96717f2d5d123cd159a3e5fe66c33df2afa21
ebola-27baaa72a1a0c3029ecdf971ca95eaa5986d4d36fca262799f3b8c773afe4b71
ebola-93076c9b608722e9577a15deb1401744ed4df8d5f3abf85566e3421f322067fe
ebola-36cd088960afca2307126d503240946d5bbde76597fbb4f3937c89284f1e05e9
ebola-ce4480ea74087e64fc8a14aba880661656b4b38ab20fb3f690318a0b6ce77e27
ebola-b9a303a7559372545ab0a60fef6d61b2fee4be4e6a004bdb6faf66e088214089
ebola-da92160ac855e9e0fdfc9a57747ce7838beab3b7c3530286e7301edd073ede41
ebola-394c2f7073ace9680c85f15df4f3159562bcc8de42afcea25e5c1fb68d4eeeb4
ebola-c6cbe5f6ab79226e35a712784d92e5fddbed161f57c2feb79c72a4de7b66b531
ebola-d8a50e3939faae780d6794944bd8057e1390cce04472b2fbb736230b40cacdfe
ebola-614a047656c39c33ce692777c05bcec1c2839e9cdd193f61edbf11782025eb4a
ebola-4c3694eb64c753568133b75a30831a11d3d623d3c1fa923cd709af3f2a1569bb
ebola-cebc99a2e90696a9a6df6237402733b973f8aa4720c88b4af9e642f9e24fd834
ebola-f21c29ff667a4dd1d0436f6cd82eae257b6d81f169d739aa027056c33e30ab9f
ebola-716e389405028ff09b10b49dc54ab0059409d32b7bbabbffbd8ee143f5b0825d
ebola-934b4861f731b80642c9db01265ececc76bf441198368c81625761a8bfe29f4f
ebola-201c4fc44a3be57b85393bed1e21665847bc868fb5f8ca94aa4b09c5b5c7d046
ebola-2834e8249bad50c1290b45b663c5dd797642691381123f2b1100b500528fd3e7
ebola-806ae93ca716efcc3b1e0993315414d8cae35a009ac5c8c0da1c20f0caf123cd
ebola-7e635a08e55b8c2d59e49ec5705edf887bb2908fc118e2fcbe692d8abd64a2a2
ebola-f1d643ce81a3b2330c2c62bcf55b2e9650a5cc9a4be96d4cf649d9f7e0767d3a
ebola-f73563f9b3c47ec1a080ef5b1e22f49fade4632639b3526f2232d3e8c7538433
ebola-bc72e2c64dfbad5654cef2bd75a8402a1e0cb3fa383ad1100d02ee775e019d81
ebola-5d6b6fa5851dff38f1e65763a09ff6b4c4191cf82cf6b4581cf58b510f47a90b
ebola-2c4f6307df38581d02e705c014340cf58ad9339c8a611c5eae8478397bee0d56
ebola-061f0529227d824507b979d7795ab8246e228e1577d889b6939d869a7257e094
ebola-c203b08b595e032ecafb20aa10bcd8053ca4bd478eab7f3fa96f5e7c857c5a39
ebola-1c4eae2db553f2ccf557e72b8287078de8b2bba34359bc37e6336417483b4848
ebola-64dfe4740567e0943ea8dd5a4fb64f8749e825af9a5018ea0a173eff5ec683d8
ebola-b20ad8859e0b6b8c3ed392a68dca6cdb4b00f89056e3eec2ba9f5bbb11cba2ce
ebola-c706111b47bfa76422f3dc6f3455bb92f9f28af1f3ff9db2f628da38bd02813a
ebola-07a8013f1ca6a5ec752f6bf6fe90a5097c1198181dd1ac4c667bba479c89086d
ebola-8c3e6b0a9c9c40b5ecc4d0a482d2317d084de4145268d5ee6cdaa5ddd41806d6
ebola-4fd5f45af6a7db6c5147f305600c09e62f3b41153791c2657c8b9874a4f9778a
ebola-8fd1e418a8ca0d5be7bda38c888ec5da5c3dcedcdaf396ec690a3b8420fbc935
ebola-3afeb455539c2bebf9f9002c9696a0e0e0ffc6ed28adb0ba434b1a3a3b2ac15a
ebola-b6f3147950ebf5064e56bdf404fbaf7ce5ea6217b5c163bb93a3b8f53294b9a7
ebola-fcf6a0aaf3205db46fb21dd48f32c04aada450b432dad3021ff92003be5002ea
ebola-cbdf3736364a9ccb69c97d157f98951f7f1046044a81331f531eb10d95082472
ebola-cceac81ea237477759d163e69f6266c95f16eea773a8a0203befaf0f486cedc5
ebola-7c4a80fd96e30640b4baac3455996b763bae6703a13f93e554372608364aa265
ebola-3d8a5a125a0803076e7d5d272f112ac6d6ed39654b5b04710fe0d731527cced5
ebola-1345fdd1c1bb2d328391125acfdc210c0382d09c05e6522aa5acb9fe1ca6d882
ebola-7bf3cc3b7c31d1ac8de884d54504cd28b29ec30a0bc59ab017cf478da0738c1c
ebola-bed026f4aa70b6281d7b3401126f305698049baf591d182e9e47e26038958c36
ebola-ef839e7cea095726ba0d9a32a58f36a03a83244197d410bd93d6d3d18e5bc566
ebola-637e1958e15bf23887a7858ff6eb3a31d0276f31bf3a3289cc515a811cc8c1b9
ebola-3b907745aeed7a09d14461395b12bda46c7b96e79b87b305d6933b154718b1e2
ebola-0aef6c12f76e1e056a499f7ba155315376c87f26a909f94add25fb467567eac7
ebola-63bb63e0cf7934001483254d41746a22bfdc1b99433902977a9535a4209b1d9a
ebola-fc7e5d9d572e266d5abadc8e2f16b25c7af1f7e850ed382b126515ab29462b07
ebola-781d0ea076c6508659bce25da766831fd73b658a42bbf25e7d20a7b8e0bfd389
ebola-01012ee56435c1283e749c52e7d549d9e41f58f844bb7aeea2241b6fbae1a746
ebola-ea06edf5bba74f985b9d0fefcaf841e234c4ab06583f8cbef9153d0121395fa5
ebola-bc77038dc46b4e2368ffcf61d9cd17a4d9ee8f7e6fcc2463f3abc6aea2390bd3
ebola-01bcccc24cd0575a4d05326dc1229100c7820407c8f3e7a21c41fa9772d2d9a5
ebola-96ecb2b172d4f20131b4ba459e4979f3143a91dbeab2bf94a11b9d1d64d69396
ebola-2a8e06876313aff7cf9afcbcc62a3872e04d7be67d73e839d202e6a7a06d96b3
ebola-949dd7ecc1b4242d08bade5f16bf691319ea865fba77d640e6383c5ba69cb504
ebola-31f355b584301ecfef17383bd7f78901703905d407c063efcbc32639dbd199f5
ebola-af747ba32f0818acb8ae9201560f453a6c41c7907701c981de49f58fa672773d
ebola-0a52052b1363dc0dbbdfccd0428c81df426cb8b4a68aab496643982ce364683d
ebola-893da3d01bb7ac59f87d1371ff1677f8dd07c8a922cdccc1ff69b17d0f762b2c
ebola-c4a305dc6e9e809201f3e155989ed4490ac383244040ace84d51000a28c232bf
ebola-352267b016fb4e4cb2ab6e53cf8c509e4caa10e5ada05f3c5b958ea093450cc0
ebola-2e3a3b5444b2f6c758af50ef7ee2ba3bfb11910e76a28f17ba8021ac8d13980c
ebola-d7dfe64f42bacc7aa4a8e98196cf1614f8a74683fe9729b731f5496e95f0a2db
ebola-6cae6c32b354d056eef4002ecdc45cc19284b527321f362c04d8ef7e6af4aa64
ebola-a05c9f8b309682ad26815e83ac79907d1a6bd8e402bc8e51eed8b960dff2d25a
ebola-4427b96c7048999df087e3f1694530e755e2ef129928c71346e326d11ebbfe1d
ebola-c27633c193e58fe22a6ba7246b442858c4ee059182787ac59a0873e2ba3d2f7d
ebola-03e535794896dc6c7872d37d6f16fd753af4a661f1a5594985c0083ef6ada7ab
ebola-4315f09f644a8167a1d799ff78b771ee00d72257320bafe5dd962dc9c67fcadf
ebola-5d84a4b9ae636ae0c3cd831c676df152455d067c2d076a59380e8ba926a53930
ebola-8b19886df8ba3f05ab0f000635ab6e897866af1d93a99d2c1e7477022e108497
ebola-3b9da9201cb7ac0e89dd9ca46ddc44913f640aa11821146aba0794c23a464b4a
ebola-35fbcd24fcdc0e39ef70fffbb2f802e825e2f39cf860b61487f5e3ab0e5d431c
ebola-6adca758784ee5637ead98c0986da8f48879a23ee92394af8b7680d6df419241
ebola-05bb4c33f61d6967783f73967bc78a6659fc1295014621e2063e15b5ae591deb
ebola-9adf54af4a5cf321e2c546624b1a4ea288e844adc839dc3fc21bf1b0fe335ffd
ebola-43209e855ad7f1ee8c096efee62e57f0daacf65db7966dde34112c8b7e1b42d6
ebola-f270900a1352816dd0260d5bfa857fce480b1ccf11c593c58bdcfc84b3dd7ef8
ebola-de189531dab85e0b9c6fcc8ac0d5aebc49d82d276a4d5f9e2cd25a8bf0e6a97d
ebola-7ef3e872acc7763c140540b9e9f09b9c55826c51fb6147b4cfc231aba3563cee
ebola-1360ce9bcafdb28a025786ccddc2790489b3352f4eae3a221f3e0a34ac18ee6f
ebola-b4805d443c12f70672a9496954ab11169def0ca935e41902ef5d759cae42c70e
ebola-5418cdd34e0f2fc7b14007159564541aa338a6779d2ffe292efe408e04d4bfb1
ebola-7b6069901e2ba2c98f458c67f7bfa1b02e49cfa87d83e0d04129d6bce712e657
ebola-b2bf7425711d4a14dc87f986a47d969c68a09815541931fb985cc7ec22c63850
ebola-ed9d2661c1d4a0d2fc921b8f8355894f9063a7772416190474ae82ab7bd27cd9
ebola-f4940e673a4971534b30c8b627d5792f99136192a6ee748e087cc1a9e5a62c31
ebola-0c1eaddaae4cc86197c7e9da46c6ca6393bccff0a6436338ee36668043298124
ebola-9099afe44970dd6019c009bfe3df689bbee7089615abdc3650aba56be110f826
ebola-95ec1cb4d09e496aac663141352ead4b7e08974ea28cec63f20984726146f051
ebola-2cfb1d461635edf2e84622cf8c31729329bff1306a2cc2e08661791bb5a35778
ebola-69bee4f176804c518df412f5d0d20c077fa3ced9e55965d0af2d8b9ca506a6a1
ebola-89c1f13f03148b1116ce7f4d9a40eda62f8aa32ebe8c10bb5f8573a73dd66a6d
ebola-fe56e826e47c170fb31195d8a457d28811b63e55beba3bc41d071af0261ba195
ebola-0fd6ebf0fa271d0e65b3f26767c93fae239a8a8ce0ea6613dda11122e9bcf072
ebola-ec1db4d04b500b97c2d7dc6d610f19716f23d98b7bdc3f6453f499f28c379d76
ebola-a12c77c62bcfa533b12ff31e1215c3573c2a1638d4188c3faccbd32277bf9ba0
ebola-cbe3d5acb2b58a536cb21cb5d236c62db635e9c2422809dc113c681288b56662
ebola-721d422868a89436dd92810147834e5d849732a8fef80910a612bc2fcc8d4ddc
ebola-bff2ee2ffe13ef049fc1616572de70180c0744380d4d9a0ef27be2b4eb1fca7d
ebola-a20aede5a408cb0b17d9007d5751df71c532cdabd0a14d146ee7d11939b57fb4
ebola-928d281ca5f90c3d2961d9fb227eb322c945a1d71456dd726f224c4a422500df
ebola-5abdb1ea28ee3cec01ad9457d2ad03d78c258a6b4d63425c11c0277f3e96ae48
ebola-a0de4f0d73c92cb11519ba37b2b2810a6b4fd4d7bbd5bc7f2f95515bd381ab0c
ebola-f783c4e513344a5217938133fc665e3c361c1b3dcdfbbc7c0ce50a907ca9be56
ebola-c299298686a7fc537682b3c84d16f68f0a7d8ba8c57619cb3b0a2d05d862687c
ebola-74823ac004dafde1522ee251906e90d5e1a8c7b62d7b812c78f2818d198b8fa5
ebola-578e782b2b88e77ba6dc4d9a52e449ba8735f4f724d9826b0d418c297aaa2778
ebola-f1df9f133f0f0275dbdbb56a6fb8172a3306851d3789d33354d41930112ec1e4
ebola-823f9550deec3d3c11db179d68ac83ad087db8642a22635267d9dee1eb99b720
ebola-4b8506862f324f3cfd5a04235860eac6fbdc2b31978e7b4aaed59deb31591ab8
ebola-4770c4fe9e9453b5a0bc74e4c09917cde565d894ea0aabcad6a31687a50661c8
ebola-6ef708943c9b7cd8adb9ba957e64db4972de1cd829b3f2749a7a08ab18ddbefb
ebola-41a1b81b917df195ce4aab20b59dde6937a0f1824cac7e19ac7055fcf23cec08
ebola-b68387be76d9f92ea727c43fa0867e046680222511af04664067a5f82126a2e6
ebola-a5dc703582419bf4b77f96bcd548ec705796eeaa062c0bfb08369e4e2feddacf
ebola-36d962cdf849e1e7a05141e78f015e48ab76107b8cf2bd6c67dc57a2270e589a
ebola-58ab4b3a7127584393a126f5d5f7c86c2168a411d27129024aad9d3d54103e28
ebola-884013e21e55103219eb7dcdba1d7e00fbd46eeaa244c55fc7a01ff704ef6b42
ebola-52e853292b83b75b28c54ff04d807523f26a5a79d9b20ea6dba216cd7a845c9a
ebola-6e21bd735a8c1c3c8292434b38520a72006d997f4dadd0563ed4fa34a0a25e16
ebola-390dc7e263b45052ffecf23b298daf573f1cb22fa67dd3ca601fe9a483a4b6f8
ebola-ab61ea287a2cc6417325ac942c046a9e66da18bea21e9d21baaa8f455c024e9c
ebola-137959e5ffe2a02b04e102a6709fd83c8f4a65494df208a8a7bcbd053e841d5b
ebola-eac0b487737758a7dc13d8541832c678faac52eb39a1cd214329998ea75bac62
ebola-25ffb0348c3c16994d56f1bf03702a4a9d1fde7d43ade957e22e25de3ee5e24a
ebola-411579fc552eb5da727e325df431cede9bf60e5fc0bed5b89487b04ff70e42cf
ebola-f594ca2a9233365d2ce76dc91767b33f63acd1b859401fb277a961094b8feac8
ebola-f6a8a29a19b72d2b2afe456c4991e5b9649e6d491cf9b3b9620e6d3b8733ccd1
ebola-de9f530b243cfadf65db80bbc8cef95d20f7a0665430a1e20c9b517c38f87cf7
ebola-e96de687bb24003e17d207d90637d03f96948203943d70a9534306467ce7f150
ebola-853be5f1f204daac34f2b2850b039e2967a209b235c74d54a2ae5b33ab5ee608
ebola-953dbe194e44ba428cb67241f13af50baec6bd5c7ac734ef3acb86213e65e85e
ebola-66da9039fca76a05c36f2c405f2dcd467ae1f8191a89937ec4b3f2e7101cafc0
ebola-4c7931246b95670147a16caaad2a2f15f2a9e5c00d0160c7768692de16028f30
ebola-d4a276db4f6a95d6d8e5a09297e6bf6c252e6e781aeede27f2cbdddbc57b7de6
ebola-73c6b25c50340cf165c7e848f4412a6851b58909141c1f129bcbb5389f30bba5
ebola-ab6fbb499f4ffe4b1962dccb8ec402b2f39bc0fb96b0dbe2e58d1edf1fa214fa
ebola-eb657bb1e30d8bd36060364d99ea29597986f705415d78da805b7626bf736686
ebola-64340ad20183253cbc8309cc2847e0310d548ad515322269f16b8d94db73232a
ebola-f8dceecf1f2fe05fa2f7399fe92fdd63fee24b68097031a775132a8b0347127f
ebola-211a0a70cfecac375e6a9f306cf3862fc5fe64d390561207aa875e6fe5b73a30
ebola-ee0f28fadf2dc8616312d7ffde8ae72dbfe2f1c8a226b643801c1b3f3bc81e9d
ebola-d22f820b2561ffa6fbc0e62f6cc0494c8eb4718bc7a312c024e93c18f951bb68
ebola-18ecef40ee8c1af12326054bfaefe0801be253cf683990a467f5db901ef3db04
ebola-5add163b9c62faf9fe7e01c2f36dfc52e69c990eaf3c6a7efcbf01159a7b37b7
ebola-8f50ddf4440860761b0c9d088b8998e767977911bc29e385af8d882df959804c
ebola-aa5aaccb2c9a15574b03e6f7ebb15a560edd0a7f639eab94904b1679daf71a2a
ebola-48ca6eaafd68e387db19abae639be349ebc46a82975eee8b1501cac6b189c61d
ebola-dc9d13b7af32381e56de4c43d19b8366c536cec63f2be000577bb4dffb0f9218
ebola-2aa08e60f0955410e7ca062f4e9d075d28ae016562b8332d319e9ce048b3035a
ebola-839f89a150dce30e1a9aaf999515f64bfef372699ef86bf97a8175c5d1e7427b
ebola-5d9fa49e7fdd4072afd9a25f2b97ec67000ffc9bcefb7adfcc94b7d2722fc19a
ebola-a50c14b63b6fbe4d83adf3f616dbe147cc533d6fe607009985d079d4b8c2c707
ebola-98b8d69a7930967b8be88b47ed39061d6eafa45889bd45d4f17cd00522570075
ebola-9de6c1e7ae3dc7120204377c5b17f5668a98ffc2bf93e461d0518004b9c2fdf2
ebola-a9a8a6d0459c55905f5cc6631422f5163e666cbd48c2c31371787459d3b9907d
ebola-714c2dd715d6553507322a0c2a69a4086e2e4d12be6b961ea1d96b26c2b6557e
ebola-359810fa0dd436bd1a2906a121e29e78c925e600d4b2ac4fdf8666b6f2b9504c
ebola-0797cea78992df76cf2a7195fb77845241769e74e227fe305059533617b012df
ebola-561c2d1979eaec7ab23fb691d4498f96399c5381acf71ea19b102a71449dd5b1
ebola-7184b3363d4e3711fa13f5505da3b3d1e039e2586c9dd4093b6c9914a662abfe
ebola-f4d1d6423e761534976d9201fc0f46e9c3f6da675e24fbf64ab10cce7bfb7cf2
ebola-bcdd8ef1cd7192ba1ee6dc57b6a84fa6da2d30cec75cdde2e608e780eb0fc52f
ebola-656451c302e37be99b748d2df3c455f448e028e3f4fdb7ebbda0a4a9e549fac9
ebola-9cf6a71b382531a6309d0c2225fb44d12a9408bdb079388c713f6efaff3e9f54
ebola-7a61c070710acec13bf7cff7c59c575ab33044fbebcb767d76bb10361750219c
ebola-6f21b40979d7d8647f17e72a584c8d254a93c7ade090a29180e877bdf22d6f2a
ebola-cbd3a6797e67c68d2c20b848b74a65d7bc34b801339c5c97f0add8ea4f43cb60
ebola-9330a73369d4444733103b99e4531c2f15843728ffc40dbfd47ca72d5b62ead3
ebola-bc4ccc9e5d2359ba8faccf7ec693c5ff9367dc59832e9c855fb48316ad9cecb2
ebola-848debfd49cf98b2d58354df95a0a2deb2e2677798315002ece4f51b63b7c941
ebola-3c7e03ec950d338a24203d26d1953af564b63dc7206a3f4968efa3e4e67ce5fc
ebola-32065244f93ffac8f67726d7654122a76057e6990d8b6452eb6d8b383b7bbae8
ebola-cca153776388d04f34055020a0edb6ce65e9893e93fe2335748f9eaa48c170fc
ebola-28c1e4030e5f95c832a03da6917dee1db3f445f658572f4888060289018320be
ebola-4afbd6eb5c23b033d4bcfd2851548a56c42f5f8b96e4124fc975b8ea77636297
ebola-873c7bd99fbbab6d2f4a2aaa60b7e0af876c5df0f8a5ea6ce1dd1cb9d92e6238
ebola-8b4410c9e8b1ec65916cf02e48a177363ece0f00143e250795c3fa5e0b02c31f
ebola-698a84a2ab7b385f07025193553fbd27b655c146b9b9904850e9961b6b282421
ebola-acf7cf2f3a5ad7a88062fa6fcce3f4b10623eecf1a4ddc24387c6d469507ec04
ebola-66e1423267d8656490b560dfe92f6f4c0a46fa04591e7dc49158f6b2bcae57ba
ebola-febd914e1973dbbb7bdd5ddf365e6c0fa23bc8fe87a12290bf17ccf56de4d985
ebola-f0ff21c51f1ce1523312d56ee35740b970599d7c55db8bd7f357e8149efcdb8f
ebola-59afff12c7d30b2ef57c3af0b5bfd66f30dedbebfeb226eef0c8f23aea3e2635
ebola-551ac15a047d81a3982fc229bfaeded83f6fbd1695db88d7bb730ca9d6108f22
ebola-22cb77eb8899341cf426afb4463ee92e1946d45bbf3cd7e281c35d7d85ac8c9e
ebola-5b0a1416ceecbc92a93dcb7e300dcd5e95f5447c2b336c90178ae721043a82e4
ebola-2f2e35edac2d4f1481d14c018fd3724ce63f5d1596b58e749989e49537fa6ce0
ebola-a6510be88a1afc4225f4c225f5a1e49dac2c4d7f9175281f7c9cef7b05d42777
ebola-34b7aed0e8bbfd2d7d9283e46a44591da00b30b09c693d109b51fe98b46ba268
ebola-7fc5584f337cf48371461f744349095d6e4ce9441376fabf2b9bcd9aeb3ab1cc
ebola-6aa95604062e52ae3b8b6b3bba003bd7dfaebef7e2961f10501fc39331bd3f88
ebola-1f55b4e7ce78e5591aee11364314ef8a3478cfbc9cf1aba657aade2d3b56e79c
ebola-3c4306187d9f5bdc1ed23db255db3115c6971d8850891f48b460ff2362f0f3ce
ebola-3318f39c3eb17ac61dbf4a48693bb6ed65e7e949a5b677ca069d25da2d7042b9
ebola-178acbf9cf03dfb7fb59dcc312f7b7857f748b76fe4d04ee8a8b2724b2e4008b
ebola-8386b261ea3232f65b5a89753d2233dfb86beb0e85664af61e28ab51194a91be
ebola-3fb7afb4ab4a4f551b4844092b19691eed1fc5d3f8352343f17d5b415b61f4a1
ebola-66f8686feff255b08a4aef7cb048eb0d182bf251f77cc71b9c9a7f00dbe1dac3
ebola-60b25b3733d9748722f658498b0a7c7838fa332eab0390b3318ca2ef865fb0e8
ebola-ae08d614cc0b4fcc1657705da8d065e326cad31d13a30e2fc0f6cd5854eaa6ae
ebola-3749e6693a956637f98269c703f89e47c6d099aed0f314957cb70749c1af4002
ebola-3380525b26529e44c612304ddfe1aa46b9852727fb76ecee475f629c99471ea4
ebola-219b6a6aeef9095499446bba4bdd97f497b037a9711d75d770fa145b7065ee95
ebola-fb7391993c36876fd011634aa63874f1a00e40a70c623a67be6639ddb6e58b1d
ebola-7e3c643f619c8e648b470b81650b44ebb47b3fdd697140573b8656d5a6f70398
ebola-3ea79ba72d252cb1fa9c4a95ad55f30a2a2e7622062d78116245c1ce5f827197
ebola-bcad6dc2c74e9846eef79aed7fc67d6f47f1997215a96b87a5ad72c7a05c5a9d
ebola-40f59532613383fac44ab1d3e6315bce9413b63385a83c7875548f5cd75430fc
ebola-aff4bf906cddedfffce7363199b33727595fa1efba45d68dbc2b5d5bbab7f9e7
ebola-09cac3316e9097aeeee37ff0ed65d9abb5adb4c8957655bfc30c08c492c42815
ebola-cf5c192c74a99df41cd6f26958eed79e425521621ec2ed5c4a036b7641893050
ebola-61a65749907d3f7046a36694d693008731eb535c280df3617c92fb1194e9a0ed
ebola-accceb93df4f05b1587a3b661601f6b4c129cf569ac562f44e1ca5dfe9103a1a
ebola-d0899b9abc07983ff3f5223e9be6f644c46fa9aa8050f2cae2e72b6629482f8a
ebola-d4961613f3e80da0d3a24e388b2e3934bef1f35acf61702e769b30c67009e3fb
ebola-f42b7095da0ddd245f52f52e126454365bf9296b25418447a1f5b45cb31a11e0
ebola-adbc9de84aac53c56f4a7218f25e3d2b94280ef936aa73274fba6979baa0570f
ebola-f5cf2539ef16f182833c083ca20013873710f6ff7a4f80443e119b30484cda22
ebola-508f20f62b43991966f6b5d7430a6f9e3d14866b757ebda9e850b1a1f6c16055
ebola-6d5ad6487a858bce2b215eecc1fa15ec3588e1d985061a79cd2deb19a1dce744
ebola-e80c99cf4dc1e5e2b575d7f410f8db7a31178310c1c7fb332aca56759e7e21a5
ebola-8dc7167c5029eb7a2fdc0706ca0a4797c462ea2f8bee34debe85bdaedb1edf16
ebola-e1c340a3ebea00da4e1882b0462bf6a7e2506d28a2275629ad004bee06257d1d
ebola-417f5572e5c6e0184c1ca9e26ef0a0ae3b58689b7fccb2d0c6093d1efd7fad50

list/click  |  time: 2016-04-25 14:40:42 505000  |  # of fields: 4  |  topic_id: 417  |  docno: ebola-7286d9037b236b5d3e36d1672d4ccffbaf8cfe8091582499d40f38d3dcd8f630  |  listsource: pink_findmore

highlight  |  time: 2016-04-25 14:40  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-7286d9037b236b5d3e36d1672d4ccffbaf8cfe8091582499d40f38d3dcd8f630  |  highlight_string: ebola, medical waste, cost, containment, disposal

doc/irrelevant  |  time: 2016-04-25 14:45:50 684518  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7286d9037b236b5d3e36d1672d4ccffbaf8cfe8091582499d40f38d3dcd8f630

doc/irrelevant  |  time: 2016-04-25 14:46:13 453717  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a795f546ed849731fb26d6e6ea7b46b036259e16a6ff7d798ca59c9d6f022c77

doc/irrelevant  |  time: 2016-04-25 14:46:43 245592  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-bfaf99b5ee4a612211377426bf96b0b33ef26aabaaede1fe7fa83c85f3eb85e0

doc/irrelevant  |  time: 2016-04-25 14:47:18 109418  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5139c0f38416c331db6ccd4471aa319f92006745c18042e3998967f94680c52c

doc/irrelevant  |  time: 2016-04-25 14:47:50 800960  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fe2f91abd2025791e61f6bd89ac76efa0234db7f677f7ce0d8cc9ab837707870

doc/irrelevant  |  time: 2016-04-25 14:47:59 497261  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-75c760fdbc95e2373ed8f3acf38894e03a09e3f123bfb093fe6237deb84a50ac

doc/irrelevant  |  time: 2016-04-25 14:48:08 683181  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8a137793d0e534753d54c5ed6c76ac01d256e99a5319b327d202be31a4fd2ee9

doc/irrelevant  |  time: 2016-04-25 14:48:24 974232  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-69011e54413760c68f0420f761250e215405fbbde8d065e86b810654644cd1e3

doc/irrelevant  |  time: 2016-04-25 14:48:38 593252  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f6bb1c00a73395b1c017737211c7d6b0f0e111203e7762b997c1a3f89ad9ce33

doc/irrelevant  |  time: 2016-04-25 14:48:49 424032  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-28ce2d14db016b716e1cb8d79d5551f5ad9a7d33530917fc2b6186156d92f979

doc/irrelevant  |  time: 2016-04-25 14:48:57 370109  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7a871e5cd556923f885b394c9ed96717f2d5d123cd159a3e5fe66c33df2afa21

doc/irrelevant  |  time: 2016-04-25 14:49:10 959660  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-27baaa72a1a0c3029ecdf971ca95eaa5986d4d36fca262799f3b8c773afe4b71

doc/irrelevant  |  time: 2016-04-25 14:53:00 519934  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-93076c9b608722e9577a15deb1401744ed4df8d5f3abf85566e3421f322067fe

doc/irrelevant  |  time: 2016-04-25 14:53:19 156441  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-36cd088960afca2307126d503240946d5bbde76597fbb4f3937c89284f1e05e9

doc/irrelevant  |  time: 2016-04-25 14:53:31 898816  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ce4480ea74087e64fc8a14aba880661656b4b38ab20fb3f690318a0b6ce77e27

doc/irrelevant  |  time: 2016-04-25 14:53:41 469626  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b9a303a7559372545ab0a60fef6d61b2fee4be4e6a004bdb6faf66e088214089

doc/irrelevant  |  time: 2016-04-25 14:53:51 103817  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-da92160ac855e9e0fdfc9a57747ce7838beab3b7c3530286e7301edd073ede41

login  |  time: 2016-04-26 08:18:32 344649

doc/irrelevant  |  time: 2016-04-26 08:18:44 403539  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-394c2f7073ace9680c85f15df4f3159562bcc8de42afcea25e5c1fb68d4eeeb4

highlight  |  time: 2016-04-26 08:19  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-c6cbe5f6ab79226e35a712784d92e5fddbed161f57c2feb79c72a4de7b66b531  |  highlight_string: ebola, medical waste, cost, containment

highlight  |  time: 2016-04-26 08:19  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-c6cbe5f6ab79226e35a712784d92e5fddbed161f57c2feb79c72a4de7b66b531  |  highlight_string: ebola, medical waste, cost, containment

doc/irrelevant  |  time: 2016-04-26 08:19:44 479296  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c6cbe5f6ab79226e35a712784d92e5fddbed161f57c2feb79c72a4de7b66b531

doc/irrelevant  |  time: 2016-04-26 08:47:51 965079  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d8a50e3939faae780d6794944bd8057e1390cce04472b2fbb736230b40cacdfe

doc/irrelevant  |  time: 2016-04-26 08:47:59 879829  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-614a047656c39c33ce692777c05bcec1c2839e9cdd193f61edbf11782025eb4a

doc/irrelevant  |  time: 2016-04-26 08:48:03 394086  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4c3694eb64c753568133b75a30831a11d3d623d3c1fa923cd709af3f2a1569bb

doc/irrelevant  |  time: 2016-04-26 08:48:13 466154  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-cebc99a2e90696a9a6df6237402733b973f8aa4720c88b4af9e642f9e24fd834

doc/irrelevant  |  time: 2016-04-26 08:59:48 292989  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f21c29ff667a4dd1d0436f6cd82eae257b6d81f169d739aa027056c33e30ab9f

doc/irrelevant  |  time: 2016-04-26 09:02:56 187352  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-716e389405028ff09b10b49dc54ab0059409d32b7bbabbffbd8ee143f5b0825d

doc/irrelevant  |  time: 2016-04-26 09:04:13 192750  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-934b4861f731b80642c9db01265ececc76bf441198368c81625761a8bfe29f4f

doc/irrelevant  |  time: 2016-04-26 09:04:16 401118  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-201c4fc44a3be57b85393bed1e21665847bc868fb5f8ca94aa4b09c5b5c7d046

passage/create  |  time: 2016-04-26 09:05:35 200790  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5508  |  passage_name:  Background  Given the systems currently in place to identify people with Ebola virus disease (EVD), any Ebola-related deaths in the United States would likely occur within a hospital setting. The Ebola virus can be detected throughout the bodies of patients who die of the disease. Ebola can be transmitted in postmortem care settings by laceration and puncture with contaminated instruments used during postmortem care, through direct handling of human remains without recommended PPE, and through splashes of blood or other body fluids such as urine, saliva, feces, or vomit to unprotected mucosa such as eyes, nose, or mouth during postmortem care.  This guidance is based on current knowledge of Ebola. Check CDCâs Ebola website frequently for updated information. Guidance for specific occupational groups that may have risks of exposure to Ebola is also available on the National Institute for Occupational Safety and Health (NIOSH) Ebola website and the Occupational Safety and Health Administration (OSHA) Ebola website.  In addition to federal laws and guidelines that apply to mortuary workers, mortuary practices and workers may also be subject to a variety of state, tribal, territorial, and local regulations. Consult officials or licensed attorneys in your jurisdiction for additional guidance on laws that affect mortuary practices. CDC recommends close collaboration with public health officials in the state or local jurisdiction, as well as with the licensed funeral director who has agreed to accept the bagged remains, to safely implement each step of the process.  Key Points  Ebola virus can be transmitted in postmortem care settings through unsafe handling of remains. Ensure that only personnel trained in handling infected human remains and wearing recommended PPE touch or move any remains that contain Ebola virus. Do not wash or clean the body. Do not embalm the body. Do not perform an autopsy. If an autopsy is necessary, consult the state health department and CDC regarding necessary precautions. Do not remove any inserted medical equipment from the body such as intravenous (IV) lines, endotracheal or other tubing, or implanted electronic medical devices. Cremate the body. If cremation cannot be done because of safety concerns, the body should be buried in a standard metal casket or other comparable burial method. Definitions for Terms Used in this Guidance  If a hospital has a patient with EVD, hot and cold safety zones should already be established. Thus, hospitals with an Ebola-related death should be familiar with the following terminology.  Hot zone â contaminated area that includes the patient treatment room. Only workers wearing PPE that conforms to CDCâs Guidance on Personal Protective Equipment for Healthcare Workers are allowed to be in this area. Cold zone â noncontaminated area used for planning and staging. Only workers who have not entered the hot zone or who have properly doffed their PPE after being in the hot zone are permitted in the cold zone. Workers put on clean PPE in the cold zone under the direction of a trained observer. Cremation â the act of reducing human remains to ash by intense heat. Leakproof bag â a body bag that is puncture-resistant and sealed in a manner to contain all contents and prevent leakage of fluids during handling, transport, or shipping. Equipment List  The following equipment should be used in the hot zone:  Hospital gurney containing three pre-opened cremation-compatible body bags with the following specifications: First bag (top layer on gurney): vinyl or other chlorine-free material, minimum of 6 mil thickness (152 micrometers). To prevent any leakage of fluids, all seams should be factory heat-sealed or welded, not sewn, and the zipper should be on top. Second bag (middle layer on gurney): chlorine-free material impervious to fluids that can be heat-sealed around the body to form a leakproof body bag. This bag should be specifically designed for the containment and transport of infectious bodies. The material should be precut to provide sufficient material to envelop the body and first bag. Third bag (bottom layer on gurney): laminated vinyl or other chlorine-free material, minimum of 18 mil thickness (457 micrometers) with handles that are not sewn on, such as riveted handles reinforced with handle straps that run under the pouch. To prevent any leakage of fluids, all seams should be factory heat-sealed or welded, not sewn, and the zipper should be on top. Thermal sealer for sealing the second bag PPE recommended for personnel entering the room of a patient with EVD as described in CDCâs Guidance on Personal Protective Equipment for Healthcare Workers Scissors for cutting excess material from heat-sealed bag Camera or mobile phone capable of securely transferring photographs electronically via Wi-Fi, e-mail, or text message U.S. Environmental Protection Agency (EPA)-registered hospital disinfectant and wipes with a label-claim for use against a nonenveloped virus Alcohol-based hand rub (ABHR) Red biohazard bag for medical waste Zip tie for locking the third bag shut at the zipper Enlarged copy of the Mortuary Guidance Job Aid: Postmortem Preparation in a Hospital Room [PDF - 1 page] and tape for posting these step-by-step guidelines to a wall in the hot zone The following equipment should be used in the cold zone:  Hospital gurney or mortuary stretcher Adhesive-backed pouch that is applied to the decontaminated body bag Single-use (disposable) gloves with extended cuffs and a long-sleeved disposable gown Biohazard spill kit, including: recommended PPE, absorbent materials such as paper towels, kitty litter or a solidifier, an EPA-registered hospital disinfectant, and biohazard waste bags Infectious substance labels that are applied to the decontaminated body bag. These include the following: Black and white âinfectious substanceâ label United Nations (UN) 2814 label âDo not openâ label Name and phone number of the hospital administrator

passage/grade  |  time: 2016-04-26 09:05:39 037878  |  # of fields: 2  |  passage_id: 5508  |  score: 2

doc/next  |  time: 2016-04-26 09:05:41 058779  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2834e8249bad50c1290b45b663c5dd797642691381123f2b1100b500528fd3e7

highlight  |  time: 2016-04-26 09:13  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-806ae93ca716efcc3b1e0993315414d8cae35a009ac5c8c0da1c20f0caf123cd  |  highlight_string: ebola, cost, containment, medical waste, dangers

doc/duplicate  |  time: 2016-04-26 11:03:22 697455  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-806ae93ca716efcc3b1e0993315414d8cae35a009ac5c8c0da1c20f0caf123cd

doc/irrelevant  |  time: 2016-04-26 11:03:47 451283  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7e635a08e55b8c2d59e49ec5705edf887bb2908fc118e2fcbe692d8abd64a2a2

doc/irrelevant  |  time: 2016-04-26 11:04:12 771322  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f1d643ce81a3b2330c2c62bcf55b2e9650a5cc9a4be96d4cf649d9f7e0767d3a

doc/irrelevant  |  time: 2016-04-26 11:04:21 856256  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f73563f9b3c47ec1a080ef5b1e22f49fade4632639b3526f2232d3e8c7538433

doc/irrelevant  |  time: 2016-04-26 11:04:33 258935  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-bc72e2c64dfbad5654cef2bd75a8402a1e0cb3fa383ad1100d02ee775e019d81

doc/irrelevant  |  time: 2016-04-26 11:04:54 591328  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5d6b6fa5851dff38f1e65763a09ff6b4c4191cf82cf6b4581cf58b510f47a90b

doc/irrelevant  |  time: 2016-04-26 11:04:58 913345  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2c4f6307df38581d02e705c014340cf58ad9339c8a611c5eae8478397bee0d56

doc/irrelevant  |  time: 2016-04-26 11:05:08 008659  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-061f0529227d824507b979d7795ab8246e228e1577d889b6939d869a7257e094

doc/irrelevant  |  time: 2016-04-26 11:05:34 397359  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c203b08b595e032ecafb20aa10bcd8053ca4bd478eab7f3fa96f5e7c857c5a39

doc/irrelevant  |  time: 2016-04-26 11:05:40 658245  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1c4eae2db553f2ccf557e72b8287078de8b2bba34359bc37e6336417483b4848

doc/irrelevant  |  time: 2016-04-26 11:05:46 228112  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-64dfe4740567e0943ea8dd5a4fb64f8749e825af9a5018ea0a173eff5ec683d8

doc/irrelevant  |  time: 2016-04-26 11:05:54 869281  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b20ad8859e0b6b8c3ed392a68dca6cdb4b00f89056e3eec2ba9f5bbb11cba2ce

passage/create  |  time: 2016-04-26 11:20:00 445506  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5611  |  passage_name:  Federal Guidelines Prevent Disposal of Ebola Waste  Chris Carrington  Ready Nutrition   tagreuters-com2014binary_lynxmpea7l0h9-filedimage169-300x179  Many hospitals may not be aware of the Federal guidelinesÂ that prevent waste disposal contractors removing any waste products that may be contaminated with Ebola. Experts fear this could cause huge problems should Ebola get to the United States.  Emory University Hospital in Atlanta treated both the US missionaries that were infected with Ebola. Stericycle, their contracted waste removal company refused to remove anything that had been in contact with the patients, citing Federal regulations.  With up to 40 bags of Ebola contaminated clinical waste a day being produced, staff at Emory had to use their own initiative to deal with the issue.  Emory Hospital staff were despatched to Home Depot and instructed to buy as many 32 gallon rubber waste barrels with lids as they could get their hands on. They then packed the waste into the barrels and kept them in a containment area for SIX DAYS until the problem was resolved.  âOur waste management obstacles and the logistics we had to put in place were amazing,â Patricia Olinger, director of environmental health and safety at Emory, said in an interview.  The CDC stepped in and eventually Stericycle removed the waste. The issue has occurredÂ because of Department of Transport rules on how Category A clinical waste can be transported and who it can be transported by.  Category A waste requires special packaging and those moving the waste, and transporting it has to have full Hazmat training. The CDC state there is no recommended packaging that is no packaging that is currently approved for transporting Ebola waste and this is what lead to Stericycle refusing to handle the waste materials.  The Emory University Hospital was able to sterilize all the waste in a massive autoclave before handing it over to Stericycle for incineration…but very few hospitals have the ability to do this on site, which leads back to the transportation issues.  âFor this reason, it would be very difficult for a hospital to agree to care for Ebola cases â this desperately needs a fix,â said Dr Jeffrey Duchin, chair of the Infectious Diseases Society of Americaâs Public Health Committee.  Dr Gavin Macgregor-Skinner, an expert on public health preparedness at Pennsylvania State University, said thereâs âno way in the worldâ that US hospitals are ready to treat patients with highly infectious diseases like Ebola.Â (my emphasis)  The Department of Â Transport and The National Waste Recycling Association are in talks with the CDC in an attempt to resolve the situation but in the meantime both groups insist they are bound by the regulations.  If two patients generate 40 bags a day of infectious waste you can imagine what 20 patients would generate, or 200…  Learn how to better prepare for pandemicsÂ and other short and long term disasters. Or, purchase bestsellerÂ The Prepper’s BlueprintÂ to have pertinent prepper information at your fingertips when you need it the most.  

passage/grade  |  time: 2016-04-26 11:20:02 769557  |  # of fields: 2  |  passage_id: 5611  |  score: 2

doc/next  |  time: 2016-04-26 11:20:05 104720  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c706111b47bfa76422f3dc6f3455bb92f9f28af1f3ff9db2f628da38bd02813a

doc/irrelevant  |  time: 2016-04-26 11:20:13 538086  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-07a8013f1ca6a5ec752f6bf6fe90a5097c1198181dd1ac4c667bba479c89086d

doc/irrelevant  |  time: 2016-04-26 11:23:53 348742  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8c3e6b0a9c9c40b5ecc4d0a482d2317d084de4145268d5ee6cdaa5ddd41806d6

doc/duplicate  |  time: 2016-04-26 11:24:39 765452  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4fd5f45af6a7db6c5147f305600c09e62f3b41153791c2657c8b9874a4f9778a

doc/irrelevant  |  time: 2016-04-26 11:31:10 474331  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8fd1e418a8ca0d5be7bda38c888ec5da5c3dcedcdaf396ec690a3b8420fbc935

doc/irrelevant  |  time: 2016-04-26 11:31:15 932770  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3afeb455539c2bebf9f9002c9696a0e0e0ffc6ed28adb0ba434b1a3a3b2ac15a

doc/irrelevant  |  time: 2016-04-26 11:31:32 500823  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b6f3147950ebf5064e56bdf404fbaf7ce5ea6217b5c163bb93a3b8f53294b9a7

doc/irrelevant  |  time: 2016-04-26 11:35:14 248590  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fcf6a0aaf3205db46fb21dd48f32c04aada450b432dad3021ff92003be5002ea

doc/irrelevant  |  time: 2016-04-26 11:35:31 980331  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-cbdf3736364a9ccb69c97d157f98951f7f1046044a81331f531eb10d95082472

doc/irrelevant  |  time: 2016-04-26 11:35:42 997867  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-cceac81ea237477759d163e69f6266c95f16eea773a8a0203befaf0f486cedc5

doc/irrelevant  |  time: 2016-04-26 11:35:49 139765  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7c4a80fd96e30640b4baac3455996b763bae6703a13f93e554372608364aa265

doc/irrelevant  |  time: 2016-04-26 11:35:58 684652  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3d8a5a125a0803076e7d5d272f112ac6d6ed39654b5b04710fe0d731527cced5

doc/irrelevant  |  time: 2016-04-26 11:36:00 847977  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1345fdd1c1bb2d328391125acfdc210c0382d09c05e6522aa5acb9fe1ca6d882

doc/irrelevant  |  time: 2016-04-26 11:36:11 555199  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7bf3cc3b7c31d1ac8de884d54504cd28b29ec30a0bc59ab017cf478da0738c1c

doc/irrelevant  |  time: 2016-04-26 11:36:18 607452  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-bed026f4aa70b6281d7b3401126f305698049baf591d182e9e47e26038958c36

doc/irrelevant  |  time: 2016-04-26 11:36:25 024291  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ef839e7cea095726ba0d9a32a58f36a03a83244197d410bd93d6d3d18e5bc566

doc/irrelevant  |  time: 2016-04-26 11:36:36 421380  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-637e1958e15bf23887a7858ff6eb3a31d0276f31bf3a3289cc515a811cc8c1b9

doc/irrelevant  |  time: 2016-04-26 11:36:49 717944  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3b907745aeed7a09d14461395b12bda46c7b96e79b87b305d6933b154718b1e2

doc/irrelevant  |  time: 2016-04-26 11:36:58 867814  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-0aef6c12f76e1e056a499f7ba155315376c87f26a909f94add25fb467567eac7

doc/irrelevant  |  time: 2016-04-26 11:37:06 658984  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-63bb63e0cf7934001483254d41746a22bfdc1b99433902977a9535a4209b1d9a

doc/irrelevant  |  time: 2016-04-26 11:37:14 104510  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fc7e5d9d572e266d5abadc8e2f16b25c7af1f7e850ed382b126515ab29462b07

doc/irrelevant  |  time: 2016-04-26 11:37:20 682047  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-781d0ea076c6508659bce25da766831fd73b658a42bbf25e7d20a7b8e0bfd389

doc/irrelevant  |  time: 2016-04-26 11:37:28 117794  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-01012ee56435c1283e749c52e7d549d9e41f58f844bb7aeea2241b6fbae1a746

doc/irrelevant  |  time: 2016-04-26 12:12:20 446818  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ea06edf5bba74f985b9d0fefcaf841e234c4ab06583f8cbef9153d0121395fa5

doc/irrelevant  |  time: 2016-04-26 12:21:48 667306  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-bc77038dc46b4e2368ffcf61d9cd17a4d9ee8f7e6fcc2463f3abc6aea2390bd3

doc/irrelevant  |  time: 2016-04-26 12:21:50 643680  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-01bcccc24cd0575a4d05326dc1229100c7820407c8f3e7a21c41fa9772d2d9a5

doc/irrelevant  |  time: 2016-04-26 12:21:58 242013  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-96ecb2b172d4f20131b4ba459e4979f3143a91dbeab2bf94a11b9d1d64d69396

doc/irrelevant  |  time: 2016-04-26 12:30:59 555333  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2a8e06876313aff7cf9afcbcc62a3872e04d7be67d73e839d202e6a7a06d96b3

doc/irrelevant  |  time: 2016-04-26 12:31:14 434755  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-949dd7ecc1b4242d08bade5f16bf691319ea865fba77d640e6383c5ba69cb504

doc/irrelevant  |  time: 2016-04-26 12:31:21 960916  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-31f355b584301ecfef17383bd7f78901703905d407c063efcbc32639dbd199f5

doc/irrelevant  |  time: 2016-04-26 12:31:33 188380  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-af747ba32f0818acb8ae9201560f453a6c41c7907701c981de49f58fa672773d

doc/irrelevant  |  time: 2016-04-26 12:31:44 252694  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-0a52052b1363dc0dbbdfccd0428c81df426cb8b4a68aab496643982ce364683d

doc/irrelevant  |  time: 2016-04-26 12:35:24 184209  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-893da3d01bb7ac59f87d1371ff1677f8dd07c8a922cdccc1ff69b17d0f762b2c

doc/irrelevant  |  time: 2016-04-26 12:35:34 173557  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c4a305dc6e9e809201f3e155989ed4490ac383244040ace84d51000a28c232bf

doc/duplicate  |  time: 2016-04-26 12:35:38 196024  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-352267b016fb4e4cb2ab6e53cf8c509e4caa10e5ada05f3c5b958ea093450cc0

doc/irrelevant  |  time: 2016-04-26 12:37:34 292830  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2e3a3b5444b2f6c758af50ef7ee2ba3bfb11910e76a28f17ba8021ac8d13980c

doc/irrelevant  |  time: 2016-04-26 12:45:14 490419  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d7dfe64f42bacc7aa4a8e98196cf1614f8a74683fe9729b731f5496e95f0a2db

doc/irrelevant  |  time: 2016-04-26 13:22:13 090183  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6cae6c32b354d056eef4002ecdc45cc19284b527321f362c04d8ef7e6af4aa64

doc/irrelevant  |  time: 2016-04-26 13:53:40 938845  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a05c9f8b309682ad26815e83ac79907d1a6bd8e402bc8e51eed8b960dff2d25a

doc/irrelevant  |  time: 2016-04-26 13:56:42 168433  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4427b96c7048999df087e3f1694530e755e2ef129928c71346e326d11ebbfe1d

doc/irrelevant  |  time: 2016-04-26 13:56:50 276389  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c27633c193e58fe22a6ba7246b442858c4ee059182787ac59a0873e2ba3d2f7d

doc/irrelevant  |  time: 2016-04-26 13:56:57 329477  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-03e535794896dc6c7872d37d6f16fd753af4a661f1a5594985c0083ef6ada7ab

doc/irrelevant  |  time: 2016-04-26 13:57:05 636971  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4315f09f644a8167a1d799ff78b771ee00d72257320bafe5dd962dc9c67fcadf

doc/irrelevant  |  time: 2016-04-26 14:06:16 696135  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5d84a4b9ae636ae0c3cd831c676df152455d067c2d076a59380e8ba926a53930

doc/irrelevant  |  time: 2016-04-26 14:10:30 942710  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8b19886df8ba3f05ab0f000635ab6e897866af1d93a99d2c1e7477022e108497

doc/irrelevant  |  time: 2016-04-26 14:19:17 414578  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3b9da9201cb7ac0e89dd9ca46ddc44913f640aa11821146aba0794c23a464b4a

doc/irrelevant  |  time: 2016-04-26 14:19:24 399613  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-35fbcd24fcdc0e39ef70fffbb2f802e825e2f39cf860b61487f5e3ab0e5d431c

doc/irrelevant  |  time: 2016-04-26 14:19:33 607700  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6adca758784ee5637ead98c0986da8f48879a23ee92394af8b7680d6df419241

doc/irrelevant  |  time: 2016-04-26 15:30:48 789474  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-05bb4c33f61d6967783f73967bc78a6659fc1295014621e2063e15b5ae591deb

doc/irrelevant  |  time: 2016-04-26 15:30:54 367404  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9adf54af4a5cf321e2c546624b1a4ea288e844adc839dc3fc21bf1b0fe335ffd

doc/irrelevant  |  time: 2016-04-26 15:46:26 333563  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-43209e855ad7f1ee8c096efee62e57f0daacf65db7966dde34112c8b7e1b42d6

doc/irrelevant  |  time: 2016-04-26 15:50:22 916986  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f270900a1352816dd0260d5bfa857fce480b1ccf11c593c58bdcfc84b3dd7ef8

doc/irrelevant  |  time: 2016-04-26 15:50:27 529679  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-de189531dab85e0b9c6fcc8ac0d5aebc49d82d276a4d5f9e2cd25a8bf0e6a97d

doc/next  |  time: 2016-04-26 16:03:39 681734  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f270900a1352816dd0260d5bfa857fce480b1ccf11c593c58bdcfc84b3dd7ef8

list/go back  |  time: 2016-04-26 16:03:39 872516  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-f270900a1352816dd0260d5bfa857fce480b1ccf11c593c58bdcfc84b3dd7ef8  |  listsource: pink_findmore

list/click  |  time: 2016-04-26 16:03:50 026739  |  # of fields: 4  |  topic_id: 417  |  docno: ebola-7ef3e872acc7763c140540b9e9f09b9c55826c51fb6147b4cfc231aba3563cee  |  listsource: pink_findmore

doc/irrelevant  |  time: 2016-04-26 16:04:04 218256  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7ef3e872acc7763c140540b9e9f09b9c55826c51fb6147b4cfc231aba3563cee

doc/irrelevant  |  time: 2016-04-26 16:04:10 962191  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1360ce9bcafdb28a025786ccddc2790489b3352f4eae3a221f3e0a34ac18ee6f

findmore/pink  |  time: 2016-04-26 16:04:28 293852  |  # of fields: 3  |  topic_id: 417  |  subtopic_id: 259  |  subtopic_name: cost of ebola medical waste

result_size: 145  |  num_tagged:  0
ebola-b4805d443c12f70672a9496954ab11169def0ca935e41902ef5d759cae42c70e
ebola-5418cdd34e0f2fc7b14007159564541aa338a6779d2ffe292efe408e04d4bfb1
ebola-7b6069901e2ba2c98f458c67f7bfa1b02e49cfa87d83e0d04129d6bce712e657
ebola-b2bf7425711d4a14dc87f986a47d969c68a09815541931fb985cc7ec22c63850
ebola-ed9d2661c1d4a0d2fc921b8f8355894f9063a7772416190474ae82ab7bd27cd9
ebola-f4940e673a4971534b30c8b627d5792f99136192a6ee748e087cc1a9e5a62c31
ebola-0c1eaddaae4cc86197c7e9da46c6ca6393bccff0a6436338ee36668043298124
ebola-9099afe44970dd6019c009bfe3df689bbee7089615abdc3650aba56be110f826
ebola-95ec1cb4d09e496aac663141352ead4b7e08974ea28cec63f20984726146f051
ebola-2cfb1d461635edf2e84622cf8c31729329bff1306a2cc2e08661791bb5a35778
ebola-69bee4f176804c518df412f5d0d20c077fa3ced9e55965d0af2d8b9ca506a6a1
ebola-89c1f13f03148b1116ce7f4d9a40eda62f8aa32ebe8c10bb5f8573a73dd66a6d
ebola-fe56e826e47c170fb31195d8a457d28811b63e55beba3bc41d071af0261ba195
ebola-0fd6ebf0fa271d0e65b3f26767c93fae239a8a8ce0ea6613dda11122e9bcf072
ebola-ec1db4d04b500b97c2d7dc6d610f19716f23d98b7bdc3f6453f499f28c379d76
ebola-a12c77c62bcfa533b12ff31e1215c3573c2a1638d4188c3faccbd32277bf9ba0
ebola-cbe3d5acb2b58a536cb21cb5d236c62db635e9c2422809dc113c681288b56662
ebola-721d422868a89436dd92810147834e5d849732a8fef80910a612bc2fcc8d4ddc
ebola-bff2ee2ffe13ef049fc1616572de70180c0744380d4d9a0ef27be2b4eb1fca7d
ebola-a20aede5a408cb0b17d9007d5751df71c532cdabd0a14d146ee7d11939b57fb4
ebola-928d281ca5f90c3d2961d9fb227eb322c945a1d71456dd726f224c4a422500df
ebola-5abdb1ea28ee3cec01ad9457d2ad03d78c258a6b4d63425c11c0277f3e96ae48
ebola-a0de4f0d73c92cb11519ba37b2b2810a6b4fd4d7bbd5bc7f2f95515bd381ab0c
ebola-f783c4e513344a5217938133fc665e3c361c1b3dcdfbbc7c0ce50a907ca9be56
ebola-c299298686a7fc537682b3c84d16f68f0a7d8ba8c57619cb3b0a2d05d862687c
ebola-74823ac004dafde1522ee251906e90d5e1a8c7b62d7b812c78f2818d198b8fa5
ebola-578e782b2b88e77ba6dc4d9a52e449ba8735f4f724d9826b0d418c297aaa2778
ebola-f1df9f133f0f0275dbdbb56a6fb8172a3306851d3789d33354d41930112ec1e4
ebola-823f9550deec3d3c11db179d68ac83ad087db8642a22635267d9dee1eb99b720
ebola-4b8506862f324f3cfd5a04235860eac6fbdc2b31978e7b4aaed59deb31591ab8
ebola-4770c4fe9e9453b5a0bc74e4c09917cde565d894ea0aabcad6a31687a50661c8
ebola-6ef708943c9b7cd8adb9ba957e64db4972de1cd829b3f2749a7a08ab18ddbefb
ebola-41a1b81b917df195ce4aab20b59dde6937a0f1824cac7e19ac7055fcf23cec08
ebola-b68387be76d9f92ea727c43fa0867e046680222511af04664067a5f82126a2e6
ebola-a5dc703582419bf4b77f96bcd548ec705796eeaa062c0bfb08369e4e2feddacf
ebola-36d962cdf849e1e7a05141e78f015e48ab76107b8cf2bd6c67dc57a2270e589a
ebola-58ab4b3a7127584393a126f5d5f7c86c2168a411d27129024aad9d3d54103e28
ebola-884013e21e55103219eb7dcdba1d7e00fbd46eeaa244c55fc7a01ff704ef6b42
ebola-52e853292b83b75b28c54ff04d807523f26a5a79d9b20ea6dba216cd7a845c9a
ebola-6e21bd735a8c1c3c8292434b38520a72006d997f4dadd0563ed4fa34a0a25e16
ebola-390dc7e263b45052ffecf23b298daf573f1cb22fa67dd3ca601fe9a483a4b6f8
ebola-ab61ea287a2cc6417325ac942c046a9e66da18bea21e9d21baaa8f455c024e9c
ebola-137959e5ffe2a02b04e102a6709fd83c8f4a65494df208a8a7bcbd053e841d5b
ebola-eac0b487737758a7dc13d8541832c678faac52eb39a1cd214329998ea75bac62
ebola-25ffb0348c3c16994d56f1bf03702a4a9d1fde7d43ade957e22e25de3ee5e24a
ebola-411579fc552eb5da727e325df431cede9bf60e5fc0bed5b89487b04ff70e42cf
ebola-f594ca2a9233365d2ce76dc91767b33f63acd1b859401fb277a961094b8feac8
ebola-f6a8a29a19b72d2b2afe456c4991e5b9649e6d491cf9b3b9620e6d3b8733ccd1
ebola-de9f530b243cfadf65db80bbc8cef95d20f7a0665430a1e20c9b517c38f87cf7
ebola-e96de687bb24003e17d207d90637d03f96948203943d70a9534306467ce7f150
ebola-853be5f1f204daac34f2b2850b039e2967a209b235c74d54a2ae5b33ab5ee608
ebola-953dbe194e44ba428cb67241f13af50baec6bd5c7ac734ef3acb86213e65e85e
ebola-66da9039fca76a05c36f2c405f2dcd467ae1f8191a89937ec4b3f2e7101cafc0
ebola-4c7931246b95670147a16caaad2a2f15f2a9e5c00d0160c7768692de16028f30
ebola-d4a276db4f6a95d6d8e5a09297e6bf6c252e6e781aeede27f2cbdddbc57b7de6
ebola-73c6b25c50340cf165c7e848f4412a6851b58909141c1f129bcbb5389f30bba5
ebola-ab6fbb499f4ffe4b1962dccb8ec402b2f39bc0fb96b0dbe2e58d1edf1fa214fa
ebola-eb657bb1e30d8bd36060364d99ea29597986f705415d78da805b7626bf736686
ebola-64340ad20183253cbc8309cc2847e0310d548ad515322269f16b8d94db73232a
ebola-f8dceecf1f2fe05fa2f7399fe92fdd63fee24b68097031a775132a8b0347127f
ebola-211a0a70cfecac375e6a9f306cf3862fc5fe64d390561207aa875e6fe5b73a30
ebola-ee0f28fadf2dc8616312d7ffde8ae72dbfe2f1c8a226b643801c1b3f3bc81e9d
ebola-d22f820b2561ffa6fbc0e62f6cc0494c8eb4718bc7a312c024e93c18f951bb68
ebola-18ecef40ee8c1af12326054bfaefe0801be253cf683990a467f5db901ef3db04
ebola-5add163b9c62faf9fe7e01c2f36dfc52e69c990eaf3c6a7efcbf01159a7b37b7
ebola-8f50ddf4440860761b0c9d088b8998e767977911bc29e385af8d882df959804c
ebola-aa5aaccb2c9a15574b03e6f7ebb15a560edd0a7f639eab94904b1679daf71a2a
ebola-48ca6eaafd68e387db19abae639be349ebc46a82975eee8b1501cac6b189c61d
ebola-dc9d13b7af32381e56de4c43d19b8366c536cec63f2be000577bb4dffb0f9218
ebola-2aa08e60f0955410e7ca062f4e9d075d28ae016562b8332d319e9ce048b3035a
ebola-839f89a150dce30e1a9aaf999515f64bfef372699ef86bf97a8175c5d1e7427b
ebola-5d9fa49e7fdd4072afd9a25f2b97ec67000ffc9bcefb7adfcc94b7d2722fc19a
ebola-a50c14b63b6fbe4d83adf3f616dbe147cc533d6fe607009985d079d4b8c2c707
ebola-98b8d69a7930967b8be88b47ed39061d6eafa45889bd45d4f17cd00522570075
ebola-9de6c1e7ae3dc7120204377c5b17f5668a98ffc2bf93e461d0518004b9c2fdf2
ebola-a9a8a6d0459c55905f5cc6631422f5163e666cbd48c2c31371787459d3b9907d
ebola-714c2dd715d6553507322a0c2a69a4086e2e4d12be6b961ea1d96b26c2b6557e
ebola-359810fa0dd436bd1a2906a121e29e78c925e600d4b2ac4fdf8666b6f2b9504c
ebola-0797cea78992df76cf2a7195fb77845241769e74e227fe305059533617b012df
ebola-561c2d1979eaec7ab23fb691d4498f96399c5381acf71ea19b102a71449dd5b1
ebola-7184b3363d4e3711fa13f5505da3b3d1e039e2586c9dd4093b6c9914a662abfe
ebola-f4d1d6423e761534976d9201fc0f46e9c3f6da675e24fbf64ab10cce7bfb7cf2
ebola-bcdd8ef1cd7192ba1ee6dc57b6a84fa6da2d30cec75cdde2e608e780eb0fc52f
ebola-656451c302e37be99b748d2df3c455f448e028e3f4fdb7ebbda0a4a9e549fac9
ebola-9cf6a71b382531a6309d0c2225fb44d12a9408bdb079388c713f6efaff3e9f54
ebola-7a61c070710acec13bf7cff7c59c575ab33044fbebcb767d76bb10361750219c
ebola-6f21b40979d7d8647f17e72a584c8d254a93c7ade090a29180e877bdf22d6f2a
ebola-cbd3a6797e67c68d2c20b848b74a65d7bc34b801339c5c97f0add8ea4f43cb60
ebola-9330a73369d4444733103b99e4531c2f15843728ffc40dbfd47ca72d5b62ead3
ebola-bc4ccc9e5d2359ba8faccf7ec693c5ff9367dc59832e9c855fb48316ad9cecb2
ebola-848debfd49cf98b2d58354df95a0a2deb2e2677798315002ece4f51b63b7c941
ebola-3c7e03ec950d338a24203d26d1953af564b63dc7206a3f4968efa3e4e67ce5fc
ebola-32065244f93ffac8f67726d7654122a76057e6990d8b6452eb6d8b383b7bbae8
ebola-cca153776388d04f34055020a0edb6ce65e9893e93fe2335748f9eaa48c170fc
ebola-28c1e4030e5f95c832a03da6917dee1db3f445f658572f4888060289018320be
ebola-4afbd6eb5c23b033d4bcfd2851548a56c42f5f8b96e4124fc975b8ea77636297
ebola-873c7bd99fbbab6d2f4a2aaa60b7e0af876c5df0f8a5ea6ce1dd1cb9d92e6238
ebola-8b4410c9e8b1ec65916cf02e48a177363ece0f00143e250795c3fa5e0b02c31f
ebola-698a84a2ab7b385f07025193553fbd27b655c146b9b9904850e9961b6b282421
ebola-acf7cf2f3a5ad7a88062fa6fcce3f4b10623eecf1a4ddc24387c6d469507ec04
ebola-66e1423267d8656490b560dfe92f6f4c0a46fa04591e7dc49158f6b2bcae57ba
ebola-febd914e1973dbbb7bdd5ddf365e6c0fa23bc8fe87a12290bf17ccf56de4d985
ebola-f0ff21c51f1ce1523312d56ee35740b970599d7c55db8bd7f357e8149efcdb8f
ebola-59afff12c7d30b2ef57c3af0b5bfd66f30dedbebfeb226eef0c8f23aea3e2635
ebola-551ac15a047d81a3982fc229bfaeded83f6fbd1695db88d7bb730ca9d6108f22
ebola-22cb77eb8899341cf426afb4463ee92e1946d45bbf3cd7e281c35d7d85ac8c9e
ebola-5b0a1416ceecbc92a93dcb7e300dcd5e95f5447c2b336c90178ae721043a82e4
ebola-2f2e35edac2d4f1481d14c018fd3724ce63f5d1596b58e749989e49537fa6ce0
ebola-a6510be88a1afc4225f4c225f5a1e49dac2c4d7f9175281f7c9cef7b05d42777
ebola-34b7aed0e8bbfd2d7d9283e46a44591da00b30b09c693d109b51fe98b46ba268
ebola-7fc5584f337cf48371461f744349095d6e4ce9441376fabf2b9bcd9aeb3ab1cc
ebola-6aa95604062e52ae3b8b6b3bba003bd7dfaebef7e2961f10501fc39331bd3f88
ebola-1f55b4e7ce78e5591aee11364314ef8a3478cfbc9cf1aba657aade2d3b56e79c
ebola-3c4306187d9f5bdc1ed23db255db3115c6971d8850891f48b460ff2362f0f3ce
ebola-3318f39c3eb17ac61dbf4a48693bb6ed65e7e949a5b677ca069d25da2d7042b9
ebola-178acbf9cf03dfb7fb59dcc312f7b7857f748b76fe4d04ee8a8b2724b2e4008b
ebola-8386b261ea3232f65b5a89753d2233dfb86beb0e85664af61e28ab51194a91be
ebola-3fb7afb4ab4a4f551b4844092b19691eed1fc5d3f8352343f17d5b415b61f4a1
ebola-66f8686feff255b08a4aef7cb048eb0d182bf251f77cc71b9c9a7f00dbe1dac3
ebola-60b25b3733d9748722f658498b0a7c7838fa332eab0390b3318ca2ef865fb0e8
ebola-ae08d614cc0b4fcc1657705da8d065e326cad31d13a30e2fc0f6cd5854eaa6ae
ebola-3749e6693a956637f98269c703f89e47c6d099aed0f314957cb70749c1af4002
ebola-3380525b26529e44c612304ddfe1aa46b9852727fb76ecee475f629c99471ea4
ebola-219b6a6aeef9095499446bba4bdd97f497b037a9711d75d770fa145b7065ee95
ebola-fb7391993c36876fd011634aa63874f1a00e40a70c623a67be6639ddb6e58b1d
ebola-7e3c643f619c8e648b470b81650b44ebb47b3fdd697140573b8656d5a6f70398
ebola-3ea79ba72d252cb1fa9c4a95ad55f30a2a2e7622062d78116245c1ce5f827197
ebola-bcad6dc2c74e9846eef79aed7fc67d6f47f1997215a96b87a5ad72c7a05c5a9d
ebola-40f59532613383fac44ab1d3e6315bce9413b63385a83c7875548f5cd75430fc
ebola-aff4bf906cddedfffce7363199b33727595fa1efba45d68dbc2b5d5bbab7f9e7
ebola-09cac3316e9097aeeee37ff0ed65d9abb5adb4c8957655bfc30c08c492c42815
ebola-cf5c192c74a99df41cd6f26958eed79e425521621ec2ed5c4a036b7641893050
ebola-61a65749907d3f7046a36694d693008731eb535c280df3617c92fb1194e9a0ed
ebola-accceb93df4f05b1587a3b661601f6b4c129cf569ac562f44e1ca5dfe9103a1a
ebola-d0899b9abc07983ff3f5223e9be6f644c46fa9aa8050f2cae2e72b6629482f8a
ebola-d4961613f3e80da0d3a24e388b2e3934bef1f35acf61702e769b30c67009e3fb
ebola-f42b7095da0ddd245f52f52e126454365bf9296b25418447a1f5b45cb31a11e0
ebola-adbc9de84aac53c56f4a7218f25e3d2b94280ef936aa73274fba6979baa0570f
ebola-f5cf2539ef16f182833c083ca20013873710f6ff7a4f80443e119b30484cda22
ebola-508f20f62b43991966f6b5d7430a6f9e3d14866b757ebda9e850b1a1f6c16055
ebola-6d5ad6487a858bce2b215eecc1fa15ec3588e1d985061a79cd2deb19a1dce744
ebola-e80c99cf4dc1e5e2b575d7f410f8db7a31178310c1c7fb332aca56759e7e21a5
ebola-8dc7167c5029eb7a2fdc0706ca0a4797c462ea2f8bee34debe85bdaedb1edf16
ebola-e1c340a3ebea00da4e1882b0462bf6a7e2506d28a2275629ad004bee06257d1d
ebola-417f5572e5c6e0184c1ca9e26ef0a0ae3b58689b7fccb2d0c6093d1efd7fad50

list/click  |  time: 2016-04-26 16:04:49 969250  |  # of fields: 4  |  topic_id: 417  |  docno: ebola-b4805d443c12f70672a9496954ab11169def0ca935e41902ef5d759cae42c70e  |  listsource: pink_findmore

doc/irrelevant  |  time: 2016-04-26 16:05:08 660992  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b4805d443c12f70672a9496954ab11169def0ca935e41902ef5d759cae42c70e

doc/irrelevant  |  time: 2016-04-26 16:05:13 844786  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5418cdd34e0f2fc7b14007159564541aa338a6779d2ffe292efe408e04d4bfb1

doc/irrelevant  |  time: 2016-04-26 16:05:19 482637  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7b6069901e2ba2c98f458c67f7bfa1b02e49cfa87d83e0d04129d6bce712e657

doc/irrelevant  |  time: 2016-04-26 16:09:22 903473  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b2bf7425711d4a14dc87f986a47d969c68a09815541931fb985cc7ec22c63850

highlight  |  time: 2016-04-26 16:10  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-ed9d2661c1d4a0d2fc921b8f8355894f9063a7772416190474ae82ab7bd27cd9  |  highlight_string: ebola, medical waste, cost, containment, disposal

doc/irrelevant  |  time: 2016-04-26 16:10:14 290687  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ed9d2661c1d4a0d2fc921b8f8355894f9063a7772416190474ae82ab7bd27cd9

doc/irrelevant  |  time: 2016-04-26 16:10:31 129563  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f4940e673a4971534b30c8b627d5792f99136192a6ee748e087cc1a9e5a62c31

doc/irrelevant  |  time: 2016-04-26 16:11:15 223291  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-0c1eaddaae4cc86197c7e9da46c6ca6393bccff0a6436338ee36668043298124

passage/create  |  time: 2016-04-26 16:11:35 901440  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 5617  |  passage_name:  The Dallas Ebola waste was quickly shipped to a Kansas City Stericycle incinerator, Gotnews.com has learned from a tipster.  “Actually not much at issue with treatment facility or transport, they just got it done before anyone raised hell about it,” says a Twitter tipster who works at a federal regulatory agency. Our source points us to this permit quietly granted on October 3. Kansas Department of Health and Environment has primary oversight of the incinerator. The ebola material arrived and was incinerated on Saturday. 

doc/next  |  time: 2016-04-26 16:11:40 567987  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9099afe44970dd6019c009bfe3df689bbee7089615abdc3650aba56be110f826

doc/irrelevant  |  time: 2016-04-26 16:12:04 058472  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-95ec1cb4d09e496aac663141352ead4b7e08974ea28cec63f20984726146f051

doc/irrelevant  |  time: 2016-04-26 16:12:11 563949  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2cfb1d461635edf2e84622cf8c31729329bff1306a2cc2e08661791bb5a35778

doc/irrelevant  |  time: 2016-04-26 16:24:41 349898  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-69bee4f176804c518df412f5d0d20c077fa3ced9e55965d0af2d8b9ca506a6a1

doc/irrelevant  |  time: 2016-04-26 16:25:18 310489  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-89c1f13f03148b1116ce7f4d9a40eda62f8aa32ebe8c10bb5f8573a73dd66a6d

doc/irrelevant  |  time: 2016-04-26 16:30:48 158106  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fe56e826e47c170fb31195d8a457d28811b63e55beba3bc41d071af0261ba195

doc/irrelevant  |  time: 2016-04-26 16:30:56 284125  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-0fd6ebf0fa271d0e65b3f26767c93fae239a8a8ce0ea6613dda11122e9bcf072

doc/irrelevant  |  time: 2016-04-26 16:31:04 924544  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ec1db4d04b500b97c2d7dc6d610f19716f23d98b7bdc3f6453f499f28c379d76

doc/irrelevant  |  time: 2016-04-26 16:31:16 595788  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a12c77c62bcfa533b12ff31e1215c3573c2a1638d4188c3faccbd32277bf9ba0

doc/irrelevant  |  time: 2016-04-26 16:34:44 337681  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-cbe3d5acb2b58a536cb21cb5d236c62db635e9c2422809dc113c681288b56662

doc/irrelevant  |  time: 2016-04-26 16:46:48 058877  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-721d422868a89436dd92810147834e5d849732a8fef80910a612bc2fcc8d4ddc

doc/irrelevant  |  time: 2016-04-26 17:16:29 202329  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-bff2ee2ffe13ef049fc1616572de70180c0744380d4d9a0ef27be2b4eb1fca7d

logout  |  time: 2016-04-26 17:16:33 472677

login  |  time: 2016-04-27 11:04:00 807518

doc/irrelevant  |  time: 2016-04-27 11:14:54 485547  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a20aede5a408cb0b17d9007d5751df71c532cdabd0a14d146ee7d11939b57fb4

doc/irrelevant  |  time: 2016-04-27 11:24:26 275807  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-928d281ca5f90c3d2961d9fb227eb322c945a1d71456dd726f224c4a422500df

doc/irrelevant  |  time: 2016-04-27 11:39:33 651220  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5abdb1ea28ee3cec01ad9457d2ad03d78c258a6b4d63425c11c0277f3e96ae48

doc/irrelevant  |  time: 2016-04-27 11:47:51 259975  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a0de4f0d73c92cb11519ba37b2b2810a6b4fd4d7bbd5bc7f2f95515bd381ab0c

doc/irrelevant  |  time: 2016-04-27 11:56:01 509353  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f783c4e513344a5217938133fc665e3c361c1b3dcdfbbc7c0ce50a907ca9be56

doc/irrelevant  |  time: 2016-04-27 12:53:28 449081  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c299298686a7fc537682b3c84d16f68f0a7d8ba8c57619cb3b0a2d05d862687c

doc/irrelevant  |  time: 2016-04-27 13:12:49 768142  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-74823ac004dafde1522ee251906e90d5e1a8c7b62d7b812c78f2818d198b8fa5

doc/irrelevant  |  time: 2016-04-27 13:30:27 349513  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-578e782b2b88e77ba6dc4d9a52e449ba8735f4f724d9826b0d418c297aaa2778

doc/irrelevant  |  time: 2016-04-27 13:31:55 649237  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f1df9f133f0f0275dbdbb56a6fb8172a3306851d3789d33354d41930112ec1e4

doc/irrelevant  |  time: 2016-04-27 13:37:57 049402  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-823f9550deec3d3c11db179d68ac83ad087db8642a22635267d9dee1eb99b720

doc/irrelevant  |  time: 2016-04-27 13:51:28 633162  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4b8506862f324f3cfd5a04235860eac6fbdc2b31978e7b4aaed59deb31591ab8

doc/irrelevant  |  time: 2016-04-27 13:51:33 165069  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4770c4fe9e9453b5a0bc74e4c09917cde565d894ea0aabcad6a31687a50661c8

doc/irrelevant  |  time: 2016-04-27 14:05:19 415364  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6ef708943c9b7cd8adb9ba957e64db4972de1cd829b3f2749a7a08ab18ddbefb

doc/irrelevant  |  time: 2016-04-27 14:13:18 213796  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-41a1b81b917df195ce4aab20b59dde6937a0f1824cac7e19ac7055fcf23cec08

doc/irrelevant  |  time: 2016-04-27 14:13:22 982151  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b68387be76d9f92ea727c43fa0867e046680222511af04664067a5f82126a2e6

doc/irrelevant  |  time: 2016-04-27 14:35:04 461722  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a5dc703582419bf4b77f96bcd548ec705796eeaa062c0bfb08369e4e2feddacf

doc/irrelevant  |  time: 2016-04-27 14:55:01 386168  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-36d962cdf849e1e7a05141e78f015e48ab76107b8cf2bd6c67dc57a2270e589a

doc/irrelevant  |  time: 2016-04-27 15:10:45 028667  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-58ab4b3a7127584393a126f5d5f7c86c2168a411d27129024aad9d3d54103e28

doc/irrelevant  |  time: 2016-04-27 15:23:53 728440  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-884013e21e55103219eb7dcdba1d7e00fbd46eeaa244c55fc7a01ff704ef6b42

doc/irrelevant  |  time: 2016-04-27 15:28:04 731616  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-52e853292b83b75b28c54ff04d807523f26a5a79d9b20ea6dba216cd7a845c9a

doc/irrelevant  |  time: 2016-04-27 15:32:53 055991  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6e21bd735a8c1c3c8292434b38520a72006d997f4dadd0563ed4fa34a0a25e16

doc/irrelevant  |  time: 2016-04-27 15:39:46 693531  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-390dc7e263b45052ffecf23b298daf573f1cb22fa67dd3ca601fe9a483a4b6f8

doc/irrelevant  |  time: 2016-04-27 15:39:49 606977  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ab61ea287a2cc6417325ac942c046a9e66da18bea21e9d21baaa8f455c024e9c

doc/irrelevant  |  time: 2016-04-27 15:39:55 390874  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-137959e5ffe2a02b04e102a6709fd83c8f4a65494df208a8a7bcbd053e841d5b

doc/irrelevant  |  time: 2016-04-27 15:40:00 432903  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-eac0b487737758a7dc13d8541832c678faac52eb39a1cd214329998ea75bac62

doc/irrelevant  |  time: 2016-04-27 15:42:58 007810  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-25ffb0348c3c16994d56f1bf03702a4a9d1fde7d43ade957e22e25de3ee5e24a

doc/irrelevant  |  time: 2016-04-27 15:43:04 639325  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-411579fc552eb5da727e325df431cede9bf60e5fc0bed5b89487b04ff70e42cf

doc/irrelevant  |  time: 2016-04-27 15:52:14 347268  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f594ca2a9233365d2ce76dc91767b33f63acd1b859401fb277a961094b8feac8

doc/irrelevant  |  time: 2016-04-27 15:58:58 358492  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f6a8a29a19b72d2b2afe456c4991e5b9649e6d491cf9b3b9620e6d3b8733ccd1

doc/irrelevant  |  time: 2016-04-27 16:07:47 734514  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-de9f530b243cfadf65db80bbc8cef95d20f7a0665430a1e20c9b517c38f87cf7

doc/irrelevant  |  time: 2016-04-27 16:07:54 096767  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e96de687bb24003e17d207d90637d03f96948203943d70a9534306467ce7f150

doc/irrelevant  |  time: 2016-04-27 16:16:50 572547  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-853be5f1f204daac34f2b2850b039e2967a209b235c74d54a2ae5b33ab5ee608

doc/irrelevant  |  time: 2016-04-27 16:16:59 791355  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-953dbe194e44ba428cb67241f13af50baec6bd5c7ac734ef3acb86213e65e85e

doc/irrelevant  |  time: 2016-04-27 16:17:08 574350  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-66da9039fca76a05c36f2c405f2dcd467ae1f8191a89937ec4b3f2e7101cafc0

doc/irrelevant  |  time: 2016-04-27 16:17:16 861641  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4c7931246b95670147a16caaad2a2f15f2a9e5c00d0160c7768692de16028f30

doc/irrelevant  |  time: 2016-04-27 16:17:23 402206  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d4a276db4f6a95d6d8e5a09297e6bf6c252e6e781aeede27f2cbdddbc57b7de6

doc/irrelevant  |  time: 2016-04-27 16:17:27 690884  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-73c6b25c50340cf165c7e848f4412a6851b58909141c1f129bcbb5389f30bba5

doc/irrelevant  |  time: 2016-04-27 16:17:36 864730  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ab6fbb499f4ffe4b1962dccb8ec402b2f39bc0fb96b0dbe2e58d1edf1fa214fa

doc/irrelevant  |  time: 2016-04-27 16:17:43 794500  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-eb657bb1e30d8bd36060364d99ea29597986f705415d78da805b7626bf736686

doc/irrelevant  |  time: 2016-04-27 16:17:51 147871  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-64340ad20183253cbc8309cc2847e0310d548ad515322269f16b8d94db73232a

doc/irrelevant  |  time: 2016-04-27 16:18:03 505175  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f8dceecf1f2fe05fa2f7399fe92fdd63fee24b68097031a775132a8b0347127f

doc/irrelevant  |  time: 2016-04-27 16:18:12 238315  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-211a0a70cfecac375e6a9f306cf3862fc5fe64d390561207aa875e6fe5b73a30

doc/irrelevant  |  time: 2016-04-27 16:40:52 543635  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ee0f28fadf2dc8616312d7ffde8ae72dbfe2f1c8a226b643801c1b3f3bc81e9d

doc/irrelevant  |  time: 2016-04-27 16:40:59 384488  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d22f820b2561ffa6fbc0e62f6cc0494c8eb4718bc7a312c024e93c18f951bb68

doc/irrelevant  |  time: 2016-04-27 16:43:52 329565  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-18ecef40ee8c1af12326054bfaefe0801be253cf683990a467f5db901ef3db04

doc/irrelevant  |  time: 2016-04-27 16:44:02 893631  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5add163b9c62faf9fe7e01c2f36dfc52e69c990eaf3c6a7efcbf01159a7b37b7

doc/irrelevant  |  time: 2016-04-27 16:49:07 301776  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8f50ddf4440860761b0c9d088b8998e767977911bc29e385af8d882df959804c

doc/irrelevant  |  time: 2016-04-27 16:49:09 730792  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-aa5aaccb2c9a15574b03e6f7ebb15a560edd0a7f639eab94904b1679daf71a2a

doc/irrelevant  |  time: 2016-04-27 16:49:15 162113  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-48ca6eaafd68e387db19abae639be349ebc46a82975eee8b1501cac6b189c61d

doc/irrelevant  |  time: 2016-04-27 16:49:21 551256  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-dc9d13b7af32381e56de4c43d19b8366c536cec63f2be000577bb4dffb0f9218

doc/irrelevant  |  time: 2016-04-27 16:50:07 925694  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2aa08e60f0955410e7ca062f4e9d075d28ae016562b8332d319e9ce048b3035a

doc/irrelevant  |  time: 2016-04-27 16:50:12 675452  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-839f89a150dce30e1a9aaf999515f64bfef372699ef86bf97a8175c5d1e7427b

doc/irrelevant  |  time: 2016-04-27 16:50:15 975669  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5d9fa49e7fdd4072afd9a25f2b97ec67000ffc9bcefb7adfcc94b7d2722fc19a

doc/irrelevant  |  time: 2016-04-27 16:50:23 116298  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a50c14b63b6fbe4d83adf3f616dbe147cc533d6fe607009985d079d4b8c2c707

doc/irrelevant  |  time: 2016-04-27 16:50:29 034002  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-98b8d69a7930967b8be88b47ed39061d6eafa45889bd45d4f17cd00522570075

doc/irrelevant  |  time: 2016-04-27 16:51:37 570319  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9de6c1e7ae3dc7120204377c5b17f5668a98ffc2bf93e461d0518004b9c2fdf2

doc/irrelevant  |  time: 2016-04-27 16:51:56 531804  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a9a8a6d0459c55905f5cc6631422f5163e666cbd48c2c31371787459d3b9907d

doc/irrelevant  |  time: 2016-04-27 16:52:02 711687  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-714c2dd715d6553507322a0c2a69a4086e2e4d12be6b961ea1d96b26c2b6557e

doc/irrelevant  |  time: 2016-04-27 16:52:10 145782  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-359810fa0dd436bd1a2906a121e29e78c925e600d4b2ac4fdf8666b6f2b9504c

doc/irrelevant  |  time: 2016-04-27 16:52:28 030650  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-0797cea78992df76cf2a7195fb77845241769e74e227fe305059533617b012df

doc/irrelevant  |  time: 2016-04-27 16:52:35 290419  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-561c2d1979eaec7ab23fb691d4498f96399c5381acf71ea19b102a71449dd5b1

doc/irrelevant  |  time: 2016-04-27 16:52:42 154435  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7184b3363d4e3711fa13f5505da3b3d1e039e2586c9dd4093b6c9914a662abfe

doc/irrelevant  |  time: 2016-04-27 16:53:54 703406  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f4d1d6423e761534976d9201fc0f46e9c3f6da675e24fbf64ab10cce7bfb7cf2

doc/irrelevant  |  time: 2016-04-27 16:53:58 805847  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-bcdd8ef1cd7192ba1ee6dc57b6a84fa6da2d30cec75cdde2e608e780eb0fc52f

doc/irrelevant  |  time: 2016-04-27 16:54:07 838014  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-656451c302e37be99b748d2df3c455f448e028e3f4fdb7ebbda0a4a9e549fac9

doc/irrelevant  |  time: 2016-04-27 16:54:17 050506  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9cf6a71b382531a6309d0c2225fb44d12a9408bdb079388c713f6efaff3e9f54

doc/irrelevant  |  time: 2016-04-27 16:54:25 144540  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7a61c070710acec13bf7cff7c59c575ab33044fbebcb767d76bb10361750219c

doc/irrelevant  |  time: 2016-04-27 16:54:30 940034  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6f21b40979d7d8647f17e72a584c8d254a93c7ade090a29180e877bdf22d6f2a

doc/irrelevant  |  time: 2016-04-27 16:55:20 073635  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-cbd3a6797e67c68d2c20b848b74a65d7bc34b801339c5c97f0add8ea4f43cb60

doc/irrelevant  |  time: 2016-04-27 16:55:27 524019  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9330a73369d4444733103b99e4531c2f15843728ffc40dbfd47ca72d5b62ead3

doc/irrelevant  |  time: 2016-04-27 16:55:33 338560  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-bc4ccc9e5d2359ba8faccf7ec693c5ff9367dc59832e9c855fb48316ad9cecb2

doc/irrelevant  |  time: 2016-04-27 16:55:38 348112  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-848debfd49cf98b2d58354df95a0a2deb2e2677798315002ece4f51b63b7c941

doc/irrelevant  |  time: 2016-04-27 16:55:45 609744  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3c7e03ec950d338a24203d26d1953af564b63dc7206a3f4968efa3e4e67ce5fc

doc/irrelevant  |  time: 2016-04-27 16:55:49 991986  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-32065244f93ffac8f67726d7654122a76057e6990d8b6452eb6d8b383b7bbae8

doc/irrelevant  |  time: 2016-04-27 16:55:58 053286  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-cca153776388d04f34055020a0edb6ce65e9893e93fe2335748f9eaa48c170fc

doc/irrelevant  |  time: 2016-04-27 16:56:05 079955  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-28c1e4030e5f95c832a03da6917dee1db3f445f658572f4888060289018320be

doc/irrelevant  |  time: 2016-04-27 16:56:12 549404  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4afbd6eb5c23b033d4bcfd2851548a56c42f5f8b96e4124fc975b8ea77636297

doc/irrelevant  |  time: 2016-04-27 16:56:19 834744  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-873c7bd99fbbab6d2f4a2aaa60b7e0af876c5df0f8a5ea6ce1dd1cb9d92e6238

doc/irrelevant  |  time: 2016-04-27 16:56:27 453958  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8b4410c9e8b1ec65916cf02e48a177363ece0f00143e250795c3fa5e0b02c31f

doc/irrelevant  |  time: 2016-04-27 16:56:36 039371  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-698a84a2ab7b385f07025193553fbd27b655c146b9b9904850e9961b6b282421

doc/irrelevant  |  time: 2016-04-27 16:56:41 231849  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-acf7cf2f3a5ad7a88062fa6fcce3f4b10623eecf1a4ddc24387c6d469507ec04

doc/irrelevant  |  time: 2016-04-27 16:56:45 514091  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-66e1423267d8656490b560dfe92f6f4c0a46fa04591e7dc49158f6b2bcae57ba

doc/irrelevant  |  time: 2016-04-27 16:56:50 316831  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-febd914e1973dbbb7bdd5ddf365e6c0fa23bc8fe87a12290bf17ccf56de4d985

doc/irrelevant  |  time: 2016-04-27 16:56:55 654499  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f0ff21c51f1ce1523312d56ee35740b970599d7c55db8bd7f357e8149efcdb8f

doc/irrelevant  |  time: 2016-04-27 16:57:00 490838  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-59afff12c7d30b2ef57c3af0b5bfd66f30dedbebfeb226eef0c8f23aea3e2635

doc/irrelevant  |  time: 2016-04-27 16:57:10 540590  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-551ac15a047d81a3982fc229bfaeded83f6fbd1695db88d7bb730ca9d6108f22

doc/irrelevant  |  time: 2016-04-27 16:57:15 843165  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-22cb77eb8899341cf426afb4463ee92e1946d45bbf3cd7e281c35d7d85ac8c9e

doc/irrelevant  |  time: 2016-04-27 16:57:20 853642  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5b0a1416ceecbc92a93dcb7e300dcd5e95f5447c2b336c90178ae721043a82e4

doc/irrelevant  |  time: 2016-04-27 16:57:25 322866  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2f2e35edac2d4f1481d14c018fd3724ce63f5d1596b58e749989e49537fa6ce0

doc/irrelevant  |  time: 2016-04-27 16:57:31 444866  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a6510be88a1afc4225f4c225f5a1e49dac2c4d7f9175281f7c9cef7b05d42777

doc/irrelevant  |  time: 2016-04-27 16:58:44 823549  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-34b7aed0e8bbfd2d7d9283e46a44591da00b30b09c693d109b51fe98b46ba268

doc/irrelevant  |  time: 2016-04-27 16:58:49 593047  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7fc5584f337cf48371461f744349095d6e4ce9441376fabf2b9bcd9aeb3ab1cc

logout  |  time: 2016-04-27 16:58:56 142661

login  |  time: 2016-04-28 09:59:37 699308

doc/irrelevant  |  time: 2016-04-28 10:09:10 043750  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6aa95604062e52ae3b8b6b3bba003bd7dfaebef7e2961f10501fc39331bd3f88

doc/irrelevant  |  time: 2016-04-28 10:15:18 771832  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1f55b4e7ce78e5591aee11364314ef8a3478cfbc9cf1aba657aade2d3b56e79c

doc/irrelevant  |  time: 2016-04-28 10:15:29 116557  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3c4306187d9f5bdc1ed23db255db3115c6971d8850891f48b460ff2362f0f3ce

doc/irrelevant  |  time: 2016-04-28 10:26:33 948478  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3318f39c3eb17ac61dbf4a48693bb6ed65e7e949a5b677ca069d25da2d7042b9

doc/duplicate  |  time: 2016-04-28 10:26:41 231843  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-178acbf9cf03dfb7fb59dcc312f7b7857f748b76fe4d04ee8a8b2724b2e4008b

doc/irrelevant  |  time: 2016-04-28 10:34:21 340308  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8386b261ea3232f65b5a89753d2233dfb86beb0e85664af61e28ab51194a91be

doc/irrelevant  |  time: 2016-04-28 10:34:47 018822  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3fb7afb4ab4a4f551b4844092b19691eed1fc5d3f8352343f17d5b415b61f4a1

doc/irrelevant  |  time: 2016-04-28 10:35:08 619728  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-66f8686feff255b08a4aef7cb048eb0d182bf251f77cc71b9c9a7f00dbe1dac3

doc/irrelevant  |  time: 2016-04-28 10:35:14 921209  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-60b25b3733d9748722f658498b0a7c7838fa332eab0390b3318ca2ef865fb0e8

doc/irrelevant  |  time: 2016-04-28 10:35:22 514429  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ae08d614cc0b4fcc1657705da8d065e326cad31d13a30e2fc0f6cd5854eaa6ae

doc/irrelevant  |  time: 2016-04-28 10:35:24 756985  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3749e6693a956637f98269c703f89e47c6d099aed0f314957cb70749c1af4002

doc/irrelevant  |  time: 2016-04-28 10:35:30 369410  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3380525b26529e44c612304ddfe1aa46b9852727fb76ecee475f629c99471ea4

doc/irrelevant  |  time: 2016-04-28 10:35:41 143773  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-219b6a6aeef9095499446bba4bdd97f497b037a9711d75d770fa145b7065ee95

doc/irrelevant  |  time: 2016-04-28 10:35:51 011635  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fb7391993c36876fd011634aa63874f1a00e40a70c623a67be6639ddb6e58b1d

doc/irrelevant  |  time: 2016-04-28 10:36:07 181596  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7e3c643f619c8e648b470b81650b44ebb47b3fdd697140573b8656d5a6f70398

highlight  |  time: 2016-04-28 10:37  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-3ea79ba72d252cb1fa9c4a95ad55f30a2a2e7622062d78116245c1ce5f827197  |  highlight_string: ebola

doc/irrelevant  |  time: 2016-04-28 10:37:12 162529  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3ea79ba72d252cb1fa9c4a95ad55f30a2a2e7622062d78116245c1ce5f827197

doc/irrelevant  |  time: 2016-04-28 10:37:21 126819  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-bcad6dc2c74e9846eef79aed7fc67d6f47f1997215a96b87a5ad72c7a05c5a9d

doc/irrelevant  |  time: 2016-04-28 10:49:34 115607  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-40f59532613383fac44ab1d3e6315bce9413b63385a83c7875548f5cd75430fc

doc/irrelevant  |  time: 2016-04-28 11:02:37 552771  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-aff4bf906cddedfffce7363199b33727595fa1efba45d68dbc2b5d5bbab7f9e7

doc/irrelevant  |  time: 2016-04-28 11:12:31 187739  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-09cac3316e9097aeeee37ff0ed65d9abb5adb4c8957655bfc30c08c492c42815

doc/irrelevant  |  time: 2016-04-28 11:15:31 823777  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-cf5c192c74a99df41cd6f26958eed79e425521621ec2ed5c4a036b7641893050

doc/irrelevant  |  time: 2016-04-28 11:27:23 836884  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-61a65749907d3f7046a36694d693008731eb535c280df3617c92fb1194e9a0ed

doc/irrelevant  |  time: 2016-04-28 11:27:56 981137  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-accceb93df4f05b1587a3b661601f6b4c129cf569ac562f44e1ca5dfe9103a1a

doc/irrelevant  |  time: 2016-04-28 11:40:26 282747  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d0899b9abc07983ff3f5223e9be6f644c46fa9aa8050f2cae2e72b6629482f8a

doc/irrelevant  |  time: 2016-04-28 11:53:39 329677  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d4961613f3e80da0d3a24e388b2e3934bef1f35acf61702e769b30c67009e3fb

doc/irrelevant  |  time: 2016-04-28 11:53:49 818602  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f42b7095da0ddd245f52f52e126454365bf9296b25418447a1f5b45cb31a11e0

doc/irrelevant  |  time: 2016-04-28 11:53:55 019631  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-adbc9de84aac53c56f4a7218f25e3d2b94280ef936aa73274fba6979baa0570f

doc/irrelevant  |  time: 2016-04-28 12:38:46 480912  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f5cf2539ef16f182833c083ca20013873710f6ff7a4f80443e119b30484cda22

doc/irrelevant  |  time: 2016-04-28 12:45:49 417851  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-508f20f62b43991966f6b5d7430a6f9e3d14866b757ebda9e850b1a1f6c16055

doc/irrelevant  |  time: 2016-04-28 12:58:05 668968  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6d5ad6487a858bce2b215eecc1fa15ec3588e1d985061a79cd2deb19a1dce744

doc/irrelevant  |  time: 2016-04-28 13:04:56 396513  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e80c99cf4dc1e5e2b575d7f410f8db7a31178310c1c7fb332aca56759e7e21a5

doc/irrelevant  |  time: 2016-04-28 13:13:57 705589  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8dc7167c5029eb7a2fdc0706ca0a4797c462ea2f8bee34debe85bdaedb1edf16

doc/irrelevant  |  time: 2016-04-28 13:23:08 383713  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e1c340a3ebea00da4e1882b0462bf6a7e2506d28a2275629ad004bee06257d1d

doc/irrelevant  |  time: 2016-04-28 13:23:20 115628  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-417f5572e5c6e0184c1ca9e26ef0a0ae3b58689b7fccb2d0c6093d1efd7fad50

list/go back  |  time: 2016-04-28 13:23:20 297337  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-417f5572e5c6e0184c1ca9e26ef0a0ae3b58689b7fccb2d0c6093d1efd7fad50  |  listsource: pink_findmore

findmore/pink  |  time: 2016-04-28 13:23:40 959178  |  # of fields: 3  |  topic_id: 417  |  subtopic_id: 260  |  subtopic_name: dangers of ebola medical waste

result_size: 162  |  num_tagged:  0
ebola-3a74d7a31e909bafc5bc4a1309e7713d4ea8ac659fb146a999531e145f849cb5
ebola-c9e29bf436ce9926248b3474995d5f12c3d91eeab212bd0fdd61277c24d42fac
ebola-d18403321f6e0f5a1f0a03030d6fd6eb50f83baebcd5a241712741f63c0ce524
ebola-f567377d39a3ea72fb12ff36b6783a0db3bf4de6963e8414b685e339155bff2a
ebola-afdc21148809fcbaa325bf86276ed26a27fa393ad95439786e2fb49562c124f7
ebola-9e6ff11cbc79cec4ffec7c3624700b169737d11e211b6c6e046191a30bfc7b92
ebola-d54bdbbee94c8fe8ac1a0e0530d53191446d5d64034de431f8de95e1eb44f846
ebola-a840c20f4a05aec16fb9cb5f1e24beada6555f3448c702728bc5c4dab1ee38ec
ebola-bbabe9745e03cdc03ae5351ff4e59144b8ad90af68e8595c333daeb0e90cff79
ebola-d9e595cefa56ea33c370f9cbafde9860b3b4563b72f8df9999cdb226cf5db6e7
ebola-c84b70f7a40a164556199ac081e1da29678f08e61dbf5e7db0b06b49de3a7629
ebola-9bd2ed9cf489adf3d48ba3eb3fe64ddbc15172ba4f883d251edb0c7c412e5a3d
ebola-de38cfd634dd9ef2a62191f2927c7c328c6c8d66c5d31332afa8370aeaf9be1f
ebola-3b567321a937d2d4abd2384e6edf2eee5c11bb61af45fdfabed45d7f1639ed71
ebola-717d47f3cbeaaef6d7f843a1a756cadd4d05ce607edb420598a480f0c0cf4923
ebola-8b24b315cef0788ec68e7feaf97903efff4f61006b949f31a9c3cc394dbbfb00
ebola-92c1850de5b9832b4e53282f460e3dc96e5be90db0a9c554898a7868dd561098
ebola-cb32379110b1ef7c0d9ba82e94e6d3f0887d488455346b02564865cede6a0503
ebola-96b8b7e11b301dfdd931f5ff356fde5c00190c4392f7183e412a9cca956537b1
ebola-af3ed6bbe3bb4bc4b7beefec4fd162020d83dbb10e224228a0294a1906cd0b3f
ebola-52a50b5f8a38382dfc068742cd4d0568f2b5a1a1b2a0fc32c3c27e404169b397
ebola-129fb9fb9b17bf0aea38e5dc1c99a6dbe04996237ea1c1e2fdfb95037f7a29f8
ebola-e31d790a7383ea9e89fe28074d6b1f9f225e2b5e067d847200865088ebd86851
ebola-9757a26707187190319b2ddebc6d6dca4bdae696623a4843262e422230a7b8c6
ebola-07cd5592a136d0fca49ccca1f936bda5d872c2b01f0528b50e21a3247eb862e8
ebola-d58f8fd30bcea666ce854e6ad3a27afe4203e5052c522316826613681c46371a
ebola-07fe8a4ae3908a0c0bd0eff74e57468109ff6071c8194d37c93fb0f2998d0f09
ebola-eb81a0bffb372769d62c9debda4ab3fbfa0e726fd102e8ec21b3cee780a53529
ebola-3f868e3f8ee5c125351aa11178b2da3abdee86def8ee5bf01be642fbc242e2e6
ebola-9abe2c3e38c1449f08c9fe615ffd3223a4f80ff9c462cb4ae1b5f6658afaa4dd
ebola-709e8257d8c5cac244aba38b3b8829350cc05909f89e71a61e7dcdc7f2dec06c
ebola-42d14b5109d02cdd8041c5706f8c2388ade3d63bd0e73eae9c173215df4cfb52
ebola-c7627fc3a2c6e99a45775ab325e2e7c379145255ef81194c87e7a6a2ad1a776b
ebola-6ebacb5b9309bd1092d8795bfa5a42fbd1761c353fc8ffe1422ee04431874315
ebola-9963e575b0613a5739c4e19835fc0fcd55f05ce109b0a9991c2e9c8b0a33cabd
ebola-c28597b587e6c3a240f0b00432623dbfea70e5b06ea86174e68a42d49337c8c3
ebola-ed40962f29f32c7649095728bf60548ed35f0118d1e5a42460132df7022b4df6
ebola-319af5118f75860de36da842128077e17719dd22bd45aed5f4a7ea8e15e760c0
ebola-8260e002b524d9c376df40e984dcd594921d15d976eab6bb412f839aaf2071ea
ebola-f4398c288b570ea2743b25c2bbfefdcf8b1449614498b3df484a9af9d8102836
ebola-7db04d4279ce1d7b860cfd810b4f0c72e86ae3b06f0eb008f9b65ef3a60ce154
ebola-5ca096f9f3ec6cff7900f683e2b6da77193acde926428ff74e82852386ba333a
ebola-9ef5e6489d32f26d5d2f52332d7a3da7ee280584f572b5cb68ba20088ae5b1af
ebola-784ac16e5cee4a6d052b7bdec3d5ec9fcb666a488823d71faabe04fe1174f4ea
ebola-6af020be19bbc532cf4f0c666c3fd9dfd3e01bb9d23626ca3f0bcd5c2fb661b5
ebola-a45b451a64a3a26283b8c27b7d52eb279d34023ebae072342a8b1e1c33db88fa
ebola-b08ba1709d80bc064e7361cd4b5c7fa4d408882e72c443207f991b8797322fcf
ebola-b90d6da5eaf31f9328ba66124dc5af35cc6742d2ccaced260d739d0aa49c054a
ebola-2fbbd51f3397899cf02d6e943f9af60a8ce3ca0d2bf6b806aa6de4df0c64b3f7
ebola-c6e7405aaaee4caf29ed9bd5c12bd5f12f8d57d4d1a9aa14dc80594344da92c2
ebola-69e26972fcf2cd3582f3c8724ab42dd9c3f25e568cd969bf92996e16462d2d10
ebola-e160066712eabd2f04600d2bb244035431a9e7c6f1f9050b49b65652a3a569f2
ebola-9172eeb773204d8659e5dd14efb93a51b71e28e5ee9a32263d8adbc8cf646e69
ebola-3a5332dd5a6e290bc9134e77d14842af820708c6458fde1dc01c2226cf5d4f01
ebola-1810c09f3c6a215d8a3c205ac4ce5e8f53742bbfdc8e0024a939fbd15084f91b
ebola-05e77eca0aea976edc5f817204a5cbed11ae3a01b86905fc0bf140699cc4e638
ebola-ca4c380a35d0c11658fa9adb3d6097664d576348d0718887f968ff71247779c1
ebola-4fc07f1fc9435028a027506a6f41309cf2bfecb74eacd01eb758f3c28f50ba0c
ebola-964433db59630714e1c559aa916d8521ba53b5fd7289e6391f535db13ed961f0
ebola-9c6bed9458d528b6d1a18cba2813e9c64a4da8ff7103f417568d12d751725ad1
ebola-da850757931e883981ace85b125d3e459e8396dae7b96117d90f218b5ddd63b8
ebola-5556501a827fa0bf9aa1562d6661d561dfafd8c8509de046eafb8bc8d536fd96
ebola-fe8392df698917e9f910b570ecbbc08c80f78731bceab7c5d60169225f526f98
ebola-91439d8837178ee420287aeaf3c42de1545c6ecac9dd56a8337c9bb468a49c02
ebola-51a8f5797214382f6de0b3d5636b144b3477fd3e20da382ac7606d80a91f15ba
ebola-f6a9f95fa14e7ceb554ed01501955263dc501e800e828597ea7931c6577684ff
ebola-6200284a673332eba4e59def9b404bcf3d909481e497b209739b9a8e49e6e56a
ebola-8ed438390e361a7df721283f666002b5f78f505f99a346de7de4ba8fd81a116e
ebola-9ec8bdc3a0750d45166d50a425062acb14fbb896f24a523e4e5167ffe276d07d
ebola-a9892e033ccb7545c4cc525e2b6f29a217ac0940ed26e357177d8b0406b90037
ebola-267c0e4aabc53aebe9edddc497cbb9b89b66a8b212c668c05c420f075a3d454a
ebola-fa33da01cccb6fba579ed6b358238dafbc8a894713b1de46aa3fadc90a7f5ff5
ebola-91ca04396b201366db37a913e4426d2d88eb1ef4b9e7b94f5e58be8b85cd0054
ebola-72b3b2a2a1eb4c00aa16225cba8781ee06dcc2b42cfe57e53db04ef05ab8cb4f
ebola-9cd728c7b1ca7a344bf86e53be716d208d14ec2d3e9f576a78e0c7ec8aa21c3b
ebola-161580a42461d3e6b72ede7228475dd75e6ef432558f978750cfb9a7bb5fc729
ebola-b71da5915a5f1c8b0dc3ed68f9f5892cb4b79c5e6fba17ad597a38e369eed996
ebola-676a89034c1a0a6e2e1e38d0b7953be31772f896dcb2a35195a14675e4fbaf51
ebola-3c09a1971605fd1f66b12b9726e71d9800e6911ab2c23f086c6547f8000537fb
ebola-d98675f9aaebc128d93f877567936c5e8de3d9eeeb5a37064dabad9a5a2767f1
ebola-93478c315ffbd3e234c3e5a06228f529e1f4f9e0a893da68c8cbd84adf90b456
ebola-eee27ff8db871b890a8ab44dde2ad907c61bb8149b59aafa164bb4530e6bcdd0
ebola-2c69612e2edcef08f3b5a0e26f8348682c88a9dc957761e615123ac8abef1911
ebola-75f355517d2af9e52c8e9dc6370948c047de821d8a0dc74730405904d7c81781
ebola-64d714d5d73797e06aea7b0d7522452811443d6753e229607fd3edd4bb4d7d0f
ebola-6c5bba0303a90b4ae0ba5d367c40ee85ed96bb2621789d64a8a09ea83cc047f1
ebola-25b42d2f5be98ebc2c6a237da93c3da2240b9e20c5f475f4024dbe4501f6eb71
ebola-1212116604e1b9aad91f9f0bc7ed5cca7c97603c1643613ae44f81e7e5ed963e
ebola-8457b4056fd922dbd5edad0f4c06a8b2c76bd894b942040020e36352a6d6598a
ebola-fccc3dbd60610b936f1431e0d45fdf38cae8f59819cf47cae80de6b2edc28361
ebola-a61a67cfa34d0fcbb7edf87a5351a4e6adad857f2866ea4e5c05e3238f9797ca
ebola-e7514c7f6130d78944e34541f50490bd9c5c472b30973e3bf26f327393194bb8
ebola-f611fb07d1314b9cf6a5acf98cba86aef4f3ba0bea1316a2c99856da5da1cdb1
ebola-029759de88aff60f9b5e6550c1a376b331aa7f7a3dd786792c9ad123726fa39e
ebola-d619c5c0ac29a5f4a7ae165be940564e6f28082c2087c7effb32ffd17a92a7de
ebola-5e2abc5773a07c6b0c0f1521dff18ab54a0af815c0e24f15ca436a87c3c4be83
ebola-353484c6119a71a188bab133377ca24fbd9752f2efb3e14511d0341d26471583
ebola-9fbdde79df98c2c292b8c31dec036adc357534631717e11f699e8dbfa8558c92
ebola-cb5c7796f34781d5e1d2380509358101c7588aa84c577ae45d175d10ae9c3295
ebola-b7058ddd12dcc759eed3909de9e9c1420edb9b1278f630c8872541e4903caef5
ebola-2351d62f523808ed7a46ce02efb2171ce8f07ab312ff833b988850d0d46efa66
ebola-6d50bf330c11dbbfd979e34f1c3d0d0b0cc67d61d4cd64e211bee53c1ab12b07
ebola-7c85d1056337e5dd1cee9fde0bbaa059eea94807f4156fd135e7b5dfbb4ded64
ebola-c32e75567f5a8c535a63c1a61dded0a643dcf6bf006969d10dd6d0c30c95eeb3
ebola-18a6c279cd64cda13f556e9f3df1a161a84dc22f611c18b76714f1d9961b617e
ebola-9a36392b875244b868beb6cc841958bcb4e9ef2288e52c9d48b26b68edfa3b5f
ebola-f79b9f7cff8d441926eba8da3e30c91b50283a6d32dd14ec4ad2d8b27797a31d
ebola-efe8619c1de2769e934cb458d50e954e752c4baa1750f4b3998011a00dc4afe4
ebola-40e9e45e1584ca132636d1dae6cbea1d6196c5ce7d79b83467deb81822abf575
ebola-cc03bb3ee6cf198f433c9c9e0ce67d6ad978985eca88b6f76b04c6362ea5eeff
ebola-d52c8d4ba224fa74b739de859781ab75602701539079401911618a13207ccdaa
ebola-e43108ca1ec377cca12302199201795bc62f479c83f1c7f0fa40bbfe314c785c
ebola-05ea842a08ebab4f5618b2d5504d84e6a6bd3cce5671f97de7d49c6fa3efcddf
ebola-2048eb9c9cb2a635ab1e2ea6ddb345c70be6bb13aa50e2e62c0fcf47ea9d8cd7
ebola-2ae72db3a7d3e06474b06be0be71a205e03b0ce3320f3d1004675d3fdbaa70f3
ebola-84c11e5173f89385e0b4afd41c4ca3623fbdf3ee45faea48fe02354dbbd68924
ebola-efa805268b6829482efdbae09fd9cbee76b6f93afb8e63faa0b8ad2c6223e760
ebola-eab9087eb986a120060eda3af1d88c79887bd0552ddf7798ea2a2365035c0747
ebola-0fa131085a890cf4feb0924b8d5ecf213c3e8aba02813630543bdea79bed9989
ebola-fc36ddbcc0ccb94dc94461a31c186c77d4eafd6729a5a75bd095f1f28c7fb5e1
ebola-20de82ee19bbed43504eb7a3f352a609f05fe507de7f8b41d5caf762923a3c4d
ebola-0dd99a8c3384a1741d2e918c7e4859ef92abc7fe9cdea6bb6960bebce93ae45b
ebola-0258327307a331f7b266636d8c8be2569658924d63303c41569b9dbe21d64655
ebola-f422e7124a415662eef89e5f030ca67fca4bc5bf476d353e005821fdba0beaf1
ebola-93b16479787e10062705027e76adc2ff542f492abc55945589a691c9d10d1c0a
ebola-5b506189732c0d677002853f5611ad4a592c38873f5ad175ad0339a0724c6c28
ebola-b19adfa0457ef5d3438d1597f169e3676cdce928007bf3be2093104919b049fd
ebola-76796635a9892835ae52af1686a7328dd614d32eedbde2cd5ce113964088e367
ebola-93e334021d9f40276f0c868a68ecb2e7825485d2fa71ffb8bf36a48c58950db4
ebola-f06f2c094a813a014dd28a550ec0b599394cd3fa0da7306a1c899609a548cbdc
ebola-5e71318a69908ef122d822d123d8b0fbbcc54b36ec2e11ff9ce8be0b4252ccab
ebola-6e6afd8441cc4a2b27c0f8a48bf7f9308ef49eb7a3c0ee231bd692cddffc0531
ebola-d9cb3de45d404214ce453a4b3e17e32d13405a375d8b12caddb93ee41cac050d
ebola-d068c9a642f66dba2cda2f3f8a3b12d249f7f92dbad6eb04d0c9a177f3a1ea23
ebola-d7ae1a872f56c798496338f1302865ff09ad3a74666d5d3acb7a4c98519c32d7
ebola-53bad10316c8b693b8728ba7c03aa31240943ab688eb78ecf7206ef2c85f9461
ebola-54781fe0e9568658e5cb2f0722cf86ec80da96c68372cba25c2469879a4e423a
ebola-d45c122c020c9517a0a1b385ae0b9bbef4d9d85f03a89400c673a5ddfaf34e0f
ebola-8dfaf443f32fec990842182208f33a8e1d5c1a2c60b64864f44e921798b32835
ebola-c74af686b1061e48a8501fdcb24955c8fb5b3834c7e8047be43632c3bcc3be64
ebola-b8d47a8fa378029df36dfc26974121eafbebec8562132e294fed09c2d0bfb19b
ebola-7ef006de5e7dad1bb9f0b322a4a3d6a87587b7281fcbfda8bcce317074a7f5dc
ebola-660e5250b03debabff6de141be8cd4c4bc1a641bb6879be24dc01c3189e4ad47
ebola-2554a7f08f48914c3b740f9f259d1571f8bdd2d91f8fde4aa0de643522d1d4ef
ebola-d9760b5d154ecf991012d82c1659bcb5f8e8e11537ad873443da50692e7bfe8d
ebola-121703cbabe3b35675dafaa6030b44dc429961463f2950f19c4dd85b40a9d1f4
ebola-6a82b92b8a7fbd73da27ccc905cfc8f24dd11ac4c9fc9cb953fb400957585a74
ebola-721e2b194251ed1cd27e5a6ded619ea334eaf93176dcb676cc91730b25d01ea3
ebola-3ff57a62a123e05b19044e0702570e2a294db9ee5534b56a800e925cc668ed4f
ebola-1a87ad2083467e5b5f57675253c9ea45032d9682bc8be97fbe1539af547b015e
ebola-7f5754857374bc77f70b8f89d54ba84c780a5ac612b0558b621ef20470ae6858
ebola-86d93a86f9cfdbd5314012e8c29267aaf95fa39eedd8cdc8fb3bcc1b18636e5b
ebola-637511affb9960987a385f86395b7b306e05fb2f888318d51d8fa0e0dce9888b
ebola-26e4bb94532c8cda2e0f59fd2adef22de5ff01d3dd5d0247166ab29fde9a79ea
ebola-6500c0b386cae1eed09eee5aa4bd910d95affd273720e459df7b79069bd2843b
ebola-d9f8d217f2697a7cef56379fbe9d7a49747d92f761625d950c1d5b028ab90768
ebola-a008277dea75819d4c57cb532a34a4268a0fb995d3cf9638dcb17c34a4a3ae5f
ebola-de6336bce59334a5e4ddf516a09668b9a0c44f94a34051695bc8ed08e12cd55c
ebola-f07faabd220841b07b118ffa3aba17ffa736f748e94dfdc04cb6cdf8b6053a73
ebola-69baaf61b5a1f78dd7a438e650c328a5611a007f3b6c1a4255385f4083359960
ebola-900ccaf7a2cbded9b158f38be5ecf056567221cccd5eda014b9db986117e78aa
ebola-03ea3cc8144e1a99f812a16ae00e921414e7a4be61400b862ead406ea0bed443

list/click  |  time: 2016-04-28 13:23:54 658235  |  # of fields: 4  |  topic_id: 417  |  docno: ebola-3a74d7a31e909bafc5bc4a1309e7713d4ea8ac659fb146a999531e145f849cb5  |  listsource: pink_findmore

highlight  |  time: 2016-04-28 13:24  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-3a74d7a31e909bafc5bc4a1309e7713d4ea8ac659fb146a999531e145f849cb5  |  highlight_string: ebola, medical waste, dangers, cost, containment

doc/irrelevant  |  time: 2016-04-28 13:24:42 074610  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3a74d7a31e909bafc5bc4a1309e7713d4ea8ac659fb146a999531e145f849cb5

doc/irrelevant  |  time: 2016-04-28 13:32:29 619096  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c9e29bf436ce9926248b3474995d5f12c3d91eeab212bd0fdd61277c24d42fac

doc/irrelevant  |  time: 2016-04-28 13:41:54 781396  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d18403321f6e0f5a1f0a03030d6fd6eb50f83baebcd5a241712741f63c0ce524

doc/irrelevant  |  time: 2016-04-28 13:42:02 793480  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f567377d39a3ea72fb12ff36b6783a0db3bf4de6963e8414b685e339155bff2a

doc/irrelevant  |  time: 2016-04-28 13:48:06 148051  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-afdc21148809fcbaa325bf86276ed26a27fa393ad95439786e2fb49562c124f7

doc/irrelevant  |  time: 2016-04-28 13:56:56 244676  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9e6ff11cbc79cec4ffec7c3624700b169737d11e211b6c6e046191a30bfc7b92

doc/irrelevant  |  time: 2016-04-28 13:57:05 610236  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d54bdbbee94c8fe8ac1a0e0530d53191446d5d64034de431f8de95e1eb44f846

highlight  |  time: 2016-04-28 14:04  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-a840c20f4a05aec16fb9cb5f1e24beada6555f3448c702728bc5c4dab1ee38ec  |  highlight_string: ebola, dangers, cost, containment, disposal, medical waste

doc/irrelevant  |  time: 2016-04-28 14:04:59 118376  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a840c20f4a05aec16fb9cb5f1e24beada6555f3448c702728bc5c4dab1ee38ec

doc/irrelevant  |  time: 2016-04-28 14:07:54 981975  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-bbabe9745e03cdc03ae5351ff4e59144b8ad90af68e8595c333daeb0e90cff79

doc/irrelevant  |  time: 2016-04-28 14:08:03 500946  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d9e595cefa56ea33c370f9cbafde9860b3b4563b72f8df9999cdb226cf5db6e7

doc/irrelevant  |  time: 2016-04-28 14:09:26 631069  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c84b70f7a40a164556199ac081e1da29678f08e61dbf5e7db0b06b49de3a7629

doc/irrelevant  |  time: 2016-04-28 14:09:38 027028  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9bd2ed9cf489adf3d48ba3eb3fe64ddbc15172ba4f883d251edb0c7c412e5a3d

doc/irrelevant  |  time: 2016-04-28 14:09:45 682959  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-de38cfd634dd9ef2a62191f2927c7c328c6c8d66c5d31332afa8370aeaf9be1f

doc/irrelevant  |  time: 2016-04-28 14:10:02 595454  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3b567321a937d2d4abd2384e6edf2eee5c11bb61af45fdfabed45d7f1639ed71

doc/irrelevant  |  time: 2016-04-28 14:10:09 558224  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-717d47f3cbeaaef6d7f843a1a756cadd4d05ce607edb420598a480f0c0cf4923

doc/irrelevant  |  time: 2016-04-28 14:10:16 218001  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8b24b315cef0788ec68e7feaf97903efff4f61006b949f31a9c3cc394dbbfb00

doc/irrelevant  |  time: 2016-04-28 14:16:10 250251  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-92c1850de5b9832b4e53282f460e3dc96e5be90db0a9c554898a7868dd561098

doc/irrelevant  |  time: 2016-04-28 14:19:07 782766  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-cb32379110b1ef7c0d9ba82e94e6d3f0887d488455346b02564865cede6a0503

doc/irrelevant  |  time: 2016-04-28 14:19:16 602132  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-96b8b7e11b301dfdd931f5ff356fde5c00190c4392f7183e412a9cca956537b1

doc/irrelevant  |  time: 2016-04-28 14:19:24 761949  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-af3ed6bbe3bb4bc4b7beefec4fd162020d83dbb10e224228a0294a1906cd0b3f

doc/irrelevant  |  time: 2016-04-28 14:19:28 695410  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-52a50b5f8a38382dfc068742cd4d0568f2b5a1a1b2a0fc32c3c27e404169b397

doc/irrelevant  |  time: 2016-04-28 14:19:35 447468  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-129fb9fb9b17bf0aea38e5dc1c99a6dbe04996237ea1c1e2fdfb95037f7a29f8

doc/irrelevant  |  time: 2016-04-28 14:19:41 925021  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e31d790a7383ea9e89fe28074d6b1f9f225e2b5e067d847200865088ebd86851

doc/irrelevant  |  time: 2016-04-28 14:19:53 831834  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9757a26707187190319b2ddebc6d6dca4bdae696623a4843262e422230a7b8c6

doc/irrelevant  |  time: 2016-04-28 14:20:00 133720  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-07cd5592a136d0fca49ccca1f936bda5d872c2b01f0528b50e21a3247eb862e8

doc/irrelevant  |  time: 2016-04-28 14:39:05 533033  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d58f8fd30bcea666ce854e6ad3a27afe4203e5052c522316826613681c46371a

passage/create  |  time: 2016-04-28 14:40:16 733810  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 258  |  subtopic_name: containment of ebola medical waste  |  passage_id: 6152  |  passage_name:  The autoclave in the Nebraska Medical Center's biocontainment unit was designed with a pass-through feature. Contaminated items from the patient and medical team are put into the autoclave on one side shown here, get sterilized, and are removed on the other side.  An Omaha company, Primus Sterilizer, made the autoclave â a high-pressure steam sterilizer â for the Nebraska Medical Centerâs biocontainment unit.  Installing an autoclave âturned out to be an amazing decision,â the unitâs medical director said.  âWe thought we might encounter diseases where the environment would be a major concern,â said Dr. Phil Smith, who pushed to get the unit built in 2004. âThe guidelines at that time said for Ebola and smallpox, you should autoclave everything that goes out of a containment area.â  The other decision made by leaders at the time was to have it be a pass-through autoclave, âwhich turned out to be very handy,â Smith said. Contaminated protective gear, bedsheets and the patientâs clothing go in one side, get sterilized and are pulled out the other side to be hauled away to be incinerated.  The machine was designed by Primus founder Ron Thompson and is like those sold for more than 25 years. It is 20 inches by 20 inches by 38 inches â less than half the size of a normal refrigerator. Itâs one of more than 20 different sizes made at the companyâs manufacturing site in Great Bend, Kansas, said CEO Michael Douglas. The companyâs headquarters are at 6565 S. 118th St. in Omaha.  Primusâ largest autoclave is 308 cubic feet â big enough to hold an automobile.  Surgical instruments also are cleaned in autoclaves, and laboratories use autoclaves to sterilize equipment.  Primus has gotten calls from international clients about how the autoclave worked for treating the Ebola patients who came to Omaha, said Connie Mansfield, marketing and communications manager.  âWeâre seeing some interest because of that situation, because they did such a good job of treating both patients, and there were no problems with the staff,â Mansfield said.  The large amount of contaminated material and waste generated by Ebola patients is an issue that medical facilities will have to deal with, she said.  Nebraska Med Center officials said the time it takes to autoclave all the waste â one load takes about 30 minutes â is one of the reasons for limiting the number of Ebola patients that can be treated at one time.  The gear, clothing, etc., that needed to be autoclaved during the treatment of the unitâs first Ebola patient, Dr. Rick Sacra, weighed more than 1,011 pounds after it was treated. For the second patient, Ashoka Mukpo, the treated waste weighed more than 1,806 pounds.  Even though Mukpo was treated for about 17 days versus the 21 needed for Sacra, more potentially contaminated gear was generated, partly because lab technicians worked in a lab set up inside the unit after Sacraâs departure.  If the biocontainment unit didnât have an autoclave, its Ebola-related waste would be treated as a Category A infectious substance, said Thom Metzger of the National Waste & Recycling Association. That would mean much more packaging and stricter handling â including hauling to a special out-of-state site.

passage/grade  |  time: 2016-04-28 14:40:19 902639  |  # of fields: 2  |  passage_id: 6152  |  score: 2

doc/next  |  time: 2016-04-28 14:40:21 800858  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-07fe8a4ae3908a0c0bd0eff74e57468109ff6071c8194d37c93fb0f2998d0f09

doc/irrelevant  |  time: 2016-04-28 14:40:35 066990  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-eb81a0bffb372769d62c9debda4ab3fbfa0e726fd102e8ec21b3cee780a53529

doc/irrelevant  |  time: 2016-04-28 14:40:42 916580  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3f868e3f8ee5c125351aa11178b2da3abdee86def8ee5bf01be642fbc242e2e6

doc/irrelevant  |  time: 2016-04-28 14:40:51 222948  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9abe2c3e38c1449f08c9fe615ffd3223a4f80ff9c462cb4ae1b5f6658afaa4dd

doc/irrelevant  |  time: 2016-04-28 14:49:21 395997  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-709e8257d8c5cac244aba38b3b8829350cc05909f89e71a61e7dcdc7f2dec06c

doc/irrelevant  |  time: 2016-04-28 14:49:27 000002  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-42d14b5109d02cdd8041c5706f8c2388ade3d63bd0e73eae9c173215df4cfb52

doc/irrelevant  |  time: 2016-04-28 14:49:57 028589  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c7627fc3a2c6e99a45775ab325e2e7c379145255ef81194c87e7a6a2ad1a776b

doc/irrelevant  |  time: 2016-04-28 14:50:05 276092  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6ebacb5b9309bd1092d8795bfa5a42fbd1761c353fc8ffe1422ee04431874315

doc/irrelevant  |  time: 2016-04-28 14:51:56 423971  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9963e575b0613a5739c4e19835fc0fcd55f05ce109b0a9991c2e9c8b0a33cabd

doc/irrelevant  |  time: 2016-04-28 14:52:40 683379  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c28597b587e6c3a240f0b00432623dbfea70e5b06ea86174e68a42d49337c8c3

doc/irrelevant  |  time: 2016-04-28 14:52:46 253475  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ed40962f29f32c7649095728bf60548ed35f0118d1e5a42460132df7022b4df6

doc/irrelevant  |  time: 2016-04-28 14:52:51 984237  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-319af5118f75860de36da842128077e17719dd22bd45aed5f4a7ea8e15e760c0

doc/irrelevant  |  time: 2016-04-28 14:53:02 733327  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8260e002b524d9c376df40e984dcd594921d15d976eab6bb412f839aaf2071ea

doc/irrelevant  |  time: 2016-04-28 14:53:15 534029  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f4398c288b570ea2743b25c2bbfefdcf8b1449614498b3df484a9af9d8102836

doc/irrelevant  |  time: 2016-04-28 14:53:32 909940  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7db04d4279ce1d7b860cfd810b4f0c72e86ae3b06f0eb008f9b65ef3a60ce154

doc/duplicate  |  time: 2016-04-28 14:53:38 934481  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5ca096f9f3ec6cff7900f683e2b6da77193acde926428ff74e82852386ba333a

doc/irrelevant  |  time: 2016-04-28 14:53:47 198649  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9ef5e6489d32f26d5d2f52332d7a3da7ee280584f572b5cb68ba20088ae5b1af

passage/create  |  time: 2016-04-28 15:54:22 682485  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 6187  |  passage_name:  Attorney General Buddy Caldwell is seeking to keep the waste of Dallas' Ebola victim from being disposed in the state of Louisiana.  The Louisiana attorney general requested for a restraining order to keep the incarcerated waste of Ebola victim Thomas Eric Duncan from being dumped at a landfill in Louisiana.  Like Us on Facebook  According to reports, there are about six truckloads of Duncan's personal items and belongings, which are potentially contaminated with Ebola, that were taken from his apartment and were brought for processing to the Veolia Environmental Services incinerator in Port Arthur, Texas, on Friday.   The waste will then be taken from the Veolia incinerator facility and is planned to be transported to a Louisiana landfill for final disposal.  Caldwell said that because the Ebola virus is not yet fully understood, Louisiana wanted to avoid any risks associated with dealing with it.  In a statement released by Caldwell, he said the state sympathizes with those who have lost their loved ones to the deadly virus, but the top priority of the state is the health and safety of its residents.  According to the attorney general, "there is still a lot of unknowns at this point," adding that bringing a potentially dangerous material across the state line was "absurd."  Caldwell added that Louisiana wanted to proceed with caution on the matter since the situation involving the virus is unprecedented, and that unnecessary risks cannot be taken by the state when it came to the deadly virus.  According to the office of the Louisiana Attorney General, the application for a temporary restraining order is already in its final stages and is expected to be filed Monday morning.  The office also said that it will send a letter to federal authorities, private contractors and Texas state officers to demand additional information regarding the proper handling and disposal of Duncan's waste.  The attorney general's office is currently coordinating with environmental agencies regarding the matter.  TagsEbola, dallas ebola, Thomas Eric Duncan, what is ebola, ebola in Louisiana  ©2014 Chinatopix All rights reserved. Do not reproduce without permission  RELATED READING

passage/grade  |  time: 2016-04-28 15:54:25 223428  |  # of fields: 2  |  passage_id: 6187  |  score: 2

doc/next  |  time: 2016-04-28 15:54:27 385301  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-784ac16e5cee4a6d052b7bdec3d5ec9fcb666a488823d71faabe04fe1174f4ea

doc/irrelevant  |  time: 2016-04-28 15:55:47 730101  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6af020be19bbc532cf4f0c666c3fd9dfd3e01bb9d23626ca3f0bcd5c2fb661b5

doc/irrelevant  |  time: 2016-04-28 15:55:57 508854  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a45b451a64a3a26283b8c27b7d52eb279d34023ebae072342a8b1e1c33db88fa

doc/irrelevant  |  time: 2016-04-28 15:56:05 242730  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b08ba1709d80bc064e7361cd4b5c7fa4d408882e72c443207f991b8797322fcf

doc/irrelevant  |  time: 2016-04-28 15:56:16 373925  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b90d6da5eaf31f9328ba66124dc5af35cc6742d2ccaced260d739d0aa49c054a

doc/irrelevant  |  time: 2016-04-28 15:56:23 968581  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2fbbd51f3397899cf02d6e943f9af60a8ce3ca0d2bf6b806aa6de4df0c64b3f7

doc/irrelevant  |  time: 2016-04-28 15:56:27 297781  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c6e7405aaaee4caf29ed9bd5c12bd5f12f8d57d4d1a9aa14dc80594344da92c2

doc/irrelevant  |  time: 2016-04-28 15:56:33 651815  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-69e26972fcf2cd3582f3c8724ab42dd9c3f25e568cd969bf92996e16462d2d10

doc/irrelevant  |  time: 2016-04-28 15:56:39 507548  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e160066712eabd2f04600d2bb244035431a9e7c6f1f9050b49b65652a3a569f2

doc/irrelevant  |  time: 2016-04-28 15:56:45 268163  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9172eeb773204d8659e5dd14efb93a51b71e28e5ee9a32263d8adbc8cf646e69

doc/irrelevant  |  time: 2016-04-28 15:56:51 956229  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3a5332dd5a6e290bc9134e77d14842af820708c6458fde1dc01c2226cf5d4f01

doc/irrelevant  |  time: 2016-04-28 15:57:00 835802  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1810c09f3c6a215d8a3c205ac4ce5e8f53742bbfdc8e0024a939fbd15084f91b

doc/irrelevant  |  time: 2016-04-28 15:57:07 947566  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-05e77eca0aea976edc5f817204a5cbed11ae3a01b86905fc0bf140699cc4e638

doc/irrelevant  |  time: 2016-04-28 15:57:12 949819  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ca4c380a35d0c11658fa9adb3d6097664d576348d0718887f968ff71247779c1

doc/duplicate  |  time: 2016-04-28 15:57:17 750469  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4fc07f1fc9435028a027506a6f41309cf2bfecb74eacd01eb758f3c28f50ba0c

doc/irrelevant  |  time: 2016-04-28 16:03:20 420865  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-964433db59630714e1c559aa916d8521ba53b5fd7289e6391f535db13ed961f0

doc/irrelevant  |  time: 2016-04-28 16:03:26 239882  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9c6bed9458d528b6d1a18cba2813e9c64a4da8ff7103f417568d12d751725ad1

doc/irrelevant  |  time: 2016-04-28 16:03:33 442427  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-da850757931e883981ace85b125d3e459e8396dae7b96117d90f218b5ddd63b8

doc/irrelevant  |  time: 2016-04-28 16:03:47 328917  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5556501a827fa0bf9aa1562d6661d561dfafd8c8509de046eafb8bc8d536fd96

doc/irrelevant  |  time: 2016-04-28 16:04:00 707803  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fe8392df698917e9f910b570ecbbc08c80f78731bceab7c5d60169225f526f98

doc/irrelevant  |  time: 2016-04-28 16:05:10 696595  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-91439d8837178ee420287aeaf3c42de1545c6ecac9dd56a8337c9bb468a49c02

doc/irrelevant  |  time: 2016-04-28 16:05:17 749940  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-51a8f5797214382f6de0b3d5636b144b3477fd3e20da382ac7606d80a91f15ba

doc/irrelevant  |  time: 2016-04-28 16:05:24 591940  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f6a9f95fa14e7ceb554ed01501955263dc501e800e828597ea7931c6577684ff

passage/create  |  time: 2016-04-28 16:06:00 893680  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 6199  |  passage_name:  While most of the news regarding Ebola has centered on monitoring passengers from West Africa and protocols for healthcare workers, the procedures for disposing of Ebola waste have received less attention.  To prevent any future missteps with disposal, the U.S. Department of Transportation has issued five non-site-specific special permits to companies for handling waste related to the Ebola virus, reported News Daily.  With the permits, the five companies do not have restrictions on where they can pick up Ebola-related waste or dispose of it, through March 31, 2015. These permits can later be extended for up to two years.  Advanced Environmental Options (AEO), one of the approved companies, has had two training sessions for employees on treating Ebola waste, account manager Dana West said. The employees have been trained on what equipment to wear.    AEO has previous experience handling Category A waste, a classification by the Transportation Department, meaning that it is capable of killing people and animals, West further added.  The four other companies include Veolia ES Technical Solutions LLC, Stericyle Inc., Triumvirate Environmental Inc. and Smith Systems Transportation Inc., according to a spokeswoman for the Pipeline and Hazardous Materials Safety Administration.  The thorough disposal process requires that the waste is disinfected, then put in a red "bio bag," disinfected, then placed in another bag, disinfected and then placed in a 55-gallon watertight drum that is sealed and contains disinfectant. Finally, the waste is incinerated.  "Although many of our members have not handled Category A waste before, but they are familiar with federal guidelines for handling the waste," said Anne Germain, director of waste and recycling technology at the National Waste & Recycling Association.  "Our members have decades of experience dealing with healthcare waste and now have the information to handle Ebola-infected materials," Germain further added. "The incinerators they use kill a broad range of pathogens, including the Ebola virus."  Related

passage/grade  |  time: 2016-04-28 16:06:03 559057  |  # of fields: 2  |  passage_id: 6199  |  score: 2

doc/next  |  time: 2016-04-28 16:06:05 042754  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6200284a673332eba4e59def9b404bcf3d909481e497b209739b9a8e49e6e56a

doc/irrelevant  |  time: 2016-04-28 16:25:46 028509  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8ed438390e361a7df721283f666002b5f78f505f99a346de7de4ba8fd81a116e

doc/irrelevant  |  time: 2016-04-28 16:25:54 975802  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9ec8bdc3a0750d45166d50a425062acb14fbb896f24a523e4e5167ffe276d07d

doc/irrelevant  |  time: 2016-04-28 16:26:05 466822  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a9892e033ccb7545c4cc525e2b6f29a217ac0940ed26e357177d8b0406b90037

doc/irrelevant  |  time: 2016-04-28 16:26:11 622308  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-267c0e4aabc53aebe9edddc497cbb9b89b66a8b212c668c05c420f075a3d454a

doc/irrelevant  |  time: 2016-04-28 16:26:20 884889  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fa33da01cccb6fba579ed6b358238dafbc8a894713b1de46aa3fadc90a7f5ff5

doc/irrelevant  |  time: 2016-04-28 16:26:29 674717  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-91ca04396b201366db37a913e4426d2d88eb1ef4b9e7b94f5e58be8b85cd0054

doc/irrelevant  |  time: 2016-04-28 16:26:35 681396  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-72b3b2a2a1eb4c00aa16225cba8781ee06dcc2b42cfe57e53db04ef05ab8cb4f

doc/irrelevant  |  time: 2016-04-28 16:26:44 174230  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9cd728c7b1ca7a344bf86e53be716d208d14ec2d3e9f576a78e0c7ec8aa21c3b

doc/irrelevant  |  time: 2016-04-28 16:26:55 444555  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-161580a42461d3e6b72ede7228475dd75e6ef432558f978750cfb9a7bb5fc729

doc/irrelevant  |  time: 2016-04-28 16:27:05 649793  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b71da5915a5f1c8b0dc3ed68f9f5892cb4b79c5e6fba17ad597a38e369eed996

doc/irrelevant  |  time: 2016-04-28 16:27:16 151547  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-676a89034c1a0a6e2e1e38d0b7953be31772f896dcb2a35195a14675e4fbaf51

doc/irrelevant  |  time: 2016-04-28 16:34:04 055816  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3c09a1971605fd1f66b12b9726e71d9800e6911ab2c23f086c6547f8000537fb

doc/irrelevant  |  time: 2016-04-28 16:35:20 319346  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d98675f9aaebc128d93f877567936c5e8de3d9eeeb5a37064dabad9a5a2767f1

doc/irrelevant  |  time: 2016-04-28 16:35:56 585365  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-93478c315ffbd3e234c3e5a06228f529e1f4f9e0a893da68c8cbd84adf90b456

doc/irrelevant  |  time: 2016-04-28 16:36:04 296144  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-eee27ff8db871b890a8ab44dde2ad907c61bb8149b59aafa164bb4530e6bcdd0

doc/irrelevant  |  time: 2016-04-28 16:36:11 440353  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2c69612e2edcef08f3b5a0e26f8348682c88a9dc957761e615123ac8abef1911

doc/irrelevant  |  time: 2016-04-28 16:36:17 251372  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-75f355517d2af9e52c8e9dc6370948c047de821d8a0dc74730405904d7c81781

doc/irrelevant  |  time: 2016-04-28 16:36:24 485209  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-64d714d5d73797e06aea7b0d7522452811443d6753e229607fd3edd4bb4d7d0f

doc/irrelevant  |  time: 2016-04-28 16:36:30 663975  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6c5bba0303a90b4ae0ba5d367c40ee85ed96bb2621789d64a8a09ea83cc047f1

doc/irrelevant  |  time: 2016-04-28 16:36:38 377593  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-25b42d2f5be98ebc2c6a237da93c3da2240b9e20c5f475f4024dbe4501f6eb71

doc/irrelevant  |  time: 2016-04-28 16:36:43 869413  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1212116604e1b9aad91f9f0bc7ed5cca7c97603c1643613ae44f81e7e5ed963e

doc/irrelevant  |  time: 2016-04-28 16:36:52 062819  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8457b4056fd922dbd5edad0f4c06a8b2c76bd894b942040020e36352a6d6598a

doc/irrelevant  |  time: 2016-04-28 16:36:59 345085  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fccc3dbd60610b936f1431e0d45fdf38cae8f59819cf47cae80de6b2edc28361

doc/irrelevant  |  time: 2016-04-28 16:37:19 592216  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a61a67cfa34d0fcbb7edf87a5351a4e6adad857f2866ea4e5c05e3238f9797ca

doc/irrelevant  |  time: 2016-04-28 16:38:19 200865  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e7514c7f6130d78944e34541f50490bd9c5c472b30973e3bf26f327393194bb8

doc/irrelevant  |  time: 2016-04-28 16:38:26 976994  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f611fb07d1314b9cf6a5acf98cba86aef4f3ba0bea1316a2c99856da5da1cdb1

doc/irrelevant  |  time: 2016-04-28 16:38:34 639120  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-029759de88aff60f9b5e6550c1a376b331aa7f7a3dd786792c9ad123726fa39e

doc/irrelevant  |  time: 2016-04-28 16:38:42 122042  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d619c5c0ac29a5f4a7ae165be940564e6f28082c2087c7effb32ffd17a92a7de

doc/irrelevant  |  time: 2016-04-28 16:39:40 779078  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5e2abc5773a07c6b0c0f1521dff18ab54a0af815c0e24f15ca436a87c3c4be83

doc/irrelevant  |  time: 2016-04-28 16:39:46 386760  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-353484c6119a71a188bab133377ca24fbd9752f2efb3e14511d0341d26471583

doc/irrelevant  |  time: 2016-04-28 16:39:54 274792  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9fbdde79df98c2c292b8c31dec036adc357534631717e11f699e8dbfa8558c92

doc/irrelevant  |  time: 2016-04-28 16:40:00 544782  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-cb5c7796f34781d5e1d2380509358101c7588aa84c577ae45d175d10ae9c3295

doc/irrelevant  |  time: 2016-04-28 16:40:09 510823  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b7058ddd12dcc759eed3909de9e9c1420edb9b1278f630c8872541e4903caef5

doc/irrelevant  |  time: 2016-04-28 16:40:16 739616  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2351d62f523808ed7a46ce02efb2171ce8f07ab312ff833b988850d0d46efa66

doc/irrelevant  |  time: 2016-04-28 16:40:22 054142  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6d50bf330c11dbbfd979e34f1c3d0d0b0cc67d61d4cd64e211bee53c1ab12b07

doc/irrelevant  |  time: 2016-04-28 16:40:30 186372  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7c85d1056337e5dd1cee9fde0bbaa059eea94807f4156fd135e7b5dfbb4ded64

doc/irrelevant  |  time: 2016-04-28 16:40:57 757064  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c32e75567f5a8c535a63c1a61dded0a643dcf6bf006969d10dd6d0c30c95eeb3

doc/irrelevant  |  time: 2016-04-28 16:41:04 806216  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-18a6c279cd64cda13f556e9f3df1a161a84dc22f611c18b76714f1d9961b617e

doc/irrelevant  |  time: 2016-04-28 16:41:13 596086  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9a36392b875244b868beb6cc841958bcb4e9ef2288e52c9d48b26b68edfa3b5f

doc/irrelevant  |  time: 2016-04-28 16:41:19 057286  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f79b9f7cff8d441926eba8da3e30c91b50283a6d32dd14ec4ad2d8b27797a31d

doc/irrelevant  |  time: 2016-04-28 16:41:25 027785  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-efe8619c1de2769e934cb458d50e954e752c4baa1750f4b3998011a00dc4afe4

doc/irrelevant  |  time: 2016-04-28 16:41:35 855387  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-40e9e45e1584ca132636d1dae6cbea1d6196c5ce7d79b83467deb81822abf575

doc/irrelevant  |  time: 2016-04-28 16:41:41 997782  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-cc03bb3ee6cf198f433c9c9e0ce67d6ad978985eca88b6f76b04c6362ea5eeff

doc/irrelevant  |  time: 2016-04-28 16:41:50 044128  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d52c8d4ba224fa74b739de859781ab75602701539079401911618a13207ccdaa

doc/irrelevant  |  time: 2016-04-28 16:41:57 957730  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e43108ca1ec377cca12302199201795bc62f479c83f1c7f0fa40bbfe314c785c

doc/irrelevant  |  time: 2016-04-28 16:42:03 690145  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-05ea842a08ebab4f5618b2d5504d84e6a6bd3cce5671f97de7d49c6fa3efcddf

doc/irrelevant  |  time: 2016-04-28 16:42:09 540206  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2048eb9c9cb2a635ab1e2ea6ddb345c70be6bb13aa50e2e62c0fcf47ea9d8cd7

doc/irrelevant  |  time: 2016-04-28 16:42:22 147588  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2ae72db3a7d3e06474b06be0be71a205e03b0ce3320f3d1004675d3fdbaa70f3

doc/irrelevant  |  time: 2016-04-28 16:42:27 485305  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-84c11e5173f89385e0b4afd41c4ca3623fbdf3ee45faea48fe02354dbbd68924

doc/irrelevant  |  time: 2016-04-28 16:42:34 506601  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-efa805268b6829482efdbae09fd9cbee76b6f93afb8e63faa0b8ad2c6223e760

doc/irrelevant  |  time: 2016-04-28 16:42:40 053047  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-eab9087eb986a120060eda3af1d88c79887bd0552ddf7798ea2a2365035c0747

doc/irrelevant  |  time: 2016-04-28 16:42:45 726209  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-0fa131085a890cf4feb0924b8d5ecf213c3e8aba02813630543bdea79bed9989

doc/irrelevant  |  time: 2016-04-28 16:44:09 266793  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fc36ddbcc0ccb94dc94461a31c186c77d4eafd6729a5a75bd095f1f28c7fb5e1

doc/irrelevant  |  time: 2016-04-28 16:44:20 582999  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-20de82ee19bbed43504eb7a3f352a609f05fe507de7f8b41d5caf762923a3c4d

doc/irrelevant  |  time: 2016-04-28 16:44:29 936628  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-0dd99a8c3384a1741d2e918c7e4859ef92abc7fe9cdea6bb6960bebce93ae45b

doc/irrelevant  |  time: 2016-04-28 16:44:36 214851  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-0258327307a331f7b266636d8c8be2569658924d63303c41569b9dbe21d64655

doc/irrelevant  |  time: 2016-04-28 16:44:43 171306  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f422e7124a415662eef89e5f030ca67fca4bc5bf476d353e005821fdba0beaf1

doc/duplicate  |  time: 2016-04-28 16:44:50 666296  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-93b16479787e10062705027e76adc2ff542f492abc55945589a691c9d10d1c0a

doc/irrelevant  |  time: 2016-04-28 16:47:36 603003  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5b506189732c0d677002853f5611ad4a592c38873f5ad175ad0339a0724c6c28

doc/irrelevant  |  time: 2016-04-28 16:47:44 609000  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b19adfa0457ef5d3438d1597f169e3676cdce928007bf3be2093104919b049fd

doc/irrelevant  |  time: 2016-04-28 16:47:50 670110  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-76796635a9892835ae52af1686a7328dd614d32eedbde2cd5ce113964088e367

doc/irrelevant  |  time: 2016-04-28 16:47:56 043873  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-93e334021d9f40276f0c868a68ecb2e7825485d2fa71ffb8bf36a48c58950db4

doc/irrelevant  |  time: 2016-04-28 16:48:04 414046  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f06f2c094a813a014dd28a550ec0b599394cd3fa0da7306a1c899609a548cbdc

doc/irrelevant  |  time: 2016-04-28 16:48:11 845596  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5e71318a69908ef122d822d123d8b0fbbcc54b36ec2e11ff9ce8be0b4252ccab

doc/irrelevant  |  time: 2016-04-28 16:48:18 228403  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6e6afd8441cc4a2b27c0f8a48bf7f9308ef49eb7a3c0ee231bd692cddffc0531

doc/irrelevant  |  time: 2016-04-28 16:48:24 148734  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d9cb3de45d404214ce453a4b3e17e32d13405a375d8b12caddb93ee41cac050d

doc/irrelevant  |  time: 2016-04-28 16:48:34 984344  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d068c9a642f66dba2cda2f3f8a3b12d249f7f92dbad6eb04d0c9a177f3a1ea23

doc/irrelevant  |  time: 2016-04-28 16:48:41 132681  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d7ae1a872f56c798496338f1302865ff09ad3a74666d5d3acb7a4c98519c32d7

doc/irrelevant  |  time: 2016-04-28 16:48:47 759221  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-53bad10316c8b693b8728ba7c03aa31240943ab688eb78ecf7206ef2c85f9461

doc/irrelevant  |  time: 2016-04-28 16:48:55 796428  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-54781fe0e9568658e5cb2f0722cf86ec80da96c68372cba25c2469879a4e423a

doc/irrelevant  |  time: 2016-04-28 16:49:02 971847  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d45c122c020c9517a0a1b385ae0b9bbef4d9d85f03a89400c673a5ddfaf34e0f

doc/irrelevant  |  time: 2016-04-28 16:49:18 686045  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8dfaf443f32fec990842182208f33a8e1d5c1a2c60b64864f44e921798b32835

doc/irrelevant  |  time: 2016-04-28 16:49:24 443397  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c74af686b1061e48a8501fdcb24955c8fb5b3834c7e8047be43632c3bcc3be64

doc/irrelevant  |  time: 2016-04-28 16:49:30 265340  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b8d47a8fa378029df36dfc26974121eafbebec8562132e294fed09c2d0bfb19b

doc/irrelevant  |  time: 2016-04-28 16:49:36 862336  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7ef006de5e7dad1bb9f0b322a4a3d6a87587b7281fcbfda8bcce317074a7f5dc

doc/duplicate  |  time: 2016-04-28 16:49:41 912562  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-660e5250b03debabff6de141be8cd4c4bc1a641bb6879be24dc01c3189e4ad47

doc/irrelevant  |  time: 2016-04-28 16:49:47 605860  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2554a7f08f48914c3b740f9f259d1571f8bdd2d91f8fde4aa0de643522d1d4ef

doc/irrelevant  |  time: 2016-04-28 16:49:52 585750  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d9760b5d154ecf991012d82c1659bcb5f8e8e11537ad873443da50692e7bfe8d

doc/irrelevant  |  time: 2016-04-28 16:50:01 980576  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-121703cbabe3b35675dafaa6030b44dc429961463f2950f19c4dd85b40a9d1f4

doc/irrelevant  |  time: 2016-04-28 16:50:08 965429  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6a82b92b8a7fbd73da27ccc905cfc8f24dd11ac4c9fc9cb953fb400957585a74

doc/irrelevant  |  time: 2016-04-28 16:50:18 118326  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-721e2b194251ed1cd27e5a6ded619ea334eaf93176dcb676cc91730b25d01ea3

doc/irrelevant  |  time: 2016-04-28 16:50:29 341269  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3ff57a62a123e05b19044e0702570e2a294db9ee5534b56a800e925cc668ed4f

doc/irrelevant  |  time: 2016-04-28 16:50:35 910710  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1a87ad2083467e5b5f57675253c9ea45032d9682bc8be97fbe1539af547b015e

doc/irrelevant  |  time: 2016-04-28 16:50:40 733927  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7f5754857374bc77f70b8f89d54ba84c780a5ac612b0558b621ef20470ae6858

doc/irrelevant  |  time: 2016-04-28 16:50:47 940530  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-86d93a86f9cfdbd5314012e8c29267aaf95fa39eedd8cdc8fb3bcc1b18636e5b

doc/irrelevant  |  time: 2016-04-28 16:50:54 777774  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-637511affb9960987a385f86395b7b306e05fb2f888318d51d8fa0e0dce9888b

doc/irrelevant  |  time: 2016-04-28 16:51:01 742463  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-26e4bb94532c8cda2e0f59fd2adef22de5ff01d3dd5d0247166ab29fde9a79ea

doc/irrelevant  |  time: 2016-04-28 16:51:08 098401  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6500c0b386cae1eed09eee5aa4bd910d95affd273720e459df7b79069bd2843b

doc/irrelevant  |  time: 2016-04-28 16:51:17 995205  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d9f8d217f2697a7cef56379fbe9d7a49747d92f761625d950c1d5b028ab90768

doc/irrelevant  |  time: 2016-04-28 16:51:25 532892  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a008277dea75819d4c57cb532a34a4268a0fb995d3cf9638dcb17c34a4a3ae5f

doc/irrelevant  |  time: 2016-04-28 16:51:32 248452  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-de6336bce59334a5e4ddf516a09668b9a0c44f94a34051695bc8ed08e12cd55c

doc/irrelevant  |  time: 2016-04-28 16:51:38 727075  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f07faabd220841b07b118ffa3aba17ffa736f748e94dfdc04cb6cdf8b6053a73

doc/irrelevant  |  time: 2016-04-28 16:51:46 290363  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-69baaf61b5a1f78dd7a438e650c328a5611a007f3b6c1a4255385f4083359960

doc/irrelevant  |  time: 2016-04-28 16:53:10 830724  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-900ccaf7a2cbded9b158f38be5ecf056567221cccd5eda014b9db986117e78aa

doc/irrelevant  |  time: 2016-04-28 16:53:18 357752  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-03ea3cc8144e1a99f812a16ae00e921414e7a4be61400b862ead406ea0bed443

list/go back  |  time: 2016-04-28 16:53:18 470277  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-03ea3cc8144e1a99f812a16ae00e921414e7a4be61400b862ead406ea0bed443  |  listsource: pink_findmore

logout  |  time: 2016-04-28 16:53:47 660729

login  |  time: 2016-04-29 08:24:14 119470

findmore/pink  |  time: 2016-04-29 08:24:35 112793  |  # of fields: 3  |  topic_id: 417  |  subtopic_id: 258  |  subtopic_name: containment of ebola medical waste

result_size: 110  |  num_tagged:  0
ebola-6d2fe5f994d6be624f0b988382df138fe49310dfd7fa636cf0730bfe473ed267
ebola-e556a574f0440b0ce9ac10c81f18150cf1039aebd199bdd5f945032ff2458f8f
ebola-9b92487a33fdebff97bf5b10640b5a90eb73e656ea505c5dffe14b3d6ffa7767
ebola-dd3a2a60471e95720a86cb326508f1833c47a82963271ab1d63725825db2619f
ebola-1592612fe3805a96e59bfaaa4463926139948bfa172f1d6505b430527c8eb150
ebola-4cba5276d079241dcc8b1faa2dfeeac55c370b2faf8a54076649ed0f15131f2b
ebola-c9acee8a58639778f95978cefc6e4339ab14ad637d327f4e5f517f55166eb616
ebola-e1daf9000b3cd99c22dc9a170c02a09b120f519cff801ed88c40babe0411848a
ebola-27c8f923d97823ef5569ac58ee3dc2702a834775574fe7ddc6a6c0987376ef63
ebola-576358dbd6db0fffc9fea483e1778a13d70adcf06e0b58bce40fbf00f64324ae
ebola-27331266b930cfcceb775458bf1adab7dc8127e77eb5f5b19fcfe53c716711a3
ebola-edc81b294ebc4bac8b01664508892c524bf8083053da0dcf55962b05eccf015b
ebola-0084f624781cca39fd19d334cfe6be5e6230329cdb658c07caa1ba3923ab2243
ebola-14407dedda242f91fecba8a23a3b17f312f535504c951e900969945a6b868d2e
ebola-dce005763d3946fba2cb980d601c98ad90dad5333d644a8c1c365e16cc0852b5
ebola-ee8e59425d7aa738013813045e2b061f9f6a436aa564175c7b9827812e052cc2
ebola-fa05ab1d7fc61a92b4a528c7f537febfeed9c0bfd79a5f293e1fdca59682d313
ebola-47762a9d8f19e22e1f78a2cff17963fd82aac1f055ac0656abb4577a621cdf5e
ebola-92b8b35075bdeff4e02c9ebb2442cfaf8124d3fd7b12c8c5b852628a82f69f58
ebola-a5c6fc96df093f4bc1ee16d5eb0b726be7c23d819f8ea5ff7a3c5ec11c05c0be
ebola-ad21eea9ca4078a8f267c7ce266a42dc7572bd50a23aacfd95ac00780c4438c7
ebola-b5fa86ed55d4e671c80461bd8b16c33bc48173dfd2ef2679849f31fdf84da608
ebola-bcba7c03615e0f56ed4718e8b9faa3272b26d37903bbf816e4bc3ea46ee1c331
ebola-d9d4b9171690e39a2a478ceed107e111d8ce3ab2b4865b718a177ca511a18b59
ebola-050fa6fd2560b7bd2360a2b7c25d395814f9d3e7253861fd539eb50582249440
ebola-4dcca06a9ee37d81a7bbd169d06bd9967f1eb1b1f819afc9e6529aaad6eaa4b1
ebola-e130d785b6f727791e16d228230695f316a6e6c9311a67635fd3a2049509ac33
ebola-183d930a763db2c747d36ded804d5d51a3a23a8ca03d200327d0ad59c1341b42
ebola-025574f4b6fd4d82af0c24e822e4dd9265aadb371eacd99b1ab691c8b364a034
ebola-a8f0d95a4d7c6e15944d9c3ac2659dd26b6e7309045d32779307385cfd5f112e
ebola-16c3f6892c606e85cca74dff2efea5e2683ce9d59791b09a326df7cfc06d94f3
ebola-adb3fcf1af46ec338db64bda339d9474ff4d028259d93746d85faa164aa7f74b
ebola-a977a9f423c60d6fe1d9a07cb06766ae130f99fc152da8d7a641b9d7c20154f2
ebola-b6fdfc4847dbd3397ff59adca2298013e7e70bba6019c658bcb6620b8e24271d
ebola-4598ed551a44663b01f284aab873b3e5f089c6cea2be9deb68252d32759babb6
ebola-e4cf5fa4c2e3f5890dffa3f0f56112c14abaa307a957168616e40f704466f038
ebola-6b7cb97828a1d8587e24e51c338b1cf1920d56a1537f28708ff64fcaa9099592
ebola-788b6a5f4f9381ba8547526eafa8df97679c5dd4afbf33fc0d969bef82bec0bd
ebola-6de004399458978ffdbad458804c4f7eb8e7dda9282478b2d5caa53671d7ad3c
ebola-ce999668829b690544e4d136126d93c81626a58c770f2da8a0efbd1d833f19cb
ebola-d72d3f5c23d3e9f68b2342bf5b56a6a8f29e27c952aa5254f0ac6bff612f43c6
ebola-74c437a8f609b25c2cc7f7da5e15df84a14b38b3a8ed217b1cc44a7a38928c8a
ebola-ea7a33833a9b4f3b0c39c1b3796d58800a3434f00644e0a43e1fbf6e394446d4
ebola-516bebbc9e27d65158861069e69cea567a242fe92652f5eb6b29ddcf19330b51
ebola-2669653fbe4a11a1be602f7567f4897a1a9f75eafef932c0485f2e8417d53f9d
ebola-4c7cd0c180bb8498744e14411f72c2aa41b71ecf0448a1c320f49fa815e8443c
ebola-a50dac73ee3d81799b874d22282ee699eb6426a7c2fe1eca526f02a425833ede
ebola-4ffcde44905004a5f57957ebfd92e22e0e184b0c7d884669c153a16ad58a516e
ebola-677843c3df79bd7526297f0123e96fa59f60a875843a11a73f2a399dc087ee51
ebola-7ae8326805f9b127688dc3f1612724c4de5a9133d3fa2c1694be2671b8f15fb0
ebola-704e12096de5028c3b8ad327b11fff44abf6e3389f58a7d99bf9d046bb2cc4a0
ebola-e372e3c86b0348356ede52989dba6d0a7847fa8372493ab445092a9727d91a81
ebola-27a097e25533ede8b3db8b2edf8865d873924c80c13f47bc7e260b3fc429308a
ebola-8072a41462c84624166166b8ddfac505f90a0ee7a04d2c3b3a84d8c575cecbe4
ebola-b30594acc6433373fbcfd31fac6da3e666e3a2cd1df608ac795c55db11eed52b
ebola-8ae6fb25fb091d7fe5a4001b5d139baf8f6e7cabdb40e8d7143c0c0d0e32b9c6
ebola-c9d7c3e8fb42e66631dcfdc3e63b29379d88400e8233dbcfe51c669cc28adc63
ebola-ba14f1ab72dd3460885e8fa0b20c47b6d90334b89c8a3041a61c430fb69bd126
ebola-883c6cb8d67daf7f9ebba5b44c936ae1bef78d194c46e443a9a3cfc4177f45e1
ebola-4ff6054b1dbe46a5db6140e351a4f67fa2f9574bfd4f170ceedc7cb3eb1b788a
ebola-3180fc79511a2d749da7e7d6ff5fd7728072156f0ebd4e4125c358b0809948d4
ebola-4cbc80bb6ea9d170028f710816740419dbde8ff08460ef2467d880b06a709609
ebola-4d816f5cdc5059c9713ed28293cccb486462fe0ed86d6bcce89f90c964d8135f
ebola-d9e6e9dede2f739adca952674b9791817d30939244b7336b66218e7150cf46b8
ebola-fc014cd29a0bb23214d9b2d1f14a90d5b7b2ab5a76f933195da1c2465fa35441
ebola-fdb42b9a30ee2d236722ba079183f25940900f99b736e92767faa179bc610ef7
ebola-010470deb6185ba63b97d2dbd7797a9f29ed9841d427c5a9789c375110c52054
ebola-dba89938312effc7079e96593c249de368e06f870f793d009df071417dd6a344
ebola-6614fc1656b3a5d007af7d897b3f17ec24f2eb4e93bc2cf4fd6c0e9812bef9c4
ebola-80a5ff337f200616dadd57ddbc4d123a9c1a28b2ebe4e4115ea572f61497915f
ebola-91318932531f7489f24b86b5ca2cab26fab9923b083551a731ff3244a3e9e56c
ebola-90c488227f13af50d72e7c79ba15227c88b9f6f481888dccc1b7699645aef221
ebola-940e3c9dcabef9aeeacd0a2e86b9f24fe34f8acf067d49388c6cd7c2e10c5e9b
ebola-caf840fadccf4b9d6d78e79e598c1581c3d5a0db80a6626ccaed07e3880c7c53
ebola-a0a20c9ec090b200a4c06ca7ca10eec27f5c7bc771523d0b5a69bf227febcf5d
ebola-8941dc043187cdc5ee09f189939ab9849b2df454c2361632d635fc1d7c8cd24d
ebola-35e5997fa48bab6d7bb20eaa2aec1e262bcc73379850c27114a7d671b70d1bc5
ebola-fdaa87987d4c9d809ae52d015461db97a912d155ae7999e9a4681d3e8bf01a07
ebola-fc53d091dadc39d67dd71098f41a7d2c0a1d51543f90f4506a5a216041014f78
ebola-9ee3025b7739a4e7eea0d0a04a12990708b39321b7a8d9797fac7ebac91e55f6
ebola-b6698ff6631ea085a453ec656e76fadef322f6f71efb323de041c3938bb7c87f
ebola-1c61473ec1b183aba5d794faac0b19dc420f9fe899dcb1b3d06f54e389e7433f
ebola-7220c029475bd08572c3c86d0111c11b9ea0fc3ac81ed9987a5045389f61dd6d
ebola-ba2ee7bec60d75915430a6a7432b846effb7034abd60d1e122559bc382af15b6
ebola-ff112a83a6989cd2ac2afc5c56015c3924fbc97ad42d5bf4f3fe59273973fda5
ebola-af06509e557dfafae24c32f7ec9df6f693b1f557c94889f18d9f0b399bb868a3
ebola-1e5a225e6c1076befdc47b29ca0ad5043f8bbbba4446afc6c8c6f47785d4f065
ebola-37171132fad90b6e380fe2d7a0eb0c1d518ce8f92bd788621a0d202c3633b6e8
ebola-46eefa2e01b30390fde7d374392b3d50f808022b730bdb5a6a7600254735f48f
ebola-71a648a95e4795b5cdc7108cb3382c21e0bb6b430df8e5b77afe566b04f4aac3
ebola-f3e4b7124229898229bf9371c91fff4b3cad23c9b6277dcdf9267a9f49c7deba
ebola-485eeea29e0fbb3510f6dfcc166a1afdfd5290ad5c1b1d1442e9a1c35cc8c6d2
ebola-034a903c7b31f745a178739951e4855f2098e091ec78524833462d1ef431ca2b
ebola-e3192641b0a6fe0ab43e710e0195d85bc01e88974d1d2dcfa51f1fda7d828e01
ebola-1aa2fcb81b6e349626f64a836fa78382c38e08d7ab0263ca2f19e2d1549e1bb2
ebola-2cb87d7394f342cdb97cca7e980c7bc091eee910b5b4ce7a89dbce2740989cc8
ebola-6856fc17429a3ed5014876448c9abfad11f2d9a5329a14885f663acc3123e698
ebola-e62a416b9d2f9ec88a21a29df64110ce822477a0adb6c5aa774976f2ae4a423b
ebola-962cbec9a83a19ebbcde0345d73f14caf93c35351b4bf33041e9557c4a5a6c0a
ebola-dff638e46ebb3ce02e4f7196d56a01275f3baa6d8be369d3e0f7bbe7b87bd716
ebola-b32399f2bbb606b0cbf781501a0b5e2cafb0862e16fe23b1c04fe7c844d585e5
ebola-d203cef33920cf33278baf79443a9c9e9d6154d460c3b20766cf5b71bedc110b
ebola-913ad2db19c4f446fe633aba0b9f8b933a9055e2d012c9f6c2943cb7ce08a73c
ebola-59393b07c51fdbe9ba4f690938a206346992096ed0e33daae38661ac74eb4190
ebola-7989054afcd2584aaf1a37e3b396702867c48a45a927120457899b1a67121d7e
ebola-cf49b57693aba067fdfe9da1a4a2aa39d733f1fb98986585608672aab4c84a80
ebola-0de9bfc89e2c7bec4943bd76ea483beef432cb2d4e5b12d35f40a7e9c9e796eb
ebola-f3403afeeccde745b8ad624c6f4369f66a59b3149b0fbfd2e60fb875da7c5cce
ebola-ac55648fadf95d8192a86fa35873abd225f877ae6f080a45d8506e6fbc9398ee
ebola-8476348b6bde489c2ef2b23bdc6cd8570e120e67a20ae1f91670531e59457a88

list/click  |  time: 2016-04-29 08:25:00 521649  |  # of fields: 4  |  topic_id: 417  |  docno: ebola-6d2fe5f994d6be624f0b988382df138fe49310dfd7fa636cf0730bfe473ed267  |  listsource: pink_findmore

highlight  |  time: 2016-04-29 08:25  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-6d2fe5f994d6be624f0b988382df138fe49310dfd7fa636cf0730bfe473ed267  |  highlight_string: ebola, medical waste, containment,  cost, disposal

doc/irrelevant  |  time: 2016-04-29 08:26:08 578598  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6d2fe5f994d6be624f0b988382df138fe49310dfd7fa636cf0730bfe473ed267

doc/irrelevant  |  time: 2016-04-29 08:26:21 202199  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e556a574f0440b0ce9ac10c81f18150cf1039aebd199bdd5f945032ff2458f8f

doc/irrelevant  |  time: 2016-04-29 08:26:23 815901  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9b92487a33fdebff97bf5b10640b5a90eb73e656ea505c5dffe14b3d6ffa7767

doc/irrelevant  |  time: 2016-04-29 08:26:29 269103  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-dd3a2a60471e95720a86cb326508f1833c47a82963271ab1d63725825db2619f

doc/irrelevant  |  time: 2016-04-29 08:26:34 826154  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1592612fe3805a96e59bfaaa4463926139948bfa172f1d6505b430527c8eb150

doc/irrelevant  |  time: 2016-04-29 08:26:44 033850  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4cba5276d079241dcc8b1faa2dfeeac55c370b2faf8a54076649ed0f15131f2b

doc/irrelevant  |  time: 2016-04-29 08:26:47 628876  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c9acee8a58639778f95978cefc6e4339ab14ad637d327f4e5f517f55166eb616

doc/irrelevant  |  time: 2016-04-29 08:26:53 693842  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e1daf9000b3cd99c22dc9a170c02a09b120f519cff801ed88c40babe0411848a

doc/irrelevant  |  time: 2016-04-29 08:26:56 273023  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-27c8f923d97823ef5569ac58ee3dc2702a834775574fe7ddc6a6c0987376ef63

doc/irrelevant  |  time: 2016-04-29 08:27:02 879079  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-576358dbd6db0fffc9fea483e1778a13d70adcf06e0b58bce40fbf00f64324ae

doc/irrelevant  |  time: 2016-04-29 08:32:23 725494  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-27331266b930cfcceb775458bf1adab7dc8127e77eb5f5b19fcfe53c716711a3

doc/irrelevant  |  time: 2016-04-29 08:32:29 478339  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-edc81b294ebc4bac8b01664508892c524bf8083053da0dcf55962b05eccf015b

doc/irrelevant  |  time: 2016-04-29 08:32:35 628811  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-0084f624781cca39fd19d334cfe6be5e6230329cdb658c07caa1ba3923ab2243

doc/irrelevant  |  time: 2016-04-29 08:32:44 028017  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-14407dedda242f91fecba8a23a3b17f312f535504c951e900969945a6b868d2e

doc/duplicate  |  time: 2016-04-29 08:32:50 419958  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-dce005763d3946fba2cb980d601c98ad90dad5333d644a8c1c365e16cc0852b5

doc/duplicate  |  time: 2016-04-29 08:32:56 028172  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ee8e59425d7aa738013813045e2b061f9f6a436aa564175c7b9827812e052cc2

doc/irrelevant  |  time: 2016-04-29 08:33:03 922730  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fa05ab1d7fc61a92b4a528c7f537febfeed9c0bfd79a5f293e1fdca59682d313

doc/irrelevant  |  time: 2016-04-29 08:33:10 880945  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-47762a9d8f19e22e1f78a2cff17963fd82aac1f055ac0656abb4577a621cdf5e

doc/irrelevant  |  time: 2016-04-29 08:33:18 264187  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-92b8b35075bdeff4e02c9ebb2442cfaf8124d3fd7b12c8c5b852628a82f69f58

doc/irrelevant  |  time: 2016-04-29 08:33:29 207345  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a5c6fc96df093f4bc1ee16d5eb0b726be7c23d819f8ea5ff7a3c5ec11c05c0be

doc/irrelevant  |  time: 2016-04-29 08:33:37 278026  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ad21eea9ca4078a8f267c7ce266a42dc7572bd50a23aacfd95ac00780c4438c7

doc/irrelevant  |  time: 2016-04-29 08:33:51 565527  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b5fa86ed55d4e671c80461bd8b16c33bc48173dfd2ef2679849f31fdf84da608

doc/irrelevant  |  time: 2016-04-29 08:34:00 736886  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-bcba7c03615e0f56ed4718e8b9faa3272b26d37903bbf816e4bc3ea46ee1c331

doc/irrelevant  |  time: 2016-04-29 08:34:07 908433  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d9d4b9171690e39a2a478ceed107e111d8ce3ab2b4865b718a177ca511a18b59

doc/irrelevant  |  time: 2016-04-29 08:34:14 808906  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-050fa6fd2560b7bd2360a2b7c25d395814f9d3e7253861fd539eb50582249440

doc/irrelevant  |  time: 2016-04-29 08:36:11 567122  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4dcca06a9ee37d81a7bbd169d06bd9967f1eb1b1f819afc9e6529aaad6eaa4b1

doc/irrelevant  |  time: 2016-04-29 08:36:26 418498  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e130d785b6f727791e16d228230695f316a6e6c9311a67635fd3a2049509ac33

doc/irrelevant  |  time: 2016-04-29 08:36:51 614922  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-183d930a763db2c747d36ded804d5d51a3a23a8ca03d200327d0ad59c1341b42

doc/irrelevant  |  time: 2016-04-29 08:37:03 081869  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-025574f4b6fd4d82af0c24e822e4dd9265aadb371eacd99b1ab691c8b364a034

doc/irrelevant  |  time: 2016-04-29 08:37:11 175566  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a8f0d95a4d7c6e15944d9c3ac2659dd26b6e7309045d32779307385cfd5f112e

doc/irrelevant  |  time: 2016-04-29 08:39:26 055891  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-16c3f6892c606e85cca74dff2efea5e2683ce9d59791b09a326df7cfc06d94f3

doc/next  |  time: 2016-04-29 08:41:41 028078  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-adb3fcf1af46ec338db64bda339d9474ff4d028259d93746d85faa164aa7f74b

doc/irrelevant  |  time: 2016-04-29 08:41:56 477252  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a977a9f423c60d6fe1d9a07cb06766ae130f99fc152da8d7a641b9d7c20154f2

doc/irrelevant  |  time: 2016-04-29 08:42:05 316781  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b6fdfc4847dbd3397ff59adca2298013e7e70bba6019c658bcb6620b8e24271d

doc/irrelevant  |  time: 2016-04-29 08:42:19 392229  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4598ed551a44663b01f284aab873b3e5f089c6cea2be9deb68252d32759babb6

doc/irrelevant  |  time: 2016-04-29 08:42:27 857056  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e4cf5fa4c2e3f5890dffa3f0f56112c14abaa307a957168616e40f704466f038

highlight  |  time: 2016-04-29 09:10  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-6b7cb97828a1d8587e24e51c338b1cf1920d56a1537f28708ff64fcaa9099592  |  highlight_string: ebola

doc/irrelevant  |  time: 2016-04-29 09:11:03 426015  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6b7cb97828a1d8587e24e51c338b1cf1920d56a1537f28708ff64fcaa9099592

doc/irrelevant  |  time: 2016-04-29 09:11:11 255565  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-788b6a5f4f9381ba8547526eafa8df97679c5dd4afbf33fc0d969bef82bec0bd

doc/irrelevant  |  time: 2016-04-29 09:18:39 418184  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6de004399458978ffdbad458804c4f7eb8e7dda9282478b2d5caa53671d7ad3c

doc/irrelevant  |  time: 2016-04-29 09:18:53 849391  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ce999668829b690544e4d136126d93c81626a58c770f2da8a0efbd1d833f19cb

doc/irrelevant  |  time: 2016-04-29 09:19:02 513088  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d72d3f5c23d3e9f68b2342bf5b56a6a8f29e27c952aa5254f0ac6bff612f43c6

doc/irrelevant  |  time: 2016-04-29 09:19:19 019572  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-74c437a8f609b25c2cc7f7da5e15df84a14b38b3a8ed217b1cc44a7a38928c8a

doc/duplicate  |  time: 2016-04-29 09:19:28 977503  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ea7a33833a9b4f3b0c39c1b3796d58800a3434f00644e0a43e1fbf6e394446d4

doc/duplicate  |  time: 2016-04-29 09:19:32 308610  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-516bebbc9e27d65158861069e69cea567a242fe92652f5eb6b29ddcf19330b51

doc/duplicate  |  time: 2016-04-29 09:19:39 091007  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2669653fbe4a11a1be602f7567f4897a1a9f75eafef932c0485f2e8417d53f9d

doc/irrelevant  |  time: 2016-04-29 09:19:53 430112  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4c7cd0c180bb8498744e14411f72c2aa41b71ecf0448a1c320f49fa815e8443c

doc/irrelevant  |  time: 2016-04-29 09:20:02 602228  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a50dac73ee3d81799b874d22282ee699eb6426a7c2fe1eca526f02a425833ede

doc/irrelevant  |  time: 2016-04-29 09:20:19 855903  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4ffcde44905004a5f57957ebfd92e22e0e184b0c7d884669c153a16ad58a516e

doc/irrelevant  |  time: 2016-04-29 09:20:31 442230  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-677843c3df79bd7526297f0123e96fa59f60a875843a11a73f2a399dc087ee51

doc/irrelevant  |  time: 2016-04-29 09:20:35 032359  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7ae8326805f9b127688dc3f1612724c4de5a9133d3fa2c1694be2671b8f15fb0

doc/irrelevant  |  time: 2016-04-29 09:20:45 566507  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-704e12096de5028c3b8ad327b11fff44abf6e3389f58a7d99bf9d046bb2cc4a0

doc/irrelevant  |  time: 2016-04-29 09:20:57 148807  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e372e3c86b0348356ede52989dba6d0a7847fa8372493ab445092a9727d91a81

doc/irrelevant  |  time: 2016-04-29 09:21:16 286820  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-27a097e25533ede8b3db8b2edf8865d873924c80c13f47bc7e260b3fc429308a

doc/irrelevant  |  time: 2016-04-29 09:21:31 674791  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8072a41462c84624166166b8ddfac505f90a0ee7a04d2c3b3a84d8c575cecbe4

doc/duplicate  |  time: 2016-04-29 09:21:34 735116  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b30594acc6433373fbcfd31fac6da3e666e3a2cd1df608ac795c55db11eed52b

doc/irrelevant  |  time: 2016-04-29 09:21:54 149751  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8ae6fb25fb091d7fe5a4001b5d139baf8f6e7cabdb40e8d7143c0c0d0e32b9c6

doc/irrelevant  |  time: 2016-04-29 09:22:02 072119  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c9d7c3e8fb42e66631dcfdc3e63b29379d88400e8233dbcfe51c669cc28adc63

doc/irrelevant  |  time: 2016-04-29 09:22:35 424277  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ba14f1ab72dd3460885e8fa0b20c47b6d90334b89c8a3041a61c430fb69bd126

doc/irrelevant  |  time: 2016-04-29 09:22:48 297478  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-883c6cb8d67daf7f9ebba5b44c936ae1bef78d194c46e443a9a3cfc4177f45e1

doc/irrelevant  |  time: 2016-04-29 09:22:57 831383  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4ff6054b1dbe46a5db6140e351a4f67fa2f9574bfd4f170ceedc7cb3eb1b788a

doc/irrelevant  |  time: 2016-04-29 09:23:09 177329  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3180fc79511a2d749da7e7d6ff5fd7728072156f0ebd4e4125c358b0809948d4

doc/irrelevant  |  time: 2016-04-29 09:23:21 178507  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4cbc80bb6ea9d170028f710816740419dbde8ff08460ef2467d880b06a709609

doc/duplicate  |  time: 2016-04-29 09:23:26 934047  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4d816f5cdc5059c9713ed28293cccb486462fe0ed86d6bcce89f90c964d8135f

doc/irrelevant  |  time: 2016-04-29 09:23:38 542773  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d9e6e9dede2f739adca952674b9791817d30939244b7336b66218e7150cf46b8

doc/irrelevant  |  time: 2016-04-29 09:23:52 857185  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fc014cd29a0bb23214d9b2d1f14a90d5b7b2ab5a76f933195da1c2465fa35441

doc/irrelevant  |  time: 2016-04-29 09:24:04 409947  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fdb42b9a30ee2d236722ba079183f25940900f99b736e92767faa179bc610ef7

doc/irrelevant  |  time: 2016-04-29 09:24:21 300488  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-010470deb6185ba63b97d2dbd7797a9f29ed9841d427c5a9789c375110c52054

doc/irrelevant  |  time: 2016-04-29 09:24:30 889996  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-dba89938312effc7079e96593c249de368e06f870f793d009df071417dd6a344

doc/irrelevant  |  time: 2016-04-29 09:24:41 669523  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6614fc1656b3a5d007af7d897b3f17ec24f2eb4e93bc2cf4fd6c0e9812bef9c4

doc/irrelevant  |  time: 2016-04-29 09:24:51 536432  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-80a5ff337f200616dadd57ddbc4d123a9c1a28b2ebe4e4115ea572f61497915f

doc/irrelevant  |  time: 2016-04-29 09:25:00 778663  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-91318932531f7489f24b86b5ca2cab26fab9923b083551a731ff3244a3e9e56c

doc/irrelevant  |  time: 2016-04-29 09:25:11 153496  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-90c488227f13af50d72e7c79ba15227c88b9f6f481888dccc1b7699645aef221

doc/irrelevant  |  time: 2016-04-29 09:25:21 708834  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-940e3c9dcabef9aeeacd0a2e86b9f24fe34f8acf067d49388c6cd7c2e10c5e9b

doc/irrelevant  |  time: 2016-04-29 09:25:39 658833  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-caf840fadccf4b9d6d78e79e598c1581c3d5a0db80a6626ccaed07e3880c7c53

doc/irrelevant  |  time: 2016-04-29 09:26:02 603443  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a0a20c9ec090b200a4c06ca7ca10eec27f5c7bc771523d0b5a69bf227febcf5d

doc/irrelevant  |  time: 2016-04-29 09:26:04 791044  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8941dc043187cdc5ee09f189939ab9849b2df454c2361632d635fc1d7c8cd24d

doc/irrelevant  |  time: 2016-04-29 09:26:19 431705  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-35e5997fa48bab6d7bb20eaa2aec1e262bcc73379850c27114a7d671b70d1bc5

doc/irrelevant  |  time: 2016-04-29 09:26:33 113296  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fdaa87987d4c9d809ae52d015461db97a912d155ae7999e9a4681d3e8bf01a07

doc/irrelevant  |  time: 2016-04-29 09:26:43 581356  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fc53d091dadc39d67dd71098f41a7d2c0a1d51543f90f4506a5a216041014f78

doc/irrelevant  |  time: 2016-04-29 09:26:53 948530  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9ee3025b7739a4e7eea0d0a04a12990708b39321b7a8d9797fac7ebac91e55f6

doc/irrelevant  |  time: 2016-04-29 09:27:16 161847  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b6698ff6631ea085a453ec656e76fadef322f6f71efb323de041c3938bb7c87f

doc/irrelevant  |  time: 2016-04-29 09:27:35 301604  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1c61473ec1b183aba5d794faac0b19dc420f9fe899dcb1b3d06f54e389e7433f

doc/irrelevant  |  time: 2016-04-29 09:27:41 517220  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7220c029475bd08572c3c86d0111c11b9ea0fc3ac81ed9987a5045389f61dd6d

doc/irrelevant  |  time: 2016-04-29 09:27:54 507855  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ba2ee7bec60d75915430a6a7432b846effb7034abd60d1e122559bc382af15b6

doc/irrelevant  |  time: 2016-04-29 09:28:15 977861  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ff112a83a6989cd2ac2afc5c56015c3924fbc97ad42d5bf4f3fe59273973fda5

doc/irrelevant  |  time: 2016-04-29 09:28:38 931637  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-af06509e557dfafae24c32f7ec9df6f693b1f557c94889f18d9f0b399bb868a3

doc/irrelevant  |  time: 2016-04-29 09:28:43 038444  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1e5a225e6c1076befdc47b29ca0ad5043f8bbbba4446afc6c8c6f47785d4f065

doc/irrelevant  |  time: 2016-04-29 09:28:56 121418  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-37171132fad90b6e380fe2d7a0eb0c1d518ce8f92bd788621a0d202c3633b6e8

doc/irrelevant  |  time: 2016-04-29 09:29:13 491381  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-46eefa2e01b30390fde7d374392b3d50f808022b730bdb5a6a7600254735f48f

doc/irrelevant  |  time: 2016-04-29 09:29:37 437797  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-71a648a95e4795b5cdc7108cb3382c21e0bb6b430df8e5b77afe566b04f4aac3

doc/irrelevant  |  time: 2016-04-29 09:29:56 516416  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f3e4b7124229898229bf9371c91fff4b3cad23c9b6277dcdf9267a9f49c7deba

doc/irrelevant  |  time: 2016-04-29 09:30:13 191233  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-485eeea29e0fbb3510f6dfcc166a1afdfd5290ad5c1b1d1442e9a1c35cc8c6d2

doc/irrelevant  |  time: 2016-04-29 09:30:32 123619  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-034a903c7b31f745a178739951e4855f2098e091ec78524833462d1ef431ca2b

doc/irrelevant  |  time: 2016-04-29 09:30:49 196872  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e3192641b0a6fe0ab43e710e0195d85bc01e88974d1d2dcfa51f1fda7d828e01

doc/irrelevant  |  time: 2016-04-29 09:31:31 521475  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1aa2fcb81b6e349626f64a836fa78382c38e08d7ab0263ca2f19e2d1549e1bb2

doc/irrelevant  |  time: 2016-04-29 09:31:37 552782  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2cb87d7394f342cdb97cca7e980c7bc091eee910b5b4ce7a89dbce2740989cc8

doc/irrelevant  |  time: 2016-04-29 09:32:00 168278  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6856fc17429a3ed5014876448c9abfad11f2d9a5329a14885f663acc3123e698

doc/irrelevant  |  time: 2016-04-29 09:32:19 819586  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-e62a416b9d2f9ec88a21a29df64110ce822477a0adb6c5aa774976f2ae4a423b

doc/irrelevant  |  time: 2016-04-29 09:32:28 612138  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-962cbec9a83a19ebbcde0345d73f14caf93c35351b4bf33041e9557c4a5a6c0a

doc/irrelevant  |  time: 2016-04-29 09:32:33 352175  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-dff638e46ebb3ce02e4f7196d56a01275f3baa6d8be369d3e0f7bbe7b87bd716

doc/irrelevant  |  time: 2016-04-29 09:32:35 610061  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-b32399f2bbb606b0cbf781501a0b5e2cafb0862e16fe23b1c04fe7c844d585e5

doc/irrelevant  |  time: 2016-04-29 09:32:56 361719  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d203cef33920cf33278baf79443a9c9e9d6154d460c3b20766cf5b71bedc110b

doc/irrelevant  |  time: 2016-04-29 09:32:59 394303  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-913ad2db19c4f446fe633aba0b9f8b933a9055e2d012c9f6c2943cb7ce08a73c

doc/irrelevant  |  time: 2016-04-29 09:33:11 432074  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-59393b07c51fdbe9ba4f690938a206346992096ed0e33daae38661ac74eb4190

doc/irrelevant  |  time: 2016-04-29 09:38:43 343240  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-7989054afcd2584aaf1a37e3b396702867c48a45a927120457899b1a67121d7e

doc/irrelevant  |  time: 2016-04-29 10:45:19 694740  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-cf49b57693aba067fdfe9da1a4a2aa39d733f1fb98986585608672aab4c84a80

logout  |  time: 2016-04-29 10:45:21 376603

login  |  time: 2016-04-29 14:24:35 787974

highlight  |  time: 2016-04-29 14:24  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-0de9bfc89e2c7bec4943bd76ea483beef432cb2d4e5b12d35f40a7e9c9e796eb  |  highlight_string: ebola, medical waste

highlight  |  time: 2016-04-29 14:38  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-0de9bfc89e2c7bec4943bd76ea483beef432cb2d4e5b12d35f40a7e9c9e796eb  |  highlight_string: ebola, medical waste

doc/irrelevant  |  time: 2016-04-29 14:39:40 644647  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-0de9bfc89e2c7bec4943bd76ea483beef432cb2d4e5b12d35f40a7e9c9e796eb

doc/irrelevant  |  time: 2016-04-29 14:46:11 151098  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f3403afeeccde745b8ad624c6f4369f66a59b3149b0fbfd2e60fb875da7c5cce

doc/irrelevant  |  time: 2016-04-29 14:46:35 053123  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ac55648fadf95d8192a86fa35873abd225f877ae6f080a45d8506e6fbc9398ee

doc/irrelevant  |  time: 2016-04-29 14:53:16 874272  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8476348b6bde489c2ef2b23bdc6cd8570e120e67a20ae1f91670531e59457a88

list/go back  |  time: 2016-04-29 14:53:17 031382  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-8476348b6bde489c2ef2b23bdc6cd8570e120e67a20ae1f91670531e59457a88  |  listsource: pink_findmore

findmore/pink  |  time: 2016-04-29 14:53:52 237782  |  # of fields: 3  |  topic_id: 417  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste

result_size: 45  |  num_tagged:  0
ebola-2e9696e511a36a115c124c0e6334b5972c4bbe10a0bac15f830ecdb689de11c9
ebola-3cecf5af27c42bbc5f098671fb8940c60e021343514edbe3aa555b2f1d686dec
ebola-96a7772a19733e9a381227777d2d756ec3408d654ed5831deaf7611938a124a6
ebola-054d5d9b9c2018ff499be2aca347de5a7119c626ac99b8d2e1b82f616c423442
ebola-2ab4f93500d7a43845497b9ed531e5aea56cecb25aa45a21295f3e33600fefad
ebola-9413cc41ab0cfa94187705ab6a319081f73cc1dc1f44a0d8316e74302c60c0d0
ebola-2cb069c0cca747b18a797fe75ce27998131c61a9482495b76cc5078c9b2400bb
ebola-023aafa8ef42c7179e83f2657be5f34f16783d666aecfa0323a2d8a9872170f6
ebola-1e99f22767b1537773fa8bc8e1c67389cb16751923d55dd6f20c36c2f7666d0d
ebola-cfee67265fe3fd3019f727ee53c6cf7561dfcb0779cadf676ec856799a964cd8
ebola-a4bcc60ba0e59f1387124fab5011f6caddd8a49868e9ee2e0ec306de4b629858
ebola-61e30a8c3c9b9ea7dbdc998ab04ee372eb69ecedec46c788041407ce526582d8
ebola-c34d24de458bc237521200ca0eeb8b58fc8deb2c71443656c976e7881711f6ba
ebola-f93e6a20b4937a6bcc4f6cac0780fe88a88aa90ddef7f26ac76779fbcb0cf063
ebola-fa0251f81f878fc59e6ff06e31bd831b14727fdf4a069849795d4de3a78c7a27
ebola-d9362a15bb6c19f6d8b70c3d848e08af36f78b70a2b2d8b4f6a215b8b0d215a8
ebola-084c66661256741f7b7e7e6a8873dfb805661e411f4907f0358db4ed94527255
ebola-31e6d3527d2b7e4263c875519f1e0bb5d0837a2fc4881fb91e967442a7552cd6
ebola-ebde68cdafe75e920cd341945bcf4f7b5c0855000a3c214db59078700b6b26de
ebola-cd8f613ad9b3f144e7f6c702d63b499fc291bf59b9b9f579b0d0da1882a2c662
ebola-20a933b9e7e7448030ba57d08097ac3431ea552c39e475aa988d20c93027eec4
ebola-af336a9004d1b8a1a38638ff188a6ff217d92e4cca1ca4e7bae59b337ed0574a
ebola-de7e58802a104cbdbf1bb115c3dbab608d6c3cf1b22ebfda93b68e017f78fd4d
ebola-54c9d6d2e0d3cf438275d525b63d5fb0e4883199a0952af4aebab8dac54ab088
ebola-8381a98a82f2107da36cc44d924f5e366a70882e5ef06a9413a15b939e4f548f
ebola-6c96c69704cc9ea40b4f8f55b40d8978d62771c84e4d0ca2ef4b01cc7ea8a1b7
ebola-d326e92eb0e5ba828702a8165ee2a6951816e38e495386ed760bc85dd01b82d7
ebola-f8f1939e1266b1abef6a025e516fe9bfcd888afdf6a1b952cccbb875a5d85106
ebola-df2c077c3b1710d993ef951074624f7a7a49b430c94e329ebbce524a9474955c
ebola-36f4bb1c2e38f7992ac6726a5d650d745a8b2b4418edf292c5c4f2cf4eedb125
ebola-3b37ae04a02e759fa0df1cc66ac1ed99925331627d0cc94f3fd857eabd152d68
ebola-97a42120f27802edcec54a4c19fdbc84c386a3a2fb47f5967135a50e11f51f65
ebola-bcae9b66b06e7e3cf2c4aaa74bddec875eef9dd0fbf247c5da4bf2e74d9d92fd
ebola-2bea3bbeacf09e97d469c4feeaeae61bf163b57820f86b783edc98b7497a0812
ebola-cacdb54e752b525004603009daba3fb40273cc2ed488223af535ca1462d300d4
ebola-06e52a4843fd1c7dff8d1626ad236db41b30ad3b7fd7199a35cd401c485e323d
ebola-1f346e865aef63e00ff3abd7e7f3e8f99de52f6c42ff891f36fbce3e9fa08653
ebola-4f0a08f0a14a5f7dac8009c92e3236b018781fc7ae954deb25f8bd61e7088d59
ebola-ef09ca70952aa43bb8e261ad8ab74f97eab576308a52dfa8395e8228e6021209
ebola-5ef40bda88ec0a8058df1f0a3c2bc1652618922bce3e1f22e804776c1a43c4ad
ebola-1fa8f92bb4d327d7bf6b523e11d7e96112075c91391123b4735f241418bb2519
ebola-ab39e3d23858db08bba74a00d7b84196c4bb4234ecc78446122446d4b6101b5e
ebola-a35f34746eccb87a1319a0b377b501dcf23f4c550a6cff965d00cadd983238aa
ebola-f2aa744f3de00877d2c808050514ebbdfab20ef01de3b667370682f93871558c
ebola-82415e9d4c5975305951509d21c2458f5c9730447ea8fa3484792d1cc506a3e2

list/click  |  time: 2016-04-29 14:54:01 694283  |  # of fields: 4  |  topic_id: 417  |  docno: ebola-2e9696e511a36a115c124c0e6334b5972c4bbe10a0bac15f830ecdb689de11c9  |  listsource: pink_findmore

doc/irrelevant  |  time: 2016-04-29 15:01:49 512545  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2e9696e511a36a115c124c0e6334b5972c4bbe10a0bac15f830ecdb689de11c9

passage/create  |  time: 2016-04-29 15:12:10 177841  |  # of fields: 6  |  topic_id: 417  |  topic_name: Ebola medical waste  |  subtopic_id: 257  |  subtopic_name: disposal of ebola medical waste  |  passage_id: 6449  |  passage_name:  Sierra Leone focuses on safe disposal of Ebola waste  Listen /  Autoclave installation and testing. (UNifeed video capture)  A new environmentally-friendly sterilizing machine is helping Sierra Leone to safely dispose of contaminated equipment and infectious waste generated in treating Ebola patients.  The deadly disease has killed about, 6,900 people in West Africa, mainly in Guinea, Liberia and Sierra Leone.  Known as an autoclave, the machine was designed under a project by the UN Development Programme (UNDP) and the Global Environment Facility (GEF).  

passage/grade  |  time: 2016-04-29 15:12:12 247321  |  # of fields: 2  |  passage_id: 6449  |  score: 2

doc/next  |  time: 2016-04-29 15:12:18 243289  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3cecf5af27c42bbc5f098671fb8940c60e021343514edbe3aa555b2f1d686dec

doc/irrelevant  |  time: 2016-04-29 15:13:09 420192  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-96a7772a19733e9a381227777d2d756ec3408d654ed5831deaf7611938a124a6

doc/irrelevant  |  time: 2016-04-29 15:37:39 769801  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-054d5d9b9c2018ff499be2aca347de5a7119c626ac99b8d2e1b82f616c423442

doc/irrelevant  |  time: 2016-04-29 15:46:26 702703  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2ab4f93500d7a43845497b9ed531e5aea56cecb25aa45a21295f3e33600fefad

doc/irrelevant  |  time: 2016-04-29 16:04:07 620519  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-9413cc41ab0cfa94187705ab6a319081f73cc1dc1f44a0d8316e74302c60c0d0

doc/duplicate  |  time: 2016-04-29 16:05:41 762647  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2cb069c0cca747b18a797fe75ce27998131c61a9482495b76cc5078c9b2400bb

doc/irrelevant  |  time: 2016-04-29 16:05:54 519214  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-023aafa8ef42c7179e83f2657be5f34f16783d666aecfa0323a2d8a9872170f6

doc/irrelevant  |  time: 2016-04-29 16:06:18 870649  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1e99f22767b1537773fa8bc8e1c67389cb16751923d55dd6f20c36c2f7666d0d

doc/irrelevant  |  time: 2016-04-29 16:06:30 424244  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-cfee67265fe3fd3019f727ee53c6cf7561dfcb0779cadf676ec856799a964cd8

doc/irrelevant  |  time: 2016-04-29 16:06:39 902358  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a4bcc60ba0e59f1387124fab5011f6caddd8a49868e9ee2e0ec306de4b629858

doc/duplicate  |  time: 2016-04-29 16:10:39 600160  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-61e30a8c3c9b9ea7dbdc998ab04ee372eb69ecedec46c788041407ce526582d8

doc/irrelevant  |  time: 2016-04-29 16:10:48 092465  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-c34d24de458bc237521200ca0eeb8b58fc8deb2c71443656c976e7881711f6ba

doc/irrelevant  |  time: 2016-04-29 16:11:00 572190  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f93e6a20b4937a6bcc4f6cac0780fe88a88aa90ddef7f26ac76779fbcb0cf063

doc/irrelevant  |  time: 2016-04-29 16:11:11 909354  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-fa0251f81f878fc59e6ff06e31bd831b14727fdf4a069849795d4de3a78c7a27

doc/irrelevant  |  time: 2016-04-29 16:11:28 319619  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d9362a15bb6c19f6d8b70c3d848e08af36f78b70a2b2d8b4f6a215b8b0d215a8

doc/irrelevant  |  time: 2016-04-29 16:11:37 977632  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-084c66661256741f7b7e7e6a8873dfb805661e411f4907f0358db4ed94527255

doc/irrelevant  |  time: 2016-04-29 16:11:51 904903  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-31e6d3527d2b7e4263c875519f1e0bb5d0837a2fc4881fb91e967442a7552cd6

doc/irrelevant  |  time: 2016-04-29 16:14:57 574991  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ebde68cdafe75e920cd341945bcf4f7b5c0855000a3c214db59078700b6b26de

duplicate/view  |  time: 2016-04-29 16:19:16 065016  |  # of  fields: 1  |  topic_id: 417

doc/irrelevant  |  time: 2016-04-29 16:19:19 681013  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-cd8f613ad9b3f144e7f6c702d63b499fc291bf59b9b9f579b0d0da1882a2c662

doc/irrelevant  |  time: 2016-04-29 16:19:21 808843  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-20a933b9e7e7448030ba57d08097ac3431ea552c39e475aa988d20c93027eec4

doc/irrelevant  |  time: 2016-04-29 16:19:29 520306  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-af336a9004d1b8a1a38638ff188a6ff217d92e4cca1ca4e7bae59b337ed0574a

doc/irrelevant  |  time: 2016-04-29 16:19:37 948241  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-de7e58802a104cbdbf1bb115c3dbab608d6c3cf1b22ebfda93b68e017f78fd4d

doc/irrelevant  |  time: 2016-04-29 16:19:59 635546  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-54c9d6d2e0d3cf438275d525b63d5fb0e4883199a0952af4aebab8dac54ab088

doc/irrelevant  |  time: 2016-04-29 16:20:13 591811  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-8381a98a82f2107da36cc44d924f5e366a70882e5ef06a9413a15b939e4f548f

doc/irrelevant  |  time: 2016-04-29 16:20:21 985747  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-6c96c69704cc9ea40b4f8f55b40d8978d62771c84e4d0ca2ef4b01cc7ea8a1b7

doc/irrelevant  |  time: 2016-04-29 16:20:24 690296  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-d326e92eb0e5ba828702a8165ee2a6951816e38e495386ed760bc85dd01b82d7

doc/irrelevant  |  time: 2016-04-29 16:20:38 971640  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f8f1939e1266b1abef6a025e516fe9bfcd888afdf6a1b952cccbb875a5d85106

doc/irrelevant  |  time: 2016-04-29 16:21:03 481045  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-df2c077c3b1710d993ef951074624f7a7a49b430c94e329ebbce524a9474955c

doc/irrelevant  |  time: 2016-04-29 16:21:20 007730  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-36f4bb1c2e38f7992ac6726a5d650d745a8b2b4418edf292c5c4f2cf4eedb125

doc/irrelevant  |  time: 2016-04-29 16:21:32 577258  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-3b37ae04a02e759fa0df1cc66ac1ed99925331627d0cc94f3fd857eabd152d68

doc/irrelevant  |  time: 2016-04-29 16:21:42 447897  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-97a42120f27802edcec54a4c19fdbc84c386a3a2fb47f5967135a50e11f51f65

doc/irrelevant  |  time: 2016-04-29 16:21:49 912587  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-bcae9b66b06e7e3cf2c4aaa74bddec875eef9dd0fbf247c5da4bf2e74d9d92fd

doc/irrelevant  |  time: 2016-04-29 16:22:05 762368  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-2bea3bbeacf09e97d469c4feeaeae61bf163b57820f86b783edc98b7497a0812

doc/irrelevant  |  time: 2016-04-29 16:22:32 099414  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-cacdb54e752b525004603009daba3fb40273cc2ed488223af535ca1462d300d4

doc/irrelevant  |  time: 2016-04-29 16:22:35 007186  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-06e52a4843fd1c7dff8d1626ad236db41b30ad3b7fd7199a35cd401c485e323d

doc/irrelevant  |  time: 2016-04-29 16:22:37 255064  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1f346e865aef63e00ff3abd7e7f3e8f99de52f6c42ff891f36fbce3e9fa08653

doc/irrelevant  |  time: 2016-04-29 16:22:39 121996  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-4f0a08f0a14a5f7dac8009c92e3236b018781fc7ae954deb25f8bd61e7088d59

doc/irrelevant  |  time: 2016-04-29 16:22:58 019482  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ef09ca70952aa43bb8e261ad8ab74f97eab576308a52dfa8395e8228e6021209

doc/irrelevant  |  time: 2016-04-29 16:23:04 198648  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-5ef40bda88ec0a8058df1f0a3c2bc1652618922bce3e1f22e804776c1a43c4ad

doc/irrelevant  |  time: 2016-04-29 16:23:10 193771  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-1fa8f92bb4d327d7bf6b523e11d7e96112075c91391123b4735f241418bb2519

doc/irrelevant  |  time: 2016-04-29 16:23:16 881293  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-ab39e3d23858db08bba74a00d7b84196c4bb4234ecc78446122446d4b6101b5e

doc/irrelevant  |  time: 2016-04-29 16:23:22 766414  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-a35f34746eccb87a1319a0b377b501dcf23f4c550a6cff965d00cadd983238aa

doc/irrelevant  |  time: 2016-04-29 16:23:38 634698  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-f2aa744f3de00877d2c808050514ebbdfab20ef01de3b667370682f93871558c

doc/irrelevant  |  time: 2016-04-29 16:23:43 583161  |  # of fields: 2  |  topic_id: 417  |  docno: ebola-82415e9d4c5975305951509d21c2458f5c9730447ea8fa3484792d1cc506a3e2

list/go back  |  time: 2016-04-29 16:23:43 762229  |  # of fields: 3  |  topic_id: 417  |  docno: ebola-82415e9d4c5975305951509d21c2458f5c9730447ea8fa3484792d1cc506a3e2  |  listsource: pink_findmore

topic/select  |  time: 2016-04-29 16:31:08 287981  |  # of fields: 2  |  topic_id: 351  |  topic_name: is there a natural immunity to ebola

findmore/pink  |  time: 2016-04-29 16:31:17 332358  |  # of fields: 3  |  topic_id: 351  |  subtopic_id: 35  |  subtopic_name: can your immune system prevent ebola

result_size: 915  |  num_tagged:  0
ebola-a18de29b69737494a6c9c47cc015dac8314452b86e50dac2e2f47c4ae9c58758
ebola-e4bfd61574e5bcdd72bf8990c7a00e1c46fcdd038f07ea16f09a852ec730b16e
ebola-d949d0dfcbb45a834ea6a272137854fa5c330ee752fa8c62a16b750773cb992a
ebola-466bcf55c6d549e87f238fe4a13c167dc1a5f1ef6a3d707502acf5fc6157b347
ebola-82375ad7f127d340bb0889010f21665d4fbbf301ef60f32800a9d8890cf61d6d
ebola-1d4f5439115000149f6277e8882d8ace38465a7ddc1e9486f3c407261b93c43f
ebola-0334c9d2d8c6fc20ebeaf2a717d8e6509a722987ceb82b73a45a57fb3826dacf
ebola-1c6bcb8a39a303740c6026e170781e6094396e8dc7eee005a1ab8a264d433bcd
ebola-68f2391013b50e09e82ec25466f7d88d1bd0bf9ae252ecbe20f3072bb86aae5b
ebola-500fb3d97196849479dcee1a2ebae78a3be40e0ceb0a9dcecb2b9d5df6dd74b3
ebola-998033bc626605f4768f1e0b347944ea68c6c8e84630f6183df2ef639533e753
ebola-a83a57b2fcb3526bbe38eac2f241a6bf774c2e2c0368c908ea2db6b4fbc4a248
ebola-e02c91972a5845520a6abe0d8e431ebed9cc8d5808ec5936029abbfe8c80cc5d
ebola-25ad218cd55ffd3af12363062ddd9d384803708ad3d096933d1359ce4c9980ce
ebola-9f4e9edf846627f8390ccf509f8e08ba31799407395c1f0e560c5331684af3c7
ebola-7e9088036cab19f2697a74169c3cf2bc9daa9a05afc8512b08030b9eae90c2c4
ebola-6441d5c6e88eb3121c3528cb70d298ec44f6399184bb5e864e553161e908bc0c
ebola-86649e495037b3cebdeb320a4e6a99747a29524c6c086605337dbe76cc95cc7e
ebola-a1a36abbedea15cd2f10b5640ac43a0efff9ff015aebc37abfab33150f775bd1
ebola-78c6e6d2990461763accecb60c6d51d530c8d06efdd8433cd587145e53396e39
ebola-8bd2cfc6a94d475eb626fb3beb998559946db7e62a74439e49fd759186ed3f3f
ebola-0d25e6a0b0f4f2d079e7a9d374eb8ef9e16ba100a1879232765ecc831da98078
ebola-05858a5ffd051447b1678ab6663d3ff1b5409ef2cb6b5f1e2aae6413c51f05c6
ebola-0ada436d2a63e50cf879d78ed9655eb12083ab7ae74b2b1585421b5007f729bc
ebola-f2da06627db9570ff9c54e34b5d3d5990d9f1918d91b7d0a25aa92cbe847f1fd
ebola-b8eb2fe2093a83773059a5266688505381f6364a3079581f634f4796d84fc5d1
ebola-a621e73c19eb48767e5ee6f2b6387a890ff0cc115a8f603a7028c90985043c49
ebola-ab8f3c4e471ea321804d2c403d7216010c91c847585636d84495312246d3c8b0
ebola-b8f032268d188fd2fd45319edcfcbe961e0e2e31fdcd69471a6cb1da9dcd442a
ebola-a4708906468409f2545e2509b4e53d966c1acc4068e0faf7c02e9394b65d56f4
ebola-ceb7b65c94a94baedc0a813b9057adf29219a511b522d55e6608db5a63322f0f
ebola-d31d7399abc91ed8035993a43687c6197d06b5c6af532f296f4570c3685edf36
ebola-1b452e1b9daf017aed79aab57a12faba8f1879bb02844444f36f56d9eabc9630
ebola-6a15a3183f1ddf66111408ed168a0a3fe34a04709aa68f8c6af84475fbd92bd4
ebola-42f4f57f8171c846dd4facee2377ca5ed7049cebbbb00da1cf1db39d74d8eab0
ebola-e921ee9b9840166f24acbd07c50de1ec248074a4d91b2981eb5d2cb667ef445c
ebola-72b2c5b95ba5d7c04863fd13dc804f6692c85113600283312567feca366188f6
ebola-83e871529b8963a46257cf6152f506eb30112bf829dd965c279b23fbac9bb412
ebola-46eefa2e01b30390fde7d374392b3d50f808022b730bdb5a6a7600254735f48f
ebola-f4a387bc1cfcd1f30559e8580892d20a3f415ec30bbe9576b29db62eb8581053
ebola-cffeb10942c7e8606a8f512fceb31dcbf6cf9138c105b584c68f0c2cdaa2eae5
ebola-a49ee790bcc24c56fa4dfe5f004d9e253f493fc1662e12b48cc86ad0298fefb3
ebola-1b300dffe371b20714789df7db1e45def9e2935d307d047a4bcf81d8839f3fe7
ebola-5736865a4a43c1b2beb2a62a6fc08645abb3eb4bf326b3dee094ba9d500e00e4
ebola-724c7cee8d029fe371f4b7d13d9f86d045229f93a58435d93bf2861f9e186b1d
ebola-42b5f3bd409dc23af6ad42e1e33c069b3069676090a72011e3faf504f66459e0
ebola-4a4324f9656dde1abad51a4e98371836240e2ee5e46685a33b8cadab2506238f
ebola-8f5f7023343b7b93174355a611fe6f7a08f0bf6cfbf18eb8ef8c8783bf67ec35
ebola-bf5741c65ac233065a4cb32e37f89475313d3b90785a3148751bd3a679c8e95a
ebola-2146bb9c29c058c51195205c72f89fd08c78944f6b601f822044c31e3d30f24f
ebola-b7909a84290ebe8b710ee8edd71abfe9b4a478752ba2caca914bc23d3866cd2c
ebola-6723f0618012bad253872ac1afc876965cd68777e1124c7229349e19aaecbb7e
ebola-eb08b1087db222c3f02c36898412b00c5d325f12653d8ee5c8cc2f062c4ba8b5
ebola-bb0ca20c33793fd54898ac3162efb29e3603b252a353768e829670b6389e9456
ebola-32781d4b6edbe35f750d888fbb725258e42b2974e291ed7d812026f75e82465d
ebola-fe819595b81cbef8d5e182f173e1dc09b2f0cba4c66cc27e0f693d9beab2190b
ebola-32393089ed980103c09aa716390a89d151a0edd24202011991b2116a2cb2fbe1
ebola-a189ed3d8f965651b82793d27efec14ed2cec45705ced11bc8f99f44636520c2
ebola-63f6f849f220503ed2ae40fd41dc8066fb54e0ee3991f52f46b9baef8971e05d
ebola-546dcd00fca990f182f87c95cd937a64efc3c4267b6db0c51ee0963d99cdb6b3
ebola-d8817bae92feca7fd0f83eccb7c5247d4f1a21107578b8dc0fc78afd6ae41e44
ebola-92460c51d4b8cc5cde29e79a4b1e5218c46d52dbd3d23185cbd5b7d9f6a0305c
ebola-809ec8361ba53ce870a7f350266bd43611b1a8f8a390eb644598b11015e73969
ebola-e1a4aa2573e57ad48fb44c802b0301921106aa9a6167a96619ae6bf14ac9ecd3
ebola-89045402a0e06ea81e7e01cdb03aaee11c1fc418a08a99ed1d31e9a05331a771
ebola-9259cfa27b87ca909826a5bb356c8fef307579c3734712145788ec5a0db6f4ef
ebola-abc06ea6264594aa0e83358e2b9979bd195dca84ae1877cb3ddd0fb6a612df4a
ebola-e8f1dcf19d51d0bf108b90fc0f72862a3525ab43af2a182c10eb622013635cba
ebola-85ed1de542be882339d05f47f07f68489350b09db0adc92a9461c7bda25e6299
ebola-ed6211c74b4a6e13aba25c6709a2fd42e9117aff12bc72925f3a469a77d44a61
ebola-37ed8b557d3e2e42451a6e8813d13150fb030592151aa767cbccba6e23061c16
ebola-4fd418f4dfc7c8307f221e82fcd81dbc865a54cf86c868cadf593d2e90b1761e
ebola-661d96c694afcc9d7b691b8938514f79ba85cc2cfa43d31f05312513f88bea19
ebola-7f4daf081be67fd643729272b7525ba0c04c75a58be2c25bd8fc76feef4c5a2b
ebola-9b456fae8941bc06b6fa3ff7089662bf83acfeadabab0d422e4ea2b000000fde
ebola-5d140bde858545d96d6d4851fda01d5ee38a318c3ff81dd5e12f9d00013b3d02
ebola-6c1a110bf0e469c04e162a56a5579900acf93cd50a514f8287e39c4edc7bae72
ebola-ee5782985f4aa62d8638784bf55d1a47c4740559ddf0ff3aad3d5b26ae983e1b
ebola-4516fbc1378b1a34462d9c7c91a6972e3f81cfa60d602fc58c42cbef36dfce12
ebola-1a875faeb598254c3e51cafa9b623fbe6ecf705b3d02d05ff625c5147435c385
ebola-00b0b1da306d028db39297da9ba6f7e7aa16f507f2bbd8c15ef1bfb1b6926c1e
ebola-e1c340a3ebea00da4e1882b0462bf6a7e2506d28a2275629ad004bee06257d1d
ebola-6970bd2509b611e180d45b2a71690d63d1e91c894a54656d3adb904e62781199
ebola-705400fbe6b697b0f8341e0c9f4f50f7c40126305d168008fb81d02a3c4b554f
ebola-7288f62209c623ddca8e6b572adb619aba398ba5f181a01aff82bfa3968bc52b
ebola-ee1780bbb53aaf5d88445e4c3867c96aec8242755190c4e108e27b9abef048cc
ebola-b1f151980953211cc6edc9fe0e8a0bf0bea093ecb2abf0a5612940cbf6cef89f
ebola-1d4a88284cca279b6f7070de62b18bb42aaefc5792085061351d81bfc8738d4f
ebola-40a1549c3d036781d98496d749d3d4c7dfbd0eb5da51d3e04a8b9522c1ba8975
ebola-71b484ee9fad07469c1c1237b6248065d68bde61dac5cfe3396b58f5e3aae33f
ebola-e8bffed944f541dbe04b6ef9c570e944ba54e2a7290d0fd69cb3a13bf5fbe8ea
ebola-e6d1c2c0092f1b3232f9b50fbedfff05fff3396835b329ab2fee95c84e0449df
ebola-a620e3357da00cedf24927d489fe82f69d37ec4a2c3526ee02c33f302b800604
ebola-63433e3b17ea95131561103140e396580ed22d6f0173c6681b9951819ae2ca7a
ebola-0da014208f8f8d1700a842972b9fdef64eec1ff8189d91517262ecc85b40aa67
ebola-f815a90640217bdfee82be020006d6fbaa797184a27732bca020ef4971e3bb76
ebola-176bbfdff294090ad587ee0f324e5c5f0790ae529468e1d2f9267dd7a322345c
ebola-1be400435b0435b44ecc90dee7aa3755d1950b1e52526f13d11822457e6f734d
ebola-58013873ce9b75d9fbec66b54c8f329b09a80ed57caaa89c51800b145f366a38
ebola-2011c310c9333b885c506496eaef67ea263c72604906ed965b7371ebc9579538
ebola-6b34186061a85c3ae0ef7c23b87418b799cded9abe3702fb8d6b47ad325e1cd2
ebola-552363938baf9b78f4ef1a4e582d59c48f05d07c81f8321b77148b8b974a6626
ebola-ad16f96b74da7bb12ba2929f5dae287f2c9d96ae1168494dc001f9832b9e6950
ebola-9279a1e5b40d5f036bf38a854e40e9e07fc59c2e3d7a462a28a774fbe106c519
ebola-bb351cea5a8a8711a2acf86646e56981e9ddb08bd016d2e99d0081fd80fbc889
ebola-089147fd31d5b54658dfbf055fc4050dad287ace943ebb441b917255d1da6ed5
ebola-16d3bc983791896dbf96578199822b3865c6c0afc7b75e690806ca48234ca0b5
ebola-b08ba1709d80bc064e7361cd4b5c7fa4d408882e72c443207f991b8797322fcf
ebola-f630f9081f10e200dbc56709733fd8d7e98a844392c3687ea7769cb8213f74bf
ebola-ab215c89c6a408c31b5a337ce016ed847d92cff4e71485f8db80b2a08695edca
ebola-937cf35fc113c3def740a92dd3766095a00db7fa0790fb97fd4218fe3df68e33
ebola-dc698eeb70b623ae78f20a70da0c302fbdefb40b858d2aaa921dd22a8e9490c2
ebola-ea233d8b7047c41c3b8fab8d7f57d403a72d18c960445f40006ef3d30868e028
ebola-e9970791abd4a625e81afb0dbd6902ba1bec6829df9cef565ff6196891379b26
ebola-e31ad3cd632b53ba4ccf103ab7edb64d2def09d2d8cdd46784268875b4e55a41
ebola-e6385b4b306de151bf70078f3263e2cc1d458e498858871c7eb256a0f4066707
ebola-bbf102ae70d2bdf07763b57d10bc4dfcc42019a8d08117f156dc8ba652d5af7b
ebola-f4941a91fdcd59a81f2152c9436eaf4b175fe6475dd16b5abd388265c5f2bd8f
ebola-c2c58d29db70fc96ce73d86d461529491ebaa44c8ac957282ee603e59e11768b
ebola-6606242415912c07ec4a62a0272f316088260e7c85547f35b1ad5b2f92b6b150
ebola-d930266d4682d5b984112f7d0677d7f6770b63687849d2887ff7a5bafb405611
ebola-2c35432f3741ce618a7bb78c00b174cb55f61906e9e52a4f9e1455ecdafc2a0d
ebola-8c40976215563e895c858f379df11f504a1a536775f658b9a4de5a7c21b2328d
ebola-a325cafd7efb7908c2bd5bf89ad9fb19c9200513221a53b530fb7475db317df2
ebola-dc56ecd196a11321e093143272f3854be6734874024a950fad5215996dd8edbf
ebola-6ea2a593e0dca431065237f6f7004adac88281a5d882d3f24d1ab9c893515d8e
ebola-8f09d8b3a0e4699da0200cc8083104af3fcad5cc34a0b693da417bb7fc947c5d
ebola-189dd0fffbc9cecc7c6041380a69bf5eddaf7592fcb376c50bb8909ee2fcf7f6
ebola-3daad44fa5a067ce5f2d5bc75a743eb0720aeeb75d074bdaeda01ebdaffad805
ebola-9e5a4e5ef7d6704f6fac5da19f96f8140cab6855939ffff189444243e62bd45d
ebola-2645c65d4b4f0d40ad893227a05c60a5cf4da411ea78af48e2dea0872ba58620
ebola-c45fdbb7198db4619684f06d0938e1d916a4b9a15b8dfd5b8e02002e9274aad3
ebola-f3c6e7674afdb02fec3c0af56cf1511658538990d9f356735840ffc2e124cc53
ebola-aeefb4eb595bc337634445cb2ece60eeb3cbecd7d51298d48c24ebe488d6257d
ebola-3d38262f233ef0fa569b8694543a69dd19db97c31910b76f1bb647c3aa746bfc
ebola-675e11938a1de76dab6e210406db778dd35f71334875090edb7c39a1ab56fd9f
ebola-31d25210ef47e23924e78a0b14caa57babfb7053b025f692814caf2bf2b78e21
ebola-b25b09e67f67e4edecf435ff2c8a2ecfd02f859bd7564c6f05f9bf430ed88fa9
ebola-85a043ed0b317ba4623da056e119a130504b4dd27ae699d861a4169b18a0fe1a
ebola-c0699aaf46b5b4ba81bb5f725f9dbe027f65f93736675d2fd8039add46ea3771
ebola-cbb922ab9aee6fcec2adb4c4423907ae4f19411fc358a2b61e184cb938f46236
ebola-41bc6e2b8d4eda08bc5f423c343892e09622a483b3fdb0f12803f2fd8bd4454e
ebola-0da37617cac7cbd38ace3da9d0a325d07cade21aa9a09c323bdd0566e53c2088
ebola-f377ae4bf8b2d416dfdba78eb638bc3f8d73b83c39a6b25ea64bb06ac1ddeb59
ebola-d6ca2d463016b2c9c1fb53a48d379ddf3cca8c1884f362332abc786316d4e188
ebola-824c09437cbdcb047c5501491e616eec75c28ca27f229f006053feda054752e5
ebola-1cb96ac2fd2db2737090f6fb370b38ce028e55120091ef5a80dfe37b1e2cf854
ebola-cb251f9b581398ab0f5eff35983cf1ae74869ee249199e148b837110acadf915
ebola-164fce488043adebf94ff0c0c3646e48a536a28aa076e53ded95e49f7fea8bfb
ebola-cf017bd93f5a25c3887bf24d62a14907d66112a491713cfa3ddae66e09923551
ebola-8c16ba0e735d553e8f17208a587c320666106422e79ba495a8d265c689a48988
ebola-7f913cccda8c0eb1354fab7666e0c8a89a8830db74f7186ecd5225ff26819581
ebola-88d0adde1591955eae8d2432d85b62ccebb4a63e8be72cca82cbfc67c2b87139
ebola-4b610a4df21ef7a2d0f7786b7771ea702d0b0bfa6692ddd8cec0428e272e0a5f
ebola-a9a1cbf1c088d65725819fa1a042f225ea139d33f6cd49cd49f226bf2ccba38e
ebola-20c93466e7785a4373d216487f46b5abd66d58ceb1ba260f3b8ac333caabb5b7
ebola-dcdc7cb18848ab0b2a56037afeb87cb902274823b9e8d6f913962d5dbb20a917
ebola-10410109473f96e02403c09b1997513613c748bdb08a32603cecdba22993db52
ebola-817b0897d9d7ef5f30fa738ef64d586f4f58b2653b3ac830f3d921fd5795dd00
ebola-ddedf4e4b40c510b9414b503952865320f588a1e676d308c01bbbc1f398d8ce7
ebola-c17bd6efb72303e69a73220b9e812f231705bc2f558102ce200482843330c3b9
ebola-1d2bad9e215bdcae81861275871d0632f7150c6d14e13afdbc2fb90815d72a72
ebola-cdcaebe40b8485f508533078f556afd2a07ac73c8c295394f375fd3665c8625f
ebola-d26146040ea2673eee485f9cb3c3f98f1e53024f75925c1b65c2420a6d723076
ebola-b95d201a836a34d841fc341ff06d1d443ca82637d52c4cf74284a781b8451ccc
ebola-e8a61c724fecbbdc1b4035102e7b94a55f33f998a2208da036dd1ca9b72d8119
ebola-26a07e9ef2684d6bff7e2e261a436e1f86924c8726559879e1caec16a1220f10
ebola-5f4d30e1c588f586189ef327c8c5086ea0096bd25fb37c3a47f8850d5f58bfea
ebola-b2031f8a3a0d787a624363b6c9ab12b935348a767e29833e1646898ceb58eeb3
ebola-8703d7570ed2bf278730ff281dba1665846b62df38dd9a814fa2cd1971a8c977
ebola-2bbf05d7d68d24855de7932b4f7bfe5ec3597cee8b4aa0cfa730c890e72fd8ab
ebola-231b3da235f0823b0f45fef0041d64f8a32145d44bbec68386e0e7600d984707
ebola-b381000c7a28d3c459ddface7a267ace1d81a20ab2395b8fa66bea2c6bf9b6b9
ebola-d9be15322169ebee63ce0fccfa6aaee7c720227080110dd072f4e32559cc6045
ebola-2c409404f66a34dc959e868e302e61e68b9e2a3fefe829ae4380f85612771f04
ebola-453a84d9343ba8442915d6d456cf260c91a6964453d2c7684ab0e3f1bba062cf
ebola-a6f50f5c5757097ee3d14c0cfc6087c2a15dabadfd0717b6899d455f30fd61c2
ebola-f81f98d94b9e32a719b360928069f1aa3705be195971e74f4ca03ed2d09d66d3
ebola-c25b8dec85677deba8bb96e00a70adc6c5f8248e5929e256c7a846d36e5279c1
ebola-d572e13b02a626fb12f0f205774f5d9f2b77ca83c0baf04268d561e90250393f
ebola-ac0cd14836b27c152cb74ec30e9625d07b50b69d8bfdb01bec4b4f2b4c0cda1b
ebola-1525100f9b0d54844f12eab335394c0dece7a5fabd90a4b8bef752e522aa5f50
ebola-cb92191b27e1c156c0e08f9f24d47b89454dccbc921c1916aaee52aaddda6a17
ebola-da6652d46d295bf5b272efdec0fca9a553d315f15a6fcc7563094ba5346dd60b
ebola-a36f4f23b20a563c1425e63345824230306899e288572217284db939568e673b
ebola-675cb51877ddab47a6345bdbc1e3e8a4a42f3e3deda906d7131b50e5abab2619
ebola-df4e89a0ed2a42a24597237998bfbbc7583a2ab2c7572328e2e9608b569ab5db
ebola-71223dac68a57cf20201d862dc507668ca4ec1a14a7fddf82070abe39224ae75
ebola-5bf21bade02b08d90b7b773e8733c75e1b3af39d060c09cf191679435d2c461f
ebola-d740dd52ccf12cd9d50e86b08522c2d144dcb99ba31f3885f270268d3ff515fd
ebola-d22f820b2561ffa6fbc0e62f6cc0494c8eb4718bc7a312c024e93c18f951bb68
ebola-18ecef40ee8c1af12326054bfaefe0801be253cf683990a467f5db901ef3db04
ebola-68036c6356012f8dbf3f4c0e05159781529eea8b6e6e62d62a7f1da7389285ee
ebola-5610b3180dacd3143d77eb6f362553efe4680ed1cbe7326e8230620aa03f6931
ebola-3b37bc3ea3ad82e88846d6f097044ac4ba463a7c954d748d900aa6c6ace708d2
ebola-31f1c07699e9461b7266fe62fecbfe70c4075e4871cda7b02c4b2e88fa51d33e
ebola-a41e6561c7287380ea5d7247ab9d656ed17b432f00ee34859d9211790a7935be
ebola-6edf4d615a2125a50fa6d45883e7bcd01392cba7115de38f3d37fe7d3bccfa26
ebola-643e04fb7d62be0fbeaeff07c52e10d073c97e9ed023ce711f04c5b64e6d65f3
ebola-649d7a8eeaff6b274d2c582f29b7296f103e29e9faf8f720fd14302a41c2ec30
ebola-9b63371276784ea6ab63d6c6cc09a04eac658b9978466ab13cbba2e590700ea6
ebola-36355ddfac5badc3a582461d3be7eb0b664c10c9f50c95313c8084e3fde9c09d
ebola-7b5a8a779d0206f600dfcf1e347c83022fb8d5c7a6f341d50a6b433724b865b9
ebola-37c128f44b0a535084bc33ae554c7374ae8b42ad71d1830a859e876812fb23d9
ebola-0ef3f0aed5fd23fa7c5214e709ecc89d436ce7116e806ea74067fe7d376bc393
ebola-eea696902b826990b1d0de8b20563a9a5f063d9e6ebf77263730967b6de31d74
ebola-20abc79b3e2830b21c3ace3f37cfd0001b8c54e93b94d99289ea7ea680d0017b
ebola-8179ad3c79accb27d82c25498a20f8b02448f3ad3d5ab514d6b8590919050083
ebola-acab304d49c904137cf9d6617d391406f47f79aaa514fbdcd78151817286e610
ebola-f27fa74252f35ca797c81e1f1b99015fcc5c02008ba864cef940c06edc1c961e
ebola-018703f1924bd78df72b8f18e8618d8c95afc41253715b41de9284bda7b62dab
ebola-4d38df452f221b9fdae96a983dd0d94f57f8bc9ba12ed272471e54e366febdb9
ebola-3669c784fb14321af753d2b9bf377b9b805bf6a810348edac7df7092930592af
ebola-fb487f4261d11d666b9e349d8ab36aacf6e1e651973243c6b1a67e1def650d79
ebola-c922253239debc1f4cdef0e0459304ea66c0fd01a73287588c49dffc2fc6fbaa
ebola-00e02860a2a5aeb02c06ccbc3bd05a5fd81a6f59e5e4c8b3c5b32ce9381bbac5
ebola-2efaf26fa623980e6a98616e7bafcbee2ab423f622af33205088861782ff9838
ebola-a49ac4f632cdb4f059dbd558262ae8dafa198d1c6ce97d393d7d370039a5e993
ebola-9b0ba4d22b20ddc45096b58dc0af6796bb7140e268be0c61614e08a6bfaab7bd
ebola-8386b261ea3232f65b5a89753d2233dfb86beb0e85664af61e28ab51194a91be
ebola-7099354457a9e5ffb1c157f76d3274c616bd36f9e9131d4b013de810d05c99f7
ebola-a1a2041aa4771100a50285eccac441e5aee299c954cbde86091ce08d41528243
ebola-33c4bb72232e66083fb4659d94c92d5d060fb64e4715761f968afc8be5996e6e
ebola-b5d9777b40fb63c94479ff5beb1d0d1239daf2a1b34155cfc169b4c349fcc229
ebola-63e49f45df38c439e18821a30228e8f6bb2b02797f7a3d4f11134043eab6958e
ebola-98f46e75a9fe138b53fbc4b47286d0fe2c07b753826aa2fb01acd2c6e792f272
ebola-29ca97de5c7374cf148e68a900bb1bb3194c18305a28f706fbb1fb64dcabd2eb
ebola-dd0b92d526a4572a2ce6aa66b8c289299c5836844a0eff62bc25bf137e9dc37c
ebola-d79f8ff5f42fb4d3a6ff5df1402aca1269d85673e760f89c93669c64a843bce3
ebola-b929b6d69fe0f9a6d5ca4b4e28bc7ab61d6b9f3e05a7e7b0ea533fda42d6b49e
ebola-fd1ac749e7549ea29247bf3572b5a0caa2d10c82cf463d0aee031214c7de4961
ebola-94b56302ef662f9f24151ebde31d096c64394ba2d9e426b9160fe3c6d466d801
ebola-7d33901668ee9b975cbb483badfcb2473eda600b6c5c9701caebbc2c963298a1
ebola-86ac72dd701020c66df3769c6c3c3e6187a8986bd1ed820635695a7f89f4c717
ebola-be6a2961ba5b83cf0230cda0065f7a8417d8ecd9c8703dcec5850723a4817d49
ebola-33cac1e1cc1735c43a6db7f58a07dcf70bfa7215ebd7fcb67cbbdf18b1c8209f
ebola-630b51d3e4767313eed9814de1f92d04d7bbbc453170d455bc6047e8cd61101d
ebola-30bec5c5bbb6fd9d81e7d5896485c2ad791ff7a0de5ee258696a43f9a8487757
ebola-e3f963e21d5e3d62c9e8a20ef374815015b25db7ca9d833f0cf625c695a9b4a2
ebola-35ff1030d868605b05457b473c8652811a4a250a394d21215072b71eb4efe411
ebola-e1a43cd09edcfce8474b59d8a0523a1c00e55d53478ea097a783b6152ae29c8b
ebola-f8b957639b22d1756280703aa30402d570757c3267a9c8aa9b746d3ec3804bf5
ebola-d37b8538d611feeca71d24afab33320fef7d8ad8592120dcf8c28c7226ed2efb
ebola-c0dcb6cfe1760223d2e32e5556fbb55a498547bf83746b8f8a53e53c95ba279a
ebola-fa27aeff2c0bfda3887d0af7d8919d9b8e5f9dcd9a01678c57cc9634d8203344
ebola-8579b6884641dc373a18cf12792f87f1f44a1e743b8bcc788d6fdd1a0f9b31aa
ebola-3958f022f280d790b0502eab807145d7a2ab4d87cdc2579f77a7e5fa67016630
ebola-76daeeac0d2b857fe94ea2f6c522fa42200c2325e41a487ad1da10861080711c
ebola-02b7035c1589e64c33102cd5d53f364525ba523d4e0ddfeaf498136da9c12d60
ebola-64bc34d4313d64e549f08d9c84c4c5274680fa0c8f08136eb6e58723029fb66e
ebola-8d7d717d7ef757fb8f0e762948a4d8eca5f74e9a5ed036045c2420a794bbbdfd
ebola-12d17f4ff0e6a05e0782315f4838c840008f2abeec770b92d13a6528f94018bc
ebola-892bcddec2ede4b8113559308dea9467bcf5c8d9021ce1cab1768837a31cd806
ebola-a569092a5b775b7cad1f2ce87e340bd0dc947ae04b5c3fa42914c7099d100f73
ebola-37bf99785f4b6365a92e61dee860fbc902f641763bcd38beb6cce9fb8da941e3
ebola-e7d14ff071b3afeedff5c53783317cc7535f5c129cfce6fe3d81986f91a85f27
ebola-496865f3857ead3dd90dd91e954c5329ba87153e3cdd3662b385374e41528d5a
ebola-b4aea8dc78c325f55ebaa25f9e593eccc69ca9b2f81dcc62d961f9cfec5c5d98
ebola-03b00782006f016de24907b31a2844c4eb11b6ded584054028e84ac54368586a
ebola-286f3df2d24a8afd859f0b957ba2ca16ba683958d8a4775403c40498912f95d7
ebola-a732928237cc1df6d0ac38b62fe4aaba64c60ad7d450953805b80f36d44610d1
ebola-15e029fa721d9714c8d36059b3540a48d9ceeb2bad9573bc5bf66082b98ada13
ebola-ca81e01606e52c60edb9a2ed82d3661d93bfd6a11a77242ed6bb253042cca0ed
ebola-55ced704f349d123333674474d99fd0807b1df9bee5ef50ddf87060ea128d663
ebola-0fb450103b9a64e10f52207bc4d4aa987e3a22d7711b93fde3eb81b99190bac9
ebola-29d7ae6f7d996b58381ea405a0b24c05c6aea578868d77551a0a2e494ed875d4
ebola-b96186edbf8fc2abcf17f6276e4f87aa285f7840c28660af509a68c1323989c7
ebola-3180fc79511a2d749da7e7d6ff5fd7728072156f0ebd4e4125c358b0809948d4
ebola-3f4a27be908c6357e261c54c5f88b8b658965d8cd401f3ade8a5a3d61ef8363b
ebola-a63aac758e730666b2eac9e1d0892e0e6671bb9b2226f0d9a7a53c4f513e1366
ebola-05b43a334ca1cd219f6e81d10c5e4fcfcc4607dc2200d67cd7c2edc7daa67e8f
ebola-aba2632a074ec8aba1c4b9e71205115d9921a0be268208b64db3adcb24d337bc
ebola-523bd3f25d4be60c78c4df7e8fd46da3cb0f11133b444eea7c22d4235dde962c
ebola-2000918a373062179c55c5145db1fc5d4587aa90799e0b6cdb410c9e6461901c
ebola-b9ff06e75ccb8ba361d25072ad25cd8d716455e8ff648e81e602f7fa7ed927a3
ebola-95bd26d14f93ac6151b0aa8d2cc5c82e224a219cea857fe071db085a030e2f95
ebola-5fbb3ce9e42362f9f1fcd48951dd470a2bd82769ef9886e51de7355509ba6f80
ebola-02b065f01f9f1738496422a08fbceef09f966d33c3828885b036b93b45454576
ebola-52ec8a31a2d110626bdd051c8878afd6489ff1edd12ab66ff70b172b7ca8f7a4
ebola-9689515fb12ba62025974fa54240d9461b79c6f03c70160ccb3156030fb00445
ebola-44a0d2eaa4842e8797d30ed62e620d415e14ee19a26d483f26b7fe7b9140a00d
ebola-c50a5068d30fb7369f01733e70409a7099673a1515c15bb63314fec5dbfc4032
ebola-f27697f3382b41e2afbe90a1a1c1a999dcde204ae0a4d5d80aaaf721e3a33947
ebola-c5d9789eae42d5cd7bbbecc0bfd8776d9457f99ce9e910305cc2ea6dae51731c
ebola-16dcba7f2f67804538fe4bbaabc5ebf793e44bcf8a2c133ed8bcf4ab3a64f8e2
ebola-f754a3015a2389ee92f4cd0b5ae420b3d01167b8b1bf2d49271a15e0709b2e73
ebola-06983215cb0e680dac9f9933c989f37865de0f425120af0f39ce65f136780ce9
ebola-e6cb13403920dce188e5af4886100116a83b427d8cf8a85d4b62b781ee3b60aa
ebola-8ac3a9e81a5ca443c13245ffab4b9ea98955544ef4643bcbde606066e3edc01a
ebola-04d41ae86e34840948ef63cc263214e6fe2bdbed6525cd89ad99582bfd1ee28f
ebola-a5605a48d91ff6fed5d074f98989f391a906d608be6c77ebe0ee3493cb92773b
ebola-d2bde1f956270dd4314381fdc5b7b2159ec2fe5dac533c3d15b471e2c4d5cfe7
ebola-9f2fec5bd0324f943bf2fee481f2bd020504696596b8b1236790c56aaf87bf87
ebola-8d5ebbad80447f9b4d051067af2ff25da5bb1868eb23103dfb8376b896e2bda3
ebola-135c8f7a7d9a862aed3798c85f90f9da01cc26052fac033a34a0a596ceb6b9b9
ebola-1562efc55522851a02e4c442d53549847d2c9e22d564840f3361d07c5d4e372d
ebola-e408bce41e4f6ba0a085b27c96110167abb7b07caf2b98201e6e486930ebcf8f
ebola-5eac0f1470828e7b86cd52a4ed20e0c9d6825bf9f3f5d278deb1cc2ae9eab38b
ebola-0b5506d927283ebd61c27f207bfa0392a3bbb405a83af0155136ed8f462b4a38
ebola-5255d3cc62ceab2fafab8c92a056b7cf8be1dae923df2c7d31da3edc5e4f24f0
ebola-3b9660935df12d7be4618a486d141a017116680abc9337fee3dcc9020b42a9a5
ebola-04596ea5bb216977d5055b9608ec239b0d5100a6802324997c45a55b52a9bf72
ebola-5b77f12f71efa2c0e1ab83e941d5af3c64d4a0cb941be6ee8d5349068e0e5e85
ebola-1ebe30d5a9a86a5241acdd9587ed940f01863ba6bd8ed534ff37f9221d952fd4
ebola-ef64b4c8546e215d16120326f5b5ce04192d8d207735169c08290974da65cba6
ebola-4e7b2bd51285c97c98a018449c48c11719be7f07547bc3c0fc979450a1f45b2d
ebola-75e3ad902a11bc5e071e96993894023a325129a8fabbfe3c27d7dd7751c7349a
ebola-963c5bae770533ff025f80fc508af41c19b30e470e4f364e27f06a11f27a61d4
ebola-4411049c535032e045d6b73f951294f0a590491d7fe51ca1a95f3dffb2fd1577
ebola-b39ceeb409faa9966e02fd13e930449993e3efabd3e60504b98312068f0c680f
ebola-6ae9304a50817f4ddf711d37d51f679d73303b4200800180ce0bb1d12d6b10a5
ebola-1a6f2c82c5951b1736550abc72fd70ace15db57da4b4b40655f72330eb1915db
ebola-4c1c0f1c9bdd1e376043c8192ec8ad2dc6a852cd7263976ab1eb481544db0bcc
ebola-e3c790420d1cd7b6a0fa099c9d2258af1f24b35b5bd8ea134c19639ac023fac4
ebola-1a26e1727d9116c38a0976e20063a6bee83d85828962423773b2c31128db9684
ebola-5603c5a9138b16d72fb9109908a85bf0619639936e881653346dc6588aea788e
ebola-c79363aafda665ae15c1ade7d097a9595a785c890b981de4e31f72b6713e07fc
ebola-063146f4cde9b482d164a0c953963dd41a7b82681ce382f67ccb1fe572b10c74
ebola-2ef8888fc7704c6bb7467ed5814872a5168455b5fb2ab578025e983d65e8aad2
ebola-b19eb5fa1b0784dc6b942686ce873838220663268df4e81e5498a72e2678d3f5
ebola-f53b76e90c5dfcd04b08ae277ccadc10215a13feb1f68f67b12fa8016fae4074
ebola-d3f9311de6893a832204c7c920d8bdceddf2701c5d2f5b292de75ed52ee807a8
ebola-923dee57c5b59f805ccca496af3a587a9b6088482c0af236d24fe00e145b5e07
ebola-f8430d3fae8c1f1267c2ddf309d4360c082aa119fd8600cd50970169d642f0e4
ebola-258b856803ca78390be2e4328132873a1b80d2e75121a46c5305ff6692d61026
ebola-695a880b3c9b416d4ee7ec65d0c0da2baaf02e0197b05c385162078504b66933
ebola-f445cc684d83129f98e6185e576722ff07be85b94eab9a6c53f15107a58adc01
ebola-5c80165c0c9c6d7bf19bee76c7b50520eb5bbd3e54a068c3d101975941bcdafe
ebola-841f7b45fc8db176f2145294a023905c6f1b07e8d3fa8a5c42f74b81ed1570cc
ebola-9b6de55be3658b7a295425dc611ed5a0c720f55636bbfa144130fd7cca951dc2
ebola-78200d78713617755714e3081b13798bbdadb8bdbae204b302ec8c889c5bd3ae
ebola-3262e58d8b12a0439b4fd975019369df681484d81777db41dffa136ff07ce704
ebola-105a80ab2cc9e31f81c5e7a582d6dc7811dbcbc5aaf470c8fad928ccdb5e8eda
ebola-d3eeaa201fd3c447dae9814473ca2839a6546ff773f2361150c720f62007cd61
ebola-2692dea23c728796b566a8e9671e137b805447131177c941197ee5236980bf16
ebola-0124f1f947dd5805a0856dccdc7b572d0c069ed7c775c9a6f72ebe90bcc8e128
ebola-38de0bf0af7a438554fe10dc15607eafa138fb625973fb852952a4fe4c3e2ae4
ebola-421849d9f5bd1e59167a01d48a78cf8bbfff3eb2ab1a84ac9043bbbeb60b0f48
ebola-64781891d107e70a7d027ee852f9767dca8669f28ff674f96e41b4c7699f5085
ebola-0b6ae5a5a99c8064f5f5ba1372e9cc4ea19492305526817f3bb1086b31728890
ebola-e0f2835041e72f78a759e81f043e8791d29433c34e41f5f9403ea1921fc05384
ebola-f908222922b69550790d9e7985e38749e9c6668347a36011679ffb69c65af0ad
ebola-b286b48392a7a53cd378cc8c472d5a6146686dcaae6ecb462ceec876b2db0f74
ebola-219fcd807fde3000437701b103a86bc542e17d040bff7f94842753a7540d397b
ebola-85b25d14e902b7da70d96caf47685de282c3fe7426b51c4e8b885258b665d1f6
ebola-e8c1990573e78ee12f801673ddde767d18b6b44bb47822ead431de76d2bde5ec
ebola-37673f033c53d8d4141089210a9342f1acbdfc9d1b491b3cca0b9b2c3e8eb68f
ebola-f833cf04a117307cd34c10f3a79eab63f18a4202f92f9a55dd2a20ec156bf15d
ebola-a8b0dc51cb798e1f5dbf59e6e64533fed65ba79f79eadeef19e77d8c3a4b733e
ebola-e2a1409cd46aa403c897dcae60a4a8914b56837f49495f11617bf7aeb9f80719
ebola-7d3952a20ea5b535c6c3431ee221448397a2a6016e3f39f08cac7a2cb8cbb851
ebola-d11b14c6f1a73cca075581a1c31bd2d291819f4e1ad5f684edd0298886a821f1
ebola-49f7cafb8115cefcf1a3ce664d1dc0b3a2db5535203007a3ae457fba1f045b3d
ebola-34c0f05131ee5cabd28a385cb0b4fadb0af08be86cd4b48cde751fd0441b564f
ebola-cc32e09f14d9595f20e3bb5c8c8dae56220c0244602a033a3a5214b990aae93a
ebola-12eef17e2ad052d05684317dfb137d79fa2ad11bb5b7699bd331bce7a9f30ccb
ebola-01737bdd2198b18809b609b8c103ea0aabb707a6dba2c3bcefb188d2ef5f35b1
ebola-f546be2987246b8c908644146b66ac8e942cc628429257588dfa28ee6abbfaba
ebola-5b97b91322f9f220badfce2214d6992aa0ee72c34b22c496f73f1d2e46188c0a
ebola-a89b7c17fcc3edf538b893027cf35197201e1913d0af2a2c290c18aa6b3d2b20
ebola-256f3c71833d809a5cad195f9c004ee02605287fbee5a81ed67e83b97bebbf3d
ebola-6c2ed39460411f761a10a98ec70f93d77ef04ea204830c3e9b027a60437a70e8
ebola-3c02608629a5648a2844078ab141c3b418dd7d645430d91f5f091a034ae99a16
ebola-b932de9c9f0cbfcc68373c3b5639912522d35a9c049ec6aefabf1d59c24e9c34
ebola-bf3fad2c3eaf878826f7a692d9930dfa8bafc1125c9645f53e8c0bb41a50f53c
ebola-e5d4ee564effceb55074b92605e148cea4e6bd77c0ffb6f77e3e53c0d2ed85e3
ebola-665d8b86a888e8334754b8cc5448a61300eaf3a4ae3af9c58786be58fc8e2160
ebola-ef9e36027bc27ac38aca851cbcd1c331be4ac2a28d997210971b60b987251c7c
ebola-f092ee4dff1344df074fe7d01dd849a87670790a59910f8385906c0b28b6f062
ebola-4e3571112cfaa56359cfc8abd7e661c13c4814a9aab373039f56d015788ad725
ebola-cc47d9b3659990ebbad658c66027c99878597a679b00c06d097d86fb389ce72b
ebola-e8d611543776b81e798c28b405ecf5d3372e69ba2286edc006caa78bde06a401
ebola-6fafb0e65c5a282cb4de9a4189346ebcb23928039698c031e3873f5f795d2c8f
ebola-3aeb256fdf773571b6e590302d6a215c5f36096e955cac197959929958daaf62
ebola-ad9f28b949b72a76af9ba9b6340d7ccb014d399d45e0d809f1165dc70a5e216c
ebola-07c45cad7aacadf9ac07005fc2b669760e02f6e7e3594c9af83626cc67ee5e69
ebola-14e47c14c2d6ed8dc9c6c4000141178de33529366f6a3b4b97100597f77803b7
ebola-1719b79e2f6ac9c28b393fbc7877bc5dc79ec139d575f8e70f24f4428b528d19
ebola-ed0e8308570084c26cf4043b2070526feb57dbce3bc66e4dda6280b9e47536b3
ebola-c93dc3d4c95f5766f82b468eda9d2712fec8f71cc4d864228951da0885192897
ebola-210327f64fd8b4f54f103e6cdfc71c8efae5e8c3f2eb92afa7856d6ea6f55562
ebola-cf56724c75c5ad7551ba895adb041a8cad59429a1b30102b064785e3956dac28
ebola-90983431ee364aceedc31cb47f7615f270248682fa01cd21d8636e2eb5b7309e
ebola-0cf76720cb71d4b5a24a181537a02fac920dfe9e9d55ecfef436d3758cdeea25
ebola-0a05769fff893735a2221ec817ccfdfdbd6669ef6809d10f32d62a8a023855d8
ebola-0a847d656d4d4b47e8e4cfa3a6f8229995326a0869fffe5fcc0e698c42bafd99
ebola-9802c1f640c9d431d7349ea39f7708805fae4aa7aec2b902b4cb48e519e71291
ebola-a40abde60dc92669ac3b29e8fe7398687b4e61b8411efdfb55accbc8d7c37027
ebola-3a6f586272d3887be134b6f894c9f10a038a5650c93546eae1df93187551512a
ebola-2172c4377f3ecffa553676125e4f6cf312858e907c12b2f612d9ee681d1ce254
ebola-c4c214a74f389276f4f7ee8bf90600555fa12a3fbae8572670c2b5cb24874ae6
ebola-3c4da6150c42847730c58f99891f6d96bfe3412be6209cd6dc8dfa7ac7db295e
ebola-0356e7187dda787814c3b7aacdf91423da407842ed46f949d4cf8ce4020d977f
ebola-5c71dc082dd4a949ee9ddfdb37db0cdb12ed6afec342b75e4c76fc50942828fd
ebola-9a6fc846bfb79eec344af78485c415468c78c5ecc2c38a39fea026e535bf030c
ebola-7083ee06e0f205169e2bc66df4ea9ab27f8e66ed0aea02b3d71e214d64891968
ebola-a1515651e3539e7d95a17f9cf233f2ce615472d55c4add93377eb7e60c02058b
ebola-1c0b6cbd0c76c4859369aa84aa9e08e045bb4a111df6851c4e94f40bf803325f
ebola-311bee5570449a5dbb1c5d0ba130d9d7377f49f0767cb8ffdcd897e72cc750ef
ebola-0d5e6bf66833aec76968961cb152b508619752214da2cf572b48d56e2ec1f8b8
ebola-beb8a40ee003cef6a9ce27daecc77304923cd6367e917046168faa2b35e757d5
ebola-40ab92d8aa794992199ceaa87b14cf9d771655141f5608e88970184af1c730ef
ebola-a4004a5a4246f0526e2192ccc4bb62c866dd7d18706ea3d9264263101161a972
ebola-d20affeb0c543e6a683dda89b1bcd9bd9c1e9f404c209e64b09a4f05c1f97f20
ebola-365503503419b735d0253b3e3da09f12048e8ec8e3e560a9a3b1d8ad5cbc76e2
ebola-9436c584aefb9462e986ff7b70955f0ef04f092cbde249d3ff69dae7572ec11e
ebola-01012ee56435c1283e749c52e7d549d9e41f58f844bb7aeea2241b6fbae1a746
ebola-ecb688153a7464a7b25917e3134c8341f2dbbab4450d9ccb7f639924fd6be6dd
ebola-bc77038dc46b4e2368ffcf61d9cd17a4d9ee8f7e6fcc2463f3abc6aea2390bd3
ebola-c89db7a9362f8c00636adfa457c8863723a14f8affa5164c316a15e3f40b65e0
ebola-f212a8b4d58dfd396f651131a20e615ddad881aa96e87a8335c4c99fdd2bd7b1
ebola-3caf25fafb5dee334d879e46d0ae322935c4ffe6861b9820e43e13776ca69378
ebola-5805e1a2f3ada22c2aeedb85d72dae1a5f1d623a01a40a3528aac2431580ff0a
ebola-ded9f063c080907dbb5282bee0feb6cb1511fc934298e7b3f24de6b267288f29
ebola-601efc2f78577f394abfd267c464e0e8c42ee27fde9a5b0d11780a722ad5e1d3
ebola-925820aa2897f326f05f6371d8e2de92e8a942e27cb8a72f172ef47ae027104e
ebola-aeac4fbcc248976f1b7a6860235604fefe6f2d701fba9fa63231132d46515d67
ebola-e0030ae0dbee0424b5b9481b27ade18a2522b8362c0efb13575e4a8b816b9248
ebola-c7a245874d194424b9ad39a5b863631c6341d745eada2aad0d5ccb73443854d4
ebola-78af51df68e84d3af37d121cdeffe5df83bc0a92a26efb9409a4408614373555
ebola-a767b6434f48e41ed0304231155b895b353843f84d1e646ef822014f370579cf
ebola-06be494266468790eb7b8f9c07f7640f1538d72cc6bb72815e3ddef6ba4512a0
ebola-3d34ba2133d558071a2a004210718babf63fdcc09d276e5f683e37306f6f2bbe
ebola-4c462d22ab59d134039f75d1998eb8d7ef384b9841d10816eb5f6d41fc7124ce
ebola-28469837419eb7c08f62bc473376df1e4930b34cc5c51bb58f040233c8ce3de8
ebola-0e51efa5aab015b69e1b5422bd7426c4b851fe26561f3162bcc6c935a1157f69
ebola-a50b4160657a86239a8f520058c648c177d8e9057bb63193d0119a1f53d2a879
ebola-45044175cca108d60f8f9e95be5470ad5239eb7bf0e5c6554e150927e41064c9
ebola-a06b049f1ef557624d9099fe7a4c1ed673b1a8e7a833daf701807ce00e701fc8
ebola-98ae90aecf782e7922de5c3075948967c49592c017895a2db2e2e18efc7cfbd3
ebola-6bfedd170edcc11bdf8df536f8ff1e07788de18ca1c36417b95f464017660576
ebola-eb710dd650901a770568d6a9abd7f640785448d2cecb89157f2a57784217eeec
ebola-dea2c6c2615ed4ab05be029248dd2ac41b4037a6bbd0fb09fae3bff5191eeb9d
ebola-53c7839f84bac7fe127e5ad2abba5843e03ad81af58511981045585d84d52a3a
ebola-b27b610de1c99a2244af31156f6db1dbabca228f6e8fbbd0505519e2f2847e27
ebola-8be9f88ed0b4673b0fdc19e209ec51eebe0a9690320feffc1eae20755a8ddebe
ebola-914805f8360279863b166741eda1a5129b25a6a0f4a4fadceec5d352d27d9b66
ebola-aafd7a0b21b0de932db883002095a444ec2517da3e580bfcde996729a57b21b4
ebola-c4a305dc6e9e809201f3e155989ed4490ac383244040ace84d51000a28c232bf
ebola-488cef8947526f47ebeab3f0109f655381d593adb3ed223a87cbdc1865a19772
ebola-352267b016fb4e4cb2ab6e53cf8c509e4caa10e5ada05f3c5b958ea093450cc0
ebola-5cdd40d067b9c5291129c2c2412ef22fd958d757236fe145f37fbe2f0bc1a45d
ebola-0b32fa8e09cbbeba945154f618b05af057b1ddbbda744fd9762c4b4f3477e80a
ebola-7dbd6f26223464de4a6f90bd9dcca687f3f4dfd5a454530a028eed2dcfa254af
ebola-46d6dfb81679211e5feafe4dbba59f51b5ded8d245cd33430196fdff4b17e095
ebola-58e3160a41c08df44f3707cd4f76004286fe975a0cab53632b52b41c5a03f83f
ebola-fd151cfe935eb9544cbded5b011036a671659cb575b7300321366313d2a22205
ebola-6fd11dfd78eff66973ff5b67e404aa5ad659b420b24f94959d0bfd749e800cc5
ebola-abb7acc19ee0e523878135f120d0471e30d51d0f3766f85a66fc714e914a89e4
ebola-a06ecd17cde184c5057a5bddd5ac8ce0887030cad75c7d18e4f5ca213beb9e51
ebola-bd523bc85e3143257cd6a4c67bbba44983ba638b724e9d156ce9fc3fef73c077
ebola-0ca18b67a42749f067becce3706eb5c3f719a89386da9f4c3db72d0293e95396
ebola-ba5ba23e77ead5d37dc2e85bf56b737d6fe499e5ddc25deaf9119baeba6a6caa
ebola-01aaa5e0d262161fa6a7cd2c5c7df4e7651852713d340f2796b8bd056a7d40b6
ebola-a70df5fba8cb9e9a686587cfdff6c06ec2f7a5af12b4dd1ef69771a26cb031d1
ebola-32913d88147ef8b05e01dda30c27f8bfdf73e795f8b97298aaa61ad5ddde8c87
ebola-a8fcb222af6ebb5b2d23f1aa3026c67346b23a7981f8991ff192902b1aee7308
ebola-65c0ac8f25b64d417f52b2fd07b3b6ccc5bea8666afbbb5a11c381383fd82a08
ebola-3515a09b4f535499747b1dfd61d7f4aabbc0725ccf9b48b37435bbc7262d8c22
ebola-6614fc1656b3a5d007af7d897b3f17ec24f2eb4e93bc2cf4fd6c0e9812bef9c4
ebola-e8aa7c577c392ac0e015505cb6446a9b4c5547c86c650b6353adf264e4dd0d9c
ebola-bf8fb959e21b0516aeb3ec344dcd8e9e817206474a308ed2a23e5b4ab570fe82
ebola-3ce57df9e6a26e3ce1a653103c744f778d8c2f7ceeb639a145010601ce847f90
ebola-fcc5bd91f5a958fb5e784b9fc463b757b505f41ec5fe3019b7dc67f9f416f70a
ebola-ab9cd57cebb1d9cea466414209b832655a33fd1e11bf2c8b81a709dd47dcfbbe
ebola-742c01211cda86d1638fd6259bdc4ad855fff461924dcbea38eaac976d8b72f2
ebola-37ba0b3ad145e58259d47795c5e51877e5a378fe91d4de0f7a96b95271752f06
ebola-bf6e1c3791c1058d79de14a757f47d89b3bb31ebef968dfabc8ca084e98c2c7c
ebola-932599f2b35ff6b5ab91e653701b0ba9a07c4951fffd0720ed11e354cf11b218
ebola-329b634779d041eeccb5da9b3a1e2fae095af52f16fd95a3af1f89f902e9f281
ebola-a178ab480f2eeda58acd1ff5d5f6e24936180f1acffd1839211d093f843ece74
ebola-a5e436406143d0446649d7bb1f402389c6eba5decbfb0a21bcad47c1e48e781b
ebola-604057ad35887835878760d0fc304edb69c0c80194d862633923b903ec080ca3
ebola-d522d5b5e0f13273f3603f56699e825bfaac56450ff63e4adf7df4b55dbc0136
ebola-a7058dfbb21239d809601475c1170e7dc8dc086b1fa21d2e7537a0a01aa7adfe
ebola-7c3e80239da616626023a8f07aca36b0912b81bbd2296dc7b2b8403a9f7e62cd
ebola-7925b94d6a27e1c024d457c1f871641c4e70e013dbc3104b38fa0f2f1fc4e22a
ebola-47762a9d8f19e22e1f78a2cff17963fd82aac1f055ac0656abb4577a621cdf5e
ebola-7172531754e2443f5851b24c90c559d8e2bd6ac35831296f12f3351bc1ce9841
ebola-8283e3d646232b27f2fb4884e42d1817540451c8d695cdc7d4d93656d4e8d71f
ebola-47f30a5bfa13afd72898296bd673b6d3caf5a941522bfda013d3e5a83872e16f
ebola-9184d567a273af5c6ce0d448fad57adda15fea78ea6bab1b19c879d89b7a7bc9
ebola-3bb3f7312309995fa5af5e8a62c1a6679a170a1ef78f4aa70291621a6144c967
ebola-059bff8a826a28c2742cd083f226baa3b308542d45b37986a81c946edc3d923c
ebola-2cee63d3711fdc297e70ef2bf2fbbfa8caf3a0371ac30bbc50f1c39e0dd38372
ebola-f6fe41aca64270a532b8436c8ede8de91a87e3b731be78d10f6e217dd22011f5
ebola-93f7a5a047fa7bbab2aabd85054a43a74c658ed0d9fd8ada32b2cb9c95838e5b
ebola-282d42817b54d7a6b100c183e9012d8699527114772244de3999fb6ace0928be
ebola-75b84a107885d20028bb27e9de345075f5d0c14abba2763d784535edd38d5b28
ebola-e7c53cc76ed22991d745e948322c8670011aeb5c917de197afb538445536e7f9
ebola-8cecb0ed0f6b964349f850663de905a2449589ffe2fff548f76a8147aec79937
ebola-986a0f374095b3ae93bbd9e9980d8d41ae84da668e2b5f304fb76d2ace0fab74
ebola-b9af27246f3d942c8996aa7c4064f970ddd3ab89b654e4e58c76c4adb3575f56
ebola-7cf144251c45ea69e2d3227e16f9cf03717fb14c184df8146cc8ef386dfdbffb
ebola-3adb392b0bbdabcb8c77421548f148cc229ab7b555d0f28495ad448a0b2e71ab
ebola-2aeb6eaa2f3d1c463419e7a2e1fad2cc99f7630331e7949b744e2652ae12a9fa
ebola-ad1c4267375d0364648682ea1b5ab80e691d0f409f30fe75604a6c3dbb23f1fe
ebola-a767da5f00a3745ae183c02a61be0687a99ce1f7ae76e14815168b3b4596909f
ebola-e05d779a3fe45f2944a8b105fd323b34a160507303540fd4ff7c2a4e392ea04d
ebola-f51194f28361213a49d4ae51313a19f9eb1f0f7bf6c87feec341960682094592
ebola-ca0dc61f6ca4f0ab8f4c7ffe760f7c231a444105b8f20dd12787f84c5f265d43
ebola-6cae01ea0de2d050ced10934646e814977ce5a59060a7531a5f8edce78772639
ebola-845adb3625b60b16bdb7e7e6bb3e1f8c324a56d65412a5c2b922647f9c2586d0
ebola-a56bc58e698b0aeb567694e2684717533ef86da44e6234ad019e60ea1aee32b4
ebola-11af54bbdd09fca53be266f2d30072626856d62ab01bf8fc495164f147254b1f
ebola-540e5103508540aa0553da5d7dae6b1044d14532ce22d798f631c70aa67210e0
ebola-688c668ed3f4a102f43c64011e571fc49b393d34a123aa493f35834cf85a7a0c
ebola-cc71ec4b5a9163db92da66654c6d94d13e0ab21f8a6e41ccaec360a1a41d251c
ebola-66de96556a7b2d7f202fcaac54a0aeaf9fa60452b5cdcba054f758e6bba78fa4
ebola-24bd596de73c0c10b2a91809c14c7eb563a15403804dcdae94e8ab1d02a8c2fe
ebola-e00d076e451d05071c608fb69015054ca7984f9b31af0dc0de55c08880f60561
ebola-6c4f84fdfee2f49485c4d76ea535d11fd51f664896cba6574711ed8a42ce443a
ebola-564e30107795b932872ee21ae710cca3ecea2b749e3c4130d4204130a7b7cf74
ebola-8590f49ba4630b403a249ae5f1a9b13fc40c6a7c5ab48da88c3ca7db296f2b19
ebola-59b1f07a6530a8f8e2bac5271e691755e9046212dba2d4326132226467aecf56
ebola-a8d0fda426bae375222e108bb9153cf03ddba334e0db021e90f271be13502d70
ebola-e439b4d79aa45faefed6ab6d7189f3b9a23710138c2ba53a722154fac5adec3b
ebola-e83cd3f9d0f9efdd6822c9e100bf9597a83ba6bf506cc90124e6a345d2b68d55
ebola-d82bb8350f6ec3d4f188f6175578c4fc8ebca06198f8434315d422cdf1c817be
ebola-fccd0832b3a97eda336d5c08eb7722776d126c67f8855dafbdde3cd928376fe1
ebola-66adea9ecf6d2551858327d26a5b075db18cba89951ffee0cf0a902028346a01
ebola-af0285858bba058899884774cd6d458c897fda432c5c723d458d397b62097aa7
ebola-ae02a6165a7cc0aa44ea1e272374d58717a7bc34a869422b5e8ec5ce00709225
ebola-b215b97321fca20f81e52c6fdc6640fc6cf50a5fc3972417b63cd1e4fccd959d
ebola-cd314159dd03436c418da45d498e9be0bfb601ff7756b3866d536bec131eee1a
ebola-22cc1915357ec68763b035dfa41a926d74622f003823988fec7e176a415893f6
ebola-49456811f0d8ed0897420ca368fa539dd9cd2cd17829eb1bdbc2393eb6832504
ebola-5d7f09a4d5c6cb87cc1a0b0b3e17c692c0017e7f4934a89227de496cc4cea2ae
ebola-fdb22170bada6deef59dda4d9ecfef657a23f988357999145b32fa551fb43e6c
ebola-c1e777c291a41692dcb790421f21b4d3c32772d89f31267d1ed32aef76eccb61
ebola-6c992b30311ad8048f8aa04e14b5a0151208c77037a22a9e38d5faad5bba63d7
ebola-c19962bbb5b02c8d436f0cec2b94d0e089bdcaec7ec869436b9c2e7c5594a674
ebola-e19a268e05eeccf5ecce97f37e338bd137d969b836d470019b6f7eb22d007997
ebola-11acc1e4ba3ab946daea521f0e197b3e74db8853f62b6133588ebc46f413b79d
ebola-b1b42c6ccb392a31f0928249d5bfdf732e209cdab63604656a60da308973be4b
ebola-b1b74f2706deecadd682acbf49621beaad8fa72c2b435c158bfe91d80f3cac5b
ebola-4b7a574b8374974374c5c1750d3c94217a5845ed868685c9798faf44147b3d68
ebola-954f058f96e1bcf760146e9b34d83b8144d4c85e975f7e0a6cade4186bab3582
ebola-cbf72df8f8d0b626fdd9573cabbfc79e476921210afb410b91331f2d9355d5fc
ebola-2857cb2f8d645b7bed3705dccc07eefa8fb7bbee87076dd9bda08991ac63a2f9
ebola-304b63b43756f6cc27a536f189ee2f7a39fb90e2733148d6d2ab56df6f48b3a3
ebola-16a7fa818c3ea3c4aed9216e67372fc744b16063acca2fbbc28d12f131dff0b5
ebola-69b11a5e6c62a9d5fd32ace01cfa594a2c5548bc6c5883a0cded71905c269c79
ebola-164c04bd9b8001592574a2a0c18a7c8b00842f8f9c71e1773c09aa41cc084c13
ebola-96d217cc620ce8a1e4c0c8bd94325ed2bd8526a3e11e47306cfb9ddd8449561b
ebola-21a5d0567628551040155a44fa5d8df0970fc94ff1efa7d0552191dd5679f8d2
ebola-1e2014c8c90d662119e416a100ce008c0c8002b8d4c3b12b2a1408dbd8e1d897
ebola-865b39996640a0594c613e273290da0dca6d4040324ab662c35e9aa4833e09cc
ebola-7dae7fc7a6fcb9ed87b436cdb9944b8f54983321a89ce5fa6cd83b811a121e70
ebola-c9c58e444864598eff4ef9b55f256413b1e9a0994bb28067b91753399f6e060e
ebola-044214362ec3af58e633724ddc67f57ef5f79e7b081ac888e04c56b720e69339
ebola-655b65c64c42e660b63ea52285dff6638354cff62d0336a09b53709974eb393c
ebola-6222c67e806e966a5cbe281bfc9ffd1f37599e1446ee1f7045318362c1a5fefd
ebola-48011179d4e8e143ff8b232add65bc3f785886fafc81dd36bb8356c432eefb03
ebola-b7422bb3d02e82c93eed7416f4ff19386e5f9a932a953101cfbc1ff279ac15f6
ebola-5f8681696a08fc6eb4458fa4d67eda2f53698a9783494025141b2f9674ac7929
ebola-cbc544cd02e88b9665d4cbcf8b619730b38ba1b4f93e1b2639f2556be18b8898
ebola-6564a09159ff42785443cba2c7d182114ae602c777d094d64823a7ce63f68c8d
ebola-2bed41e07a17f480711ca5435175277053680d5c2ba91b5e7adabd511e842401
ebola-61e2f7e403186f829787185909695fd2266ff3fe1e9645d75d3d2fe6f653029c
ebola-ee6007f92c423dcfc9cb615f0f73769b4f8652262ba9ba5622c66746da5f82bb
ebola-52776f99a2a4356929cef81cdd2b2c88824cfe5cc20a97bc401c04f35127afc5
ebola-91687929940f7ec0b7570f2ccbc8ab5b8b59938c25c4fb6a44df5cd7a0a0afde
ebola-697d9755a2b280fc40818c728e104019deb84a30d27cde57076a9dfed3d49e59
ebola-f3e3f69ba568f50975875da0e35c927e9b52e2a5ea8eaf84d66c90e1fb70a7a2
ebola-242286cb5c62c86669258246ba1cb25a5fcab7b7e66922c95798e27fa81a778d
ebola-885d00999af4017312cf104dabe4f1cbd32ab7bf5dfe7c7d8a31bc0eb5dad727
ebola-5dd026a7bef2d02bf3d81c46f5280342827b0ea83ff454ce500e453e720e4d7d
ebola-6a6a423f7723a57f36b209efd279e1499320387109ded5487c95a14b155b2d38
ebola-fa460dc600e79ab49bfcd160c1102c1a1a3756206671e85ab7ccaf93bc6789e7
ebola-95968eb2b6a1c94352d4fb8a750e2b624f9fd6c11b674050275e867ac684dbfc
ebola-cdeb57f24534e00a883f28b0d702d8cc559d252c0ff757a3aa5b5c73f39e4ee9
ebola-5fba7c02925829ab4aa8579f36788319462319780ef16cf3b129afd875194566
ebola-13af5df4ec833ea98c763043a49b4485319f9cf447843ae469e4fe5aa8e9e31a
ebola-aa1e273257fb99eeedea50437a507d7446dc7be12839f1ef6679cdfddeb5d7c9
ebola-e870689ff729528cb7be75a766acdfc7d5dfc3c07b4cc9f7055de542cd389829
ebola-70d73c95e8c2385b5ad4f23da20fb5ff79271cf673dfb377ca29259932e37a47
ebola-73f6f8a807b017a5f2f4b638897687c0da4565dd491f4154747ffd16cc570e81
ebola-68f09190a3db2a0f4d5a6552b119c090e2c818e463753cd03ab628f1c4adc1d4
ebola-4a0ccc2347c517962ac9b33d1f79648cf1848e7a717ad0f695dfb4a113dc0aaf
ebola-cebfb67c024120a5055604d6ef634ef8306e41583561377597ef9274418a3c8f
ebola-41940b4ebde08e7822de4c03cf6b830994b3650c06595dfcc5ae4102bac508c6
ebola-b7f0ac53ce0f4dae14aa3505a6fa21f7fc4f50eca84a6b82ed7edba7da2a6bc2
ebola-ec1db4d04b500b97c2d7dc6d610f19716f23d98b7bdc3f6453f499f28c379d76
ebola-2da17c56dd0fd13544f09d653a1b3f6d4962ef786835016f9c886afe9acb47a8
ebola-55606385a24c55b870ef3920bf59fe335a3add6adc95d5e1bddfdf94c7aedafb
ebola-cbe3d5acb2b58a536cb21cb5d236c62db635e9c2422809dc113c681288b56662
ebola-9f634599de8f87a469d041f51e04030d10990cb466ab9d0214b22f10bc9d1250
ebola-21831356cda05cdc673536ac629b3b5800b549201680e0f89aada4fe804628bd
ebola-f7c9fc99060b3deddbdc787e09a6884f2774c83bfcc1da6936bf871a9343e99e
ebola-975b8281ab5b62cdffa877933300176963263676a8b76c2fd7d2bd9997d907f0
ebola-753bb3c3e55a7e8562c97cba98635cc10d9ad899a9911777d3f6aabfb6384e3e
ebola-6c40dce15cb915ef86c41083f27460f5da18641e6c47479958b37918e2907629
ebola-a68060cc6198d20913cbc540b6bc79b9cdd7ffc42110b0da95c148c0ce82da61
ebola-cb7ee7b6e4d96ce7b06491a846a002c74bcd121a276784e5c17b64737cf6736c
ebola-20702daf1c34c7b91bd1010eaedbdf9cc8826946aef60a133aa4130ef5154e1f
ebola-b6a388826d58f8911ace295f593b936d831919b78ae4b5d3b33f74e8f1bac911
ebola-5e0b983ec4b0852d78ceb10172094033661294b9725b718b85675a29e34cb269
ebola-51dc6063c3649e5ee4d642192db8aa9d009f23ca58506d064fad8fe0ae513967
ebola-c8ecfe076e1200642b7993184a2ef252c425665eeb4a46ed94ae87415c02e8c9
ebola-cf2c2980f4b301ecf37286f8cf21338fb5a569a864ca5955ed665b8650cb6510
ebola-572dcae826bdff5aa2ec1e21f152ca961af4a6a8b6b178d0b26041985a0d551c
ebola-3cab5052ca0eb819f2f0d2aed3e063267aee22de28cef2110830519d0299e022
ebola-fb54e122c14c2454d24831388dae45a39f644181e0dfdc99e6925b36512f3c28
ebola-792271a90116614ffd7af4a323042ee446502e2bc1b2d2da8b9c72021f8b3fd0
ebola-67f96f830598a34ce04a40abd265e1242118ace4cd2697dcbdae221494661e00
ebola-ac241e13addc59a22800de1ae84781791bae50a418a11d590deae1c8fd83ddd2
ebola-dc440addb2fde607ed7f6a015005e88b07b11e38649c3b535e4458ff174f1a43
ebola-99b13d97de291a31b2351eec74aba77c3b47f2f42e9a3519a40a0998ffa68de5
ebola-a7d6d958105c9d65d84e6dd6496619e09c7c36d47eca422ba13efb129d4b9228
ebola-ef4e1b1050fcadcc04eaf3a05ed3916472413441b35bc3e90e1aa4742d711871
ebola-7918bde4af3a152d2777122b5a38dfb89ab0a2718649bc83bab8f1857a85ea79
ebola-2eb13889b96abfa1ef399e4bad04f226b262bfd8975ae0f73e96c11297420488
ebola-985b8577b1ad30e8bb6b3a75fd937e987de4912bf0f3cbd245648f8dbe115994
ebola-fe9db3e253c245e082fa5e9895787175a4d7322d2096f8cb7da6d043c59c5cfb
ebola-90676edb6270e21c6460fcbbb96fa8ed4f156f9499dcd589de07b18ea6dac3e8
ebola-1ae4cbd8d255b467b807c929c6b4f4597fdcb4bbc775c624b390ab9a6720dda7
ebola-6ceb3839f85415f8dd6084b8ddbaafa7a7516d240eb1b4d6b5d1626d33a4f400
ebola-23407d4d3c69184ffe6cb0cf27930659607145337e7268b534bfae13dfdd97ea
ebola-989f903cc696ee8ea604617278c20a41942f0356dbc9359e06948c238877dd85
ebola-e1854d83d60db9a2826247bab1b8896a867032efe5b9a3ad11d5939dac07e820
ebola-496a6f6d8596d9c5187f8c2705b6288c6cfb0d6f2c7dac97ce7d981c731a037f
ebola-9d3c08bd7d51df8e133f352738de74ff8ab3bcb7b0d40f204c7a0ed1753ddd4c
ebola-24a196086c44cf3ee933c853ff4e74be2f015ff6a3e8843ef89801a2d7383a4c
ebola-3cf00e06f319d0c261e0425ea1b6e5bfeeb205461461644844ee9696245f427b
ebola-04098531a1bb5aacdc1ed017300d3e6c3e32c9c577d875c581d1df040313cc80
ebola-1c6005743a4ecc962de820721ba067b6d90ff0003e63132e5b9c51f1a06e902a
ebola-bb1942ff49f1fedecb28c3623b71004211ec07e7e3e3d8b716c581ec75854cf2
ebola-ef979a98fa2c7645a42e8e74bb60e720801b0593f03ecca2aa5cf774a0742cb2
ebola-b96704bacbd725514215237d69885130edadd38a6d702bff5ae45264b7643264
ebola-899da8ac52ec69c550d97ac5d65ead054420ef36080b4c58a3dc85b9cc9fff02
ebola-2e60dda7a03de84cbf58c28a2db9cd1400aaaea081623d30296021dd74fc95bf
ebola-a62697774aa923a90469166f3f7469b89549e44a7796603dabf6838587491aa8
ebola-d21461443397314c16830b8d1fc09c6c86624aa946f42f60247cbc3924e860d5
ebola-de02422be5abf9a837bba7300581e71322ad4d19eb16a45843d460112682af63
ebola-eb29f6ec4e3393fcf1560b77a19bd5ad66042ce6fbeea18919d28dfeb65e4bda
ebola-04272f2329aea924a2eea913ed87647e054a12688bde272e80517b476d0cd81a
ebola-730b566fae04af959e7f514d6d9afd18b72680532fbac812e5ffdcaf5be02a90
ebola-beab2dd8b773979044dd3623690aad0130ea9688ce1d6501391a970b090232ff
ebola-66aff1a86b9cd23b5851ae6f80cfd4edc168790737549be1092e7e4682d250e0
ebola-6a0df5b25a28923c26aec6f760e0c8e55a638002e0534e8afde8d99fd1e63e23
ebola-bad1d9c274b7580a6218d5643ef16192df491abed8fce1a92019c4a9c4e6b9d2
ebola-53500aea18652c657bf33aeb8e21ff7ea2e5a0e929e2f0f7b7d427a1698b5047
ebola-b9051caa2d8037a6249e0a6793247e814f4069f22e831a8db3e4ca949491ab6b
ebola-6fd98d6c6513e446baa3b233eb420eb080ab92b3c3c01828d8706439a96b0df4
ebola-deeaabb8323d50c3c483c20d4b190623f1ff7ffd9a04496bf0f58fa96dde8be1
ebola-f30b8cbc1a9b49eaec2edcc125082071c46bda92ec56c50cdf52b5fe67e0d22a
ebola-b334fd9b73cf026dc713037629a69e138edc68d76a133680f43ce3695b651073
ebola-8acf214ac116df25259ad687c6fada6a700897b54a8be79ebc1597c8d24c3892
ebola-e062cf366741acd8a2a1d5190157b7a4f97a6b10a6ab1e4c7aca495a4ebbd7ab
ebola-7095bc3e9b343245b9ac1171415ce8b18e1c394420a80f19d5bab8d3238aaca6
ebola-80f112391a34c51fcbfb6c4b37d39e3a4b1f41baffb3af2ebe39f7afeaaea13b
ebola-ce4a03e626f0a324b53dcb0b3613ff49b7ac9d584e09b87848b62db1eaf6d197
ebola-3450ae3160a15808679c0fa5c28a0eb49997a420b9c6ce1bca099a0ab94bdada
ebola-4438b1cb5063e4f902e8fe542e80d9a99405080d502c3c035753cee7b27f9317
ebola-6938ef8f470d6ce4958b67eb6417d3e09cb31b1d015f830e0bd282393c16ea7d
ebola-27c21d463781715fc5b84b4fc5109d0258c6702ad403dfa81727aa866bf904f1
ebola-ea90013e011932aab3be4e7f616d5d75c3bf5f05cf99ae839ee7820f2e6e7ba0
ebola-b99808e0bcf85c446d01ea8e4a9708301d29034fc21cadc4a637cf973a5b38de
ebola-c6deb3ca815378733d5c6647b0cc0f4ae60da669b6f2de21fac940ff53eb7d4a
ebola-6d08953fe5238022299cfb4c7f62bb8b1ba9bbee7d5c26b19ded71462acd5007
ebola-d11e1feba451a9eb2ec0914360c9e8f20fa187a56217e999e3fe963ecd1b4abb
ebola-66048953b921ad0d76dcde2ce7605ab8ab01e20e285b10e282a3c242cdfd6a87
ebola-213c99a70e663bf7d9217789483ff2ff3f2901e197a5ae7fe6669449663556aa
ebola-e0930abf5bf13e8b7ef671f4aad651a1aefbc1ccc5a263fde9b57a4aaecb7366
ebola-0d7a0c58fe8f4b66988dd66909cbb6bb16db7bcb3e91716fabc746d99132e5f5
ebola-75b5894f588b6824c9cd724c62800a91c0e696f95b80632b7bfc6c90383d966c
ebola-438e7f0f484d14a7e3bee417a31234efb92a9932626b90d262ddb34c72fce57d
ebola-38f9197e9778a3e4b3d23bc40f939f0fe401d863411fcfcdf6ba2c2816e6ef9d
ebola-27740d348ae09453efecf62381d3acc637cdfe49a9e037356b10f07b800c4dfc
ebola-92dfd01e35910bf86eed0e71c026864130e2ea6751133bdc23a123ea53137ccd
ebola-c594fae4aa4c79f125c52f70f69c27ecb700af81a21a4a0ef674953087455fd8
ebola-d97ac77306f2e6a6fe52ada6b2fc980fd0abd72e23887a5809591cad4e40b2fa
ebola-b996f2956ca92f851eafd528474205230d867d30e8a38cfe0f882601a96b0ec0
ebola-a4c447a18c665d6bc48586c14b4db38d020f197ffd7cb3f9d610e0032dc245b8
ebola-e89a0e2502331cb76bec3db9f5d892a92ae76ea11f6c507172de581f38d2d16e
ebola-ddab0bc0295624d792e7dc8463a152876e366f93c5679b618e21e7c4d1379fa7
ebola-6525f5ef4f132820c28a79120e916559d9052437f4b3ad0a527a051202f75093
ebola-6a6553a5ae9f693b3c8a04f25849259c8af4b075a7c65f03ba018259566a24c6
ebola-a4ae48dd10b21cf2e088833f71f3b955e078d8de9aa043029c769c838914e5d4
ebola-084cbcd9cc5514e44ed7417eed47dce74463d77e0ebb0fba7bac6468dd620d0b
ebola-b64b7a407cca349068e0642ca465917dfdd2a957a57a0656386dc8a05ffdab36
ebola-89986b5a77bd298223b6c14cc1dea31581203e7217c96bff6b734b20a71b42a6
ebola-4da3437c9fb586434202e4d0796c60c812888fb2b16c5cd14fce6961174e5a9f
ebola-d52d01f92f32d69b9c937d3906f46548282ddd4682c7222b89fafe741d62c40e
ebola-2d318f5fb8cd99e52a139f865a4decb6804f9dfb31e3612248fafd7abde1f274
ebola-ef5a24dd1ff15282a3d6979bd34579109f1db1f1099ad862490ca31d864bf6d0
ebola-9db5763f208bdb61e7255f673e1ef7e1365994d3c8a9cc37bd7c38f7944b42c0
ebola-ce9a096571a34309d3127ae6b7542f3d62b9436d145e7f7532fd5a77382b839c
ebola-4899bcd2715ee910a47ee1065d43b156f02b9f6d44bca97980752ba8caa1e20f
ebola-d03702cf99eab90d907ee4e361c022c5bee8ac1368871f0da8945c2475090d04
ebola-b4805d443c12f70672a9496954ab11169def0ca935e41902ef5d759cae42c70e
ebola-c9543453c01e864c08d4536e6e111c26df0c0bd19317b6294d24a1e11f1c04ae
ebola-b7e8352546c4df0b4379b7fb851fed45ac48fdbd6d7f624f25192d2edd680133
ebola-21eaa3c6e4b767ba8c52d450bfa38a6ec74e3e985a619a6b9931845cf583dfd5
ebola-fa269e9de43e2ab4e0a2251f9b0acfd3b8af80c45e930fd0e8dc8147ba3d6091
ebola-bc72e2c64dfbad5654cef2bd75a8402a1e0cb3fa383ad1100d02ee775e019d81
ebola-a5c6fc96df093f4bc1ee16d5eb0b726be7c23d819f8ea5ff7a3c5ec11c05c0be
ebola-ca300405e62a4b3db1b750666994067bc5a1a076a68092502af52ece1b2409a3
ebola-9d2a5050ceee7c64efedd953c2c03390c5d52ff62061ff1d6a225c8de9a026ae
ebola-694a4ba81f15da1aff2da0c8cf54372c2023d505ceebf0ca5207bb88160179e3
ebola-7899a0578d3ec475ab4fa570c76b67abb87deff38eddc375ca9a90f0f1c59a8f
ebola-a9b58133b102f6b7205f30c9af08da264d10bd1facacb232fbffef052815bc04
ebola-8f7f91d9077fa0741fb99b026ff075b1a8006854082efed70e72063a3ba19570
ebola-c2dbaa1bab07393fab6b220ba5ed11f33ea092a71268c5b9f347f6dd2d78f46c
ebola-f410c372d0ea9218433bdf940271c2998faaa70963026c34433fdcb814ca8520
ebola-f86bbe7427e8dda75e6056ca03635e6bca9ef12445fe08c49308f8ef971b9bad
ebola-3fdeab8571b8d4ce39dbefc6000176b2cfa91ea7e6541132e83800a717bdaf77
ebola-641ff3381196308245ec821d6481cb4a451a421489d17b9608506d197fa953ae
ebola-9f7487c08463dfcba9bcd539c053ddd196940976d44b2d8b72ff7146e2617ef0
ebola-6337876ae5dddf5e7265369abc2ac4a5214780dfdadd2d716a88d00142e978f0
ebola-743c1dca9a5917adfdc1a8d62f8db597cf9ba5663a6d9eb4a3fac96b748a263f
ebola-519134a02a958e0b4fee5b92c826d1ffd7500e5b02f09b611ac71e52ee91b8e8
ebola-e3ef2b63366fc76859293270f43bbc5e2ad130d8e7b82a73ffca37ccd4d4b435
ebola-f3261cda4173d6d140483cd534f034c5cb1e1260cfdec440b90d3a3d590a6606
ebola-2d32f8520da72c345a13791ccf85e5e5586af3fb9e24cbe97f0c87ef7f88861d
ebola-c77cf524075052be36eab7214717512ee3af19949e191c11215cdaad4313fd6b
ebola-d3a523f33cb1b811da48a7afcafea3aba4139dc1d6b6273cf7cbfc398662099a
ebola-8be48d6a72c261993f28f6eb63264a393bb873d99302a03f5ba1e31a3182cd8a
ebola-bdf865e0dfc2c6874ea78e0527caf916f844467eb613c775c4daafa7d3fb4b6c
ebola-e665c4e3783a03f2e6aa636b6e787211b12b2458643607fd14aa5c48a53c5727
ebola-48772d467a839b4ae29687ecc54f5617f0c68157812cd6b516448ffbaad929f6
ebola-814709b97a3326d240bae756e1213c1abfd06bf46f213fd0040a23e90196af10
ebola-06ee94aa216df494d601bde4411c19d1a5eb9ab45ff0662c4b849ed5c40b011a
ebola-7a94100d88af5b35fceab5da549ce2bde7a23cd2137118e9250252386abac1b6
ebola-6decfa3a70b7c5ad21efa738c088c985db75564312ff1ef670ae2016eacacfb7
ebola-d0ebd6f416ae8bd01d1c097ab07c762fc6c22c7ac4bb2bafb5f6d11e642f2b36
ebola-7d25fa01ac94d6c38bce8642ba5720d459abccc97a683c0ff49343161a422ce4
ebola-ce510489d7f54a59264affc9f0caea3c93de7098e83a19b0bd17e1325d4f69b4
ebola-d36768232e944eaa31a35e6a996838b293c939982e1134046bb42dda8174e865
ebola-3d08190ae57ab5bbd793a3bb400cf2b27616eb0300c5edc490793ad40f6fb0ab
ebola-b4481a606d5eedf6ad0c45481e0dc98ace8a667458245b8a7b5d0ed4217f6a4c
ebola-4b6fb3c09a65f676364be83d42fe6c9360ed19f152c8a334dc2fea6cf7a31b93
ebola-d9d4b9171690e39a2a478ceed107e111d8ce3ab2b4865b718a177ca511a18b59
ebola-96a185444572254db852b00ed420a90cca0f3e106ae8a44ed3c874abfe3bb936
ebola-1fe2b28d1fac2c390d954297a9b9710322553e4e280c00ca8bef1190e2a12b9a
ebola-17a32082331740582a980f5568ba926f69d7b31ebadaf8669d505c1f4361dc38
ebola-eea0406bd85cf48131508b764dc7442b739d7ca73a246ba2a2273d9fba181626
ebola-d0f27e54e53206208a6418695c5e859c48e9f74eeae8a026f8f940c0a2cdf4bf
ebola-f04977637fbde3bd8b61522690eae6d699d5f47821c68b4d4fc0df6b963d2499
ebola-d3a2db51bc7b771d47628de8410d73a9615a124bbeea570fb0276b580c97b60f
ebola-d76e9345b1f3eeac5b89b9b4ee8283a1fbe1d0c2ab360747e8a499764f208973
ebola-23d6540f667f383fcf31ff8a2fd83d1b935695fa7b93e5fda1167f9c6a58768f
ebola-14906819191ef726c3cbaa93616c4e9d119c9465d7bf0fc3d379c176cf179074
ebola-b6b6a0dc9639116dee601e3ae1ad5182e3aa90d6c7ae195c328fd36c5b0cfa7b
ebola-0ee90aff92210a7054afb572e6aefdda006b873390fdc0d9a6592969b5b0f987
ebola-f60655df66b73581b4d3a238c08bfcda4f968acbd5932afdc2944e42852b84fb
ebola-c69d0593e8e5f6e7db64fed89012b2834a27eee4e9d9dfa9bfe764fa55e10165
ebola-41b1340e24cb124815455bd730210244c95b191bc05fce32d23ee8f2dd5f24bf
ebola-e081d896fcc09ce725918344d740b72ec895de9170c4e3f2e2603d4e37069a89
ebola-a5059f3123bdd612c02bc50784e44929d49c9cbc8acba8e29bdba1f18eb83a1e
ebola-b4464e2ca5151918ad0074dab1d7339d098ff46f369291373e6764b354d10dac
ebola-f4adfd42d3ece0e468bf30639f102685c48168062d795371b3032521a2ef9ad2
ebola-8b91fc6eae92bd4a2ff261ae1e6981e071d86effd890b3c54cdec33fa225e1c0
ebola-40e9e45e1584ca132636d1dae6cbea1d6196c5ce7d79b83467deb81822abf575
ebola-3cd32d4c9fef170b6e8f497eafe29b0633231af7102f844158698ecb5ea0c05d
ebola-5916a1a39dd7d7191b86c0aba07327eaf67f4e3a4d13cbc088bab07cbf6f9565
ebola-3f3b8716fb8ae14a9718ec3c9c3c2c67fe53ecd3fd2cacd4f4a5db9f7e3798b3
ebola-44d461af29deb9e6f2cf000cca1bea87d0d5c926033898432b82ab985e6017f0
ebola-9a2c02c05d642654795a0870a75e3777be0d98baeeda0d2088ca42d5ae0a5a46
ebola-ea1d73e77cd60702ac6768794563bb6df3edefa448e0bc3aa0d9b1d20f066f6c
ebola-3112b173612edb3c1d5c3f7f505908b4cc5af0e72f9a1abfa2dc6beae8835c32
ebola-e14c98d536384d3bb4bab5d37bbbd86893490162f2071eb1016d1e69c08268b6
ebola-23a3de3618601ce7525cd13ff7463bbf2dcfd3399dc5375786eae78558fd5f94
ebola-8e2d5b3dfb4e745dab8cb414d001115e7e8bbca0bcf93efd5776d73789ef27e3
ebola-a3a8d4885f27ddb5d1fca732a9a0c7c0285d1c2f43b26f5b5fd8ca22f4cc156b
ebola-2c51e9754fddac864e4164b71ffb37ffe8fb8cec3894e755a897215f0065053d
ebola-ff0ca5828f65f33b13e1d8ffbf810a9ee4f283da96c2f2684f5dec873123fafe
ebola-173c7b7c99f6914e03965485ba69d7c7e599cf3c7d997adaccc901d4f69bb153
ebola-2ef85bc55872f57d6a5b1548d53c0e3d45e7fb4fe1cd45ca4e27b1ad2e95ede8
ebola-3dd8d11382e8feac9d9a9e381df84768e5e5a3290a330bc21418c4638a9b3efd
ebola-32f8dca8ef2c71cb12045b3b08df1a0e5ec2fe42def8ec7a9c8b132cf6b14b79
ebola-96393327b30443c960ef4fcf3621e26abee314016151094a35ced92b48ab5790
ebola-db5744d557b07260a7ab0334325e7f90672a610ff4a3adbd8f45fb45a10e8967
ebola-444f8293f38810f832ea3a5f9cdd08c98f9a4b8e1be0f7b7f16848b65271934b
ebola-37de84fcc08540159390e6223918b3fe871e87ba0a93d2d43d589067889c6693
ebola-87999a571af96d506060f9dfe1e2fe9cad76b6cccaa59ac2739431ddeeab647a
ebola-1090d2f14cfe24a31831159cc8a005f0f0afee99c7c19d0fcce425b0c2e5d3c2
ebola-56c8d4e92132ad152e0446ccd8c557b5c54ab617999498f62978d66b10767f48
ebola-8aae33aa4f71bbbc6b6faec05f8428b3cc40cbdd01bb8a5ae2267f33f3926d67
ebola-1ab5c1d5a43245b64cab00b82788f9609aed2b03d012e754e18c4cb1dc998c7b
ebola-42546240fbe6810778237986bb453563407bca0d5c66ed922c354af838dd4b13
ebola-a9bc8f91a7cbad1e142cafca25d964d90959f975dd43cf7e298ca27cee834ec1
ebola-ba5a9fcdf4cec5c4be034f441edd3cd3fb601ab21d61f7c0b228e24942faaf11
ebola-b304321c56bd8a55b8563b89c0b3fbc180312e605afcd31ed1a0d37a63dfa049
ebola-c3351dc03c2bbc2b38075aae66ff996f10be06f51340702e7c1cd664a9a3cc1f
ebola-fbb0b1e5772f1db9be3ad325f2a47095b1aab507ecb9f409df25e98256808657
ebola-97ed0cda49464e4ccac1fdbfb97a37c8c1bbfe9b513258990b8346b36a650e79
ebola-d24409ef0eda80127710451fb77f712fd8428107fd3141d3edd40f4106ff8cd4
ebola-0c9e5896920cd6f221c6599f347cf9a18c6b05a604ae5bc4dd2d6f10879f4259
ebola-890528fa5af4b54f18c01394493f18417f379e7f2d102c17572bffba0d8c6d25
ebola-926440e7c1b8b4b65168cd9950cfeba1aa0567cb3ab755071b26e810638031ab
ebola-aa22d1478854116e876c676c1ea9d49e41997e982f1fdfe12b038c6a269dc031
ebola-c6892f7a74cebe5da71819cd36bc24e551b2a9557aed08e36db93539f1102fcd
ebola-c58796e3e39bffaa4286294b7bad249a081449756ff03a38341dd25b6238f13d
ebola-5270d77c1182b2b180173f790911e3c880a13ad50808e012c83ea1716c78fece
ebola-e7aea067dd0ea446ed8367fe415511cbac10c341e31ae51db1fb9c23a68252c7
ebola-7c1b5466689500d9d3787e31987ae71181bde61f9bd89d9467b8b51925348c5e
ebola-5567c5d3eb4fc9eb2097c2cfc2d5ae4e01a91a26de97f5871d597579ba446b4b
ebola-66f695e4ae3e17aea5a2b1a711a9977c898b33bf55111390f90361425a568f06
ebola-ce031dce913f3a4d236e767ffad79179e246bb8cfaaa0a26324b7b65adb88fe3
ebola-a0ee3346ec656777bf93e77acf4e70ef0ab976f265bf989dff72bff6e69b35a0
ebola-daf7795dc680cfda505fd2fb9b7236a5f39c5d20ff8e2b1fdcae1c72ffffbfaa
ebola-57d10134cbe5cb12fde24f26a8a949e387a11a35d17dfe5777bf03b578cb1ef4
ebola-24cf65d38d3ecdabfa99d80fa0a00d7914527c53ff43ebc27a1a089794becf81
ebola-1971574c74c393856ea0c525dd3b7ba78755de8154c32f83d7ee466901bf9640
ebola-78ecb66e1511cd68e28b02d7f8be8f897da28fccd849dab082c6dc003869a138
ebola-66df7d5e40a837d25104be675fe47ee381057c84e659dc9cd89e59555de0fc23
ebola-4430c1d444c8660b8f6dddb801ee792aeda845ea778eb0db1dd14e5c41e00b87
ebola-ce664995de353f3dbf6c932180dc765f97a959abea647c6c532b2270e2116eb2
ebola-c3a1c80c50457e6e0dd1c1491fbebcb1d8a208abb0582f7c2f0add239f28c2ff
ebola-7223958661cdc13470cd5c2fc60089c6b1f9cad321c96d20160c124062c243da
ebola-11a00684c403ceb6d8b8b42b44cb8d4f150bcc3d1abd1f23485990c4e0a03e29
ebola-5f980ebc7058ec709cdc415d95d47739b5f0670ff6ef543990d5519c0aa1669c
ebola-1a71d9fe8ce49b3343c2838c23fc0e50a5bddec71c4720753583e7a52bc0e4e9
ebola-1144aa3360093c05fb8f6c54dd7fbaf564c27bd2836b2b176ab8e94478f77882
ebola-ca4831e4385abc9facdbbc25af4e2e502dbf0d6c593d3f9daf8631cde26c5520
ebola-662c565505a4b33d6a93387198a55038706626fd79e0de88138abdaf01ea3407
ebola-88f356a2d909eb6dac2f5425a04861d7cb515d423d7c84c038b0bda0f4e00ccb
ebola-7067ddafca278685f54458947e041dfcac29745ab327b978ff92b3db66ceb1c3
ebola-f92ce047d21c9755d58969d2f5e0ceabfe3b331fb2382619c6e934d50dabb95f
ebola-000f0b559e4eb98f0c485de23adf96603a9428662bf724726405903365083580
ebola-64aec65a1d13dd1583a626096511f5c3126658faeffebfe638345bdab3dd3849
ebola-ff4fc6daff8429a596c3e4acdfd2208aa1cae0fe863673108472e5882f05b96b
ebola-0a7a6a4c04bc4c115b5be0fbcd2c63df6f14fe6457d155b1fc0fb921f4b465c8
ebola-308205d8d92621d78d19153225fafc3b0b2af57aadd7ee826c89f21e9529f40e
ebola-3cd9ffec4d63b5770aff54ea89623308ee0076cf4e36ff04042ce698786b44bb
ebola-1bbeeb19386c25d249ba04a946b4a9ef92c14c265d1d562fea828233941c3b79
ebola-037af0677c50a9026774ba44e675a334075d65bdf62267f6f4b9a0a513479579
ebola-605e2966434072cd21f9d2f3530ceb53381db94708caea6f9ce93924375e266a
ebola-d7fad7d113495b36ad23321ef6d860348ca624c8100c2b8218b6dc58675373c3
ebola-7f9a422434a04ac9110d4f651e7e669062cd83f7538478557ea1c5bd15d52808
ebola-bfe838ea80b9671002db08bc778f093de19252114e480c3edac4f66ccb01562e
ebola-6e06d3d692e5e1f6805c72354979e4f6ed7d7b659d3589e5adb5977667f11f2b
ebola-3d049a8c9946f9da11f8e001a2df1baaad4ef6e9ce355898461a6ac54ecf44d7
ebola-8502c59c4fa20ae2941100d421735aa6beb1522466f3d4664e34aa5493cc9e88
ebola-76c852c52591056a12e40b6a08a5ba5296b45170af2b94b7912c56b7b29e4f5d
ebola-48844d0bc173344df14670703892b8fe0baa82a2f85d8e0c23bcf0a05ea4dd71
ebola-45415c13e093f4dba103f79354b1793bc0ea5e903b745cf488bb1a43cbe42c51
ebola-3b4178477116416e04e75ddfc46ab21a8ed8dda4f1d320f0a389ac50f91d8789
ebola-e7bd3a3b90618e4956d8a1555abc0b4401125837d13e10a578de1ac59422a231
ebola-f0c878c5af10d854f7b2744af73c936dff57510419a9aad7eb928291e76450ab
ebola-604da2a58f0ac442dc2c177a414a489cdca8db0769fc63d270642ed3f51bb7ee
ebola-9857935a4fe8f6560e1d75cdcb9bf9ba0f530f505bbeeb1f2dc26d6faedd4d04
ebola-0ba374ed4fca1cd76b0f9407b8898e987bb9217edae278aa0d1cbbf9b593258b
ebola-cc02196f3d14c4f0ea20d7a5c4329740d99beae4cee07b108d1e7e7014c0b027
ebola-431d7b44d9ed7038e56bb462d7241df172f91586fc3656c2a861a86ce4899bba
ebola-c964ccd73144babdf8b227cd42e7db3062422a1c16bd2012a51117e597c4b31f
ebola-e05892a51f9bc3415c4c03d5dfec55aa4256b19764f8f14fa491d96fd9e41c93
ebola-4c5087c384240e3fda68701438841a1087da0a3787921ab54bf29bc74c82c51b
ebola-47657a28b34a933ab92a240270dca53a63021f43d34d1628da4bbebeb1c4fe9a
ebola-cca153776388d04f34055020a0edb6ce65e9893e93fe2335748f9eaa48c170fc
ebola-d96275e1df01b0fafca840a1260bf25f5056dbb876d7ef66e1142264ad536ad2
ebola-087f104215b80621a22d893d397373e5b16bcdab1e00df515e2920d5f77f486d
ebola-b9ffcf1369b435160f70124b7b59e5ac5f253855418a24fa1d0d722ef0fdb8dc
ebola-52835d8edde3b7e757114f403077f88d2372296b6c916e7ede1b223004edcc93
ebola-f09bcf82f1879408a3f0e8951f45fa673ec9ddcbc02fc7d14e113d7d8508ef46
ebola-01584c473b22a39a628999ef1e91309816bfee79056646dbd2c6e03e6a7c27d5
ebola-20624b4cbc9a448c05e3dc1a7c6dc49c107f63fca986fadd9b35e1c46e06d39c
ebola-4d07d82d7613d44de87b22077781572873fdf9daf1cd82af6fec82ddda881813
ebola-67753d705828e5128b3254977ebcd0ae1a32db5a6bc7008b16e56389464565a4
ebola-7acff7409238ed913e9142159cfa0fc8009ac0cf0142b334b1f4840269d9b30a
ebola-f5af9737336f4d6067d463608df1878578eb11e27e178506d1d26120f81ded03
ebola-15a406c91da93bc944de929c37e7d10f09f5db438f447e24f107e6e13aace9b4
ebola-b14ebbe7b8aed81e0cf6f50c942d94b12c48703d842fe94ead2730847639950b
ebola-4fde3bfa7421453bb3ed125fa362965c993f02d3c0db82ead184116a3ce2fe2d
ebola-94715d479dff4d6addc9ad533344bc20377fc413919116fa72f650e85cc822c7
ebola-4e183b1c0e5c5abce9c7e9cbaf5682d8b30841de8c347eb83e2feb566dd4a161
ebola-9df2b1caa462d0e70b4b43842cffe235571c7d821c0ab72f1d0dc3d2b21b0c4e
ebola-fc75bac53586819c737d45f9d2bfb417736ddf53b799b9bbd76b586b17d0a56e
ebola-04a156ad3b88a2ace558631c0772ef14ee31dc86432ae14204225440bba02d58
ebola-54d774c8efa77d5fc3ff2c469d69180d5f7a4b9dc9a5507d73b79d4ddb4cc03d
ebola-9d8d247edc631141b2490ace4e126b1ed5dc35520980ff7ac2ec1036644190fc
ebola-ee6e8544f2f4539e639528838f0dbf37c265359e085ae76c41510c295d8d68ac
ebola-ead5d86af3250ed0cf493d468985f088d0d3c0e57dd2201053ce0dc65076ce49
ebola-4a8cf523530d71e52ac9000eef3c950db919a45670bf09900144b85b8cfbb7f5
ebola-9c4d26c4414cdc598990cecc77e16e2ffa82d2de25d91366f8ebc710bf0716db
ebola-b128bc3aca57c7b3c927668aa108fe6e0cb0840eca4e486de8f766f70af91991
ebola-07408104a26be232cec5eb56795ac9d591091168fab2154c643c83a17bd2bc20
ebola-00dd813dbb8668e4165cdac03ab99abcce380c5f0c257b89e568fac31fc61e77
ebola-696c85c814b173a7827213d1ddf3222e265bc2e420e462185493a9ff03e9873e
ebola-4671b17a856d00ea2030dd4c834bc9a9f97fc2daadf4bff8429c0ecd0478160e
ebola-a3cb6beb621dd636986e05e08c0bdae222a039e82a148d5bb030d113dd0ecfdf
ebola-60b71fa9f46a03654632c97f63257530c4a82baeebf4c07841eba055a7d13031
ebola-d628b92fbf70b9f22c90aad1f6a9c242219fb47ec984aff79b1cc542eeef9175
ebola-0a11f4feaeb05e9e47954d8f356bbe91e06dca477abaa42ac309c95bf085c5b7
ebola-dfeb4f515ce2861fd2c3c1e7b4d4f24657b96e5d913807a1c7e140a39f656b6e
ebola-471b79021f564106e9013ea07bb7f65da4538edfda0d9cbe1a208008a7ddc886
ebola-30a74ef43a7ea0ef6a31d86486799d4064af6669c436b0529981fb9218db7b0d
ebola-d7ae1a872f56c798496338f1302865ff09ad3a74666d5d3acb7a4c98519c32d7
ebola-79b7f4d43bee6e745ca6245e2d1f0c2ce0629022514d181808c9066c0d1efb4d
ebola-3c266728e933b4a3a7d971a862490b5dbac9af4ea77c808768f0b236a25e562c
ebola-51196a0085283e2df2ba5ebf75f8c2d6c8d95246caa8d0fef6f83975943be253
ebola-ecd3c3a0afe970aeec1f18da13cfe5975285a3761b634a8b7e8ff2b474c67e0d
ebola-b3f125bd545e9b01e5fb00d2cc91a1ce1ec100c3eb4570ca0f728583041e41b1
ebola-3241907642ac48df1db727917f49c1254bf3194eb701dfe493f0553e29567f61
ebola-0c56eed4287155fa8b88611cd708c16a0f3e2f4c2378b92992059762a2250088
ebola-e1352ee2b7d54d68838bb18691755b910e416fb41053f82c59cdb699c4d37cff
ebola-6bcc8ed4db362e187bd6b16ea40e91533b4d7f774d965ff5d3bb3313e8ebe90c
ebola-4bffa5ada497a66ae99764e2426e87e1358b8a5f6a6919b4c477b88f3b33179c
ebola-7fa928577041eefac7cec9dd74dcf76801912b152ffae94503db921c880e21b3
ebola-f4e60762f9a009d5760d8be45fe890db55415699cfa375334f91b132f5b406dc
ebola-0b3c51d90674388f5d65bdcb8cd03d2c19d3b215bd3f5612eae1cc9b7d9d34ab
ebola-800a6f0a545e51a9687078d0642b1dd6012cbca991329099f6545acb27d48ed8
ebola-72530e35f991863f1ced24d933f1e933a366c2950195bdf416d858867b1c2b5c
ebola-d4936b4b01da6ecd495b212595a89d9884b31d5e1e83be6179f8227a5fefa82c
ebola-d0a7d6aae7b7f83de9660861776dc2e0a35e1f21b13e298daff9abed78c8891b
ebola-4ab8652922ebc9ac4486bd36934f2c266b3601911be7c75647689cee56dd2cbc
ebola-f1ef38639a018771fab9f96803f144dabfaf29de1812b708c3fd74088095d8e2
ebola-59b31f001e2e69c9fd183cca18abcf07d2233bf8153a2236b9733de4982ff968
ebola-06307f7e042b3ee23bd89f8b4bcb045f23f63840f0ab7b22778396b60e543dd7
ebola-5d824b80ba2ddfc1c0f191a67abde14888dfd5b559db129ce3b10c18d44498ce
ebola-3ed11b625252b728bb0bb010b56ad64187fa84e68d1ed9f17cf2b9715f336057
ebola-30b9f9962c6433277f4a5380fc7b451a3f3ddd0d5fd14b8e3a4179db3a967e30
ebola-7f58d12e11253063eed39403cebbdd343afb5ee7449efd31ebdc71e2ba387d82

list/click  |  time: 2016-04-29 16:44:21 362257  |  # of fields: 4  |  topic_id: 351  |  docno: ebola-a18de29b69737494a6c9c47cc015dac8314452b86e50dac2e2f47c4ae9c58758  |  listsource: pink_findmore

highlight  |  time: 2016-04-29 16:44  |  # of fields: 3  |  topic_id: 351  |  docno: ebola-a18de29b69737494a6c9c47cc015dac8314452b86e50dac2e2f47c4ae9c58758  |  highlight_string: ebola, natural immunity 

